data_2jmm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jmm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.49 ' H ' ' HA ' ' A' ' 34' ' ' VAL . 33.7 m-80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 122.696 1.236 . . . . 15.0 111.614 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.9 p -116.31 158.79 22.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.584 -1.644 . . . . 15.0 111.801 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.5 ' HB3' ' CA ' ' A' ' 150' ' ' PHE . 1.8 t90 -94.23 140.45 29.76 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.287 1.041 . . . . 15.0 111.76 -172.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -115.28 105.86 13.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.068 1.747 . . . . 15.0 109.234 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 m -124.33 118.2 26.21 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.6 161.81 28.58 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 115.151 0.82 . . . . 15.0 115.151 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.71 50.88 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.39 -0.905 . . . . 15.0 110.516 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -151.66 150.77 30.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.177 1.177 . . . . 15.0 114.177 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.69 133.46 55.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.287 -1.324 . . . . 15.0 112.66 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -124.6 151.09 17.2 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.307 -1.769 . . . . 15.0 114.984 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -126.06 140.76 52.33 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.515 -1.342 . . . . 15.0 111.557 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.7 p -113.2 144.33 42.86 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.18 1.467 . . . . 15.0 114.51 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -54.54 120.51 6.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.782 -2.008 . . . . 15.0 111.025 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.6 t80 58.86 41.63 21.07 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.228 -1.351 . . . . 15.0 113.727 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -67.18 80.56 0.13 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.34 1.067 . . . . 15.0 113.69 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -61.69 -37.29 83.57 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.194 -1.367 . . . . 15.0 114.112 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -82.72 141.96 32.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.133 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -70.28 87.09 0.6 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.303 1.002 . . . . 15.0 110.573 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -143.15 129.49 19.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.984 -1.916 . . . . 15.0 108.991 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.13 132.59 56.0 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.054 -1.43 . . . . 15.0 108.125 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.65 46.47 1.11 Allowed Glycine 0 N--CA 1.48 1.584 0 C-N-CA 125.099 1.333 . . . . 15.0 115.095 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.71 92.99 1.6 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.734 1.214 . . . . 15.0 109.192 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.33 139.57 14.29 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.189 -1.823 . . . . 15.0 112.903 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 121.2 41.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.725 -1.737 . . . . 15.0 106.928 171.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 42' ' ' MET . 21.4 m-85 -111.86 113.42 25.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.916 -1.493 . . . . 15.0 110.734 -173.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.99 146.51 16.15 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 112.453 -2.158 . . . . 15.0 110.243 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.27 -154.5 20.51 Favored Glycine 0 N--CA 1.473 1.165 0 CA-C-N 114.546 -0.827 . . . . 15.0 112.837 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 141.83 34.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 113.257 -1.471 . . . . 15.0 112.807 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -117.0 98.14 6.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.654 1.216 . . . . 15.0 110.772 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.49 ' HA ' ' H ' ' A' ' 5' ' ' ASN . 14.6 m -79.74 -38.68 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 112.934 -1.939 . . . . 15.0 115.636 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -139.96 154.22 70.31 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 118.696 -0.669 . . . . 15.0 112.745 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.44 66.64 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 15.0 110.485 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.43 -79.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.792 2.037 . . . . 15.0 108.488 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.58 145.22 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.145 1.165 . . . . 15.0 114.145 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.36 -179.98 25.67 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 112.61 -2.086 . . . . 15.0 110.721 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.82 133.64 55.31 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.142 -0.529 . . . . 15.0 112.414 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 26.7 tt0 -129.49 128.83 43.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.339 -1.301 . . . . 15.0 110.673 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 67.1 mtm -123.21 139.33 54.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.381 -0.827 . . . . 15.0 110.586 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.04 114.17 2.44 Favored Glycine 0 N--CA 1.476 1.322 0 O-C-N 124.61 1.194 . . . . 15.0 111.778 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 46' ' ' TRP . 72.5 t80 -107.02 109.52 21.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.465 1.106 . . . . 15.0 111.235 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -113.7 118.45 34.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.49 -1.232 . . . . 15.0 108.768 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.484 ' HB2' ' CE2' ' A' ' 44' ' ' TYR . 24.0 t90 -114.84 119.16 35.65 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.984 -1.007 . . . . 15.0 110.84 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.664 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 18.7 tp . . . . . 0 N--CA 1.474 0.774 0 CA-C-N 114.556 -1.202 . . . . 15.0 110.983 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 122.486 1.136 . . . . 15.0 110.744 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -93.95 103.14 15.24 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.389 -2.187 . . . . 15.0 110.292 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.03 2.34 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 108.892 -1.683 . . . . 15.0 108.892 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 t -117.83 133.15 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 114.467 -0.867 . . . . 15.0 109.735 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.751 HE22 ' NH1' ' A' ' 78' ' ' ARG . 13.7 pt20 -109.7 139.52 44.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.486 -1.234 . . . . 15.0 111.487 170.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.32 111.05 17.28 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.489 -1.687 . . . . 15.0 108.893 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.426 HG21 ' CZ ' ' A' ' 78' ' ' ARG . 39.9 p -131.29 146.74 52.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.003 -1.453 . . . . 15.0 113.301 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -100.37 128.37 46.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.018 -1.446 . . . . 15.0 108.146 172.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.45 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.1 pttm -113.5 136.53 52.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.62 -1.173 . . . . 15.0 112.857 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 3.2 tt -105.98 108.41 19.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.532 -1.667 . . . . 15.0 108.226 172.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.88 98.12 2.11 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.011 -1.904 . . . . 15.0 109.363 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -117.21 138.22 24.7 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.975 -1.112 . . . . 15.0 111.761 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HA ' ' OD2' ' A' ' 74' ' ' ASP . 58.4 Cg_endo -64.22 -37.7 39.67 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.252 2.635 . . . . 15.0 115.814 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 tptt 49.92 32.06 5.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.838 1.655 . . . . 15.0 114.762 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.45 47.87 23.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.978 1.311 . . . . 15.0 114.138 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 73' ' ' LEU . . . -63.46 84.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.651 0 C-N-CA 124.257 0.932 . . . . 15.0 112.26 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -67.88 28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.938 2.94 . . . . 15.0 118.938 -165.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -169.82 -68.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.881 2.072 . . . . 15.0 107.775 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -170.05 87.48 0.14 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.009 1.324 . . . . 15.0 108.47 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.417 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 19.6 tp -159.35 141.09 13.27 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.334 171.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.519 ' OD2' ' HA ' ' A' ' 66' ' ' PRO . 10.7 m-20 -138.1 150.45 46.88 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.277 -1.328 . . . . 15.0 110.923 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 tt -108.68 140.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.394 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 51.5 p90 -125.71 128.73 48.24 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.548 -1.205 . . . . 15.0 109.33 169.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.4 m -113.66 122.54 47.47 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.46 -1.311 . . . . 15.0 107.46 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.751 ' NH1' HE22 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -120.67 123.29 42.39 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.057 -1.429 . . . . 15.0 113.108 -175.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 136.78 54.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.995 -1.457 . . . . 15.0 110.941 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.39 -143.21 7.47 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.448 1.092 . . . . 15.0 113.272 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 105' ' ' SER . . . -130.25 143.9 15.18 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 114.047 -1.077 . . . . 15.0 114.066 -174.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.484 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 25.5 ptt? -116.11 120.15 38.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.165 0.983 . . . . 15.0 112.93 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.67 140.82 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 113.359 -1.746 . . . . 15.0 108.493 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 18.7 p90 . . . . . 0 N--CA 1.474 0.762 0 CA-C-N 114.83 -1.077 . . . . 15.0 108.614 177.298 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.9 p . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 114.973 1.471 . . . . 15.0 114.973 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -71.46 137.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 113.398 -1.728 . . . . 15.0 111.461 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.631 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 78.8 p -120.09 117.94 31.79 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.372 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.6 101.78 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.096 2.531 . . . . 15.0 112.278 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 131' ' ' GLN . 16.4 m -125.02 130.87 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.19 -1.823 . . . . 15.0 113.112 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -127.96 131.36 49.29 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 113.749 -1.569 . . . . 15.0 111.114 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 131' ' ' GLN . . . -128.77 143.73 50.99 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.722 1.008 . . . . 15.0 113.722 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.56 108.63 2.12 Favored Glycine 0 N--CA 1.474 1.217 0 CA-C-N 112.932 -1.94 . . . . 15.0 108.732 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -119.5 144.11 17.42 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.723 -0.739 . . . . 15.0 112.955 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.49 137.17 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 114.539 -0.831 . . . . 15.0 111.633 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -125.4 139.33 53.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.241 -1.799 . . . . 15.0 113.757 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -117.87 141.81 48.02 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 112.694 -2.048 . . . . 15.0 109.255 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.7 m -105.69 132.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.158 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 pt -62.2 95.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.104 1.89 . . . . 15.0 116.104 -171.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -78.6 82.9 4.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.503 1.144 . . . . 15.0 109.58 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.3 ttt-85 -175.38 -143.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.393 2.277 . . . . 15.0 107.366 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.34 99.85 0.15 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.829 1.252 . . . . 15.0 112.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.6 mt 64.63 85.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.715 2.006 . . . . 15.0 111.401 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 m -59.86 -45.78 98.28 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 117.188 -1.386 . . . . 15.0 114.076 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.89 70.75 6.89 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.938 1.759 . . . . 15.0 111.531 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 36.1 tt0 -138.74 -83.84 0.28 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.188 -1.823 . . . . 15.0 108.834 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.74 143.51 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.663 0.986 . . . . 15.0 113.663 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.42 123.53 48.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.611 -2.086 . . . . 15.0 109.406 172.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.469 ' HA ' HG12 ' A' ' 146' ' ' VAL . 11.9 m -80.83 116.87 21.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.423 -1.695 . . . . 15.0 106.423 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.47 ' HB2' ' HH ' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -125.49 135.44 52.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.104 -1.407 . . . . 15.0 113.749 -172.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.98 111.07 13.14 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.648 -2.069 . . . . 15.0 110.327 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.532 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 21.9 tt0 -114.67 135.24 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.984 -1.916 . . . . 15.0 110.156 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -115.31 107.17 14.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.713 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 0.0 OUTLIER -96.62 114.76 26.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 112.581 -2.099 . . . . 15.0 109.73 -170.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -118.77 146.57 44.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.326 1.232 . . . . 15.0 114.326 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.478 0.96 0 CA-C-N 113.268 -1.787 . . . . 15.0 112.363 172.152 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.212 0 CA-C-O 122.423 1.013 . . . . 15.0 114.639 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.713 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 56.9 ttm -117.79 137.14 52.94 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.287 -1.456 . . . . 15.0 109.141 170.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.93 101.94 11.17 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.165 -1.38 . . . . 15.0 109.98 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 57.0 m -109.98 125.14 52.56 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.892 -1.504 . . . . 15.0 110.616 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.85 140.89 44.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.441 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.04 -162.57 29.59 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 114.801 -1.091 . . . . 15.0 113.585 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 126' ' ' THR . 15.1 m -128.4 139.72 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 113.846 -1.177 . . . . 15.0 112.547 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 p -115.16 134.25 55.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.527 -1.215 . . . . 15.0 112.217 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 41.9 t80 -103.53 135.09 45.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.331 -1.304 . . . . 15.0 109.195 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -73.69 124.97 27.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.178 -1.828 . . . . 15.0 112.033 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.5 ' CA ' ' HB3' ' A' ' 7' ' ' TRP . 55.1 m-85 . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 126.504 1.922 . . . . 15.0 111.806 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 121.025 0.44 . . . . 15.0 111.308 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 150' ' ' PHE . 4.7 p -148.39 139.38 23.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.579 -1.191 . . . . 15.0 111.195 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -127.86 136.21 51.1 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.91 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -125.72 127.57 46.41 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.131 -1.395 . . . . 15.0 110.728 168.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -126.6 137.93 53.38 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.524 -1.217 . . . . 15.0 111.19 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.51 -149.93 9.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 124.275 0.984 . . . . 15.0 113.847 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -160.77 139.25 9.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.906 1.282 . . . . 15.0 111.185 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.655 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.342 18.2 tptt -171.91 169.59 5.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.518 1.527 . . . . 15.0 113.205 166.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' A' ' 12' ' ' LYS . 1.5 pt? -114.73 161.73 17.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.178 0.991 . . . . 15.0 113.199 -164.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.664 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -122.8 140.73 13.43 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.484 -1.234 . . . . 15.0 111.719 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -118.41 145.39 45.23 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.582 0.813 . . . . 15.0 110.858 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 p -93.85 126.13 38.86 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -49.8 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.646 1.978 . . . . 15.0 114.703 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 49.58 25.91 1.58 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 116.273 1.953 . . . . 15.0 116.273 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 t -110.03 -39.41 5.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.294 -1.321 . . . . 15.0 113.003 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 72.36 -30.98 0.22 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.958 1.703 . . . . 15.0 113.165 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -59.54 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.08 1.352 . . . . 15.0 113.238 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -168.12 129.4 1.39 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.892 -1.958 . . . . 15.0 110.127 164.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.0 31.94 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.64 -1.618 . . . . 15.0 113.056 167.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -165.51 142.29 5.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.787 1.403 . . . . 15.0 114.787 -170.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.16 -92.38 0.6 Allowed Glycine 0 N--CA 1.475 1.289 0 CA-C-N 113.777 -1.556 . . . . 15.0 112.782 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 158.14 6.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.762 1.225 . . . . 15.0 113.745 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 -124.79 1.52 Allowed Glycine 0 N--CA 1.477 1.399 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.882 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.47 121.61 42.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.61 -0.795 . . . . 15.0 110.698 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 147' ' ' SER . 35.6 p90 -125.23 146.49 49.5 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.921 1.822 . . . . 15.0 115.921 -168.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.24 104.29 1.24 Allowed Glycine 0 CA--C 1.535 1.282 0 CA-C-N 111.769 -2.468 . . . . 15.0 108.527 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.53 100.77 1.09 Allowed Glycine 0 N--CA 1.476 1.332 0 N-CA-C 110.117 -1.193 . . . . 15.0 110.117 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -114.57 145.09 42.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.321 0.581 . . . . 15.0 110.807 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.628 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 5.3 tt0 -120.84 136.17 54.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.957 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -104.56 -34.55 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 113.607 -1.633 . . . . 15.0 113.755 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -121.0 134.77 24.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 106.574 -1.639 . . . . 15.0 106.574 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.63 84.09 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.137 2.558 . . . . 15.0 111.288 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 158.82 -41.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 128.182 2.593 . . . . 15.0 111.195 -165.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.83 138.83 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.811 1.411 . . . . 15.0 114.811 -171.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 33' ' ' GLN . . . -162.11 -154.6 7.6 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 112.412 -2.176 . . . . 15.0 110.824 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HE1' ' HB2' ' A' ' 59' ' ' LEU . 9.0 t80 -143.28 145.45 32.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.804 0.811 . . . . 15.0 111.862 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' OE1' ' HG2' ' A' ' 78' ' ' ARG . 9.9 pt-20 -128.23 129.78 46.94 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.353 -1.294 . . . . 15.0 113.053 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -120.61 114.35 21.59 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.983 -1.462 . . . . 15.0 110.655 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.65 114.06 3.97 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 124.607 1.192 . . . . 15.0 110.71 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -102.84 141.17 36.09 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.178 0.99 . . . . 15.0 111.278 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -137.22 130.25 30.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.872 -1.967 . . . . 15.0 112.367 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -122.63 137.2 54.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.202 -1.817 . . . . 15.0 108.512 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 122.697 1.237 . . . . 15.0 108.982 -173.055 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 84' ' ' TRP . . . . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 113.361 0.874 . . . . 15.0 113.361 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 49.96 42.64 24.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.922 1.689 . . . . 15.0 113.964 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.572 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -116.29 165.28 12.25 Favored Glycine 0 N--CA 1.474 1.193 0 CA-C-N 113.699 -1.592 . . . . 15.0 114.329 -161.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.26 144.39 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 113.485 -1.357 . . . . 15.0 111.749 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 8.4 pt20 -109.77 116.8 32.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.648 1.213 . . . . 15.0 109.421 162.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.401 ' HB2' ' HE1' ' A' ' 40' ' ' PHE . 1.9 pt? -121.47 120.3 34.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 113.074 -1.875 . . . . 15.0 111.383 -170.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.4 p -133.14 150.63 52.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.984 -1.462 . . . . 15.0 112.432 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -92.35 132.33 36.82 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.304 -1.316 . . . . 15.0 108.452 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.548 ' HE3' HE21 ' A' ' 33' ' ' GLN . 35.4 ttpt -110.06 104.26 13.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.613 -1.63 . . . . 15.0 110.404 -166.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.7 tt -120.7 134.43 55.28 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.125 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.57 -151.23 11.64 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 115.604 -0.725 . . . . 15.0 113.635 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' CE2' HD11 ' A' ' 75' ' ' ILE . 48.1 p90 -173.91 154.66 2.3 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.853 1.261 . . . . 15.0 113.044 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.6 Cg_endo -64.71 115.43 3.23 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.756 2.304 . . . . 15.0 110.989 169.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -66.2 127.54 32.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.818 -1.083 . . . . 15.0 109.584 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.3 tp 57.44 22.62 8.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.605 1.562 . . . . 15.0 113.397 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.69 20.19 61.46 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.039 1.304 . . . . 15.0 114.484 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -87.55 89.24 7.92 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.426 -1.324 . . . . 15.0 107.426 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.66 79.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 112.885 -1.962 . . . . 15.0 113.134 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -174.14 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 109.587 -3.46 . . . . 15.0 110.668 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.58 98.19 7.26 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.833 1.301 . . . . 15.0 111.711 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 22.6 p-10 -115.43 111.06 20.22 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.931 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.65 HG22 HG22 ' A' ' 112' ' ' VAL . 2.9 pp -79.05 148.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.896 -1.502 . . . . 15.0 110.925 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -146.36 143.23 28.95 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.783 1.302 . . . . 15.0 113.925 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -112.22 122.55 48.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.905 -1.952 . . . . 15.0 107.776 166.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 0.8 OUTLIER -115.05 123.23 48.49 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 112.923 -1.944 . . . . 15.0 109.62 -176.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.79 129.35 48.14 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.676 -1.602 . . . . 15.0 113.256 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.44 -103.98 0.2 Allowed Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.146 -1.182 . . . . 15.0 110.146 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.553 ' HA2' ' HB ' ' A' ' 107' ' ' VAL . . . 154.01 -152.15 23.78 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 124.641 0.848 . . . . 15.0 115.017 173.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 33.9 ttm -119.92 139.3 52.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.491 -0.854 . . . . 15.0 111.742 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 103' ' ' SER . 57.8 t -125.62 113.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 113.98 -1.463 . . . . 15.0 108.109 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.572 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 CA-C-N 114.419 -1.264 . . . . 15.0 110.766 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 28.5 t . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 120.85 0.357 . . . . 15.0 110.78 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 82' ' ' MET . 10.0 p -113.37 115.29 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 113.997 -1.456 . . . . 15.0 111.408 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.501 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 80.5 p -117.87 131.83 23.95 Favored Pre-proline 0 N--CA 1.479 1.001 0 CA-C-N 113.745 -1.571 . . . . 15.0 112.398 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 122.21 6.0 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.921 2.414 . . . . 15.0 111.397 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.553 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 53.1 t -131.11 140.03 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.597 -1.183 . . . . 15.0 109.69 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.47 123.29 48.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.16 -1.382 . . . . 15.0 109.844 171.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 129' ' ' GLU . . . -123.23 112.58 17.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.352 -1.295 . . . . 15.0 111.263 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.63 137.07 13.51 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.6 -0.727 . . . . 15.0 112.618 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 128' ' ' LEU . . . 176.99 -147.79 8.56 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 116.198 1.239 . . . . 15.0 116.198 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 75' ' ' ILE . 16.3 t -130.76 144.68 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 113.506 -1.347 . . . . 15.0 109.805 -170.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.502 ' HB2' ' HG3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -109.75 120.95 44.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.292 -1.373 . . . . 15.0 107.292 165.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -117.75 117.66 29.94 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.115 -1.402 . . . . 15.0 111.24 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 116' ' ' ILE . 13.2 p -129.65 143.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 113.279 -1.782 . . . . 15.0 110.163 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 115' ' ' VAL . 44.0 mt 62.95 144.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 125.877 1.671 . . . . 15.0 113.577 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 63.33 155.38 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.886 1.674 . . . . 15.0 111.746 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 69.33 -50.28 0.61 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.882 2.073 . . . . 15.0 113.925 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -66.57 126.63 29.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.152 1.381 . . . . 15.0 110.491 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.4 tt -45.1 -35.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 115.671 1.73 . . . . 15.0 115.671 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.2 m -129.12 97.61 25.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 108.398 -0.964 . . . . 15.0 108.398 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.47 66.06 2.89 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.706 2.937 . . . . 15.0 114.304 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.466 ' HG3' HG23 ' A' ' 124' ' ' ILE . 15.0 pt-20 -120.04 -17.75 8.31 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.798 -1.546 . . . . 15.0 114.958 178.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.466 HG23 ' HG3' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -119.57 152.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.708 0.766 . . . . 15.0 112.586 -173.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.47 34.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.516 -2.129 . . . . 15.0 109.03 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 37.1 m -93.25 116.76 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.182 -1.784 . . . . 15.0 106.182 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 34.4 ttp180 -115.6 108.07 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.101 -1.409 . . . . 15.0 107.925 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.475 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 5.3 tt -111.83 130.67 55.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.58 -1.646 . . . . 15.0 108.991 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 143' ' ' SER . 13.6 pt-20 -128.57 140.97 51.52 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.435 -2.166 . . . . 15.0 111.421 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 11.7 m-85 -97.25 114.56 26.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.516 -1.22 . . . . 15.0 109.061 164.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 14.7 mt-30 -96.57 108.77 21.42 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.95 -1.932 . . . . 15.0 108.309 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -131.49 146.4 52.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 111.918 -2.401 . . . . 15.0 111.755 -171.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.481 1.082 0 CA-C-N 112.56 -2.109 . . . . 15.0 115.524 177.444 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 N-CA-C 110.542 -1.023 . . . . 15.0 110.542 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.587 ' HB2' ' HB2' ' A' ' 131' ' ' GLN . 67.0 mtt -121.47 122.69 40.31 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.565 0.95 . . . . 15.0 113.565 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 142' ' ' LEU . 1.2 pt? -84.77 97.34 9.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.035 -1.439 . . . . 15.0 108.032 171.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.664 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 37.1 t -114.0 128.63 56.47 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.433 -1.712 . . . . 15.0 110.896 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 1.3 pt? -126.36 139.51 53.23 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.962 -1.017 . . . . 15.0 111.043 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.504 ' HA2' ' HB3' ' A' ' 12' ' ' LYS . . . -123.59 131.19 7.98 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 125.822 1.951 . . . . 15.0 111.128 173.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.49 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 34.8 m -112.58 127.42 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.801 0.8 . . . . 15.0 111.111 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . 63.5 p -131.68 153.49 49.94 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.845 -1.525 . . . . 15.0 114.605 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -108.02 143.64 36.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.052 -1.431 . . . . 15.0 109.468 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.769 ' HD3' ' H ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -70.29 115.88 9.98 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.941 -1.027 . . . . 15.0 112.896 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 81.0 m-85 . . . . . 0 N--CA 1.48 1.061 0 CA-C-N 112.751 -2.022 . . . . 15.0 114.288 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.674 ' HA ' HG22 ' A' ' 34' ' ' VAL . 24.6 t-20 . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 122.591 1.186 . . . . 15.0 111.064 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 p -126.92 152.6 46.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.062 -1.426 . . . . 15.0 110.554 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -118.66 138.57 52.52 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.032 1.123 . . . . 15.0 114.032 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -120.26 136.35 54.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.869 -1.514 . . . . 15.0 110.818 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -163.6 133.35 4.16 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.807 -1.088 . . . . 15.0 111.691 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -177.73 -167.76 36.33 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 115.163 -0.926 . . . . 15.0 112.711 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.54 134.82 47.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.802 -0.699 . . . . 15.0 112.107 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.452 ' HD3' ' HD3' ' A' ' 127' ' ' ARG . 45.1 mtmt -134.16 144.74 48.7 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.898 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.5 pp -114.17 145.29 41.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.886 -1.052 . . . . 15.0 111.092 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.29 110.35 2.48 Favored Glycine 0 N--CA 1.477 1.414 0 O-C-N 125.003 1.439 . . . . 15.0 111.483 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.741 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 49.4 t90 -118.72 140.46 49.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.859 1.059 . . . . 15.0 113.859 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.9 p -92.85 98.16 11.21 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.336 1.236 . . . . 15.0 114.336 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -14.76 -76.91 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.207 2.603 . . . . 15.0 117.871 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -131.45 77.03 1.75 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.9 t -165.04 140.69 5.43 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 112.987 -1.915 . . . . 15.0 110.544 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -90.15 76.7 6.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.147 -1.388 . . . . 15.0 107.352 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -142.74 -70.86 0.33 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.448 -1.705 . . . . 15.0 114.071 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.741 ' ND2' ' HA ' ' A' ' 15' ' ' TRP . 7.3 m120 62.45 -65.52 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.09 1.885 . . . . 15.0 116.09 -171.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 63.43 -62.81 0.14 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 127.055 2.142 . . . . 15.0 110.612 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.06 139.8 50.51 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.889 -1.05 . . . . 15.0 108.658 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.55 -98.24 2.23 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 108.898 -1.681 . . . . 15.0 108.898 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.87 131.15 57.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.521 -1.34 . . . . 15.0 110.041 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.58 141.8 13.88 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-N 113.541 -1.663 . . . . 15.0 110.89 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.4 121.19 41.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.965 -1.118 . . . . 15.0 108.061 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 42' ' ' MET . 94.0 m-85 -116.24 113.39 22.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.075 -1.42 . . . . 15.0 110.351 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.17 145.96 17.15 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.468 -1.696 . . . . 15.0 112.189 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 41' ' ' GLU . . . 172.32 -161.6 33.33 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 114.461 -0.869 . . . . 15.0 112.765 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -126.46 142.17 51.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.943 -1.128 . . . . 15.0 111.986 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.502 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 59.3 tt0 -111.54 82.3 1.59 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 124.092 1.901 . . . . 15.0 106.397 169.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 5' ' ' ASN . 29.4 t -140.75 72.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 111.842 -2.435 . . . . 15.0 105.941 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' A' ' 36' ' ' PRO . 50.0 t30 -175.89 144.88 0.74 Allowed Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 111.913 -2.403 . . . . 15.0 105.248 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.441 ' HD2' ' OD1' ' A' ' 35' ' ' ASN . 28.6 Cg_endo -50.33 104.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.57 2.847 . . . . 15.0 114.332 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 71.25 -24.47 0.17 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.477 2.311 . . . . 15.0 116.747 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.717 HG12 ' HG ' ' A' ' 63' ' ' LEU . 25.6 m -111.04 147.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.582 1.182 . . . . 15.0 113.5 -172.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -118.63 155.26 16.15 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.515 -2.13 . . . . 15.0 112.289 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -118.12 114.14 22.63 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.437 -0.882 . . . . 15.0 109.515 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.451 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -130.78 146.48 52.25 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.253 -1.794 . . . . 15.0 111.532 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 24.0 ptt? -112.59 145.0 41.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.412 -1.267 . . . . 15.0 111.268 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -106.03 127.62 9.02 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 113.22 -1.809 . . . . 15.0 109.726 172.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.82 104.57 11.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.578 -1.311 . . . . 15.0 111.191 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.6 121.59 43.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.098 -1.41 . . . . 15.0 110.127 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 t-105 -102.43 142.95 32.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.523 -1.671 . . . . 15.0 110.235 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 116.511 2.041 . . . . 15.0 116.511 -177.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 112.255 0.465 . . . . 15.0 112.255 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 28.3 pt20 34.13 86.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.603 1.961 . . . . 15.0 115.106 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.45 97.06 1.49 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.817 -1.992 . . . . 15.0 109.971 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 43' ' ' GLY . 11.8 p -109.88 118.53 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.956 1.033 . . . . 15.0 111.112 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.79 116.79 32.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.841 -1.527 . . . . 15.0 112.401 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.8 114.39 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.707 -1.588 . . . . 15.0 108.643 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.623 HG21 ' HD3' ' A' ' 78' ' ' ARG . 51.9 p -127.27 148.4 50.22 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.135 -1.848 . . . . 15.0 114.035 -170.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.53 128.52 54.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 113.136 -1.847 . . . . 15.0 107.823 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -119.75 138.35 53.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.119 -1.855 . . . . 15.0 111.83 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.717 ' HG ' HG12 ' A' ' 38' ' ' VAL . 5.2 mp -117.07 131.36 56.94 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.157 -1.838 . . . . 15.0 108.669 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.71 131.66 10.1 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 124.616 1.198 . . . . 15.0 111.006 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.584 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 72.3 m-85 -121.75 97.98 45.95 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 124.512 0.772 . . . . 15.0 112.313 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.35 84.9 0.72 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.984 2.456 . . . . 15.0 110.991 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -120.18 153.02 36.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.726 -2.034 . . . . 15.0 110.008 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.8 84.61 0.31 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.374 -0.83 . . . . 15.0 112.809 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.25 141.9 15.35 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 113.812 -1.54 . . . . 15.0 112.398 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.524 ' O ' HD13 ' A' ' 73' ' ' LEU . 3.2 m -49.36 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.76 2.824 . . . . 15.0 112.639 -171.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 52.65 71.09 0.5 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.722 -1.581 . . . . 15.0 112.919 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 115' ' ' VAL . 11.1 m-20 78.91 41.51 0.09 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.861 -1.518 . . . . 15.0 114.277 165.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 70' ' ' THR . 9.0 mp -105.32 115.37 30.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.168 -1.378 . . . . 15.0 111.157 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -105.26 135.97 45.65 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.231 -1.35 . . . . 15.0 108.255 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 65' ' ' TYR . 37.1 mm -83.34 137.42 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.252 -1.018 . . . . 15.0 108.252 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -133.18 135.47 45.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.528 1.307 . . . . 15.0 114.528 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 58.5 m -118.35 124.93 48.94 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 112.537 -2.119 . . . . 15.0 107.424 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.623 ' HD3' HG21 ' A' ' 60' ' ' THR . 1.2 tmm_? -124.64 135.73 53.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.611 0.765 . . . . 15.0 109.864 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 pp -150.76 139.55 20.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.371 -0.832 . . . . 15.0 113.225 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.49 -151.68 10.73 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.626 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.33 151.6 20.87 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 114.154 -1.023 . . . . 15.0 113.088 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.0 ptm -114.49 135.28 54.29 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.712 1.004 . . . . 15.0 113.712 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 104' ' ' VAL . 44.7 t -125.34 119.92 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 113.756 -1.566 . . . . 15.0 108.024 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.42 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 35.9 p90 . . . . . 0 N--CA 1.478 0.927 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.689 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.642 0.734 . . . . 15.0 111.643 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 83' ' ' VAL . 42.9 t -83.52 80.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.49 -1.232 . . . . 15.0 109.216 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.7 m -65.27 132.07 95.18 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 113.762 -1.563 . . . . 15.0 111.909 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.68 113.7 2.84 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.115 2.543 . . . . 15.0 110.555 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.8 t -116.9 120.27 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.298 -1.319 . . . . 15.0 109.023 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -118.37 144.72 45.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 113.288 -1.778 . . . . 15.0 109.66 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -141.5 131.11 23.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.7 -1.136 . . . . 15.0 110.788 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.99 130.47 7.83 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 129' ' ' GLU . . . -173.1 -160.42 21.61 Favored Glycine 0 N--CA 1.476 1.338 0 CA-C-O 122.199 0.888 . . . . 15.0 115.228 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.32 144.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 113.244 -1.478 . . . . 15.0 109.682 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -121.2 129.06 53.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.96 -1.473 . . . . 15.0 109.058 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.443 ' CZ ' ' HA ' ' A' ' 116' ' ' ILE . 19.9 t80 -100.21 130.82 46.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.316 1.046 . . . . 15.0 109.88 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 72' ' ' ASP . 15.6 m -98.4 113.07 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 113.336 -1.757 . . . . 15.0 110.597 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -54.44 100.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.089 -1.869 . . . . 15.0 113.32 -174.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -108.21 -32.56 7.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.405 -1.725 . . . . 15.0 112.976 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -54.54 -20.54 8.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.886 2.18 . . . . 15.0 116.886 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD3' ' N ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -127.56 144.17 51.1 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.443 -0.947 . . . . 15.0 108.443 178.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.577 ' H ' HD12 ' A' ' 120' ' ' ILE . 4.7 mp -57.78 136.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.319 1.448 . . . . 15.0 109.653 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 28.7 m 65.14 92.22 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.045 1.738 . . . . 15.0 111.637 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 121' ' ' THR . 57.4 Cg_endo -64.58 134.21 40.2 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.924 2.416 . . . . 15.0 111.331 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG2' HG13 ' A' ' 124' ' ' ILE . 30.5 tt0 -119.34 -81.63 0.63 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.403 -1.271 . . . . 15.0 112.177 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.508 HG13 ' HG2' ' A' ' 123' ' ' GLU . 32.7 mt -116.36 146.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.64 24.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.794 1.238 . . . . 15.0 110.984 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.0 m -100.32 122.59 43.34 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.196 -0.911 . . . . 15.0 109.387 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.452 ' HD3' ' HD3' ' A' ' 12' ' ' LYS . 37.1 ttt85 -120.88 127.94 52.34 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.461 -0.79 . . . . 15.0 112.479 -175.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.0 119.53 24.45 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.93 -1.487 . . . . 15.0 110.775 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.514 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 6.1 pt-20 -134.2 145.42 49.19 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.88 -1.054 . . . . 15.0 113.49 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.38 122.09 43.1 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.307 -1.315 . . . . 15.0 109.307 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.59 122.48 47.93 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 113.656 -1.611 . . . . 15.0 110.942 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -124.45 145.28 49.6 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 111.985 -2.37 . . . . 15.0 110.532 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.477 0.888 0 CA-C-N 114.764 -1.107 . . . . 15.0 109.188 171.35 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 116.899 1.52 . . . . 15.0 116.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -117.42 139.0 51.45 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.046 0.927 . . . . 15.0 110.599 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.19 108.98 18.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 113.89 -1.505 . . . . 15.0 109.535 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.514 ' HB2' ' HG3' ' A' ' 129' ' ' GLU . 61.4 m -109.02 125.22 51.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.472 -1.24 . . . . 15.0 108.783 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 pp -148.22 145.25 28.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.201 -1.363 . . . . 15.0 112.311 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.96 -162.51 29.53 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 114.15 -1.386 . . . . 15.0 113.119 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.32 130.48 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.159 -1.52 . . . . 15.0 111.494 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.538 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 63.9 p -130.39 146.35 51.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.755 -1.566 . . . . 15.0 113.053 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -115.96 118.95 34.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.259 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.86 119.27 34.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.031 -1.44 . . . . 15.0 108.55 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 t80 . . . . . 0 N--CA 1.475 0.815 0 CA-C-N 113.873 -1.512 . . . . 15.0 110.112 -174.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 6.1 t30 . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 123.608 1.67 . . . . 15.0 112.461 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.419 ' HA ' ' CE1' ' A' ' 150' ' ' PHE . 11.6 t -120.94 150.91 40.36 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 112.207 -2.27 . . . . 15.0 111.448 173.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -106.92 131.79 53.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.568 -1.196 . . . . 15.0 111.959 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.35 101.6 8.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.619 -1.628 . . . . 15.0 108.681 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -108.07 118.32 36.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.246 -1.797 . . . . 15.0 107.114 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -130.9 153.0 20.1 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 114.316 -1.311 . . . . 15.0 113.971 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.29 124.11 42.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.736 -1.232 . . . . 15.0 108.261 170.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -144.19 155.97 44.12 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.756 -1.111 . . . . 15.0 112.869 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 26' ' ' ALA . 3.1 pp -114.09 140.37 48.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.604 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -108.5 97.76 1.13 Allowed Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.691 -1.595 . . . . 15.0 111.097 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.474 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t90 -111.05 150.16 29.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.493 1.139 . . . . 15.0 112.418 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.3 p -122.34 159.38 27.58 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 112.439 -2.164 . . . . 15.0 111.081 -173.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -48.48 153.21 0.79 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.221 -0.899 . . . . 15.0 109.593 165.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.49 89.62 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.861 0.838 . . . . 15.0 111.641 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 t -167.81 141.0 3.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.651 -2.068 . . . . 15.0 107.963 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HG2' ' H ' ' A' ' 21' ' ' GLU . 32.0 ttt-85 53.21 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.897 1.679 . . . . 15.0 113.649 -175.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.575 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 15.3 pt-20 -69.69 75.18 0.43 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.927 1.084 . . . . 15.0 113.927 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -130.1 147.59 51.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.877 -1.056 . . . . 15.0 112.242 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -173.15 -75.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.675 -1.602 . . . . 15.0 110.47 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -104.56 89.45 3.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.473 0.654 . . . . 15.0 111.394 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.98 111.97 1.02 Allowed Glycine 0 N--CA 1.478 1.485 0 CA-C-N 113.599 -1.637 . . . . 15.0 112.018 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -119.75 142.47 48.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.193 0.597 . . . . 15.0 112.081 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.41 20.38 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 124.952 1.408 . . . . 15.0 112.511 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . . . -102.96 135.94 43.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.733 -1.234 . . . . 15.0 111.2 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -111.72 118.0 34.42 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.007 -1.451 . . . . 15.0 110.817 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.12 90.12 0.45 Allowed Glycine 0 N--CA 1.476 1.325 0 CA-C-N 114.647 -1.161 . . . . 15.0 110.545 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.04 117.26 4.21 Favored Glycine 0 N--CA 1.477 1.419 0 O-C-N 124.44 0.729 . . . . 15.0 112.101 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -115.25 123.01 47.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.474 1.13 . . . . 15.0 111.856 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -109.03 82.21 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.499 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 5' ' ' ASN 0.276 7.3 p -71.2 -73.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.236 -2.257 . . . . 15.0 112.243 174.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 22.7 t30 -70.55 127.86 91.61 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.229 1.411 . . . . 15.0 112.146 -176.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 35' ' ' ASN . 71.8 Cg_endo -72.5 69.5 3.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.323 2.682 . . . . 15.0 111.728 170.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -175.94 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.196 2.199 . . . . 15.0 107.941 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.28 141.01 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.465 -0.788 . . . . 15.0 111.962 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.67 158.95 14.08 Favored Glycine 0 N--CA 1.477 1.39 0 CA-C-N 113.638 -1.619 . . . . 15.0 109.577 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 136.2 52.73 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.257 0.551 . . . . 15.0 110.524 -176.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.46 ' HB3' ' OG1' ' A' ' 60' ' ' THR . 0.9 OUTLIER -127.89 133.91 49.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.584 -1.189 . . . . 15.0 110.621 -173.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.4 mtm -124.23 128.27 48.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.133 -1.394 . . . . 15.0 111.547 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.99 134.08 11.93 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 113.385 -1.734 . . . . 15.0 109.676 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 28' ' ' ALA . 82.8 m-85 -120.12 115.06 22.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.311 -0.945 . . . . 15.0 111.695 -173.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -128.93 143.67 50.95 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.066 -1.425 . . . . 15.0 109.719 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.85 142.53 50.15 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.744 0.646 . . . . 15.0 112.744 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 122.813 1.292 . . . . 15.0 110.075 -177.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 121.814 0.816 . . . . 15.0 112.419 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -127.69 156.27 42.63 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.973 -1.921 . . . . 15.0 111.219 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.43 100.57 0.88 Allowed Glycine 0 N--CA 1.475 1.295 0 O-C-N 124.482 1.114 . . . . 15.0 110.427 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -110.74 131.86 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.599 1.19 . . . . 15.0 112.306 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -109.86 124.1 50.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.52 -1.673 . . . . 15.0 109.003 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.19 111.18 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.673 -1.149 . . . . 15.0 109.305 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.487 ' HB ' ' HG2' ' A' ' 78' ' ' ARG . 32.2 p -136.2 156.36 48.79 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.148 -1.842 . . . . 15.0 112.634 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -116.56 141.66 47.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.745 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -110.77 126.07 54.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.375 -1.284 . . . . 15.0 111.402 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.24 146.84 49.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.616 -1.629 . . . . 15.0 110.866 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.96 -155.29 21.56 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 115.694 -0.685 . . . . 15.0 112.04 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.466 ' CE2' ' HG2' ' A' ' 67' ' ' LYS . 18.9 p90 -166.4 158.94 11.97 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -167.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.73 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.5 Cg_endo -68.57 134.0 29.39 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.825 2.35 . . . . 15.0 111.982 167.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 4.8 tmtp? -129.44 122.75 30.0 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.234 -1.348 . . . . 15.0 110.725 -177.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 68' ' ' LEU . 1.8 pt? -69.93 125.68 27.47 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.384 -1.28 . . . . 15.0 110.769 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.34 -86.18 0.41 Allowed Glycine 0 N--CA 1.477 1.378 0 CA-C-N 114.562 -1.199 . . . . 15.0 112.94 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.441 HG23 ' OH ' ' A' ' 114' ' ' TYR . 2.4 t -126.43 -39.8 2.0 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.634 -1.283 . . . . 15.0 110.517 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -116.87 -146.37 0.4 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.502 -1.296 . . . . 15.0 107.502 148.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -107.76 103.31 12.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.2 pt? -111.1 143.54 41.66 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.056 -1.429 . . . . 15.0 113.733 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.73 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 1.1 m-20 -111.85 123.44 50.24 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.513 -1.221 . . . . 15.0 108.914 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.7 mt -111.59 113.19 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 124.38 1.05 . . . . 15.0 108.681 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -122.27 141.83 51.1 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.478 -1.692 . . . . 15.0 111.885 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 m -108.53 122.64 47.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.257 -2.127 . . . . 15.0 105.257 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.68 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 18.2 ttm180 -115.73 123.22 47.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 112.831 -1.986 . . . . 15.0 108.134 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.2 tp -131.57 138.39 48.84 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.244 -0.889 . . . . 15.0 111.065 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.22 -145.39 8.06 Favored Glycine 0 N--CA 1.477 1.423 0 O-C-N 124.749 1.281 . . . . 15.0 113.178 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.43 152.35 22.86 Favored Glycine 0 N--CA 1.476 1.349 0 O-C-N 125.235 1.197 . . . . 15.0 112.599 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.75 118.71 35.06 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.548 0.69 . . . . 15.0 111.136 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.75 125.71 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 113.768 -1.56 . . . . 15.0 108.089 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 . . . . . 0 N--CA 1.472 0.643 0 CA-C-N 114.286 -1.325 . . . . 15.0 110.729 176.233 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.363 -0.606 . . . . 15.0 109.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.45 99.74 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.438 -1.255 . . . . 15.0 108.843 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -118.65 136.45 24.15 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 114.31 -1.313 . . . . 15.0 111.904 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.21 96.58 0.72 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.06 2.507 . . . . 15.0 111.074 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.667 ' HB ' ' HA ' ' A' ' 133' ' ' THR . 21.5 m -116.98 143.48 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.836 -1.529 . . . . 15.0 111.566 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.661 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 5.6 p90 -129.7 138.18 51.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.8 -169.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.68 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -124.79 134.28 52.83 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.631 1.832 . . . . 15.0 111.962 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.638 ' N ' ' HB2' ' A' ' 131' ' ' GLN . . . -104.29 99.24 1.65 Allowed Glycine 0 N--CA 1.476 1.31 0 N-CA-C 108.251 -1.939 . . . . 15.0 108.251 175.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.67 114.45 4.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 125.081 1.107 . . . . 15.0 112.127 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 52.3 t -117.29 131.96 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 122.576 1.179 . . . . 15.0 108.997 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.696 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 10.5 mm-40 -110.74 109.58 19.87 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 112.623 -2.081 . . . . 15.0 108.711 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.449 ' CD1' ' HB3' ' A' ' 73' ' ' LEU . 13.6 t80 -107.26 126.08 51.97 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.611 0.719 . . . . 15.0 112.21 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.5 t -114.22 133.01 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.389 -1.278 . . . . 15.0 109.023 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.1 mt -118.78 142.94 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 114.517 -1.219 . . . . 15.0 108.727 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -70.83 97.11 1.34 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.903 1.075 . . . . 15.0 113.903 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -127.12 149.91 49.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.331 -1.304 . . . . 15.0 112.095 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -57.03 -42.9 81.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.146 1.165 . . . . 15.0 114.146 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.9 mt -120.8 89.05 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.0 m -118.0 90.25 36.61 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.238 -1.346 . . . . 15.0 109.191 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.31 82.64 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.735 2.29 . . . . 15.0 112.281 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 148' ' ' TYR . 1.5 mp0 46.57 32.12 1.56 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.759 2.133 . . . . 15.0 116.759 176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.595 HD11 ' HB ' ' A' ' 146' ' ' VAL . 7.3 tp -116.71 129.57 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.103 0.954 . . . . 15.0 112.414 -169.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.61 153.2 38.41 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.077 -1.874 . . . . 15.0 110.563 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.3 m -80.76 122.61 27.38 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 108.11 20.72 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.348 -1.296 . . . . 15.0 107.995 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.57 111.02 16.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.548 -1.66 . . . . 15.0 108.017 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 110' ' ' GLY . 1.4 tm-20 -129.28 120.51 25.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.553 -1.203 . . . . 15.0 111.054 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 141' ' ' MET . 86.5 t80 -134.95 105.55 6.43 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 117.699 -1.143 . . . . 15.0 110.199 170.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.661 ' HB3' ' O ' ' A' ' 108' ' ' PHE 0.756 1.1 mp0 -149.88 159.28 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 110.884 -2.871 . . . . 15.0 116.751 164.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -78.23 111.6 14.36 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 122.422 1.106 . . . . 15.0 108.207 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.667 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 36.4 p . . . . . 0 N--CA 1.483 1.224 0 CA-C-N 113.457 -1.701 . . . . 15.0 115.583 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 CA-C-O 121.323 0.402 . . . . 15.0 113.262 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.482 ' O ' ' HA ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -130.79 133.9 46.38 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.921 1.082 . . . . 15.0 113.921 176.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -112.55 105.18 13.33 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.487 -1.688 . . . . 15.0 112.079 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 14.9 m -102.26 125.18 48.88 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.775 -2.012 . . . . 15.0 107.847 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.08 136.88 48.81 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.258 -1.337 . . . . 15.0 111.426 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.08 -162.46 29.39 Favored Glycine 0 N--CA 1.476 1.327 0 O-C-N 124.837 1.335 . . . . 15.0 112.612 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.595 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.7 m -121.0 140.1 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 113.824 -1.188 . . . . 15.0 112.022 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.509 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 25.0 t -123.63 136.17 54.35 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.437 -1.256 . . . . 15.0 110.661 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 123' ' ' GLU . 34.7 t80 -111.72 135.21 52.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.607 -1.179 . . . . 15.0 109.482 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -91.01 128.7 36.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.42 -1.263 . . . . 15.0 109.842 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 6' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 C-N-CA 126.888 2.075 . . . . 15.0 114.098 -173.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 123.348 1.547 . . . . 15.0 113.053 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 33' ' ' GLN . 12.2 p -98.27 115.12 27.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.013 -2.358 . . . . 15.0 109.337 -172.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -94.18 130.43 40.4 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.683 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 148' ' ' TYR . 1.2 t80 -143.4 111.26 6.03 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.487 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.585 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 40.4 p -117.96 174.57 6.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.869 -1.969 . . . . 15.0 110.503 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.0 -159.21 28.36 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.224 0.902 . . . . 15.0 114.4 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.82 132.75 24.22 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.725 -1.237 . . . . 15.0 111.019 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HA ' ' HA3' ' A' ' 145' ' ' GLY . 22.7 pttp -137.3 150.47 47.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.481 -1.236 . . . . 15.0 112.341 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.6 pp -114.21 143.59 44.58 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.875 -1.057 . . . . 15.0 111.723 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.31 119.09 6.26 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-N 113.2 -1.818 . . . . 15.0 110.316 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -114.82 141.1 48.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 113.502 -1.349 . . . . 15.0 111.72 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 m -122.21 98.04 5.75 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.063 -1.426 . . . . 15.0 113.708 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -85.32 48.64 1.61 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.45 1.278 . . . . 15.0 114.45 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -166.57 26.4 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.073 1.509 . . . . 15.0 115.073 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -155.38 144.23 20.65 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.593 0.59 . . . . 15.0 112.593 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -80.88 90.38 5.9 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 15.0 110.193 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 57.6 28.72 16.09 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.371 1.989 . . . . 15.0 116.371 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -114.82 133.96 55.51 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.466 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 10.5 mm-40 53.07 93.76 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.137 1.903 . . . . 15.0 116.137 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pp -154.23 137.22 15.47 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 111.681 -2.509 . . . . 15.0 110.151 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.07 -169.88 37.56 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.138 0.899 . . . . 15.0 113.486 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -124.39 142.62 51.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.573 0.749 . . . . 15.0 112.695 -175.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.16 145.92 16.75 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 114.188 -1.369 . . . . 15.0 111.16 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.67 121.27 43.21 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.32 -0.94 . . . . 15.0 109.351 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -127.23 152.88 46.81 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.699 -1.137 . . . . 15.0 112.165 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -174.36 149.23 10.46 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 115.413 -0.812 . . . . 15.0 114.813 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.22 -146.74 7.62 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 113.634 -1.283 . . . . 15.0 113.298 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -158.35 149.55 20.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.722 -1.239 . . . . 15.0 113.621 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.523 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 42.2 tt0 -114.66 95.17 5.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.303 1.441 . . . . 15.0 108.657 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.6 -48.17 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.222 -0.899 . . . . 15.0 111.693 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.99 154.93 61.37 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-O 118.055 -0.974 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.47 53.36 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.877 3.051 . . . . 15.0 113.42 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.91 -82.3 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.515 1.526 . . . . 15.0 108.667 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.38 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.939 0.896 . . . . 15.0 108.854 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.62 166.88 17.09 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.188 1.375 . . . . 15.0 110.671 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.96 139.39 52.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.41 137.15 43.83 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.363 -1.29 . . . . 15.0 111.805 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.18 143.33 31.41 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.756 -1.565 . . . . 15.0 109.85 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.32 7.75 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.05 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -118.99 133.96 55.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.364 1.078 . . . . 15.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -125.11 133.82 52.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.921 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.668 ' HA ' ' HG3' ' A' ' 55' ' ' GLN . 37.7 p-90 -102.8 133.54 47.69 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.814 -1.085 . . . . 15.0 110.192 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 N--CA 1.476 0.864 0 CA-C-N 113.595 -1.639 . . . . 15.0 113.764 -173.82 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 111.632 0.234 . . . . 15.0 111.632 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.668 ' HG3' ' HA ' ' A' ' 46' ' ' TRP . 2.9 mp0 -51.6 147.1 6.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.906 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 135.87 16.04 Favored Glycine 0 N--CA 1.478 1.467 0 CA-C-N 114.37 -1.286 . . . . 15.0 112.576 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.13 137.32 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.73 1.252 . . . . 15.0 112.988 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.568 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -126.84 139.77 52.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.089 -1.869 . . . . 15.0 111.733 175.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.44 111.19 17.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.585 -1.643 . . . . 15.0 109.114 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.548 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 34.2 m -124.55 140.86 52.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.986 -1.461 . . . . 15.0 109.884 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.843 ' O ' ' HB3' ' A' ' 78' ' ' ARG . . . -101.06 138.5 38.02 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.998 -1.853 . . . . 15.0 105.998 168.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.749 ' HA ' ' CB ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -124.95 139.24 54.0 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.93 2.019 . . . . 15.0 114.365 -178.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 77' ' ' THR 0.27 4.6 pp -127.15 120.7 29.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 166.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . -121.91 135.05 10.19 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.678 -2.51 . . . . 15.0 112.58 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.08 145.43 50.29 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 125.348 1.263 . . . . 15.0 114.118 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.4 91.22 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.069 2.513 . . . . 15.0 110.728 167.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.678 ' HD3' ' H ' ' A' ' 68' ' ' LEU . 6.3 tmtt? -144.6 152.16 40.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.405 -1.725 . . . . 15.0 108.895 -178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.678 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 1.2 tm? 62.95 85.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.79 2.036 . . . . 15.0 109.624 -170.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -140.74 15.82 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 112.926 -1.943 . . . . 15.0 109.584 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.55 HG23 ' H ' ' A' ' 71' ' ' ASP . 3.2 t -136.34 -86.96 0.33 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.188 -1.006 . . . . 15.0 112.153 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.55 ' H ' HG23 ' A' ' 70' ' ' THR . 8.5 m-20 -124.97 106.6 10.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.108 1.363 . . . . 15.0 108.093 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t0 176.32 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 113.175 -1.83 . . . . 15.0 110.138 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 114' ' ' TYR . 1.3 pt? -135.32 151.79 50.86 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.799 1.312 . . . . 15.0 112.218 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 7.0 m-20 -132.56 138.78 47.58 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.398 -1.274 . . . . 15.0 111.022 172.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.491 ' HA ' HG12 ' A' ' 112' ' ' VAL . 7.8 tp -87.71 135.84 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.275 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -123.94 128.86 50.04 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.992 1.433 . . . . 15.0 111.646 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.503 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 24.0 p -137.2 122.35 19.18 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.942 -1.132 . . . . 15.0 107.942 158.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.843 ' HB3' ' O ' ' A' ' 61' ' ' ALA 0.609 8.0 mmt180 -158.9 164.6 35.53 Favored 'General case' 0 N--CA 1.478 0.972 1 N-CA-C 122.946 4.424 . . . . 15.0 122.946 172.822 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.725 HD13 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -127.93 156.0 43.33 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.096 0.776 . . . . 15.0 113.096 -176.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -165.12 -176.55 36.86 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 114.96 -1.018 . . . . 15.0 113.365 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.93 144.16 14.97 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 123.889 0.757 . . . . 15.0 113.286 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.568 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -123.79 140.68 52.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.617 1.34 . . . . 15.0 114.617 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.87 144.27 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 125.157 1.536 . . . . 15.0 112.309 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 . . . . . 0 N--CA 1.478 0.949 0 C-N-CA 124.38 1.072 . . . . 15.0 111.798 175.72 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.651 0.738 . . . . 15.0 111.903 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 t -117.0 120.67 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.0 m -122.12 142.01 35.67 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.305 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.16 148.7 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.666 2.244 . . . . 15.0 113.274 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.41 135.05 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.643 -1.617 . . . . 15.0 109.64 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -107.11 123.36 48.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -127.55 112.51 15.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.907 -173.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 138.56 11.76 Favored Glycine 0 N--CA 1.479 1.539 0 CA-C-N 113.581 -1.645 . . . . 15.0 110.713 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 129' ' ' GLU . . . 174.79 -152.95 14.73 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.298 0.475 . . . . 15.0 113.244 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 75' ' ' ILE . 5.4 m -141.77 156.97 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.992 1.108 . . . . 15.0 113.992 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -110.13 136.89 48.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.426 -1.716 . . . . 15.0 108.669 159.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 73' ' ' LEU . 11.5 t80 -132.37 143.61 49.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.865 -1.516 . . . . 15.0 108.957 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.44 135.32 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 120.949 0.404 . . . . 15.0 109.991 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.7 mt -43.61 -39.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.805 1.78 . . . . 15.0 115.805 -164.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -164.1 -60.13 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.589 0.755 . . . . 15.0 110.495 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.16 135.52 34.34 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.767 -0.651 . . . . 15.0 109.701 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.79 -33.8 50.5 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.975 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.0 tt -99.84 82.92 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 122.236 1.017 . . . . 15.0 109.893 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 89.2 m -136.76 88.96 18.25 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 112.325 -2.216 . . . . 15.0 108.163 167.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.37 -177.11 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.949 2.433 . . . . 15.0 111.733 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 54.4 mt-10 66.83 -55.6 0.43 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.631 1.973 . . . . 15.0 115.309 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.541 HG12 ' CE2' ' A' ' 148' ' ' TYR . 6.6 mt -116.72 115.16 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.254 1.022 . . . . 15.0 108.649 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.07 147.98 44.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.369 -1.287 . . . . 15.0 111.343 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 m -80.75 116.8 20.94 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.498 HH11 ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -116.83 112.04 20.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.115 0.96 . . . . 15.0 109.889 -177.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.53 112.75 18.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 15.0 110.841 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.401 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 18.0 tt0 -134.98 136.45 42.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.928 -1.487 . . . . 15.0 111.491 -173.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 30.7 m-85 -97.4 131.96 43.56 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.425 -1.262 . . . . 15.0 109.341 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.38 117.0 30.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.356 -1.747 . . . . 15.0 111.592 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -120.72 111.83 18.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.493 -1.685 . . . . 15.0 113.186 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 N--CA 1.483 1.22 0 CA-C-N 112.64 -2.073 . . . . 15.0 111.557 167.11 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 109.057 -1.617 . . . . 15.0 109.057 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.0 ttt -117.65 135.11 54.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.586 0.708 . . . . 15.0 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.2 tt -105.17 108.8 20.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.694 -1.139 . . . . 15.0 109.708 -174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m -93.25 125.11 37.68 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.208 1.004 . . . . 15.0 110.081 170.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.4 pp -133.9 135.22 43.49 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 112.903 -1.953 . . . . 15.0 110.109 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -178.94 -162.52 28.48 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 114.82 -1.082 . . . . 15.0 112.848 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.3 m -117.04 131.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 113.518 -1.341 . . . . 15.0 112.633 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.7 p -113.17 145.73 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 112.342 -2.208 . . . . 15.0 111.535 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 70.7 m-85 -124.07 143.45 50.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.009 -1.905 . . . . 15.0 112.482 -172.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -95.84 141.54 29.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 113.583 -1.644 . . . . 15.0 111.41 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 . . . . . 0 N--CA 1.484 1.267 0 C-N-CA 125.825 1.65 . . . . 15.0 114.347 -177.819 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 34' ' ' VAL . 60.0 t30 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.563 1.32 . . . . 15.0 114.563 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.611 ' HA ' ' HB3' ' A' ' 149' ' ' ARG . 10.2 t -110.98 114.72 28.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.162 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -136.79 133.57 36.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.905 -2.407 . . . . 15.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 144.17 -98.11 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 129.293 3.037 . . . . 15.0 108.09 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.663 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 11.2 t -163.51 153.18 15.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -131.06 -170.07 12.59 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.166 -1.379 . . . . 15.0 112.793 170.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.73 131.57 5.44 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.752 1.621 . . . . 15.0 109.522 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.693 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.425 5.2 tptp -171.94 169.61 5.65 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.185 -1.825 . . . . 15.0 115.142 168.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.45 ' HB3' ' H ' ' A' ' 26' ' ' ALA . 1.9 pt? -130.47 161.64 30.98 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.427 -1.261 . . . . 15.0 111.681 -173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -120.0 155.57 16.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.513 -1.222 . . . . 15.0 112.548 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -121.65 137.02 54.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.924 -1.138 . . . . 15.0 112.49 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -116.8 151.78 35.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.09 -1.414 . . . . 15.0 109.919 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -71.43 78.73 0.76 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.164 1.172 . . . . 15.0 114.164 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -158.92 139.49 12.51 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.135 -1.393 . . . . 15.0 111.717 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.9 m -66.46 -40.41 89.39 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 116.664 2.098 . . . . 15.0 116.664 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 mtt-85 -76.78 92.08 3.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.54 0.686 . . . . 15.0 111.841 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -124.58 131.5 53.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.096 -1.865 . . . . 15.0 113.03 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -131.65 -163.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.239 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -74.68 74.64 2.04 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.535 1.159 . . . . 15.0 111.024 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.63 101.43 3.67 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.663 -1.608 . . . . 15.0 108.502 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.66 -153.82 23.06 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 114.146 -1.388 . . . . 15.0 111.377 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' H ' ' HB3' ' A' ' 13' ' ' LEU . . . 50.13 91.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.191 1.796 . . . . 15.0 114.19 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.11 148.77 16.48 Favored Glycine 0 N--CA 1.475 1.269 0 CA-C-N 113.807 -1.542 . . . . 15.0 109.99 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.45 121.14 41.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.692 -0.855 . . . . 15.0 108.692 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.449 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 97.3 m-85 -125.75 113.43 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.562 -1.199 . . . . 15.0 110.114 -170.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.67 -174.59 14.44 Favored Glycine 0 N--CA 1.477 1.405 0 CA-C-N 115.353 -0.84 . . . . 15.0 114.309 -173.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.92 -140.04 13.86 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.441 -0.88 . . . . 15.0 113.705 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -127.19 104.93 8.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.406 -1.397 . . . . 15.0 112.969 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.497 HE22 ' HB2' ' A' ' 62' ' ' LYS . 15.5 mm100 -114.93 82.27 1.71 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 123.066 1.412 . . . . 15.0 108.249 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 5' ' ' ASN . 47.9 t -124.78 -63.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 112.749 -2.023 . . . . 15.0 113.315 -170.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.5 t-20 -62.17 139.09 96.13 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 114.354 1.242 . . . . 15.0 114.354 -170.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.59 41.13 0.59 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.652 3.568 . . . . 15.0 116.444 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 1.2 t80 -167.51 -58.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 15.0 111.236 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 57.2 t -124.65 136.32 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.794 0.806 . . . . 15.0 110.279 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.37 154.57 21.3 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 113.785 -1.552 . . . . 15.0 110.055 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.95 114.31 20.81 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.737 0.303 . . . . 15.0 110.503 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.428 ' CD ' ' HB3' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -131.94 119.91 21.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.159 -0.928 . . . . 15.0 111.047 -172.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.3 mtp -112.21 135.6 52.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.796 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 29' ' ' PHE . . . -115.87 147.67 18.91 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 113.382 -1.735 . . . . 15.0 111.948 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -132.29 143.03 49.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.846 1.425 . . . . 15.0 114.846 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.09 118.44 24.39 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 111.722 -2.49 . . . . 15.0 107.238 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -112.51 145.18 40.71 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.518 -1.219 . . . . 15.0 110.073 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.212 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 117.184 2.29 . . . . 15.0 117.184 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 58.41 109.54 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.125 1.77 . . . . 15.0 114.516 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.26 134.76 10.58 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 114.021 -1.445 . . . . 15.0 111.282 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.2 p -119.05 141.33 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 122.111 0.958 . . . . 15.0 111.259 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.517 ' HG2' ' HB3' ' A' ' 82' ' ' MET . 47.4 mt-30 -120.66 140.29 51.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.284 -1.326 . . . . 15.0 109.976 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.64 114.82 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.397 -1.274 . . . . 15.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.2 p -130.41 131.73 45.4 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.746 0.784 . . . . 15.0 110.881 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -114.77 123.3 48.87 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.982 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.655 ' HG2' ' CD2' ' A' ' 76' ' ' TYR . 11.9 tmtt? -79.31 106.41 11.32 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.2 -1.818 . . . . 15.0 108.575 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.79 108.82 15.32 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.472 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 37' ' ' TYR . . . 177.65 -153.69 13.85 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 114.021 -1.445 . . . . 15.0 113.517 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.98 152.22 76.87 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 113.934 -1.133 . . . . 15.0 111.23 -170.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.491 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 35.2 Cg_endo -61.29 -73.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.497 2.131 . . . . 15.0 111.24 170.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 60.95 143.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.599 1.96 . . . . 15.0 111.621 -176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.72 -61.63 2.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.878 -1.056 . . . . 15.0 112.055 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA3' HD13 ' A' ' 73' ' ' LEU . . . 64.11 -85.15 0.06 OUTLIER Glycine 0 N--CA 1.478 1.462 0 C-N-CA 124.76 1.171 . . . . 15.0 111.492 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 p -134.83 -73.01 0.47 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.653 1.181 . . . . 15.0 109.383 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -165.81 135.33 3.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.869 2.068 . . . . 15.0 108.684 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' HB2' ' CE1' ' A' ' 114' ' ' TYR . 7.3 m-20 62.03 43.64 8.78 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.903 1.281 . . . . 15.0 112.775 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.403 HD13 ' HA3' ' A' ' 69' ' ' GLY . 7.7 tt -117.57 137.36 52.64 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.776 -1.102 . . . . 15.0 112.942 -167.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 14.9 t70 -126.61 139.41 53.21 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 112.079 -2.328 . . . . 15.0 109.002 165.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.9 tt -118.16 119.12 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.119 0.968 . . . . 15.0 109.831 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.655 ' CD2' ' HG2' ' A' ' 62' ' ' LYS . 8.8 p90 -153.86 168.9 24.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.012 1.115 . . . . 15.0 114.012 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.599 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 8.9 t -118.66 133.53 55.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.569 166.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.505 ' HB3' ' HE2' ' A' ' 76' ' ' TYR . 7.8 ppt_? -100.53 123.17 44.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.55 1.167 . . . . 15.0 109.149 172.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 pp -124.41 144.57 49.98 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.221 -2.263 . . . . 15.0 113.483 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.64 -97.36 0.17 Allowed Glycine 0 N--CA 1.476 1.304 0 CA-C-N 113.46 -1.7 . . . . 15.0 109.309 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.59 -153.66 23.75 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 115.057 0.783 . . . . 15.0 115.057 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.517 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 21.9 ptp -129.14 138.5 51.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.217 1.562 . . . . 15.0 115.217 -172.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.2 t -128.05 115.58 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 112.902 -1.953 . . . . 15.0 109.185 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 113.85 -1.523 . . . . 15.0 109.721 170.858 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.964 0.888 . . . . 15.0 112.78 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.97 90.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 114.778 -1.101 . . . . 15.0 108.375 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.8 m -130.04 90.17 43.25 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.112 1.153 . . . . 15.0 114.112 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.11 141.42 29.47 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.288 2.659 . . . . 15.0 112.66 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.437 HG22 HG21 ' A' ' 133' ' ' THR . 97.8 t -134.37 139.31 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.363 -1.29 . . . . 15.0 109.855 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -124.32 123.34 39.99 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.656 1.223 . . . . 15.0 109.139 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -136.33 112.66 9.88 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.952 1.093 . . . . 15.0 113.952 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 77' ' ' THR . . . -113.29 142.07 17.24 Favored Glycine 0 N--CA 1.479 1.527 0 CA-C-N 114.096 -1.411 . . . . 15.0 112.662 -173.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.16 -148.93 10.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-O 121.928 0.738 . . . . 15.0 114.606 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.35 143.86 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 113.483 -1.358 . . . . 15.0 113.859 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -122.83 121.92 37.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.069 -1.878 . . . . 15.0 109.898 178.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 72' ' ' ASP . 78.1 t80 -117.71 137.36 52.74 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.888 1.367 . . . . 15.0 110.196 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.83 130.62 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.288 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.94 106.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.905 1.817 . . . . 15.0 115.905 -169.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -118.89 87.37 2.72 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.092 -1.413 . . . . 15.0 110.36 171.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.496 HH21 ' HD2' ' A' ' 119' ' ' ARG . 21.7 ttp180 -174.08 -79.94 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.512 -1.676 . . . . 15.0 112.438 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.496 ' HD2' HH21 ' A' ' 118' ' ' ARG . 65.1 ttt180 -101.53 146.86 27.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.425 0.631 . . . . 15.0 112.658 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.26 100.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.078 1.751 . . . . 15.0 112.523 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.1 p -140.18 151.41 64.61 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 112.066 -2.334 . . . . 15.0 110.281 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.68 82.21 1.22 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.377 2.051 . . . . 15.0 110.141 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -0.7 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.939 2.496 . . . . 15.0 116.596 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.438 HG22 ' HB3' ' A' ' 148' ' ' TYR . 2.7 pp -116.53 140.79 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 112.687 -2.051 . . . . 15.0 112.4 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.403 ' HB1' ' OE1' ' A' ' 113' ' ' GLU . . . -118.47 127.78 53.97 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.489 -2.141 . . . . 15.0 109.333 175.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 8.9 t -109.33 129.28 55.53 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.426 -1.261 . . . . 15.0 112.182 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.453 ' O ' HD12 ' A' ' 144' ' ' LEU . 52.0 ttp180 -113.3 108.12 16.82 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.431 -1.713 . . . . 15.0 110.19 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.5 tp -106.73 111.02 23.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.855 -1.521 . . . . 15.0 108.061 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.469 ' OE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -138.18 150.41 46.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.136 -2.302 . . . . 15.0 113.161 -168.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 38.3 p90 -96.99 129.52 44.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 172.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 44.5 tt0 -108.04 110.01 21.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.806 -1.997 . . . . 15.0 108.5 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -123.43 136.54 54.67 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.117 -1.856 . . . . 15.0 112.802 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.437 HG21 HG22 ' A' ' 107' ' ' VAL . 8.8 t . . . . . 0 N--CA 1.482 1.145 0 CA-C-N 110.927 -2.852 . . . . 15.0 108.761 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.435 0 CA-C-O 121.481 0.489 . . . . 15.0 112.616 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.485 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 25.5 ttt -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.129 -1.035 . . . . 15.0 110.874 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.1 tp -114.32 112.22 22.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.398 -1.334 . . . . 15.0 107.398 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.54 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 9.8 t -120.56 138.34 53.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.952 -1.476 . . . . 15.0 112.693 -166.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.693 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 37.7 tp -120.1 134.58 55.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.589 -1.641 . . . . 15.0 109.861 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.27 128.33 5.75 Favored Glycine 0 N--CA 1.481 1.655 0 O-C-N 125.774 1.921 . . . . 15.0 110.247 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.489 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 48.2 t -121.43 127.55 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 118.718 1.259 . . . . 15.0 109.249 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.581 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 65.9 p -118.71 138.68 52.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.559 ' CE2' ' HA2' ' A' ' 10' ' ' GLY . 13.5 p90 -125.26 148.31 48.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.481 1.134 . . . . 15.0 113.65 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.611 ' HB3' ' HA ' ' A' ' 6' ' ' THR . 36.6 ptt180 -101.32 153.37 19.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.354 -1.748 . . . . 15.0 114.516 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 N--CA 1.481 1.118 0 C-N-CA 127.251 2.22 . . . . 15.0 115.161 -178.059 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 58.8 t30 . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 123.016 1.388 . . . . 15.0 112.811 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.502 ' HB ' ' CE2' ' A' ' 8' ' ' TYR . 81.5 p -98.38 119.49 37.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.078 -1.873 . . . . 15.0 108.306 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.599 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 6.6 m0 -113.91 130.28 56.52 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.237 -1.023 . . . . 15.0 108.237 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.502 ' CE2' ' HB ' ' A' ' 6' ' ' THR . 89.6 m-85 -132.22 106.0 7.68 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.229 0.956 . . . . 15.0 112.348 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.0 p -104.07 137.9 41.36 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.547 -0.751 . . . . 15.0 111.341 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.11 -145.46 7.28 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 113.92 -1.491 . . . . 15.0 112.038 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.55 144.15 50.21 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.891 -0.655 . . . . 15.0 112.675 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -118.29 140.16 50.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.434 -1.257 . . . . 15.0 111.312 174.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 143' ' ' SER . 0.9 OUTLIER -127.53 133.43 49.81 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.247 -1.342 . . . . 15.0 111.391 176.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -111.45 116.99 4.36 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 125.223 1.577 . . . . 15.0 110.626 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -109.26 145.46 35.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.848 0.832 . . . . 15.0 111.723 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -98.98 98.17 9.25 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.5 -1.227 . . . . 15.0 114.289 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.92 90.0 7.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.82 -1.082 . . . . 15.0 109.438 170.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.22 -86.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.743 -2.026 . . . . 15.0 110.081 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -119.24 -165.45 1.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.537 1.135 . . . . 15.0 109.07 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.33 83.6 0.25 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.805 1.242 . . . . 15.0 113.904 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.94 136.97 50.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.669 -1.605 . . . . 15.0 111.763 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -121.18 97.1 5.36 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.117 -1.401 . . . . 15.0 109.549 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.01 133.72 55.27 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.329 1.233 . . . . 15.0 114.329 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.96 156.17 33.98 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.971 -1.922 . . . . 15.0 110.57 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.87 -86.91 0.07 OUTLIER Glycine 0 N--CA 1.478 1.495 0 O-C-N 124.245 0.965 . . . . 15.0 112.085 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 69.72 149.71 0.08 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.339 2.256 . . . . 15.0 114.801 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.25 149.8 16.96 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 113.636 -1.62 . . . . 15.0 110.812 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.54 121.34 42.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.226 0.536 . . . . 15.0 110.249 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.439 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 2.4 m-85 -129.83 150.3 51.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 116.103 1.89 . . . . 15.0 116.103 -166.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.29 121.07 4.43 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 112.985 -1.916 . . . . 15.0 110.352 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA3' HH12 ' A' ' 127' ' ' ARG . . . -104.99 98.91 1.54 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 113.732 -1.234 . . . . 15.0 110.215 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -105.97 101.1 10.62 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.586 1.184 . . . . 15.0 108.822 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.536 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 18.8 tm0? -106.37 82.46 1.74 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.8 -1.556 . . . . 15.0 106.8 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 44.0 t -80.37 -84.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.199 -1.819 . . . . 15.0 109.163 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' H ' ' CD ' ' A' ' 36' ' ' PRO . 19.3 t-20 163.5 51.42 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 128.916 2.886 . . . . 15.0 114.445 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.542 ' CD ' ' H ' ' A' ' 35' ' ' ASN . 96.0 Cg_endo -85.98 55.61 3.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 N-CA-C 108.669 -1.32 . . . . 15.0 108.669 157.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 66.72 -33.87 0.21 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.195 2.198 . . . . 15.0 114.858 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.08 160.5 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.894 1.677 . . . . 15.0 111.966 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -82.72 153.28 31.2 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 109.846 -1.302 . . . . 15.0 109.846 170.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -117.6 118.3 31.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.593 0.711 . . . . 15.0 110.774 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.554 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.7 tp10 -111.1 110.1 20.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.9 -1.518 . . . . 15.0 106.9 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.413 ' HG3' ' HB3' ' A' ' 59' ' ' LEU . 57.3 ttp -135.28 136.34 41.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.087 -1.415 . . . . 15.0 109.934 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 29' ' ' PHE . . . -172.73 177.23 45.38 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 114.7 -1.136 . . . . 15.0 112.921 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -116.16 145.69 42.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.74 1.257 . . . . 15.0 113.749 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -117.32 118.49 32.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.031 -2.349 . . . . 15.0 109.478 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.46 ' HE1' ' HB1' ' A' ' 54' ' ' ALA . 42.0 t90 -129.45 152.41 49.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.41 -1.268 . . . . 15.0 110.47 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 N--CA 1.482 1.152 0 O-C-N 125.188 1.555 . . . . 15.0 110.622 -176.816 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.46 ' HB1' ' HE1' ' A' ' 46' ' ' TRP . . . . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 116.087 1.884 . . . . 15.0 116.087 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.79 158.75 21.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.87 1.268 . . . . 15.0 113.566 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -121.41 148.33 17.35 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.498 169.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.25 131.97 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.446 0.641 . . . . 15.0 110.74 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.72 127.77 54.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.649 -1.16 . . . . 15.0 110.091 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 42' ' ' MET . 1.0 OUTLIER -128.49 117.07 20.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.996 -1.911 . . . . 15.0 111.415 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.553 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 36.3 p -120.44 145.94 46.72 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.111 -1.404 . . . . 15.0 111.91 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.09 115.82 27.92 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.86 -1.518 . . . . 15.0 107.583 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.554 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.4 pttm -108.32 136.02 48.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 113.86 -1.518 . . . . 15.0 113.298 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.724 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 20.0 tp -128.99 135.9 49.59 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 113.599 -1.637 . . . . 15.0 108.812 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.04 137.56 11.58 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 125.366 1.666 . . . . 15.0 110.03 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.547 ' H ' ' HB2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -114.61 110.01 47.49 Favored Pre-proline 0 N--CA 1.477 0.882 0 N-CA-C 113.64 0.978 . . . . 15.0 113.64 177.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 65' ' ' TYR . 73.0 Cg_endo -72.99 92.51 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.483 2.122 . . . . 15.0 109.893 172.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -46.59 -44.88 18.5 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.208 -1.36 . . . . 15.0 114.28 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -172.01 157.36 4.36 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.175 1.39 . . . . 15.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.73 -91.31 0.5 Allowed Glycine 0 N--CA 1.476 1.327 0 CA-C-N 114.794 -1.093 . . . . 15.0 111.028 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -158.9 -94.6 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.42 0.688 . . . . 15.0 109.661 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.97 94.53 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.052 0.941 . . . . 15.0 109.369 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -159.65 -58.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.81 -1.541 . . . . 15.0 110.824 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.74 122.64 47.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.619 0.768 . . . . 15.0 111.1 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.442 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -125.37 106.64 9.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.964 -1.471 . . . . 15.0 111.088 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 tt -104.74 107.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.089 -0.96 . . . . 15.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.724 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -168.78 -171.9 1.49 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 112.466 -2.152 . . . . 15.0 111.553 -178.22 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.0 p -119.21 154.05 33.99 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.092 0.949 . . . . 15.0 112.894 -163.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -128.4 140.41 51.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.868 -1.514 . . . . 15.0 112.704 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 80' ' ' GLY . 1.6 tt -134.92 141.53 46.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.611 -1.177 . . . . 15.0 109.563 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -173.7 -143.0 4.12 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 114.92 -1.037 . . . . 15.0 111.838 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.37 156.07 27.3 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 114.429 -0.885 . . . . 15.0 113.617 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -113.27 138.15 50.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.284 -1.458 . . . . 15.0 112.089 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.618 HG22 HG12 ' A' ' 104' ' ' VAL . 31.4 t -118.63 134.17 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.212 -1.774 . . . . 15.0 106.212 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.409 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.854 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.235 -174.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 121.585 0.707 . . . . 15.0 112.905 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.618 HG12 HG22 ' A' ' 83' ' ' VAL . 16.7 m -129.85 141.75 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.005 -1.907 . . . . 15.0 110.433 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 67.6 m -135.0 107.78 10.51 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-N 115.477 -0.783 . . . . 15.0 113.037 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 105' ' ' SER . 71.0 Cg_endo -65.39 139.19 58.41 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.129 2.553 . . . . 15.0 112.561 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.91 139.62 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.968 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -126.57 137.29 53.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.516 -1.22 . . . . 15.0 110.98 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -137.6 137.44 38.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.228 -0.897 . . . . 15.0 111.864 176.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.86 138.0 10.0 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 115.43 -0.805 . . . . 15.0 112.329 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.41 -148.76 11.85 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 121.749 0.638 . . . . 15.0 114.582 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -124.49 131.47 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.513 1.149 . . . . 15.0 111.94 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.442 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 9.8 pt-20 -112.49 121.01 43.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.975 -1.921 . . . . 15.0 110.229 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -113.57 137.12 52.02 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.305 -1.316 . . . . 15.0 110.734 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.29 136.2 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 113.213 -1.812 . . . . 15.0 109.102 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 124' ' ' ILE . 8.5 tp -63.24 142.97 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 114.441 -1.254 . . . . 15.0 112.424 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -90.42 -91.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.255 -1.339 . . . . 15.0 109.758 168.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -118.84 114.47 22.68 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.033 0.533 . . . . 15.0 111.872 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -169.34 172.91 6.9 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.085 1.754 . . . . 15.0 110.276 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.9 tt -53.79 124.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.874 0.87 . . . . 15.0 110.918 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 m 56.35 74.83 0.64 Allowed Pre-proline 0 N--CA 1.483 1.185 0 CA-C-N 113.738 -1.573 . . . . 15.0 110.091 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.07 72.82 5.71 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 15.0 112.744 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 149' ' ' ARG . 6.1 pt-20 -163.55 30.57 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.177 -1.829 . . . . 15.0 113.145 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.418 ' H ' HG22 ' A' ' 116' ' ' ILE . 17.5 pt -116.64 136.17 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.251 -0.905 . . . . 15.0 113.438 -173.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.93 140.61 52.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.021 -1.9 . . . . 15.0 111.654 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 t -125.14 116.76 22.55 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.056 -1.884 . . . . 15.0 109.763 175.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.469 HH12 ' HA3' ' A' ' 31' ' ' GLY . 97.9 mtt180 -115.69 108.18 16.04 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.453 -1.703 . . . . 15.0 110.475 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.64 110.88 19.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.666 1.222 . . . . 15.0 111.585 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.76 150.18 39.7 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.54 -2.118 . . . . 15.0 112.07 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 25.2 p90 -97.21 128.06 43.74 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.18 123.83 48.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.264 -1.334 . . . . 15.0 111.598 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -126.38 146.59 50.0 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.501 -2.136 . . . . 15.0 110.868 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.483 1.181 0 CA-C-N 113.582 -1.644 . . . . 15.0 110.762 -171.785 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.339 0 N-CA-C 110.619 -0.992 . . . . 15.0 110.619 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 98.8 mtp -117.58 135.14 54.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.508 -0.846 . . . . 15.0 109.956 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 100.87 11.18 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.845 0.831 . . . . 15.0 111.757 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 61.2 m -93.11 125.2 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.682 -2.054 . . . . 15.0 109.949 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.67 126.87 53.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.514 -2.13 . . . . 15.0 109.096 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -115.17 110.89 2.37 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 112.486 -2.143 . . . . 15.0 110.423 -176.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.92 127.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 113.95 -1.125 . . . . 15.0 108.731 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 77.6 p -148.05 154.1 39.81 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.38 -1.736 . . . . 15.0 113.032 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -116.4 142.86 46.31 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.093 -1.412 . . . . 15.0 110.892 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 33.6 ttp-105 -70.13 126.14 28.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.452 -1.704 . . . . 15.0 109.618 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 113.63 -1.623 . . . . 15.0 110.013 -178.649 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.419 ' OD1' ' HA ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.965 0.888 . . . . 15.0 111.568 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' A' ' 33' ' ' GLN . 29.5 m -153.58 142.95 21.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.09 1.756 . . . . 15.0 108.499 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -101.23 130.49 47.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.064 -0.971 . . . . 15.0 108.672 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.532 ' HH ' ' NH2' ' A' ' 127' ' ' ARG . 71.3 t80 -125.2 105.86 9.45 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.474 -166.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.583 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.0 m -123.24 128.97 50.74 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.421 0.451 . . . . 15.0 110.046 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -137.48 151.17 21.06 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 114.995 -1.002 . . . . 15.0 115.447 -173.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -118.01 124.2 47.57 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.382 -1.409 . . . . 15.0 108.67 170.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.37 154.42 47.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.351 1.241 . . . . 15.0 114.351 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.2 161.76 20.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.339 -1.755 . . . . 15.0 111.949 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.62 96.72 0.59 Allowed Glycine 0 N--CA 1.476 1.362 0 N-CA-C 110.183 -1.167 . . . . 15.0 110.183 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.422 ' CZ3' ' HA ' ' A' ' 17' ' ' GLN . 50.2 t90 -102.63 123.1 45.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.767 0.794 . . . . 15.0 111.508 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 p -104.02 133.57 48.74 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.11 -0.95 . . . . 15.0 112.49 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.422 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 42.8 tt0 -64.12 -55.69 20.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.823 -1.535 . . . . 15.0 113.681 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.32 86.86 2.63 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.169 0.985 . . . . 15.0 111.689 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -137.41 134.1 35.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.968 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -54.54 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.048 1.499 . . . . 15.0 115.048 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -129.63 95.21 3.93 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.531 0.732 . . . . 15.0 110.293 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -122.76 149.16 44.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.58 -1.191 . . . . 15.0 113.761 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -74.31 154.07 39.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.849 -1.523 . . . . 15.0 110.314 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.63 -33.54 76.17 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.482 1.29 . . . . 15.0 114.482 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 140.38 8.61 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.519 1.057 . . . . 15.0 111.161 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 45' ' ' ASP . . . -141.6 86.47 2.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.613 -0.794 . . . . 15.0 110.136 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.15 92.93 0.59 Allowed Glycine 0 N--CA 1.474 1.19 0 CA-C-N 113.664 -1.607 . . . . 15.0 111.311 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . . . -117.99 121.03 39.59 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.071 0.512 . . . . 15.0 109.866 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.652 ' HB3' ' O ' ' A' ' 42' ' ' MET 0.293 5.2 t80 -161.63 179.81 7.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.332 -1.758 . . . . 15.0 111.625 175.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.83 -178.55 15.55 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 115.044 -0.98 . . . . 15.0 112.091 -170.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.5 -155.04 12.97 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 113.071 -1.565 . . . . 15.0 112.722 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -126.28 138.81 53.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 112.597 -1.802 . . . . 15.0 112.976 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.573 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 1.1 tm0? -115.73 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.098 -1.41 . . . . 15.0 107.982 167.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.419 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 43.8 t -107.47 -29.74 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 111.095 -2.775 . . . . 15.0 110.412 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 48.6 54.48 16.07 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 116.954 2.205 . . . . 15.0 116.954 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.65 -22.42 37.76 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.097 1.865 . . . . 15.0 112.077 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -166.67 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 128.95 2.9 . . . . 15.0 109.292 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.408 HG21 ' HB1' ' A' ' 61' ' ' ALA . 12.1 m -135.33 160.49 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.255 1.422 . . . . 15.0 112.246 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 148.12 26.92 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 108.785 -1.726 . . . . 15.0 108.785 161.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.21 126.29 52.53 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.439 0.296 . . . . 15.0 111.399 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.55 ' HG3' HH22 ' A' ' 127' ' ' ARG . 4.1 pm0 -142.33 133.56 26.19 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.058 0.849 . . . . 15.0 113.123 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.652 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.5 137.11 54.84 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.271 -1.331 . . . . 15.0 108.233 174.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.52 129.81 8.5 Favored Glycine 0 N--CA 1.48 1.582 0 O-C-N 126.072 2.108 . . . . 15.0 110.745 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.472 ' H ' ' HB2' ' A' ' 29' ' ' PHE . 6.8 t80 -104.75 112.68 25.88 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.493 0.663 . . . . 15.0 109.602 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 15.0 t70 -106.74 118.4 36.58 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.122 -1.399 . . . . 15.0 110.005 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -120.54 110.05 15.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.613 -1.63 . . . . 15.0 111.06 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 6.9 tt . . . . . 0 N--CA 1.48 1.027 0 CA-C-N 113.108 -1.86 . . . . 15.0 112.84 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 114.129 1.159 . . . . 15.0 114.129 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -115.46 101.97 9.38 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 15.0 112.467 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -119.26 142.19 16.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 112.226 -2.261 . . . . 15.0 111.141 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.71 135.16 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.185 -1.008 . . . . 15.0 111.164 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -109.8 116.63 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.912 -1.144 . . . . 15.0 107.912 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.6 111.19 21.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.82 -1.991 . . . . 15.0 109.095 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.7 p -130.21 147.41 51.93 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.453 -1.703 . . . . 15.0 113.797 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.408 ' HB1' HG21 ' A' ' 38' ' ' VAL . . . -104.28 134.21 47.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.422 -2.172 . . . . 15.0 109.232 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.545 ' HD3' HH21 ' A' ' 127' ' ' ARG . 22.0 ttpp -107.2 114.15 28.02 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.201 -1.363 . . . . 15.0 111.421 -172.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.91 142.81 46.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.084 -1.871 . . . . 15.0 109.755 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.88 -156.34 23.7 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.829 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.63 159.11 9.92 Favored Pre-proline 0 N--CA 1.481 1.116 0 N-CA-C 114.397 1.258 . . . . 15.0 114.397 -168.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.62 104.71 0.32 Allowed 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 123.264 2.643 . . . . 15.0 111.487 164.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -146.16 148.79 32.92 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.765 -2.016 . . . . 15.0 106.594 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp 70.29 -47.2 0.62 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.455 1.902 . . . . 15.0 111.548 -164.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.64 125.06 5.99 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.353 -1.099 . . . . 15.0 110.353 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -64.51 -57.28 9.63 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.58 0.752 . . . . 15.0 109.558 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -133.93 82.12 1.96 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.223 -0.899 . . . . 15.0 108.586 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -169.35 -75.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.979 -1.919 . . . . 15.0 108.944 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.534 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . 1.4 pt? -123.46 132.0 53.8 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.305 1.003 . . . . 15.0 110.847 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.92 135.56 54.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.436 -1.711 . . . . 15.0 108.757 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 tt -91.41 116.74 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.105 -0.952 . . . . 15.0 110.015 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.52 ' CD1' ' HG2' ' A' ' 62' ' ' LYS . 26.9 m-85 -135.96 138.82 42.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.25 -1.796 . . . . 15.0 115.06 -175.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 55.4 p -113.08 143.3 44.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 112.083 -2.326 . . . . 15.0 109.598 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 29.0 mtm105 -115.09 123.22 48.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.832 -1.531 . . . . 15.0 109.735 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tt -119.65 122.92 42.61 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.51 -1.223 . . . . 15.0 109.315 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -130.83 2.22 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 110.102 -1.199 . . . . 15.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 105' ' ' SER . . . 170.98 -166.44 39.63 Favored Glycine 0 N--CA 1.477 1.431 0 O-C-N 125.171 1.16 . . . . 15.0 114.999 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.7 ttm -119.4 129.68 54.92 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.175 -1.012 . . . . 15.0 112.146 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -122.59 135.8 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 113.521 -1.672 . . . . 15.0 108.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.439 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 9.2 p90 . . . . . 0 N--CA 1.476 0.867 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.778 172.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.031 0.444 . . . . 15.0 111.912 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.26 -27.32 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.008 -0.996 . . . . 15.0 112.814 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.507 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 4.7 t 32.84 70.93 0.72 Allowed Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 127.328 2.251 . . . . 15.0 114.533 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.07 95.04 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.678 2.919 . . . . 15.0 114.26 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.55 HG11 HE21 ' A' ' 131' ' ' GLN . 70.2 t -123.96 134.37 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.508 -1.223 . . . . 15.0 109.981 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.91 123.35 40.76 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.245 -1.798 . . . . 15.0 109.626 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -120.99 136.75 54.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.232 0.613 . . . . 15.0 110.878 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.67 135.3 7.86 Favored Glycine 0 N--CA 1.478 1.453 0 CA-C-N 115.452 -0.794 . . . . 15.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.47 -146.84 8.19 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 124.362 0.683 . . . . 15.0 113.605 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.76 154.28 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.159 -1.021 . . . . 15.0 113.43 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -119.57 143.64 47.52 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.902 -1.499 . . . . 15.0 110.403 167.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.534 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 46.0 m-85 -117.0 139.1 51.08 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.527 1.142 . . . . 15.0 111.892 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.95 104.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.266 -1.334 . . . . 15.0 111.275 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . 0.265 18.1 tt -79.95 84.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 123.076 1.417 . . . . 15.0 112.97 -175.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -115.68 102.54 9.84 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.677 -2.056 . . . . 15.0 109.5 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -170.77 -83.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.617 -1.629 . . . . 15.0 106.804 176.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.436 ' H ' ' HB3' ' A' ' 118' ' ' ARG . 35.6 mtt180 -69.17 155.81 39.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.392 0.677 . . . . 15.0 111.572 166.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.62 97.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 114.359 -1.291 . . . . 15.0 113.534 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.2 p -110.0 135.94 20.46 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 113.83 -1.532 . . . . 15.0 111.642 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.92 73.31 4.31 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.788 2.325 . . . . 15.0 114.053 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 50.11 39.39 19.23 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.899 1.679 . . . . 15.0 114.636 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.477 HD11 ' HB ' ' A' ' 146' ' ' VAL . 3.9 tt -123.4 142.23 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.663 -1.153 . . . . 15.0 113.748 -164.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.89 157.82 29.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.017 -1.902 . . . . 15.0 110.338 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 32.7 p -106.41 132.23 52.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.296 -0.865 . . . . 15.0 111.046 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.55 HH22 ' HG3' ' A' ' 41' ' ' GLU . 19.4 ttm180 -112.85 130.53 56.06 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.824 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.62 111.03 8.5 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.9 1.375 . . . . 15.0 111.757 173.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.37 150.21 52.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.368 -1.287 . . . . 15.0 112.624 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 57.1 t80 -97.27 116.32 29.26 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.282 1.039 . . . . 15.0 108.376 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.55 HE21 HG11 ' A' ' 107' ' ' VAL . 62.5 tt0 -96.59 108.75 21.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 111.971 -2.377 . . . . 15.0 110.251 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -112.03 146.51 37.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.92 -1.945 . . . . 15.0 112.296 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.48 1.056 0 CA-C-N 112.762 -2.017 . . . . 15.0 109.896 176.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.098 0 CA-C-O 121.987 0.771 . . . . 15.0 111.401 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -119.19 148.24 43.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.048 -1.576 . . . . 15.0 109.983 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.8 97.42 10.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.681 -1.229 . . . . 15.0 107.681 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.6 t -94.96 125.13 39.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.211 -1.359 . . . . 15.0 107.947 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.54 150.08 24.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.944 -1.934 . . . . 15.0 111.818 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.02 -162.6 29.64 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 114.094 -1.412 . . . . 15.0 113.707 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.477 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.0 m -119.38 127.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.449 -1.876 . . . . 15.0 110.64 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.494 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 23.1 t -130.01 132.1 46.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.857 -1.519 . . . . 15.0 110.507 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.56 154.99 34.61 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.643 0.735 . . . . 15.0 111.793 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -115.48 135.18 54.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.383 -1.281 . . . . 15.0 112.119 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 90.9 m-85 . . . . . 0 N--CA 1.482 1.164 0 CA-C-N 113.355 -1.748 . . . . 15.0 115.373 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 122.357 1.075 . . . . 15.0 113.003 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m -98.02 124.63 42.61 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.422 -1.717 . . . . 15.0 108.263 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.621 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 21.4 m0 -97.86 130.42 44.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.389 -1.278 . . . . 15.0 111.027 -177.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 97.6 m-85 -122.51 86.05 2.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.935 -1.939 . . . . 15.0 108.41 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -108.82 123.6 49.3 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.103 -1.408 . . . . 15.0 110.058 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.83 -144.52 4.14 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 125.019 1.449 . . . . 15.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.68 148.07 47.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -130.91 140.17 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 125.007 1.442 . . . . 15.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 143' ' ' SER . 40.1 tp -114.13 133.53 55.5 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.031 -1.441 . . . . 15.0 108.763 173.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.65 112.49 3.96 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 113.535 -1.666 . . . . 15.0 110.138 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -121.82 145.48 48.03 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.788 0.835 . . . . 15.0 110.833 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -130.32 145.48 51.78 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.308 -0.86 . . . . 15.0 111.259 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -79.94 79.34 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.055 0.931 . . . . 15.0 109.151 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -147.17 -82.36 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 112.846 -1.979 . . . . 15.0 111.281 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -116.18 136.84 52.65 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.402 0.681 . . . . 15.0 110.575 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.5 ptt-85 -65.77 -20.88 66.43 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.306 -1.315 . . . . 15.0 114.0 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -117.54 95.94 5.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.161 0.984 . . . . 15.0 109.683 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -173.69 -69.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.462 1.505 . . . . 15.0 111.048 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 54.8 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.652 1.581 . . . . 15.0 114.726 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.04 -37.54 80.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.477 -1.692 . . . . 15.0 114.556 -173.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.07 87.1 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 N-CA-C 118.0 1.96 . . . . 15.0 118.0 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.17 89.6 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.661 1.356 . . . . 15.0 114.661 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.43 -118.67 6.12 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.936 0.779 . . . . 15.0 111.9 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.42 137.99 39.94 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.306 -0.947 . . . . 15.0 110.112 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -117.6 113.66 22.26 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.643 -1.162 . . . . 15.0 111.143 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.3 101.42 1.04 Allowed Glycine 0 N--CA 1.476 1.342 0 CA-C-N 113.429 -1.714 . . . . 15.0 110.91 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.68 135.24 12.6 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 114.428 -0.886 . . . . 15.0 113.156 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -129.22 111.33 12.78 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.79 -1.205 . . . . 15.0 110.972 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.04 83.28 1.88 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.235 -0.893 . . . . 15.0 108.891 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.26 -83.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.552 -1.658 . . . . 15.0 110.456 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -81.22 135.44 50.76 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 117.535 -1.221 . . . . 15.0 109.407 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.26 78.93 0.81 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.436 2.758 . . . . 15.0 112.08 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -177.05 -76.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.005 2.122 . . . . 15.0 108.955 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.35 135.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.123 0.969 . . . . 15.0 108.466 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.34 -168.13 12.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 113.91 -1.496 . . . . 15.0 110.794 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.74 148.23 52.56 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.788 1.032 . . . . 15.0 113.788 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.517 ' HG2' ' HD3' ' A' ' 62' ' ' LYS . 70.9 mm-40 -127.26 127.21 44.02 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.239 -1.346 . . . . 15.0 110.644 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 90.9 mtp -116.64 134.45 54.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.158 -1.383 . . . . 15.0 110.608 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -115.72 114.17 3.06 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.215 -1.554 . . . . 15.0 109.215 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -116.57 122.32 44.32 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.871 0.843 . . . . 15.0 111.561 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -137.78 142.61 40.89 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.485 -1.689 . . . . 15.0 111.397 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -165.03 129.46 2.47 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.74 0.645 . . . . 15.0 112.74 173.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 CA-C-N 112.344 -2.207 . . . . 15.0 113.862 165.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' H ' ' NE2' ' A' ' 55' ' ' GLN . . . . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 123.648 1.69 . . . . 15.0 110.014 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.449 ' NE2' ' H ' ' A' ' 54' ' ' ALA . 24.7 mp0 -126.74 146.64 50.15 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.028 -1.896 . . . . 15.0 109.909 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.04 17.26 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 124.285 0.991 . . . . 15.0 113.978 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.613 ' O ' ' HB3' ' A' ' 82' ' ' MET . 12.7 p -147.29 148.26 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 112.978 -1.611 . . . . 15.0 111.239 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -121.27 126.22 49.01 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.536 1.934 . . . . 15.0 109.374 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.559 ' N ' ' HB2' ' A' ' 82' ' ' MET . 3.5 tm? -117.34 111.19 19.02 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.934 -0.395 . . . . 15.0 109.934 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 41' ' ' GLU . 13.7 t -131.9 146.32 52.04 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.42 -0.809 . . . . 15.0 112.829 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -103.13 136.39 43.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.039 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.532 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 59.6 pttt -115.83 143.56 45.23 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.914 1.45 . . . . 15.0 114.914 -171.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 45.4 mt -115.5 136.41 53.11 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.925 -1.943 . . . . 15.0 110.058 169.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.42 111.92 4.2 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 124.744 1.277 . . . . 15.0 111.529 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.437 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 4.1 m-30 -110.69 105.0 56.89 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.933 1.293 . . . . 15.0 111.713 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.58 -145.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.052 2.502 . . . . 15.0 111.584 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 69.03 -68.97 0.17 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 127.487 2.315 . . . . 15.0 115.181 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.512 ' HB3' HD11 ' A' ' 75' ' ' ILE . 28.4 tp -60.91 99.7 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.439 1.096 . . . . 15.0 113.596 -168.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.92 -85.74 0.44 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.827 -1.988 . . . . 15.0 109.461 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 t -179.1 171.36 1.36 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.406 1.482 . . . . 15.0 110.083 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -51.54 -31.09 22.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.669 1.729 . . . . 15.0 115.669 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.05 -29.41 63.4 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.338 1.236 . . . . 15.0 114.338 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.46 112.99 18.17 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.098 0.959 . . . . 15.0 111.423 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.54 134.26 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.08 -1.418 . . . . 15.0 109.721 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 68' ' ' LEU . 4.5 mp -91.34 141.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.509 -1.678 . . . . 15.0 107.388 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 79.6 m-85 -126.6 128.79 47.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.793 -1.094 . . . . 15.0 109.763 173.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.2 p -108.4 122.57 47.28 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.378 -1.283 . . . . 15.0 108.397 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HG2' ' HB3' ' A' ' 62' ' ' LYS . 99.2 mtt180 -125.19 123.22 39.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.508 -2.133 . . . . 15.0 111.534 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.44 132.09 52.77 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.908 -1.042 . . . . 15.0 112.449 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.34 -140.18 5.77 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.967 -1.015 . . . . 15.0 113.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.01 140.87 3.0 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.187 1.375 . . . . 15.0 111.8 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.613 ' HB3' ' O ' ' A' ' 57' ' ' VAL 0.364 0.4 OUTLIER -156.91 164.33 38.16 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.515 -2.168 . . . . 15.0 112.659 159.424 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 103' ' ' SER . 18.8 m -97.99 125.97 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.234 0.959 . . . . 15.0 110.18 -172.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.9 p90 . . . . . 0 N--CA 1.476 0.826 0 CA-C-N 115.484 -0.78 . . . . 15.0 112.858 -176.717 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.452 ' HB3' HG12 ' A' ' 83' ' ' VAL . 17.1 t . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.596 0.712 . . . . 15.0 112.142 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.49 167.9 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 113.988 -1.46 . . . . 15.0 111.264 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m 68.14 148.53 0.12 Allowed Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 125.918 1.687 . . . . 15.0 114.368 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -61.19 142.05 95.37 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.651 2.234 . . . . 15.0 113.102 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.87 136.72 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 112.838 -1.983 . . . . 15.0 107.216 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.55 129.66 54.78 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.408 -1.724 . . . . 15.0 110.13 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -122.65 131.54 53.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.102 -1.408 . . . . 15.0 112.061 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.38 99.04 0.92 Allowed Glycine 0 N--CA 1.475 1.278 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.786 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -115.5 145.52 18.7 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 124.79 0.936 . . . . 15.0 112.85 -174.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 127' ' ' ARG . 19.2 m -121.59 138.46 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.716 -0.742 . . . . 15.0 112.042 171.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.28 109.34 19.76 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.077 -1.874 . . . . 15.0 107.94 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -120.59 136.08 54.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.716 -1.584 . . . . 15.0 111.64 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.39 107.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.46 -1.7 . . . . 15.0 110.689 171.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.9 tp -113.22 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 122.837 1.303 . . . . 15.0 111.648 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.682 ' HD3' HG21 ' A' ' 121' ' ' THR . 47.9 mtt-85 -122.23 -30.79 3.95 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.791 2.515 . . . . 15.0 117.791 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.27 -28.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 118.456 2.762 . . . . 15.0 118.456 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 47.7 mtt-85 -101.09 149.71 23.68 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.393 1.077 . . . . 15.0 112.244 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.491 ' H ' HG13 ' A' ' 120' ' ' ILE . 16.9 mt -11.78 -81.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 128.311 2.644 . . . . 15.0 113.735 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.682 HG21 ' HD3' ' A' ' 117' ' ' ARG . 67.8 p 58.49 159.61 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 126.233 1.813 . . . . 15.0 115.489 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.64 161.87 33.79 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.655 2.236 . . . . 15.0 111.415 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -68.46 78.21 0.27 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.215 1.006 . . . . 15.0 112.191 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mm -120.94 105.35 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.595 1.158 . . . . 15.0 109.486 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.3 120.49 40.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.571 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -80.78 117.01 21.07 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.921 -1.036 . . . . 15.0 109.359 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.485 ' NE ' HH22 ' A' ' 78' ' ' ARG . 33.6 mtt180 -115.21 119.91 37.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.626 -1.17 . . . . 15.0 112.721 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.48 118.04 28.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.054 -1.43 . . . . 15.0 110.39 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.568 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 31.3 tt0 -120.65 132.98 55.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 112.727 -2.033 . . . . 15.0 111.285 -171.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 76.3 m-85 -97.4 128.22 44.02 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.302 -1.317 . . . . 15.0 110.336 171.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 141' ' ' MET . 48.1 tt0 -109.85 108.76 19.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.432 -1.713 . . . . 15.0 109.108 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -117.93 146.58 43.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.599 -2.091 . . . . 15.0 112.066 -174.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.48 1.034 0 CA-C-N 114.138 -1.392 . . . . 15.0 111.791 174.565 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 CA-C-O 122.033 0.796 . . . . 15.0 113.174 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.67 ' HB2' ' HB3' ' A' ' 131' ' ' GLN . 48.1 mtt -117.6 148.26 42.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.716 -1.242 . . . . 15.0 110.925 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.03 112.32 18.11 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.98 -1.009 . . . . 15.0 110.055 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 68.1 m -105.86 125.09 50.58 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.69 -1.595 . . . . 15.0 107.348 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 pp -132.65 141.1 48.47 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.84 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.13 -162.46 29.35 Favored Glycine 0 N--CA 1.473 1.121 0 O-C-N 124.191 0.932 . . . . 15.0 113.509 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.07 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.606 -1.297 . . . . 15.0 109.442 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 62.5 p -115.85 138.25 51.34 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.89 1.369 . . . . 15.0 110.731 170.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -111.51 135.22 52.38 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.009 -1.45 . . . . 15.0 110.768 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 45.8 ttm180 -78.86 123.93 27.72 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.544 -1.207 . . . . 15.0 108.562 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 7' ' ' TRP . 88.7 t80 . . . . . 0 N--CA 1.483 1.189 0 O-C-N 125.347 1.654 . . . . 15.0 115.377 -173.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 122.092 0.948 . . . . 15.0 113.501 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 p -98.19 140.07 33.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.785 -1.098 . . . . 15.0 112.907 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -110.35 131.08 55.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.766 -2.015 . . . . 15.0 110.184 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.479 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 5.5 m-85 -124.1 131.28 53.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.617 -1.629 . . . . 15.0 108.978 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -126.96 133.43 50.6 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.496 0.718 . . . . 15.0 111.623 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -172.94 -146.23 5.34 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-N 115.191 -0.913 . . . . 15.0 113.191 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.42 150.1 51.79 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.423 0.898 . . . . 15.0 113.423 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.32 142.91 50.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.454 1.096 . . . . 15.0 112.727 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.6 tp -114.05 140.4 48.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.199 -1.819 . . . . 15.0 108.8 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.4 127.41 7.73 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.153 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 10.2 t-105 -118.33 141.15 48.82 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.463 -0.868 . . . . 15.0 110.948 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 t -108.73 105.2 14.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.528 -1.214 . . . . 15.0 109.818 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -52.79 -44.11 66.35 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.975 -1.466 . . . . 15.0 111.753 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -65.66 -49.15 69.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.111 0.964 . . . . 15.0 113.297 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -103.2 83.65 2.23 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.747 1.26 . . . . 15.0 112.045 -172.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' HG2' ' HG3' ' A' ' 21' ' ' GLU . 53.8 ttt85 -5.98 -81.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.04 2.936 . . . . 15.0 117.614 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.488 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 40.6 mt-10 -125.4 92.01 3.53 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.89 0.852 . . . . 15.0 111.802 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -114.18 91.63 3.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.457 -1.247 . . . . 15.0 112.918 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.7 87.94 1.27 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.911 -1.495 . . . . 15.0 111.573 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -106.37 -41.41 5.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.993 -1.912 . . . . 15.0 112.848 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.62 -151.4 18.42 Favored Glycine 0 N--CA 1.476 1.308 0 O-C-N 123.905 0.753 . . . . 15.0 112.1 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.33 148.49 50.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.755 -1.223 . . . . 15.0 111.299 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.54 -166.64 16.29 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.776 1.297 . . . . 15.0 110.556 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.01 49.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.501 0.667 . . . . 15.0 111.44 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.01 113.37 19.48 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.722 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.72 112.0 3.95 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 112.732 -2.031 . . . . 15.0 110.198 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.84 142.88 15.95 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 110.702 -0.959 . . . . 15.0 110.702 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 11.4 t80 -141.11 132.67 27.04 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.104 -0.548 . . . . 15.0 111.124 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -121.41 94.1 4.22 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.966 0.888 . . . . 15.0 110.617 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.31 -63.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.483 -2.144 . . . . 15.0 111.688 174.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -143.82 144.85 28.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.43 1.492 . . . . 15.0 109.618 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.98 89.5 0.37 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.488 2.792 . . . . 15.0 111.768 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 t80 172.7 -48.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.51 -2.132 . . . . 15.0 109.058 -169.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 48.3 t -131.52 124.02 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.154 0.982 . . . . 15.0 108.83 175.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.37 148.23 16.72 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.924 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 78.5 m-85 -112.78 136.66 52.15 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.1 0.778 . . . . 15.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.54 114.21 14.0 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.843 -1.526 . . . . 15.0 112.034 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.4 ttp -104.08 128.66 51.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.686 -1.597 . . . . 15.0 109.062 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.25 114.16 3.9 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 113.88 -1.509 . . . . 15.0 109.751 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.66 109.44 18.6 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.407 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -121.2 124.08 43.81 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.559 -1.2 . . . . 15.0 111.361 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -125.11 145.18 50.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.753 -1.567 . . . . 15.0 109.783 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.1 tp . . . . . 0 N--CA 1.476 0.849 0 CA-C-N 115.775 -0.648 . . . . 15.0 112.359 179.376 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 122.493 1.139 . . . . 15.0 113.316 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 pm0 -115.34 154.83 28.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.438 -1.256 . . . . 15.0 112.309 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.47 118.41 4.37 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 114.578 -1.192 . . . . 15.0 111.114 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.65 127.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 122.193 0.997 . . . . 15.0 111.687 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 82' ' ' MET . 0.3 OUTLIER -116.54 140.79 48.99 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.114 -1.403 . . . . 15.0 112.035 174.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.21 111.14 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.185 -1.825 . . . . 15.0 109.011 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -124.65 134.74 52.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.146 0.975 . . . . 15.0 112.621 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.16 46.09 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.836 -1.529 . . . . 15.0 110.79 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.542 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 1.8 ttpm? -84.18 129.15 34.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.301 -1.772 . . . . 15.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.683 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 41.7 tp -108.95 114.58 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.505 -2.134 . . . . 15.0 107.691 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 76' ' ' TYR . . . 127.94 -147.38 17.24 Favored Glycine 0 CA--C 1.541 1.692 0 O-C-N 126.346 2.279 . . . . 15.0 113.941 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.533 ' H ' ' HB2' ' A' ' 76' ' ' TYR . 43.3 t80 160.81 -60.5 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 116.546 -1.692 . . . . 15.0 112.821 -160.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -79.15 -147.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.447 2.764 . . . . 15.0 112.788 -167.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 53.98 84.76 0.06 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.291 1.836 . . . . 15.0 110.053 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp 69.36 -26.13 0.15 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.245 1.418 . . . . 15.0 114.54 -165.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.83 64.22 0.19 Allowed Glycine 0 N--CA 1.483 1.786 0 C-N-CA 124.949 1.261 . . . . 15.0 114.312 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.89 37.77 3.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.038 1.335 . . . . 15.0 109.458 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -167.52 -63.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.386 1.074 . . . . 15.0 112.475 -172.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 114' ' ' TYR . 4.7 m-20 -56.62 -49.46 74.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.524 0.935 . . . . 15.0 113.524 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER 141.82 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 130.372 3.469 . . . . 15.0 107.385 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.542 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 7.7 m-20 -113.34 105.35 13.29 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.924 -0.485 . . . . 15.0 110.307 -174.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.633 ' HB ' HG12 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -119.85 111.0 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.656 -1.239 . . . . 15.0 107.656 176.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.683 ' HB3' ' O ' ' A' ' 63' ' ' LEU 0.437 0.2 OUTLIER -169.01 -171.74 1.4 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 111.384 -2.644 . . . . 15.0 114.773 -177.474 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.9 t -108.12 139.48 42.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.223 1.011 . . . . 15.0 110.585 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 109' ' ' ALA . 9.8 ptp180 -118.95 139.69 51.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.033 -1.894 . . . . 15.0 114.147 -170.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 108' ' ' PHE . 2.7 pp -125.19 143.48 50.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 112.07 -2.332 . . . . 15.0 111.015 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.42 -154.45 11.75 Favored Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.33 1.019 . . . . 15.0 114.671 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.12 151.52 21.83 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 113.567 -1.316 . . . . 15.0 114.059 -173.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.469 ' HG2' ' HB3' ' A' ' 58' ' ' GLN . 90.1 mtp -116.54 115.41 25.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.588 1.555 . . . . 15.0 110.361 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.18 132.59 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 114.943 -1.026 . . . . 15.0 108.905 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 . . . . . 0 N--CA 1.475 0.786 0 CA-C-N 114.79 -1.095 . . . . 15.0 110.041 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 121.871 0.843 . . . . 15.0 113.057 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -59.4 -32.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 15.0 113.263 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.81 84.62 0.19 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 127.265 2.226 . . . . 15.0 112.595 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -63.33 133.87 42.44 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.685 2.257 . . . . 15.0 112.747 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.33 138.02 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.422 -1.717 . . . . 15.0 109.695 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -122.88 129.86 52.15 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.636 -1.165 . . . . 15.0 111.817 175.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.581 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -133.7 147.32 51.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.281 -1.327 . . . . 15.0 111.149 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 138.64 10.75 Favored Glycine 0 N--CA 1.48 1.619 0 CA-C-O 119.011 -0.883 . . . . 15.0 111.221 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.14 -158.08 25.42 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 118.208 2.043 . . . . 15.0 118.208 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.633 HG12 ' HB ' ' A' ' 75' ' ' ILE . 33.0 m -120.67 130.66 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 111.911 -2.144 . . . . 15.0 111.556 -171.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.87 125.4 48.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.184 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 60.0 t80 -108.48 139.19 43.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 111.9 -2.409 . . . . 15.0 108.633 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 11.8 p -129.11 145.61 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 113.908 -1.496 . . . . 15.0 107.833 168.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 0.3 OUTLIER -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 124.483 1.114 . . . . 15.0 113.152 -177.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -80.64 -89.14 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.465 -2.152 . . . . 15.0 109.364 175.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 108.98 8.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.222 0.609 . . . . 15.0 109.81 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -167.71 164.55 14.4 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.568 -1.197 . . . . 15.0 111.37 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.1 mt -53.08 131.49 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.511 1.524 . . . . 15.0 109.95 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.411 HG22 ' HG2' ' A' ' 123' ' ' GLU . 17.6 m 55.83 79.84 0.32 Allowed Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 125.58 1.552 . . . . 15.0 109.68 -174.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.46 80.36 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.633 2.888 . . . . 15.0 113.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.7 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 14.2 pt-20 -162.36 22.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.802 1.779 . . . . 15.0 115.802 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.533 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 20.4 mt -116.7 108.15 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.92 -0.487 . . . . 15.0 110.542 -169.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 115' ' ' VAL . . . -110.68 143.13 41.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.024 -0.989 . . . . 15.0 111.031 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.8 m -139.63 116.93 11.24 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.254 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.693 ' CZ ' ' HG ' ' A' ' 147' ' ' SER . 0.0 OUTLIER -128.24 137.61 52.08 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.832 -1.076 . . . . 15.0 112.78 178.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.34 120.02 16.17 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.774 -1.103 . . . . 15.0 112.089 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -137.29 142.33 41.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 112.547 -2.115 . . . . 15.0 112.879 -174.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 79.2 m-85 -97.43 112.57 24.35 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.218 -1.355 . . . . 15.0 110.053 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -108.04 130.86 55.05 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.887 1.367 . . . . 15.0 113.695 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.458 ' HZ3' ' HB3' ' A' ' 130' ' ' TYR . 1.3 m-90 -120.51 120.37 35.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.492 -1.685 . . . . 15.0 112.289 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.483 1.183 0 CA-C-N 113.594 -1.639 . . . . 15.0 111.372 164.148 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 112.042 -0.423 . . . . 15.0 112.042 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 9.6 ttt -126.15 148.18 49.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.919 0.888 . . . . 15.0 111.904 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 6.4 tt -88.38 126.75 35.36 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.192 -1.41 . . . . 15.0 107.192 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.2 t -120.4 125.35 47.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.774 0.797 . . . . 15.0 111.163 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.1 tp -121.19 126.87 50.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.705 -1.589 . . . . 15.0 109.332 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.38 138.17 10.33 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 114.482 -1.235 . . . . 15.0 112.813 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.1 m -125.55 127.61 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 113.91 -1.145 . . . . 15.0 110.651 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.693 ' HG ' ' CZ ' ' A' ' 127' ' ' ARG . 14.5 p -134.6 155.81 49.81 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.742 1.386 . . . . 15.0 114.742 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.7 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 12.1 m-85 -114.1 139.32 49.4 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.228 -1.806 . . . . 15.0 111.24 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -70.25 157.41 37.73 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.198 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.1 t80 . . . . . 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.003 . . . . 15.0 111.565 174.823 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 116.865 2.172 . . . . 15.0 116.865 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.527 ' HB2' ' HD2' ' A' ' 149' ' ' ARG . 69.1 Cg_endo -78.51 31.78 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.028 1.818 . . . . 15.0 114.611 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -132.32 146.96 52.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.116 0.966 . . . . 15.0 109.735 -173.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.578 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 28.1 m-20 72.21 99.2 0.07 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.94 1.696 . . . . 15.0 113.78 175.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.49 ' H ' ' HA ' ' A' ' 34' ' ' VAL . 33.7 m-80 59.67 48.31 9.54 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 112.799 -2.0 . . . . 15.0 111.614 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.9 p -116.31 158.79 22.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.584 -1.644 . . . . 15.0 111.801 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.5 ' HB3' ' CA ' ' A' ' 150' ' ' PHE . 1.8 t90 -94.23 140.45 29.76 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.287 1.041 . . . . 15.0 111.76 -172.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -115.28 105.86 13.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.068 1.747 . . . . 15.0 109.234 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 m -124.33 118.2 26.21 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.6 161.81 28.58 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 115.151 0.82 . . . . 15.0 115.151 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.71 50.88 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.39 -0.905 . . . . 15.0 110.516 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -151.66 150.77 30.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.177 1.177 . . . . 15.0 114.177 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.69 133.46 55.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.287 -1.324 . . . . 15.0 112.66 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -124.6 151.09 17.2 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.307 -1.769 . . . . 15.0 114.984 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -126.06 140.76 52.33 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.515 -1.342 . . . . 15.0 111.557 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.7 p -113.2 144.33 42.86 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.18 1.467 . . . . 15.0 114.51 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -54.54 120.51 6.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.782 -2.008 . . . . 15.0 111.025 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.6 t80 58.86 41.63 21.07 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.228 -1.351 . . . . 15.0 113.727 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -67.18 80.56 0.13 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.34 1.067 . . . . 15.0 113.69 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -61.69 -37.29 83.57 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.194 -1.367 . . . . 15.0 114.112 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -82.72 141.96 32.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.133 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -70.28 87.09 0.6 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.303 1.002 . . . . 15.0 110.573 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -143.15 129.49 19.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.984 -1.916 . . . . 15.0 108.991 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.13 132.59 56.0 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.054 -1.43 . . . . 15.0 108.125 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.65 46.47 1.11 Allowed Glycine 0 N--CA 1.48 1.584 0 C-N-CA 125.099 1.333 . . . . 15.0 115.095 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.71 92.99 1.6 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.734 1.214 . . . . 15.0 109.192 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.33 139.57 14.29 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.189 -1.823 . . . . 15.0 112.903 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 121.2 41.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.725 -1.737 . . . . 15.0 106.928 171.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 42' ' ' MET . 21.4 m-85 -111.86 113.42 25.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.916 -1.493 . . . . 15.0 110.734 -173.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.99 146.51 16.15 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 112.453 -2.158 . . . . 15.0 110.243 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.27 -154.5 20.51 Favored Glycine 0 N--CA 1.473 1.165 0 CA-C-N 114.546 -0.827 . . . . 15.0 112.837 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 141.83 34.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 113.257 -1.471 . . . . 15.0 112.807 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -117.0 98.14 6.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.654 1.216 . . . . 15.0 110.772 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 4' ' ' ASP . 14.6 m -79.74 -38.68 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 112.934 -1.939 . . . . 15.0 115.636 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -139.96 154.22 70.31 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 118.696 -0.669 . . . . 15.0 112.745 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.44 66.64 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 15.0 110.485 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.43 -79.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.792 2.037 . . . . 15.0 108.488 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.58 145.22 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.145 1.165 . . . . 15.0 114.145 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.36 -179.98 25.67 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 112.61 -2.086 . . . . 15.0 110.721 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.82 133.64 55.31 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.142 -0.529 . . . . 15.0 112.414 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 26.7 tt0 -129.49 128.83 43.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.339 -1.301 . . . . 15.0 110.673 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 67.1 mtm -123.21 139.33 54.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.381 -0.827 . . . . 15.0 110.586 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.04 114.17 2.44 Favored Glycine 0 N--CA 1.476 1.322 0 O-C-N 124.61 1.194 . . . . 15.0 111.778 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 46' ' ' TRP . 72.5 t80 -107.02 109.52 21.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.465 1.106 . . . . 15.0 111.235 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -113.7 118.45 34.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.49 -1.232 . . . . 15.0 108.768 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.484 ' HB2' ' CE2' ' A' ' 44' ' ' TYR . 24.0 t90 -114.84 119.16 35.65 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.984 -1.007 . . . . 15.0 110.84 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.664 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 18.7 tp -81.69 75.2 8.65 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.556 -1.202 . . . . 15.0 110.983 177.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.96 55.86 2.23 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-N 113.72 -1.582 . . . . 15.0 112.121 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.07 -70.61 0.68 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.201 1.4 . . . . 15.0 108.554 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.8 mmt -63.88 147.66 95.89 Favored Pre-proline 0 N--CA 1.477 0.914 0 CA-C-O 118.163 -0.922 . . . . 15.0 111.334 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -70.27 30.54 0.2 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.589 2.859 . . . . 15.0 115.95 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -132.64 139.25 47.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.296 1.439 . . . . 15.0 107.919 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HA ' ' HE1' ' A' ' 46' ' ' TRP . 63.4 mttp -75.57 76.26 2.59 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.888 1.328 . . . . 15.0 112.734 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . . . -76.22 83.38 3.02 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.994 -1.457 . . . . 15.0 110.744 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -93.95 103.14 15.24 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.389 -2.187 . . . . 15.0 110.292 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.03 2.34 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 108.892 -1.683 . . . . 15.0 108.892 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 t -117.83 133.15 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 114.467 -0.867 . . . . 15.0 109.735 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.751 HE22 ' NH1' ' A' ' 78' ' ' ARG . 13.7 pt20 -109.7 139.52 44.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.486 -1.234 . . . . 15.0 111.487 170.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.32 111.05 17.28 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.489 -1.687 . . . . 15.0 108.893 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.426 HG21 ' CZ ' ' A' ' 78' ' ' ARG . 39.9 p -131.29 146.74 52.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.003 -1.453 . . . . 15.0 113.301 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -100.37 128.37 46.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.018 -1.446 . . . . 15.0 108.146 172.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.45 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.1 pttm -113.5 136.53 52.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.62 -1.173 . . . . 15.0 112.857 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 3.2 tt -105.98 108.41 19.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.532 -1.667 . . . . 15.0 108.226 172.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.88 98.12 2.11 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.011 -1.904 . . . . 15.0 109.363 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -117.21 138.22 24.7 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.975 -1.112 . . . . 15.0 111.761 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HA ' ' OD2' ' A' ' 74' ' ' ASP . 58.4 Cg_endo -64.22 -37.7 39.67 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.252 2.635 . . . . 15.0 115.814 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 tptt 49.92 32.06 5.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.838 1.655 . . . . 15.0 114.762 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.45 47.87 23.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.978 1.311 . . . . 15.0 114.138 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 73' ' ' LEU . . . -63.46 84.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.651 0 C-N-CA 124.257 0.932 . . . . 15.0 112.26 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -67.88 28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.938 2.94 . . . . 15.0 118.938 -165.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -169.82 -68.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.881 2.072 . . . . 15.0 107.775 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -170.05 87.48 0.14 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.009 1.324 . . . . 15.0 108.47 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 19.6 tp -159.35 141.09 13.27 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.334 171.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.519 ' OD2' ' HA ' ' A' ' 66' ' ' PRO . 10.7 m-20 -138.1 150.45 46.88 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.277 -1.328 . . . . 15.0 110.923 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 tt -108.68 140.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.394 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 51.5 p90 -125.71 128.73 48.24 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.548 -1.205 . . . . 15.0 109.33 169.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.4 m -113.66 122.54 47.47 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.46 -1.311 . . . . 15.0 107.46 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.751 ' NH1' HE22 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -120.67 123.29 42.39 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.057 -1.429 . . . . 15.0 113.108 -175.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 136.78 54.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.995 -1.457 . . . . 15.0 110.941 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.39 -143.21 7.47 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.448 1.092 . . . . 15.0 113.272 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 105' ' ' SER . . . -130.25 143.9 15.18 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 114.047 -1.077 . . . . 15.0 114.066 -174.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.484 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 25.5 ptt? -116.11 120.15 38.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.165 0.983 . . . . 15.0 112.93 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.67 140.82 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 113.359 -1.746 . . . . 15.0 108.493 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -113.84 140.37 48.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.83 -1.077 . . . . 15.0 108.614 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.413 ' HD3' ' CB ' ' A' ' 88' ' ' THR . 88.9 mtt180 68.24 -36.01 0.3 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 117.164 2.283 . . . . 15.0 117.164 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 70.7 -54.06 0.65 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 128.289 2.635 . . . . 15.0 113.388 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 7.7 t70 -149.81 105.68 3.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.917 0.887 . . . . 15.0 109.532 172.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.413 ' CB ' ' HD3' ' A' ' 85' ' ' ARG . 10.1 t -79.99 157.65 26.76 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.877 -1.056 . . . . 15.0 112.948 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 t -116.37 151.79 35.23 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.771 -1.104 . . . . 15.0 111.278 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -169.84 -39.58 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 113.65 -1.614 . . . . 15.0 112.803 -171.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.9 tttm 56.61 88.28 0.05 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.011 1.724 . . . . 15.0 112.95 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.72 76.64 4.25 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.928 -1.487 . . . . 15.0 111.598 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.7 -89.72 0.19 Allowed Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.346 -1.297 . . . . 15.0 112.443 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -178.57 157.94 1.02 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.127 2.171 . . . . 15.0 110.544 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.96 -141.45 14.89 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.991 -1.004 . . . . 15.0 111.443 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -109.12 91.22 3.55 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.283 1.039 . . . . 15.0 111.64 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.7 130.41 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 113.1 -1.864 . . . . 15.0 107.647 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 t -64.68 150.69 46.69 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.134 -0.939 . . . . 15.0 111.913 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.62 130.23 42.57 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.837 -1.074 . . . . 15.0 111.613 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 87' ' ' ASP . . . -77.81 64.23 3.02 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.241 1.496 . . . . 15.0 113.198 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -76.16 124.42 27.41 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.106 -1.861 . . . . 15.0 111.464 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.09 149.61 30.57 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 113.984 -1.462 . . . . 15.0 111.086 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.9 p -91.12 144.8 25.25 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.973 1.471 . . . . 15.0 114.973 -170.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -71.46 137.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 113.398 -1.728 . . . . 15.0 111.461 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.631 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 78.8 p -120.09 117.94 31.79 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.372 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.6 101.78 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.096 2.531 . . . . 15.0 112.278 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 131' ' ' GLN . 16.4 m -125.02 130.87 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.19 -1.823 . . . . 15.0 113.112 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -127.96 131.36 49.29 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 113.749 -1.569 . . . . 15.0 111.114 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 131' ' ' GLN . . . -128.77 143.73 50.99 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.722 1.008 . . . . 15.0 113.722 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.56 108.63 2.12 Favored Glycine 0 N--CA 1.474 1.217 0 CA-C-N 112.932 -1.94 . . . . 15.0 108.732 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -119.5 144.11 17.42 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.723 -0.739 . . . . 15.0 112.955 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.49 137.17 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 114.539 -0.831 . . . . 15.0 111.633 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -125.4 139.33 53.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.241 -1.799 . . . . 15.0 113.757 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -117.87 141.81 48.02 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 112.694 -2.048 . . . . 15.0 109.255 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.7 m -105.69 132.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.158 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 pt -62.2 95.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.104 1.89 . . . . 15.0 116.104 -171.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -78.6 82.9 4.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.503 1.144 . . . . 15.0 109.58 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.3 ttt-85 -175.38 -143.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.393 2.277 . . . . 15.0 107.366 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.34 99.85 0.15 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.829 1.252 . . . . 15.0 112.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.6 mt 64.63 85.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.715 2.006 . . . . 15.0 111.401 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 m -59.86 -45.78 98.28 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 117.188 -1.386 . . . . 15.0 114.076 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.89 70.75 6.89 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.938 1.759 . . . . 15.0 111.531 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 36.1 tt0 -138.74 -83.84 0.28 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.188 -1.823 . . . . 15.0 108.834 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.74 143.51 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.663 0.986 . . . . 15.0 113.663 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.42 123.53 48.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.611 -2.086 . . . . 15.0 109.406 172.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.469 ' HA ' HG12 ' A' ' 146' ' ' VAL . 11.9 m -80.83 116.87 21.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.423 -1.695 . . . . 15.0 106.423 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.47 ' HB2' ' HH ' ' A' ' 76' ' ' TYR . 0.8 OUTLIER -125.49 135.44 52.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.104 -1.407 . . . . 15.0 113.749 -172.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.98 111.07 13.14 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.648 -2.069 . . . . 15.0 110.327 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.532 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 21.9 tt0 -114.67 135.24 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.984 -1.916 . . . . 15.0 110.156 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -115.31 107.17 14.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.713 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 0.0 OUTLIER -96.62 114.76 26.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 112.581 -2.099 . . . . 15.0 109.73 -170.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -118.77 146.57 44.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.326 1.232 . . . . 15.0 114.326 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.7 t -124.46 150.76 45.35 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.268 -1.787 . . . . 15.0 112.363 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.673 ' ND2' ' H ' ' A' ' 135' ' ' ASN . 36.5 t30 54.41 -162.84 0.13 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.752 2.021 . . . . 15.0 112.99 -173.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.673 ' H ' ' ND2' ' A' ' 134' ' ' ASN . 5.7 t-20 -110.71 166.81 10.71 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.782 0.833 . . . . 15.0 110.746 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 54.64 -171.89 0.05 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.156 1.782 . . . . 15.0 112.127 -170.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.4 p -65.99 85.3 0.09 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.811 0.815 . . . . 15.0 110.624 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -102.31 -101.63 0.28 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.242 -1.799 . . . . 15.0 110.187 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -133.89 125.97 29.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.58 0.752 . . . . 15.0 110.419 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -118.33 143.21 17.5 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 125.592 1.807 . . . . 15.0 114.639 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.713 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 56.9 ttm -117.79 137.14 52.94 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.287 -1.456 . . . . 15.0 109.141 170.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.93 101.94 11.17 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.165 -1.38 . . . . 15.0 109.98 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 57.0 m -109.98 125.14 52.56 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.892 -1.504 . . . . 15.0 110.616 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.85 140.89 44.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.441 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.04 -162.57 29.59 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 114.801 -1.091 . . . . 15.0 113.585 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 126' ' ' THR . 15.1 m -128.4 139.72 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 113.846 -1.177 . . . . 15.0 112.547 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 p -115.16 134.25 55.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.527 -1.215 . . . . 15.0 112.217 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 41.9 t80 -103.53 135.09 45.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.331 -1.304 . . . . 15.0 109.195 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.527 ' HD2' ' HB2' ' A' ' 2' ' ' PRO . 19.2 mmt180 -73.69 124.97 27.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.178 -1.828 . . . . 15.0 112.033 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.5 ' CA ' ' HB3' ' A' ' 7' ' ' TRP . 55.1 m-85 69.55 -77.61 0.05 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.504 1.922 . . . . 15.0 111.806 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.35 77.69 1.0 Allowed Glycine 0 N--CA 1.477 1.403 0 N-CA-C 110.64 -0.984 . . . . 15.0 110.64 -171.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -56.1 -41.92 75.99 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.077 1.351 . . . . 15.0 113.287 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.92 73.98 2.23 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 108.995 -1.642 . . . . 15.0 108.995 168.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.79 85.68 0.21 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.667 1.223 . . . . 15.0 112.828 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.88 99.14 0.6 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.643 -1.617 . . . . 15.0 112.827 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.324 0 CA-C-N 114.001 -1.454 . . . . 15.0 114.182 177.379 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 114.236 1.198 . . . . 15.0 114.236 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.34 62.56 6.95 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.32 2.68 . . . . 15.0 113.737 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.14 50.42 1.05 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.908 1.283 . . . . 15.0 112.756 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -164.58 45.69 0.1 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.141 -1.39 . . . . 15.0 112.205 -170.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -56.11 -54.23 47.52 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.091 -0.959 . . . . 15.0 111.308 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 150' ' ' PHE . 4.7 p -148.39 139.38 23.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.579 -1.191 . . . . 15.0 111.195 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -127.86 136.21 51.1 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.91 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -125.72 127.57 46.41 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.131 -1.395 . . . . 15.0 110.728 168.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -126.6 137.93 53.38 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.524 -1.217 . . . . 15.0 111.19 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.51 -149.93 9.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 124.275 0.984 . . . . 15.0 113.847 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -160.77 139.25 9.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.906 1.282 . . . . 15.0 111.185 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.655 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.342 18.2 tptt -171.91 169.59 5.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.518 1.527 . . . . 15.0 113.205 166.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' A' ' 12' ' ' LYS . 1.5 pt? -114.73 161.73 17.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.178 0.991 . . . . 15.0 113.199 -164.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.664 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -122.8 140.73 13.43 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.484 -1.234 . . . . 15.0 111.719 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -118.41 145.39 45.23 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.582 0.813 . . . . 15.0 110.858 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 p -93.85 126.13 38.86 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.725 ' HG3' ' HB2' ' A' ' 139' ' ' ASN . 9.1 mm100 -49.8 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.646 1.978 . . . . 15.0 114.703 -173.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 49.58 25.91 1.58 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 116.273 1.953 . . . . 15.0 116.273 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 t -110.03 -39.41 5.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.294 -1.321 . . . . 15.0 113.003 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 72.36 -30.98 0.22 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.958 1.703 . . . . 15.0 113.165 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -59.54 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.08 1.352 . . . . 15.0 113.238 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -168.12 129.4 1.39 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.892 -1.958 . . . . 15.0 110.127 164.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.0 31.94 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.64 -1.618 . . . . 15.0 113.056 167.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -165.51 142.29 5.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.787 1.403 . . . . 15.0 114.787 -170.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.16 -92.38 0.6 Allowed Glycine 0 N--CA 1.475 1.289 0 CA-C-N 113.777 -1.556 . . . . 15.0 112.782 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 158.14 6.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.762 1.225 . . . . 15.0 113.745 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 -124.79 1.52 Allowed Glycine 0 N--CA 1.477 1.399 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.882 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.47 121.61 42.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.61 -0.795 . . . . 15.0 110.698 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 147' ' ' SER . 35.6 p90 -125.23 146.49 49.5 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.921 1.822 . . . . 15.0 115.921 -168.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.24 104.29 1.24 Allowed Glycine 0 CA--C 1.535 1.282 0 CA-C-N 111.769 -2.468 . . . . 15.0 108.527 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.53 100.77 1.09 Allowed Glycine 0 N--CA 1.476 1.332 0 N-CA-C 110.117 -1.193 . . . . 15.0 110.117 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -114.57 145.09 42.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.321 0.581 . . . . 15.0 110.807 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.628 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 5.3 tt0 -120.84 136.17 54.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.957 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -104.56 -34.55 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 113.607 -1.633 . . . . 15.0 113.755 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -121.0 134.77 24.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 106.574 -1.639 . . . . 15.0 106.574 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.63 84.09 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.137 2.558 . . . . 15.0 111.288 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 158.82 -41.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 128.182 2.593 . . . . 15.0 111.195 -165.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.83 138.83 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.811 1.411 . . . . 15.0 114.811 -171.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 33' ' ' GLN . . . -162.11 -154.6 7.6 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 112.412 -2.176 . . . . 15.0 110.824 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HE1' ' HB2' ' A' ' 59' ' ' LEU . 9.0 t80 -143.28 145.45 32.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.804 0.811 . . . . 15.0 111.862 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' OE1' ' HG2' ' A' ' 78' ' ' ARG . 9.9 pt-20 -128.23 129.78 46.94 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.353 -1.294 . . . . 15.0 113.053 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -120.61 114.35 21.59 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.983 -1.462 . . . . 15.0 110.655 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.65 114.06 3.97 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 124.607 1.192 . . . . 15.0 110.71 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -102.84 141.17 36.09 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.178 0.99 . . . . 15.0 111.278 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -137.22 130.25 30.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.872 -1.967 . . . . 15.0 112.367 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.628 ' CZ2' ' HA ' ' A' ' 49' ' ' ARG . 12.4 t90 -122.63 137.2 54.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.202 -1.817 . . . . 15.0 108.512 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp -118.87 75.92 1.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 122.697 1.237 . . . . 15.0 108.982 -173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.44 -165.95 35.17 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 113.107 -1.86 . . . . 15.0 111.015 -167.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.628 ' HA ' ' CZ2' ' A' ' 46' ' ' TRP . 100.0 mtt180 -57.72 -88.54 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.904 0.882 . . . . 15.0 113.275 -174.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.4 mtt -134.35 95.86 16.04 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 123.996 0.918 . . . . 15.0 108.757 166.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.22 -38.83 3.39 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.739 2.293 . . . . 15.0 114.269 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 174.21 -62.38 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 128.433 2.693 . . . . 15.0 108.346 -175.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 97.7 mttt -111.48 -112.39 0.33 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.369 -1.287 . . . . 15.0 110.814 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 84' ' ' TRP . . . 61.25 -142.0 0.49 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.651 1.58 . . . . 15.0 113.361 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 49.96 42.64 24.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.922 1.689 . . . . 15.0 113.964 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.572 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -116.29 165.28 12.25 Favored Glycine 0 N--CA 1.474 1.193 0 CA-C-N 113.699 -1.592 . . . . 15.0 114.329 -161.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.26 144.39 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 113.485 -1.357 . . . . 15.0 111.749 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 82' ' ' MET . 8.4 pt20 -109.77 116.8 32.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.648 1.213 . . . . 15.0 109.421 162.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.401 ' HB2' ' HE1' ' A' ' 40' ' ' PHE . 1.9 pt? -121.47 120.3 34.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 113.074 -1.875 . . . . 15.0 111.383 -170.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.4 p -133.14 150.63 52.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.984 -1.462 . . . . 15.0 112.432 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -92.35 132.33 36.82 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.304 -1.316 . . . . 15.0 108.452 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.548 ' HE3' HE21 ' A' ' 33' ' ' GLN . 35.4 ttpt -110.06 104.26 13.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.613 -1.63 . . . . 15.0 110.404 -166.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.7 tt -120.7 134.43 55.28 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.125 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.57 -151.23 11.64 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 115.604 -0.725 . . . . 15.0 113.635 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' CE2' HD11 ' A' ' 75' ' ' ILE . 48.1 p90 -173.91 154.66 2.3 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.853 1.261 . . . . 15.0 113.044 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.6 Cg_endo -64.71 115.43 3.23 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.756 2.304 . . . . 15.0 110.989 169.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -66.2 127.54 32.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.818 -1.083 . . . . 15.0 109.584 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.3 tp 57.44 22.62 8.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.605 1.562 . . . . 15.0 113.397 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.69 20.19 61.46 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.039 1.304 . . . . 15.0 114.484 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -87.55 89.24 7.92 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.426 -1.324 . . . . 15.0 107.426 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.66 79.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 112.885 -1.962 . . . . 15.0 113.134 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -174.14 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 109.587 -3.46 . . . . 15.0 110.668 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.58 98.19 7.26 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.833 1.301 . . . . 15.0 111.711 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 22.6 p-10 -115.43 111.06 20.22 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.931 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.65 HG22 HG22 ' A' ' 112' ' ' VAL . 2.9 pp -79.05 148.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.896 -1.502 . . . . 15.0 110.925 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -146.36 143.23 28.95 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.783 1.302 . . . . 15.0 113.925 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -112.22 122.55 48.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.905 -1.952 . . . . 15.0 107.776 166.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 0.8 OUTLIER -115.05 123.23 48.49 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 112.923 -1.944 . . . . 15.0 109.62 -176.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.79 129.35 48.14 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.676 -1.602 . . . . 15.0 113.256 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.44 -103.98 0.2 Allowed Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.146 -1.182 . . . . 15.0 110.146 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.553 ' HA2' ' HB ' ' A' ' 107' ' ' VAL . . . 154.01 -152.15 23.78 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 124.641 0.848 . . . . 15.0 115.017 173.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 33.9 ttm -119.92 139.3 52.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.491 -0.854 . . . . 15.0 111.742 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 103' ' ' SER . 57.8 t -125.62 113.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 113.98 -1.463 . . . . 15.0 108.109 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.572 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -115.98 136.86 52.64 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.419 -1.264 . . . . 15.0 110.766 175.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 50.0 mtt-85 -79.47 141.86 36.37 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.672 0.619 . . . . 15.0 112.672 -173.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.425 ' HA ' ' HG2' ' A' ' 53' ' ' LYS . . . -119.06 -50.27 2.38 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.112 -1.404 . . . . 15.0 114.119 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.2 t70 54.61 90.62 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.21 1.804 . . . . 15.0 115.193 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -72.33 86.68 1.12 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 114.915 -1.039 . . . . 15.0 110.791 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -125.32 85.93 2.48 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.516 -1.22 . . . . 15.0 109.688 170.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -168.93 150.62 4.64 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.752 -1.567 . . . . 15.0 111.945 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -67.15 146.49 54.19 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.782 -1.099 . . . . 15.0 111.551 172.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.09 -25.06 63.47 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.778 1.77 . . . . 15.0 115.778 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 47.86 80.96 0.05 OUTLIER Glycine 0 N--CA 1.484 1.884 0 C-N-CA 125.648 1.594 . . . . 15.0 112.121 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 65.95 -165.32 0.23 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.04 1.336 . . . . 15.0 111.375 -156.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.56 61.15 3.98 Favored Glycine 0 N--CA 1.48 1.623 0 C-N-CA 124.092 0.853 . . . . 15.0 114.451 -175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -118.65 101.0 7.78 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.308 1.052 . . . . 15.0 112.01 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.507 ' H ' HD12 ' A' ' 97' ' ' ILE . 4.7 mp -73.73 80.91 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 113.776 -1.556 . . . . 15.0 108.875 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.7 t -72.83 59.71 0.49 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.001 -1.454 . . . . 15.0 113.544 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.01 87.83 2.36 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.958 -1.019 . . . . 15.0 113.324 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.05 137.51 51.31 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.634 -1.166 . . . . 15.0 112.921 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -123.79 163.42 21.22 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.09 -1.868 . . . . 15.0 110.86 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 131.37 50.58 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.268 0.556 . . . . 15.0 110.711 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 28.5 t -75.07 105.92 6.32 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.29 -1.323 . . . . 15.0 110.78 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 82' ' ' MET . 10.0 p -113.37 115.29 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 113.997 -1.456 . . . . 15.0 111.408 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.501 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 80.5 p -117.87 131.83 23.95 Favored Pre-proline 0 N--CA 1.479 1.001 0 CA-C-N 113.745 -1.571 . . . . 15.0 112.398 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 122.21 6.0 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.921 2.414 . . . . 15.0 111.397 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.553 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 53.1 t -131.11 140.03 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.597 -1.183 . . . . 15.0 109.69 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.47 123.29 48.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.16 -1.382 . . . . 15.0 109.844 171.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 129' ' ' GLU . . . -123.23 112.58 17.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.352 -1.295 . . . . 15.0 111.263 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.63 137.07 13.51 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.6 -0.727 . . . . 15.0 112.618 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 128' ' ' LEU . . . 176.99 -147.79 8.56 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 116.198 1.239 . . . . 15.0 116.198 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 75' ' ' ILE . 16.3 t -130.76 144.68 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 113.506 -1.347 . . . . 15.0 109.805 -170.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.502 ' HB2' ' HG3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -109.75 120.95 44.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.292 -1.373 . . . . 15.0 107.292 165.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -117.75 117.66 29.94 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.115 -1.402 . . . . 15.0 111.24 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.552 HG22 HG13 ' A' ' 116' ' ' ILE . 13.2 p -129.65 143.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 113.279 -1.782 . . . . 15.0 110.163 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 115' ' ' VAL . 44.0 mt 62.95 144.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 125.877 1.671 . . . . 15.0 113.577 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 63.33 155.38 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.886 1.674 . . . . 15.0 111.746 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 69.33 -50.28 0.61 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.882 2.073 . . . . 15.0 113.925 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -66.57 126.63 29.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.152 1.381 . . . . 15.0 110.491 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.4 tt -45.1 -35.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 115.671 1.73 . . . . 15.0 115.671 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.2 m -129.12 97.61 25.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 108.398 -0.964 . . . . 15.0 108.398 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.47 66.06 2.89 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.706 2.937 . . . . 15.0 114.304 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.466 ' HG3' HG23 ' A' ' 124' ' ' ILE . 15.0 pt-20 -120.04 -17.75 8.31 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.798 -1.546 . . . . 15.0 114.958 178.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.466 HG23 ' HG3' ' A' ' 123' ' ' GLU . 0.2 OUTLIER -119.57 152.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.708 0.766 . . . . 15.0 112.586 -173.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.47 34.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.516 -2.129 . . . . 15.0 109.03 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 37.1 m -93.25 116.76 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.182 -1.784 . . . . 15.0 106.182 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 34.4 ttp180 -115.6 108.07 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.101 -1.409 . . . . 15.0 107.925 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.475 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 5.3 tt -111.83 130.67 55.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.58 -1.646 . . . . 15.0 108.991 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 143' ' ' SER . 13.6 pt-20 -128.57 140.97 51.52 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.435 -2.166 . . . . 15.0 111.421 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 11.7 m-85 -97.25 114.56 26.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.516 -1.22 . . . . 15.0 109.061 164.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 14.7 mt-30 -96.57 108.77 21.42 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.95 -1.932 . . . . 15.0 108.309 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.405 ' CH2' ' HA ' ' A' ' 135' ' ' ASN . 27.2 t90 -131.49 146.4 52.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 111.918 -2.401 . . . . 15.0 111.755 -171.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p -122.91 -25.08 4.65 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 112.56 -2.109 . . . . 15.0 115.524 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -122.44 96.54 5.08 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 116.336 1.976 . . . . 15.0 116.336 -163.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.405 ' HA ' ' CH2' ' A' ' 132' ' ' TRP . 58.2 m-20 -13.85 -58.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 127.995 2.518 . . . . 15.0 117.772 172.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.02 81.83 1.56 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.059 0.933 . . . . 15.0 110.075 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.4 t -171.04 160.29 6.4 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.082 -1.872 . . . . 15.0 110.605 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -62.67 151.06 39.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.477 1.111 . . . . 15.0 111.017 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.725 ' HB2' ' HG3' ' A' ' 17' ' ' GLN . 8.2 m120 -7.15 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 119.564 3.172 . . . . 15.0 119.564 171.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.57 -97.76 1.76 Allowed Glycine 0 N--CA 1.475 1.243 0 N-CA-C 110.542 -1.023 . . . . 15.0 110.542 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.587 ' HB2' ' HB2' ' A' ' 131' ' ' GLN . 67.0 mtt -121.47 122.69 40.31 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.565 0.95 . . . . 15.0 113.565 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 142' ' ' LEU . 1.2 pt? -84.77 97.34 9.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.035 -1.439 . . . . 15.0 108.032 171.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.664 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 37.1 t -114.0 128.63 56.47 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.433 -1.712 . . . . 15.0 110.896 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 1.3 pt? -126.36 139.51 53.23 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.962 -1.017 . . . . 15.0 111.043 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.504 ' HA2' ' HB3' ' A' ' 12' ' ' LYS . . . -123.59 131.19 7.98 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 125.822 1.951 . . . . 15.0 111.128 173.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.49 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 34.8 m -112.58 127.42 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.801 0.8 . . . . 15.0 111.111 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . 63.5 p -131.68 153.49 49.94 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.845 -1.525 . . . . 15.0 114.605 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -108.02 143.64 36.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.052 -1.431 . . . . 15.0 109.468 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.769 ' HD3' ' H ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -70.29 115.88 9.98 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.941 -1.027 . . . . 15.0 112.896 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 81.0 m-85 54.72 139.02 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 112.751 -2.022 . . . . 15.0 114.288 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.76 83.52 0.29 Allowed Glycine 0 N--CA 1.479 1.56 0 CA-C-N 114.611 -1.177 . . . . 15.0 113.366 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -58.59 -43.51 89.52 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.473 1.109 . . . . 15.0 113.572 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 169.09 -152.57 20.33 Favored Glycine 0 N--CA 1.478 1.448 0 C-N-CA 124.143 0.878 . . . . 15.0 111.485 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.52 141.55 51.98 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.681 -0.76 . . . . 15.0 111.38 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.1 90.6 1.2 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.194 0.997 . . . . 15.0 112.481 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 N-CA-C 114.925 1.454 . . . . 15.0 114.925 177.424 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 19.3 mmt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 116.426 2.01 . . . . 15.0 116.426 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 90.6 Cg_endo -68.66 -23.49 36.3 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.31 2.673 . . . . 15.0 114.86 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 97.0 mttt 50.06 46.36 24.61 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 123.459 1.6 . . . . 15.0 113.977 -175.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.527 ' OD1' ' HA ' ' A' ' 36' ' ' PRO . 69.5 m-20 -122.35 26.4 8.43 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.503 -1.681 . . . . 15.0 113.315 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.674 ' HA ' HG22 ' A' ' 34' ' ' VAL . 24.6 t-20 178.89 48.67 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.469 1.508 . . . . 15.0 111.064 -173.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 p -126.92 152.6 46.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.062 -1.426 . . . . 15.0 110.554 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -118.66 138.57 52.52 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.032 1.123 . . . . 15.0 114.032 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -120.26 136.35 54.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.869 -1.514 . . . . 15.0 110.818 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -163.6 133.35 4.16 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.807 -1.088 . . . . 15.0 111.691 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -177.73 -167.76 36.33 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 115.163 -0.926 . . . . 15.0 112.711 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.54 134.82 47.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.802 -0.699 . . . . 15.0 112.107 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' HD3' ' HD3' ' A' ' 127' ' ' ARG . 45.1 mtmt -134.16 144.74 48.7 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.898 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.5 pp -114.17 145.29 41.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.886 -1.052 . . . . 15.0 111.092 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.29 110.35 2.48 Favored Glycine 0 N--CA 1.477 1.414 0 O-C-N 125.003 1.439 . . . . 15.0 111.483 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.741 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 49.4 t90 -118.72 140.46 49.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.859 1.059 . . . . 15.0 113.859 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.9 p -92.85 98.16 11.21 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.336 1.236 . . . . 15.0 114.336 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -14.76 -76.91 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.207 2.603 . . . . 15.0 117.871 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -131.45 77.03 1.75 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.9 t -165.04 140.69 5.43 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 112.987 -1.915 . . . . 15.0 110.544 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -90.15 76.7 6.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.147 -1.388 . . . . 15.0 107.352 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -142.74 -70.86 0.33 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.448 -1.705 . . . . 15.0 114.071 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.741 ' ND2' ' HA ' ' A' ' 15' ' ' TRP . 7.3 m120 62.45 -65.52 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.09 1.885 . . . . 15.0 116.09 -171.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 63.43 -62.81 0.14 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 127.055 2.142 . . . . 15.0 110.612 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.06 139.8 50.51 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.889 -1.05 . . . . 15.0 108.658 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.55 -98.24 2.23 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 108.898 -1.681 . . . . 15.0 108.898 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.87 131.15 57.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.521 -1.34 . . . . 15.0 110.041 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.58 141.8 13.88 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-N 113.541 -1.663 . . . . 15.0 110.89 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.4 121.19 41.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.965 -1.118 . . . . 15.0 108.061 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 42' ' ' MET . 94.0 m-85 -116.24 113.39 22.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.075 -1.42 . . . . 15.0 110.351 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.17 145.96 17.15 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.468 -1.696 . . . . 15.0 112.189 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 41' ' ' GLU . . . 172.32 -161.6 33.33 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 114.461 -0.869 . . . . 15.0 112.765 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -126.46 142.17 51.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.943 -1.128 . . . . 15.0 111.986 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.502 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 59.3 tt0 -111.54 82.3 1.59 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 124.092 1.901 . . . . 15.0 106.397 169.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.674 HG22 ' HA ' ' A' ' 5' ' ' ASN . 29.4 t -140.75 72.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 111.842 -2.435 . . . . 15.0 105.941 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' A' ' 36' ' ' PRO . 50.0 t30 -175.89 144.88 0.74 Allowed Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 111.913 -2.403 . . . . 15.0 105.248 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.527 ' HA ' ' OD1' ' A' ' 4' ' ' ASP . 28.6 Cg_endo -50.33 104.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.57 2.847 . . . . 15.0 114.332 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 71.25 -24.47 0.17 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.477 2.311 . . . . 15.0 116.747 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.717 HG12 ' HG ' ' A' ' 63' ' ' LEU . 25.6 m -111.04 147.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.582 1.182 . . . . 15.0 113.5 -172.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -118.63 155.26 16.15 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.515 -2.13 . . . . 15.0 112.289 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -118.12 114.14 22.63 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.437 -0.882 . . . . 15.0 109.515 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.451 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -130.78 146.48 52.25 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.253 -1.794 . . . . 15.0 111.532 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 24.0 ptt? -112.59 145.0 41.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.412 -1.267 . . . . 15.0 111.268 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -106.03 127.62 9.02 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 113.22 -1.809 . . . . 15.0 109.726 172.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.82 104.57 11.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.578 -1.311 . . . . 15.0 111.191 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.6 121.59 43.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.098 -1.41 . . . . 15.0 110.127 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 t-105 -102.43 142.95 32.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.523 -1.671 . . . . 15.0 110.235 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 44.09 39.6 2.94 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.511 2.041 . . . . 15.0 116.511 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.22 84.17 0.1 OUTLIER Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.423 -1.071 . . . . 15.0 110.423 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 56.3 mtt-85 68.53 -51.16 0.56 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.561 2.344 . . . . 15.0 116.266 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.2 mtt -66.9 107.33 1.59 Allowed Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 125.38 1.472 . . . . 15.0 113.494 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.16 -55.93 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.777 2.318 . . . . 15.0 112.473 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.2 84.81 6.94 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.141 0.976 . . . . 15.0 108.461 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 66.51 110.89 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 112.628 -2.078 . . . . 15.0 115.63 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.83 -78.0 0.58 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 112.27 -2.241 . . . . 15.0 112.255 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 28.3 pt20 34.13 86.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.603 1.961 . . . . 15.0 115.106 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.45 97.06 1.49 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.817 -1.992 . . . . 15.0 109.971 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 43' ' ' GLY . 11.8 p -109.88 118.53 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.956 1.033 . . . . 15.0 111.112 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.79 116.79 32.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.841 -1.527 . . . . 15.0 112.401 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.8 114.39 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.707 -1.588 . . . . 15.0 108.643 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.623 HG21 ' HD3' ' A' ' 78' ' ' ARG . 51.9 p -127.27 148.4 50.22 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.135 -1.848 . . . . 15.0 114.035 -170.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.53 128.52 54.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 113.136 -1.847 . . . . 15.0 107.823 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -119.75 138.35 53.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.119 -1.855 . . . . 15.0 111.83 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.717 ' HG ' HG12 ' A' ' 38' ' ' VAL . 5.2 mp -117.07 131.36 56.94 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.157 -1.838 . . . . 15.0 108.669 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.71 131.66 10.1 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 124.616 1.198 . . . . 15.0 111.006 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.584 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 72.3 m-85 -121.75 97.98 45.95 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 124.512 0.772 . . . . 15.0 112.313 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.35 84.9 0.72 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.984 2.456 . . . . 15.0 110.991 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -120.18 153.02 36.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.726 -2.034 . . . . 15.0 110.008 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.8 84.61 0.31 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.374 -0.83 . . . . 15.0 112.809 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.25 141.9 15.35 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 113.812 -1.54 . . . . 15.0 112.398 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.524 ' O ' HD13 ' A' ' 73' ' ' LEU . 3.2 m -49.36 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.76 2.824 . . . . 15.0 112.639 -171.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 52.65 71.09 0.5 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.722 -1.581 . . . . 15.0 112.919 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 115' ' ' VAL . 11.1 m-20 78.91 41.51 0.09 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.861 -1.518 . . . . 15.0 114.277 165.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 70' ' ' THR . 9.0 mp -105.32 115.37 30.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.168 -1.378 . . . . 15.0 111.157 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -105.26 135.97 45.65 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.231 -1.35 . . . . 15.0 108.255 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 65' ' ' TYR . 37.1 mm -83.34 137.42 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.252 -1.018 . . . . 15.0 108.252 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -133.18 135.47 45.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.528 1.307 . . . . 15.0 114.528 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 58.5 m -118.35 124.93 48.94 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 112.537 -2.119 . . . . 15.0 107.424 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.623 ' HD3' HG21 ' A' ' 60' ' ' THR . 1.2 tmm_? -124.64 135.73 53.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.611 0.765 . . . . 15.0 109.864 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 pp -150.76 139.55 20.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.371 -0.832 . . . . 15.0 113.225 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.49 -151.68 10.73 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.626 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.33 151.6 20.87 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 114.154 -1.023 . . . . 15.0 113.088 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.0 ptm -114.49 135.28 54.29 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.712 1.004 . . . . 15.0 113.712 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 104' ' ' VAL . 44.7 t -125.34 119.92 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 113.756 -1.566 . . . . 15.0 108.024 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.42 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 35.9 p90 -129.95 151.83 50.07 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.689 175.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.4 ttt-85 -102.11 80.98 2.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.09 1.424 . . . . 15.0 111.839 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.86 96.37 4.29 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.747 -2.024 . . . . 15.0 110.641 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -65.58 144.07 57.21 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.682 -1.145 . . . . 15.0 111.852 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 m -57.18 102.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.759 1.623 . . . . 15.0 112.888 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -61.54 147.15 46.39 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.729 -1.578 . . . . 15.0 113.229 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -66.4 151.22 47.61 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.52 -1.673 . . . . 15.0 109.264 165.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.3 tttt 66.53 145.93 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.718 2.007 . . . . 15.0 113.092 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -172.35 -41.42 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.392 1.477 . . . . 15.0 111.721 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.63 -87.28 0.39 Allowed Glycine 0 N--CA 1.475 1.287 0 N-CA-C 109.37 -1.492 . . . . 15.0 109.37 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -100.2 149.1 23.9 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.408 -0.896 . . . . 15.0 111.137 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.95 80.66 0.07 OUTLIER Glycine 0 N--CA 1.482 1.729 0 C-N-CA 124.638 1.114 . . . . 15.0 115.256 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -115.29 94.09 4.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 122.326 1.06 . . . . 15.0 112.783 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.0 pt -122.68 142.53 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 112.811 -1.995 . . . . 15.0 111.232 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.1 t -170.34 -103.51 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.079 1.351 . . . . 15.0 109.57 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 63.02 152.31 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.741 2.016 . . . . 15.0 114.276 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.23 -65.71 0.15 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.169 -1.378 . . . . 15.0 112.584 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.29 142.21 50.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.781 0.833 . . . . 15.0 109.253 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 147.13 53.02 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 124.072 0.857 . . . . 15.0 110.543 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 m -71.26 105.74 3.57 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.548 -0.751 . . . . 15.0 111.643 -174.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 83' ' ' VAL . 42.9 t -83.52 80.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.49 -1.232 . . . . 15.0 109.216 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.7 m -65.27 132.07 95.18 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 113.762 -1.563 . . . . 15.0 111.909 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.68 113.7 2.84 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.115 2.543 . . . . 15.0 110.555 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.8 t -116.9 120.27 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.298 -1.319 . . . . 15.0 109.023 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -118.37 144.72 45.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 113.288 -1.778 . . . . 15.0 109.66 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -141.5 131.11 23.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.7 -1.136 . . . . 15.0 110.788 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.99 130.47 7.83 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 129' ' ' GLU . . . -173.1 -160.42 21.61 Favored Glycine 0 N--CA 1.476 1.338 0 CA-C-O 122.199 0.888 . . . . 15.0 115.228 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.32 144.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 113.244 -1.478 . . . . 15.0 109.682 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -121.2 129.06 53.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.96 -1.473 . . . . 15.0 109.058 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.443 ' CZ ' ' HA ' ' A' ' 116' ' ' ILE . 19.9 t80 -100.21 130.82 46.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.316 1.046 . . . . 15.0 109.88 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 72' ' ' ASP . 15.6 m -98.4 113.07 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 113.336 -1.757 . . . . 15.0 110.597 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -54.44 100.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.089 -1.869 . . . . 15.0 113.32 -174.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -108.21 -32.56 7.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.405 -1.725 . . . . 15.0 112.976 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -54.54 -20.54 8.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.886 2.18 . . . . 15.0 116.886 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD3' ' N ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -127.56 144.17 51.1 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.443 -0.947 . . . . 15.0 108.443 178.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.577 ' H ' HD12 ' A' ' 120' ' ' ILE . 4.7 mp -57.78 136.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.319 1.448 . . . . 15.0 109.653 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.445 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 28.7 m 65.14 92.22 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.045 1.738 . . . . 15.0 111.637 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 121' ' ' THR . 57.4 Cg_endo -64.58 134.21 40.2 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.924 2.416 . . . . 15.0 111.331 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HG2' HG13 ' A' ' 124' ' ' ILE . 30.5 tt0 -119.34 -81.63 0.63 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.403 -1.271 . . . . 15.0 112.177 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.508 HG13 ' HG2' ' A' ' 123' ' ' GLU . 32.7 mt -116.36 146.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.64 24.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.794 1.238 . . . . 15.0 110.984 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.0 m -100.32 122.59 43.34 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.196 -0.911 . . . . 15.0 109.387 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.452 ' HD3' ' HD3' ' A' ' 12' ' ' LYS . 37.1 ttt85 -120.88 127.94 52.34 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.461 -0.79 . . . . 15.0 112.479 -175.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.0 119.53 24.45 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.93 -1.487 . . . . 15.0 110.775 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.514 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 6.1 pt-20 -134.2 145.42 49.19 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.88 -1.054 . . . . 15.0 113.49 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.38 122.09 43.1 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.307 -1.315 . . . . 15.0 109.307 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.59 122.48 47.93 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 113.656 -1.611 . . . . 15.0 110.942 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -124.45 145.28 49.6 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 111.985 -2.37 . . . . 15.0 110.532 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.3 t -126.02 138.45 53.73 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.764 -1.107 . . . . 15.0 109.188 171.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -76.02 73.32 2.89 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.595 1.188 . . . . 15.0 110.644 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.48 154.0 49.18 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.83 -1.986 . . . . 15.0 110.218 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.21 85.72 1.9 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 122.921 1.343 . . . . 15.0 110.719 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.8 t -173.7 163.06 4.19 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 112.691 -2.05 . . . . 15.0 109.434 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.34 -26.88 68.96 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.179 -0.919 . . . . 15.0 111.555 164.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 57.61 -94.07 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.78 2.032 . . . . 15.0 112.656 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.31 85.6 0.01 OUTLIER Glycine 0 N--CA 1.482 1.714 0 C-N-CA 125.846 1.689 . . . . 15.0 116.899 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -117.42 139.0 51.45 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.046 0.927 . . . . 15.0 110.599 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.19 108.98 18.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 113.89 -1.505 . . . . 15.0 109.535 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.514 ' HB2' ' HG3' ' A' ' 129' ' ' GLU . 61.4 m -109.02 125.22 51.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.472 -1.24 . . . . 15.0 108.783 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 pp -148.22 145.25 28.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.201 -1.363 . . . . 15.0 112.311 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.96 -162.51 29.53 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 114.15 -1.386 . . . . 15.0 113.119 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.32 130.48 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.159 -1.52 . . . . 15.0 111.494 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.538 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 63.9 p -130.39 146.35 51.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.755 -1.566 . . . . 15.0 113.053 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -115.96 118.95 34.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.259 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.86 119.27 34.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.031 -1.44 . . . . 15.0 108.55 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -152.75 -123.55 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.873 -1.512 . . . . 15.0 110.112 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 140.45 157.0 7.06 Favored Glycine 0 N--CA 1.478 1.482 0 C-N-CA 124.83 1.205 . . . . 15.0 111.424 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 53.52 33.66 16.69 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 116.623 2.083 . . . . 15.0 116.623 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.32 136.36 13.53 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 115.456 -0.793 . . . . 15.0 111.703 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -96.2 -56.77 2.53 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.208 -0.996 . . . . 15.0 113.442 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 60.64 163.96 0.07 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.588 1.555 . . . . 15.0 113.536 -172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 CA-C-O 116.825 -1.559 . . . . 15.0 113.792 179.167 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 115.088 1.514 . . . . 15.0 115.088 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.14 128.15 17.09 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.77 2.313 . . . . 15.0 111.596 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.499 ' HE2' ' HH ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -109.08 -71.49 0.76 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.12 -1.4 . . . . 15.0 114.339 -177.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.2 t0 43.51 82.81 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.67 1.588 . . . . 15.0 115.257 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 6.1 t30 58.68 73.5 0.47 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.395 1.878 . . . . 15.0 112.461 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.459 HG21 ' HG3' ' A' ' 3' ' ' LYS . 11.6 t -120.94 150.91 40.36 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 112.207 -2.27 . . . . 15.0 111.448 173.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -106.92 131.79 53.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.568 -1.196 . . . . 15.0 111.959 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.499 ' HH ' ' HE2' ' A' ' 3' ' ' LYS . 79.2 m-85 -118.35 101.6 8.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.619 -1.628 . . . . 15.0 108.681 169.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -108.07 118.32 36.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.246 -1.797 . . . . 15.0 107.114 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -130.9 153.0 20.1 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 114.316 -1.311 . . . . 15.0 113.971 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.29 124.11 42.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.736 -1.232 . . . . 15.0 108.261 170.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -144.19 155.97 44.12 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.756 -1.111 . . . . 15.0 112.869 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 26' ' ' ALA . 3.1 pp -114.09 140.37 48.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.604 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -108.5 97.76 1.13 Allowed Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.691 -1.595 . . . . 15.0 111.097 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.474 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t90 -111.05 150.16 29.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.493 1.139 . . . . 15.0 112.418 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.3 p -122.34 159.38 27.58 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 112.439 -2.164 . . . . 15.0 111.081 -173.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -48.48 153.21 0.79 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.221 -0.899 . . . . 15.0 109.593 165.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.49 89.62 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.861 0.838 . . . . 15.0 111.641 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 t -167.81 141.0 3.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.651 -2.068 . . . . 15.0 107.963 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.575 ' HG2' ' H ' ' A' ' 21' ' ' GLU . 32.0 ttt-85 53.21 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.897 1.679 . . . . 15.0 113.649 -175.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.575 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 15.3 pt-20 -69.69 75.18 0.43 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.927 1.084 . . . . 15.0 113.927 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -130.1 147.59 51.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.877 -1.056 . . . . 15.0 112.242 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -173.15 -75.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.675 -1.602 . . . . 15.0 110.47 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -104.56 89.45 3.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.473 0.654 . . . . 15.0 111.394 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.98 111.97 1.02 Allowed Glycine 0 N--CA 1.478 1.485 0 CA-C-N 113.599 -1.637 . . . . 15.0 112.018 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -119.75 142.47 48.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.193 0.597 . . . . 15.0 112.081 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.41 20.38 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 124.952 1.408 . . . . 15.0 112.511 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.542 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . . . -102.96 135.94 43.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.733 -1.234 . . . . 15.0 111.2 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -111.72 118.0 34.42 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.007 -1.451 . . . . 15.0 110.817 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.12 90.12 0.45 Allowed Glycine 0 N--CA 1.476 1.325 0 CA-C-N 114.647 -1.161 . . . . 15.0 110.545 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.04 117.26 4.21 Favored Glycine 0 N--CA 1.477 1.419 0 O-C-N 124.44 0.729 . . . . 15.0 112.101 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -115.25 123.01 47.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.474 1.13 . . . . 15.0 111.856 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -109.03 82.21 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.499 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 5' ' ' ASN 0.276 7.3 p -71.2 -73.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.236 -2.257 . . . . 15.0 112.243 174.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 36' ' ' PRO . 22.7 t30 -70.55 127.86 91.61 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.229 1.411 . . . . 15.0 112.146 -176.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 35' ' ' ASN . 71.8 Cg_endo -72.5 69.5 3.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.323 2.682 . . . . 15.0 111.728 170.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -175.94 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.196 2.199 . . . . 15.0 107.941 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.28 141.01 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.465 -0.788 . . . . 15.0 111.962 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.67 158.95 14.08 Favored Glycine 0 N--CA 1.477 1.39 0 CA-C-N 113.638 -1.619 . . . . 15.0 109.577 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 136.2 52.73 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.257 0.551 . . . . 15.0 110.524 -176.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.46 ' HB3' ' OG1' ' A' ' 60' ' ' THR . 0.9 OUTLIER -127.89 133.91 49.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.584 -1.189 . . . . 15.0 110.621 -173.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.4 mtm -124.23 128.27 48.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.133 -1.394 . . . . 15.0 111.547 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.99 134.08 11.93 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 113.385 -1.734 . . . . 15.0 109.676 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 28' ' ' ALA . 82.8 m-85 -120.12 115.06 22.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.311 -0.945 . . . . 15.0 111.695 -173.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -128.93 143.67 50.95 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.066 -1.425 . . . . 15.0 109.719 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.85 142.53 50.15 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.744 0.646 . . . . 15.0 112.744 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 tp -88.87 77.37 7.77 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.813 1.292 . . . . 15.0 110.075 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.23 -143.98 36.84 Favored Glycine 0 N--CA 1.478 1.488 0 CA-C-N 113.178 -1.828 . . . . 15.0 110.92 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -69.85 -90.86 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.646 0.778 . . . . 15.0 111.178 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.0 ttm -142.03 98.67 6.17 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.176 0.991 . . . . 15.0 108.428 170.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HG2' ' HB3' ' A' ' 54' ' ' ALA . 68.5 Cg_endo -69.47 -45.36 1.78 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.755 2.303 . . . . 15.0 112.428 177.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -179.24 -99.45 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.847 2.459 . . . . 15.0 106.048 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -124.44 80.15 1.82 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.333 1.063 . . . . 15.0 108.438 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.447 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . . . -148.61 99.5 3.01 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 112.725 -2.034 . . . . 15.0 112.419 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -127.69 156.27 42.63 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.973 -1.921 . . . . 15.0 111.219 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.43 100.57 0.88 Allowed Glycine 0 N--CA 1.475 1.295 0 O-C-N 124.482 1.114 . . . . 15.0 110.427 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -110.74 131.86 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.599 1.19 . . . . 15.0 112.306 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -109.86 124.1 50.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.52 -1.673 . . . . 15.0 109.003 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.19 111.18 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.673 -1.149 . . . . 15.0 109.305 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.487 ' HB ' ' HG2' ' A' ' 78' ' ' ARG . 32.2 p -136.2 156.36 48.79 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.148 -1.842 . . . . 15.0 112.634 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -116.56 141.66 47.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.745 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -110.77 126.07 54.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.375 -1.284 . . . . 15.0 111.402 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.24 146.84 49.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.616 -1.629 . . . . 15.0 110.866 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.96 -155.29 21.56 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 115.694 -0.685 . . . . 15.0 112.04 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.466 ' CE2' ' HG2' ' A' ' 67' ' ' LYS . 18.9 p90 -166.4 158.94 11.97 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -167.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.73 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.5 Cg_endo -68.57 134.0 29.39 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.825 2.35 . . . . 15.0 111.982 167.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 4.8 tmtp? -129.44 122.75 30.0 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.234 -1.348 . . . . 15.0 110.725 -177.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 68' ' ' LEU . 1.8 pt? -69.93 125.68 27.47 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.384 -1.28 . . . . 15.0 110.769 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.34 -86.18 0.41 Allowed Glycine 0 N--CA 1.477 1.378 0 CA-C-N 114.562 -1.199 . . . . 15.0 112.94 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.441 HG23 ' OH ' ' A' ' 114' ' ' TYR . 2.4 t -126.43 -39.8 2.0 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.634 -1.283 . . . . 15.0 110.517 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -116.87 -146.37 0.4 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.502 -1.296 . . . . 15.0 107.502 148.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -107.76 103.31 12.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.459 ' H ' HD23 ' A' ' 73' ' ' LEU . 1.2 pt? -111.1 143.54 41.66 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.056 -1.429 . . . . 15.0 113.733 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.73 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 1.1 m-20 -111.85 123.44 50.24 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.513 -1.221 . . . . 15.0 108.914 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.7 mt -111.59 113.19 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 124.38 1.05 . . . . 15.0 108.681 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -122.27 141.83 51.1 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.478 -1.692 . . . . 15.0 111.885 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 m -108.53 122.64 47.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.257 -2.127 . . . . 15.0 105.257 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.68 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 18.2 ttm180 -115.73 123.22 47.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 112.831 -1.986 . . . . 15.0 108.134 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.2 tp -131.57 138.39 48.84 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.244 -0.889 . . . . 15.0 111.065 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.22 -145.39 8.06 Favored Glycine 0 N--CA 1.477 1.423 0 O-C-N 124.749 1.281 . . . . 15.0 113.178 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.43 152.35 22.86 Favored Glycine 0 N--CA 1.476 1.349 0 O-C-N 125.235 1.197 . . . . 15.0 112.599 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.75 118.71 35.06 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.548 0.69 . . . . 15.0 111.136 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.75 125.71 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 113.768 -1.56 . . . . 15.0 108.089 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.491 ' CZ3' ' HB2' ' A' ' 86' ' ' ALA . 15.8 p-90 -117.08 148.22 41.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.286 -1.325 . . . . 15.0 110.729 176.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -100.79 133.46 45.23 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.174 -1.376 . . . . 15.0 110.418 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . . . -127.07 135.37 50.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.257 -1.338 . . . . 15.0 111.58 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -73.96 95.42 2.48 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.942 -1.026 . . . . 15.0 111.805 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 m 54.16 46.71 24.78 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.511 1.524 . . . . 15.0 110.727 -174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.4 p 61.8 -109.4 0.35 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.973 2.109 . . . . 15.0 112.22 -172.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -132.05 104.99 7.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.22 1.008 . . . . 15.0 109.814 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.4 tmmt? -64.27 98.47 0.23 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 114.902 -1.044 . . . . 15.0 111.955 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -108.28 85.85 2.19 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.063 -1.426 . . . . 15.0 110.233 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.62 -149.84 51.67 Favored Glycine 0 N--CA 1.478 1.451 0 CA-C-N 113.51 -1.677 . . . . 15.0 113.179 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -71.74 75.9 0.85 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.287 1.035 . . . . 15.0 113.705 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.31 137.83 2.72 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 114.404 -1.271 . . . . 15.0 113.14 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -124.25 50.54 1.66 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.55 1.167 . . . . 15.0 112.237 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.84 134.09 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 114.522 -1.217 . . . . 15.0 111.571 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.6 t -172.27 147.7 2.02 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.856 1.347 . . . . 15.0 109.642 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.63 84.75 2.24 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.223 1.011 . . . . 15.0 110.869 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.72 140.13 24.5 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 113.549 -1.659 . . . . 15.0 111.179 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -116.53 89.33 3.09 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.196 -0.911 . . . . 15.0 110.104 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 53.84 -142.52 0.79 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.852 -1.522 . . . . 15.0 112.273 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m -151.24 106.05 3.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.962 0.905 . . . . 15.0 109.363 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.45 99.74 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.438 -1.255 . . . . 15.0 108.843 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -118.65 136.45 24.15 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 114.31 -1.313 . . . . 15.0 111.904 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.21 96.58 0.72 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.06 2.507 . . . . 15.0 111.074 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.667 ' HB ' ' HA ' ' A' ' 133' ' ' THR . 21.5 m -116.98 143.48 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.836 -1.529 . . . . 15.0 111.566 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.661 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 5.6 p90 -129.7 138.18 51.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.8 -169.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.68 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -124.79 134.28 52.83 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.631 1.832 . . . . 15.0 111.962 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.638 ' N ' ' HB2' ' A' ' 131' ' ' GLN . . . -104.29 99.24 1.65 Allowed Glycine 0 N--CA 1.476 1.31 0 N-CA-C 108.251 -1.939 . . . . 15.0 108.251 175.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.67 114.45 4.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 125.081 1.107 . . . . 15.0 112.127 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 52.3 t -117.29 131.96 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 122.576 1.179 . . . . 15.0 108.997 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.696 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 10.5 mm-40 -110.74 109.58 19.87 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 112.623 -2.081 . . . . 15.0 108.711 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.449 ' CD1' ' HB3' ' A' ' 73' ' ' LEU . 13.6 t80 -107.26 126.08 51.97 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.611 0.719 . . . . 15.0 112.21 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.5 t -114.22 133.01 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.389 -1.278 . . . . 15.0 109.023 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.1 mt -118.78 142.94 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 114.517 -1.219 . . . . 15.0 108.727 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -70.83 97.11 1.34 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.903 1.075 . . . . 15.0 113.903 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -127.12 149.91 49.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.331 -1.304 . . . . 15.0 112.095 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -57.03 -42.9 81.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.146 1.165 . . . . 15.0 114.146 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.9 mt -120.8 89.05 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.0 m -118.0 90.25 36.61 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.238 -1.346 . . . . 15.0 109.191 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.31 82.64 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.735 2.29 . . . . 15.0 112.281 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 148' ' ' TYR . 1.5 mp0 46.57 32.12 1.56 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.759 2.133 . . . . 15.0 116.759 176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.595 HD11 ' HB ' ' A' ' 146' ' ' VAL . 7.3 tp -116.71 129.57 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.103 0.954 . . . . 15.0 112.414 -169.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.61 153.2 38.41 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.077 -1.874 . . . . 15.0 110.563 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.3 m -80.76 122.61 27.38 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 108.11 20.72 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.348 -1.296 . . . . 15.0 107.995 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.57 111.02 16.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.548 -1.66 . . . . 15.0 108.017 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 110' ' ' GLY . 1.4 tm-20 -129.28 120.51 25.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.553 -1.203 . . . . 15.0 111.054 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 141' ' ' MET . 86.5 t80 -134.95 105.55 6.43 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 117.699 -1.143 . . . . 15.0 110.199 170.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.661 ' HB3' ' O ' ' A' ' 108' ' ' PHE 0.756 1.1 mp0 -149.88 159.28 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 110.884 -2.871 . . . . 15.0 116.751 164.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -78.23 111.6 14.36 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 122.422 1.106 . . . . 15.0 108.207 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.667 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 36.4 p -119.34 -18.47 8.56 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 113.457 -1.701 . . . . 15.0 115.583 -176.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.565 ' ND2' ' HG3' ' A' ' 141' ' ' MET . 11.2 p30 -164.27 -166.49 1.13 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.547 1.939 . . . . 15.0 107.915 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 62.78 149.58 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.982 1.475 . . . . 15.0 114.982 -174.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.68 -67.5 0.9 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.433 -1.712 . . . . 15.0 111.935 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -99.82 82.29 2.57 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -171.21 141.47 1.62 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.31 -1.768 . . . . 15.0 108.956 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -80.53 83.36 6.35 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.624 0.726 . . . . 15.0 112.301 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 62.26 -165.3 22.39 Favored Glycine 0 N--CA 1.482 1.71 0 CA-C-N 114.419 -1.264 . . . . 15.0 113.262 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.565 ' HG3' ' ND2' ' A' ' 134' ' ' ASN . 0.0 OUTLIER -130.79 133.9 46.38 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.921 1.082 . . . . 15.0 113.921 176.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -112.55 105.18 13.33 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.487 -1.688 . . . . 15.0 112.079 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 14.9 m -102.26 125.18 48.88 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.775 -2.012 . . . . 15.0 107.847 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.08 136.88 48.81 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.258 -1.337 . . . . 15.0 111.426 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.08 -162.46 29.39 Favored Glycine 0 N--CA 1.476 1.327 0 O-C-N 124.837 1.335 . . . . 15.0 112.612 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.595 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.7 m -121.0 140.1 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 113.824 -1.188 . . . . 15.0 112.022 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.509 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 25.0 t -123.63 136.17 54.35 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.437 -1.256 . . . . 15.0 110.661 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 123' ' ' GLU . 34.7 t80 -111.72 135.21 52.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.607 -1.179 . . . . 15.0 109.482 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -91.01 128.7 36.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.42 -1.263 . . . . 15.0 109.842 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.419 ' CE1' ' HA ' ' A' ' 6' ' ' THR . 0.9 OUTLIER 60.05 82.89 0.15 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.888 2.075 . . . . 15.0 114.098 -173.134 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.42 -138.35 0.36 Allowed Glycine 0 CA--C 1.537 1.41 0 CA-C-N 112.667 -2.061 . . . . 15.0 112.179 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -66.95 79.66 0.12 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.284 1.587 . . . . 15.0 115.284 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.91 87.53 0.08 OUTLIER Glycine 0 N--CA 1.478 1.467 0 CA-C-N 113.895 -1.502 . . . . 15.0 112.852 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -123.68 135.74 54.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.808 0.843 . . . . 15.0 109.997 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.81 94.35 1.4 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.06 -0.973 . . . . 15.0 111.589 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-N 113.744 -1.571 . . . . 15.0 114.066 177.656 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mtt . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 115.513 1.671 . . . . 15.0 115.513 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.439 ' HG2' ' OD1' ' A' ' 4' ' ' ASP . 89.0 Cg_endo -77.26 55.77 5.21 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.965 2.443 . . . . 15.0 114.004 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.27 0.6 OUTLIER 40.9 26.32 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 118.94 2.941 . . . . 15.0 118.94 178.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 2' ' ' PRO . 18.5 p-10 -135.11 138.69 44.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.096 1.358 . . . . 15.0 110.294 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 45.98 46.79 12.6 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.625 1.57 . . . . 15.0 113.053 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 33' ' ' GLN . 12.2 p -98.27 115.12 27.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.013 -2.358 . . . . 15.0 109.337 -172.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.555 ' HB3' ' H ' ' A' ' 151' ' ' GLY . 55.5 m95 -94.18 130.43 40.4 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.683 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 148' ' ' TYR . 1.2 t80 -143.4 111.26 6.03 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.487 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.585 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 40.4 p -117.96 174.57 6.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.869 -1.969 . . . . 15.0 110.503 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.0 -159.21 28.36 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.224 0.902 . . . . 15.0 114.4 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.82 132.75 24.22 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.725 -1.237 . . . . 15.0 111.019 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HA ' ' HA3' ' A' ' 145' ' ' GLY . 22.7 pttp -137.3 150.47 47.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.481 -1.236 . . . . 15.0 112.341 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.6 pp -114.21 143.59 44.58 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.875 -1.057 . . . . 15.0 111.723 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.31 119.09 6.26 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-N 113.2 -1.818 . . . . 15.0 110.316 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -114.82 141.1 48.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 113.502 -1.349 . . . . 15.0 111.72 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 m -122.21 98.04 5.75 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.063 -1.426 . . . . 15.0 113.708 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -85.32 48.64 1.61 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.45 1.278 . . . . 15.0 114.45 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -166.57 26.4 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.073 1.509 . . . . 15.0 115.073 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -155.38 144.23 20.65 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.593 0.59 . . . . 15.0 112.593 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -80.88 90.38 5.9 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 15.0 110.193 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 57.6 28.72 16.09 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.371 1.989 . . . . 15.0 116.371 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -114.82 133.96 55.51 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.466 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 10.5 mm-40 53.07 93.76 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.137 1.903 . . . . 15.0 116.137 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pp -154.23 137.22 15.47 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 111.681 -2.509 . . . . 15.0 110.151 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.07 -169.88 37.56 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.138 0.899 . . . . 15.0 113.486 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -124.39 142.62 51.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.573 0.749 . . . . 15.0 112.695 -175.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.16 145.92 16.75 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 114.188 -1.369 . . . . 15.0 111.16 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.67 121.27 43.21 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.32 -0.94 . . . . 15.0 109.351 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -127.23 152.88 46.81 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.699 -1.137 . . . . 15.0 112.165 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -174.36 149.23 10.46 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 115.413 -0.812 . . . . 15.0 114.813 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.22 -146.74 7.62 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 113.634 -1.283 . . . . 15.0 113.298 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -158.35 149.55 20.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.722 -1.239 . . . . 15.0 113.621 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.523 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 42.2 tt0 -114.66 95.17 5.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.303 1.441 . . . . 15.0 108.657 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.6 -48.17 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.222 -0.899 . . . . 15.0 111.693 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.99 154.93 61.37 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-O 118.055 -0.974 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.47 53.36 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.877 3.051 . . . . 15.0 113.42 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.91 -82.3 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.515 1.526 . . . . 15.0 108.667 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.38 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.939 0.896 . . . . 15.0 108.854 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.62 166.88 17.09 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.188 1.375 . . . . 15.0 110.671 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.96 139.39 52.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.41 137.15 43.83 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.363 -1.29 . . . . 15.0 111.805 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.18 143.33 31.41 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.756 -1.565 . . . . 15.0 109.85 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.32 7.75 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.05 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -118.99 133.96 55.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.364 1.078 . . . . 15.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -125.11 133.82 52.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.921 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.668 ' HA ' ' HG3' ' A' ' 55' ' ' GLN . 37.7 p-90 -102.8 133.54 47.69 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.814 -1.085 . . . . 15.0 110.192 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 87' ' ' ASP . 37.9 tp -106.23 -35.83 7.06 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.595 -1.639 . . . . 15.0 113.764 -173.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.81 29.62 4.89 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.459 1.028 . . . . 15.0 112.637 -175.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.587 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.7 OUTLIER -112.94 165.46 12.31 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.42 1.088 . . . . 15.0 110.992 -178.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.1 mtm -46.82 146.99 2.38 Favored Pre-proline 0 N--CA 1.48 1.029 0 N-CA-C 115.144 1.535 . . . . 15.0 115.144 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.01 157.03 55.19 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.662 2.242 . . . . 15.0 111.149 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 65.98 93.63 0.07 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.416 1.887 . . . . 15.0 112.394 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 57.17 94.56 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 116.211 1.93 . . . . 15.0 116.211 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 49' ' ' ARG . . . -170.1 -66.53 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.584 -1.643 . . . . 15.0 111.632 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.668 ' HG3' ' HA ' ' A' ' 46' ' ' TRP . 2.9 mp0 -51.6 147.1 6.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.906 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 135.87 16.04 Favored Glycine 0 N--CA 1.478 1.467 0 CA-C-N 114.37 -1.286 . . . . 15.0 112.576 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.13 137.32 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.73 1.252 . . . . 15.0 112.988 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.568 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -126.84 139.77 52.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.089 -1.869 . . . . 15.0 111.733 175.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.44 111.19 17.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.585 -1.643 . . . . 15.0 109.114 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.548 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 34.2 m -124.55 140.86 52.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.986 -1.461 . . . . 15.0 109.884 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.843 ' O ' ' HB3' ' A' ' 78' ' ' ARG . . . -101.06 138.5 38.02 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.998 -1.853 . . . . 15.0 105.998 168.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.749 ' HA ' ' CB ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -124.95 139.24 54.0 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.93 2.019 . . . . 15.0 114.365 -178.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 77' ' ' THR 0.27 4.6 pp -127.15 120.7 29.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 166.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . -121.91 135.05 10.19 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.678 -2.51 . . . . 15.0 112.58 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.08 145.43 50.29 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 125.348 1.263 . . . . 15.0 114.118 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.4 91.22 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.069 2.513 . . . . 15.0 110.728 167.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.678 ' HD3' ' H ' ' A' ' 68' ' ' LEU . 6.3 tmtt? -144.6 152.16 40.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.405 -1.725 . . . . 15.0 108.895 -178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.678 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 1.2 tm? 62.95 85.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.79 2.036 . . . . 15.0 109.624 -170.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -140.74 15.82 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 112.926 -1.943 . . . . 15.0 109.584 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.55 HG23 ' H ' ' A' ' 71' ' ' ASP . 3.2 t -136.34 -86.96 0.33 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.188 -1.006 . . . . 15.0 112.153 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.55 ' H ' HG23 ' A' ' 70' ' ' THR . 8.5 m-20 -124.97 106.6 10.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.108 1.363 . . . . 15.0 108.093 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t0 176.32 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 113.175 -1.83 . . . . 15.0 110.138 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.437 ' HB3' ' CD2' ' A' ' 114' ' ' TYR . 1.3 pt? -135.32 151.79 50.86 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.799 1.312 . . . . 15.0 112.218 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 7.0 m-20 -132.56 138.78 47.58 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.398 -1.274 . . . . 15.0 111.022 172.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.491 ' HA ' HG12 ' A' ' 112' ' ' VAL . 7.8 tp -87.71 135.84 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.275 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -123.94 128.86 50.04 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.992 1.433 . . . . 15.0 111.646 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.503 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 24.0 p -137.2 122.35 19.18 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.942 -1.132 . . . . 15.0 107.942 158.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.843 ' HB3' ' O ' ' A' ' 61' ' ' ALA 0.609 8.0 mmt180 -158.9 164.6 35.53 Favored 'General case' 0 N--CA 1.478 0.972 1 N-CA-C 122.946 4.424 . . . . 15.0 122.946 172.822 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.725 HD13 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -127.93 156.0 43.33 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.096 0.776 . . . . 15.0 113.096 -176.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.548 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -165.12 -176.55 36.86 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 114.96 -1.018 . . . . 15.0 113.365 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.93 144.16 14.97 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 123.889 0.757 . . . . 15.0 113.286 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.568 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -123.79 140.68 52.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.617 1.34 . . . . 15.0 114.617 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.87 144.27 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 125.157 1.536 . . . . 15.0 112.309 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -122.75 151.26 41.76 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.38 1.072 . . . . 15.0 111.798 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.563 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -123.63 160.32 27.37 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.429 -0.805 . . . . 15.0 112.158 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 61.83 -145.01 0.42 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.757 1.623 . . . . 15.0 111.323 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.619 ' HB2' HD21 ' A' ' 47' ' ' LEU . 26.7 t0 46.76 59.53 3.89 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.987 1.477 . . . . 15.0 114.987 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.6 p -102.63 -74.46 0.63 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.303 1.223 . . . . 15.0 114.303 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 t 68.92 117.64 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.16 2.184 . . . . 15.0 113.309 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -168.41 140.67 2.87 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.639 -1.619 . . . . 15.0 109.101 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -69.95 155.89 39.91 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.299 1.0 . . . . 15.0 111.21 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -115.56 150.31 36.82 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.173 -0.921 . . . . 15.0 112.675 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.48 -108.01 0.24 Allowed Glycine 0 N--CA 1.478 1.453 0 O-C-N 125.359 1.662 . . . . 15.0 109.134 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -56.64 -31.22 64.14 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.877 1.436 . . . . 15.0 114.877 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.43 -103.41 0.79 Allowed Glycine 0 N--CA 1.478 1.451 0 C-N-CA 124.03 0.824 . . . . 15.0 113.209 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -69.94 92.69 0.73 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.261 1.024 . . . . 15.0 112.179 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.607 HG23 ' H ' ' A' ' 98' ' ' SER 0.326 0.0 OUTLIER -117.02 -88.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 114.436 -1.256 . . . . 15.0 112.384 174.141 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.607 ' H ' HG23 ' A' ' 97' ' ' ILE . 23.0 m -63.39 -20.37 65.47 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 118.219 2.674 . . . . 15.0 118.219 -172.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -10.84 84.91 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 118.227 2.677 . . . . 15.0 118.227 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.92 66.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 117.199 2.296 . . . . 15.0 117.199 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 62.63 146.74 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.244 1.818 . . . . 15.0 114.684 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.32 90.35 5.57 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.484 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t -73.44 143.98 46.48 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 113.759 -1.564 . . . . 15.0 111.903 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 t -117.0 120.67 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.0 m -122.12 142.01 35.67 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.305 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.16 148.7 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.666 2.244 . . . . 15.0 113.274 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.41 135.05 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.643 -1.617 . . . . 15.0 109.64 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -107.11 123.36 48.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -127.55 112.51 15.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.907 -173.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 138.56 11.76 Favored Glycine 0 N--CA 1.479 1.539 0 CA-C-N 113.581 -1.645 . . . . 15.0 110.713 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 129' ' ' GLU . . . 174.79 -152.95 14.73 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.298 0.475 . . . . 15.0 113.244 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 75' ' ' ILE . 5.4 m -141.77 156.97 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.992 1.108 . . . . 15.0 113.992 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -110.13 136.89 48.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.426 -1.716 . . . . 15.0 108.669 159.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 73' ' ' LEU . 11.5 t80 -132.37 143.61 49.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.865 -1.516 . . . . 15.0 108.957 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.44 135.32 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 120.949 0.404 . . . . 15.0 109.991 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.7 mt -43.61 -39.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.805 1.78 . . . . 15.0 115.805 -164.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -164.1 -60.13 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.589 0.755 . . . . 15.0 110.495 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.16 135.52 34.34 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.767 -0.651 . . . . 15.0 109.701 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.79 -33.8 50.5 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.975 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.0 tt -99.84 82.92 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 122.236 1.017 . . . . 15.0 109.893 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 89.2 m -136.76 88.96 18.25 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 112.325 -2.216 . . . . 15.0 108.163 167.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.37 -177.11 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.949 2.433 . . . . 15.0 111.733 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 54.4 mt-10 66.83 -55.6 0.43 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.631 1.973 . . . . 15.0 115.309 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.541 HG12 ' CE2' ' A' ' 148' ' ' TYR . 6.6 mt -116.72 115.16 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.254 1.022 . . . . 15.0 108.649 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.07 147.98 44.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.369 -1.287 . . . . 15.0 111.343 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 m -80.75 116.8 20.94 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.498 HH11 ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -116.83 112.04 20.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.115 0.96 . . . . 15.0 109.889 -177.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.53 112.75 18.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 15.0 110.841 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.401 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 18.0 tt0 -134.98 136.45 42.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.928 -1.487 . . . . 15.0 111.491 -173.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 30.7 m-85 -97.4 131.96 43.56 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.425 -1.262 . . . . 15.0 109.341 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.38 117.0 30.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.356 -1.747 . . . . 15.0 111.592 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -120.72 111.83 18.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.493 -1.685 . . . . 15.0 113.186 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 92.1 m -111.02 -34.31 6.24 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 112.64 -2.073 . . . . 15.0 111.557 167.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -77.76 117.24 18.95 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.111 0.482 . . . . 15.0 111.417 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.6 -33.48 60.45 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.339 -1.301 . . . . 15.0 112.708 172.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.3 94.02 3.52 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.041 0.924 . . . . 15.0 111.048 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.2 m -56.56 85.15 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.185 -1.825 . . . . 15.0 112.712 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -110.42 -31.1 7.39 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 113.462 -1.699 . . . . 15.0 115.06 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -176.8 -79.29 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.034 1.334 . . . . 15.0 109.444 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 117.25 -176.69 16.31 Favored Glycine 0 N--CA 1.478 1.436 0 N-CA-C 109.057 -1.617 . . . . 15.0 109.057 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.0 ttt -117.65 135.11 54.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.586 0.708 . . . . 15.0 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.2 tt -105.17 108.8 20.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.694 -1.139 . . . . 15.0 109.708 -174.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m -93.25 125.11 37.68 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.208 1.004 . . . . 15.0 110.081 170.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.4 pp -133.9 135.22 43.49 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 112.903 -1.953 . . . . 15.0 110.109 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -178.94 -162.52 28.48 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 114.82 -1.082 . . . . 15.0 112.848 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.3 m -117.04 131.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 113.518 -1.341 . . . . 15.0 112.633 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.7 p -113.17 145.73 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 112.342 -2.208 . . . . 15.0 111.535 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 70.7 m-85 -124.07 143.45 50.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.009 -1.905 . . . . 15.0 112.482 -172.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -95.84 141.54 29.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 113.583 -1.644 . . . . 15.0 111.41 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 69.1 92.11 0.09 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.825 1.65 . . . . 15.0 114.347 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.555 ' H ' ' HB3' ' A' ' 7' ' ' TRP . . . -78.69 101.87 1.83 Allowed Glycine 0 N--CA 1.476 1.354 0 CA-C-N 113.269 -1.787 . . . . 15.0 111.168 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -60.49 94.19 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.121 0.962 . . . . 15.0 112.526 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.25 94.75 0.1 Allowed Glycine 0 N--CA 1.476 1.332 0 CA-C-N 113.406 -1.724 . . . . 15.0 111.84 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 70.36 101.28 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.494 1.917 . . . . 15.0 112.632 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.78 93.19 0.1 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.698 -1.592 . . . . 15.0 112.268 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.261 0 CA-C-N 113.631 -1.622 . . . . 15.0 113.97 177.606 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 97.9 mtp . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 115.949 1.833 . . . . 15.0 115.949 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 72.7 Cg_endo -73.17 86.13 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.691 2.261 . . . . 15.0 110.797 172.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.699 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 14.7 ttpt -68.49 -87.87 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 113.598 -1.637 . . . . 15.0 112.506 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.477 ' H ' ' HE2' ' A' ' 3' ' ' LYS . 25.6 t0 -72.5 -41.25 66.14 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.414 0.686 . . . . 15.0 110.919 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 34' ' ' VAL . 60.0 t30 59.64 30.93 20.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.857 1.663 . . . . 15.0 114.563 165.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.611 ' HA ' ' HB3' ' A' ' 149' ' ' ARG . 10.2 t -110.98 114.72 28.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.162 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -136.79 133.57 36.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.905 -2.407 . . . . 15.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 144.17 -98.11 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 129.293 3.037 . . . . 15.0 108.09 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.663 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 11.2 t -163.51 153.18 15.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -131.06 -170.07 12.59 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.166 -1.379 . . . . 15.0 112.793 170.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.73 131.57 5.44 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.752 1.621 . . . . 15.0 109.522 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.693 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.425 5.2 tptp -171.94 169.61 5.65 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.185 -1.825 . . . . 15.0 115.142 168.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.45 ' HB3' ' H ' ' A' ' 26' ' ' ALA . 1.9 pt? -130.47 161.64 30.98 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.427 -1.261 . . . . 15.0 111.681 -173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -120.0 155.57 16.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.513 -1.222 . . . . 15.0 112.548 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -121.65 137.02 54.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.924 -1.138 . . . . 15.0 112.49 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -116.8 151.78 35.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.09 -1.414 . . . . 15.0 109.919 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -71.43 78.73 0.76 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.164 1.172 . . . . 15.0 114.164 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -158.92 139.49 12.51 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.135 -1.393 . . . . 15.0 111.717 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.9 m -66.46 -40.41 89.39 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 116.664 2.098 . . . . 15.0 116.664 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 mtt-85 -76.78 92.08 3.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.54 0.686 . . . . 15.0 111.841 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -124.58 131.5 53.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.096 -1.865 . . . . 15.0 113.03 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -131.65 -163.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.239 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -74.68 74.64 2.04 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.535 1.159 . . . . 15.0 111.024 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.63 101.43 3.67 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.663 -1.608 . . . . 15.0 108.502 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.66 -153.82 23.06 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 114.146 -1.388 . . . . 15.0 111.377 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' H ' ' HB3' ' A' ' 13' ' ' LEU . . . 50.13 91.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.191 1.796 . . . . 15.0 114.19 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.11 148.77 16.48 Favored Glycine 0 N--CA 1.475 1.269 0 CA-C-N 113.807 -1.542 . . . . 15.0 109.99 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.45 121.14 41.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.692 -0.855 . . . . 15.0 108.692 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 97.3 m-85 -125.75 113.43 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.562 -1.199 . . . . 15.0 110.114 -170.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.67 -174.59 14.44 Favored Glycine 0 N--CA 1.477 1.405 0 CA-C-N 115.353 -0.84 . . . . 15.0 114.309 -173.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.92 -140.04 13.86 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.441 -0.88 . . . . 15.0 113.705 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -127.19 104.93 8.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.406 -1.397 . . . . 15.0 112.969 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.497 HE22 ' HB2' ' A' ' 62' ' ' LYS . 15.5 mm100 -114.93 82.27 1.71 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 123.066 1.412 . . . . 15.0 108.249 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG22 ' HA ' ' A' ' 5' ' ' ASN . 47.9 t -124.78 -63.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 112.749 -2.023 . . . . 15.0 113.315 -170.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.5 t-20 -62.17 139.09 96.13 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 114.354 1.242 . . . . 15.0 114.354 -170.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.699 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 75.6 Cg_endo -73.59 41.13 0.59 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.652 3.568 . . . . 15.0 116.444 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 1.2 t80 -167.51 -58.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 15.0 111.236 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 57.2 t -124.65 136.32 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.794 0.806 . . . . 15.0 110.279 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.37 154.57 21.3 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 113.785 -1.552 . . . . 15.0 110.055 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.95 114.31 20.81 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.737 0.303 . . . . 15.0 110.503 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.428 ' CD ' ' HB3' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -131.94 119.91 21.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.159 -0.928 . . . . 15.0 111.047 -172.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.3 mtp -112.21 135.6 52.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.796 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 29' ' ' PHE . . . -115.87 147.67 18.91 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 113.382 -1.735 . . . . 15.0 111.948 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -132.29 143.03 49.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.846 1.425 . . . . 15.0 114.846 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.09 118.44 24.39 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 111.722 -2.49 . . . . 15.0 107.238 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -112.51 145.18 40.71 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.518 -1.219 . . . . 15.0 110.073 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.478 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -91.2 71.37 6.23 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.212 -172.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.32 -152.37 18.02 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 112.248 -2.251 . . . . 15.0 110.704 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -122.91 -81.72 0.64 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.937 -1.132 . . . . 15.0 109.968 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -58.78 -35.76 35.97 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-O 118.391 -0.814 . . . . 15.0 112.353 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -94.33 141.4 1.45 Allowed 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 121.062 1.175 . . . . 15.0 111.038 160.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -140.56 94.24 2.71 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.591 -1.186 . . . . 15.0 108.592 169.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' H ' ' HB3' ' A' ' 47' ' ' LEU . 9.5 tmtt? -91.14 -89.28 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 114.458 -1.246 . . . . 15.0 112.886 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.28 -49.38 61.34 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 117.184 2.29 . . . . 15.0 117.184 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 58.41 109.54 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.125 1.77 . . . . 15.0 114.516 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.26 134.76 10.58 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 114.021 -1.445 . . . . 15.0 111.282 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.2 p -119.05 141.33 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 122.111 0.958 . . . . 15.0 111.259 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.517 ' HG2' ' HB3' ' A' ' 82' ' ' MET . 47.4 mt-30 -120.66 140.29 51.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.284 -1.326 . . . . 15.0 109.976 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.64 114.82 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.397 -1.274 . . . . 15.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.2 p -130.41 131.73 45.4 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.746 0.784 . . . . 15.0 110.881 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -114.77 123.3 48.87 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.982 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.655 ' HG2' ' CD2' ' A' ' 76' ' ' TYR . 11.9 tmtt? -79.31 106.41 11.32 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.2 -1.818 . . . . 15.0 108.575 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.79 108.82 15.32 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.472 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 37' ' ' TYR . . . 177.65 -153.69 13.85 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 114.021 -1.445 . . . . 15.0 113.517 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.98 152.22 76.87 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 113.934 -1.133 . . . . 15.0 111.23 -170.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.491 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 35.2 Cg_endo -61.29 -73.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.497 2.131 . . . . 15.0 111.24 170.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 60.95 143.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.599 1.96 . . . . 15.0 111.621 -176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.72 -61.63 2.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.878 -1.056 . . . . 15.0 112.055 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.403 ' HA3' HD13 ' A' ' 73' ' ' LEU . . . 64.11 -85.15 0.06 OUTLIER Glycine 0 N--CA 1.478 1.462 0 C-N-CA 124.76 1.171 . . . . 15.0 111.492 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 p -134.83 -73.01 0.47 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.653 1.181 . . . . 15.0 109.383 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -165.81 135.33 3.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.869 2.068 . . . . 15.0 108.684 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' HB2' ' CE1' ' A' ' 114' ' ' TYR . 7.3 m-20 62.03 43.64 8.78 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.903 1.281 . . . . 15.0 112.775 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.403 HD13 ' HA3' ' A' ' 69' ' ' GLY . 7.7 tt -117.57 137.36 52.64 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.776 -1.102 . . . . 15.0 112.942 -167.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 14.9 t70 -126.61 139.41 53.21 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 112.079 -2.328 . . . . 15.0 109.002 165.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.9 tt -118.16 119.12 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.119 0.968 . . . . 15.0 109.831 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.655 ' CD2' ' HG2' ' A' ' 62' ' ' LYS . 8.8 p90 -153.86 168.9 24.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.012 1.115 . . . . 15.0 114.012 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.599 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 8.9 t -118.66 133.53 55.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.569 166.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.505 ' HB3' ' HE2' ' A' ' 76' ' ' TYR . 7.8 ppt_? -100.53 123.17 44.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.55 1.167 . . . . 15.0 109.149 172.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 pp -124.41 144.57 49.98 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.221 -2.263 . . . . 15.0 113.483 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.64 -97.36 0.17 Allowed Glycine 0 N--CA 1.476 1.304 0 CA-C-N 113.46 -1.7 . . . . 15.0 109.309 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.59 -153.66 23.75 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 115.057 0.783 . . . . 15.0 115.057 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.517 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 21.9 ptp -129.14 138.5 51.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.217 1.562 . . . . 15.0 115.217 -172.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.2 t -128.05 115.58 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 112.902 -1.953 . . . . 15.0 109.185 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -100.92 151.44 21.74 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.85 -1.523 . . . . 15.0 109.721 170.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.71 67.72 0.1 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 123.527 1.632 . . . . 15.0 112.535 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 101' ' ' GLU . . . -72.15 89.3 1.15 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.983 -1.462 . . . . 15.0 111.15 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t70 116.78 128.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 129.716 3.207 . . . . 15.0 111.376 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.6 t -131.32 157.46 43.27 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.09 -1.868 . . . . 15.0 109.313 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -24.59 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 117.055 2.243 . . . . 15.0 117.055 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -72.32 84.4 1.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.586 -1.188 . . . . 15.0 111.589 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -2.71 -75.69 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.231 2.613 . . . . 15.0 116.551 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -130.4 146.98 52.05 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.965 -1.124 . . . . 15.0 107.965 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . -118.08 -153.48 9.59 Favored Glycine 0 N--CA 1.474 1.232 0 O-C-N 124.372 1.045 . . . . 15.0 113.744 -174.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -168.58 -160.99 0.32 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.981 1.712 . . . . 15.0 108.03 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.38 83.97 0.14 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.755 1.169 . . . . 15.0 112.971 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 51.15 82.55 0.06 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.736 2.014 . . . . 15.0 114.149 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.502 HD11 ' HA2' ' A' ' 93' ' ' GLY . 10.9 pt -123.59 164.3 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 113.129 -1.85 . . . . 15.0 111.92 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.0 m 58.08 75.59 0.37 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.857 1.663 . . . . 15.0 113.977 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.23 85.72 2.42 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.071 -1.422 . . . . 15.0 111.097 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -161.25 140.44 10.2 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 113.17 -1.832 . . . . 15.0 110.72 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 86' ' ' ALA . 41.7 tt0 -160.3 134.94 7.58 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.373 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 60.1 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.565 1.946 . . . . 15.0 115.84 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p -98.94 105.94 18.14 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.964 0.888 . . . . 15.0 112.78 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.97 90.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 114.778 -1.101 . . . . 15.0 108.375 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.8 m -130.04 90.17 43.25 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.112 1.153 . . . . 15.0 114.112 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.11 141.42 29.47 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.288 2.659 . . . . 15.0 112.66 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.437 HG22 HG21 ' A' ' 133' ' ' THR . 97.8 t -134.37 139.31 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.363 -1.29 . . . . 15.0 109.855 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -124.32 123.34 39.99 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.656 1.223 . . . . 15.0 109.139 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -136.33 112.66 9.88 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.952 1.093 . . . . 15.0 113.952 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 77' ' ' THR . . . -113.29 142.07 17.24 Favored Glycine 0 N--CA 1.479 1.527 0 CA-C-N 114.096 -1.411 . . . . 15.0 112.662 -173.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.16 -148.93 10.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-O 121.928 0.738 . . . . 15.0 114.606 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.35 143.86 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 113.483 -1.358 . . . . 15.0 113.859 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -122.83 121.92 37.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.069 -1.878 . . . . 15.0 109.898 178.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 72' ' ' ASP . 78.1 t80 -117.71 137.36 52.74 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.888 1.367 . . . . 15.0 110.196 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.83 130.62 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.288 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.94 106.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.905 1.817 . . . . 15.0 115.905 -169.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -118.89 87.37 2.72 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.092 -1.413 . . . . 15.0 110.36 171.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.496 HH21 ' HD2' ' A' ' 119' ' ' ARG . 21.7 ttp180 -174.08 -79.94 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.512 -1.676 . . . . 15.0 112.438 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.496 ' HD2' HH21 ' A' ' 118' ' ' ARG . 65.1 ttt180 -101.53 146.86 27.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.425 0.631 . . . . 15.0 112.658 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.26 100.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.078 1.751 . . . . 15.0 112.523 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.1 p -140.18 151.41 64.61 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 112.066 -2.334 . . . . 15.0 110.281 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.68 82.21 1.22 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.377 2.051 . . . . 15.0 110.141 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -0.7 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.939 2.496 . . . . 15.0 116.596 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.438 HG22 ' HB3' ' A' ' 148' ' ' TYR . 2.7 pp -116.53 140.79 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 112.687 -2.051 . . . . 15.0 112.4 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.403 ' HB1' ' OE1' ' A' ' 113' ' ' GLU . . . -118.47 127.78 53.97 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.489 -2.141 . . . . 15.0 109.333 175.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 8.9 t -109.33 129.28 55.53 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.426 -1.261 . . . . 15.0 112.182 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.453 ' O ' HD12 ' A' ' 144' ' ' LEU . 52.0 ttp180 -113.3 108.12 16.82 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.431 -1.713 . . . . 15.0 110.19 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.5 tp -106.73 111.02 23.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.855 -1.521 . . . . 15.0 108.061 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.469 ' OE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -138.18 150.41 46.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.136 -2.302 . . . . 15.0 113.161 -168.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 38.3 p90 -96.99 129.52 44.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 172.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 44.5 tt0 -108.04 110.01 21.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.806 -1.997 . . . . 15.0 108.5 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -123.43 136.54 54.67 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.117 -1.856 . . . . 15.0 112.802 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.437 HG21 HG22 ' A' ' 107' ' ' VAL . 8.8 t -179.08 74.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 110.927 -2.852 . . . . 15.0 108.761 173.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -171.74 149.88 2.6 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.439 -1.71 . . . . 15.0 111.964 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -61.4 -30.94 70.87 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.428 1.27 . . . . 15.0 114.428 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.7 91.12 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.966 1.365 . . . . 15.0 114.519 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.3 p -64.69 147.57 52.79 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.61 -1.632 . . . . 15.0 111.262 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 67.84 -3.43 1.18 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 115.331 1.604 . . . . 15.0 115.331 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -119.25 -163.16 0.95 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.626 1.17 . . . . 15.0 109.335 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 127.58 -153.2 19.13 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.506 1.051 . . . . 15.0 112.616 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.485 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 25.5 ttt -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.129 -1.035 . . . . 15.0 110.874 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.1 tp -114.32 112.22 22.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.398 -1.334 . . . . 15.0 107.398 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.54 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 9.8 t -120.56 138.34 53.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.952 -1.476 . . . . 15.0 112.693 -166.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.693 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 37.7 tp -120.1 134.58 55.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.589 -1.641 . . . . 15.0 109.861 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.27 128.33 5.75 Favored Glycine 0 N--CA 1.481 1.655 0 O-C-N 125.774 1.921 . . . . 15.0 110.247 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.489 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 48.2 t -121.43 127.55 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 118.718 1.259 . . . . 15.0 109.249 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.581 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 65.9 p -118.71 138.68 52.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.559 ' CE2' ' HA2' ' A' ' 10' ' ' GLY . 13.5 p90 -125.26 148.31 48.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.481 1.134 . . . . 15.0 113.65 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.611 ' HB3' ' HA ' ' A' ' 6' ' ' THR . 36.6 ptt180 -101.32 153.37 19.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.354 -1.748 . . . . 15.0 114.516 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 64.13 132.47 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.251 2.22 . . . . 15.0 115.161 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.32 103.36 2.45 Favored Glycine 0 N--CA 1.475 1.291 0 CA-C-N 112.575 -2.102 . . . . 15.0 109.219 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 10.61 102.23 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 127.629 2.372 . . . . 15.0 115.559 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -67.84 72.81 0.27 Allowed Glycine 0 N--CA 1.48 1.626 0 CA-C-N 114.426 -1.261 . . . . 15.0 114.835 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 51.31 79.36 0.1 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.841 2.056 . . . . 15.0 114.357 170.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.87 88.98 2.33 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.456 1.122 . . . . 15.0 111.96 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 CA-C-N 113.76 -1.563 . . . . 15.0 114.866 178.429 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 119.06 2.985 . . . . 15.0 119.06 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.15 140.35 49.09 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 121.963 1.775 . . . . 15.0 112.764 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.9 107.67 1.04 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.909 -1.496 . . . . 15.0 112.593 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -143.97 134.99 25.45 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.168 -1.378 . . . . 15.0 109.985 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 58.8 t30 57.1 39.6 28.96 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.801 1.64 . . . . 15.0 112.811 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.502 ' HB ' ' CE2' ' A' ' 8' ' ' TYR . 81.5 p -98.38 119.49 37.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.078 -1.873 . . . . 15.0 108.306 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.599 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 6.6 m0 -113.91 130.28 56.52 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.237 -1.023 . . . . 15.0 108.237 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.502 ' CE2' ' HB ' ' A' ' 6' ' ' THR . 89.6 m-85 -132.22 106.0 7.68 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.229 0.956 . . . . 15.0 112.348 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.0 p -104.07 137.9 41.36 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.547 -0.751 . . . . 15.0 111.341 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.11 -145.46 7.28 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 113.92 -1.491 . . . . 15.0 112.038 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.55 144.15 50.21 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.891 -0.655 . . . . 15.0 112.675 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -118.29 140.16 50.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.434 -1.257 . . . . 15.0 111.312 174.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 143' ' ' SER . 0.9 OUTLIER -127.53 133.43 49.81 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.247 -1.342 . . . . 15.0 111.391 176.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -111.45 116.99 4.36 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 125.223 1.577 . . . . 15.0 110.626 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -109.26 145.46 35.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.848 0.832 . . . . 15.0 111.723 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -98.98 98.17 9.25 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.5 -1.227 . . . . 15.0 114.289 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.92 90.0 7.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.82 -1.082 . . . . 15.0 109.438 170.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.22 -86.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.743 -2.026 . . . . 15.0 110.081 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -119.24 -165.45 1.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.537 1.135 . . . . 15.0 109.07 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.33 83.6 0.25 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.805 1.242 . . . . 15.0 113.904 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.94 136.97 50.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.669 -1.605 . . . . 15.0 111.763 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -121.18 97.1 5.36 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.117 -1.401 . . . . 15.0 109.549 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.01 133.72 55.27 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.329 1.233 . . . . 15.0 114.329 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.96 156.17 33.98 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.971 -1.922 . . . . 15.0 110.57 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.87 -86.91 0.07 OUTLIER Glycine 0 N--CA 1.478 1.495 0 O-C-N 124.245 0.965 . . . . 15.0 112.085 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 69.72 149.71 0.08 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.339 2.256 . . . . 15.0 114.801 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.25 149.8 16.96 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 113.636 -1.62 . . . . 15.0 110.812 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.54 121.34 42.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.226 0.536 . . . . 15.0 110.249 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.439 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 2.4 m-85 -129.83 150.3 51.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 116.103 1.89 . . . . 15.0 116.103 -166.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.29 121.07 4.43 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 112.985 -1.916 . . . . 15.0 110.352 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA3' HH12 ' A' ' 127' ' ' ARG . . . -104.99 98.91 1.54 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 113.732 -1.234 . . . . 15.0 110.215 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -105.97 101.1 10.62 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.586 1.184 . . . . 15.0 108.822 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.536 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 18.8 tm0? -106.37 82.46 1.74 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.8 -1.556 . . . . 15.0 106.8 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 44.0 t -80.37 -84.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.199 -1.819 . . . . 15.0 109.163 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' H ' ' CD ' ' A' ' 36' ' ' PRO . 19.3 t-20 163.5 51.42 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 128.916 2.886 . . . . 15.0 114.445 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.542 ' CD ' ' H ' ' A' ' 35' ' ' ASN . 96.0 Cg_endo -85.98 55.61 3.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 N-CA-C 108.669 -1.32 . . . . 15.0 108.669 157.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 66.72 -33.87 0.21 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.195 2.198 . . . . 15.0 114.858 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.08 160.5 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.894 1.677 . . . . 15.0 111.966 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -82.72 153.28 31.2 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 109.846 -1.302 . . . . 15.0 109.846 170.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -117.6 118.3 31.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.593 0.711 . . . . 15.0 110.774 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.7 tp10 -111.1 110.1 20.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.9 -1.518 . . . . 15.0 106.9 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.413 ' HG3' ' HB3' ' A' ' 59' ' ' LEU . 57.3 ttp -135.28 136.34 41.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.087 -1.415 . . . . 15.0 109.934 -174.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 29' ' ' PHE . . . -172.73 177.23 45.38 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 114.7 -1.136 . . . . 15.0 112.921 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -116.16 145.69 42.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.74 1.257 . . . . 15.0 113.749 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -117.32 118.49 32.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.031 -2.349 . . . . 15.0 109.478 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.46 ' HE1' ' HB1' ' A' ' 54' ' ' ALA . 42.0 t90 -129.45 152.41 49.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.41 -1.268 . . . . 15.0 110.47 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.9 tp -177.26 -46.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 125.188 1.555 . . . . 15.0 110.622 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.42 95.87 0.27 Allowed Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.948 1.261 . . . . 15.0 113.051 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.5 ptt-85 -69.03 79.76 0.32 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.62 1.2 . . . . 15.0 113.165 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -118.2 138.33 25.48 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 113.7 -1.591 . . . . 15.0 113.094 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.98 134.93 22.32 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.68 2.254 . . . . 15.0 110.787 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.604 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.3 OUTLIER 56.05 94.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.275 1.43 . . . . 15.0 112.234 -174.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 85' ' ' ARG . 99.1 mttt 65.96 150.49 0.05 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.869 1.667 . . . . 15.0 112.684 -172.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.46 ' HB1' ' HE1' ' A' ' 46' ' ' TRP . . . -174.96 -20.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 116.087 1.884 . . . . 15.0 116.087 -157.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.79 158.75 21.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.87 1.268 . . . . 15.0 113.566 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -121.41 148.33 17.35 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.498 169.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.25 131.97 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.446 0.641 . . . . 15.0 110.74 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.72 127.77 54.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.649 -1.16 . . . . 15.0 110.091 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 42' ' ' MET . 1.0 OUTLIER -128.49 117.07 20.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.996 -1.911 . . . . 15.0 111.415 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.553 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 36.3 p -120.44 145.94 46.72 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.111 -1.404 . . . . 15.0 111.91 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.09 115.82 27.92 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.86 -1.518 . . . . 15.0 107.583 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.554 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.4 pttm -108.32 136.02 48.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 113.86 -1.518 . . . . 15.0 113.298 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.724 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 20.0 tp -128.99 135.9 49.59 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 113.599 -1.637 . . . . 15.0 108.812 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.04 137.56 11.58 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 125.366 1.666 . . . . 15.0 110.03 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.547 ' H ' ' HB2' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -114.61 110.01 47.49 Favored Pre-proline 0 N--CA 1.477 0.882 0 N-CA-C 113.64 0.978 . . . . 15.0 113.64 177.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 65' ' ' TYR . 73.0 Cg_endo -72.99 92.51 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.483 2.122 . . . . 15.0 109.893 172.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -46.59 -44.88 18.5 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.208 -1.36 . . . . 15.0 114.28 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -172.01 157.36 4.36 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.175 1.39 . . . . 15.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.73 -91.31 0.5 Allowed Glycine 0 N--CA 1.476 1.327 0 CA-C-N 114.794 -1.093 . . . . 15.0 111.028 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -158.9 -94.6 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.42 0.688 . . . . 15.0 109.661 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.97 94.53 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.052 0.941 . . . . 15.0 109.369 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -159.65 -58.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.81 -1.541 . . . . 15.0 110.824 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.74 122.64 47.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.619 0.768 . . . . 15.0 111.1 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.442 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -125.37 106.64 9.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.964 -1.471 . . . . 15.0 111.088 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 tt -104.74 107.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.089 -0.96 . . . . 15.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.724 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -168.78 -171.9 1.49 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 112.466 -2.152 . . . . 15.0 111.553 -178.22 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.0 p -119.21 154.05 33.99 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.092 0.949 . . . . 15.0 112.894 -163.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -128.4 140.41 51.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.868 -1.514 . . . . 15.0 112.704 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 80' ' ' GLY . 1.6 tt -134.92 141.53 46.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.611 -1.177 . . . . 15.0 109.563 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -173.7 -143.0 4.12 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 114.92 -1.037 . . . . 15.0 111.838 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.37 156.07 27.3 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 114.429 -0.885 . . . . 15.0 113.617 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -113.27 138.15 50.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.284 -1.458 . . . . 15.0 112.089 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.618 HG22 HG12 ' A' ' 104' ' ' VAL . 31.4 t -118.63 134.17 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.212 -1.774 . . . . 15.0 106.212 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.409 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -113.97 141.66 47.12 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.235 -174.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 47.5 mtt-85 -111.12 102.99 11.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.164 1.172 . . . . 15.0 114.164 -175.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -124.3 144.62 49.89 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 113.082 -1.872 . . . . 15.0 110.606 171.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 52' ' ' ARG . 22.2 t70 -58.18 147.34 30.57 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.636 1.347 . . . . 15.0 114.636 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.8 p -107.12 137.41 45.24 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.85 -1.523 . . . . 15.0 110.837 171.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m 61.91 144.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.318 1.847 . . . . 15.0 115.275 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -175.59 -46.02 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.346 -1.297 . . . . 15.0 112.345 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.94 142.82 56.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.489 0.716 . . . . 15.0 111.921 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -113.6 157.56 21.95 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.08 -1.418 . . . . 15.0 112.194 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.81 -97.13 0.45 Allowed Glycine 0 N--CA 1.477 1.424 0 O-C-N 124.655 1.222 . . . . 15.0 111.436 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -128.45 154.67 45.83 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.355 0.68 . . . . 15.0 110.415 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -121.06 146.44 17.41 Favored Glycine 0 N--CA 1.477 1.367 0 O-C-N 124.173 0.92 . . . . 15.0 112.475 -169.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -120.29 -84.5 0.66 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.962 -1.119 . . . . 15.0 112.479 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 tp -122.82 141.53 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.288 0.635 . . . . 15.0 111.952 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 m -65.4 88.88 0.09 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.617 -1.174 . . . . 15.0 111.132 172.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.46 -39.54 61.23 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.67 2.1 . . . . 15.0 116.67 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 56.25 163.81 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 115.202 1.556 . . . . 15.0 115.202 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -124.78 90.61 3.28 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.784 -1.098 . . . . 15.0 111.577 173.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.91 92.69 3.52 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.064 -1.425 . . . . 15.0 110.69 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -130.44 134.17 46.89 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.466 -1.243 . . . . 15.0 112.905 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.618 HG12 HG22 ' A' ' 83' ' ' VAL . 16.7 m -129.85 141.75 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.005 -1.907 . . . . 15.0 110.433 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 67.6 m -135.0 107.78 10.51 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-N 115.477 -0.783 . . . . 15.0 113.037 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 105' ' ' SER . 71.0 Cg_endo -65.39 139.19 58.41 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.129 2.553 . . . . 15.0 112.561 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.91 139.62 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.968 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -126.57 137.29 53.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.516 -1.22 . . . . 15.0 110.98 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -137.6 137.44 38.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.228 -0.897 . . . . 15.0 111.864 176.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.86 138.0 10.0 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 115.43 -0.805 . . . . 15.0 112.329 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.41 -148.76 11.85 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 121.749 0.638 . . . . 15.0 114.582 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -124.49 131.47 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.513 1.149 . . . . 15.0 111.94 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.442 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 9.8 pt-20 -112.49 121.01 43.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.975 -1.921 . . . . 15.0 110.229 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -113.57 137.12 52.02 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.305 -1.316 . . . . 15.0 110.734 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.29 136.2 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 113.213 -1.812 . . . . 15.0 109.102 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.418 HG22 ' H ' ' A' ' 124' ' ' ILE . 8.5 tp -63.24 142.97 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 114.441 -1.254 . . . . 15.0 112.424 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -90.42 -91.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.255 -1.339 . . . . 15.0 109.758 168.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -118.84 114.47 22.68 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.033 0.533 . . . . 15.0 111.872 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -169.34 172.91 6.9 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.085 1.754 . . . . 15.0 110.276 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.9 tt -53.79 124.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.874 0.87 . . . . 15.0 110.918 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 m 56.35 74.83 0.64 Allowed Pre-proline 0 N--CA 1.483 1.185 0 CA-C-N 113.738 -1.573 . . . . 15.0 110.091 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.07 72.82 5.71 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 15.0 112.744 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 149' ' ' ARG . 6.1 pt-20 -163.55 30.57 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.177 -1.829 . . . . 15.0 113.145 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.418 ' H ' HG22 ' A' ' 116' ' ' ILE . 17.5 pt -116.64 136.17 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.251 -0.905 . . . . 15.0 113.438 -173.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.93 140.61 52.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.021 -1.9 . . . . 15.0 111.654 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 t -125.14 116.76 22.55 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.056 -1.884 . . . . 15.0 109.763 175.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.469 HH12 ' HA3' ' A' ' 31' ' ' GLY . 97.9 mtt180 -115.69 108.18 16.04 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.453 -1.703 . . . . 15.0 110.475 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.64 110.88 19.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.666 1.222 . . . . 15.0 111.585 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.76 150.18 39.7 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.54 -2.118 . . . . 15.0 112.07 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 25.2 p90 -97.21 128.06 43.74 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.18 123.83 48.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.264 -1.334 . . . . 15.0 111.598 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.535 ' HE1' ' HB3' ' A' ' 136' ' ' ALA . 16.7 t90 -126.38 146.59 50.0 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.501 -2.136 . . . . 15.0 110.868 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 134' ' ' ASN . 3.6 t -164.49 -86.1 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.582 -1.644 . . . . 15.0 110.762 -171.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.502 ' H ' HG23 ' A' ' 133' ' ' THR . 11.8 m-20 -42.3 138.1 1.81 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.461 1.504 . . . . 15.0 112.674 172.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -46.24 102.28 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.328 1.451 . . . . 15.0 114.858 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.535 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . . . -148.18 -47.47 0.16 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 113.293 -1.776 . . . . 15.0 113.298 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.7 t 51.57 40.93 28.17 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 114.787 1.403 . . . . 15.0 114.787 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -151.9 -77.74 0.12 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.667 -1.151 . . . . 15.0 109.697 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -123.21 158.21 31.34 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.412 0.685 . . . . 15.0 110.267 173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.5 -148.81 8.8 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 114.112 -1.404 . . . . 15.0 110.619 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 98.8 mtp -117.58 135.14 54.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.508 -0.846 . . . . 15.0 109.956 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 100.87 11.18 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.845 0.831 . . . . 15.0 111.757 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 61.2 m -93.11 125.2 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.682 -2.054 . . . . 15.0 109.949 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.67 126.87 53.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.514 -2.13 . . . . 15.0 109.096 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -115.17 110.89 2.37 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 112.486 -2.143 . . . . 15.0 110.423 -176.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.92 127.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 113.95 -1.125 . . . . 15.0 108.731 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 77.6 p -148.05 154.1 39.81 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.38 -1.736 . . . . 15.0 113.032 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -116.4 142.86 46.31 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.093 -1.412 . . . . 15.0 110.892 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 33.6 ttp-105 -70.13 126.14 28.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.452 -1.704 . . . . 15.0 109.618 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -78.98 77.23 5.45 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 113.63 -1.623 . . . . 15.0 110.013 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -47.7 -35.66 11.98 Favored Glycine 0 N--CA 1.482 1.763 0 CA-C-N 112.963 -1.926 . . . . 15.0 114.995 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 61.46 136.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.809 2.044 . . . . 15.0 114.273 174.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -38.07 -62.97 0.97 Allowed Glycine 0 N--CA 1.485 1.913 0 C-N-CA 125.819 1.676 . . . . 15.0 113.005 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -126.78 91.96 3.45 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.584 -0.808 . . . . 15.0 109.653 161.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.66 88.37 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.876 1.322 . . . . 15.0 112.598 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.273 0 CA-C-N 113.606 -1.634 . . . . 15.0 114.216 179.199 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 114.801 1.408 . . . . 15.0 114.801 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.87 -46.12 5.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.046 2.498 . . . . 15.0 113.19 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 tttm 61.63 -58.59 0.11 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 128.18 2.592 . . . . 15.0 116.56 170.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.436 ' HA ' HG22 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -168.82 74.62 0.1 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.894 2.078 . . . . 15.0 109.277 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.419 ' OD1' ' HA ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -55.27 -35.8 65.41 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 112.429 -2.169 . . . . 15.0 111.568 -176.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' A' ' 33' ' ' GLN . 29.5 m -153.58 142.95 21.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.09 1.756 . . . . 15.0 108.499 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -101.23 130.49 47.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.064 -0.971 . . . . 15.0 108.672 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.532 ' HH ' ' NH2' ' A' ' 127' ' ' ARG . 71.3 t80 -125.2 105.86 9.45 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.474 -166.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.583 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.0 m -123.24 128.97 50.74 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.421 0.451 . . . . 15.0 110.046 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -137.48 151.17 21.06 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 114.995 -1.002 . . . . 15.0 115.447 -173.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 28' ' ' ALA . . . -118.01 124.2 47.57 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.382 -1.409 . . . . 15.0 108.67 170.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.37 154.42 47.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.351 1.241 . . . . 15.0 114.351 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.2 161.76 20.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.339 -1.755 . . . . 15.0 111.949 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.62 96.72 0.59 Allowed Glycine 0 N--CA 1.476 1.362 0 N-CA-C 110.183 -1.167 . . . . 15.0 110.183 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.422 ' CZ3' ' HA ' ' A' ' 17' ' ' GLN . 50.2 t90 -102.63 123.1 45.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.767 0.794 . . . . 15.0 111.508 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 p -104.02 133.57 48.74 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.11 -0.95 . . . . 15.0 112.49 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.422 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 42.8 tt0 -64.12 -55.69 20.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.823 -1.535 . . . . 15.0 113.681 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.32 86.86 2.63 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.169 0.985 . . . . 15.0 111.689 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -137.41 134.1 35.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.968 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -54.54 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.048 1.499 . . . . 15.0 115.048 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -129.63 95.21 3.93 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.531 0.732 . . . . 15.0 110.293 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -122.76 149.16 44.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.58 -1.191 . . . . 15.0 113.761 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -74.31 154.07 39.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.849 -1.523 . . . . 15.0 110.314 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.63 -33.54 76.17 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.482 1.29 . . . . 15.0 114.482 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 140.38 8.61 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.519 1.057 . . . . 15.0 111.161 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 45' ' ' ASP . . . -141.6 86.47 2.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.613 -0.794 . . . . 15.0 110.136 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.15 92.93 0.59 Allowed Glycine 0 N--CA 1.474 1.19 0 CA-C-N 113.664 -1.607 . . . . 15.0 111.311 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . . . -117.99 121.03 39.59 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.071 0.512 . . . . 15.0 109.866 176.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.652 ' HB3' ' O ' ' A' ' 42' ' ' MET 0.293 5.2 t80 -161.63 179.81 7.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.332 -1.758 . . . . 15.0 111.625 175.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.83 -178.55 15.55 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 115.044 -0.98 . . . . 15.0 112.091 -170.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.5 -155.04 12.97 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 113.071 -1.565 . . . . 15.0 112.722 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -126.28 138.81 53.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 112.597 -1.802 . . . . 15.0 112.976 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.573 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 1.1 tm0? -115.73 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.098 -1.41 . . . . 15.0 107.982 167.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 4' ' ' ASP . 43.8 t -107.47 -29.74 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 111.095 -2.775 . . . . 15.0 110.412 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 48.6 54.48 16.07 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 116.954 2.205 . . . . 15.0 116.954 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.65 -22.42 37.76 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.097 1.865 . . . . 15.0 112.077 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -166.67 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 128.95 2.9 . . . . 15.0 109.292 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.408 HG21 ' HB1' ' A' ' 61' ' ' ALA . 12.1 m -135.33 160.49 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.255 1.422 . . . . 15.0 112.246 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 148.12 26.92 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 108.785 -1.726 . . . . 15.0 108.785 161.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.21 126.29 52.53 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.439 0.296 . . . . 15.0 111.399 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.55 ' HG3' HH22 ' A' ' 127' ' ' ARG . 4.1 pm0 -142.33 133.56 26.19 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.058 0.849 . . . . 15.0 113.123 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.652 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.5 137.11 54.84 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.271 -1.331 . . . . 15.0 108.233 174.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.52 129.81 8.5 Favored Glycine 0 N--CA 1.48 1.582 0 O-C-N 126.072 2.108 . . . . 15.0 110.745 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.472 ' H ' ' HB2' ' A' ' 29' ' ' PHE . 6.8 t80 -104.75 112.68 25.88 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.493 0.663 . . . . 15.0 109.602 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 15.0 t70 -106.74 118.4 36.58 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.122 -1.399 . . . . 15.0 110.005 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -120.54 110.05 15.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.613 -1.63 . . . . 15.0 111.06 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 6.9 tt -62.4 -31.08 71.71 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 113.108 -1.86 . . . . 15.0 112.84 177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.28 -147.54 16.57 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.516 1.055 . . . . 15.0 111.717 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.8 ptt-85 -76.75 67.2 2.8 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 122.808 1.29 . . . . 15.0 113.672 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.0 tpt -118.2 102.12 50.87 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 114.386 -1.279 . . . . 15.0 112.277 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.63 69.95 5.11 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.915 2.41 . . . . 15.0 111.615 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.9 ttt85 -175.48 -97.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.762 2.025 . . . . 15.0 107.376 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -114.97 93.25 4.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.531 0.733 . . . . 15.0 111.231 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 47' ' ' LEU . . . -111.13 -54.36 2.61 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.062 -2.335 . . . . 15.0 114.129 178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -115.46 101.97 9.38 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 15.0 112.467 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -119.26 142.19 16.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 112.226 -2.261 . . . . 15.0 111.141 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.71 135.16 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.185 -1.008 . . . . 15.0 111.164 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -109.8 116.63 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.912 -1.144 . . . . 15.0 107.912 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.6 111.19 21.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.82 -1.991 . . . . 15.0 109.095 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.7 p -130.21 147.41 51.93 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.453 -1.703 . . . . 15.0 113.797 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.408 ' HB1' HG21 ' A' ' 38' ' ' VAL . . . -104.28 134.21 47.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.422 -2.172 . . . . 15.0 109.232 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.545 ' HD3' HH21 ' A' ' 127' ' ' ARG . 22.0 ttpp -107.2 114.15 28.02 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.201 -1.363 . . . . 15.0 111.421 -172.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.91 142.81 46.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.084 -1.871 . . . . 15.0 109.755 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.88 -156.34 23.7 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.829 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.63 159.11 9.92 Favored Pre-proline 0 N--CA 1.481 1.116 0 N-CA-C 114.397 1.258 . . . . 15.0 114.397 -168.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.62 104.71 0.32 Allowed 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 123.264 2.643 . . . . 15.0 111.487 164.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -146.16 148.79 32.92 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.765 -2.016 . . . . 15.0 106.594 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp 70.29 -47.2 0.62 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.455 1.902 . . . . 15.0 111.548 -164.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.64 125.06 5.99 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.353 -1.099 . . . . 15.0 110.353 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -64.51 -57.28 9.63 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.58 0.752 . . . . 15.0 109.558 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -133.93 82.12 1.96 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.223 -0.899 . . . . 15.0 108.586 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -169.35 -75.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.979 -1.919 . . . . 15.0 108.944 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . 1.4 pt? -123.46 132.0 53.8 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.305 1.003 . . . . 15.0 110.847 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.92 135.56 54.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.436 -1.711 . . . . 15.0 108.757 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 tt -91.41 116.74 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.105 -0.952 . . . . 15.0 110.015 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.52 ' CD1' ' HG2' ' A' ' 62' ' ' LYS . 26.9 m-85 -135.96 138.82 42.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.25 -1.796 . . . . 15.0 115.06 -175.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 55.4 p -113.08 143.3 44.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 112.083 -2.326 . . . . 15.0 109.598 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 29.0 mtm105 -115.09 123.22 48.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.832 -1.531 . . . . 15.0 109.735 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tt -119.65 122.92 42.61 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.51 -1.223 . . . . 15.0 109.315 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -130.83 2.22 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 110.102 -1.199 . . . . 15.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 105' ' ' SER . . . 170.98 -166.44 39.63 Favored Glycine 0 N--CA 1.477 1.431 0 O-C-N 125.171 1.16 . . . . 15.0 114.999 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.7 ttm -119.4 129.68 54.92 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.175 -1.012 . . . . 15.0 112.146 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -122.59 135.8 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 113.521 -1.672 . . . . 15.0 108.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.439 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 9.2 p90 -108.0 119.18 38.73 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.778 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -121.18 -48.38 2.22 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 113.599 -1.637 . . . . 15.0 114.988 -170.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 60.5 -78.62 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.104 1.761 . . . . 15.0 114.911 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -173.9 108.77 0.14 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.937 1.295 . . . . 15.0 112.192 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 m -112.97 95.88 5.64 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.819 -1.082 . . . . 15.0 109.729 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -142.8 158.31 43.76 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.739 -1.119 . . . . 15.0 112.29 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.51 95.05 6.46 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.184 -0.917 . . . . 15.0 111.658 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -66.06 85.94 0.09 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.621 -1.172 . . . . 15.0 113.004 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -177.33 -55.99 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 112.472 -2.149 . . . . 15.0 110.296 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.34 -49.08 0.91 Allowed Glycine 0 CA--C 1.537 1.454 0 O-C-N 124.33 1.019 . . . . 15.0 110.889 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -66.85 156.27 36.1 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.81 0.67 . . . . 15.0 112.81 172.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.59 -97.47 0.62 Allowed Glycine 0 N--CA 1.474 1.215 0 CA-C-N 114.089 -1.414 . . . . 15.0 110.552 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.6 t80 47.95 86.7 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.375 1.47 . . . . 15.0 112.667 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 tp -161.85 143.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.77 -1.559 . . . . 15.0 110.182 -175.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.0 t 63.44 172.98 0.16 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.798 1.639 . . . . 15.0 112.982 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.63 152.09 36.71 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.58 1.152 . . . . 15.0 111.12 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.21 87.44 0.11 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 122.7 1.238 . . . . 15.0 111.799 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.1 90.15 0.09 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.198 -1.819 . . . . 15.0 113.248 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 144.35 56.22 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.336 -1.756 . . . . 15.0 112.129 171.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -71.49 140.2 49.88 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.283 -0.871 . . . . 15.0 111.912 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.26 -27.32 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.008 -0.996 . . . . 15.0 112.814 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.507 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 4.7 t 32.84 70.93 0.72 Allowed Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 127.328 2.251 . . . . 15.0 114.533 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.07 95.04 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.678 2.919 . . . . 15.0 114.26 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.55 HG11 HE21 ' A' ' 131' ' ' GLN . 70.2 t -123.96 134.37 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.508 -1.223 . . . . 15.0 109.981 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.91 123.35 40.76 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.245 -1.798 . . . . 15.0 109.626 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -120.99 136.75 54.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.232 0.613 . . . . 15.0 110.878 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.67 135.3 7.86 Favored Glycine 0 N--CA 1.478 1.453 0 CA-C-N 115.452 -0.794 . . . . 15.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.47 -146.84 8.19 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 124.362 0.683 . . . . 15.0 113.605 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.76 154.28 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.159 -1.021 . . . . 15.0 113.43 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -119.57 143.64 47.52 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.902 -1.499 . . . . 15.0 110.403 167.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.534 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 46.0 m-85 -117.0 139.1 51.08 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.527 1.142 . . . . 15.0 111.892 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.95 104.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.266 -1.334 . . . . 15.0 111.275 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . 0.265 18.1 tt -79.95 84.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 123.076 1.417 . . . . 15.0 112.97 -175.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -115.68 102.54 9.84 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.677 -2.056 . . . . 15.0 109.5 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -170.77 -83.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.617 -1.629 . . . . 15.0 106.804 176.534 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.436 ' H ' ' HB3' ' A' ' 118' ' ' ARG . 35.6 mtt180 -69.17 155.81 39.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.392 0.677 . . . . 15.0 111.572 166.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.62 97.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 114.359 -1.291 . . . . 15.0 113.534 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.2 p -110.0 135.94 20.46 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 113.83 -1.532 . . . . 15.0 111.642 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.92 73.31 4.31 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.788 2.325 . . . . 15.0 114.053 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 50.11 39.39 19.23 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.899 1.679 . . . . 15.0 114.636 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.477 HD11 ' HB ' ' A' ' 146' ' ' VAL . 3.9 tt -123.4 142.23 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.663 -1.153 . . . . 15.0 113.748 -164.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.89 157.82 29.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.017 -1.902 . . . . 15.0 110.338 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 32.7 p -106.41 132.23 52.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.296 -0.865 . . . . 15.0 111.046 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.55 HH22 ' HG3' ' A' ' 41' ' ' GLU . 19.4 ttm180 -112.85 130.53 56.06 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.824 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.62 111.03 8.5 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.9 1.375 . . . . 15.0 111.757 173.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.37 150.21 52.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.368 -1.287 . . . . 15.0 112.624 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 57.1 t80 -97.27 116.32 29.26 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.282 1.039 . . . . 15.0 108.376 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.55 HE21 HG11 ' A' ' 107' ' ' VAL . 62.5 tt0 -96.59 108.75 21.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 111.971 -2.377 . . . . 15.0 110.251 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -112.03 146.51 37.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.92 -1.945 . . . . 15.0 112.296 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.3 t -171.59 156.54 4.43 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 112.762 -2.017 . . . . 15.0 109.896 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -69.22 81.14 0.35 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.51 1.3 . . . . 15.0 114.51 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -114.22 169.71 8.82 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.851 -1.522 . . . . 15.0 112.474 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.61 44.46 2.47 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.322 1.049 . . . . 15.0 112.675 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.9 m -170.84 110.28 0.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.833 1.253 . . . . 15.0 113.263 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.4 t0 63.98 -36.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.153 2.581 . . . . 15.0 115.637 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 54.34 82.13 0.09 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.647 2.379 . . . . 15.0 115.227 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 117.33 130.76 4.43 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 111.426 -2.625 . . . . 15.0 111.401 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -119.19 148.24 43.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.048 -1.576 . . . . 15.0 109.983 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.8 97.42 10.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.681 -1.229 . . . . 15.0 107.681 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.6 t -94.96 125.13 39.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.211 -1.359 . . . . 15.0 107.947 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.54 150.08 24.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.944 -1.934 . . . . 15.0 111.818 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.02 -162.6 29.64 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 114.094 -1.412 . . . . 15.0 113.707 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.477 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.0 m -119.38 127.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.449 -1.876 . . . . 15.0 110.64 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.494 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 23.1 t -130.01 132.1 46.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.857 -1.519 . . . . 15.0 110.507 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.56 154.99 34.61 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.643 0.735 . . . . 15.0 111.793 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -115.48 135.18 54.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.383 -1.281 . . . . 15.0 112.119 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 90.9 m-85 61.62 156.86 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 113.355 -1.748 . . . . 15.0 115.373 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.08 89.69 1.52 Allowed Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.175 -1.375 . . . . 15.0 111.661 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -69.07 82.12 0.32 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.7 0.762 . . . . 15.0 112.861 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.55 133.88 1.82 Allowed Glycine 0 N--CA 1.477 1.412 0 CA-C-N 114.265 -1.334 . . . . 15.0 112.841 173.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.63 -23.11 66.12 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.487 1.662 . . . . 15.0 115.487 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -7.68 88.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 118.278 2.696 . . . . 15.0 118.278 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.242 0 CA-C-N 113.776 -1.556 . . . . 15.0 113.86 -179.41 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 115.564 1.69 . . . . 15.0 115.564 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.71 -46.37 1.81 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.062 2.508 . . . . 15.0 114.265 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 10.0 mmpt? -132.98 140.14 47.63 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.437 1.095 . . . . 15.0 109.263 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 10.7 t70 -173.18 100.03 0.12 Allowed 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.485 1.116 . . . . 15.0 110.178 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 57.5 49.8 12.21 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.838 1.255 . . . . 15.0 113.003 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m -98.02 124.63 42.61 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.422 -1.717 . . . . 15.0 108.263 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.621 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 21.4 m0 -97.86 130.42 44.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.389 -1.278 . . . . 15.0 111.027 -177.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 97.6 m-85 -122.51 86.05 2.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.935 -1.939 . . . . 15.0 108.41 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -108.82 123.6 49.3 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.103 -1.408 . . . . 15.0 110.058 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.83 -144.52 4.14 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 125.019 1.449 . . . . 15.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.68 148.07 47.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -130.91 140.17 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 125.007 1.442 . . . . 15.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 143' ' ' SER . 40.1 tp -114.13 133.53 55.5 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.031 -1.441 . . . . 15.0 108.763 173.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.65 112.49 3.96 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 113.535 -1.666 . . . . 15.0 110.138 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -121.82 145.48 48.03 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.788 0.835 . . . . 15.0 110.833 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -130.32 145.48 51.78 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.308 -0.86 . . . . 15.0 111.259 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -79.94 79.34 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.055 0.931 . . . . 15.0 109.151 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -147.17 -82.36 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 112.846 -1.979 . . . . 15.0 111.281 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -116.18 136.84 52.65 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.402 0.681 . . . . 15.0 110.575 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.5 ptt-85 -65.77 -20.88 66.43 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.306 -1.315 . . . . 15.0 114.0 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -117.54 95.94 5.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.161 0.984 . . . . 15.0 109.683 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -173.69 -69.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.462 1.505 . . . . 15.0 111.048 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 54.8 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.652 1.581 . . . . 15.0 114.726 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.04 -37.54 80.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.477 -1.692 . . . . 15.0 114.556 -173.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.07 87.1 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 N-CA-C 118.0 1.96 . . . . 15.0 118.0 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.17 89.6 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.661 1.356 . . . . 15.0 114.661 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.43 -118.67 6.12 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.936 0.779 . . . . 15.0 111.9 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.42 137.99 39.94 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.306 -0.947 . . . . 15.0 110.112 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -117.6 113.66 22.26 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.643 -1.162 . . . . 15.0 111.143 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.3 101.42 1.04 Allowed Glycine 0 N--CA 1.476 1.342 0 CA-C-N 113.429 -1.714 . . . . 15.0 110.91 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.68 135.24 12.6 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 114.428 -0.886 . . . . 15.0 113.156 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -129.22 111.33 12.78 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.79 -1.205 . . . . 15.0 110.972 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.04 83.28 1.88 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.235 -0.893 . . . . 15.0 108.891 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 4' ' ' ASP . 59.8 t -69.26 -83.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.552 -1.658 . . . . 15.0 110.456 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -81.22 135.44 50.76 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 117.535 -1.221 . . . . 15.0 109.407 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.547 ' HB3' ' HB2' ' A' ' 3' ' ' LYS . 72.7 Cg_endo -69.26 78.93 0.81 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.436 2.758 . . . . 15.0 112.08 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -177.05 -76.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.005 2.122 . . . . 15.0 108.955 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.35 135.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.123 0.969 . . . . 15.0 108.466 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.34 -168.13 12.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 113.91 -1.496 . . . . 15.0 110.794 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.74 148.23 52.56 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.788 1.032 . . . . 15.0 113.788 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.517 ' HG2' ' HD3' ' A' ' 62' ' ' LYS . 70.9 mm-40 -127.26 127.21 44.02 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.239 -1.346 . . . . 15.0 110.644 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 90.9 mtp -116.64 134.45 54.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.158 -1.383 . . . . 15.0 110.608 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -115.72 114.17 3.06 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.215 -1.554 . . . . 15.0 109.215 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -116.57 122.32 44.32 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.871 0.843 . . . . 15.0 111.561 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -137.78 142.61 40.89 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.485 -1.689 . . . . 15.0 111.397 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -165.03 129.46 2.47 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.74 0.645 . . . . 15.0 112.74 173.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.75 6.81 18.31 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 112.344 -2.207 . . . . 15.0 113.862 165.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.95 72.83 1.55 Allowed Glycine 0 N--CA 1.476 1.346 0 C-N-CA 124.599 1.095 . . . . 15.0 112.253 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -88.26 77.43 8.23 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.457 1.122 . . . . 15.0 112.022 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.576 ' HG2' ' HB2' ' A' ' 52' ' ' ARG . 1.7 pmm? -170.73 156.92 5.19 Favored Pre-proline 0 N--CA 1.481 1.09 0 CA-C-N 113.206 -1.816 . . . . 15.0 109.838 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.35 83.15 0.37 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.631 2.221 . . . . 15.0 111.678 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.646 HH21 ' HB2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -169.32 145.32 3.28 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 112.68 -2.055 . . . . 15.0 107.809 -177.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.646 ' HB2' HH21 ' A' ' 52' ' ' ARG . 68.5 mttm -80.12 89.99 5.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.725 -0.671 . . . . 15.0 110.007 172.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' H ' ' NE2' ' A' ' 55' ' ' GLN . . . -133.01 56.69 1.84 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.542 -2.117 . . . . 15.0 110.014 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.449 ' NE2' ' H ' ' A' ' 54' ' ' ALA . 24.7 mp0 -126.74 146.64 50.15 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.028 -1.896 . . . . 15.0 109.909 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.04 17.26 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 124.285 0.991 . . . . 15.0 113.978 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.613 ' O ' ' HB3' ' A' ' 82' ' ' MET . 12.7 p -147.29 148.26 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 112.978 -1.611 . . . . 15.0 111.239 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -121.27 126.22 49.01 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.536 1.934 . . . . 15.0 109.374 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.559 ' N ' ' HB2' ' A' ' 82' ' ' MET . 3.5 tm? -117.34 111.19 19.02 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.934 -0.395 . . . . 15.0 109.934 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 41' ' ' GLU . 13.7 t -131.9 146.32 52.04 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.42 -0.809 . . . . 15.0 112.829 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -103.13 136.39 43.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.039 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.532 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 59.6 pttt -115.83 143.56 45.23 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.914 1.45 . . . . 15.0 114.914 -171.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 45.4 mt -115.5 136.41 53.11 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.925 -1.943 . . . . 15.0 110.058 169.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.42 111.92 4.2 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 124.744 1.277 . . . . 15.0 111.529 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.437 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 4.1 m-30 -110.69 105.0 56.89 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.933 1.293 . . . . 15.0 111.713 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.58 -145.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.052 2.502 . . . . 15.0 111.584 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 69.03 -68.97 0.17 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 127.487 2.315 . . . . 15.0 115.181 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.512 ' HB3' HD11 ' A' ' 75' ' ' ILE . 28.4 tp -60.91 99.7 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.439 1.096 . . . . 15.0 113.596 -168.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.92 -85.74 0.44 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.827 -1.988 . . . . 15.0 109.461 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 t -179.1 171.36 1.36 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.406 1.482 . . . . 15.0 110.083 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -51.54 -31.09 22.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.669 1.729 . . . . 15.0 115.669 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.05 -29.41 63.4 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.338 1.236 . . . . 15.0 114.338 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.46 112.99 18.17 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.098 0.959 . . . . 15.0 111.423 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.54 134.26 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.08 -1.418 . . . . 15.0 109.721 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 68' ' ' LEU . 4.5 mp -91.34 141.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.509 -1.678 . . . . 15.0 107.388 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 79.6 m-85 -126.6 128.79 47.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.793 -1.094 . . . . 15.0 109.763 173.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.2 p -108.4 122.57 47.28 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.378 -1.283 . . . . 15.0 108.397 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HG2' ' HB3' ' A' ' 62' ' ' LYS . 99.2 mtt180 -125.19 123.22 39.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.508 -2.133 . . . . 15.0 111.534 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.44 132.09 52.77 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.908 -1.042 . . . . 15.0 112.449 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.34 -140.18 5.77 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.967 -1.015 . . . . 15.0 113.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.01 140.87 3.0 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.187 1.375 . . . . 15.0 111.8 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.613 ' HB3' ' O ' ' A' ' 57' ' ' VAL 0.364 0.4 OUTLIER -156.91 164.33 38.16 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.515 -2.168 . . . . 15.0 112.659 159.424 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 103' ' ' SER . 18.8 m -97.99 125.97 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.234 0.959 . . . . 15.0 110.18 -172.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -109.68 152.7 25.27 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.484 -0.78 . . . . 15.0 112.858 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.488 ' HA ' ' NE ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -95.96 96.61 9.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.779 -1.101 . . . . 15.0 110.455 -172.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -120.58 -87.59 0.64 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.595 -1.638 . . . . 15.0 114.063 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -157.69 147.08 19.91 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.143 0.977 . . . . 15.0 110.733 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.3 t -167.1 158.71 12.41 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.069 1.348 . . . . 15.0 110.733 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -123.51 158.92 30.22 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.379 1.05 . . . . 15.0 111.113 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.13 150.01 52.34 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.17 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.53 ' HG2' ' HH ' ' A' ' 96' ' ' TYR . 7.2 tmtm? 64.84 132.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.347 1.859 . . . . 15.0 113.248 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -119.09 -79.19 0.59 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 113.728 -1.578 . . . . 15.0 110.723 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.82 96.51 0.11 Allowed Glycine 0 N--CA 1.475 1.251 0 N-CA-C 108.954 -1.658 . . . . 15.0 108.954 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.3 t30 72.07 162.61 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.385 1.474 . . . . 15.0 111.015 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.22 87.06 0.33 Allowed Glycine 0 N--CA 1.477 1.43 0 C-N-CA 124.96 1.267 . . . . 15.0 111.397 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.53 ' HH ' ' HG2' ' A' ' 91' ' ' LYS . 67.8 m-85 -124.74 141.76 51.88 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.307 -0.946 . . . . 15.0 111.194 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 98' ' ' SER . 15.8 tt -171.97 -69.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 125.11 1.506 . . . . 15.0 112.38 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.451 ' H ' HG23 ' A' ' 97' ' ' ILE . 57.3 p -167.59 -71.0 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.592 1.157 . . . . 15.0 112.691 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 67.0 142.75 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.575 2.35 . . . . 15.0 113.75 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.34 84.82 1.44 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.46 -1.245 . . . . 15.0 113.108 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.95 36.33 0.09 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.18 -1.373 . . . . 15.0 114.613 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.31 147.7 23.91 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.172 1.389 . . . . 15.0 110.519 -174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.452 ' HB3' HG12 ' A' ' 83' ' ' VAL . 17.1 t -70.86 143.38 51.07 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.21 -0.905 . . . . 15.0 112.142 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.49 167.9 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 113.988 -1.46 . . . . 15.0 111.264 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m 68.14 148.53 0.12 Allowed Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 125.918 1.687 . . . . 15.0 114.368 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -61.19 142.05 95.37 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.651 2.234 . . . . 15.0 113.102 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.87 136.72 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 112.838 -1.983 . . . . 15.0 107.216 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.55 129.66 54.78 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.408 -1.724 . . . . 15.0 110.13 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -122.65 131.54 53.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.102 -1.408 . . . . 15.0 112.061 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.38 99.04 0.92 Allowed Glycine 0 N--CA 1.475 1.278 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.786 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -115.5 145.52 18.7 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 124.79 0.936 . . . . 15.0 112.85 -174.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 127' ' ' ARG . 19.2 m -121.59 138.46 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.716 -0.742 . . . . 15.0 112.042 171.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.28 109.34 19.76 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.077 -1.874 . . . . 15.0 107.94 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -120.59 136.08 54.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.716 -1.584 . . . . 15.0 111.64 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.39 107.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.46 -1.7 . . . . 15.0 110.689 171.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.9 tp -113.22 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 122.837 1.303 . . . . 15.0 111.648 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.682 ' HD3' HG21 ' A' ' 121' ' ' THR . 47.9 mtt-85 -122.23 -30.79 3.95 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.791 2.515 . . . . 15.0 117.791 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.27 -28.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 118.456 2.762 . . . . 15.0 118.456 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 47.7 mtt-85 -101.09 149.71 23.68 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.393 1.077 . . . . 15.0 112.244 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.491 ' H ' HG13 ' A' ' 120' ' ' ILE . 16.9 mt -11.78 -81.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 128.311 2.644 . . . . 15.0 113.735 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.682 HG21 ' HD3' ' A' ' 117' ' ' ARG . 67.8 p 58.49 159.61 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 126.233 1.813 . . . . 15.0 115.489 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.64 161.87 33.79 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.655 2.236 . . . . 15.0 111.415 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -68.46 78.21 0.27 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.215 1.006 . . . . 15.0 112.191 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mm -120.94 105.35 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.595 1.158 . . . . 15.0 109.486 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.3 120.49 40.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.571 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -80.78 117.01 21.07 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.921 -1.036 . . . . 15.0 109.359 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.485 ' NE ' HH22 ' A' ' 78' ' ' ARG . 33.6 mtt180 -115.21 119.91 37.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.626 -1.17 . . . . 15.0 112.721 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.48 118.04 28.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.054 -1.43 . . . . 15.0 110.39 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.568 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 31.3 tt0 -120.65 132.98 55.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 112.727 -2.033 . . . . 15.0 111.285 -171.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 76.3 m-85 -97.4 128.22 44.02 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.302 -1.317 . . . . 15.0 110.336 171.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.67 ' HB3' ' HB2' ' A' ' 141' ' ' MET . 48.1 tt0 -109.85 108.76 19.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.432 -1.713 . . . . 15.0 109.108 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -117.93 146.58 43.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.599 -2.091 . . . . 15.0 112.066 -174.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 m -133.2 -78.16 0.48 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.138 -1.392 . . . . 15.0 111.791 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -173.25 -57.13 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.222 1.009 . . . . 15.0 110.973 -173.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -56.14 155.56 6.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.369 1.068 . . . . 15.0 110.287 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 139' ' ' ASN . . . 64.16 95.82 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.899 2.08 . . . . 15.0 112.611 -168.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.0 m -49.3 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.435 -1.711 . . . . 15.0 113.409 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 62.76 26.58 15.68 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 113.393 -1.73 . . . . 15.0 114.379 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.429 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 6.0 t-20 -129.61 169.13 15.43 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.272 1.029 . . . . 15.0 109.6 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -176.51 -152.8 10.01 Favored Glycine 0 N--CA 1.477 1.414 0 CA-C-O 122.033 0.796 . . . . 15.0 113.174 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.67 ' HB2' ' HB3' ' A' ' 131' ' ' GLN . 48.1 mtt -117.6 148.26 42.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.716 -1.242 . . . . 15.0 110.925 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.03 112.32 18.11 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.98 -1.009 . . . . 15.0 110.055 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 68.1 m -105.86 125.09 50.58 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.69 -1.595 . . . . 15.0 107.348 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 pp -132.65 141.1 48.47 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.84 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.13 -162.46 29.35 Favored Glycine 0 N--CA 1.473 1.121 0 O-C-N 124.191 0.932 . . . . 15.0 113.509 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.07 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.606 -1.297 . . . . 15.0 109.442 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 62.5 p -115.85 138.25 51.34 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.89 1.369 . . . . 15.0 110.731 170.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -111.51 135.22 52.38 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.009 -1.45 . . . . 15.0 110.768 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 45.8 ttm180 -78.86 123.93 27.72 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.544 -1.207 . . . . 15.0 108.562 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HB2' ' HB2' ' A' ' 7' ' ' TRP . 88.7 t80 -35.28 -74.97 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 O-C-N 125.347 1.654 . . . . 15.0 115.377 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 44.97 -121.28 4.33 Favored Glycine 0 N--CA 1.48 1.603 0 C-N-CA 125.137 1.351 . . . . 15.0 112.918 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -72.21 88.8 1.15 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.105 -1.048 . . . . 15.0 111.271 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.15 -146.42 0.14 Allowed Glycine 0 CA--C 1.539 1.586 0 CA-C-N 113.142 -1.844 . . . . 15.0 112.747 168.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.93 84.07 0.49 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.411 1.1 . . . . 15.0 113.424 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.81 84.51 4.12 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.15 -1.387 . . . . 15.0 111.3 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.261 0 CA-C-N 113.701 -1.591 . . . . 15.0 114.19 -179.771 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 114.823 1.416 . . . . 15.0 114.823 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.91 146.14 29.2 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.938 2.425 . . . . 15.0 112.138 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.533 ' HD3' ' HD3' ' A' ' 36' ' ' PRO . 2.3 ttmp? 64.31 164.11 0.13 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.169 1.788 . . . . 15.0 112.61 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.638 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 41.3 m-20 68.88 86.35 0.13 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.209 1.804 . . . . 15.0 112.505 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 66.06 41.99 3.41 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 111.759 -2.473 . . . . 15.0 113.501 -174.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 p -98.19 140.07 33.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.785 -1.098 . . . . 15.0 112.907 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -110.35 131.08 55.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.766 -2.015 . . . . 15.0 110.184 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.479 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 5.5 m-85 -124.1 131.28 53.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.617 -1.629 . . . . 15.0 108.978 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -126.96 133.43 50.6 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.496 0.718 . . . . 15.0 111.623 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -172.94 -146.23 5.34 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-N 115.191 -0.913 . . . . 15.0 113.191 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.42 150.1 51.79 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.423 0.898 . . . . 15.0 113.423 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.32 142.91 50.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.454 1.096 . . . . 15.0 112.727 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.6 tp -114.05 140.4 48.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.199 -1.819 . . . . 15.0 108.8 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.4 127.41 7.73 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.153 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 10.2 t-105 -118.33 141.15 48.82 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.463 -0.868 . . . . 15.0 110.948 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 t -108.73 105.2 14.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.528 -1.214 . . . . 15.0 109.818 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -52.79 -44.11 66.35 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.975 -1.466 . . . . 15.0 111.753 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -65.66 -49.15 69.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.111 0.964 . . . . 15.0 113.297 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -103.2 83.65 2.23 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.747 1.26 . . . . 15.0 112.045 -172.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' HG2' ' HG3' ' A' ' 21' ' ' GLU . 53.8 ttt85 -5.98 -81.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.04 2.936 . . . . 15.0 117.614 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.488 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 40.6 mt-10 -125.4 92.01 3.53 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.89 0.852 . . . . 15.0 111.802 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -114.18 91.63 3.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.457 -1.247 . . . . 15.0 112.918 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.7 87.94 1.27 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.911 -1.495 . . . . 15.0 111.573 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -106.37 -41.41 5.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.993 -1.912 . . . . 15.0 112.848 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.62 -151.4 18.42 Favored Glycine 0 N--CA 1.476 1.308 0 O-C-N 123.905 0.753 . . . . 15.0 112.1 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.33 148.49 50.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.755 -1.223 . . . . 15.0 111.299 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.54 -166.64 16.29 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.776 1.297 . . . . 15.0 110.556 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.01 49.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.501 0.667 . . . . 15.0 111.44 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.01 113.37 19.48 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.722 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.72 112.0 3.95 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 112.732 -2.031 . . . . 15.0 110.198 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.84 142.88 15.95 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 110.702 -0.959 . . . . 15.0 110.702 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 11.4 t80 -141.11 132.67 27.04 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.104 -0.548 . . . . 15.0 111.124 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -121.41 94.1 4.22 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.966 0.888 . . . . 15.0 110.617 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 4' ' ' ASP . 7.1 p -68.31 -63.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.483 -2.144 . . . . 15.0 111.688 174.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -143.82 144.85 28.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.43 1.492 . . . . 15.0 109.618 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.533 ' HD3' ' HD3' ' A' ' 3' ' ' LYS . 73.4 Cg_endo -67.98 89.5 0.37 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.488 2.792 . . . . 15.0 111.768 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 t80 172.7 -48.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.51 -2.132 . . . . 15.0 109.058 -169.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 48.3 t -131.52 124.02 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.154 0.982 . . . . 15.0 108.83 175.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.37 148.23 16.72 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.924 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.425 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 78.5 m-85 -112.78 136.66 52.15 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.1 0.778 . . . . 15.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.54 114.21 14.0 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.843 -1.526 . . . . 15.0 112.034 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.4 ttp -104.08 128.66 51.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.686 -1.597 . . . . 15.0 109.062 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.25 114.16 3.9 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 113.88 -1.509 . . . . 15.0 109.751 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.66 109.44 18.6 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.407 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -121.2 124.08 43.81 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.559 -1.2 . . . . 15.0 111.361 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -125.11 145.18 50.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.753 -1.567 . . . . 15.0 109.783 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.469 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 42.1 tp -68.39 99.59 0.96 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.775 -0.648 . . . . 15.0 112.359 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.05 65.62 0.14 Allowed Glycine 0 CA--C 1.541 1.69 0 CA-C-N 114.044 -1.435 . . . . 15.0 113.437 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -169.43 -94.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 128.864 2.866 . . . . 15.0 107.165 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.3 mtt -126.19 93.13 44.15 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.594 0.758 . . . . 15.0 111.19 167.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HA ' ' HB3' ' A' ' 47' ' ' LEU . 83.2 Cg_endo -67.0 -17.94 51.57 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.544 2.829 . . . . 15.0 115.809 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -0.3 87.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.014 2.526 . . . . 15.0 117.656 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.12 20.15 4.24 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 117.809 2.522 . . . . 15.0 117.809 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.11 86.9 2.26 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.493 1.139 . . . . 15.0 113.316 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 pm0 -115.34 154.83 28.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.438 -1.256 . . . . 15.0 112.309 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.47 118.41 4.37 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 114.578 -1.192 . . . . 15.0 111.114 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.65 127.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 122.193 0.997 . . . . 15.0 111.687 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.469 ' HB3' ' HG2' ' A' ' 82' ' ' MET . 0.3 OUTLIER -116.54 140.79 48.99 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.114 -1.403 . . . . 15.0 112.035 174.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.21 111.14 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.185 -1.825 . . . . 15.0 109.011 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -124.65 134.74 52.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.146 0.975 . . . . 15.0 112.621 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.16 46.09 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.836 -1.529 . . . . 15.0 110.79 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.542 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 1.8 ttpm? -84.18 129.15 34.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.301 -1.772 . . . . 15.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.683 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 41.7 tp -108.95 114.58 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.505 -2.134 . . . . 15.0 107.691 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 76' ' ' TYR . . . 127.94 -147.38 17.24 Favored Glycine 0 CA--C 1.541 1.692 0 O-C-N 126.346 2.279 . . . . 15.0 113.941 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.533 ' H ' ' HB2' ' A' ' 76' ' ' TYR . 43.3 t80 160.81 -60.5 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 116.546 -1.692 . . . . 15.0 112.821 -160.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -79.15 -147.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.447 2.764 . . . . 15.0 112.788 -167.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 53.98 84.76 0.06 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.291 1.836 . . . . 15.0 110.053 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp 69.36 -26.13 0.15 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.245 1.418 . . . . 15.0 114.54 -165.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.83 64.22 0.19 Allowed Glycine 0 N--CA 1.483 1.786 0 C-N-CA 124.949 1.261 . . . . 15.0 114.312 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.89 37.77 3.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.038 1.335 . . . . 15.0 109.458 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -167.52 -63.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.386 1.074 . . . . 15.0 112.475 -172.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 114' ' ' TYR . 4.7 m-20 -56.62 -49.46 74.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.524 0.935 . . . . 15.0 113.524 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER 141.82 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 130.372 3.469 . . . . 15.0 107.385 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.542 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 7.7 m-20 -113.34 105.35 13.29 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.924 -0.485 . . . . 15.0 110.307 -174.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.633 ' HB ' HG12 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -119.85 111.0 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.656 -1.239 . . . . 15.0 107.656 176.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.683 ' HB3' ' O ' ' A' ' 63' ' ' LEU 0.437 0.2 OUTLIER -169.01 -171.74 1.4 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 111.384 -2.644 . . . . 15.0 114.773 -177.474 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.9 t -108.12 139.48 42.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.223 1.011 . . . . 15.0 110.585 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 109' ' ' ALA . 9.8 ptp180 -118.95 139.69 51.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.033 -1.894 . . . . 15.0 114.147 -170.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 108' ' ' PHE . 2.7 pp -125.19 143.48 50.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 112.07 -2.332 . . . . 15.0 111.015 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.42 -154.45 11.75 Favored Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.33 1.019 . . . . 15.0 114.671 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.12 151.52 21.83 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 113.567 -1.316 . . . . 15.0 114.059 -173.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.469 ' HG2' ' HB3' ' A' ' 58' ' ' GLN . 90.1 mtp -116.54 115.41 25.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.588 1.555 . . . . 15.0 110.361 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.18 132.59 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 114.943 -1.026 . . . . 15.0 108.905 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -120.56 140.98 50.71 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.79 -1.095 . . . . 15.0 110.041 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.85 85.8 0.96 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 122.694 1.235 . . . . 15.0 112.75 173.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.43 83.72 3.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.557 -1.656 . . . . 15.0 112.167 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.4 -24.76 62.99 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.317 1.969 . . . . 15.0 116.317 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 t -89.93 142.19 27.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.623 0.972 . . . . 15.0 113.623 -171.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -172.55 155.79 3.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.813 1.645 . . . . 15.0 110.482 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -139.01 148.77 43.86 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.802 0.841 . . . . 15.0 111.756 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -114.01 128.01 56.2 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.92 0.762 . . . . 15.0 110.064 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -126.13 157.2 38.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.636 -1.62 . . . . 15.0 107.97 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.24 68.75 0.35 Allowed Glycine 0 N--CA 1.482 1.742 0 C-N-CA 125.032 1.301 . . . . 15.0 113.171 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -115.8 92.93 4.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.532 -1.334 . . . . 15.0 109.393 -171.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.8 44.75 0.29 Allowed Glycine 0 N--CA 1.485 1.913 0 C-N-CA 124.821 1.201 . . . . 15.0 114.763 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -170.66 35.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.835 2.054 . . . . 15.0 113.286 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.9 tp -117.56 129.8 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 116.007 -0.542 . . . . 15.0 111.131 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.8 t -171.61 167.85 6.46 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.288 1.435 . . . . 15.0 110.304 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 53.13 88.48 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.913 2.085 . . . . 15.0 116.089 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.78 129.59 51.29 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.693 -1.594 . . . . 15.0 110.106 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -166.56 146.94 6.02 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.444 1.098 . . . . 15.0 112.191 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.1 140.21 54.8 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.221 0.95 . . . . 15.0 111.894 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p -74.52 138.18 42.97 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.106 -0.952 . . . . 15.0 113.057 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -59.4 -32.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 15.0 113.263 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.81 84.62 0.19 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 127.265 2.226 . . . . 15.0 112.595 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -63.33 133.87 42.44 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.685 2.257 . . . . 15.0 112.747 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.33 138.02 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.422 -1.717 . . . . 15.0 109.695 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -122.88 129.86 52.15 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.636 -1.165 . . . . 15.0 111.817 175.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.581 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -133.7 147.32 51.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.281 -1.327 . . . . 15.0 111.149 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 138.64 10.75 Favored Glycine 0 N--CA 1.48 1.619 0 CA-C-O 119.011 -0.883 . . . . 15.0 111.221 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.14 -158.08 25.42 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 118.208 2.043 . . . . 15.0 118.208 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.633 HG12 ' HB ' ' A' ' 75' ' ' ILE . 33.0 m -120.67 130.66 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 111.911 -2.144 . . . . 15.0 111.556 -171.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.87 125.4 48.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.184 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 60.0 t80 -108.48 139.19 43.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 111.9 -2.409 . . . . 15.0 108.633 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 11.8 p -129.11 145.61 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 113.908 -1.496 . . . . 15.0 107.833 168.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 0.3 OUTLIER -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 124.483 1.114 . . . . 15.0 113.152 -177.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -80.64 -89.14 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.465 -2.152 . . . . 15.0 109.364 175.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 108.98 8.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.222 0.609 . . . . 15.0 109.81 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -167.71 164.55 14.4 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.568 -1.197 . . . . 15.0 111.37 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.1 mt -53.08 131.49 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.511 1.524 . . . . 15.0 109.95 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.411 HG22 ' HG2' ' A' ' 123' ' ' GLU . 17.6 m 55.83 79.84 0.32 Allowed Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 125.58 1.552 . . . . 15.0 109.68 -174.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.46 80.36 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.633 2.888 . . . . 15.0 113.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.7 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 14.2 pt-20 -162.36 22.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.802 1.779 . . . . 15.0 115.802 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.533 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 20.4 mt -116.7 108.15 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.92 -0.487 . . . . 15.0 110.542 -169.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 115' ' ' VAL . . . -110.68 143.13 41.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.024 -0.989 . . . . 15.0 111.031 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.8 m -139.63 116.93 11.24 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.254 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.693 ' CZ ' ' HG ' ' A' ' 147' ' ' SER . 0.0 OUTLIER -128.24 137.61 52.08 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.832 -1.076 . . . . 15.0 112.78 178.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.34 120.02 16.17 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.774 -1.103 . . . . 15.0 112.089 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -137.29 142.33 41.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 112.547 -2.115 . . . . 15.0 112.879 -174.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 79.2 m-85 -97.43 112.57 24.35 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.218 -1.355 . . . . 15.0 110.053 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -108.04 130.86 55.05 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.887 1.367 . . . . 15.0 113.695 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.458 ' HZ3' ' HB3' ' A' ' 130' ' ' TYR . 1.3 m-90 -120.51 120.37 35.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.492 -1.685 . . . . 15.0 112.289 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.448 ' OG1' ' HA ' ' A' ' 139' ' ' ASN . 60.3 p -81.99 -36.82 27.46 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 113.594 -1.639 . . . . 15.0 111.372 164.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 63.4 t30 58.18 96.64 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.529 1.932 . . . . 15.0 110.534 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 85.74 162.81 0.09 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.878 2.471 . . . . 15.0 111.673 -167.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 61.36 -169.17 0.17 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.37 1.868 . . . . 15.0 113.055 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.8 t -60.86 157.33 15.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.781 0.832 . . . . 15.0 112.233 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 69.54 -53.91 0.6 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.004 2.122 . . . . 15.0 114.04 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.448 ' HA ' ' OG1' ' A' ' 133' ' ' THR . 66.1 t30 52.09 -132.69 1.91 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.562 1.545 . . . . 15.0 111.902 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.23 95.77 1.08 Allowed Glycine 0 N--CA 1.478 1.436 0 C-N-CA 125.17 1.366 . . . . 15.0 112.042 171.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 9.6 ttt -126.15 148.18 49.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.919 0.888 . . . . 15.0 111.904 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 6.4 tt -88.38 126.75 35.36 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.192 -1.41 . . . . 15.0 107.192 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.2 t -120.4 125.35 47.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.774 0.797 . . . . 15.0 111.163 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.1 tp -121.19 126.87 50.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.705 -1.589 . . . . 15.0 109.332 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.38 138.17 10.33 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 114.482 -1.235 . . . . 15.0 112.813 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.1 m -125.55 127.61 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 113.91 -1.145 . . . . 15.0 110.651 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.693 ' HG ' ' CZ ' ' A' ' 127' ' ' ARG . 14.5 p -134.6 155.81 49.81 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.742 1.386 . . . . 15.0 114.742 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.7 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 12.1 m-85 -114.1 139.32 49.4 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.228 -1.806 . . . . 15.0 111.24 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -70.25 157.41 37.73 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.198 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -51.8 144.64 10.91 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.003 . . . . 15.0 111.565 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.27 105.05 0.42 Allowed Glycine 0 N--CA 1.477 1.401 0 C-N-CA 125.762 1.649 . . . . 15.0 114.067 -173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -63.57 130.6 45.02 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.201 -1.0 . . . . 15.0 111.788 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -63.72 157.64 41.57 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-N 113.664 -1.607 . . . . 15.0 113.073 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -55.19 134.23 49.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.739 1.215 . . . . 15.0 111.422 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -107.95 145.44 33.83 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.313 -1.312 . . . . 15.0 110.866 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 CA-C-O 117.021 -1.466 . . . . 15.0 113.809 -179.2 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 122.696 1.236 . . . . 15.0 111.614 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.9 p -116.31 158.79 22.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.584 -1.644 . . . . 15.0 111.801 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.951 ' HB3' ' HA ' ' A' ' 150' ' ' PHE . 1.8 t90 -94.23 140.45 29.76 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.287 1.041 . . . . 15.0 111.76 -172.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -115.28 105.86 13.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.068 1.747 . . . . 15.0 109.234 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 m -124.33 118.2 26.21 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.6 161.81 28.58 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 115.151 0.82 . . . . 15.0 115.151 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.71 50.88 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.39 -0.905 . . . . 15.0 110.516 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -151.66 150.77 30.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.177 1.177 . . . . 15.0 114.177 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.69 133.46 55.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.287 -1.324 . . . . 15.0 112.66 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -124.6 151.09 17.2 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.307 -1.769 . . . . 15.0 114.984 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -126.06 140.76 52.33 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.515 -1.342 . . . . 15.0 111.557 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.7 p -113.2 144.33 42.86 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.18 1.467 . . . . 15.0 114.51 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -54.54 120.51 6.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.782 -2.008 . . . . 15.0 111.025 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.6 t80 58.86 41.63 21.07 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.228 -1.351 . . . . 15.0 113.727 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -67.18 80.56 0.13 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.34 1.067 . . . . 15.0 113.69 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -61.69 -37.29 83.57 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.194 -1.367 . . . . 15.0 114.112 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -82.72 141.96 32.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.133 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -70.28 87.09 0.6 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.303 1.002 . . . . 15.0 110.573 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -143.15 129.49 19.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.984 -1.916 . . . . 15.0 108.991 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.13 132.59 56.0 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.054 -1.43 . . . . 15.0 108.125 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.65 46.47 1.11 Allowed Glycine 0 N--CA 1.48 1.584 0 C-N-CA 125.099 1.333 . . . . 15.0 115.095 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.71 92.99 1.6 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.734 1.214 . . . . 15.0 109.192 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.33 139.57 14.29 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.189 -1.823 . . . . 15.0 112.903 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 121.2 41.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.725 -1.737 . . . . 15.0 106.928 171.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' MET . 21.4 m-85 -111.86 113.42 25.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.916 -1.493 . . . . 15.0 110.734 -173.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.99 146.51 16.15 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 112.453 -2.158 . . . . 15.0 110.243 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.27 -154.5 20.51 Favored Glycine 0 N--CA 1.473 1.165 0 CA-C-N 114.546 -0.827 . . . . 15.0 112.837 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 141.83 34.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 113.257 -1.471 . . . . 15.0 112.807 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -117.0 98.14 6.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.654 1.216 . . . . 15.0 110.772 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 m -79.74 -38.68 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 112.934 -1.939 . . . . 15.0 115.636 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -139.96 154.22 70.31 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 118.696 -0.669 . . . . 15.0 112.745 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.44 66.64 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 15.0 110.485 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.43 -79.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.792 2.037 . . . . 15.0 108.488 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.58 145.22 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.145 1.165 . . . . 15.0 114.145 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.36 -179.98 25.67 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 112.61 -2.086 . . . . 15.0 110.721 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.82 133.64 55.31 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.142 -0.529 . . . . 15.0 112.414 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 26.7 tt0 -129.49 128.83 43.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.339 -1.301 . . . . 15.0 110.673 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 67.1 mtm -123.21 139.33 54.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.381 -0.827 . . . . 15.0 110.586 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.04 114.17 2.44 Favored Glycine 0 N--CA 1.476 1.322 0 O-C-N 124.61 1.194 . . . . 15.0 111.778 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 46' ' ' TRP . 72.5 t80 -107.02 109.52 21.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.465 1.106 . . . . 15.0 111.235 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -113.7 118.45 34.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.49 -1.232 . . . . 15.0 108.768 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.477 ' HB2' ' CE2' ' A' ' 44' ' ' TYR . 24.0 t90 -114.84 119.16 35.65 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.984 -1.007 . . . . 15.0 110.84 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 18.7 tp . . . . . 0 N--CA 1.474 0.774 0 CA-C-N 114.556 -1.202 . . . . 15.0 110.983 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 122.486 1.136 . . . . 15.0 110.744 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -93.95 103.14 15.24 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.389 -2.187 . . . . 15.0 110.292 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.03 2.34 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 108.892 -1.683 . . . . 15.0 108.892 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 t -117.83 133.15 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 114.467 -0.867 . . . . 15.0 109.735 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 9.8 pt20 -109.7 139.52 44.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.486 -1.234 . . . . 15.0 111.487 170.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.32 111.05 17.28 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.489 -1.687 . . . . 15.0 108.893 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.416 HG21 ' CZ ' ' A' ' 78' ' ' ARG . 39.9 p -131.29 146.74 52.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.003 -1.453 . . . . 15.0 113.301 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -100.37 128.37 46.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.018 -1.446 . . . . 15.0 108.146 172.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.43 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.1 pttm -113.5 136.53 52.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.62 -1.173 . . . . 15.0 112.857 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 3.2 tt -105.98 108.41 19.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.532 -1.667 . . . . 15.0 108.226 172.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.88 98.12 2.11 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.011 -1.904 . . . . 15.0 109.363 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -117.21 138.22 24.7 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.975 -1.112 . . . . 15.0 111.761 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HA ' ' OD2' ' A' ' 74' ' ' ASP . 58.4 Cg_endo -64.22 -37.7 39.67 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.252 2.635 . . . . 15.0 115.814 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 tptt 49.92 32.06 5.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.838 1.655 . . . . 15.0 114.762 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.45 47.87 23.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.978 1.311 . . . . 15.0 114.138 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 73' ' ' LEU . . . -63.46 84.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.651 0 C-N-CA 124.257 0.932 . . . . 15.0 112.26 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -67.88 28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.938 2.94 . . . . 15.0 118.938 -165.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -169.82 -68.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.881 2.072 . . . . 15.0 107.775 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -170.05 87.48 0.14 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.009 1.324 . . . . 15.0 108.47 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.407 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 19.6 tp -159.35 141.09 13.27 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.334 171.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD2' ' HA ' ' A' ' 66' ' ' PRO . 10.7 m-20 -138.1 150.45 46.88 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.277 -1.328 . . . . 15.0 110.923 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 tt -108.68 140.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.394 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 51.5 p90 -125.71 128.73 48.24 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.548 -1.205 . . . . 15.0 109.33 169.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.4 m -113.66 122.54 47.47 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.46 -1.311 . . . . 15.0 107.46 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -120.67 123.29 42.39 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.057 -1.429 . . . . 15.0 113.108 -175.091 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 136.78 54.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.995 -1.457 . . . . 15.0 110.941 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.39 -143.21 7.47 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.448 1.092 . . . . 15.0 113.272 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 105' ' ' SER . . . -130.25 143.9 15.18 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 114.047 -1.077 . . . . 15.0 114.066 -174.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 25.5 ptt? -116.11 120.15 38.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.165 0.983 . . . . 15.0 112.93 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.67 140.82 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 113.359 -1.746 . . . . 15.0 108.493 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 18.7 p90 . . . . . 0 N--CA 1.474 0.762 0 CA-C-N 114.83 -1.077 . . . . 15.0 108.614 177.298 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.9 p . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 114.973 1.471 . . . . 15.0 114.973 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -71.46 137.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 113.398 -1.728 . . . . 15.0 111.461 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 78.8 p -120.09 117.94 31.79 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.372 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.6 101.78 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.096 2.531 . . . . 15.0 112.278 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.02 130.87 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.19 -1.823 . . . . 15.0 113.112 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -127.96 131.36 49.29 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 113.749 -1.569 . . . . 15.0 111.114 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 131' ' ' GLN . . . -128.77 143.73 50.99 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.722 1.008 . . . . 15.0 113.722 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.56 108.63 2.12 Favored Glycine 0 N--CA 1.474 1.217 0 CA-C-N 112.932 -1.94 . . . . 15.0 108.732 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -119.5 144.11 17.42 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.723 -0.739 . . . . 15.0 112.955 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.49 137.17 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 114.539 -0.831 . . . . 15.0 111.633 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -125.4 139.33 53.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.241 -1.799 . . . . 15.0 113.757 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -117.87 141.81 48.02 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 112.694 -2.048 . . . . 15.0 109.255 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.7 m -105.69 132.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.158 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 pt -62.2 95.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.104 1.89 . . . . 15.0 116.104 -171.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -78.6 82.9 4.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.503 1.144 . . . . 15.0 109.58 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.3 ttt-85 -175.38 -143.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.393 2.277 . . . . 15.0 107.366 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.34 99.85 0.15 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.829 1.252 . . . . 15.0 112.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.6 mt 64.63 85.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.715 2.006 . . . . 15.0 111.401 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 m -59.86 -45.78 98.28 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 117.188 -1.386 . . . . 15.0 114.076 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.89 70.75 6.89 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.938 1.759 . . . . 15.0 111.531 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 36.1 tt0 -138.74 -83.84 0.28 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.188 -1.823 . . . . 15.0 108.834 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.74 143.51 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.663 0.986 . . . . 15.0 113.663 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.42 123.53 48.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.611 -2.086 . . . . 15.0 109.406 172.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.455 ' HA ' HG12 ' A' ' 146' ' ' VAL . 11.9 m -80.83 116.87 21.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.423 -1.695 . . . . 15.0 106.423 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -125.49 135.44 52.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.104 -1.407 . . . . 15.0 113.749 -172.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.98 111.07 13.14 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.648 -2.069 . . . . 15.0 110.327 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.518 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 21.9 tt0 -114.67 135.24 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.984 -1.916 . . . . 15.0 110.156 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -115.31 107.17 14.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.69 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 0.1 OUTLIER -96.62 114.76 26.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 112.581 -2.099 . . . . 15.0 109.73 -170.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -118.77 146.57 44.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.326 1.232 . . . . 15.0 114.326 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.478 0.96 0 CA-C-N 113.268 -1.787 . . . . 15.0 112.363 172.152 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.212 0 CA-C-O 122.423 1.013 . . . . 15.0 114.639 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.69 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 56.9 ttm -117.79 137.14 52.94 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.287 -1.456 . . . . 15.0 109.141 170.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.93 101.94 11.17 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.165 -1.38 . . . . 15.0 109.98 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.436 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 57.0 m -109.98 125.14 52.56 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.892 -1.504 . . . . 15.0 110.616 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.85 140.89 44.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.441 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.04 -162.57 29.59 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 114.801 -1.091 . . . . 15.0 113.585 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 126' ' ' THR . 15.1 m -128.4 139.72 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 113.846 -1.177 . . . . 15.0 112.547 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 p -115.16 134.25 55.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.527 -1.215 . . . . 15.0 112.217 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 41.9 t80 -103.53 135.09 45.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.331 -1.304 . . . . 15.0 109.195 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -73.69 124.97 27.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.178 -1.828 . . . . 15.0 112.033 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 7' ' ' TRP . 55.1 m-85 . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 126.504 1.922 . . . . 15.0 111.806 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 121.025 0.44 . . . . 15.0 111.308 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 150' ' ' PHE . 4.7 p -148.39 139.38 23.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.579 -1.191 . . . . 15.0 111.195 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -127.86 136.21 51.1 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.91 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -125.72 127.57 46.41 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.131 -1.395 . . . . 15.0 110.728 168.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -126.6 137.93 53.38 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.524 -1.217 . . . . 15.0 111.19 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.51 -149.93 9.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 124.275 0.984 . . . . 15.0 113.847 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -160.77 139.25 9.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.906 1.282 . . . . 15.0 111.185 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.342 18.2 tptt -171.91 169.59 5.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.518 1.527 . . . . 15.0 113.205 166.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.458 HD23 ' HG3' ' A' ' 12' ' ' LYS . 1.5 pt? -114.73 161.73 17.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.178 0.991 . . . . 15.0 113.199 -164.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -122.8 140.73 13.43 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.484 -1.234 . . . . 15.0 111.719 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -118.41 145.39 45.23 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.582 0.813 . . . . 15.0 110.858 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 p -93.85 126.13 38.86 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -49.8 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.646 1.978 . . . . 15.0 114.703 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 49.58 25.91 1.58 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 116.273 1.953 . . . . 15.0 116.273 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 t -110.03 -39.41 5.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.294 -1.321 . . . . 15.0 113.003 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 72.36 -30.98 0.22 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.958 1.703 . . . . 15.0 113.165 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -59.54 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.08 1.352 . . . . 15.0 113.238 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -168.12 129.4 1.39 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.892 -1.958 . . . . 15.0 110.127 164.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.0 31.94 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.64 -1.618 . . . . 15.0 113.056 167.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -165.51 142.29 5.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.787 1.403 . . . . 15.0 114.787 -170.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.16 -92.38 0.6 Allowed Glycine 0 N--CA 1.475 1.289 0 CA-C-N 113.777 -1.556 . . . . 15.0 112.782 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 158.14 6.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.762 1.225 . . . . 15.0 113.745 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 -124.79 1.52 Allowed Glycine 0 N--CA 1.477 1.399 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.882 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.47 121.61 42.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.61 -0.795 . . . . 15.0 110.698 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 147' ' ' SER . 35.6 p90 -125.23 146.49 49.5 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.921 1.822 . . . . 15.0 115.921 -168.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.24 104.29 1.24 Allowed Glycine 0 CA--C 1.535 1.282 0 CA-C-N 111.769 -2.468 . . . . 15.0 108.527 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.53 100.77 1.09 Allowed Glycine 0 N--CA 1.476 1.332 0 N-CA-C 110.117 -1.193 . . . . 15.0 110.117 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -114.57 145.09 42.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.321 0.581 . . . . 15.0 110.807 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.643 HE21 ' HE3' ' A' ' 62' ' ' LYS . 5.3 tt0 -120.84 136.17 54.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.957 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -104.56 -34.55 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 113.607 -1.633 . . . . 15.0 113.755 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -121.0 134.77 24.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 106.574 -1.639 . . . . 15.0 106.574 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.63 84.09 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.137 2.558 . . . . 15.0 111.288 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 158.82 -41.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 128.182 2.593 . . . . 15.0 111.195 -165.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.83 138.83 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.811 1.411 . . . . 15.0 114.811 -171.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 33' ' ' GLN . . . -162.11 -154.6 7.6 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 112.412 -2.176 . . . . 15.0 110.824 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -143.28 145.45 32.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.804 0.811 . . . . 15.0 111.862 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.408 ' OE1' ' HG2' ' A' ' 78' ' ' ARG . 9.9 pt-20 -128.23 129.78 46.94 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.353 -1.294 . . . . 15.0 113.053 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -120.61 114.35 21.59 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.983 -1.462 . . . . 15.0 110.655 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.65 114.06 3.97 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 124.607 1.192 . . . . 15.0 110.71 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -102.84 141.17 36.09 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.178 0.99 . . . . 15.0 111.278 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -137.22 130.25 30.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.872 -1.967 . . . . 15.0 112.367 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -122.63 137.2 54.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.202 -1.817 . . . . 15.0 108.512 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 122.697 1.237 . . . . 15.0 108.982 -173.055 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HA ' ' CE2' ' A' ' 84' ' ' TRP . . . . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 113.361 0.874 . . . . 15.0 113.361 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 49.96 42.64 24.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.922 1.689 . . . . 15.0 113.964 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.561 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -116.29 165.28 12.25 Favored Glycine 0 N--CA 1.474 1.193 0 CA-C-N 113.699 -1.592 . . . . 15.0 114.329 -161.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.26 144.39 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 113.485 -1.357 . . . . 15.0 111.749 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -109.77 116.8 32.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.648 1.213 . . . . 15.0 109.421 162.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.9 pt? -121.47 120.3 34.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 113.074 -1.875 . . . . 15.0 111.383 -170.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.4 p -133.14 150.63 52.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.984 -1.462 . . . . 15.0 112.432 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.625 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -92.35 132.33 36.82 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.304 -1.316 . . . . 15.0 108.452 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HE3' HE21 ' A' ' 33' ' ' GLN . 35.4 ttpt -110.06 104.26 13.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.613 -1.63 . . . . 15.0 110.404 -166.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.7 tt -120.7 134.43 55.28 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.125 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.57 -151.23 11.64 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 115.604 -0.725 . . . . 15.0 113.635 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 75' ' ' ILE . 48.1 p90 -173.91 154.66 2.3 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.853 1.261 . . . . 15.0 113.044 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.6 Cg_endo -64.71 115.43 3.23 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.756 2.304 . . . . 15.0 110.989 169.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -66.2 127.54 32.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.818 -1.083 . . . . 15.0 109.584 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.3 tp 57.44 22.62 8.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.605 1.562 . . . . 15.0 113.397 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.69 20.19 61.46 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.039 1.304 . . . . 15.0 114.484 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -87.55 89.24 7.92 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.426 -1.324 . . . . 15.0 107.426 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.66 79.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 112.885 -1.962 . . . . 15.0 113.134 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -174.14 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 109.587 -3.46 . . . . 15.0 110.668 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.58 98.19 7.26 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.833 1.301 . . . . 15.0 111.711 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 22.6 p-10 -115.43 111.06 20.22 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.931 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.629 HG22 HG22 ' A' ' 112' ' ' VAL . 2.9 pp -79.05 148.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.896 -1.502 . . . . 15.0 110.925 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -146.36 143.23 28.95 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.783 1.302 . . . . 15.0 113.925 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -112.22 122.55 48.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.905 -1.952 . . . . 15.0 107.776 166.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 0.8 OUTLIER -115.05 123.23 48.49 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 112.923 -1.944 . . . . 15.0 109.62 -176.277 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.79 129.35 48.14 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.676 -1.602 . . . . 15.0 113.256 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.44 -103.98 0.2 Allowed Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.146 -1.182 . . . . 15.0 110.146 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.539 ' HA2' ' HB ' ' A' ' 107' ' ' VAL . . . 154.01 -152.15 23.78 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 124.641 0.848 . . . . 15.0 115.017 173.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 33.9 ttm -119.92 139.3 52.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.491 -0.854 . . . . 15.0 111.742 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' SER . 57.8 t -125.62 113.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 113.98 -1.463 . . . . 15.0 108.109 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 CA-C-N 114.419 -1.264 . . . . 15.0 110.766 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 28.5 t . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 120.85 0.357 . . . . 15.0 110.78 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 82' ' ' MET . 10.0 p -113.37 115.29 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 113.997 -1.456 . . . . 15.0 111.408 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.493 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 80.5 p -117.87 131.83 23.95 Favored Pre-proline 0 N--CA 1.479 1.001 0 CA-C-N 113.745 -1.571 . . . . 15.0 112.398 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 122.21 6.0 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.921 2.414 . . . . 15.0 111.397 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.539 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 53.1 t -131.11 140.03 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.597 -1.183 . . . . 15.0 109.69 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.47 123.29 48.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.16 -1.382 . . . . 15.0 109.844 171.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB2' ' A' ' 129' ' ' GLU . . . -123.23 112.58 17.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.352 -1.295 . . . . 15.0 111.263 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.63 137.07 13.51 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.6 -0.727 . . . . 15.0 112.618 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 128' ' ' LEU . . . 176.99 -147.79 8.56 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 116.198 1.239 . . . . 15.0 116.198 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 75' ' ' ILE . 16.3 t -130.76 144.68 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 113.506 -1.347 . . . . 15.0 109.805 -170.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.486 ' HB2' ' HG3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -109.75 120.95 44.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.292 -1.373 . . . . 15.0 107.292 165.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -117.75 117.66 29.94 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.115 -1.402 . . . . 15.0 111.24 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 116' ' ' ILE . 13.2 p -129.65 143.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 113.279 -1.782 . . . . 15.0 110.163 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.535 HG13 HG22 ' A' ' 115' ' ' VAL . 44.0 mt 62.95 144.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 125.877 1.671 . . . . 15.0 113.577 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 63.33 155.38 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.886 1.674 . . . . 15.0 111.746 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 69.33 -50.28 0.61 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.882 2.073 . . . . 15.0 113.925 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -66.57 126.63 29.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.152 1.381 . . . . 15.0 110.491 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.4 tt -45.1 -35.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 115.671 1.73 . . . . 15.0 115.671 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.2 m -129.12 97.61 25.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 108.398 -0.964 . . . . 15.0 108.398 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.47 66.06 2.89 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.706 2.937 . . . . 15.0 114.304 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 124' ' ' ILE . 15.0 pt-20 -120.04 -17.75 8.31 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.798 -1.546 . . . . 15.0 114.958 178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -119.57 152.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.708 0.766 . . . . 15.0 112.586 -173.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.47 34.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.516 -2.129 . . . . 15.0 109.03 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 37.1 m -93.25 116.76 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.182 -1.784 . . . . 15.0 106.182 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 34.4 ttp180 -115.6 108.07 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.101 -1.409 . . . . 15.0 107.925 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.467 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 5.3 tt -111.83 130.67 55.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.58 -1.646 . . . . 15.0 108.991 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.63 ' HG3' ' HB3' ' A' ' 143' ' ' SER . 13.6 pt-20 -128.57 140.97 51.52 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.435 -2.166 . . . . 15.0 111.421 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 11.7 m-85 -97.25 114.56 26.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.516 -1.22 . . . . 15.0 109.061 164.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 14.7 mt-30 -96.57 108.77 21.42 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.95 -1.932 . . . . 15.0 108.309 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -131.49 146.4 52.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 111.918 -2.401 . . . . 15.0 111.755 -171.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.481 1.082 0 CA-C-N 112.56 -2.109 . . . . 15.0 115.524 177.444 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 N-CA-C 110.542 -1.023 . . . . 15.0 110.542 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 131' ' ' GLN . 67.0 mtt -121.47 122.69 40.31 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.565 0.95 . . . . 15.0 113.565 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.588 HD23 ' H ' ' A' ' 142' ' ' LEU . 1.2 pt? -84.77 97.34 9.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.035 -1.439 . . . . 15.0 108.032 171.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.649 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 37.1 t -114.0 128.63 56.47 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.433 -1.712 . . . . 15.0 110.896 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.644 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 1.3 pt? -126.36 139.51 53.23 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.962 -1.017 . . . . 15.0 111.043 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 12' ' ' LYS . . . -123.59 131.19 7.98 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 125.822 1.951 . . . . 15.0 111.128 173.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.5 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 34.8 m -112.58 127.42 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.801 0.8 . . . . 15.0 111.111 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . 63.5 p -131.68 153.49 49.94 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.845 -1.525 . . . . 15.0 114.605 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -108.02 143.64 36.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.052 -1.431 . . . . 15.0 109.468 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.798 ' HD3' ' H ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -70.29 115.88 9.98 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.941 -1.027 . . . . 15.0 112.896 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 81.0 m-85 . . . . . 0 N--CA 1.48 1.061 0 CA-C-N 112.751 -2.022 . . . . 15.0 114.288 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.751 ' HA ' HG22 ' A' ' 34' ' ' VAL . 24.6 t-20 . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 122.591 1.186 . . . . 15.0 111.064 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 p -126.92 152.6 46.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.062 -1.426 . . . . 15.0 110.554 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -118.66 138.57 52.52 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.032 1.123 . . . . 15.0 114.032 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -120.26 136.35 54.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.869 -1.514 . . . . 15.0 110.818 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -163.6 133.35 4.16 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.807 -1.088 . . . . 15.0 111.691 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -177.73 -167.76 36.33 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 115.163 -0.926 . . . . 15.0 112.711 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.54 134.82 47.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.802 -0.699 . . . . 15.0 112.107 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HD3' ' HD3' ' A' ' 127' ' ' ARG . 45.1 mtmt -134.16 144.74 48.7 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.898 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.5 pp -114.17 145.29 41.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.886 -1.052 . . . . 15.0 111.092 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.29 110.35 2.48 Favored Glycine 0 N--CA 1.477 1.414 0 O-C-N 125.003 1.439 . . . . 15.0 111.483 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.731 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 49.4 t90 -118.72 140.46 49.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.859 1.059 . . . . 15.0 113.859 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.9 p -92.85 98.16 11.21 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.336 1.236 . . . . 15.0 114.336 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -14.76 -76.91 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.207 2.603 . . . . 15.0 117.871 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -131.45 77.03 1.75 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.9 t -165.04 140.69 5.43 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 112.987 -1.915 . . . . 15.0 110.544 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -90.15 76.7 6.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.147 -1.388 . . . . 15.0 107.352 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -142.74 -70.86 0.33 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.448 -1.705 . . . . 15.0 114.071 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.731 ' ND2' ' HA ' ' A' ' 15' ' ' TRP . 7.3 m120 62.45 -65.52 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.09 1.885 . . . . 15.0 116.09 -171.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 63.43 -62.81 0.14 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 127.055 2.142 . . . . 15.0 110.612 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.06 139.8 50.51 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.889 -1.05 . . . . 15.0 108.658 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.55 -98.24 2.23 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 108.898 -1.681 . . . . 15.0 108.898 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.87 131.15 57.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.521 -1.34 . . . . 15.0 110.041 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.58 141.8 13.88 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-N 113.541 -1.663 . . . . 15.0 110.89 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.4 121.19 41.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.965 -1.118 . . . . 15.0 108.061 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 42' ' ' MET . 94.0 m-85 -116.24 113.39 22.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.075 -1.42 . . . . 15.0 110.351 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.17 145.96 17.15 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.468 -1.696 . . . . 15.0 112.189 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 41' ' ' GLU . . . 172.32 -161.6 33.33 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 114.461 -0.869 . . . . 15.0 112.765 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -126.46 142.17 51.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.943 -1.128 . . . . 15.0 111.986 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 59.3 tt0 -111.54 82.3 1.59 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 124.092 1.901 . . . . 15.0 106.397 169.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.751 HG22 ' HA ' ' A' ' 5' ' ' ASN . 29.4 t -140.75 72.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 111.842 -2.435 . . . . 15.0 105.941 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.437 HD22 HG23 ' A' ' 38' ' ' VAL . 50.0 t30 -175.89 144.88 0.74 Allowed Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 111.913 -2.403 . . . . 15.0 105.248 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.432 ' HD2' ' OD1' ' A' ' 35' ' ' ASN . 28.6 Cg_endo -50.33 104.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.57 2.847 . . . . 15.0 114.332 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 71.25 -24.47 0.17 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.477 2.311 . . . . 15.0 116.747 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.699 HG12 ' HG ' ' A' ' 63' ' ' LEU . 25.6 m -111.04 147.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.582 1.182 . . . . 15.0 113.5 -172.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -118.63 155.26 16.15 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.515 -2.13 . . . . 15.0 112.289 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -118.12 114.14 22.63 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.437 -0.882 . . . . 15.0 109.515 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.435 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -130.78 146.48 52.25 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.253 -1.794 . . . . 15.0 111.532 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 24.0 ptt? -112.59 145.0 41.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.412 -1.267 . . . . 15.0 111.268 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -106.03 127.62 9.02 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 113.22 -1.809 . . . . 15.0 109.726 172.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.82 104.57 11.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.578 -1.311 . . . . 15.0 111.191 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.6 121.59 43.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.098 -1.41 . . . . 15.0 110.127 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 t-105 -102.43 142.95 32.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.523 -1.671 . . . . 15.0 110.235 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 116.511 2.041 . . . . 15.0 116.511 -177.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 112.255 0.465 . . . . 15.0 112.255 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 28.3 pt20 34.13 86.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.603 1.961 . . . . 15.0 115.106 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.45 97.06 1.49 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.817 -1.992 . . . . 15.0 109.971 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 43' ' ' GLY . 11.8 p -109.88 118.53 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.956 1.033 . . . . 15.0 111.112 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.79 116.79 32.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.841 -1.527 . . . . 15.0 112.401 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.8 114.39 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.707 -1.588 . . . . 15.0 108.643 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.606 HG21 ' HD3' ' A' ' 78' ' ' ARG . 51.9 p -127.27 148.4 50.22 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.135 -1.848 . . . . 15.0 114.035 -170.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.53 128.52 54.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 113.136 -1.847 . . . . 15.0 107.823 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -119.75 138.35 53.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.119 -1.855 . . . . 15.0 111.83 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HG ' HG12 ' A' ' 38' ' ' VAL . 5.2 mp -117.07 131.36 56.94 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.157 -1.838 . . . . 15.0 108.669 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.71 131.66 10.1 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 124.616 1.198 . . . . 15.0 111.006 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.751 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 72.3 m-85 -121.75 97.98 45.95 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 124.512 0.772 . . . . 15.0 112.313 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.35 84.9 0.72 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.984 2.456 . . . . 15.0 110.991 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -120.18 153.02 36.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.726 -2.034 . . . . 15.0 110.008 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.8 84.61 0.31 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.374 -0.83 . . . . 15.0 112.809 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.25 141.9 15.35 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 113.812 -1.54 . . . . 15.0 112.398 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.515 ' O ' HD13 ' A' ' 73' ' ' LEU . 3.2 m -49.36 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.76 2.824 . . . . 15.0 112.639 -171.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 52.65 71.09 0.5 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.722 -1.581 . . . . 15.0 112.919 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 78.91 41.51 0.09 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.861 -1.518 . . . . 15.0 114.277 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 70' ' ' THR . 9.0 mp -105.32 115.37 30.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.168 -1.378 . . . . 15.0 111.157 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -105.26 135.97 45.65 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.231 -1.35 . . . . 15.0 108.255 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.751 ' HB ' ' HB2' ' A' ' 65' ' ' TYR . 37.1 mm -83.34 137.42 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.252 -1.018 . . . . 15.0 108.252 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -133.18 135.47 45.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.528 1.307 . . . . 15.0 114.528 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 58.5 m -118.35 124.93 48.94 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 112.537 -2.119 . . . . 15.0 107.424 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.606 ' HD3' HG21 ' A' ' 60' ' ' THR . 1.2 tmm_? -124.64 135.73 53.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.611 0.765 . . . . 15.0 109.864 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 pp -150.76 139.55 20.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.371 -0.832 . . . . 15.0 113.225 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.49 -151.68 10.73 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.626 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.33 151.6 20.87 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 114.154 -1.023 . . . . 15.0 113.088 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.0 ptm -114.49 135.28 54.29 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.712 1.004 . . . . 15.0 113.712 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 104' ' ' VAL . 44.7 t -125.34 119.92 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 113.756 -1.566 . . . . 15.0 108.024 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.411 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 35.9 p90 . . . . . 0 N--CA 1.478 0.927 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.689 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.642 0.734 . . . . 15.0 111.643 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 83' ' ' VAL . 42.9 t -83.52 80.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.49 -1.232 . . . . 15.0 109.216 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.7 m -65.27 132.07 95.18 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 113.762 -1.563 . . . . 15.0 111.909 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.68 113.7 2.84 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.115 2.543 . . . . 15.0 110.555 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.8 t -116.9 120.27 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.298 -1.319 . . . . 15.0 109.023 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -118.37 144.72 45.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 113.288 -1.778 . . . . 15.0 109.66 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -141.5 131.11 23.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.7 -1.136 . . . . 15.0 110.788 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.99 130.47 7.83 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 129' ' ' GLU . . . -173.1 -160.42 21.61 Favored Glycine 0 N--CA 1.476 1.338 0 CA-C-O 122.199 0.888 . . . . 15.0 115.228 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.32 144.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 113.244 -1.478 . . . . 15.0 109.682 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -121.2 129.06 53.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.96 -1.473 . . . . 15.0 109.058 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 116' ' ' ILE . 19.9 t80 -100.21 130.82 46.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.316 1.046 . . . . 15.0 109.88 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.4 113.07 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 113.336 -1.757 . . . . 15.0 110.597 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -54.44 100.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.089 -1.869 . . . . 15.0 113.32 -174.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -108.21 -32.56 7.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.405 -1.725 . . . . 15.0 112.976 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -54.54 -20.54 8.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.886 2.18 . . . . 15.0 116.886 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HD3' ' N ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -127.56 144.17 51.1 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.443 -0.947 . . . . 15.0 108.443 178.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.63 ' H ' HD12 ' A' ' 120' ' ' ILE . 4.7 mp -57.78 136.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.319 1.448 . . . . 15.0 109.653 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.434 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 28.7 m 65.14 92.22 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.045 1.738 . . . . 15.0 111.637 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 121' ' ' THR . 57.4 Cg_endo -64.58 134.21 40.2 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.924 2.416 . . . . 15.0 111.331 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.49 ' HG2' HG13 ' A' ' 124' ' ' ILE . 30.5 tt0 -119.34 -81.63 0.63 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.403 -1.271 . . . . 15.0 112.177 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.49 HG13 ' HG2' ' A' ' 123' ' ' GLU . 32.7 mt -116.36 146.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.64 24.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.794 1.238 . . . . 15.0 110.984 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.0 m -100.32 122.59 43.34 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.196 -0.911 . . . . 15.0 109.387 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.435 ' HD3' ' HD3' ' A' ' 12' ' ' LYS . 37.1 ttt85 -120.88 127.94 52.34 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.461 -0.79 . . . . 15.0 112.479 -175.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.0 119.53 24.45 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.93 -1.487 . . . . 15.0 110.775 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 6.1 pt-20 -134.2 145.42 49.19 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.88 -1.054 . . . . 15.0 113.49 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.38 122.09 43.1 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.307 -1.315 . . . . 15.0 109.307 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.59 122.48 47.93 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 113.656 -1.611 . . . . 15.0 110.942 -169.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -124.45 145.28 49.6 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 111.985 -2.37 . . . . 15.0 110.532 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.477 0.888 0 CA-C-N 114.764 -1.107 . . . . 15.0 109.188 171.35 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 116.899 1.52 . . . . 15.0 116.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -117.42 139.0 51.45 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.046 0.927 . . . . 15.0 110.599 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.19 108.98 18.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 113.89 -1.505 . . . . 15.0 109.535 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.499 ' HB2' ' HG3' ' A' ' 129' ' ' GLU . 61.4 m -109.02 125.22 51.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.472 -1.24 . . . . 15.0 108.783 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 pp -148.22 145.25 28.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.201 -1.363 . . . . 15.0 112.311 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.96 -162.51 29.53 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 114.15 -1.386 . . . . 15.0 113.119 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.32 130.48 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.159 -1.52 . . . . 15.0 111.494 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.521 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 63.9 p -130.39 146.35 51.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.755 -1.566 . . . . 15.0 113.053 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -115.96 118.95 34.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.259 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.86 119.27 34.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.031 -1.44 . . . . 15.0 108.55 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 t80 . . . . . 0 N--CA 1.475 0.815 0 CA-C-N 113.873 -1.512 . . . . 15.0 110.112 -174.854 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 6.1 t30 . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 123.608 1.67 . . . . 15.0 112.461 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.411 ' HA ' ' CE1' ' A' ' 150' ' ' PHE . 11.6 t -120.94 150.91 40.36 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 112.207 -2.27 . . . . 15.0 111.448 173.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -106.92 131.79 53.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.568 -1.196 . . . . 15.0 111.959 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.35 101.6 8.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.619 -1.628 . . . . 15.0 108.681 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -108.07 118.32 36.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.246 -1.797 . . . . 15.0 107.114 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -130.9 153.0 20.1 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 114.316 -1.311 . . . . 15.0 113.971 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.29 124.11 42.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.736 -1.232 . . . . 15.0 108.261 170.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -144.19 155.97 44.12 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.756 -1.111 . . . . 15.0 112.869 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' SER . 3.1 pp -114.09 140.37 48.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.604 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -108.5 97.76 1.13 Allowed Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.691 -1.595 . . . . 15.0 111.097 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.466 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t90 -111.05 150.16 29.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.493 1.139 . . . . 15.0 112.418 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.3 p -122.34 159.38 27.58 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 112.439 -2.164 . . . . 15.0 111.081 -173.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -48.48 153.21 0.79 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.221 -0.899 . . . . 15.0 109.593 165.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.49 89.62 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.861 0.838 . . . . 15.0 111.641 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 t -167.81 141.0 3.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.651 -2.068 . . . . 15.0 107.963 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' H ' ' A' ' 21' ' ' GLU . 32.0 ttt-85 53.21 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.897 1.679 . . . . 15.0 113.649 -175.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 15.3 pt-20 -69.69 75.18 0.43 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.927 1.084 . . . . 15.0 113.927 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -130.1 147.59 51.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.877 -1.056 . . . . 15.0 112.242 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -173.15 -75.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.675 -1.602 . . . . 15.0 110.47 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -104.56 89.45 3.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.473 0.654 . . . . 15.0 111.394 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.98 111.97 1.02 Allowed Glycine 0 N--CA 1.478 1.485 0 CA-C-N 113.599 -1.637 . . . . 15.0 112.018 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -119.75 142.47 48.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.193 0.597 . . . . 15.0 112.081 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.41 20.38 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 124.952 1.408 . . . . 15.0 112.511 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . . . -102.96 135.94 43.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.733 -1.234 . . . . 15.0 111.2 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -111.72 118.0 34.42 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.007 -1.451 . . . . 15.0 110.817 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.12 90.12 0.45 Allowed Glycine 0 N--CA 1.476 1.325 0 CA-C-N 114.647 -1.161 . . . . 15.0 110.545 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.04 117.26 4.21 Favored Glycine 0 N--CA 1.477 1.419 0 O-C-N 124.44 0.729 . . . . 15.0 112.101 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -115.25 123.01 47.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.474 1.13 . . . . 15.0 111.856 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -109.03 82.21 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.499 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.464 HG13 ' H ' ' A' ' 35' ' ' ASN 0.276 7.3 p -71.2 -73.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.236 -2.257 . . . . 15.0 112.243 174.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.464 ' H ' HG13 ' A' ' 34' ' ' VAL . 22.7 t30 -70.55 127.86 91.61 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.229 1.411 . . . . 15.0 112.146 -176.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 35' ' ' ASN . 71.8 Cg_endo -72.5 69.5 3.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.323 2.682 . . . . 15.0 111.728 170.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -175.94 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.196 2.199 . . . . 15.0 107.941 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.28 141.01 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.465 -0.788 . . . . 15.0 111.962 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.67 158.95 14.08 Favored Glycine 0 N--CA 1.477 1.39 0 CA-C-N 113.638 -1.619 . . . . 15.0 109.577 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 136.2 52.73 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.257 0.551 . . . . 15.0 110.524 -176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB3' ' OG1' ' A' ' 60' ' ' THR . 0.9 OUTLIER -127.89 133.91 49.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.584 -1.189 . . . . 15.0 110.621 -173.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.4 mtm -124.23 128.27 48.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.133 -1.394 . . . . 15.0 111.547 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.99 134.08 11.93 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 113.385 -1.734 . . . . 15.0 109.676 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.524 ' HB2' ' HB3' ' A' ' 28' ' ' ALA . 82.8 m-85 -120.12 115.06 22.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.311 -0.945 . . . . 15.0 111.695 -173.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -128.93 143.67 50.95 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.066 -1.425 . . . . 15.0 109.719 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.85 142.53 50.15 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.744 0.646 . . . . 15.0 112.744 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 122.813 1.292 . . . . 15.0 110.075 -177.952 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 121.814 0.816 . . . . 15.0 112.419 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -127.69 156.27 42.63 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.973 -1.921 . . . . 15.0 111.219 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.43 100.57 0.88 Allowed Glycine 0 N--CA 1.475 1.295 0 O-C-N 124.482 1.114 . . . . 15.0 110.427 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -110.74 131.86 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.599 1.19 . . . . 15.0 112.306 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -109.86 124.1 50.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.52 -1.673 . . . . 15.0 109.003 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.19 111.18 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.673 -1.149 . . . . 15.0 109.305 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 78' ' ' ARG . 32.2 p -136.2 156.36 48.79 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.148 -1.842 . . . . 15.0 112.634 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -116.56 141.66 47.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.745 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -110.77 126.07 54.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.375 -1.284 . . . . 15.0 111.402 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.24 146.84 49.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.616 -1.629 . . . . 15.0 110.866 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.96 -155.29 21.56 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 115.694 -0.685 . . . . 15.0 112.04 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 67' ' ' LYS . 18.9 p90 -166.4 158.94 11.97 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -167.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.711 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.5 Cg_endo -68.57 134.0 29.39 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.825 2.35 . . . . 15.0 111.982 167.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 4.8 tmtp? -129.44 122.75 30.0 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.234 -1.348 . . . . 15.0 110.725 -177.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 68' ' ' LEU . 1.8 pt? -69.93 125.68 27.47 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.384 -1.28 . . . . 15.0 110.769 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.34 -86.18 0.41 Allowed Glycine 0 N--CA 1.477 1.378 0 CA-C-N 114.562 -1.199 . . . . 15.0 112.94 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.432 HG23 ' OH ' ' A' ' 114' ' ' TYR . 2.4 t -126.43 -39.8 2.0 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.634 -1.283 . . . . 15.0 110.517 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -116.87 -146.37 0.4 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.502 -1.296 . . . . 15.0 107.502 148.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -107.76 103.31 12.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 114' ' ' TYR . 1.2 pt? -111.1 143.54 41.66 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.056 -1.429 . . . . 15.0 113.733 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.711 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 1.1 m-20 -111.85 123.44 50.24 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.513 -1.221 . . . . 15.0 108.914 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.7 mt -111.59 113.19 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 124.38 1.05 . . . . 15.0 108.681 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -122.27 141.83 51.1 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.478 -1.692 . . . . 15.0 111.885 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 m -108.53 122.64 47.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.257 -2.127 . . . . 15.0 105.257 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.705 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 18.2 ttm180 -115.73 123.22 47.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 112.831 -1.986 . . . . 15.0 108.134 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.2 tp -131.57 138.39 48.84 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.244 -0.889 . . . . 15.0 111.065 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.22 -145.39 8.06 Favored Glycine 0 N--CA 1.477 1.423 0 O-C-N 124.749 1.281 . . . . 15.0 113.178 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.43 152.35 22.86 Favored Glycine 0 N--CA 1.476 1.349 0 O-C-N 125.235 1.197 . . . . 15.0 112.599 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.75 118.71 35.06 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.548 0.69 . . . . 15.0 111.136 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.75 125.71 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 113.768 -1.56 . . . . 15.0 108.089 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 . . . . . 0 N--CA 1.472 0.643 0 CA-C-N 114.286 -1.325 . . . . 15.0 110.729 176.233 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.363 -0.606 . . . . 15.0 109.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.45 99.74 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.438 -1.255 . . . . 15.0 108.843 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -118.65 136.45 24.15 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 114.31 -1.313 . . . . 15.0 111.904 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.21 96.58 0.72 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.06 2.507 . . . . 15.0 111.074 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.729 ' HB ' ' HA ' ' A' ' 133' ' ' THR . 21.5 m -116.98 143.48 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.836 -1.529 . . . . 15.0 111.566 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.65 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 5.6 p90 -129.7 138.18 51.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.8 -169.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -124.79 134.28 52.83 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.631 1.832 . . . . 15.0 111.962 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 131' ' ' GLN . . . -104.29 99.24 1.65 Allowed Glycine 0 N--CA 1.476 1.31 0 N-CA-C 108.251 -1.939 . . . . 15.0 108.251 175.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.67 114.45 4.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 125.081 1.107 . . . . 15.0 112.127 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.3 t -117.29 131.96 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 122.576 1.179 . . . . 15.0 108.997 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 10.5 mm-40 -110.74 109.58 19.87 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 112.623 -2.081 . . . . 15.0 108.711 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 73' ' ' LEU . 13.6 t80 -107.26 126.08 51.97 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.611 0.719 . . . . 15.0 112.21 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.5 t -114.22 133.01 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.389 -1.278 . . . . 15.0 109.023 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.1 mt -118.78 142.94 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 114.517 -1.219 . . . . 15.0 108.727 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -70.83 97.11 1.34 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.903 1.075 . . . . 15.0 113.903 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -127.12 149.91 49.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.331 -1.304 . . . . 15.0 112.095 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -57.03 -42.9 81.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.146 1.165 . . . . 15.0 114.146 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.9 mt -120.8 89.05 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.0 m -118.0 90.25 36.61 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.238 -1.346 . . . . 15.0 109.191 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.31 82.64 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.735 2.29 . . . . 15.0 112.281 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 148' ' ' TYR . 1.5 mp0 46.57 32.12 1.56 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.759 2.133 . . . . 15.0 116.759 176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.578 HD11 ' HB ' ' A' ' 146' ' ' VAL . 7.3 tp -116.71 129.57 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.103 0.954 . . . . 15.0 112.414 -169.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.61 153.2 38.41 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.077 -1.874 . . . . 15.0 110.563 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.3 m -80.76 122.61 27.38 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 108.11 20.72 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.348 -1.296 . . . . 15.0 107.995 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.57 111.02 16.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.548 -1.66 . . . . 15.0 108.017 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 110' ' ' GLY . 1.4 tm-20 -129.28 120.51 25.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.553 -1.203 . . . . 15.0 111.054 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 141' ' ' MET . 86.5 t80 -134.95 105.55 6.43 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 117.699 -1.143 . . . . 15.0 110.199 170.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.65 ' HB3' ' O ' ' A' ' 108' ' ' PHE 0.756 1.1 mp0 -149.88 159.28 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 110.884 -2.871 . . . . 15.0 116.751 164.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -78.23 111.6 14.36 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 122.422 1.106 . . . . 15.0 108.207 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.729 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 36.4 p . . . . . 0 N--CA 1.483 1.224 0 CA-C-N 113.457 -1.701 . . . . 15.0 115.583 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 CA-C-O 121.323 0.402 . . . . 15.0 113.262 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -130.79 133.9 46.38 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.921 1.082 . . . . 15.0 113.921 176.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -112.55 105.18 13.33 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.487 -1.688 . . . . 15.0 112.079 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 14.9 m -102.26 125.18 48.88 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.775 -2.012 . . . . 15.0 107.847 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.08 136.88 48.81 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.258 -1.337 . . . . 15.0 111.426 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.08 -162.46 29.39 Favored Glycine 0 N--CA 1.476 1.327 0 O-C-N 124.837 1.335 . . . . 15.0 112.612 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.578 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.7 m -121.0 140.1 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 113.824 -1.188 . . . . 15.0 112.022 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.495 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 25.0 t -123.63 136.17 54.35 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.437 -1.256 . . . . 15.0 110.661 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 123' ' ' GLU . 34.7 t80 -111.72 135.21 52.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.607 -1.179 . . . . 15.0 109.482 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -91.01 128.7 36.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.42 -1.263 . . . . 15.0 109.842 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 6' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 C-N-CA 126.888 2.075 . . . . 15.0 114.098 -173.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 123.348 1.547 . . . . 15.0 113.053 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 33' ' ' GLN . 12.2 p -98.27 115.12 27.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.013 -2.358 . . . . 15.0 109.337 -172.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -94.18 130.43 40.4 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.683 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 148' ' ' TYR . 1.2 t80 -143.4 111.26 6.03 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.487 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.569 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 40.4 p -117.96 174.57 6.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.869 -1.969 . . . . 15.0 110.503 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.0 -159.21 28.36 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.224 0.902 . . . . 15.0 114.4 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.82 132.75 24.22 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.725 -1.237 . . . . 15.0 111.019 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HA ' ' HA3' ' A' ' 145' ' ' GLY . 22.7 pttp -137.3 150.47 47.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.481 -1.236 . . . . 15.0 112.341 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.6 pp -114.21 143.59 44.58 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.875 -1.057 . . . . 15.0 111.723 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.31 119.09 6.26 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-N 113.2 -1.818 . . . . 15.0 110.316 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -114.82 141.1 48.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 113.502 -1.349 . . . . 15.0 111.72 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 m -122.21 98.04 5.75 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.063 -1.426 . . . . 15.0 113.708 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -85.32 48.64 1.61 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.45 1.278 . . . . 15.0 114.45 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -166.57 26.4 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.073 1.509 . . . . 15.0 115.073 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -155.38 144.23 20.65 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.593 0.59 . . . . 15.0 112.593 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -80.88 90.38 5.9 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 15.0 110.193 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 57.6 28.72 16.09 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.371 1.989 . . . . 15.0 116.371 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -114.82 133.96 55.51 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 10.5 mm-40 53.07 93.76 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.137 1.903 . . . . 15.0 116.137 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pp -154.23 137.22 15.47 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 111.681 -2.509 . . . . 15.0 110.151 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.07 -169.88 37.56 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.138 0.899 . . . . 15.0 113.486 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -124.39 142.62 51.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.573 0.749 . . . . 15.0 112.695 -175.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.16 145.92 16.75 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 114.188 -1.369 . . . . 15.0 111.16 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.67 121.27 43.21 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.32 -0.94 . . . . 15.0 109.351 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -127.23 152.88 46.81 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.699 -1.137 . . . . 15.0 112.165 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -174.36 149.23 10.46 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 115.413 -0.812 . . . . 15.0 114.813 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.22 -146.74 7.62 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 113.634 -1.283 . . . . 15.0 113.298 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -158.35 149.55 20.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.722 -1.239 . . . . 15.0 113.621 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 42.2 tt0 -114.66 95.17 5.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.303 1.441 . . . . 15.0 108.657 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.6 -48.17 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.222 -0.899 . . . . 15.0 111.693 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.99 154.93 61.37 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-O 118.055 -0.974 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.47 53.36 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.877 3.051 . . . . 15.0 113.42 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.91 -82.3 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.515 1.526 . . . . 15.0 108.667 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.38 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.939 0.896 . . . . 15.0 108.854 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.62 166.88 17.09 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.188 1.375 . . . . 15.0 110.671 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.96 139.39 52.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.41 137.15 43.83 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.363 -1.29 . . . . 15.0 111.805 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.18 143.33 31.41 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.756 -1.565 . . . . 15.0 109.85 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.32 7.75 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.05 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -118.99 133.96 55.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.364 1.078 . . . . 15.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -125.11 133.82 52.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.921 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.829 ' HA ' ' HG3' ' A' ' 55' ' ' GLN . 37.7 p-90 -102.8 133.54 47.69 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.814 -1.085 . . . . 15.0 110.192 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 N--CA 1.476 0.864 0 CA-C-N 113.595 -1.639 . . . . 15.0 113.764 -173.82 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 111.632 0.234 . . . . 15.0 111.632 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.829 ' HG3' ' HA ' ' A' ' 46' ' ' TRP . 2.9 mp0 -51.6 147.1 6.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.906 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 135.87 16.04 Favored Glycine 0 N--CA 1.478 1.467 0 CA-C-N 114.37 -1.286 . . . . 15.0 112.576 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.13 137.32 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.73 1.252 . . . . 15.0 112.988 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -126.84 139.77 52.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.089 -1.869 . . . . 15.0 111.733 175.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.44 111.19 17.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.585 -1.643 . . . . 15.0 109.114 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.532 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 34.2 m -124.55 140.86 52.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.986 -1.461 . . . . 15.0 109.884 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.833 ' O ' ' HB3' ' A' ' 78' ' ' ARG . . . -101.06 138.5 38.02 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.998 -1.853 . . . . 15.0 105.998 168.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.739 ' HA ' ' CB ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -124.95 139.24 54.0 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.93 2.019 . . . . 15.0 114.365 -178.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 77' ' ' THR 0.27 4.6 pp -127.15 120.7 29.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 166.096 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . -121.91 135.05 10.19 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.678 -2.51 . . . . 15.0 112.58 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.08 145.43 50.29 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 125.348 1.263 . . . . 15.0 114.118 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.4 91.22 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.069 2.513 . . . . 15.0 110.728 167.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' A' ' 68' ' ' LEU . 6.3 tmtt? -144.6 152.16 40.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.405 -1.725 . . . . 15.0 108.895 -178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.628 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 1.2 tm? 62.95 85.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.79 2.036 . . . . 15.0 109.624 -170.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -140.74 15.82 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 112.926 -1.943 . . . . 15.0 109.584 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 71' ' ' ASP . 3.2 t -136.34 -86.96 0.33 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.188 -1.006 . . . . 15.0 112.153 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.556 ' H ' HG23 ' A' ' 70' ' ' THR . 8.5 m-20 -124.97 106.6 10.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.108 1.363 . . . . 15.0 108.093 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t0 176.32 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 113.175 -1.83 . . . . 15.0 110.138 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 114' ' ' TYR . 1.3 pt? -135.32 151.79 50.86 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.799 1.312 . . . . 15.0 112.218 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 7.0 m-20 -132.56 138.78 47.58 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.398 -1.274 . . . . 15.0 111.022 172.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.474 ' HA ' HG12 ' A' ' 112' ' ' VAL . 7.8 tp -87.71 135.84 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.275 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -123.94 128.86 50.04 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.992 1.433 . . . . 15.0 111.646 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.495 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 24.0 p -137.2 122.35 19.18 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.942 -1.132 . . . . 15.0 107.942 158.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.833 ' HB3' ' O ' ' A' ' 61' ' ' ALA 0.609 8.0 mmt180 -158.9 164.6 35.53 Favored 'General case' 0 N--CA 1.478 0.972 1 N-CA-C 122.946 4.424 . . . . 15.0 122.946 172.822 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.707 HD13 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -127.93 156.0 43.33 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.096 0.776 . . . . 15.0 113.096 -176.048 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -165.12 -176.55 36.86 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 114.96 -1.018 . . . . 15.0 113.365 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.93 144.16 14.97 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 123.889 0.757 . . . . 15.0 113.286 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.552 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -123.79 140.68 52.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.617 1.34 . . . . 15.0 114.617 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.87 144.27 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 125.157 1.536 . . . . 15.0 112.309 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 . . . . . 0 N--CA 1.478 0.949 0 C-N-CA 124.38 1.072 . . . . 15.0 111.798 175.72 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.651 0.738 . . . . 15.0 111.903 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 t -117.0 120.67 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.0 m -122.12 142.01 35.67 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.305 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.16 148.7 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.666 2.244 . . . . 15.0 113.274 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.41 135.05 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.643 -1.617 . . . . 15.0 109.64 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -107.11 123.36 48.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -127.55 112.51 15.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.907 -173.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 138.56 11.76 Favored Glycine 0 N--CA 1.479 1.539 0 CA-C-N 113.581 -1.645 . . . . 15.0 110.713 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.79 -152.95 14.73 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.298 0.475 . . . . 15.0 113.244 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 75' ' ' ILE . 5.4 m -141.77 156.97 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.992 1.108 . . . . 15.0 113.992 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -110.13 136.89 48.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.426 -1.716 . . . . 15.0 108.669 159.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 73' ' ' LEU . 11.5 t80 -132.37 143.61 49.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.865 -1.516 . . . . 15.0 108.957 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.44 135.32 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 120.949 0.404 . . . . 15.0 109.991 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.7 mt -43.61 -39.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.805 1.78 . . . . 15.0 115.805 -164.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -164.1 -60.13 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.589 0.755 . . . . 15.0 110.495 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.16 135.52 34.34 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.767 -0.651 . . . . 15.0 109.701 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.79 -33.8 50.5 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.975 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.0 tt -99.84 82.92 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 122.236 1.017 . . . . 15.0 109.893 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 89.2 m -136.76 88.96 18.25 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 112.325 -2.216 . . . . 15.0 108.163 167.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.37 -177.11 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.949 2.433 . . . . 15.0 111.733 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 54.4 mt-10 66.83 -55.6 0.43 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.631 1.973 . . . . 15.0 115.309 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.531 HG12 ' CE2' ' A' ' 148' ' ' TYR . 6.6 mt -116.72 115.16 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.254 1.022 . . . . 15.0 108.649 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.07 147.98 44.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.369 -1.287 . . . . 15.0 111.343 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 m -80.75 116.8 20.94 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.49 HH11 ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -116.83 112.04 20.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.115 0.96 . . . . 15.0 109.889 -177.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.53 112.75 18.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 15.0 110.841 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -134.98 136.45 42.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.928 -1.487 . . . . 15.0 111.491 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 30.7 m-85 -97.4 131.96 43.56 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.425 -1.262 . . . . 15.0 109.341 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.38 117.0 30.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.356 -1.747 . . . . 15.0 111.592 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -120.72 111.83 18.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.493 -1.685 . . . . 15.0 113.186 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 N--CA 1.483 1.22 0 CA-C-N 112.64 -2.073 . . . . 15.0 111.557 167.11 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 109.057 -1.617 . . . . 15.0 109.057 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.0 ttt -117.65 135.11 54.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.586 0.708 . . . . 15.0 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.2 tt -105.17 108.8 20.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.694 -1.139 . . . . 15.0 109.708 -174.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m -93.25 125.11 37.68 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.208 1.004 . . . . 15.0 110.081 170.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.4 pp -133.9 135.22 43.49 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 112.903 -1.953 . . . . 15.0 110.109 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -178.94 -162.52 28.48 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 114.82 -1.082 . . . . 15.0 112.848 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.3 m -117.04 131.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 113.518 -1.341 . . . . 15.0 112.633 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.7 p -113.17 145.73 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 112.342 -2.208 . . . . 15.0 111.535 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 70.7 m-85 -124.07 143.45 50.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.009 -1.905 . . . . 15.0 112.482 -172.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -95.84 141.54 29.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 113.583 -1.644 . . . . 15.0 111.41 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 . . . . . 0 N--CA 1.484 1.267 0 C-N-CA 125.825 1.65 . . . . 15.0 114.347 -177.819 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.584 ' HA ' HG22 ' A' ' 34' ' ' VAL . 60.0 t30 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.563 1.32 . . . . 15.0 114.563 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.598 ' HA ' ' HB3' ' A' ' 149' ' ' ARG . 10.2 t -110.98 114.72 28.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.162 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -136.79 133.57 36.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.905 -2.407 . . . . 15.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 144.17 -98.11 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 129.293 3.037 . . . . 15.0 108.09 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.647 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 11.2 t -163.51 153.18 15.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -131.06 -170.07 12.59 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.166 -1.379 . . . . 15.0 112.793 170.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.73 131.57 5.44 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.752 1.621 . . . . 15.0 109.522 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.682 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.425 5.2 tptp -171.94 169.61 5.65 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.185 -1.825 . . . . 15.0 115.142 168.407 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HB3' ' H ' ' A' ' 26' ' ' ALA . 1.9 pt? -130.47 161.64 30.98 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.427 -1.261 . . . . 15.0 111.681 -173.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -120.0 155.57 16.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.513 -1.222 . . . . 15.0 112.548 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -121.65 137.02 54.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.924 -1.138 . . . . 15.0 112.49 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -116.8 151.78 35.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.09 -1.414 . . . . 15.0 109.919 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -71.43 78.73 0.76 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.164 1.172 . . . . 15.0 114.164 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -158.92 139.49 12.51 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.135 -1.393 . . . . 15.0 111.717 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.9 m -66.46 -40.41 89.39 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 116.664 2.098 . . . . 15.0 116.664 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 mtt-85 -76.78 92.08 3.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.54 0.686 . . . . 15.0 111.841 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -124.58 131.5 53.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.096 -1.865 . . . . 15.0 113.03 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -131.65 -163.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.239 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -74.68 74.64 2.04 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.535 1.159 . . . . 15.0 111.024 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.63 101.43 3.67 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.663 -1.608 . . . . 15.0 108.502 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.66 -153.82 23.06 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 114.146 -1.388 . . . . 15.0 111.377 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.492 ' H ' ' HB3' ' A' ' 13' ' ' LEU . . . 50.13 91.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.191 1.796 . . . . 15.0 114.19 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.11 148.77 16.48 Favored Glycine 0 N--CA 1.475 1.269 0 CA-C-N 113.807 -1.542 . . . . 15.0 109.99 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.45 121.14 41.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.692 -0.855 . . . . 15.0 108.692 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 97.3 m-85 -125.75 113.43 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.562 -1.199 . . . . 15.0 110.114 -170.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.67 -174.59 14.44 Favored Glycine 0 N--CA 1.477 1.405 0 CA-C-N 115.353 -0.84 . . . . 15.0 114.309 -173.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.92 -140.04 13.86 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.441 -0.88 . . . . 15.0 113.705 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -127.19 104.93 8.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.406 -1.397 . . . . 15.0 112.969 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -114.93 82.27 1.71 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 123.066 1.412 . . . . 15.0 108.249 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 5' ' ' ASN . 47.9 t -124.78 -63.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 112.749 -2.023 . . . . 15.0 113.315 -170.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.5 t-20 -62.17 139.09 96.13 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 114.354 1.242 . . . . 15.0 114.354 -170.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.59 41.13 0.59 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.652 3.568 . . . . 15.0 116.444 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 1.2 t80 -167.51 -58.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 15.0 111.236 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 57.2 t -124.65 136.32 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.794 0.806 . . . . 15.0 110.279 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.37 154.57 21.3 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 113.785 -1.552 . . . . 15.0 110.055 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.95 114.31 20.81 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.737 0.303 . . . . 15.0 110.503 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -131.94 119.91 21.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.159 -0.928 . . . . 15.0 111.047 -172.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.3 mtp -112.21 135.6 52.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.796 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 29' ' ' PHE . . . -115.87 147.67 18.91 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 113.382 -1.735 . . . . 15.0 111.948 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -132.29 143.03 49.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.846 1.425 . . . . 15.0 114.846 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.09 118.44 24.39 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 111.722 -2.49 . . . . 15.0 107.238 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -112.51 145.18 40.71 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.518 -1.219 . . . . 15.0 110.073 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.212 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 117.184 2.29 . . . . 15.0 117.184 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 58.41 109.54 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.125 1.77 . . . . 15.0 114.516 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.26 134.76 10.58 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 114.021 -1.445 . . . . 15.0 111.282 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.2 p -119.05 141.33 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 122.111 0.958 . . . . 15.0 111.259 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.503 ' HG2' ' HB3' ' A' ' 82' ' ' MET . 47.4 mt-30 -120.66 140.29 51.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.284 -1.326 . . . . 15.0 109.976 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.64 114.82 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.397 -1.274 . . . . 15.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.2 p -130.41 131.73 45.4 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.746 0.784 . . . . 15.0 110.881 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -114.77 123.3 48.87 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.982 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.647 ' HG2' ' CD2' ' A' ' 76' ' ' TYR . 11.9 tmtt? -79.31 106.41 11.32 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.2 -1.818 . . . . 15.0 108.575 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.79 108.82 15.32 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.472 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 37' ' ' TYR . . . 177.65 -153.69 13.85 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 114.021 -1.445 . . . . 15.0 113.517 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.98 152.22 76.87 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 113.934 -1.133 . . . . 15.0 111.23 -170.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 35.2 Cg_endo -61.29 -73.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.497 2.131 . . . . 15.0 111.24 170.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 60.95 143.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.599 1.96 . . . . 15.0 111.621 -176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.72 -61.63 2.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.878 -1.056 . . . . 15.0 112.055 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.11 -85.15 0.06 OUTLIER Glycine 0 N--CA 1.478 1.462 0 C-N-CA 124.76 1.171 . . . . 15.0 111.492 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 p -134.83 -73.01 0.47 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.653 1.181 . . . . 15.0 109.383 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -165.81 135.33 3.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.869 2.068 . . . . 15.0 108.684 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.565 ' HB2' ' CE1' ' A' ' 114' ' ' TYR . 7.3 m-20 62.03 43.64 8.78 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.903 1.281 . . . . 15.0 112.775 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tt -117.57 137.36 52.64 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.776 -1.102 . . . . 15.0 112.942 -167.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 14.9 t70 -126.61 139.41 53.21 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 112.079 -2.328 . . . . 15.0 109.002 165.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.9 tt -118.16 119.12 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.119 0.968 . . . . 15.0 109.831 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.647 ' CD2' ' HG2' ' A' ' 62' ' ' LYS . 8.8 p90 -153.86 168.9 24.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.012 1.115 . . . . 15.0 114.012 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.585 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 8.9 t -118.66 133.53 55.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.569 166.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.548 ' HB3' ' HE2' ' A' ' 76' ' ' TYR . 7.8 ppt_? -100.53 123.17 44.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.55 1.167 . . . . 15.0 109.149 172.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 pp -124.41 144.57 49.98 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.221 -2.263 . . . . 15.0 113.483 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.64 -97.36 0.17 Allowed Glycine 0 N--CA 1.476 1.304 0 CA-C-N 113.46 -1.7 . . . . 15.0 109.309 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.59 -153.66 23.75 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 115.057 0.783 . . . . 15.0 115.057 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.503 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 21.9 ptp -129.14 138.5 51.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.217 1.562 . . . . 15.0 115.217 -172.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.2 t -128.05 115.58 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 112.902 -1.953 . . . . 15.0 109.185 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 113.85 -1.523 . . . . 15.0 109.721 170.858 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.964 0.888 . . . . 15.0 112.78 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.97 90.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 114.778 -1.101 . . . . 15.0 108.375 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.8 m -130.04 90.17 43.25 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.112 1.153 . . . . 15.0 114.112 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.11 141.42 29.47 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.288 2.659 . . . . 15.0 112.66 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.42 HG22 HG21 ' A' ' 133' ' ' THR . 97.8 t -134.37 139.31 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.363 -1.29 . . . . 15.0 109.855 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -124.32 123.34 39.99 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.656 1.223 . . . . 15.0 109.139 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -136.33 112.66 9.88 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.952 1.093 . . . . 15.0 113.952 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 77' ' ' THR . . . -113.29 142.07 17.24 Favored Glycine 0 N--CA 1.479 1.527 0 CA-C-N 114.096 -1.411 . . . . 15.0 112.662 -173.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.16 -148.93 10.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-O 121.928 0.738 . . . . 15.0 114.606 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.35 143.86 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 113.483 -1.358 . . . . 15.0 113.859 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -122.83 121.92 37.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.069 -1.878 . . . . 15.0 109.898 178.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 72' ' ' ASP . 78.1 t80 -117.71 137.36 52.74 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.888 1.367 . . . . 15.0 110.196 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.83 130.62 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.288 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.94 106.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.905 1.817 . . . . 15.0 115.905 -169.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -118.89 87.37 2.72 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.092 -1.413 . . . . 15.0 110.36 171.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.489 HH21 ' HD2' ' A' ' 119' ' ' ARG . 21.7 ttp180 -174.08 -79.94 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.512 -1.676 . . . . 15.0 112.438 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.489 ' HD2' HH21 ' A' ' 118' ' ' ARG . 65.1 ttt180 -101.53 146.86 27.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.425 0.631 . . . . 15.0 112.658 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.26 100.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.078 1.751 . . . . 15.0 112.523 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.1 p -140.18 151.41 64.61 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 112.066 -2.334 . . . . 15.0 110.281 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.68 82.21 1.22 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.377 2.051 . . . . 15.0 110.141 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -0.7 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.939 2.496 . . . . 15.0 116.596 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.426 HG22 ' HB3' ' A' ' 148' ' ' TYR . 2.7 pp -116.53 140.79 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 112.687 -2.051 . . . . 15.0 112.4 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.47 127.78 53.97 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.489 -2.141 . . . . 15.0 109.333 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 8.9 t -109.33 129.28 55.53 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.426 -1.261 . . . . 15.0 112.182 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 144' ' ' LEU . 52.0 ttp180 -113.3 108.12 16.82 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.431 -1.713 . . . . 15.0 110.19 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.5 tp -106.73 111.02 23.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.855 -1.521 . . . . 15.0 108.061 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -138.18 150.41 46.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.136 -2.302 . . . . 15.0 113.161 -168.505 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 38.3 p90 -96.99 129.52 44.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 172.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 44.5 tt0 -108.04 110.01 21.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.806 -1.997 . . . . 15.0 108.5 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -123.43 136.54 54.67 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.117 -1.856 . . . . 15.0 112.802 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.42 HG21 HG22 ' A' ' 107' ' ' VAL . 8.8 t . . . . . 0 N--CA 1.482 1.145 0 CA-C-N 110.927 -2.852 . . . . 15.0 108.761 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.435 0 CA-C-O 121.481 0.489 . . . . 15.0 112.616 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.467 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 25.5 ttt -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.129 -1.035 . . . . 15.0 110.874 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.1 tp -114.32 112.22 22.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.398 -1.334 . . . . 15.0 107.398 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.53 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 9.8 t -120.56 138.34 53.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.952 -1.476 . . . . 15.0 112.693 -166.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 37.7 tp -120.1 134.58 55.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.589 -1.641 . . . . 15.0 109.861 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.27 128.33 5.75 Favored Glycine 0 N--CA 1.481 1.655 0 O-C-N 125.774 1.921 . . . . 15.0 110.247 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.427 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 48.2 t -121.43 127.55 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 118.718 1.259 . . . . 15.0 109.249 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.565 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 65.9 p -118.71 138.68 52.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.551 ' CE2' ' HA2' ' A' ' 10' ' ' GLY . 13.5 p90 -125.26 148.31 48.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.481 1.134 . . . . 15.0 113.65 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.598 ' HB3' ' HA ' ' A' ' 6' ' ' THR . 36.6 ptt180 -101.32 153.37 19.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.354 -1.748 . . . . 15.0 114.516 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 N--CA 1.481 1.118 0 C-N-CA 127.251 2.22 . . . . 15.0 115.161 -178.059 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.652 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 58.8 t30 . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 123.016 1.388 . . . . 15.0 112.811 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.494 ' HB ' ' CE2' ' A' ' 8' ' ' TYR . 81.5 p -98.38 119.49 37.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.078 -1.873 . . . . 15.0 108.306 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 6.6 m0 -113.91 130.28 56.52 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.237 -1.023 . . . . 15.0 108.237 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.494 ' CE2' ' HB ' ' A' ' 6' ' ' THR . 89.6 m-85 -132.22 106.0 7.68 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.229 0.956 . . . . 15.0 112.348 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.0 p -104.07 137.9 41.36 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.547 -0.751 . . . . 15.0 111.341 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.11 -145.46 7.28 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 113.92 -1.491 . . . . 15.0 112.038 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.55 144.15 50.21 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.891 -0.655 . . . . 15.0 112.675 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -118.29 140.16 50.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.434 -1.257 . . . . 15.0 111.312 174.595 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 143' ' ' SER . 0.9 OUTLIER -127.53 133.43 49.81 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.247 -1.342 . . . . 15.0 111.391 176.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -111.45 116.99 4.36 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 125.223 1.577 . . . . 15.0 110.626 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -109.26 145.46 35.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.848 0.832 . . . . 15.0 111.723 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -98.98 98.17 9.25 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.5 -1.227 . . . . 15.0 114.289 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.92 90.0 7.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.82 -1.082 . . . . 15.0 109.438 170.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.22 -86.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.743 -2.026 . . . . 15.0 110.081 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -119.24 -165.45 1.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.537 1.135 . . . . 15.0 109.07 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.33 83.6 0.25 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.805 1.242 . . . . 15.0 113.904 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.94 136.97 50.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.669 -1.605 . . . . 15.0 111.763 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -121.18 97.1 5.36 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.117 -1.401 . . . . 15.0 109.549 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.01 133.72 55.27 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.329 1.233 . . . . 15.0 114.329 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.96 156.17 33.98 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.971 -1.922 . . . . 15.0 110.57 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.87 -86.91 0.07 OUTLIER Glycine 0 N--CA 1.478 1.495 0 O-C-N 124.245 0.965 . . . . 15.0 112.085 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 69.72 149.71 0.08 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.339 2.256 . . . . 15.0 114.801 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.25 149.8 16.96 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 113.636 -1.62 . . . . 15.0 110.812 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.54 121.34 42.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.226 0.536 . . . . 15.0 110.249 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 2.4 m-85 -129.83 150.3 51.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 116.103 1.89 . . . . 15.0 116.103 -166.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.29 121.07 4.43 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 112.985 -1.916 . . . . 15.0 110.352 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' HH12 ' A' ' 127' ' ' ARG . . . -104.99 98.91 1.54 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 113.732 -1.234 . . . . 15.0 110.215 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -105.97 101.1 10.62 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.586 1.184 . . . . 15.0 108.822 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.521 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 18.8 tm0? -106.37 82.46 1.74 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.8 -1.556 . . . . 15.0 106.8 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 44.0 t -80.37 -84.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.199 -1.819 . . . . 15.0 109.163 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.536 ' H ' ' CD ' ' A' ' 36' ' ' PRO . 19.3 t-20 163.5 51.42 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 128.916 2.886 . . . . 15.0 114.445 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.536 ' CD ' ' H ' ' A' ' 35' ' ' ASN . 96.0 Cg_endo -85.98 55.61 3.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 N-CA-C 108.669 -1.32 . . . . 15.0 108.669 157.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 66.72 -33.87 0.21 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.195 2.198 . . . . 15.0 114.858 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.08 160.5 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.894 1.677 . . . . 15.0 111.966 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -82.72 153.28 31.2 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 109.846 -1.302 . . . . 15.0 109.846 170.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -117.6 118.3 31.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.593 0.711 . . . . 15.0 110.774 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.7 tp10 -111.1 110.1 20.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.9 -1.518 . . . . 15.0 106.9 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.3 ttp -135.28 136.34 41.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.087 -1.415 . . . . 15.0 109.934 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 29' ' ' PHE . . . -172.73 177.23 45.38 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 114.7 -1.136 . . . . 15.0 112.921 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -116.16 145.69 42.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.74 1.257 . . . . 15.0 113.749 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -117.32 118.49 32.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.031 -2.349 . . . . 15.0 109.478 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.469 ' HE1' ' HB1' ' A' ' 54' ' ' ALA . 42.0 t90 -129.45 152.41 49.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.41 -1.268 . . . . 15.0 110.47 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 N--CA 1.482 1.152 0 O-C-N 125.188 1.555 . . . . 15.0 110.622 -176.816 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB1' ' HE1' ' A' ' 46' ' ' TRP . . . . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 116.087 1.884 . . . . 15.0 116.087 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.79 158.75 21.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.87 1.268 . . . . 15.0 113.566 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -121.41 148.33 17.35 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.498 169.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.25 131.97 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.446 0.641 . . . . 15.0 110.74 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.72 127.77 54.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.649 -1.16 . . . . 15.0 110.091 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.49 117.07 20.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.996 -1.911 . . . . 15.0 111.415 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.536 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 36.3 p -120.44 145.94 46.72 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.111 -1.404 . . . . 15.0 111.91 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.09 115.82 27.92 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.86 -1.518 . . . . 15.0 107.583 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.4 pttm -108.32 136.02 48.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 113.86 -1.518 . . . . 15.0 113.298 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.714 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 20.0 tp -128.99 135.9 49.59 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 113.599 -1.637 . . . . 15.0 108.812 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.04 137.56 11.58 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 125.366 1.666 . . . . 15.0 110.03 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.61 110.01 47.49 Favored Pre-proline 0 N--CA 1.477 0.882 0 N-CA-C 113.64 0.978 . . . . 15.0 113.64 177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.99 92.51 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.483 2.122 . . . . 15.0 109.893 172.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -46.59 -44.88 18.5 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.208 -1.36 . . . . 15.0 114.28 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -172.01 157.36 4.36 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.175 1.39 . . . . 15.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.73 -91.31 0.5 Allowed Glycine 0 N--CA 1.476 1.327 0 CA-C-N 114.794 -1.093 . . . . 15.0 111.028 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -158.9 -94.6 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.42 0.688 . . . . 15.0 109.661 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.97 94.53 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.052 0.941 . . . . 15.0 109.369 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -159.65 -58.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.81 -1.541 . . . . 15.0 110.824 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.74 122.64 47.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.619 0.768 . . . . 15.0 111.1 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.427 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -125.37 106.64 9.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.964 -1.471 . . . . 15.0 111.088 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 tt -104.74 107.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.089 -0.96 . . . . 15.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.714 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -168.78 -171.9 1.49 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 112.466 -2.152 . . . . 15.0 111.553 -178.22 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.0 p -119.21 154.05 33.99 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.092 0.949 . . . . 15.0 112.894 -163.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -128.4 140.41 51.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.868 -1.514 . . . . 15.0 112.704 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tt -134.92 141.53 46.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.611 -1.177 . . . . 15.0 109.563 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -173.7 -143.0 4.12 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 114.92 -1.037 . . . . 15.0 111.838 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.37 156.07 27.3 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 114.429 -0.885 . . . . 15.0 113.617 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -113.27 138.15 50.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.284 -1.458 . . . . 15.0 112.089 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.597 HG22 HG12 ' A' ' 104' ' ' VAL . 31.4 t -118.63 134.17 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.212 -1.774 . . . . 15.0 106.212 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.4 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.854 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.235 -174.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 121.585 0.707 . . . . 15.0 112.905 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.597 HG12 HG22 ' A' ' 83' ' ' VAL . 16.7 m -129.85 141.75 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.005 -1.907 . . . . 15.0 110.433 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.6 m -135.0 107.78 10.51 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-N 115.477 -0.783 . . . . 15.0 113.037 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -65.39 139.19 58.41 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.129 2.553 . . . . 15.0 112.561 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.91 139.62 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.968 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -126.57 137.29 53.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.516 -1.22 . . . . 15.0 110.98 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -137.6 137.44 38.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.228 -0.897 . . . . 15.0 111.864 176.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.86 138.0 10.0 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 115.43 -0.805 . . . . 15.0 112.329 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.41 -148.76 11.85 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 121.749 0.638 . . . . 15.0 114.582 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -124.49 131.47 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.513 1.149 . . . . 15.0 111.94 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 9.8 pt-20 -112.49 121.01 43.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.975 -1.921 . . . . 15.0 110.229 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -113.57 137.12 52.02 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.305 -1.316 . . . . 15.0 110.734 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.29 136.2 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 113.213 -1.812 . . . . 15.0 109.102 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.5 tp -63.24 142.97 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 114.441 -1.254 . . . . 15.0 112.424 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -90.42 -91.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.255 -1.339 . . . . 15.0 109.758 168.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -118.84 114.47 22.68 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.033 0.533 . . . . 15.0 111.872 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -169.34 172.91 6.9 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.085 1.754 . . . . 15.0 110.276 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.9 tt -53.79 124.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.874 0.87 . . . . 15.0 110.918 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 m 56.35 74.83 0.64 Allowed Pre-proline 0 N--CA 1.483 1.185 0 CA-C-N 113.738 -1.573 . . . . 15.0 110.091 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.07 72.82 5.71 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 15.0 112.744 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 149' ' ' ARG . 6.1 pt-20 -163.55 30.57 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.177 -1.829 . . . . 15.0 113.145 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 17.5 pt -116.64 136.17 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.251 -0.905 . . . . 15.0 113.438 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.93 140.61 52.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.021 -1.9 . . . . 15.0 111.654 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 t -125.14 116.76 22.55 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.056 -1.884 . . . . 15.0 109.763 175.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.49 HH12 ' HA3' ' A' ' 31' ' ' GLY . 97.9 mtt180 -115.69 108.18 16.04 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.453 -1.703 . . . . 15.0 110.475 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.64 110.88 19.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.666 1.222 . . . . 15.0 111.585 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.76 150.18 39.7 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.54 -2.118 . . . . 15.0 112.07 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 25.2 p90 -97.21 128.06 43.74 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.18 123.83 48.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.264 -1.334 . . . . 15.0 111.598 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -126.38 146.59 50.0 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.501 -2.136 . . . . 15.0 110.868 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.483 1.181 0 CA-C-N 113.582 -1.644 . . . . 15.0 110.762 -171.785 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.339 0 N-CA-C 110.619 -0.992 . . . . 15.0 110.619 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 98.8 mtp -117.58 135.14 54.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.508 -0.846 . . . . 15.0 109.956 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 100.87 11.18 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.845 0.831 . . . . 15.0 111.757 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 61.2 m -93.11 125.2 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.682 -2.054 . . . . 15.0 109.949 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.67 126.87 53.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.514 -2.13 . . . . 15.0 109.096 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -115.17 110.89 2.37 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 112.486 -2.143 . . . . 15.0 110.423 -176.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.92 127.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 113.95 -1.125 . . . . 15.0 108.731 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 77.6 p -148.05 154.1 39.81 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.38 -1.736 . . . . 15.0 113.032 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -116.4 142.86 46.31 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.093 -1.412 . . . . 15.0 110.892 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 33.6 ttp-105 -70.13 126.14 28.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.452 -1.704 . . . . 15.0 109.618 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 113.63 -1.623 . . . . 15.0 110.013 -178.649 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.965 0.888 . . . . 15.0 111.568 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 33' ' ' GLN . 29.5 m -153.58 142.95 21.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.09 1.756 . . . . 15.0 108.499 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -101.23 130.49 47.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.064 -0.971 . . . . 15.0 108.672 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -125.2 105.86 9.45 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.474 -166.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.566 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.0 m -123.24 128.97 50.74 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.421 0.451 . . . . 15.0 110.046 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -137.48 151.17 21.06 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 114.995 -1.002 . . . . 15.0 115.447 -173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.01 124.2 47.57 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.382 -1.409 . . . . 15.0 108.67 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.37 154.42 47.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.351 1.241 . . . . 15.0 114.351 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.2 161.76 20.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.339 -1.755 . . . . 15.0 111.949 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.62 96.72 0.59 Allowed Glycine 0 N--CA 1.476 1.362 0 N-CA-C 110.183 -1.167 . . . . 15.0 110.183 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.414 ' CZ3' ' HA ' ' A' ' 17' ' ' GLN . 50.2 t90 -102.63 123.1 45.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.767 0.794 . . . . 15.0 111.508 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 p -104.02 133.57 48.74 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.11 -0.95 . . . . 15.0 112.49 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.414 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 42.8 tt0 -64.12 -55.69 20.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.823 -1.535 . . . . 15.0 113.681 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.32 86.86 2.63 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.169 0.985 . . . . 15.0 111.689 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -137.41 134.1 35.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.968 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -54.54 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.048 1.499 . . . . 15.0 115.048 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -129.63 95.21 3.93 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.531 0.732 . . . . 15.0 110.293 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -122.76 149.16 44.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.58 -1.191 . . . . 15.0 113.761 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -74.31 154.07 39.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.849 -1.523 . . . . 15.0 110.314 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.63 -33.54 76.17 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.482 1.29 . . . . 15.0 114.482 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 140.38 8.61 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.519 1.057 . . . . 15.0 111.161 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 45' ' ' ASP . . . -141.6 86.47 2.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.613 -0.794 . . . . 15.0 110.136 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.15 92.93 0.59 Allowed Glycine 0 N--CA 1.474 1.19 0 CA-C-N 113.664 -1.607 . . . . 15.0 111.311 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -117.99 121.03 39.59 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.071 0.512 . . . . 15.0 109.866 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 42' ' ' MET 0.293 5.2 t80 -161.63 179.81 7.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.332 -1.758 . . . . 15.0 111.625 175.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.83 -178.55 15.55 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 115.044 -0.98 . . . . 15.0 112.091 -170.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.5 -155.04 12.97 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 113.071 -1.565 . . . . 15.0 112.722 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -126.28 138.81 53.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 112.597 -1.802 . . . . 15.0 112.976 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 1.1 tm0? -115.73 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.098 -1.41 . . . . 15.0 107.982 167.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.412 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 43.8 t -107.47 -29.74 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 111.095 -2.775 . . . . 15.0 110.412 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 48.6 54.48 16.07 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 116.954 2.205 . . . . 15.0 116.954 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.65 -22.42 37.76 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.097 1.865 . . . . 15.0 112.077 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -166.67 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 128.95 2.9 . . . . 15.0 109.292 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.1 m -135.33 160.49 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.255 1.422 . . . . 15.0 112.246 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 148.12 26.92 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 108.785 -1.726 . . . . 15.0 108.785 161.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.21 126.29 52.53 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.439 0.296 . . . . 15.0 111.399 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.578 ' HG3' HH22 ' A' ' 127' ' ' ARG . 4.1 pm0 -142.33 133.56 26.19 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.058 0.849 . . . . 15.0 113.123 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.641 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.5 137.11 54.84 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.271 -1.331 . . . . 15.0 108.233 174.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.52 129.81 8.5 Favored Glycine 0 N--CA 1.48 1.582 0 O-C-N 126.072 2.108 . . . . 15.0 110.745 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.423 ' N ' ' HB2' ' A' ' 29' ' ' PHE . 6.8 t80 -104.75 112.68 25.88 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.493 0.663 . . . . 15.0 109.602 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 15.0 t70 -106.74 118.4 36.58 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.122 -1.399 . . . . 15.0 110.005 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -120.54 110.05 15.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.613 -1.63 . . . . 15.0 111.06 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tt . . . . . 0 N--CA 1.48 1.027 0 CA-C-N 113.108 -1.86 . . . . 15.0 112.84 177.723 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 114.129 1.159 . . . . 15.0 114.129 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -115.46 101.97 9.38 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 15.0 112.467 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -119.26 142.19 16.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 112.226 -2.261 . . . . 15.0 111.141 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.71 135.16 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.185 -1.008 . . . . 15.0 111.164 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HB2' ' HE2' ' A' ' 82' ' ' MET . 18.4 tt0 -109.8 116.63 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.912 -1.144 . . . . 15.0 107.912 173.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.6 111.19 21.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.82 -1.991 . . . . 15.0 109.095 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.7 p -130.21 147.41 51.93 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.453 -1.703 . . . . 15.0 113.797 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.28 134.21 47.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.422 -2.172 . . . . 15.0 109.232 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.59 ' HD3' HH21 ' A' ' 127' ' ' ARG . 22.0 ttpp -107.2 114.15 28.02 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.201 -1.363 . . . . 15.0 111.421 -172.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.91 142.81 46.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.084 -1.871 . . . . 15.0 109.755 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.88 -156.34 23.7 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.829 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.63 159.11 9.92 Favored Pre-proline 0 N--CA 1.481 1.116 0 N-CA-C 114.397 1.258 . . . . 15.0 114.397 -168.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.62 104.71 0.32 Allowed 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 123.264 2.643 . . . . 15.0 111.487 164.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -146.16 148.79 32.92 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.765 -2.016 . . . . 15.0 106.594 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp 70.29 -47.2 0.62 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.455 1.902 . . . . 15.0 111.548 -164.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.64 125.06 5.99 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.353 -1.099 . . . . 15.0 110.353 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -64.51 -57.28 9.63 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.58 0.752 . . . . 15.0 109.558 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -133.93 82.12 1.96 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.223 -0.899 . . . . 15.0 108.586 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -169.35 -75.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.979 -1.919 . . . . 15.0 108.944 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.525 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . 1.4 pt? -123.46 132.0 53.8 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.305 1.003 . . . . 15.0 110.847 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.92 135.56 54.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.436 -1.711 . . . . 15.0 108.757 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 tt -91.41 116.74 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.105 -0.952 . . . . 15.0 110.015 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CD1' ' HG2' ' A' ' 62' ' ' LYS . 26.9 m-85 -135.96 138.82 42.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.25 -1.796 . . . . 15.0 115.06 -175.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 55.4 p -113.08 143.3 44.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 112.083 -2.326 . . . . 15.0 109.598 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.501 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 29.0 mtm105 -115.09 123.22 48.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.832 -1.531 . . . . 15.0 109.735 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tt -119.65 122.92 42.61 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.51 -1.223 . . . . 15.0 109.315 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -130.83 2.22 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 110.102 -1.199 . . . . 15.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 105' ' ' SER . . . 170.98 -166.44 39.63 Favored Glycine 0 N--CA 1.477 1.431 0 O-C-N 125.171 1.16 . . . . 15.0 114.999 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.485 ' HE2' ' HB2' ' A' ' 58' ' ' GLN . 57.7 ttm -119.4 129.68 54.92 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.175 -1.012 . . . . 15.0 112.146 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -122.59 135.8 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 113.521 -1.672 . . . . 15.0 108.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.424 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 9.2 p90 . . . . . 0 N--CA 1.476 0.867 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.778 172.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.031 0.444 . . . . 15.0 111.912 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.26 -27.32 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.008 -0.996 . . . . 15.0 112.814 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.497 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 4.7 t 32.84 70.93 0.72 Allowed Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 127.328 2.251 . . . . 15.0 114.533 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.07 95.04 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.678 2.919 . . . . 15.0 114.26 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 70.2 t -123.96 134.37 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.508 -1.223 . . . . 15.0 109.981 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.91 123.35 40.76 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.245 -1.798 . . . . 15.0 109.626 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -120.99 136.75 54.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.232 0.613 . . . . 15.0 110.878 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.67 135.3 7.86 Favored Glycine 0 N--CA 1.478 1.453 0 CA-C-N 115.452 -0.794 . . . . 15.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.47 -146.84 8.19 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 124.362 0.683 . . . . 15.0 113.605 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.76 154.28 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.159 -1.021 . . . . 15.0 113.43 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -119.57 143.64 47.52 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.902 -1.499 . . . . 15.0 110.403 167.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.525 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 46.0 m-85 -117.0 139.1 51.08 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.527 1.142 . . . . 15.0 111.892 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.95 104.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.266 -1.334 . . . . 15.0 111.275 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . 0.265 18.1 tt -79.95 84.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 123.076 1.417 . . . . 15.0 112.97 -175.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -115.68 102.54 9.84 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.677 -2.056 . . . . 15.0 109.5 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.401 ' HB3' ' H ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -170.77 -83.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.617 -1.629 . . . . 15.0 106.804 176.534 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.401 ' H ' ' HB3' ' A' ' 118' ' ' ARG . 35.6 mtt180 -69.17 155.81 39.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.392 0.677 . . . . 15.0 111.572 166.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.62 97.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 114.359 -1.291 . . . . 15.0 113.534 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.2 p -110.0 135.94 20.46 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 113.83 -1.532 . . . . 15.0 111.642 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.92 73.31 4.31 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.788 2.325 . . . . 15.0 114.053 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 50.11 39.39 19.23 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.899 1.679 . . . . 15.0 114.636 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.463 HD11 ' HB ' ' A' ' 146' ' ' VAL . 3.9 tt -123.4 142.23 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.663 -1.153 . . . . 15.0 113.748 -164.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.89 157.82 29.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.017 -1.902 . . . . 15.0 110.338 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 32.7 p -106.41 132.23 52.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.296 -0.865 . . . . 15.0 111.046 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.59 HH21 ' HD3' ' A' ' 62' ' ' LYS . 19.4 ttm180 -112.85 130.53 56.06 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.824 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.62 111.03 8.5 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.9 1.375 . . . . 15.0 111.757 173.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.37 150.21 52.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.368 -1.287 . . . . 15.0 112.624 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 57.1 t80 -97.27 116.32 29.26 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.282 1.039 . . . . 15.0 108.376 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -96.59 108.75 21.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 111.971 -2.377 . . . . 15.0 110.251 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -112.03 146.51 37.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.92 -1.945 . . . . 15.0 112.296 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.48 1.056 0 CA-C-N 112.762 -2.017 . . . . 15.0 109.896 176.963 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.098 0 CA-C-O 121.987 0.771 . . . . 15.0 111.401 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -119.19 148.24 43.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.048 -1.576 . . . . 15.0 109.983 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.8 97.42 10.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.681 -1.229 . . . . 15.0 107.681 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.6 t -94.96 125.13 39.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.211 -1.359 . . . . 15.0 107.947 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.54 150.08 24.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.944 -1.934 . . . . 15.0 111.818 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.02 -162.6 29.64 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 114.094 -1.412 . . . . 15.0 113.707 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.463 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.0 m -119.38 127.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.449 -1.876 . . . . 15.0 110.64 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.481 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 23.1 t -130.01 132.1 46.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.857 -1.519 . . . . 15.0 110.507 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.56 154.99 34.61 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.643 0.735 . . . . 15.0 111.793 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -115.48 135.18 54.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.383 -1.281 . . . . 15.0 112.119 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 90.9 m-85 . . . . . 0 N--CA 1.482 1.164 0 CA-C-N 113.355 -1.748 . . . . 15.0 115.373 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 122.357 1.075 . . . . 15.0 113.003 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m -98.02 124.63 42.61 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.422 -1.717 . . . . 15.0 108.263 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 21.4 m0 -97.86 130.42 44.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.389 -1.278 . . . . 15.0 111.027 -177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.405 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 97.6 m-85 -122.51 86.05 2.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.935 -1.939 . . . . 15.0 108.41 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -108.82 123.6 49.3 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.103 -1.408 . . . . 15.0 110.058 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.83 -144.52 4.14 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 125.019 1.449 . . . . 15.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.68 148.07 47.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -130.91 140.17 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 125.007 1.442 . . . . 15.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.1 tp -114.13 133.53 55.5 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.031 -1.441 . . . . 15.0 108.763 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.65 112.49 3.96 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 113.535 -1.666 . . . . 15.0 110.138 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -121.82 145.48 48.03 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.788 0.835 . . . . 15.0 110.833 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -130.32 145.48 51.78 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.308 -0.86 . . . . 15.0 111.259 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -79.94 79.34 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.055 0.931 . . . . 15.0 109.151 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -147.17 -82.36 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 112.846 -1.979 . . . . 15.0 111.281 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -116.18 136.84 52.65 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.402 0.681 . . . . 15.0 110.575 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.5 ptt-85 -65.77 -20.88 66.43 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.306 -1.315 . . . . 15.0 114.0 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -117.54 95.94 5.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.161 0.984 . . . . 15.0 109.683 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -173.69 -69.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.462 1.505 . . . . 15.0 111.048 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 54.8 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.652 1.581 . . . . 15.0 114.726 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.04 -37.54 80.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.477 -1.692 . . . . 15.0 114.556 -173.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.07 87.1 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 N-CA-C 118.0 1.96 . . . . 15.0 118.0 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.17 89.6 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.661 1.356 . . . . 15.0 114.661 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.43 -118.67 6.12 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.936 0.779 . . . . 15.0 111.9 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.42 137.99 39.94 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.306 -0.947 . . . . 15.0 110.112 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -117.6 113.66 22.26 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.643 -1.162 . . . . 15.0 111.143 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.3 101.42 1.04 Allowed Glycine 0 N--CA 1.476 1.342 0 CA-C-N 113.429 -1.714 . . . . 15.0 110.91 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.68 135.24 12.6 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 114.428 -0.886 . . . . 15.0 113.156 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -129.22 111.33 12.78 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.79 -1.205 . . . . 15.0 110.972 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.04 83.28 1.88 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.235 -0.893 . . . . 15.0 108.891 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.26 -83.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.552 -1.658 . . . . 15.0 110.456 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -81.22 135.44 50.76 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 117.535 -1.221 . . . . 15.0 109.407 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.26 78.93 0.81 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.436 2.758 . . . . 15.0 112.08 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -177.05 -76.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.005 2.122 . . . . 15.0 108.955 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.35 135.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.123 0.969 . . . . 15.0 108.466 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.34 -168.13 12.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 113.91 -1.496 . . . . 15.0 110.794 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.74 148.23 52.56 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.788 1.032 . . . . 15.0 113.788 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HG2' ' HD3' ' A' ' 62' ' ' LYS . 70.9 mm-40 -127.26 127.21 44.02 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.239 -1.346 . . . . 15.0 110.644 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 90.9 mtp -116.64 134.45 54.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.158 -1.383 . . . . 15.0 110.608 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -115.72 114.17 3.06 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.215 -1.554 . . . . 15.0 109.215 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -116.57 122.32 44.32 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.871 0.843 . . . . 15.0 111.561 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -137.78 142.61 40.89 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.485 -1.689 . . . . 15.0 111.397 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -165.03 129.46 2.47 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.74 0.645 . . . . 15.0 112.74 173.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 CA-C-N 112.344 -2.207 . . . . 15.0 113.862 165.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 123.648 1.69 . . . . 15.0 110.014 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -126.74 146.64 50.15 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.028 -1.896 . . . . 15.0 109.909 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.04 17.26 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 124.285 0.991 . . . . 15.0 113.978 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 82' ' ' MET . 12.7 p -147.29 148.26 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 112.978 -1.611 . . . . 15.0 111.239 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -121.27 126.22 49.01 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.536 1.934 . . . . 15.0 109.374 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.585 ' H ' ' HB2' ' A' ' 82' ' ' MET . 3.5 tm? -117.34 111.19 19.02 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.934 -0.395 . . . . 15.0 109.934 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 41' ' ' GLU . 13.7 t -131.9 146.32 52.04 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.42 -0.809 . . . . 15.0 112.829 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -103.13 136.39 43.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.039 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 59.6 pttt -115.83 143.56 45.23 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.914 1.45 . . . . 15.0 114.914 -171.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.4 mt -115.5 136.41 53.11 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.925 -1.943 . . . . 15.0 110.058 169.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.42 111.92 4.2 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 124.744 1.277 . . . . 15.0 111.529 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 4.1 m-30 -110.69 105.0 56.89 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.933 1.293 . . . . 15.0 111.713 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.58 -145.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.052 2.502 . . . . 15.0 111.584 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 69.03 -68.97 0.17 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 127.487 2.315 . . . . 15.0 115.181 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 75' ' ' ILE . 28.4 tp -60.91 99.7 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.439 1.096 . . . . 15.0 113.596 -168.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.92 -85.74 0.44 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.827 -1.988 . . . . 15.0 109.461 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 t -179.1 171.36 1.36 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.406 1.482 . . . . 15.0 110.083 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -51.54 -31.09 22.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.669 1.729 . . . . 15.0 115.669 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.05 -29.41 63.4 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.338 1.236 . . . . 15.0 114.338 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.46 112.99 18.17 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.098 0.959 . . . . 15.0 111.423 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.54 134.26 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.08 -1.418 . . . . 15.0 109.721 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.495 HD11 ' HB3' ' A' ' 68' ' ' LEU . 4.5 mp -91.34 141.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.509 -1.678 . . . . 15.0 107.388 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -126.6 128.79 47.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.793 -1.094 . . . . 15.0 109.763 173.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.2 p -108.4 122.57 47.28 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.378 -1.283 . . . . 15.0 108.397 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.541 HH22 ' NE ' ' A' ' 127' ' ' ARG . 99.2 mtt180 -125.19 123.22 39.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.508 -2.133 . . . . 15.0 111.534 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.44 132.09 52.77 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.908 -1.042 . . . . 15.0 112.449 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.34 -140.18 5.77 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.967 -1.015 . . . . 15.0 113.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.01 140.87 3.0 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.187 1.375 . . . . 15.0 111.8 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.603 ' HB3' ' O ' ' A' ' 57' ' ' VAL 0.364 0.4 OUTLIER -156.91 164.33 38.16 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.515 -2.168 . . . . 15.0 112.659 159.424 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 103' ' ' SER . 18.8 m -97.99 125.97 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.234 0.959 . . . . 15.0 110.18 -172.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.9 p90 . . . . . 0 N--CA 1.476 0.826 0 CA-C-N 115.484 -0.78 . . . . 15.0 112.858 -176.717 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.435 ' HB3' HG12 ' A' ' 83' ' ' VAL . 17.1 t . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.596 0.712 . . . . 15.0 112.142 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.49 167.9 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 113.988 -1.46 . . . . 15.0 111.264 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m 68.14 148.53 0.12 Allowed Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 125.918 1.687 . . . . 15.0 114.368 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -61.19 142.05 95.37 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.651 2.234 . . . . 15.0 113.102 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.87 136.72 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 112.838 -1.983 . . . . 15.0 107.216 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.55 129.66 54.78 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.408 -1.724 . . . . 15.0 110.13 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -122.65 131.54 53.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.102 -1.408 . . . . 15.0 112.061 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.38 99.04 0.92 Allowed Glycine 0 N--CA 1.475 1.278 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.786 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -115.5 145.52 18.7 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 124.79 0.936 . . . . 15.0 112.85 -174.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 127' ' ' ARG . 19.2 m -121.59 138.46 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.716 -0.742 . . . . 15.0 112.042 171.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.28 109.34 19.76 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.077 -1.874 . . . . 15.0 107.94 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -120.59 136.08 54.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.716 -1.584 . . . . 15.0 111.64 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.39 107.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.46 -1.7 . . . . 15.0 110.689 171.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.9 tp -113.22 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 122.837 1.303 . . . . 15.0 111.648 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.664 ' HD3' HG21 ' A' ' 121' ' ' THR . 47.9 mtt-85 -122.23 -30.79 3.95 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.791 2.515 . . . . 15.0 117.791 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.27 -28.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 118.456 2.762 . . . . 15.0 118.456 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 47.7 mtt-85 -101.09 149.71 23.68 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.393 1.077 . . . . 15.0 112.244 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.43 ' H ' HG13 ' A' ' 120' ' ' ILE . 16.9 mt -11.78 -81.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 128.311 2.644 . . . . 15.0 113.735 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.664 HG21 ' HD3' ' A' ' 117' ' ' ARG . 67.8 p 58.49 159.61 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 126.233 1.813 . . . . 15.0 115.489 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.64 161.87 33.79 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.655 2.236 . . . . 15.0 111.415 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -68.46 78.21 0.27 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.215 1.006 . . . . 15.0 112.191 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mm -120.94 105.35 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.595 1.158 . . . . 15.0 109.486 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.3 120.49 40.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.571 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -80.78 117.01 21.07 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.921 -1.036 . . . . 15.0 109.359 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.541 ' NE ' HH22 ' A' ' 78' ' ' ARG . 33.6 mtt180 -115.21 119.91 37.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.626 -1.17 . . . . 15.0 112.721 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.48 118.04 28.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.054 -1.43 . . . . 15.0 110.39 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 31.3 tt0 -120.65 132.98 55.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 112.727 -2.033 . . . . 15.0 111.285 -171.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 76.3 m-85 -97.4 128.22 44.02 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.302 -1.317 . . . . 15.0 110.336 171.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.717 ' HB3' ' HB2' ' A' ' 141' ' ' MET . 48.1 tt0 -109.85 108.76 19.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.432 -1.713 . . . . 15.0 109.108 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -117.93 146.58 43.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.599 -2.091 . . . . 15.0 112.066 -174.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.48 1.034 0 CA-C-N 114.138 -1.392 . . . . 15.0 111.791 174.565 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 CA-C-O 122.033 0.796 . . . . 15.0 113.174 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.717 ' HB2' ' HB3' ' A' ' 131' ' ' GLN . 48.1 mtt -117.6 148.26 42.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.716 -1.242 . . . . 15.0 110.925 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.03 112.32 18.11 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.98 -1.009 . . . . 15.0 110.055 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.1 m -105.86 125.09 50.58 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.69 -1.595 . . . . 15.0 107.348 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 pp -132.65 141.1 48.47 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.84 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.13 -162.46 29.35 Favored Glycine 0 N--CA 1.473 1.121 0 O-C-N 124.191 0.932 . . . . 15.0 113.509 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.07 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.606 -1.297 . . . . 15.0 109.442 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 62.5 p -115.85 138.25 51.34 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.89 1.369 . . . . 15.0 110.731 170.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -111.51 135.22 52.38 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.009 -1.45 . . . . 15.0 110.768 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 45.8 ttm180 -78.86 123.93 27.72 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.544 -1.207 . . . . 15.0 108.562 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 7' ' ' TRP . 88.7 t80 . . . . . 0 N--CA 1.483 1.189 0 O-C-N 125.347 1.654 . . . . 15.0 115.377 -173.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 122.092 0.948 . . . . 15.0 113.501 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 p -98.19 140.07 33.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.785 -1.098 . . . . 15.0 112.907 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -110.35 131.08 55.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.766 -2.015 . . . . 15.0 110.184 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.47 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 5.5 m-85 -124.1 131.28 53.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.617 -1.629 . . . . 15.0 108.978 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -126.96 133.43 50.6 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.496 0.718 . . . . 15.0 111.623 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -172.94 -146.23 5.34 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-N 115.191 -0.913 . . . . 15.0 113.191 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.42 150.1 51.79 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.423 0.898 . . . . 15.0 113.423 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.32 142.91 50.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.454 1.096 . . . . 15.0 112.727 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.6 tp -114.05 140.4 48.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.199 -1.819 . . . . 15.0 108.8 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.4 127.41 7.73 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.153 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 10.2 t-105 -118.33 141.15 48.82 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.463 -0.868 . . . . 15.0 110.948 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 t -108.73 105.2 14.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.528 -1.214 . . . . 15.0 109.818 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -52.79 -44.11 66.35 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.975 -1.466 . . . . 15.0 111.753 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -65.66 -49.15 69.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.111 0.964 . . . . 15.0 113.297 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -103.2 83.65 2.23 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.747 1.26 . . . . 15.0 112.045 -172.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HG2' ' HG3' ' A' ' 21' ' ' GLU . 53.8 ttt85 -5.98 -81.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.04 2.936 . . . . 15.0 117.614 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 40.6 mt-10 -125.4 92.01 3.53 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.89 0.852 . . . . 15.0 111.802 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -114.18 91.63 3.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.457 -1.247 . . . . 15.0 112.918 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.7 87.94 1.27 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.911 -1.495 . . . . 15.0 111.573 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -106.37 -41.41 5.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.993 -1.912 . . . . 15.0 112.848 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.62 -151.4 18.42 Favored Glycine 0 N--CA 1.476 1.308 0 O-C-N 123.905 0.753 . . . . 15.0 112.1 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.33 148.49 50.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.755 -1.223 . . . . 15.0 111.299 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.54 -166.64 16.29 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.776 1.297 . . . . 15.0 110.556 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.01 49.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.501 0.667 . . . . 15.0 111.44 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.01 113.37 19.48 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.722 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.72 112.0 3.95 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 112.732 -2.031 . . . . 15.0 110.198 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.84 142.88 15.95 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 110.702 -0.959 . . . . 15.0 110.702 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 11.4 t80 -141.11 132.67 27.04 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.104 -0.548 . . . . 15.0 111.124 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -121.41 94.1 4.22 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.966 0.888 . . . . 15.0 110.617 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.31 -63.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.483 -2.144 . . . . 15.0 111.688 174.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -143.82 144.85 28.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.43 1.492 . . . . 15.0 109.618 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.98 89.5 0.37 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.488 2.792 . . . . 15.0 111.768 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 t80 172.7 -48.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.51 -2.132 . . . . 15.0 109.058 -169.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 48.3 t -131.52 124.02 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.154 0.982 . . . . 15.0 108.83 175.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.37 148.23 16.72 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.924 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 78.5 m-85 -112.78 136.66 52.15 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.1 0.778 . . . . 15.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.54 114.21 14.0 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.843 -1.526 . . . . 15.0 112.034 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.4 ttp -104.08 128.66 51.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.686 -1.597 . . . . 15.0 109.062 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.25 114.16 3.9 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 113.88 -1.509 . . . . 15.0 109.751 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.66 109.44 18.6 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.407 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -121.2 124.08 43.81 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.559 -1.2 . . . . 15.0 111.361 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -125.11 145.18 50.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.753 -1.567 . . . . 15.0 109.783 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.1 tp . . . . . 0 N--CA 1.476 0.849 0 CA-C-N 115.775 -0.648 . . . . 15.0 112.359 179.376 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 122.493 1.139 . . . . 15.0 113.316 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 pm0 -115.34 154.83 28.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.438 -1.256 . . . . 15.0 112.309 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.47 118.41 4.37 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 114.578 -1.192 . . . . 15.0 111.114 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.65 127.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 122.193 0.997 . . . . 15.0 111.687 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 82' ' ' MET . 0.3 OUTLIER -116.54 140.79 48.99 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.114 -1.403 . . . . 15.0 112.035 174.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.21 111.14 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.185 -1.825 . . . . 15.0 109.011 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -124.65 134.74 52.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.146 0.975 . . . . 15.0 112.621 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.16 46.09 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.836 -1.529 . . . . 15.0 110.79 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 1.8 ttpm? -84.18 129.15 34.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.301 -1.772 . . . . 15.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.675 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 41.7 tp -108.95 114.58 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.505 -2.134 . . . . 15.0 107.691 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 76' ' ' TYR . . . 127.94 -147.38 17.24 Favored Glycine 0 CA--C 1.541 1.692 0 O-C-N 126.346 2.279 . . . . 15.0 113.941 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 43.3 t80 160.81 -60.5 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 116.546 -1.692 . . . . 15.0 112.821 -160.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -79.15 -147.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.447 2.764 . . . . 15.0 112.788 -167.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 53.98 84.76 0.06 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.291 1.836 . . . . 15.0 110.053 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp 69.36 -26.13 0.15 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.245 1.418 . . . . 15.0 114.54 -165.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.83 64.22 0.19 Allowed Glycine 0 N--CA 1.483 1.786 0 C-N-CA 124.949 1.261 . . . . 15.0 114.312 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.89 37.77 3.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.038 1.335 . . . . 15.0 109.458 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -167.52 -63.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.386 1.074 . . . . 15.0 112.475 -172.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 114' ' ' TYR . 4.7 m-20 -56.62 -49.46 74.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.524 0.935 . . . . 15.0 113.524 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER 141.82 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 130.372 3.469 . . . . 15.0 107.385 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.528 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 7.7 m-20 -113.34 105.35 13.29 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.924 -0.485 . . . . 15.0 110.307 -174.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.616 ' HB ' HG12 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -119.85 111.0 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.656 -1.239 . . . . 15.0 107.656 176.014 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.675 ' HB3' ' O ' ' A' ' 63' ' ' LEU 0.437 0.2 OUTLIER -169.01 -171.74 1.4 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 111.384 -2.644 . . . . 15.0 114.773 -177.474 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.9 t -108.12 139.48 42.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.223 1.011 . . . . 15.0 110.585 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HG3' ' HB3' ' A' ' 109' ' ' ALA . 9.8 ptp180 -118.95 139.69 51.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.033 -1.894 . . . . 15.0 114.147 -170.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 108' ' ' PHE . 2.7 pp -125.19 143.48 50.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 112.07 -2.332 . . . . 15.0 111.015 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.42 -154.45 11.75 Favored Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.33 1.019 . . . . 15.0 114.671 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.12 151.52 21.83 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 113.567 -1.316 . . . . 15.0 114.059 -173.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 58' ' ' GLN . 90.1 mtp -116.54 115.41 25.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.588 1.555 . . . . 15.0 110.361 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.18 132.59 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 114.943 -1.026 . . . . 15.0 108.905 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 . . . . . 0 N--CA 1.475 0.786 0 CA-C-N 114.79 -1.095 . . . . 15.0 110.041 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 121.871 0.843 . . . . 15.0 113.057 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -59.4 -32.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 15.0 113.263 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.81 84.62 0.19 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 127.265 2.226 . . . . 15.0 112.595 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -63.33 133.87 42.44 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.685 2.257 . . . . 15.0 112.747 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.33 138.02 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.422 -1.717 . . . . 15.0 109.695 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -122.88 129.86 52.15 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.636 -1.165 . . . . 15.0 111.817 175.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.565 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -133.7 147.32 51.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.281 -1.327 . . . . 15.0 111.149 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 138.64 10.75 Favored Glycine 0 N--CA 1.48 1.619 0 CA-C-O 119.011 -0.883 . . . . 15.0 111.221 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.14 -158.08 25.42 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 118.208 2.043 . . . . 15.0 118.208 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' HB ' ' A' ' 75' ' ' ILE . 33.0 m -120.67 130.66 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 111.911 -2.144 . . . . 15.0 111.556 -171.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.87 125.4 48.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.184 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 60.0 t80 -108.48 139.19 43.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 111.9 -2.409 . . . . 15.0 108.633 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 11.8 p -129.11 145.61 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 113.908 -1.496 . . . . 15.0 107.833 168.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 0.3 OUTLIER -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 124.483 1.114 . . . . 15.0 113.152 -177.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -80.64 -89.14 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.465 -2.152 . . . . 15.0 109.364 175.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 108.98 8.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.222 0.609 . . . . 15.0 109.81 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -167.71 164.55 14.4 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.568 -1.197 . . . . 15.0 111.37 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.1 mt -53.08 131.49 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.511 1.524 . . . . 15.0 109.95 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.6 m 55.83 79.84 0.32 Allowed Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 125.58 1.552 . . . . 15.0 109.68 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.46 80.36 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.633 2.888 . . . . 15.0 113.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 14.2 pt-20 -162.36 22.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.802 1.779 . . . . 15.0 115.802 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.524 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 20.4 mt -116.7 108.15 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.92 -0.487 . . . . 15.0 110.542 -169.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -110.68 143.13 41.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.024 -0.989 . . . . 15.0 111.031 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.8 m -139.63 116.93 11.24 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.254 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.24 137.61 52.08 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.832 -1.076 . . . . 15.0 112.78 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.34 120.02 16.17 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.774 -1.103 . . . . 15.0 112.089 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -137.29 142.33 41.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 112.547 -2.115 . . . . 15.0 112.879 -174.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 79.2 m-85 -97.43 112.57 24.35 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.218 -1.355 . . . . 15.0 110.053 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -108.04 130.86 55.05 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.887 1.367 . . . . 15.0 113.695 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.429 ' HZ3' ' HB3' ' A' ' 130' ' ' TYR . 1.3 m-90 -120.51 120.37 35.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.492 -1.685 . . . . 15.0 112.289 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.483 1.183 0 CA-C-N 113.594 -1.639 . . . . 15.0 111.372 164.148 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 112.042 -0.423 . . . . 15.0 112.042 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 9.6 ttt -126.15 148.18 49.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.919 0.888 . . . . 15.0 111.904 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 6.4 tt -88.38 126.75 35.36 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.192 -1.41 . . . . 15.0 107.192 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.2 t -120.4 125.35 47.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.774 0.797 . . . . 15.0 111.163 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.1 tp -121.19 126.87 50.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.705 -1.589 . . . . 15.0 109.332 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.38 138.17 10.33 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 114.482 -1.235 . . . . 15.0 112.813 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.1 m -125.55 127.61 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 113.91 -1.145 . . . . 15.0 110.651 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.409 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 14.5 p -134.6 155.81 49.81 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.742 1.386 . . . . 15.0 114.742 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.69 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 12.1 m-85 -114.1 139.32 49.4 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.228 -1.806 . . . . 15.0 111.24 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -70.25 157.41 37.73 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.198 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.1 t80 . . . . . 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.003 . . . . 15.0 111.565 174.823 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 116.865 2.172 . . . . 15.0 116.865 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 149' ' ' ARG . 69.1 Cg_endo -78.51 31.78 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.028 1.818 . . . . 15.0 114.611 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -132.32 146.96 52.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.116 0.966 . . . . 15.0 109.735 -173.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 28.1 m-20 72.21 99.2 0.07 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.94 1.696 . . . . 15.0 113.78 175.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.607 ' H ' ' HA ' ' A' ' 34' ' ' VAL . 33.7 m-80 59.67 48.31 9.54 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 112.799 -2.0 . . . . 15.0 111.614 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.9 p -116.31 158.79 22.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.584 -1.644 . . . . 15.0 111.801 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.951 ' HB3' ' HA ' ' A' ' 150' ' ' PHE . 1.8 t90 -94.23 140.45 29.76 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.287 1.041 . . . . 15.0 111.76 -172.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -115.28 105.86 13.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.068 1.747 . . . . 15.0 109.234 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 m -124.33 118.2 26.21 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.6 161.81 28.58 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 115.151 0.82 . . . . 15.0 115.151 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.71 50.88 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.39 -0.905 . . . . 15.0 110.516 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -151.66 150.77 30.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.177 1.177 . . . . 15.0 114.177 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.69 133.46 55.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.287 -1.324 . . . . 15.0 112.66 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -124.6 151.09 17.2 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.307 -1.769 . . . . 15.0 114.984 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -126.06 140.76 52.33 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.515 -1.342 . . . . 15.0 111.557 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.7 p -113.2 144.33 42.86 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.18 1.467 . . . . 15.0 114.51 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -54.54 120.51 6.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.782 -2.008 . . . . 15.0 111.025 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.6 t80 58.86 41.63 21.07 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.228 -1.351 . . . . 15.0 113.727 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -67.18 80.56 0.13 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.34 1.067 . . . . 15.0 113.69 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -61.69 -37.29 83.57 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.194 -1.367 . . . . 15.0 114.112 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -82.72 141.96 32.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.133 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -70.28 87.09 0.6 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.303 1.002 . . . . 15.0 110.573 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -143.15 129.49 19.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.984 -1.916 . . . . 15.0 108.991 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.13 132.59 56.0 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.054 -1.43 . . . . 15.0 108.125 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.65 46.47 1.11 Allowed Glycine 0 N--CA 1.48 1.584 0 C-N-CA 125.099 1.333 . . . . 15.0 115.095 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.71 92.99 1.6 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.734 1.214 . . . . 15.0 109.192 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.33 139.57 14.29 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.189 -1.823 . . . . 15.0 112.903 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 121.2 41.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.725 -1.737 . . . . 15.0 106.928 171.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' MET . 21.4 m-85 -111.86 113.42 25.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.916 -1.493 . . . . 15.0 110.734 -173.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.99 146.51 16.15 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 112.453 -2.158 . . . . 15.0 110.243 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.27 -154.5 20.51 Favored Glycine 0 N--CA 1.473 1.165 0 CA-C-N 114.546 -0.827 . . . . 15.0 112.837 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 141.83 34.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 113.257 -1.471 . . . . 15.0 112.807 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -117.0 98.14 6.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.654 1.216 . . . . 15.0 110.772 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.607 ' HA ' ' H ' ' A' ' 5' ' ' ASN . 14.6 m -79.74 -38.68 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 112.934 -1.939 . . . . 15.0 115.636 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -139.96 154.22 70.31 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 118.696 -0.669 . . . . 15.0 112.745 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.44 66.64 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 15.0 110.485 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.43 -79.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.792 2.037 . . . . 15.0 108.488 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.58 145.22 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.145 1.165 . . . . 15.0 114.145 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.36 -179.98 25.67 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 112.61 -2.086 . . . . 15.0 110.721 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.82 133.64 55.31 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.142 -0.529 . . . . 15.0 112.414 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 26.7 tt0 -129.49 128.83 43.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.339 -1.301 . . . . 15.0 110.673 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 67.1 mtm -123.21 139.33 54.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.381 -0.827 . . . . 15.0 110.586 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.04 114.17 2.44 Favored Glycine 0 N--CA 1.476 1.322 0 O-C-N 124.61 1.194 . . . . 15.0 111.778 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 46' ' ' TRP . 72.5 t80 -107.02 109.52 21.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.465 1.106 . . . . 15.0 111.235 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -113.7 118.45 34.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.49 -1.232 . . . . 15.0 108.768 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.477 ' HB2' ' CE2' ' A' ' 44' ' ' TYR . 24.0 t90 -114.84 119.16 35.65 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.984 -1.007 . . . . 15.0 110.84 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 18.7 tp -81.69 75.2 8.65 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.556 -1.202 . . . . 15.0 110.983 177.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.96 55.86 2.23 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-N 113.72 -1.582 . . . . 15.0 112.121 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.07 -70.61 0.68 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.201 1.4 . . . . 15.0 108.554 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.8 mmt -63.88 147.66 95.89 Favored Pre-proline 0 N--CA 1.477 0.914 0 CA-C-O 118.163 -0.922 . . . . 15.0 111.334 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -70.27 30.54 0.2 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.589 2.859 . . . . 15.0 115.95 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -132.64 139.25 47.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.296 1.439 . . . . 15.0 107.919 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.441 ' HA ' ' HE1' ' A' ' 46' ' ' TRP . 63.4 mttp -75.57 76.26 2.59 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.888 1.328 . . . . 15.0 112.734 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . . . -76.22 83.38 3.02 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.994 -1.457 . . . . 15.0 110.744 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -93.95 103.14 15.24 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.389 -2.187 . . . . 15.0 110.292 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.03 2.34 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 108.892 -1.683 . . . . 15.0 108.892 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 t -117.83 133.15 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 114.467 -0.867 . . . . 15.0 109.735 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 9.8 pt20 -109.7 139.52 44.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.486 -1.234 . . . . 15.0 111.487 170.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.32 111.05 17.28 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.489 -1.687 . . . . 15.0 108.893 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.416 HG21 ' CZ ' ' A' ' 78' ' ' ARG . 39.9 p -131.29 146.74 52.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.003 -1.453 . . . . 15.0 113.301 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -100.37 128.37 46.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.018 -1.446 . . . . 15.0 108.146 172.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.43 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.1 pttm -113.5 136.53 52.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.62 -1.173 . . . . 15.0 112.857 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 3.2 tt -105.98 108.41 19.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.532 -1.667 . . . . 15.0 108.226 172.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.88 98.12 2.11 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.011 -1.904 . . . . 15.0 109.363 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -117.21 138.22 24.7 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.975 -1.112 . . . . 15.0 111.761 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HA ' ' OD2' ' A' ' 74' ' ' ASP . 58.4 Cg_endo -64.22 -37.7 39.67 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.252 2.635 . . . . 15.0 115.814 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 tptt 49.92 32.06 5.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.838 1.655 . . . . 15.0 114.762 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.45 47.87 23.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.978 1.311 . . . . 15.0 114.138 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 73' ' ' LEU . . . -63.46 84.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.651 0 C-N-CA 124.257 0.932 . . . . 15.0 112.26 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -67.88 28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.938 2.94 . . . . 15.0 118.938 -165.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -169.82 -68.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.881 2.072 . . . . 15.0 107.775 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -170.05 87.48 0.14 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.009 1.324 . . . . 15.0 108.47 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.407 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 19.6 tp -159.35 141.09 13.27 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.334 171.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD2' ' HA ' ' A' ' 66' ' ' PRO . 10.7 m-20 -138.1 150.45 46.88 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.277 -1.328 . . . . 15.0 110.923 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 tt -108.68 140.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.394 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 51.5 p90 -125.71 128.73 48.24 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.548 -1.205 . . . . 15.0 109.33 169.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.4 m -113.66 122.54 47.47 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.46 -1.311 . . . . 15.0 107.46 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -120.67 123.29 42.39 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.057 -1.429 . . . . 15.0 113.108 -175.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 136.78 54.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.995 -1.457 . . . . 15.0 110.941 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.39 -143.21 7.47 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.448 1.092 . . . . 15.0 113.272 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 105' ' ' SER . . . -130.25 143.9 15.18 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 114.047 -1.077 . . . . 15.0 114.066 -174.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 25.5 ptt? -116.11 120.15 38.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.165 0.983 . . . . 15.0 112.93 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.67 140.82 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 113.359 -1.746 . . . . 15.0 108.493 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -113.84 140.37 48.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.83 -1.077 . . . . 15.0 108.614 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.72 ' HD3' ' HB ' ' A' ' 88' ' ' THR . 88.9 mtt180 68.24 -36.01 0.3 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 117.164 2.283 . . . . 15.0 117.164 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 70.7 -54.06 0.65 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 128.289 2.635 . . . . 15.0 113.388 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 7.7 t70 -149.81 105.68 3.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.917 0.887 . . . . 15.0 109.532 172.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.72 ' HB ' ' HD3' ' A' ' 85' ' ' ARG . 10.1 t -79.99 157.65 26.76 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.877 -1.056 . . . . 15.0 112.948 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 t -116.37 151.79 35.23 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.771 -1.104 . . . . 15.0 111.278 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -169.84 -39.58 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 113.65 -1.614 . . . . 15.0 112.803 -171.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.9 tttm 56.61 88.28 0.05 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.011 1.724 . . . . 15.0 112.95 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.72 76.64 4.25 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.928 -1.487 . . . . 15.0 111.598 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.7 -89.72 0.19 Allowed Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.346 -1.297 . . . . 15.0 112.443 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -178.57 157.94 1.02 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.127 2.171 . . . . 15.0 110.544 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.96 -141.45 14.89 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.991 -1.004 . . . . 15.0 111.443 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -109.12 91.22 3.55 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.283 1.039 . . . . 15.0 111.64 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.7 130.41 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 113.1 -1.864 . . . . 15.0 107.647 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 t -64.68 150.69 46.69 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.134 -0.939 . . . . 15.0 111.913 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.62 130.23 42.57 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.837 -1.074 . . . . 15.0 111.613 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 87' ' ' ASP . . . -77.81 64.23 3.02 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.241 1.496 . . . . 15.0 113.198 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -76.16 124.42 27.41 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.106 -1.861 . . . . 15.0 111.464 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.09 149.61 30.57 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 113.984 -1.462 . . . . 15.0 111.086 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.9 p -91.12 144.8 25.25 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.973 1.471 . . . . 15.0 114.973 -170.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -71.46 137.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 113.398 -1.728 . . . . 15.0 111.461 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 78.8 p -120.09 117.94 31.79 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.372 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.6 101.78 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.096 2.531 . . . . 15.0 112.278 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.4 m -125.02 130.87 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.19 -1.823 . . . . 15.0 113.112 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -127.96 131.36 49.29 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 113.749 -1.569 . . . . 15.0 111.114 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 131' ' ' GLN . . . -128.77 143.73 50.99 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.722 1.008 . . . . 15.0 113.722 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.56 108.63 2.12 Favored Glycine 0 N--CA 1.474 1.217 0 CA-C-N 112.932 -1.94 . . . . 15.0 108.732 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -119.5 144.11 17.42 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.723 -0.739 . . . . 15.0 112.955 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.49 137.17 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 114.539 -0.831 . . . . 15.0 111.633 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -125.4 139.33 53.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.241 -1.799 . . . . 15.0 113.757 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -117.87 141.81 48.02 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 112.694 -2.048 . . . . 15.0 109.255 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.7 m -105.69 132.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.158 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 pt -62.2 95.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.104 1.89 . . . . 15.0 116.104 -171.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -78.6 82.9 4.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.503 1.144 . . . . 15.0 109.58 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.3 ttt-85 -175.38 -143.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.393 2.277 . . . . 15.0 107.366 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.34 99.85 0.15 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.829 1.252 . . . . 15.0 112.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.6 mt 64.63 85.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.715 2.006 . . . . 15.0 111.401 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 m -59.86 -45.78 98.28 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 117.188 -1.386 . . . . 15.0 114.076 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.89 70.75 6.89 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.938 1.759 . . . . 15.0 111.531 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 36.1 tt0 -138.74 -83.84 0.28 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.188 -1.823 . . . . 15.0 108.834 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.74 143.51 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.663 0.986 . . . . 15.0 113.663 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.42 123.53 48.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.611 -2.086 . . . . 15.0 109.406 172.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.455 ' HA ' HG12 ' A' ' 146' ' ' VAL . 11.9 m -80.83 116.87 21.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.423 -1.695 . . . . 15.0 106.423 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -125.49 135.44 52.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.104 -1.407 . . . . 15.0 113.749 -172.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.98 111.07 13.14 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.648 -2.069 . . . . 15.0 110.327 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.518 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 21.9 tt0 -114.67 135.24 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.984 -1.916 . . . . 15.0 110.156 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -115.31 107.17 14.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.69 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 0.1 OUTLIER -96.62 114.76 26.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 112.581 -2.099 . . . . 15.0 109.73 -170.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -118.77 146.57 44.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.326 1.232 . . . . 15.0 114.326 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.7 t -124.46 150.76 45.35 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.268 -1.787 . . . . 15.0 112.363 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.523 ' CG ' ' H ' ' A' ' 135' ' ' ASN . 13.2 t-20 54.41 -162.84 0.13 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.752 2.021 . . . . 15.0 112.99 -173.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.523 ' H ' ' CG ' ' A' ' 134' ' ' ASN . 5.7 t-20 -110.71 166.81 10.71 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.782 0.833 . . . . 15.0 110.746 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 54.64 -171.89 0.05 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.156 1.782 . . . . 15.0 112.127 -170.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.4 p -65.99 85.3 0.09 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.811 0.815 . . . . 15.0 110.624 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -102.31 -101.63 0.28 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.242 -1.799 . . . . 15.0 110.187 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -133.89 125.97 29.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.58 0.752 . . . . 15.0 110.419 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -118.33 143.21 17.5 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 125.592 1.807 . . . . 15.0 114.639 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.69 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 56.9 ttm -117.79 137.14 52.94 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.287 -1.456 . . . . 15.0 109.141 170.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.93 101.94 11.17 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.165 -1.38 . . . . 15.0 109.98 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.436 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 57.0 m -109.98 125.14 52.56 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.892 -1.504 . . . . 15.0 110.616 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.85 140.89 44.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.441 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.04 -162.57 29.59 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 114.801 -1.091 . . . . 15.0 113.585 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 126' ' ' THR . 15.1 m -128.4 139.72 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 113.846 -1.177 . . . . 15.0 112.547 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 p -115.16 134.25 55.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.527 -1.215 . . . . 15.0 112.217 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 41.9 t80 -103.53 135.09 45.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.331 -1.304 . . . . 15.0 109.195 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' A' ' 2' ' ' PRO . 19.2 mmt180 -73.69 124.97 27.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.178 -1.828 . . . . 15.0 112.033 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 7' ' ' TRP . 55.1 m-85 69.55 -77.61 0.05 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.504 1.922 . . . . 15.0 111.806 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.35 77.69 1.0 Allowed Glycine 0 N--CA 1.477 1.403 0 N-CA-C 110.64 -0.984 . . . . 15.0 110.64 -171.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -56.1 -41.92 75.99 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.077 1.351 . . . . 15.0 113.287 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.92 73.98 2.23 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 108.995 -1.642 . . . . 15.0 108.995 168.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.79 85.68 0.21 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.667 1.223 . . . . 15.0 112.828 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.88 99.14 0.6 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.643 -1.617 . . . . 15.0 112.827 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.324 0 CA-C-N 114.001 -1.454 . . . . 15.0 114.182 177.379 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 114.236 1.198 . . . . 15.0 114.236 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.34 62.56 6.95 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.32 2.68 . . . . 15.0 113.737 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.14 50.42 1.05 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.908 1.283 . . . . 15.0 112.756 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -164.58 45.69 0.1 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.141 -1.39 . . . . 15.0 112.205 -170.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -56.11 -54.23 47.52 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.091 -0.959 . . . . 15.0 111.308 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 150' ' ' PHE . 4.7 p -148.39 139.38 23.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.579 -1.191 . . . . 15.0 111.195 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -127.86 136.21 51.1 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.91 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -125.72 127.57 46.41 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.131 -1.395 . . . . 15.0 110.728 168.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -126.6 137.93 53.38 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.524 -1.217 . . . . 15.0 111.19 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.51 -149.93 9.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 124.275 0.984 . . . . 15.0 113.847 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -160.77 139.25 9.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.906 1.282 . . . . 15.0 111.185 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.342 18.2 tptt -171.91 169.59 5.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.518 1.527 . . . . 15.0 113.205 166.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.458 HD23 ' HG3' ' A' ' 12' ' ' LYS . 1.5 pt? -114.73 161.73 17.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.178 0.991 . . . . 15.0 113.199 -164.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -122.8 140.73 13.43 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.484 -1.234 . . . . 15.0 111.719 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -118.41 145.39 45.23 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.582 0.813 . . . . 15.0 110.858 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 p -93.85 126.13 38.86 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.708 ' HG3' ' HB2' ' A' ' 139' ' ' ASN . 9.1 mm100 -49.8 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.646 1.978 . . . . 15.0 114.703 -173.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 49.58 25.91 1.58 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 116.273 1.953 . . . . 15.0 116.273 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 t -110.03 -39.41 5.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.294 -1.321 . . . . 15.0 113.003 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 72.36 -30.98 0.22 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.958 1.703 . . . . 15.0 113.165 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -59.54 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.08 1.352 . . . . 15.0 113.238 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -168.12 129.4 1.39 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.892 -1.958 . . . . 15.0 110.127 164.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.0 31.94 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.64 -1.618 . . . . 15.0 113.056 167.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -165.51 142.29 5.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.787 1.403 . . . . 15.0 114.787 -170.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.16 -92.38 0.6 Allowed Glycine 0 N--CA 1.475 1.289 0 CA-C-N 113.777 -1.556 . . . . 15.0 112.782 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 158.14 6.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.762 1.225 . . . . 15.0 113.745 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 -124.79 1.52 Allowed Glycine 0 N--CA 1.477 1.399 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.882 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.47 121.61 42.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.61 -0.795 . . . . 15.0 110.698 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 147' ' ' SER . 35.6 p90 -125.23 146.49 49.5 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.921 1.822 . . . . 15.0 115.921 -168.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.24 104.29 1.24 Allowed Glycine 0 CA--C 1.535 1.282 0 CA-C-N 111.769 -2.468 . . . . 15.0 108.527 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.53 100.77 1.09 Allowed Glycine 0 N--CA 1.476 1.332 0 N-CA-C 110.117 -1.193 . . . . 15.0 110.117 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -114.57 145.09 42.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.321 0.581 . . . . 15.0 110.807 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.643 HE21 ' HE3' ' A' ' 62' ' ' LYS . 5.3 tt0 -120.84 136.17 54.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.957 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -104.56 -34.55 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 113.607 -1.633 . . . . 15.0 113.755 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -121.0 134.77 24.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 106.574 -1.639 . . . . 15.0 106.574 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.63 84.09 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.137 2.558 . . . . 15.0 111.288 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 158.82 -41.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 128.182 2.593 . . . . 15.0 111.195 -165.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.83 138.83 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.811 1.411 . . . . 15.0 114.811 -171.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 33' ' ' GLN . . . -162.11 -154.6 7.6 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 112.412 -2.176 . . . . 15.0 110.824 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -143.28 145.45 32.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.804 0.811 . . . . 15.0 111.862 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.408 ' OE1' ' HG2' ' A' ' 78' ' ' ARG . 9.9 pt-20 -128.23 129.78 46.94 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.353 -1.294 . . . . 15.0 113.053 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -120.61 114.35 21.59 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.983 -1.462 . . . . 15.0 110.655 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.65 114.06 3.97 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 124.607 1.192 . . . . 15.0 110.71 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -102.84 141.17 36.09 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.178 0.99 . . . . 15.0 111.278 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -137.22 130.25 30.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.872 -1.967 . . . . 15.0 112.367 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.618 ' CZ2' ' HA ' ' A' ' 49' ' ' ARG . 12.4 t90 -122.63 137.2 54.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.202 -1.817 . . . . 15.0 108.512 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp -118.87 75.92 1.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 122.697 1.237 . . . . 15.0 108.982 -173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.44 -165.95 35.17 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 113.107 -1.86 . . . . 15.0 111.015 -167.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.618 ' HA ' ' CZ2' ' A' ' 46' ' ' TRP . 100.0 mtt180 -57.72 -88.54 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.904 0.882 . . . . 15.0 113.275 -174.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.4 mtt -134.35 95.86 16.04 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 123.996 0.918 . . . . 15.0 108.757 166.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.22 -38.83 3.39 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.739 2.293 . . . . 15.0 114.269 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 174.21 -62.38 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 128.433 2.693 . . . . 15.0 108.346 -175.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 97.7 mttt -111.48 -112.39 0.33 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.369 -1.287 . . . . 15.0 110.814 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HA ' ' CE2' ' A' ' 84' ' ' TRP . . . 61.25 -142.0 0.49 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.651 1.58 . . . . 15.0 113.361 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 49.96 42.64 24.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.922 1.689 . . . . 15.0 113.964 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.561 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -116.29 165.28 12.25 Favored Glycine 0 N--CA 1.474 1.193 0 CA-C-N 113.699 -1.592 . . . . 15.0 114.329 -161.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.26 144.39 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 113.485 -1.357 . . . . 15.0 111.749 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -109.77 116.8 32.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.648 1.213 . . . . 15.0 109.421 162.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.9 pt? -121.47 120.3 34.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 113.074 -1.875 . . . . 15.0 111.383 -170.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.4 p -133.14 150.63 52.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.984 -1.462 . . . . 15.0 112.432 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.625 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -92.35 132.33 36.82 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.304 -1.316 . . . . 15.0 108.452 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HE3' HE21 ' A' ' 33' ' ' GLN . 35.4 ttpt -110.06 104.26 13.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.613 -1.63 . . . . 15.0 110.404 -166.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.7 tt -120.7 134.43 55.28 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.125 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.57 -151.23 11.64 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 115.604 -0.725 . . . . 15.0 113.635 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 75' ' ' ILE . 48.1 p90 -173.91 154.66 2.3 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.853 1.261 . . . . 15.0 113.044 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.6 Cg_endo -64.71 115.43 3.23 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.756 2.304 . . . . 15.0 110.989 169.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -66.2 127.54 32.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.818 -1.083 . . . . 15.0 109.584 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.3 tp 57.44 22.62 8.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.605 1.562 . . . . 15.0 113.397 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.69 20.19 61.46 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.039 1.304 . . . . 15.0 114.484 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -87.55 89.24 7.92 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.426 -1.324 . . . . 15.0 107.426 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.66 79.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 112.885 -1.962 . . . . 15.0 113.134 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -174.14 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 109.587 -3.46 . . . . 15.0 110.668 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.58 98.19 7.26 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.833 1.301 . . . . 15.0 111.711 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 22.6 p-10 -115.43 111.06 20.22 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.931 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.629 HG22 HG22 ' A' ' 112' ' ' VAL . 2.9 pp -79.05 148.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.896 -1.502 . . . . 15.0 110.925 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -146.36 143.23 28.95 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.783 1.302 . . . . 15.0 113.925 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -112.22 122.55 48.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.905 -1.952 . . . . 15.0 107.776 166.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 0.8 OUTLIER -115.05 123.23 48.49 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 112.923 -1.944 . . . . 15.0 109.62 -176.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.79 129.35 48.14 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.676 -1.602 . . . . 15.0 113.256 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.44 -103.98 0.2 Allowed Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.146 -1.182 . . . . 15.0 110.146 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.539 ' HA2' ' HB ' ' A' ' 107' ' ' VAL . . . 154.01 -152.15 23.78 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 124.641 0.848 . . . . 15.0 115.017 173.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 33.9 ttm -119.92 139.3 52.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.491 -0.854 . . . . 15.0 111.742 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' SER . 57.8 t -125.62 113.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 113.98 -1.463 . . . . 15.0 108.109 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -115.98 136.86 52.64 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.419 -1.264 . . . . 15.0 110.766 175.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 50.0 mtt-85 -79.47 141.86 36.37 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.672 0.619 . . . . 15.0 112.672 -173.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.407 ' HA ' ' HG2' ' A' ' 53' ' ' LYS . . . -119.06 -50.27 2.38 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.112 -1.404 . . . . 15.0 114.119 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.2 t70 54.61 90.62 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.21 1.804 . . . . 15.0 115.193 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -72.33 86.68 1.12 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 114.915 -1.039 . . . . 15.0 110.791 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -125.32 85.93 2.48 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.516 -1.22 . . . . 15.0 109.688 170.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -168.93 150.62 4.64 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.752 -1.567 . . . . 15.0 111.945 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -67.15 146.49 54.19 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.782 -1.099 . . . . 15.0 111.551 172.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.09 -25.06 63.47 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.778 1.77 . . . . 15.0 115.778 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 47.86 80.96 0.05 OUTLIER Glycine 0 N--CA 1.484 1.884 0 C-N-CA 125.648 1.594 . . . . 15.0 112.121 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 65.95 -165.32 0.23 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.04 1.336 . . . . 15.0 111.375 -156.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.56 61.15 3.98 Favored Glycine 0 N--CA 1.48 1.623 0 C-N-CA 124.092 0.853 . . . . 15.0 114.451 -175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -118.65 101.0 7.78 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.308 1.052 . . . . 15.0 112.01 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 97' ' ' ILE . 4.7 mp -73.73 80.91 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 113.776 -1.556 . . . . 15.0 108.875 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.7 t -72.83 59.71 0.49 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.001 -1.454 . . . . 15.0 113.544 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.01 87.83 2.36 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.958 -1.019 . . . . 15.0 113.324 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.05 137.51 51.31 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.634 -1.166 . . . . 15.0 112.921 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -123.79 163.42 21.22 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.09 -1.868 . . . . 15.0 110.86 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 131.37 50.58 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.268 0.556 . . . . 15.0 110.711 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 28.5 t -75.07 105.92 6.32 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.29 -1.323 . . . . 15.0 110.78 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 82' ' ' MET . 10.0 p -113.37 115.29 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 113.997 -1.456 . . . . 15.0 111.408 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.493 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 80.5 p -117.87 131.83 23.95 Favored Pre-proline 0 N--CA 1.479 1.001 0 CA-C-N 113.745 -1.571 . . . . 15.0 112.398 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 122.21 6.0 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.921 2.414 . . . . 15.0 111.397 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.539 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 53.1 t -131.11 140.03 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.597 -1.183 . . . . 15.0 109.69 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.47 123.29 48.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.16 -1.382 . . . . 15.0 109.844 171.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB2' ' A' ' 129' ' ' GLU . . . -123.23 112.58 17.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.352 -1.295 . . . . 15.0 111.263 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.63 137.07 13.51 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.6 -0.727 . . . . 15.0 112.618 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 128' ' ' LEU . . . 176.99 -147.79 8.56 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 116.198 1.239 . . . . 15.0 116.198 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 75' ' ' ILE . 16.3 t -130.76 144.68 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 113.506 -1.347 . . . . 15.0 109.805 -170.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.486 ' HB2' ' HG3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -109.75 120.95 44.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.292 -1.373 . . . . 15.0 107.292 165.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -117.75 117.66 29.94 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.115 -1.402 . . . . 15.0 111.24 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 116' ' ' ILE . 13.2 p -129.65 143.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 113.279 -1.782 . . . . 15.0 110.163 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.535 HG13 HG22 ' A' ' 115' ' ' VAL . 44.0 mt 62.95 144.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 125.877 1.671 . . . . 15.0 113.577 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 63.33 155.38 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.886 1.674 . . . . 15.0 111.746 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 69.33 -50.28 0.61 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.882 2.073 . . . . 15.0 113.925 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -66.57 126.63 29.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.152 1.381 . . . . 15.0 110.491 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.4 tt -45.1 -35.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 115.671 1.73 . . . . 15.0 115.671 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.2 m -129.12 97.61 25.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 108.398 -0.964 . . . . 15.0 108.398 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.47 66.06 2.89 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.706 2.937 . . . . 15.0 114.304 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 124' ' ' ILE . 15.0 pt-20 -120.04 -17.75 8.31 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.798 -1.546 . . . . 15.0 114.958 178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -119.57 152.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.708 0.766 . . . . 15.0 112.586 -173.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.47 34.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.516 -2.129 . . . . 15.0 109.03 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 37.1 m -93.25 116.76 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.182 -1.784 . . . . 15.0 106.182 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 34.4 ttp180 -115.6 108.07 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.101 -1.409 . . . . 15.0 107.925 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.467 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 5.3 tt -111.83 130.67 55.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.58 -1.646 . . . . 15.0 108.991 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.63 ' HG3' ' HB3' ' A' ' 143' ' ' SER . 13.6 pt-20 -128.57 140.97 51.52 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.435 -2.166 . . . . 15.0 111.421 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 11.7 m-85 -97.25 114.56 26.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.516 -1.22 . . . . 15.0 109.061 164.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 14.7 mt-30 -96.57 108.77 21.42 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.95 -1.932 . . . . 15.0 108.309 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -131.49 146.4 52.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 111.918 -2.401 . . . . 15.0 111.755 -171.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p -122.91 -25.08 4.65 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 112.56 -2.109 . . . . 15.0 115.524 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -122.44 96.54 5.08 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 116.336 1.976 . . . . 15.0 116.336 -163.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -13.85 -58.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 127.995 2.518 . . . . 15.0 117.772 172.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.02 81.83 1.56 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.059 0.933 . . . . 15.0 110.075 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.4 t -171.04 160.29 6.4 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.082 -1.872 . . . . 15.0 110.605 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -62.67 151.06 39.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.477 1.111 . . . . 15.0 111.017 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.708 ' HB2' ' HG3' ' A' ' 17' ' ' GLN . 8.2 m120 -7.15 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 119.564 3.172 . . . . 15.0 119.564 171.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.57 -97.76 1.76 Allowed Glycine 0 N--CA 1.475 1.243 0 N-CA-C 110.542 -1.023 . . . . 15.0 110.542 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 131' ' ' GLN . 67.0 mtt -121.47 122.69 40.31 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.565 0.95 . . . . 15.0 113.565 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.588 HD23 ' H ' ' A' ' 142' ' ' LEU . 1.2 pt? -84.77 97.34 9.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.035 -1.439 . . . . 15.0 108.032 171.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.649 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 37.1 t -114.0 128.63 56.47 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.433 -1.712 . . . . 15.0 110.896 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.644 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 1.3 pt? -126.36 139.51 53.23 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.962 -1.017 . . . . 15.0 111.043 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 12' ' ' LYS . . . -123.59 131.19 7.98 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 125.822 1.951 . . . . 15.0 111.128 173.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.5 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 34.8 m -112.58 127.42 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.801 0.8 . . . . 15.0 111.111 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . 63.5 p -131.68 153.49 49.94 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.845 -1.525 . . . . 15.0 114.605 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -108.02 143.64 36.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.052 -1.431 . . . . 15.0 109.468 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.798 ' HD3' ' H ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -70.29 115.88 9.98 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.941 -1.027 . . . . 15.0 112.896 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 81.0 m-85 54.72 139.02 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 112.751 -2.022 . . . . 15.0 114.288 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.76 83.52 0.29 Allowed Glycine 0 N--CA 1.479 1.56 0 CA-C-N 114.611 -1.177 . . . . 15.0 113.366 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -58.59 -43.51 89.52 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.473 1.109 . . . . 15.0 113.572 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 169.09 -152.57 20.33 Favored Glycine 0 N--CA 1.478 1.448 0 C-N-CA 124.143 0.878 . . . . 15.0 111.485 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.52 141.55 51.98 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.681 -0.76 . . . . 15.0 111.38 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.1 90.6 1.2 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.194 0.997 . . . . 15.0 112.481 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 N-CA-C 114.925 1.454 . . . . 15.0 114.925 177.424 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 19.3 mmt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 116.426 2.01 . . . . 15.0 116.426 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 90.6 Cg_endo -68.66 -23.49 36.3 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.31 2.673 . . . . 15.0 114.86 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 50.06 46.36 24.61 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 123.459 1.6 . . . . 15.0 113.977 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.519 ' OD1' ' HA ' ' A' ' 36' ' ' PRO . 69.5 m-20 -122.35 26.4 8.43 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.503 -1.681 . . . . 15.0 113.315 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.751 ' HA ' HG22 ' A' ' 34' ' ' VAL . 24.6 t-20 178.89 48.67 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.469 1.508 . . . . 15.0 111.064 -173.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 p -126.92 152.6 46.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.062 -1.426 . . . . 15.0 110.554 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -118.66 138.57 52.52 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.032 1.123 . . . . 15.0 114.032 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -120.26 136.35 54.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.869 -1.514 . . . . 15.0 110.818 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -163.6 133.35 4.16 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.807 -1.088 . . . . 15.0 111.691 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -177.73 -167.76 36.33 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 115.163 -0.926 . . . . 15.0 112.711 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.54 134.82 47.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.802 -0.699 . . . . 15.0 112.107 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HD3' ' HD3' ' A' ' 127' ' ' ARG . 45.1 mtmt -134.16 144.74 48.7 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.898 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.5 pp -114.17 145.29 41.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.886 -1.052 . . . . 15.0 111.092 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.29 110.35 2.48 Favored Glycine 0 N--CA 1.477 1.414 0 O-C-N 125.003 1.439 . . . . 15.0 111.483 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.731 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 49.4 t90 -118.72 140.46 49.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.859 1.059 . . . . 15.0 113.859 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.9 p -92.85 98.16 11.21 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.336 1.236 . . . . 15.0 114.336 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -14.76 -76.91 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.207 2.603 . . . . 15.0 117.871 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -131.45 77.03 1.75 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.9 t -165.04 140.69 5.43 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 112.987 -1.915 . . . . 15.0 110.544 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -90.15 76.7 6.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.147 -1.388 . . . . 15.0 107.352 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -142.74 -70.86 0.33 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.448 -1.705 . . . . 15.0 114.071 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.731 ' ND2' ' HA ' ' A' ' 15' ' ' TRP . 7.3 m120 62.45 -65.52 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.09 1.885 . . . . 15.0 116.09 -171.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 63.43 -62.81 0.14 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 127.055 2.142 . . . . 15.0 110.612 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.06 139.8 50.51 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.889 -1.05 . . . . 15.0 108.658 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.55 -98.24 2.23 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 108.898 -1.681 . . . . 15.0 108.898 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.87 131.15 57.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.521 -1.34 . . . . 15.0 110.041 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.58 141.8 13.88 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-N 113.541 -1.663 . . . . 15.0 110.89 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.4 121.19 41.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.965 -1.118 . . . . 15.0 108.061 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 42' ' ' MET . 94.0 m-85 -116.24 113.39 22.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.075 -1.42 . . . . 15.0 110.351 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.17 145.96 17.15 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.468 -1.696 . . . . 15.0 112.189 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 41' ' ' GLU . . . 172.32 -161.6 33.33 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 114.461 -0.869 . . . . 15.0 112.765 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -126.46 142.17 51.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.943 -1.128 . . . . 15.0 111.986 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 59.3 tt0 -111.54 82.3 1.59 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 124.092 1.901 . . . . 15.0 106.397 169.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.751 HG22 ' HA ' ' A' ' 5' ' ' ASN . 29.4 t -140.75 72.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 111.842 -2.435 . . . . 15.0 105.941 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.437 HD22 HG23 ' A' ' 38' ' ' VAL . 50.0 t30 -175.89 144.88 0.74 Allowed Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 111.913 -2.403 . . . . 15.0 105.248 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.519 ' HA ' ' OD1' ' A' ' 4' ' ' ASP . 28.6 Cg_endo -50.33 104.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.57 2.847 . . . . 15.0 114.332 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 71.25 -24.47 0.17 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.477 2.311 . . . . 15.0 116.747 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.699 HG12 ' HG ' ' A' ' 63' ' ' LEU . 25.6 m -111.04 147.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.582 1.182 . . . . 15.0 113.5 -172.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -118.63 155.26 16.15 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.515 -2.13 . . . . 15.0 112.289 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -118.12 114.14 22.63 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.437 -0.882 . . . . 15.0 109.515 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.435 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -130.78 146.48 52.25 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.253 -1.794 . . . . 15.0 111.532 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 24.0 ptt? -112.59 145.0 41.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.412 -1.267 . . . . 15.0 111.268 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -106.03 127.62 9.02 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 113.22 -1.809 . . . . 15.0 109.726 172.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.82 104.57 11.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.578 -1.311 . . . . 15.0 111.191 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.6 121.59 43.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.098 -1.41 . . . . 15.0 110.127 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 t-105 -102.43 142.95 32.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.523 -1.671 . . . . 15.0 110.235 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 44.09 39.6 2.94 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.511 2.041 . . . . 15.0 116.511 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.22 84.17 0.1 OUTLIER Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.423 -1.071 . . . . 15.0 110.423 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 56.3 mtt-85 68.53 -51.16 0.56 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.561 2.344 . . . . 15.0 116.266 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.2 mtt -66.9 107.33 1.59 Allowed Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 125.38 1.472 . . . . 15.0 113.494 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.16 -55.93 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.777 2.318 . . . . 15.0 112.473 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.2 84.81 6.94 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.141 0.976 . . . . 15.0 108.461 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 66.51 110.89 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 112.628 -2.078 . . . . 15.0 115.63 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.83 -78.0 0.58 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 112.27 -2.241 . . . . 15.0 112.255 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 28.3 pt20 34.13 86.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.603 1.961 . . . . 15.0 115.106 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.45 97.06 1.49 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.817 -1.992 . . . . 15.0 109.971 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 43' ' ' GLY . 11.8 p -109.88 118.53 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.956 1.033 . . . . 15.0 111.112 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.79 116.79 32.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.841 -1.527 . . . . 15.0 112.401 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.8 114.39 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.707 -1.588 . . . . 15.0 108.643 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.606 HG21 ' HD3' ' A' ' 78' ' ' ARG . 51.9 p -127.27 148.4 50.22 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.135 -1.848 . . . . 15.0 114.035 -170.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.53 128.52 54.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 113.136 -1.847 . . . . 15.0 107.823 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -119.75 138.35 53.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.119 -1.855 . . . . 15.0 111.83 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HG ' HG12 ' A' ' 38' ' ' VAL . 5.2 mp -117.07 131.36 56.94 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.157 -1.838 . . . . 15.0 108.669 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.71 131.66 10.1 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 124.616 1.198 . . . . 15.0 111.006 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.751 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 72.3 m-85 -121.75 97.98 45.95 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 124.512 0.772 . . . . 15.0 112.313 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.35 84.9 0.72 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.984 2.456 . . . . 15.0 110.991 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -120.18 153.02 36.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.726 -2.034 . . . . 15.0 110.008 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.8 84.61 0.31 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.374 -0.83 . . . . 15.0 112.809 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.25 141.9 15.35 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 113.812 -1.54 . . . . 15.0 112.398 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.515 ' O ' HD13 ' A' ' 73' ' ' LEU . 3.2 m -49.36 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.76 2.824 . . . . 15.0 112.639 -171.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 52.65 71.09 0.5 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.722 -1.581 . . . . 15.0 112.919 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 78.91 41.51 0.09 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.861 -1.518 . . . . 15.0 114.277 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 70' ' ' THR . 9.0 mp -105.32 115.37 30.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.168 -1.378 . . . . 15.0 111.157 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -105.26 135.97 45.65 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.231 -1.35 . . . . 15.0 108.255 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.751 ' HB ' ' HB2' ' A' ' 65' ' ' TYR . 37.1 mm -83.34 137.42 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.252 -1.018 . . . . 15.0 108.252 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -133.18 135.47 45.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.528 1.307 . . . . 15.0 114.528 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 58.5 m -118.35 124.93 48.94 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 112.537 -2.119 . . . . 15.0 107.424 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.606 ' HD3' HG21 ' A' ' 60' ' ' THR . 1.2 tmm_? -124.64 135.73 53.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.611 0.765 . . . . 15.0 109.864 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 pp -150.76 139.55 20.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.371 -0.832 . . . . 15.0 113.225 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.49 -151.68 10.73 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.626 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.33 151.6 20.87 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 114.154 -1.023 . . . . 15.0 113.088 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.0 ptm -114.49 135.28 54.29 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.712 1.004 . . . . 15.0 113.712 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 104' ' ' VAL . 44.7 t -125.34 119.92 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 113.756 -1.566 . . . . 15.0 108.024 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.411 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 35.9 p90 -129.95 151.83 50.07 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.689 175.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.4 ttt-85 -102.11 80.98 2.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.09 1.424 . . . . 15.0 111.839 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.86 96.37 4.29 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.747 -2.024 . . . . 15.0 110.641 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -65.58 144.07 57.21 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.682 -1.145 . . . . 15.0 111.852 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 m -57.18 102.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.759 1.623 . . . . 15.0 112.888 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -61.54 147.15 46.39 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.729 -1.578 . . . . 15.0 113.229 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -66.4 151.22 47.61 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.52 -1.673 . . . . 15.0 109.264 165.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.3 tttt 66.53 145.93 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.718 2.007 . . . . 15.0 113.092 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -172.35 -41.42 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.392 1.477 . . . . 15.0 111.721 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.63 -87.28 0.39 Allowed Glycine 0 N--CA 1.475 1.287 0 N-CA-C 109.37 -1.492 . . . . 15.0 109.37 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -100.2 149.1 23.9 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.408 -0.896 . . . . 15.0 111.137 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.95 80.66 0.07 OUTLIER Glycine 0 N--CA 1.482 1.729 0 C-N-CA 124.638 1.114 . . . . 15.0 115.256 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -115.29 94.09 4.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 122.326 1.06 . . . . 15.0 112.783 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.0 pt -122.68 142.53 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 112.811 -1.995 . . . . 15.0 111.232 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.1 t -170.34 -103.51 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.079 1.351 . . . . 15.0 109.57 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 63.02 152.31 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.741 2.016 . . . . 15.0 114.276 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.23 -65.71 0.15 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.169 -1.378 . . . . 15.0 112.584 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.29 142.21 50.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.781 0.833 . . . . 15.0 109.253 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 147.13 53.02 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 124.072 0.857 . . . . 15.0 110.543 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 m -71.26 105.74 3.57 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.548 -0.751 . . . . 15.0 111.643 -174.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 83' ' ' VAL . 42.9 t -83.52 80.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.49 -1.232 . . . . 15.0 109.216 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.7 m -65.27 132.07 95.18 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 113.762 -1.563 . . . . 15.0 111.909 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.68 113.7 2.84 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.115 2.543 . . . . 15.0 110.555 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.8 t -116.9 120.27 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.298 -1.319 . . . . 15.0 109.023 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -118.37 144.72 45.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 113.288 -1.778 . . . . 15.0 109.66 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -141.5 131.11 23.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.7 -1.136 . . . . 15.0 110.788 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.99 130.47 7.83 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 129' ' ' GLU . . . -173.1 -160.42 21.61 Favored Glycine 0 N--CA 1.476 1.338 0 CA-C-O 122.199 0.888 . . . . 15.0 115.228 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.32 144.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 113.244 -1.478 . . . . 15.0 109.682 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -121.2 129.06 53.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.96 -1.473 . . . . 15.0 109.058 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 116' ' ' ILE . 19.9 t80 -100.21 130.82 46.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.316 1.046 . . . . 15.0 109.88 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.4 113.07 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 113.336 -1.757 . . . . 15.0 110.597 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -54.44 100.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.089 -1.869 . . . . 15.0 113.32 -174.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -108.21 -32.56 7.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.405 -1.725 . . . . 15.0 112.976 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -54.54 -20.54 8.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.886 2.18 . . . . 15.0 116.886 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HD3' ' N ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -127.56 144.17 51.1 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.443 -0.947 . . . . 15.0 108.443 178.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.63 ' H ' HD12 ' A' ' 120' ' ' ILE . 4.7 mp -57.78 136.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.319 1.448 . . . . 15.0 109.653 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.434 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 28.7 m 65.14 92.22 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.045 1.738 . . . . 15.0 111.637 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 121' ' ' THR . 57.4 Cg_endo -64.58 134.21 40.2 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.924 2.416 . . . . 15.0 111.331 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.49 ' HG2' HG13 ' A' ' 124' ' ' ILE . 30.5 tt0 -119.34 -81.63 0.63 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.403 -1.271 . . . . 15.0 112.177 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.49 HG13 ' HG2' ' A' ' 123' ' ' GLU . 32.7 mt -116.36 146.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.64 24.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.794 1.238 . . . . 15.0 110.984 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.0 m -100.32 122.59 43.34 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.196 -0.911 . . . . 15.0 109.387 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.435 ' HD3' ' HD3' ' A' ' 12' ' ' LYS . 37.1 ttt85 -120.88 127.94 52.34 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.461 -0.79 . . . . 15.0 112.479 -175.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.0 119.53 24.45 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.93 -1.487 . . . . 15.0 110.775 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 6.1 pt-20 -134.2 145.42 49.19 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.88 -1.054 . . . . 15.0 113.49 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.38 122.09 43.1 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.307 -1.315 . . . . 15.0 109.307 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.59 122.48 47.93 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 113.656 -1.611 . . . . 15.0 110.942 -169.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -124.45 145.28 49.6 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 111.985 -2.37 . . . . 15.0 110.532 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.3 t -126.02 138.45 53.73 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.764 -1.107 . . . . 15.0 109.188 171.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -76.02 73.32 2.89 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.595 1.188 . . . . 15.0 110.644 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.48 154.0 49.18 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.83 -1.986 . . . . 15.0 110.218 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.21 85.72 1.9 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 122.921 1.343 . . . . 15.0 110.719 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.8 t -173.7 163.06 4.19 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 112.691 -2.05 . . . . 15.0 109.434 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.34 -26.88 68.96 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.179 -0.919 . . . . 15.0 111.555 164.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 57.61 -94.07 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.78 2.032 . . . . 15.0 112.656 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.31 85.6 0.01 OUTLIER Glycine 0 N--CA 1.482 1.714 0 C-N-CA 125.846 1.689 . . . . 15.0 116.899 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -117.42 139.0 51.45 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.046 0.927 . . . . 15.0 110.599 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.19 108.98 18.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 113.89 -1.505 . . . . 15.0 109.535 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.499 ' HB2' ' HG3' ' A' ' 129' ' ' GLU . 61.4 m -109.02 125.22 51.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.472 -1.24 . . . . 15.0 108.783 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 pp -148.22 145.25 28.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.201 -1.363 . . . . 15.0 112.311 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.96 -162.51 29.53 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 114.15 -1.386 . . . . 15.0 113.119 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.32 130.48 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.159 -1.52 . . . . 15.0 111.494 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.521 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 63.9 p -130.39 146.35 51.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.755 -1.566 . . . . 15.0 113.053 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -115.96 118.95 34.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.259 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.86 119.27 34.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.031 -1.44 . . . . 15.0 108.55 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -152.75 -123.55 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.873 -1.512 . . . . 15.0 110.112 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 140.45 157.0 7.06 Favored Glycine 0 N--CA 1.478 1.482 0 C-N-CA 124.83 1.205 . . . . 15.0 111.424 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 53.52 33.66 16.69 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 116.623 2.083 . . . . 15.0 116.623 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.32 136.36 13.53 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 115.456 -0.793 . . . . 15.0 111.703 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -96.2 -56.77 2.53 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.208 -0.996 . . . . 15.0 113.442 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 60.64 163.96 0.07 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.588 1.555 . . . . 15.0 113.536 -172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 CA-C-O 116.825 -1.559 . . . . 15.0 113.792 179.167 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 115.088 1.514 . . . . 15.0 115.088 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.14 128.15 17.09 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.77 2.313 . . . . 15.0 111.596 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HG3' HG21 ' A' ' 6' ' ' THR . 0.4 OUTLIER -109.08 -71.49 0.76 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.12 -1.4 . . . . 15.0 114.339 -177.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.2 t0 43.51 82.81 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.67 1.588 . . . . 15.0 115.257 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.432 ' H ' ' HA ' ' A' ' 34' ' ' VAL . 6.1 t30 58.68 73.5 0.47 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.395 1.878 . . . . 15.0 112.461 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.441 HG21 ' HG3' ' A' ' 3' ' ' LYS . 11.6 t -120.94 150.91 40.36 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 112.207 -2.27 . . . . 15.0 111.448 173.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -106.92 131.79 53.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.568 -1.196 . . . . 15.0 111.959 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.35 101.6 8.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.619 -1.628 . . . . 15.0 108.681 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -108.07 118.32 36.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.246 -1.797 . . . . 15.0 107.114 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -130.9 153.0 20.1 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 114.316 -1.311 . . . . 15.0 113.971 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.29 124.11 42.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.736 -1.232 . . . . 15.0 108.261 170.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -144.19 155.97 44.12 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.756 -1.111 . . . . 15.0 112.869 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' SER . 3.1 pp -114.09 140.37 48.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.604 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -108.5 97.76 1.13 Allowed Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.691 -1.595 . . . . 15.0 111.097 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.466 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t90 -111.05 150.16 29.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.493 1.139 . . . . 15.0 112.418 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.3 p -122.34 159.38 27.58 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 112.439 -2.164 . . . . 15.0 111.081 -173.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -48.48 153.21 0.79 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.221 -0.899 . . . . 15.0 109.593 165.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.49 89.62 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.861 0.838 . . . . 15.0 111.641 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 t -167.81 141.0 3.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.651 -2.068 . . . . 15.0 107.963 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' H ' ' A' ' 21' ' ' GLU . 32.0 ttt-85 53.21 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.897 1.679 . . . . 15.0 113.649 -175.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 15.3 pt-20 -69.69 75.18 0.43 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.927 1.084 . . . . 15.0 113.927 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -130.1 147.59 51.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.877 -1.056 . . . . 15.0 112.242 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -173.15 -75.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.675 -1.602 . . . . 15.0 110.47 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -104.56 89.45 3.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.473 0.654 . . . . 15.0 111.394 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.98 111.97 1.02 Allowed Glycine 0 N--CA 1.478 1.485 0 CA-C-N 113.599 -1.637 . . . . 15.0 112.018 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -119.75 142.47 48.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.193 0.597 . . . . 15.0 112.081 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.41 20.38 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 124.952 1.408 . . . . 15.0 112.511 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . . . -102.96 135.94 43.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.733 -1.234 . . . . 15.0 111.2 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -111.72 118.0 34.42 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.007 -1.451 . . . . 15.0 110.817 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.12 90.12 0.45 Allowed Glycine 0 N--CA 1.476 1.325 0 CA-C-N 114.647 -1.161 . . . . 15.0 110.545 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.04 117.26 4.21 Favored Glycine 0 N--CA 1.477 1.419 0 O-C-N 124.44 0.729 . . . . 15.0 112.101 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -115.25 123.01 47.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.474 1.13 . . . . 15.0 111.856 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -109.03 82.21 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.499 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.464 HG13 ' H ' ' A' ' 35' ' ' ASN 0.276 7.3 p -71.2 -73.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.236 -2.257 . . . . 15.0 112.243 174.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.464 ' H ' HG13 ' A' ' 34' ' ' VAL . 22.7 t30 -70.55 127.86 91.61 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.229 1.411 . . . . 15.0 112.146 -176.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 35' ' ' ASN . 71.8 Cg_endo -72.5 69.5 3.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.323 2.682 . . . . 15.0 111.728 170.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -175.94 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.196 2.199 . . . . 15.0 107.941 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.28 141.01 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.465 -0.788 . . . . 15.0 111.962 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.67 158.95 14.08 Favored Glycine 0 N--CA 1.477 1.39 0 CA-C-N 113.638 -1.619 . . . . 15.0 109.577 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 136.2 52.73 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.257 0.551 . . . . 15.0 110.524 -176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB3' ' OG1' ' A' ' 60' ' ' THR . 0.9 OUTLIER -127.89 133.91 49.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.584 -1.189 . . . . 15.0 110.621 -173.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.4 mtm -124.23 128.27 48.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.133 -1.394 . . . . 15.0 111.547 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.99 134.08 11.93 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 113.385 -1.734 . . . . 15.0 109.676 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.524 ' HB2' ' HB3' ' A' ' 28' ' ' ALA . 82.8 m-85 -120.12 115.06 22.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.311 -0.945 . . . . 15.0 111.695 -173.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -128.93 143.67 50.95 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.066 -1.425 . . . . 15.0 109.719 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.85 142.53 50.15 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.744 0.646 . . . . 15.0 112.744 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 tp -88.87 77.37 7.77 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.813 1.292 . . . . 15.0 110.075 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.23 -143.98 36.84 Favored Glycine 0 N--CA 1.478 1.488 0 CA-C-N 113.178 -1.828 . . . . 15.0 110.92 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -69.85 -90.86 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.646 0.778 . . . . 15.0 111.178 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.0 ttm -142.03 98.67 6.17 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.176 0.991 . . . . 15.0 108.428 170.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.434 ' HG2' ' HB3' ' A' ' 54' ' ' ALA . 68.5 Cg_endo -69.47 -45.36 1.78 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.755 2.303 . . . . 15.0 112.428 177.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -179.24 -99.45 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.847 2.459 . . . . 15.0 106.048 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -124.44 80.15 1.82 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.333 1.063 . . . . 15.0 108.438 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . . . -148.61 99.5 3.01 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 112.725 -2.034 . . . . 15.0 112.419 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -127.69 156.27 42.63 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.973 -1.921 . . . . 15.0 111.219 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.43 100.57 0.88 Allowed Glycine 0 N--CA 1.475 1.295 0 O-C-N 124.482 1.114 . . . . 15.0 110.427 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -110.74 131.86 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.599 1.19 . . . . 15.0 112.306 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -109.86 124.1 50.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.52 -1.673 . . . . 15.0 109.003 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.19 111.18 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.673 -1.149 . . . . 15.0 109.305 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 78' ' ' ARG . 32.2 p -136.2 156.36 48.79 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.148 -1.842 . . . . 15.0 112.634 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -116.56 141.66 47.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.745 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -110.77 126.07 54.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.375 -1.284 . . . . 15.0 111.402 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.24 146.84 49.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.616 -1.629 . . . . 15.0 110.866 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.96 -155.29 21.56 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 115.694 -0.685 . . . . 15.0 112.04 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 67' ' ' LYS . 18.9 p90 -166.4 158.94 11.97 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -167.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.711 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.5 Cg_endo -68.57 134.0 29.39 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.825 2.35 . . . . 15.0 111.982 167.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 4.8 tmtp? -129.44 122.75 30.0 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.234 -1.348 . . . . 15.0 110.725 -177.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 68' ' ' LEU . 1.8 pt? -69.93 125.68 27.47 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.384 -1.28 . . . . 15.0 110.769 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.34 -86.18 0.41 Allowed Glycine 0 N--CA 1.477 1.378 0 CA-C-N 114.562 -1.199 . . . . 15.0 112.94 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.432 HG23 ' OH ' ' A' ' 114' ' ' TYR . 2.4 t -126.43 -39.8 2.0 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.634 -1.283 . . . . 15.0 110.517 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -116.87 -146.37 0.4 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.502 -1.296 . . . . 15.0 107.502 148.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -107.76 103.31 12.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 114' ' ' TYR . 1.2 pt? -111.1 143.54 41.66 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.056 -1.429 . . . . 15.0 113.733 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.711 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 1.1 m-20 -111.85 123.44 50.24 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.513 -1.221 . . . . 15.0 108.914 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.7 mt -111.59 113.19 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 124.38 1.05 . . . . 15.0 108.681 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -122.27 141.83 51.1 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.478 -1.692 . . . . 15.0 111.885 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 m -108.53 122.64 47.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.257 -2.127 . . . . 15.0 105.257 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 18.2 ttm180 -115.73 123.22 47.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 112.831 -1.986 . . . . 15.0 108.134 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.2 tp -131.57 138.39 48.84 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.244 -0.889 . . . . 15.0 111.065 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.22 -145.39 8.06 Favored Glycine 0 N--CA 1.477 1.423 0 O-C-N 124.749 1.281 . . . . 15.0 113.178 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.43 152.35 22.86 Favored Glycine 0 N--CA 1.476 1.349 0 O-C-N 125.235 1.197 . . . . 15.0 112.599 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.75 118.71 35.06 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.548 0.69 . . . . 15.0 111.136 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.75 125.71 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 113.768 -1.56 . . . . 15.0 108.089 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.481 ' CZ3' ' HB2' ' A' ' 86' ' ' ALA . 15.8 p-90 -117.08 148.22 41.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.286 -1.325 . . . . 15.0 110.729 176.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -100.79 133.46 45.23 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.174 -1.376 . . . . 15.0 110.418 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . . . -127.07 135.37 50.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.257 -1.338 . . . . 15.0 111.58 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -73.96 95.42 2.48 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.942 -1.026 . . . . 15.0 111.805 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 m 54.16 46.71 24.78 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.511 1.524 . . . . 15.0 110.727 -174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.4 p 61.8 -109.4 0.35 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.973 2.109 . . . . 15.0 112.22 -172.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -132.05 104.99 7.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.22 1.008 . . . . 15.0 109.814 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.4 tmmt? -64.27 98.47 0.23 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 114.902 -1.044 . . . . 15.0 111.955 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -108.28 85.85 2.19 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.063 -1.426 . . . . 15.0 110.233 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.62 -149.84 51.67 Favored Glycine 0 N--CA 1.478 1.451 0 CA-C-N 113.51 -1.677 . . . . 15.0 113.179 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -71.74 75.9 0.85 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.287 1.035 . . . . 15.0 113.705 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.31 137.83 2.72 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 114.404 -1.271 . . . . 15.0 113.14 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -124.25 50.54 1.66 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.55 1.167 . . . . 15.0 112.237 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.419 ' H ' HD13 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -124.84 134.09 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 114.522 -1.217 . . . . 15.0 111.571 -177.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.6 t -172.27 147.7 2.02 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.856 1.347 . . . . 15.0 109.642 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.63 84.75 2.24 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.223 1.011 . . . . 15.0 110.869 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.72 140.13 24.5 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 113.549 -1.659 . . . . 15.0 111.179 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -116.53 89.33 3.09 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.196 -0.911 . . . . 15.0 110.104 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 53.84 -142.52 0.79 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.852 -1.522 . . . . 15.0 112.273 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m -151.24 106.05 3.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.962 0.905 . . . . 15.0 109.363 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.45 99.74 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.438 -1.255 . . . . 15.0 108.843 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -118.65 136.45 24.15 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 114.31 -1.313 . . . . 15.0 111.904 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.21 96.58 0.72 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.06 2.507 . . . . 15.0 111.074 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.729 ' HB ' ' HA ' ' A' ' 133' ' ' THR . 21.5 m -116.98 143.48 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.836 -1.529 . . . . 15.0 111.566 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.65 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 5.6 p90 -129.7 138.18 51.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.8 -169.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -124.79 134.28 52.83 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.631 1.832 . . . . 15.0 111.962 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 131' ' ' GLN . . . -104.29 99.24 1.65 Allowed Glycine 0 N--CA 1.476 1.31 0 N-CA-C 108.251 -1.939 . . . . 15.0 108.251 175.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.67 114.45 4.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 125.081 1.107 . . . . 15.0 112.127 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.3 t -117.29 131.96 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 122.576 1.179 . . . . 15.0 108.997 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 10.5 mm-40 -110.74 109.58 19.87 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 112.623 -2.081 . . . . 15.0 108.711 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 73' ' ' LEU . 13.6 t80 -107.26 126.08 51.97 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.611 0.719 . . . . 15.0 112.21 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.5 t -114.22 133.01 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.389 -1.278 . . . . 15.0 109.023 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.1 mt -118.78 142.94 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 114.517 -1.219 . . . . 15.0 108.727 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -70.83 97.11 1.34 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.903 1.075 . . . . 15.0 113.903 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -127.12 149.91 49.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.331 -1.304 . . . . 15.0 112.095 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -57.03 -42.9 81.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.146 1.165 . . . . 15.0 114.146 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.9 mt -120.8 89.05 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.0 m -118.0 90.25 36.61 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.238 -1.346 . . . . 15.0 109.191 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.31 82.64 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.735 2.29 . . . . 15.0 112.281 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 148' ' ' TYR . 1.5 mp0 46.57 32.12 1.56 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.759 2.133 . . . . 15.0 116.759 176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.578 HD11 ' HB ' ' A' ' 146' ' ' VAL . 7.3 tp -116.71 129.57 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.103 0.954 . . . . 15.0 112.414 -169.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.61 153.2 38.41 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.077 -1.874 . . . . 15.0 110.563 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.3 m -80.76 122.61 27.38 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 108.11 20.72 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.348 -1.296 . . . . 15.0 107.995 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.57 111.02 16.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.548 -1.66 . . . . 15.0 108.017 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 110' ' ' GLY . 1.4 tm-20 -129.28 120.51 25.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.553 -1.203 . . . . 15.0 111.054 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 141' ' ' MET . 86.5 t80 -134.95 105.55 6.43 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 117.699 -1.143 . . . . 15.0 110.199 170.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.65 ' HB3' ' O ' ' A' ' 108' ' ' PHE 0.756 1.1 mp0 -149.88 159.28 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 110.884 -2.871 . . . . 15.0 116.751 164.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -78.23 111.6 14.36 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 122.422 1.106 . . . . 15.0 108.207 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.729 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 36.4 p -119.34 -18.47 8.56 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 113.457 -1.701 . . . . 15.0 115.583 -176.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.557 ' ND2' ' HG3' ' A' ' 141' ' ' MET . 11.2 p30 -164.27 -166.49 1.13 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.547 1.939 . . . . 15.0 107.915 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 62.78 149.58 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.982 1.475 . . . . 15.0 114.982 -174.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.68 -67.5 0.9 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.433 -1.712 . . . . 15.0 111.935 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -99.82 82.29 2.57 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -171.21 141.47 1.62 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.31 -1.768 . . . . 15.0 108.956 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -80.53 83.36 6.35 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.624 0.726 . . . . 15.0 112.301 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 62.26 -165.3 22.39 Favored Glycine 0 N--CA 1.482 1.71 0 CA-C-N 114.419 -1.264 . . . . 15.0 113.262 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.557 ' HG3' ' ND2' ' A' ' 134' ' ' ASN . 0.0 OUTLIER -130.79 133.9 46.38 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.921 1.082 . . . . 15.0 113.921 176.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -112.55 105.18 13.33 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.487 -1.688 . . . . 15.0 112.079 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 14.9 m -102.26 125.18 48.88 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.775 -2.012 . . . . 15.0 107.847 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.08 136.88 48.81 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.258 -1.337 . . . . 15.0 111.426 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.08 -162.46 29.39 Favored Glycine 0 N--CA 1.476 1.327 0 O-C-N 124.837 1.335 . . . . 15.0 112.612 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.578 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.7 m -121.0 140.1 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 113.824 -1.188 . . . . 15.0 112.022 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.495 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 25.0 t -123.63 136.17 54.35 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.437 -1.256 . . . . 15.0 110.661 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 123' ' ' GLU . 34.7 t80 -111.72 135.21 52.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.607 -1.179 . . . . 15.0 109.482 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -91.01 128.7 36.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.42 -1.263 . . . . 15.0 109.842 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 6' ' ' THR . 0.9 OUTLIER 60.05 82.89 0.15 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.888 2.075 . . . . 15.0 114.098 -173.134 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.42 -138.35 0.36 Allowed Glycine 0 CA--C 1.537 1.41 0 CA-C-N 112.667 -2.061 . . . . 15.0 112.179 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -66.95 79.66 0.12 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.284 1.587 . . . . 15.0 115.284 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.91 87.53 0.08 OUTLIER Glycine 0 N--CA 1.478 1.467 0 CA-C-N 113.895 -1.502 . . . . 15.0 112.852 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -123.68 135.74 54.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.808 0.843 . . . . 15.0 109.997 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.81 94.35 1.4 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.06 -0.973 . . . . 15.0 111.589 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-N 113.744 -1.571 . . . . 15.0 114.066 177.656 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mtt . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 115.513 1.671 . . . . 15.0 115.513 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HG2' ' OD1' ' A' ' 4' ' ' ASP . 89.0 Cg_endo -77.26 55.77 5.21 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.965 2.443 . . . . 15.0 114.004 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.27 0.6 OUTLIER 40.9 26.32 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 118.94 2.941 . . . . 15.0 118.94 178.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 2' ' ' PRO . 18.5 p-10 -135.11 138.69 44.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.096 1.358 . . . . 15.0 110.294 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 45.98 46.79 12.6 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.625 1.57 . . . . 15.0 113.053 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 33' ' ' GLN . 12.2 p -98.27 115.12 27.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.013 -2.358 . . . . 15.0 109.337 -172.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.626 ' HB3' ' H ' ' A' ' 151' ' ' GLY . 55.5 m95 -94.18 130.43 40.4 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.683 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 148' ' ' TYR . 1.2 t80 -143.4 111.26 6.03 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.487 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.569 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 40.4 p -117.96 174.57 6.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.869 -1.969 . . . . 15.0 110.503 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.0 -159.21 28.36 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.224 0.902 . . . . 15.0 114.4 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.82 132.75 24.22 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.725 -1.237 . . . . 15.0 111.019 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HA ' ' HA3' ' A' ' 145' ' ' GLY . 22.7 pttp -137.3 150.47 47.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.481 -1.236 . . . . 15.0 112.341 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.6 pp -114.21 143.59 44.58 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.875 -1.057 . . . . 15.0 111.723 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.31 119.09 6.26 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-N 113.2 -1.818 . . . . 15.0 110.316 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -114.82 141.1 48.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 113.502 -1.349 . . . . 15.0 111.72 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 m -122.21 98.04 5.75 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.063 -1.426 . . . . 15.0 113.708 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -85.32 48.64 1.61 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.45 1.278 . . . . 15.0 114.45 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -166.57 26.4 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.073 1.509 . . . . 15.0 115.073 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -155.38 144.23 20.65 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.593 0.59 . . . . 15.0 112.593 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -80.88 90.38 5.9 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 15.0 110.193 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 57.6 28.72 16.09 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.371 1.989 . . . . 15.0 116.371 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -114.82 133.96 55.51 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 10.5 mm-40 53.07 93.76 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.137 1.903 . . . . 15.0 116.137 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pp -154.23 137.22 15.47 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 111.681 -2.509 . . . . 15.0 110.151 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.07 -169.88 37.56 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.138 0.899 . . . . 15.0 113.486 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -124.39 142.62 51.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.573 0.749 . . . . 15.0 112.695 -175.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.16 145.92 16.75 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 114.188 -1.369 . . . . 15.0 111.16 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.67 121.27 43.21 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.32 -0.94 . . . . 15.0 109.351 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -127.23 152.88 46.81 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.699 -1.137 . . . . 15.0 112.165 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -174.36 149.23 10.46 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 115.413 -0.812 . . . . 15.0 114.813 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.22 -146.74 7.62 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 113.634 -1.283 . . . . 15.0 113.298 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -158.35 149.55 20.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.722 -1.239 . . . . 15.0 113.621 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 42.2 tt0 -114.66 95.17 5.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.303 1.441 . . . . 15.0 108.657 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.6 -48.17 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.222 -0.899 . . . . 15.0 111.693 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.99 154.93 61.37 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-O 118.055 -0.974 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.47 53.36 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.877 3.051 . . . . 15.0 113.42 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.91 -82.3 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.515 1.526 . . . . 15.0 108.667 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.38 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.939 0.896 . . . . 15.0 108.854 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.62 166.88 17.09 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.188 1.375 . . . . 15.0 110.671 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.96 139.39 52.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.41 137.15 43.83 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.363 -1.29 . . . . 15.0 111.805 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.18 143.33 31.41 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.756 -1.565 . . . . 15.0 109.85 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.32 7.75 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.05 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -118.99 133.96 55.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.364 1.078 . . . . 15.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -125.11 133.82 52.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.921 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.829 ' HA ' ' HG3' ' A' ' 55' ' ' GLN . 37.7 p-90 -102.8 133.54 47.69 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.814 -1.085 . . . . 15.0 110.192 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 87' ' ' ASP . 37.9 tp -106.23 -35.83 7.06 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.595 -1.639 . . . . 15.0 113.764 -173.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.81 29.62 4.89 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.459 1.028 . . . . 15.0 112.637 -175.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.57 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.7 OUTLIER -112.94 165.46 12.31 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.42 1.088 . . . . 15.0 110.992 -178.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.1 mtm -46.82 146.99 2.38 Favored Pre-proline 0 N--CA 1.48 1.029 0 N-CA-C 115.144 1.535 . . . . 15.0 115.144 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.01 157.03 55.19 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.662 2.242 . . . . 15.0 111.149 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 65.98 93.63 0.07 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.416 1.887 . . . . 15.0 112.394 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 57.17 94.56 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 116.211 1.93 . . . . 15.0 116.211 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.57 ' HB1' ' HB3' ' A' ' 49' ' ' ARG . . . -170.1 -66.53 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.584 -1.643 . . . . 15.0 111.632 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.829 ' HG3' ' HA ' ' A' ' 46' ' ' TRP . 2.9 mp0 -51.6 147.1 6.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.906 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 135.87 16.04 Favored Glycine 0 N--CA 1.478 1.467 0 CA-C-N 114.37 -1.286 . . . . 15.0 112.576 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.13 137.32 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.73 1.252 . . . . 15.0 112.988 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -126.84 139.77 52.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.089 -1.869 . . . . 15.0 111.733 175.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.44 111.19 17.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.585 -1.643 . . . . 15.0 109.114 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.532 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 34.2 m -124.55 140.86 52.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.986 -1.461 . . . . 15.0 109.884 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.833 ' O ' ' HB3' ' A' ' 78' ' ' ARG . . . -101.06 138.5 38.02 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.998 -1.853 . . . . 15.0 105.998 168.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.739 ' HA ' ' CB ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -124.95 139.24 54.0 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.93 2.019 . . . . 15.0 114.365 -178.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 77' ' ' THR 0.27 4.6 pp -127.15 120.7 29.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 166.096 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . -121.91 135.05 10.19 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.678 -2.51 . . . . 15.0 112.58 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.08 145.43 50.29 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 125.348 1.263 . . . . 15.0 114.118 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.4 91.22 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.069 2.513 . . . . 15.0 110.728 167.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' A' ' 68' ' ' LEU . 6.3 tmtt? -144.6 152.16 40.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.405 -1.725 . . . . 15.0 108.895 -178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.628 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 1.2 tm? 62.95 85.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.79 2.036 . . . . 15.0 109.624 -170.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -140.74 15.82 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 112.926 -1.943 . . . . 15.0 109.584 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 71' ' ' ASP . 3.2 t -136.34 -86.96 0.33 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.188 -1.006 . . . . 15.0 112.153 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.556 ' H ' HG23 ' A' ' 70' ' ' THR . 8.5 m-20 -124.97 106.6 10.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.108 1.363 . . . . 15.0 108.093 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t0 176.32 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 113.175 -1.83 . . . . 15.0 110.138 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 114' ' ' TYR . 1.3 pt? -135.32 151.79 50.86 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.799 1.312 . . . . 15.0 112.218 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 7.0 m-20 -132.56 138.78 47.58 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.398 -1.274 . . . . 15.0 111.022 172.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.474 ' HA ' HG12 ' A' ' 112' ' ' VAL . 7.8 tp -87.71 135.84 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.275 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -123.94 128.86 50.04 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.992 1.433 . . . . 15.0 111.646 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.495 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 24.0 p -137.2 122.35 19.18 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.942 -1.132 . . . . 15.0 107.942 158.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.833 ' HB3' ' O ' ' A' ' 61' ' ' ALA 0.609 8.0 mmt180 -158.9 164.6 35.53 Favored 'General case' 0 N--CA 1.478 0.972 1 N-CA-C 122.946 4.424 . . . . 15.0 122.946 172.822 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.707 HD13 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -127.93 156.0 43.33 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.096 0.776 . . . . 15.0 113.096 -176.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -165.12 -176.55 36.86 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 114.96 -1.018 . . . . 15.0 113.365 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.93 144.16 14.97 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 123.889 0.757 . . . . 15.0 113.286 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.552 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -123.79 140.68 52.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.617 1.34 . . . . 15.0 114.617 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.87 144.27 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 125.157 1.536 . . . . 15.0 112.309 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -122.75 151.26 41.76 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.38 1.072 . . . . 15.0 111.798 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.548 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -123.63 160.32 27.37 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.429 -0.805 . . . . 15.0 112.158 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 61.83 -145.01 0.42 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.757 1.623 . . . . 15.0 111.323 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.602 ' HB2' HD21 ' A' ' 47' ' ' LEU . 26.7 t0 46.76 59.53 3.89 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.987 1.477 . . . . 15.0 114.987 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.6 p -102.63 -74.46 0.63 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.303 1.223 . . . . 15.0 114.303 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 t 68.92 117.64 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.16 2.184 . . . . 15.0 113.309 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -168.41 140.67 2.87 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.639 -1.619 . . . . 15.0 109.101 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -69.95 155.89 39.91 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.299 1.0 . . . . 15.0 111.21 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -115.56 150.31 36.82 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.173 -0.921 . . . . 15.0 112.675 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.48 -108.01 0.24 Allowed Glycine 0 N--CA 1.478 1.453 0 O-C-N 125.359 1.662 . . . . 15.0 109.134 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -56.64 -31.22 64.14 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.877 1.436 . . . . 15.0 114.877 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.43 -103.41 0.79 Allowed Glycine 0 N--CA 1.478 1.451 0 C-N-CA 124.03 0.824 . . . . 15.0 113.209 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -69.94 92.69 0.73 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.261 1.024 . . . . 15.0 112.179 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.555 HG23 ' H ' ' A' ' 98' ' ' SER 0.326 0.0 OUTLIER -117.02 -88.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 114.436 -1.256 . . . . 15.0 112.384 174.141 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.555 ' H ' HG23 ' A' ' 97' ' ' ILE . 23.0 m -63.39 -20.37 65.47 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 118.219 2.674 . . . . 15.0 118.219 -172.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -10.84 84.91 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 118.227 2.677 . . . . 15.0 118.227 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.92 66.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 117.199 2.296 . . . . 15.0 117.199 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 62.63 146.74 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.244 1.818 . . . . 15.0 114.684 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.32 90.35 5.57 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.484 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t -73.44 143.98 46.48 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 113.759 -1.564 . . . . 15.0 111.903 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 t -117.0 120.67 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.0 m -122.12 142.01 35.67 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.305 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.16 148.7 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.666 2.244 . . . . 15.0 113.274 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.41 135.05 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.643 -1.617 . . . . 15.0 109.64 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -107.11 123.36 48.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -127.55 112.51 15.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.907 -173.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 138.56 11.76 Favored Glycine 0 N--CA 1.479 1.539 0 CA-C-N 113.581 -1.645 . . . . 15.0 110.713 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.79 -152.95 14.73 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.298 0.475 . . . . 15.0 113.244 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 75' ' ' ILE . 5.4 m -141.77 156.97 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.992 1.108 . . . . 15.0 113.992 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -110.13 136.89 48.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.426 -1.716 . . . . 15.0 108.669 159.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 73' ' ' LEU . 11.5 t80 -132.37 143.61 49.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.865 -1.516 . . . . 15.0 108.957 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.44 135.32 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 120.949 0.404 . . . . 15.0 109.991 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.7 mt -43.61 -39.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.805 1.78 . . . . 15.0 115.805 -164.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -164.1 -60.13 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.589 0.755 . . . . 15.0 110.495 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.16 135.52 34.34 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.767 -0.651 . . . . 15.0 109.701 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.79 -33.8 50.5 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.975 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.0 tt -99.84 82.92 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 122.236 1.017 . . . . 15.0 109.893 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 89.2 m -136.76 88.96 18.25 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 112.325 -2.216 . . . . 15.0 108.163 167.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.37 -177.11 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.949 2.433 . . . . 15.0 111.733 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 54.4 mt-10 66.83 -55.6 0.43 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.631 1.973 . . . . 15.0 115.309 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.531 HG12 ' CE2' ' A' ' 148' ' ' TYR . 6.6 mt -116.72 115.16 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.254 1.022 . . . . 15.0 108.649 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.07 147.98 44.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.369 -1.287 . . . . 15.0 111.343 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 m -80.75 116.8 20.94 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.49 HH11 ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -116.83 112.04 20.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.115 0.96 . . . . 15.0 109.889 -177.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.53 112.75 18.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 15.0 110.841 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -134.98 136.45 42.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.928 -1.487 . . . . 15.0 111.491 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 30.7 m-85 -97.4 131.96 43.56 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.425 -1.262 . . . . 15.0 109.341 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.38 117.0 30.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.356 -1.747 . . . . 15.0 111.592 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -120.72 111.83 18.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.493 -1.685 . . . . 15.0 113.186 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 92.1 m -111.02 -34.31 6.24 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 112.64 -2.073 . . . . 15.0 111.557 167.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -77.76 117.24 18.95 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.111 0.482 . . . . 15.0 111.417 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.6 -33.48 60.45 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.339 -1.301 . . . . 15.0 112.708 172.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.3 94.02 3.52 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.041 0.924 . . . . 15.0 111.048 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.2 m -56.56 85.15 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.185 -1.825 . . . . 15.0 112.712 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -110.42 -31.1 7.39 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 113.462 -1.699 . . . . 15.0 115.06 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -176.8 -79.29 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.034 1.334 . . . . 15.0 109.444 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 117.25 -176.69 16.31 Favored Glycine 0 N--CA 1.478 1.436 0 N-CA-C 109.057 -1.617 . . . . 15.0 109.057 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.0 ttt -117.65 135.11 54.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.586 0.708 . . . . 15.0 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.2 tt -105.17 108.8 20.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.694 -1.139 . . . . 15.0 109.708 -174.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m -93.25 125.11 37.68 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.208 1.004 . . . . 15.0 110.081 170.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.4 pp -133.9 135.22 43.49 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 112.903 -1.953 . . . . 15.0 110.109 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -178.94 -162.52 28.48 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 114.82 -1.082 . . . . 15.0 112.848 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.3 m -117.04 131.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 113.518 -1.341 . . . . 15.0 112.633 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.7 p -113.17 145.73 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 112.342 -2.208 . . . . 15.0 111.535 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 70.7 m-85 -124.07 143.45 50.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.009 -1.905 . . . . 15.0 112.482 -172.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -95.84 141.54 29.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 113.583 -1.644 . . . . 15.0 111.41 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 69.1 92.11 0.09 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.825 1.65 . . . . 15.0 114.347 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.626 ' H ' ' HB3' ' A' ' 7' ' ' TRP . . . -78.69 101.87 1.83 Allowed Glycine 0 N--CA 1.476 1.354 0 CA-C-N 113.269 -1.787 . . . . 15.0 111.168 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -60.49 94.19 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.121 0.962 . . . . 15.0 112.526 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.25 94.75 0.1 Allowed Glycine 0 N--CA 1.476 1.332 0 CA-C-N 113.406 -1.724 . . . . 15.0 111.84 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 70.36 101.28 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.494 1.917 . . . . 15.0 112.632 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.78 93.19 0.1 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.698 -1.592 . . . . 15.0 112.268 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.261 0 CA-C-N 113.631 -1.622 . . . . 15.0 113.97 177.606 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 97.9 mtp . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 115.949 1.833 . . . . 15.0 115.949 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 72.7 Cg_endo -73.17 86.13 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.691 2.261 . . . . 15.0 110.797 172.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.819 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 14.7 ttpt -68.49 -87.87 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 113.598 -1.637 . . . . 15.0 112.506 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.487 ' H ' ' HE2' ' A' ' 3' ' ' LYS . 25.6 t0 -72.5 -41.25 66.14 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.414 0.686 . . . . 15.0 110.919 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.603 ' H ' ' HA ' ' A' ' 34' ' ' VAL . 60.0 t30 59.64 30.93 20.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.857 1.663 . . . . 15.0 114.563 165.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.598 ' HA ' ' HB3' ' A' ' 149' ' ' ARG . 10.2 t -110.98 114.72 28.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.162 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -136.79 133.57 36.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.905 -2.407 . . . . 15.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 144.17 -98.11 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 129.293 3.037 . . . . 15.0 108.09 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.647 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 11.2 t -163.51 153.18 15.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -131.06 -170.07 12.59 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.166 -1.379 . . . . 15.0 112.793 170.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.73 131.57 5.44 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.752 1.621 . . . . 15.0 109.522 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.682 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.425 5.2 tptp -171.94 169.61 5.65 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.185 -1.825 . . . . 15.0 115.142 168.407 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HB3' ' H ' ' A' ' 26' ' ' ALA . 1.9 pt? -130.47 161.64 30.98 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.427 -1.261 . . . . 15.0 111.681 -173.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -120.0 155.57 16.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.513 -1.222 . . . . 15.0 112.548 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -121.65 137.02 54.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.924 -1.138 . . . . 15.0 112.49 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -116.8 151.78 35.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.09 -1.414 . . . . 15.0 109.919 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -71.43 78.73 0.76 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.164 1.172 . . . . 15.0 114.164 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -158.92 139.49 12.51 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.135 -1.393 . . . . 15.0 111.717 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.9 m -66.46 -40.41 89.39 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 116.664 2.098 . . . . 15.0 116.664 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 mtt-85 -76.78 92.08 3.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.54 0.686 . . . . 15.0 111.841 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -124.58 131.5 53.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.096 -1.865 . . . . 15.0 113.03 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -131.65 -163.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.239 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -74.68 74.64 2.04 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.535 1.159 . . . . 15.0 111.024 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.63 101.43 3.67 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.663 -1.608 . . . . 15.0 108.502 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.66 -153.82 23.06 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 114.146 -1.388 . . . . 15.0 111.377 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.492 ' H ' ' HB3' ' A' ' 13' ' ' LEU . . . 50.13 91.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.191 1.796 . . . . 15.0 114.19 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.11 148.77 16.48 Favored Glycine 0 N--CA 1.475 1.269 0 CA-C-N 113.807 -1.542 . . . . 15.0 109.99 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.45 121.14 41.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.692 -0.855 . . . . 15.0 108.692 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 97.3 m-85 -125.75 113.43 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.562 -1.199 . . . . 15.0 110.114 -170.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.67 -174.59 14.44 Favored Glycine 0 N--CA 1.477 1.405 0 CA-C-N 115.353 -0.84 . . . . 15.0 114.309 -173.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.92 -140.04 13.86 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.441 -0.88 . . . . 15.0 113.705 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -127.19 104.93 8.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.406 -1.397 . . . . 15.0 112.969 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -114.93 82.27 1.71 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 123.066 1.412 . . . . 15.0 108.249 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.603 ' HA ' ' H ' ' A' ' 5' ' ' ASN . 47.9 t -124.78 -63.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 112.749 -2.023 . . . . 15.0 113.315 -170.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.5 t-20 -62.17 139.09 96.13 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 114.354 1.242 . . . . 15.0 114.354 -170.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.819 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 75.6 Cg_endo -73.59 41.13 0.59 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.652 3.568 . . . . 15.0 116.444 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 1.2 t80 -167.51 -58.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 15.0 111.236 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 57.2 t -124.65 136.32 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.794 0.806 . . . . 15.0 110.279 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.37 154.57 21.3 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 113.785 -1.552 . . . . 15.0 110.055 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.95 114.31 20.81 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.737 0.303 . . . . 15.0 110.503 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -131.94 119.91 21.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.159 -0.928 . . . . 15.0 111.047 -172.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.3 mtp -112.21 135.6 52.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.796 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 29' ' ' PHE . . . -115.87 147.67 18.91 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 113.382 -1.735 . . . . 15.0 111.948 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -132.29 143.03 49.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.846 1.425 . . . . 15.0 114.846 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.09 118.44 24.39 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 111.722 -2.49 . . . . 15.0 107.238 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -112.51 145.18 40.71 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.518 -1.219 . . . . 15.0 110.073 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.619 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -91.2 71.37 6.23 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.212 -172.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.32 -152.37 18.02 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 112.248 -2.251 . . . . 15.0 110.704 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -122.91 -81.72 0.64 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.937 -1.132 . . . . 15.0 109.968 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -58.78 -35.76 35.97 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-O 118.391 -0.814 . . . . 15.0 112.353 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -94.33 141.4 1.45 Allowed 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 121.062 1.175 . . . . 15.0 111.038 160.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -140.56 94.24 2.71 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.591 -1.186 . . . . 15.0 108.592 169.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.619 ' H ' ' HB3' ' A' ' 47' ' ' LEU . 9.5 tmtt? -91.14 -89.28 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 114.458 -1.246 . . . . 15.0 112.886 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.28 -49.38 61.34 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 117.184 2.29 . . . . 15.0 117.184 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 58.41 109.54 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.125 1.77 . . . . 15.0 114.516 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.26 134.76 10.58 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 114.021 -1.445 . . . . 15.0 111.282 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.2 p -119.05 141.33 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 122.111 0.958 . . . . 15.0 111.259 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.503 ' HG2' ' HB3' ' A' ' 82' ' ' MET . 47.4 mt-30 -120.66 140.29 51.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.284 -1.326 . . . . 15.0 109.976 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.64 114.82 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.397 -1.274 . . . . 15.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.2 p -130.41 131.73 45.4 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.746 0.784 . . . . 15.0 110.881 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -114.77 123.3 48.87 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.982 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.647 ' HG2' ' CD2' ' A' ' 76' ' ' TYR . 11.9 tmtt? -79.31 106.41 11.32 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.2 -1.818 . . . . 15.0 108.575 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.79 108.82 15.32 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.472 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 37' ' ' TYR . . . 177.65 -153.69 13.85 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 114.021 -1.445 . . . . 15.0 113.517 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.98 152.22 76.87 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 113.934 -1.133 . . . . 15.0 111.23 -170.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 35.2 Cg_endo -61.29 -73.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.497 2.131 . . . . 15.0 111.24 170.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 60.95 143.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.599 1.96 . . . . 15.0 111.621 -176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.72 -61.63 2.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.878 -1.056 . . . . 15.0 112.055 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.11 -85.15 0.06 OUTLIER Glycine 0 N--CA 1.478 1.462 0 C-N-CA 124.76 1.171 . . . . 15.0 111.492 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 p -134.83 -73.01 0.47 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.653 1.181 . . . . 15.0 109.383 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -165.81 135.33 3.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.869 2.068 . . . . 15.0 108.684 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.565 ' HB2' ' CE1' ' A' ' 114' ' ' TYR . 7.3 m-20 62.03 43.64 8.78 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.903 1.281 . . . . 15.0 112.775 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tt -117.57 137.36 52.64 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.776 -1.102 . . . . 15.0 112.942 -167.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 14.9 t70 -126.61 139.41 53.21 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 112.079 -2.328 . . . . 15.0 109.002 165.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.9 tt -118.16 119.12 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.119 0.968 . . . . 15.0 109.831 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.647 ' CD2' ' HG2' ' A' ' 62' ' ' LYS . 8.8 p90 -153.86 168.9 24.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.012 1.115 . . . . 15.0 114.012 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.585 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 8.9 t -118.66 133.53 55.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.569 166.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.548 ' HB3' ' HE2' ' A' ' 76' ' ' TYR . 7.8 ppt_? -100.53 123.17 44.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.55 1.167 . . . . 15.0 109.149 172.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 pp -124.41 144.57 49.98 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.221 -2.263 . . . . 15.0 113.483 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.64 -97.36 0.17 Allowed Glycine 0 N--CA 1.476 1.304 0 CA-C-N 113.46 -1.7 . . . . 15.0 109.309 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.59 -153.66 23.75 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 115.057 0.783 . . . . 15.0 115.057 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.503 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 21.9 ptp -129.14 138.5 51.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.217 1.562 . . . . 15.0 115.217 -172.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.2 t -128.05 115.58 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 112.902 -1.953 . . . . 15.0 109.185 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -100.92 151.44 21.74 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.85 -1.523 . . . . 15.0 109.721 170.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.71 67.72 0.1 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 123.527 1.632 . . . . 15.0 112.535 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 101' ' ' GLU . . . -72.15 89.3 1.15 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.983 -1.462 . . . . 15.0 111.15 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t70 116.78 128.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 129.716 3.207 . . . . 15.0 111.376 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.6 t -131.32 157.46 43.27 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.09 -1.868 . . . . 15.0 109.313 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -24.59 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 117.055 2.243 . . . . 15.0 117.055 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -72.32 84.4 1.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.586 -1.188 . . . . 15.0 111.589 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -2.71 -75.69 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.231 2.613 . . . . 15.0 116.551 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -130.4 146.98 52.05 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.965 -1.124 . . . . 15.0 107.965 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.485 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . -118.08 -153.48 9.59 Favored Glycine 0 N--CA 1.474 1.232 0 O-C-N 124.372 1.045 . . . . 15.0 113.744 -174.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -168.58 -160.99 0.32 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.981 1.712 . . . . 15.0 108.03 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.38 83.97 0.14 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.755 1.169 . . . . 15.0 112.971 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 51.15 82.55 0.06 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.736 2.014 . . . . 15.0 114.149 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 93' ' ' GLY . 10.9 pt -123.59 164.3 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 113.129 -1.85 . . . . 15.0 111.92 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.0 m 58.08 75.59 0.37 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.857 1.663 . . . . 15.0 113.977 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.23 85.72 2.42 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.071 -1.422 . . . . 15.0 111.097 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -161.25 140.44 10.2 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 113.17 -1.832 . . . . 15.0 110.72 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 86' ' ' ALA . 41.7 tt0 -160.3 134.94 7.58 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.373 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 60.1 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.565 1.946 . . . . 15.0 115.84 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p -98.94 105.94 18.14 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.964 0.888 . . . . 15.0 112.78 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.97 90.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 114.778 -1.101 . . . . 15.0 108.375 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.8 m -130.04 90.17 43.25 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.112 1.153 . . . . 15.0 114.112 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.11 141.42 29.47 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.288 2.659 . . . . 15.0 112.66 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.42 HG22 HG21 ' A' ' 133' ' ' THR . 97.8 t -134.37 139.31 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.363 -1.29 . . . . 15.0 109.855 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -124.32 123.34 39.99 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.656 1.223 . . . . 15.0 109.139 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -136.33 112.66 9.88 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.952 1.093 . . . . 15.0 113.952 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 77' ' ' THR . . . -113.29 142.07 17.24 Favored Glycine 0 N--CA 1.479 1.527 0 CA-C-N 114.096 -1.411 . . . . 15.0 112.662 -173.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.16 -148.93 10.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-O 121.928 0.738 . . . . 15.0 114.606 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.35 143.86 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 113.483 -1.358 . . . . 15.0 113.859 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -122.83 121.92 37.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.069 -1.878 . . . . 15.0 109.898 178.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 72' ' ' ASP . 78.1 t80 -117.71 137.36 52.74 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.888 1.367 . . . . 15.0 110.196 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.83 130.62 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.288 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.94 106.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.905 1.817 . . . . 15.0 115.905 -169.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -118.89 87.37 2.72 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.092 -1.413 . . . . 15.0 110.36 171.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.489 HH21 ' HD2' ' A' ' 119' ' ' ARG . 21.7 ttp180 -174.08 -79.94 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.512 -1.676 . . . . 15.0 112.438 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.489 ' HD2' HH21 ' A' ' 118' ' ' ARG . 65.1 ttt180 -101.53 146.86 27.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.425 0.631 . . . . 15.0 112.658 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.26 100.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.078 1.751 . . . . 15.0 112.523 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.1 p -140.18 151.41 64.61 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 112.066 -2.334 . . . . 15.0 110.281 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.68 82.21 1.22 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.377 2.051 . . . . 15.0 110.141 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -0.7 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.939 2.496 . . . . 15.0 116.596 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.426 HG22 ' HB3' ' A' ' 148' ' ' TYR . 2.7 pp -116.53 140.79 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 112.687 -2.051 . . . . 15.0 112.4 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.47 127.78 53.97 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.489 -2.141 . . . . 15.0 109.333 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 8.9 t -109.33 129.28 55.53 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.426 -1.261 . . . . 15.0 112.182 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 144' ' ' LEU . 52.0 ttp180 -113.3 108.12 16.82 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.431 -1.713 . . . . 15.0 110.19 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.5 tp -106.73 111.02 23.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.855 -1.521 . . . . 15.0 108.061 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -138.18 150.41 46.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.136 -2.302 . . . . 15.0 113.161 -168.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 38.3 p90 -96.99 129.52 44.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 172.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 44.5 tt0 -108.04 110.01 21.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.806 -1.997 . . . . 15.0 108.5 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -123.43 136.54 54.67 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.117 -1.856 . . . . 15.0 112.802 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.42 HG21 HG22 ' A' ' 107' ' ' VAL . 8.8 t -179.08 74.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 110.927 -2.852 . . . . 15.0 108.761 173.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -171.74 149.88 2.6 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.439 -1.71 . . . . 15.0 111.964 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -61.4 -30.94 70.87 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.428 1.27 . . . . 15.0 114.428 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.7 91.12 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.966 1.365 . . . . 15.0 114.519 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.3 p -64.69 147.57 52.79 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.61 -1.632 . . . . 15.0 111.262 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 67.84 -3.43 1.18 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 115.331 1.604 . . . . 15.0 115.331 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -119.25 -163.16 0.95 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.626 1.17 . . . . 15.0 109.335 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 127.58 -153.2 19.13 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.506 1.051 . . . . 15.0 112.616 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.467 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 25.5 ttt -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.129 -1.035 . . . . 15.0 110.874 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.1 tp -114.32 112.22 22.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.398 -1.334 . . . . 15.0 107.398 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.53 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 9.8 t -120.56 138.34 53.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.952 -1.476 . . . . 15.0 112.693 -166.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 37.7 tp -120.1 134.58 55.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.589 -1.641 . . . . 15.0 109.861 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.27 128.33 5.75 Favored Glycine 0 N--CA 1.481 1.655 0 O-C-N 125.774 1.921 . . . . 15.0 110.247 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.427 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 48.2 t -121.43 127.55 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 118.718 1.259 . . . . 15.0 109.249 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.565 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 65.9 p -118.71 138.68 52.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.551 ' CE2' ' HA2' ' A' ' 10' ' ' GLY . 13.5 p90 -125.26 148.31 48.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.481 1.134 . . . . 15.0 113.65 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.598 ' HB3' ' HA ' ' A' ' 6' ' ' THR . 36.6 ptt180 -101.32 153.37 19.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.354 -1.748 . . . . 15.0 114.516 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 64.13 132.47 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.251 2.22 . . . . 15.0 115.161 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.32 103.36 2.45 Favored Glycine 0 N--CA 1.475 1.291 0 CA-C-N 112.575 -2.102 . . . . 15.0 109.219 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 10.61 102.23 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 127.629 2.372 . . . . 15.0 115.559 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -67.84 72.81 0.27 Allowed Glycine 0 N--CA 1.48 1.626 0 CA-C-N 114.426 -1.261 . . . . 15.0 114.835 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 51.31 79.36 0.1 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.841 2.056 . . . . 15.0 114.357 170.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.87 88.98 2.33 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.456 1.122 . . . . 15.0 111.96 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 CA-C-N 113.76 -1.563 . . . . 15.0 114.866 178.429 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 119.06 2.985 . . . . 15.0 119.06 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.15 140.35 49.09 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 121.963 1.775 . . . . 15.0 112.764 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.9 107.67 1.04 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.909 -1.496 . . . . 15.0 112.593 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -143.97 134.99 25.45 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.168 -1.378 . . . . 15.0 109.985 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.652 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 58.8 t30 57.1 39.6 28.96 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.801 1.64 . . . . 15.0 112.811 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.494 ' HB ' ' CE2' ' A' ' 8' ' ' TYR . 81.5 p -98.38 119.49 37.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.078 -1.873 . . . . 15.0 108.306 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 6.6 m0 -113.91 130.28 56.52 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.237 -1.023 . . . . 15.0 108.237 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.494 ' CE2' ' HB ' ' A' ' 6' ' ' THR . 89.6 m-85 -132.22 106.0 7.68 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.229 0.956 . . . . 15.0 112.348 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.0 p -104.07 137.9 41.36 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.547 -0.751 . . . . 15.0 111.341 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.11 -145.46 7.28 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 113.92 -1.491 . . . . 15.0 112.038 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.55 144.15 50.21 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.891 -0.655 . . . . 15.0 112.675 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -118.29 140.16 50.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.434 -1.257 . . . . 15.0 111.312 174.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 143' ' ' SER . 0.9 OUTLIER -127.53 133.43 49.81 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.247 -1.342 . . . . 15.0 111.391 176.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -111.45 116.99 4.36 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 125.223 1.577 . . . . 15.0 110.626 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -109.26 145.46 35.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.848 0.832 . . . . 15.0 111.723 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -98.98 98.17 9.25 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.5 -1.227 . . . . 15.0 114.289 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.92 90.0 7.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.82 -1.082 . . . . 15.0 109.438 170.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.22 -86.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.743 -2.026 . . . . 15.0 110.081 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -119.24 -165.45 1.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.537 1.135 . . . . 15.0 109.07 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.33 83.6 0.25 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.805 1.242 . . . . 15.0 113.904 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.94 136.97 50.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.669 -1.605 . . . . 15.0 111.763 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -121.18 97.1 5.36 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.117 -1.401 . . . . 15.0 109.549 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.01 133.72 55.27 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.329 1.233 . . . . 15.0 114.329 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.96 156.17 33.98 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.971 -1.922 . . . . 15.0 110.57 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.87 -86.91 0.07 OUTLIER Glycine 0 N--CA 1.478 1.495 0 O-C-N 124.245 0.965 . . . . 15.0 112.085 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 69.72 149.71 0.08 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.339 2.256 . . . . 15.0 114.801 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.25 149.8 16.96 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 113.636 -1.62 . . . . 15.0 110.812 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.54 121.34 42.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.226 0.536 . . . . 15.0 110.249 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 2.4 m-85 -129.83 150.3 51.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 116.103 1.89 . . . . 15.0 116.103 -166.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.29 121.07 4.43 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 112.985 -1.916 . . . . 15.0 110.352 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' HH12 ' A' ' 127' ' ' ARG . . . -104.99 98.91 1.54 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 113.732 -1.234 . . . . 15.0 110.215 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -105.97 101.1 10.62 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.586 1.184 . . . . 15.0 108.822 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.521 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 18.8 tm0? -106.37 82.46 1.74 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.8 -1.556 . . . . 15.0 106.8 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 44.0 t -80.37 -84.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.199 -1.819 . . . . 15.0 109.163 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.536 ' H ' ' CD ' ' A' ' 36' ' ' PRO . 19.3 t-20 163.5 51.42 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 128.916 2.886 . . . . 15.0 114.445 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.536 ' CD ' ' H ' ' A' ' 35' ' ' ASN . 96.0 Cg_endo -85.98 55.61 3.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 N-CA-C 108.669 -1.32 . . . . 15.0 108.669 157.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 66.72 -33.87 0.21 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.195 2.198 . . . . 15.0 114.858 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.08 160.5 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.894 1.677 . . . . 15.0 111.966 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -82.72 153.28 31.2 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 109.846 -1.302 . . . . 15.0 109.846 170.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -117.6 118.3 31.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.593 0.711 . . . . 15.0 110.774 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.7 tp10 -111.1 110.1 20.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.9 -1.518 . . . . 15.0 106.9 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.3 ttp -135.28 136.34 41.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.087 -1.415 . . . . 15.0 109.934 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 29' ' ' PHE . . . -172.73 177.23 45.38 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 114.7 -1.136 . . . . 15.0 112.921 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -116.16 145.69 42.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.74 1.257 . . . . 15.0 113.749 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -117.32 118.49 32.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.031 -2.349 . . . . 15.0 109.478 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.469 ' HE1' ' HB1' ' A' ' 54' ' ' ALA . 42.0 t90 -129.45 152.41 49.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.41 -1.268 . . . . 15.0 110.47 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.9 tp -177.26 -46.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 125.188 1.555 . . . . 15.0 110.622 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.42 95.87 0.27 Allowed Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.948 1.261 . . . . 15.0 113.051 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.5 ptt-85 -69.03 79.76 0.32 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.62 1.2 . . . . 15.0 113.165 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -118.2 138.33 25.48 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 113.7 -1.591 . . . . 15.0 113.094 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.98 134.93 22.32 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.68 2.254 . . . . 15.0 110.787 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.3 OUTLIER 56.05 94.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.275 1.43 . . . . 15.0 112.234 -174.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 85' ' ' ARG . 99.1 mttt 65.96 150.49 0.05 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.869 1.667 . . . . 15.0 112.684 -172.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB1' ' HE1' ' A' ' 46' ' ' TRP . . . -174.96 -20.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 116.087 1.884 . . . . 15.0 116.087 -157.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.79 158.75 21.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.87 1.268 . . . . 15.0 113.566 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -121.41 148.33 17.35 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.498 169.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.25 131.97 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.446 0.641 . . . . 15.0 110.74 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.72 127.77 54.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.649 -1.16 . . . . 15.0 110.091 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.49 117.07 20.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.996 -1.911 . . . . 15.0 111.415 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.536 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 36.3 p -120.44 145.94 46.72 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.111 -1.404 . . . . 15.0 111.91 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.09 115.82 27.92 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.86 -1.518 . . . . 15.0 107.583 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.4 pttm -108.32 136.02 48.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 113.86 -1.518 . . . . 15.0 113.298 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.714 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 20.0 tp -128.99 135.9 49.59 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 113.599 -1.637 . . . . 15.0 108.812 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.04 137.56 11.58 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 125.366 1.666 . . . . 15.0 110.03 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.61 110.01 47.49 Favored Pre-proline 0 N--CA 1.477 0.882 0 N-CA-C 113.64 0.978 . . . . 15.0 113.64 177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.99 92.51 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.483 2.122 . . . . 15.0 109.893 172.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -46.59 -44.88 18.5 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.208 -1.36 . . . . 15.0 114.28 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -172.01 157.36 4.36 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.175 1.39 . . . . 15.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.73 -91.31 0.5 Allowed Glycine 0 N--CA 1.476 1.327 0 CA-C-N 114.794 -1.093 . . . . 15.0 111.028 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -158.9 -94.6 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.42 0.688 . . . . 15.0 109.661 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.97 94.53 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.052 0.941 . . . . 15.0 109.369 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -159.65 -58.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.81 -1.541 . . . . 15.0 110.824 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.74 122.64 47.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.619 0.768 . . . . 15.0 111.1 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.427 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -125.37 106.64 9.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.964 -1.471 . . . . 15.0 111.088 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 tt -104.74 107.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.089 -0.96 . . . . 15.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.714 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -168.78 -171.9 1.49 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 112.466 -2.152 . . . . 15.0 111.553 -178.22 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.0 p -119.21 154.05 33.99 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.092 0.949 . . . . 15.0 112.894 -163.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -128.4 140.41 51.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.868 -1.514 . . . . 15.0 112.704 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tt -134.92 141.53 46.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.611 -1.177 . . . . 15.0 109.563 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -173.7 -143.0 4.12 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 114.92 -1.037 . . . . 15.0 111.838 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.37 156.07 27.3 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 114.429 -0.885 . . . . 15.0 113.617 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -113.27 138.15 50.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.284 -1.458 . . . . 15.0 112.089 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.597 HG22 HG12 ' A' ' 104' ' ' VAL . 31.4 t -118.63 134.17 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.212 -1.774 . . . . 15.0 106.212 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.4 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -113.97 141.66 47.12 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.235 -174.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 47.5 mtt-85 -111.12 102.99 11.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.164 1.172 . . . . 15.0 114.164 -175.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -124.3 144.62 49.89 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 113.082 -1.872 . . . . 15.0 110.606 171.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 52' ' ' ARG . 22.2 t70 -58.18 147.34 30.57 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.636 1.347 . . . . 15.0 114.636 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.8 p -107.12 137.41 45.24 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.85 -1.523 . . . . 15.0 110.837 171.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m 61.91 144.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.318 1.847 . . . . 15.0 115.275 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -175.59 -46.02 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.346 -1.297 . . . . 15.0 112.345 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.94 142.82 56.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.489 0.716 . . . . 15.0 111.921 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -113.6 157.56 21.95 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.08 -1.418 . . . . 15.0 112.194 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.81 -97.13 0.45 Allowed Glycine 0 N--CA 1.477 1.424 0 O-C-N 124.655 1.222 . . . . 15.0 111.436 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -128.45 154.67 45.83 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.355 0.68 . . . . 15.0 110.415 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -121.06 146.44 17.41 Favored Glycine 0 N--CA 1.477 1.367 0 O-C-N 124.173 0.92 . . . . 15.0 112.475 -169.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -120.29 -84.5 0.66 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.962 -1.119 . . . . 15.0 112.479 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 tp -122.82 141.53 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.288 0.635 . . . . 15.0 111.952 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 m -65.4 88.88 0.09 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.617 -1.174 . . . . 15.0 111.132 172.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.46 -39.54 61.23 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.67 2.1 . . . . 15.0 116.67 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 56.25 163.81 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 115.202 1.556 . . . . 15.0 115.202 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -124.78 90.61 3.28 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.784 -1.098 . . . . 15.0 111.577 173.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.91 92.69 3.52 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.064 -1.425 . . . . 15.0 110.69 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -130.44 134.17 46.89 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.466 -1.243 . . . . 15.0 112.905 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.597 HG12 HG22 ' A' ' 83' ' ' VAL . 16.7 m -129.85 141.75 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.005 -1.907 . . . . 15.0 110.433 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.6 m -135.0 107.78 10.51 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-N 115.477 -0.783 . . . . 15.0 113.037 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -65.39 139.19 58.41 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.129 2.553 . . . . 15.0 112.561 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.91 139.62 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.968 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -126.57 137.29 53.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.516 -1.22 . . . . 15.0 110.98 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -137.6 137.44 38.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.228 -0.897 . . . . 15.0 111.864 176.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.86 138.0 10.0 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 115.43 -0.805 . . . . 15.0 112.329 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.41 -148.76 11.85 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 121.749 0.638 . . . . 15.0 114.582 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -124.49 131.47 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.513 1.149 . . . . 15.0 111.94 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 9.8 pt-20 -112.49 121.01 43.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.975 -1.921 . . . . 15.0 110.229 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -113.57 137.12 52.02 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.305 -1.316 . . . . 15.0 110.734 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.29 136.2 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 113.213 -1.812 . . . . 15.0 109.102 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.5 tp -63.24 142.97 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 114.441 -1.254 . . . . 15.0 112.424 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -90.42 -91.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.255 -1.339 . . . . 15.0 109.758 168.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -118.84 114.47 22.68 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.033 0.533 . . . . 15.0 111.872 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -169.34 172.91 6.9 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.085 1.754 . . . . 15.0 110.276 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.9 tt -53.79 124.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.874 0.87 . . . . 15.0 110.918 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 m 56.35 74.83 0.64 Allowed Pre-proline 0 N--CA 1.483 1.185 0 CA-C-N 113.738 -1.573 . . . . 15.0 110.091 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.07 72.82 5.71 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 15.0 112.744 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 149' ' ' ARG . 6.1 pt-20 -163.55 30.57 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.177 -1.829 . . . . 15.0 113.145 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 17.5 pt -116.64 136.17 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.251 -0.905 . . . . 15.0 113.438 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.93 140.61 52.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.021 -1.9 . . . . 15.0 111.654 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 t -125.14 116.76 22.55 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.056 -1.884 . . . . 15.0 109.763 175.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.49 HH12 ' HA3' ' A' ' 31' ' ' GLY . 97.9 mtt180 -115.69 108.18 16.04 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.453 -1.703 . . . . 15.0 110.475 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.64 110.88 19.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.666 1.222 . . . . 15.0 111.585 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.76 150.18 39.7 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.54 -2.118 . . . . 15.0 112.07 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 25.2 p90 -97.21 128.06 43.74 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.18 123.83 48.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.264 -1.334 . . . . 15.0 111.598 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.537 ' HE1' ' HB3' ' A' ' 136' ' ' ALA . 16.7 t90 -126.38 146.59 50.0 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.501 -2.136 . . . . 15.0 110.868 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.594 HG23 ' H ' ' A' ' 134' ' ' ASN . 3.6 t -164.49 -86.1 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.582 -1.644 . . . . 15.0 110.762 -171.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.594 ' H ' HG23 ' A' ' 133' ' ' THR . 11.8 m-20 -42.3 138.1 1.81 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.461 1.504 . . . . 15.0 112.674 172.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -46.24 102.28 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.328 1.451 . . . . 15.0 114.858 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.537 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . . . -148.18 -47.47 0.16 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 113.293 -1.776 . . . . 15.0 113.298 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.7 t 51.57 40.93 28.17 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 114.787 1.403 . . . . 15.0 114.787 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -151.9 -77.74 0.12 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.667 -1.151 . . . . 15.0 109.697 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -123.21 158.21 31.34 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.412 0.685 . . . . 15.0 110.267 173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.5 -148.81 8.8 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 114.112 -1.404 . . . . 15.0 110.619 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 98.8 mtp -117.58 135.14 54.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.508 -0.846 . . . . 15.0 109.956 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 100.87 11.18 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.845 0.831 . . . . 15.0 111.757 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 61.2 m -93.11 125.2 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.682 -2.054 . . . . 15.0 109.949 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.67 126.87 53.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.514 -2.13 . . . . 15.0 109.096 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -115.17 110.89 2.37 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 112.486 -2.143 . . . . 15.0 110.423 -176.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.92 127.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 113.95 -1.125 . . . . 15.0 108.731 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 77.6 p -148.05 154.1 39.81 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.38 -1.736 . . . . 15.0 113.032 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -116.4 142.86 46.31 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.093 -1.412 . . . . 15.0 110.892 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 33.6 ttp-105 -70.13 126.14 28.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.452 -1.704 . . . . 15.0 109.618 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -78.98 77.23 5.45 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 113.63 -1.623 . . . . 15.0 110.013 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -47.7 -35.66 11.98 Favored Glycine 0 N--CA 1.482 1.763 0 CA-C-N 112.963 -1.926 . . . . 15.0 114.995 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 61.46 136.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.809 2.044 . . . . 15.0 114.273 174.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -38.07 -62.97 0.97 Allowed Glycine 0 N--CA 1.485 1.913 0 C-N-CA 125.819 1.676 . . . . 15.0 113.005 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -126.78 91.96 3.45 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.584 -0.808 . . . . 15.0 109.653 161.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.66 88.37 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.876 1.322 . . . . 15.0 112.598 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.273 0 CA-C-N 113.606 -1.634 . . . . 15.0 114.216 179.199 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 114.801 1.408 . . . . 15.0 114.801 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.87 -46.12 5.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.046 2.498 . . . . 15.0 113.19 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 tttm 61.63 -58.59 0.11 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 128.18 2.592 . . . . 15.0 116.56 170.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' HA ' HG22 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -168.82 74.62 0.1 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.894 2.078 . . . . 15.0 109.277 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -55.27 -35.8 65.41 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 112.429 -2.169 . . . . 15.0 111.568 -176.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 33' ' ' GLN . 29.5 m -153.58 142.95 21.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.09 1.756 . . . . 15.0 108.499 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -101.23 130.49 47.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.064 -0.971 . . . . 15.0 108.672 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -125.2 105.86 9.45 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.474 -166.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.566 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.0 m -123.24 128.97 50.74 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.421 0.451 . . . . 15.0 110.046 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -137.48 151.17 21.06 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 114.995 -1.002 . . . . 15.0 115.447 -173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.01 124.2 47.57 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.382 -1.409 . . . . 15.0 108.67 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.37 154.42 47.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.351 1.241 . . . . 15.0 114.351 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.2 161.76 20.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.339 -1.755 . . . . 15.0 111.949 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.62 96.72 0.59 Allowed Glycine 0 N--CA 1.476 1.362 0 N-CA-C 110.183 -1.167 . . . . 15.0 110.183 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.414 ' CZ3' ' HA ' ' A' ' 17' ' ' GLN . 50.2 t90 -102.63 123.1 45.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.767 0.794 . . . . 15.0 111.508 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 p -104.02 133.57 48.74 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.11 -0.95 . . . . 15.0 112.49 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.414 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 42.8 tt0 -64.12 -55.69 20.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.823 -1.535 . . . . 15.0 113.681 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.32 86.86 2.63 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.169 0.985 . . . . 15.0 111.689 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -137.41 134.1 35.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.968 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -54.54 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.048 1.499 . . . . 15.0 115.048 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -129.63 95.21 3.93 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.531 0.732 . . . . 15.0 110.293 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -122.76 149.16 44.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.58 -1.191 . . . . 15.0 113.761 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -74.31 154.07 39.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.849 -1.523 . . . . 15.0 110.314 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.63 -33.54 76.17 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.482 1.29 . . . . 15.0 114.482 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 140.38 8.61 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.519 1.057 . . . . 15.0 111.161 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 45' ' ' ASP . . . -141.6 86.47 2.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.613 -0.794 . . . . 15.0 110.136 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.15 92.93 0.59 Allowed Glycine 0 N--CA 1.474 1.19 0 CA-C-N 113.664 -1.607 . . . . 15.0 111.311 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -117.99 121.03 39.59 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.071 0.512 . . . . 15.0 109.866 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 42' ' ' MET 0.293 5.2 t80 -161.63 179.81 7.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.332 -1.758 . . . . 15.0 111.625 175.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.83 -178.55 15.55 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 115.044 -0.98 . . . . 15.0 112.091 -170.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.5 -155.04 12.97 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 113.071 -1.565 . . . . 15.0 112.722 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -126.28 138.81 53.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 112.597 -1.802 . . . . 15.0 112.976 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 1.1 tm0? -115.73 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.098 -1.41 . . . . 15.0 107.982 167.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 4' ' ' ASP . 43.8 t -107.47 -29.74 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 111.095 -2.775 . . . . 15.0 110.412 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 48.6 54.48 16.07 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 116.954 2.205 . . . . 15.0 116.954 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.65 -22.42 37.76 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.097 1.865 . . . . 15.0 112.077 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -166.67 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 128.95 2.9 . . . . 15.0 109.292 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.1 m -135.33 160.49 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.255 1.422 . . . . 15.0 112.246 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 148.12 26.92 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 108.785 -1.726 . . . . 15.0 108.785 161.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.21 126.29 52.53 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.439 0.296 . . . . 15.0 111.399 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.578 ' HG3' HH22 ' A' ' 127' ' ' ARG . 4.1 pm0 -142.33 133.56 26.19 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.058 0.849 . . . . 15.0 113.123 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.641 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.5 137.11 54.84 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.271 -1.331 . . . . 15.0 108.233 174.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.52 129.81 8.5 Favored Glycine 0 N--CA 1.48 1.582 0 O-C-N 126.072 2.108 . . . . 15.0 110.745 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.423 ' N ' ' HB2' ' A' ' 29' ' ' PHE . 6.8 t80 -104.75 112.68 25.88 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.493 0.663 . . . . 15.0 109.602 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 15.0 t70 -106.74 118.4 36.58 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.122 -1.399 . . . . 15.0 110.005 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -120.54 110.05 15.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.613 -1.63 . . . . 15.0 111.06 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.4 -31.08 71.71 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 113.108 -1.86 . . . . 15.0 112.84 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.28 -147.54 16.57 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.516 1.055 . . . . 15.0 111.717 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.8 ptt-85 -76.75 67.2 2.8 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 122.808 1.29 . . . . 15.0 113.672 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.0 tpt -118.2 102.12 50.87 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 114.386 -1.279 . . . . 15.0 112.277 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.63 69.95 5.11 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.915 2.41 . . . . 15.0 111.615 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.9 ttt85 -175.48 -97.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.762 2.025 . . . . 15.0 107.376 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -114.97 93.25 4.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.531 0.733 . . . . 15.0 111.231 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.13 -54.36 2.61 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.062 -2.335 . . . . 15.0 114.129 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -115.46 101.97 9.38 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 15.0 112.467 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -119.26 142.19 16.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 112.226 -2.261 . . . . 15.0 111.141 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.71 135.16 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.185 -1.008 . . . . 15.0 111.164 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HB2' ' HE2' ' A' ' 82' ' ' MET . 18.4 tt0 -109.8 116.63 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.912 -1.144 . . . . 15.0 107.912 173.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.6 111.19 21.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.82 -1.991 . . . . 15.0 109.095 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.7 p -130.21 147.41 51.93 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.453 -1.703 . . . . 15.0 113.797 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.28 134.21 47.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.422 -2.172 . . . . 15.0 109.232 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.59 ' HD3' HH21 ' A' ' 127' ' ' ARG . 22.0 ttpp -107.2 114.15 28.02 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.201 -1.363 . . . . 15.0 111.421 -172.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.91 142.81 46.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.084 -1.871 . . . . 15.0 109.755 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.88 -156.34 23.7 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.829 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.63 159.11 9.92 Favored Pre-proline 0 N--CA 1.481 1.116 0 N-CA-C 114.397 1.258 . . . . 15.0 114.397 -168.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.62 104.71 0.32 Allowed 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 123.264 2.643 . . . . 15.0 111.487 164.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -146.16 148.79 32.92 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.765 -2.016 . . . . 15.0 106.594 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp 70.29 -47.2 0.62 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.455 1.902 . . . . 15.0 111.548 -164.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.64 125.06 5.99 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.353 -1.099 . . . . 15.0 110.353 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -64.51 -57.28 9.63 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.58 0.752 . . . . 15.0 109.558 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -133.93 82.12 1.96 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.223 -0.899 . . . . 15.0 108.586 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -169.35 -75.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.979 -1.919 . . . . 15.0 108.944 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.525 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . 1.4 pt? -123.46 132.0 53.8 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.305 1.003 . . . . 15.0 110.847 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.92 135.56 54.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.436 -1.711 . . . . 15.0 108.757 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 tt -91.41 116.74 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.105 -0.952 . . . . 15.0 110.015 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CD1' ' HG2' ' A' ' 62' ' ' LYS . 26.9 m-85 -135.96 138.82 42.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.25 -1.796 . . . . 15.0 115.06 -175.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 55.4 p -113.08 143.3 44.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 112.083 -2.326 . . . . 15.0 109.598 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.501 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 29.0 mtm105 -115.09 123.22 48.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.832 -1.531 . . . . 15.0 109.735 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tt -119.65 122.92 42.61 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.51 -1.223 . . . . 15.0 109.315 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -130.83 2.22 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 110.102 -1.199 . . . . 15.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 105' ' ' SER . . . 170.98 -166.44 39.63 Favored Glycine 0 N--CA 1.477 1.431 0 O-C-N 125.171 1.16 . . . . 15.0 114.999 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.485 ' HE2' ' HB2' ' A' ' 58' ' ' GLN . 57.7 ttm -119.4 129.68 54.92 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.175 -1.012 . . . . 15.0 112.146 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -122.59 135.8 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 113.521 -1.672 . . . . 15.0 108.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.424 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 9.2 p90 -108.0 119.18 38.73 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.778 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -121.18 -48.38 2.22 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 113.599 -1.637 . . . . 15.0 114.988 -170.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 60.5 -78.62 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.104 1.761 . . . . 15.0 114.911 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -173.9 108.77 0.14 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.937 1.295 . . . . 15.0 112.192 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 m -112.97 95.88 5.64 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.819 -1.082 . . . . 15.0 109.729 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -142.8 158.31 43.76 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.739 -1.119 . . . . 15.0 112.29 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.51 95.05 6.46 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.184 -0.917 . . . . 15.0 111.658 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -66.06 85.94 0.09 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.621 -1.172 . . . . 15.0 113.004 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -177.33 -55.99 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 112.472 -2.149 . . . . 15.0 110.296 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.34 -49.08 0.91 Allowed Glycine 0 CA--C 1.537 1.454 0 O-C-N 124.33 1.019 . . . . 15.0 110.889 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -66.85 156.27 36.1 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.81 0.67 . . . . 15.0 112.81 172.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.59 -97.47 0.62 Allowed Glycine 0 N--CA 1.474 1.215 0 CA-C-N 114.089 -1.414 . . . . 15.0 110.552 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.6 t80 47.95 86.7 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.375 1.47 . . . . 15.0 112.667 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 tp -161.85 143.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.77 -1.559 . . . . 15.0 110.182 -175.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.0 t 63.44 172.98 0.16 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.798 1.639 . . . . 15.0 112.982 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.63 152.09 36.71 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.58 1.152 . . . . 15.0 111.12 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.21 87.44 0.11 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 122.7 1.238 . . . . 15.0 111.799 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.1 90.15 0.09 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.198 -1.819 . . . . 15.0 113.248 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 144.35 56.22 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.336 -1.756 . . . . 15.0 112.129 171.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -71.49 140.2 49.88 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.283 -0.871 . . . . 15.0 111.912 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.26 -27.32 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.008 -0.996 . . . . 15.0 112.814 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.497 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 4.7 t 32.84 70.93 0.72 Allowed Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 127.328 2.251 . . . . 15.0 114.533 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.07 95.04 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.678 2.919 . . . . 15.0 114.26 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 70.2 t -123.96 134.37 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.508 -1.223 . . . . 15.0 109.981 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.91 123.35 40.76 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.245 -1.798 . . . . 15.0 109.626 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -120.99 136.75 54.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.232 0.613 . . . . 15.0 110.878 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.67 135.3 7.86 Favored Glycine 0 N--CA 1.478 1.453 0 CA-C-N 115.452 -0.794 . . . . 15.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.47 -146.84 8.19 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 124.362 0.683 . . . . 15.0 113.605 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.76 154.28 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.159 -1.021 . . . . 15.0 113.43 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -119.57 143.64 47.52 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.902 -1.499 . . . . 15.0 110.403 167.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.525 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 46.0 m-85 -117.0 139.1 51.08 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.527 1.142 . . . . 15.0 111.892 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.95 104.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.266 -1.334 . . . . 15.0 111.275 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . 0.265 18.1 tt -79.95 84.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 123.076 1.417 . . . . 15.0 112.97 -175.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -115.68 102.54 9.84 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.677 -2.056 . . . . 15.0 109.5 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.401 ' HB3' ' H ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -170.77 -83.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.617 -1.629 . . . . 15.0 106.804 176.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.401 ' H ' ' HB3' ' A' ' 118' ' ' ARG . 35.6 mtt180 -69.17 155.81 39.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.392 0.677 . . . . 15.0 111.572 166.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.62 97.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 114.359 -1.291 . . . . 15.0 113.534 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.2 p -110.0 135.94 20.46 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 113.83 -1.532 . . . . 15.0 111.642 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.92 73.31 4.31 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.788 2.325 . . . . 15.0 114.053 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 50.11 39.39 19.23 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.899 1.679 . . . . 15.0 114.636 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.463 HD11 ' HB ' ' A' ' 146' ' ' VAL . 3.9 tt -123.4 142.23 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.663 -1.153 . . . . 15.0 113.748 -164.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.89 157.82 29.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.017 -1.902 . . . . 15.0 110.338 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 32.7 p -106.41 132.23 52.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.296 -0.865 . . . . 15.0 111.046 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.59 HH21 ' HD3' ' A' ' 62' ' ' LYS . 19.4 ttm180 -112.85 130.53 56.06 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.824 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.62 111.03 8.5 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.9 1.375 . . . . 15.0 111.757 173.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.37 150.21 52.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.368 -1.287 . . . . 15.0 112.624 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 57.1 t80 -97.27 116.32 29.26 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.282 1.039 . . . . 15.0 108.376 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -96.59 108.75 21.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 111.971 -2.377 . . . . 15.0 110.251 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -112.03 146.51 37.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.92 -1.945 . . . . 15.0 112.296 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.3 t -171.59 156.54 4.43 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 112.762 -2.017 . . . . 15.0 109.896 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -69.22 81.14 0.35 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.51 1.3 . . . . 15.0 114.51 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -114.22 169.71 8.82 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.851 -1.522 . . . . 15.0 112.474 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.61 44.46 2.47 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.322 1.049 . . . . 15.0 112.675 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.9 m -170.84 110.28 0.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.833 1.253 . . . . 15.0 113.263 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.4 t0 63.98 -36.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.153 2.581 . . . . 15.0 115.637 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 54.34 82.13 0.09 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.647 2.379 . . . . 15.0 115.227 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 117.33 130.76 4.43 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 111.426 -2.625 . . . . 15.0 111.401 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -119.19 148.24 43.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.048 -1.576 . . . . 15.0 109.983 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.8 97.42 10.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.681 -1.229 . . . . 15.0 107.681 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.6 t -94.96 125.13 39.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.211 -1.359 . . . . 15.0 107.947 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.54 150.08 24.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.944 -1.934 . . . . 15.0 111.818 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.02 -162.6 29.64 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 114.094 -1.412 . . . . 15.0 113.707 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.463 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.0 m -119.38 127.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.449 -1.876 . . . . 15.0 110.64 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.481 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 23.1 t -130.01 132.1 46.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.857 -1.519 . . . . 15.0 110.507 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.56 154.99 34.61 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.643 0.735 . . . . 15.0 111.793 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -115.48 135.18 54.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.383 -1.281 . . . . 15.0 112.119 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 90.9 m-85 61.62 156.86 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 113.355 -1.748 . . . . 15.0 115.373 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.08 89.69 1.52 Allowed Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.175 -1.375 . . . . 15.0 111.661 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -69.07 82.12 0.32 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.7 0.762 . . . . 15.0 112.861 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.55 133.88 1.82 Allowed Glycine 0 N--CA 1.477 1.412 0 CA-C-N 114.265 -1.334 . . . . 15.0 112.841 173.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.63 -23.11 66.12 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.487 1.662 . . . . 15.0 115.487 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -7.68 88.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 118.278 2.696 . . . . 15.0 118.278 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.242 0 CA-C-N 113.776 -1.556 . . . . 15.0 113.86 -179.41 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 115.564 1.69 . . . . 15.0 115.564 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.71 -46.37 1.81 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.062 2.508 . . . . 15.0 114.265 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 10.0 mmpt? -132.98 140.14 47.63 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.437 1.095 . . . . 15.0 109.263 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 10.7 t70 -173.18 100.03 0.12 Allowed 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.485 1.116 . . . . 15.0 110.178 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 57.5 49.8 12.21 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.838 1.255 . . . . 15.0 113.003 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m -98.02 124.63 42.61 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.422 -1.717 . . . . 15.0 108.263 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 21.4 m0 -97.86 130.42 44.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.389 -1.278 . . . . 15.0 111.027 -177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.405 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 97.6 m-85 -122.51 86.05 2.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.935 -1.939 . . . . 15.0 108.41 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -108.82 123.6 49.3 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.103 -1.408 . . . . 15.0 110.058 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.83 -144.52 4.14 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 125.019 1.449 . . . . 15.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.68 148.07 47.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -130.91 140.17 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 125.007 1.442 . . . . 15.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.1 tp -114.13 133.53 55.5 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.031 -1.441 . . . . 15.0 108.763 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.65 112.49 3.96 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 113.535 -1.666 . . . . 15.0 110.138 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -121.82 145.48 48.03 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.788 0.835 . . . . 15.0 110.833 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -130.32 145.48 51.78 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.308 -0.86 . . . . 15.0 111.259 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -79.94 79.34 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.055 0.931 . . . . 15.0 109.151 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -147.17 -82.36 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 112.846 -1.979 . . . . 15.0 111.281 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -116.18 136.84 52.65 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.402 0.681 . . . . 15.0 110.575 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.5 ptt-85 -65.77 -20.88 66.43 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.306 -1.315 . . . . 15.0 114.0 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -117.54 95.94 5.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.161 0.984 . . . . 15.0 109.683 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -173.69 -69.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.462 1.505 . . . . 15.0 111.048 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 54.8 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.652 1.581 . . . . 15.0 114.726 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.04 -37.54 80.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.477 -1.692 . . . . 15.0 114.556 -173.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.07 87.1 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 N-CA-C 118.0 1.96 . . . . 15.0 118.0 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.17 89.6 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.661 1.356 . . . . 15.0 114.661 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.43 -118.67 6.12 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.936 0.779 . . . . 15.0 111.9 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.42 137.99 39.94 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.306 -0.947 . . . . 15.0 110.112 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -117.6 113.66 22.26 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.643 -1.162 . . . . 15.0 111.143 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.3 101.42 1.04 Allowed Glycine 0 N--CA 1.476 1.342 0 CA-C-N 113.429 -1.714 . . . . 15.0 110.91 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.68 135.24 12.6 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 114.428 -0.886 . . . . 15.0 113.156 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -129.22 111.33 12.78 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.79 -1.205 . . . . 15.0 110.972 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.04 83.28 1.88 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.235 -0.893 . . . . 15.0 108.891 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 4' ' ' ASP . 59.8 t -69.26 -83.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.552 -1.658 . . . . 15.0 110.456 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -81.22 135.44 50.76 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 117.535 -1.221 . . . . 15.0 109.407 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 3' ' ' LYS . 72.7 Cg_endo -69.26 78.93 0.81 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.436 2.758 . . . . 15.0 112.08 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -177.05 -76.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.005 2.122 . . . . 15.0 108.955 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.35 135.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.123 0.969 . . . . 15.0 108.466 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.34 -168.13 12.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 113.91 -1.496 . . . . 15.0 110.794 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.74 148.23 52.56 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.788 1.032 . . . . 15.0 113.788 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HG2' ' HD3' ' A' ' 62' ' ' LYS . 70.9 mm-40 -127.26 127.21 44.02 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.239 -1.346 . . . . 15.0 110.644 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 90.9 mtp -116.64 134.45 54.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.158 -1.383 . . . . 15.0 110.608 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -115.72 114.17 3.06 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.215 -1.554 . . . . 15.0 109.215 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -116.57 122.32 44.32 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.871 0.843 . . . . 15.0 111.561 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -137.78 142.61 40.89 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.485 -1.689 . . . . 15.0 111.397 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -165.03 129.46 2.47 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.74 0.645 . . . . 15.0 112.74 173.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.75 6.81 18.31 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 112.344 -2.207 . . . . 15.0 113.862 165.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.95 72.83 1.55 Allowed Glycine 0 N--CA 1.476 1.346 0 C-N-CA 124.599 1.095 . . . . 15.0 112.253 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -88.26 77.43 8.23 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.457 1.122 . . . . 15.0 112.022 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.562 ' HG2' ' HB2' ' A' ' 52' ' ' ARG . 1.7 pmm? -170.73 156.92 5.19 Favored Pre-proline 0 N--CA 1.481 1.09 0 CA-C-N 113.206 -1.816 . . . . 15.0 109.838 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.35 83.15 0.37 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.631 2.221 . . . . 15.0 111.678 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.664 HH21 ' HB2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -169.32 145.32 3.28 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 112.68 -2.055 . . . . 15.0 107.809 -177.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.664 ' HB2' HH21 ' A' ' 52' ' ' ARG . 68.5 mttm -80.12 89.99 5.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.725 -0.671 . . . . 15.0 110.007 172.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' H ' ' NE2' ' A' ' 55' ' ' GLN . . . -133.01 56.69 1.84 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.542 -2.117 . . . . 15.0 110.014 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.456 ' NE2' ' H ' ' A' ' 54' ' ' ALA . 24.7 mp0 -126.74 146.64 50.15 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.028 -1.896 . . . . 15.0 109.909 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.04 17.26 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 124.285 0.991 . . . . 15.0 113.978 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 82' ' ' MET . 12.7 p -147.29 148.26 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 112.978 -1.611 . . . . 15.0 111.239 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -121.27 126.22 49.01 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.536 1.934 . . . . 15.0 109.374 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.585 ' H ' ' HB2' ' A' ' 82' ' ' MET . 3.5 tm? -117.34 111.19 19.02 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.934 -0.395 . . . . 15.0 109.934 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 41' ' ' GLU . 13.7 t -131.9 146.32 52.04 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.42 -0.809 . . . . 15.0 112.829 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -103.13 136.39 43.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.039 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 59.6 pttt -115.83 143.56 45.23 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.914 1.45 . . . . 15.0 114.914 -171.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.4 mt -115.5 136.41 53.11 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.925 -1.943 . . . . 15.0 110.058 169.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.42 111.92 4.2 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 124.744 1.277 . . . . 15.0 111.529 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 4.1 m-30 -110.69 105.0 56.89 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.933 1.293 . . . . 15.0 111.713 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.58 -145.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.052 2.502 . . . . 15.0 111.584 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 69.03 -68.97 0.17 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 127.487 2.315 . . . . 15.0 115.181 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 75' ' ' ILE . 28.4 tp -60.91 99.7 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.439 1.096 . . . . 15.0 113.596 -168.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.92 -85.74 0.44 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.827 -1.988 . . . . 15.0 109.461 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 t -179.1 171.36 1.36 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.406 1.482 . . . . 15.0 110.083 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -51.54 -31.09 22.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.669 1.729 . . . . 15.0 115.669 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.05 -29.41 63.4 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.338 1.236 . . . . 15.0 114.338 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.46 112.99 18.17 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.098 0.959 . . . . 15.0 111.423 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.54 134.26 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.08 -1.418 . . . . 15.0 109.721 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.495 HD11 ' HB3' ' A' ' 68' ' ' LEU . 4.5 mp -91.34 141.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.509 -1.678 . . . . 15.0 107.388 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -126.6 128.79 47.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.793 -1.094 . . . . 15.0 109.763 173.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.2 p -108.4 122.57 47.28 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.378 -1.283 . . . . 15.0 108.397 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.541 HH22 ' NE ' ' A' ' 127' ' ' ARG . 99.2 mtt180 -125.19 123.22 39.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.508 -2.133 . . . . 15.0 111.534 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.44 132.09 52.77 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.908 -1.042 . . . . 15.0 112.449 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.34 -140.18 5.77 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.967 -1.015 . . . . 15.0 113.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.01 140.87 3.0 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.187 1.375 . . . . 15.0 111.8 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.603 ' HB3' ' O ' ' A' ' 57' ' ' VAL 0.364 0.4 OUTLIER -156.91 164.33 38.16 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.515 -2.168 . . . . 15.0 112.659 159.424 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 103' ' ' SER . 18.8 m -97.99 125.97 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.234 0.959 . . . . 15.0 110.18 -172.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -109.68 152.7 25.27 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.484 -0.78 . . . . 15.0 112.858 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -95.96 96.61 9.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.779 -1.101 . . . . 15.0 110.455 -172.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -120.58 -87.59 0.64 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.595 -1.638 . . . . 15.0 114.063 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -157.69 147.08 19.91 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.143 0.977 . . . . 15.0 110.733 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.3 t -167.1 158.71 12.41 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.069 1.348 . . . . 15.0 110.733 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -123.51 158.92 30.22 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.379 1.05 . . . . 15.0 111.113 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.13 150.01 52.34 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.17 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? 64.84 132.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.347 1.859 . . . . 15.0 113.248 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -119.09 -79.19 0.59 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 113.728 -1.578 . . . . 15.0 110.723 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.82 96.51 0.11 Allowed Glycine 0 N--CA 1.475 1.251 0 N-CA-C 108.954 -1.658 . . . . 15.0 108.954 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.3 t30 72.07 162.61 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.385 1.474 . . . . 15.0 111.015 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.22 87.06 0.33 Allowed Glycine 0 N--CA 1.477 1.43 0 C-N-CA 124.96 1.267 . . . . 15.0 111.397 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -124.74 141.76 51.88 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.307 -0.946 . . . . 15.0 111.194 -176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 98' ' ' SER . 15.8 tt -171.97 -69.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 125.11 1.506 . . . . 15.0 112.38 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.404 ' H ' HG23 ' A' ' 97' ' ' ILE . 57.3 p -167.59 -71.0 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.592 1.157 . . . . 15.0 112.691 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 67.0 142.75 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.575 2.35 . . . . 15.0 113.75 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.34 84.82 1.44 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.46 -1.245 . . . . 15.0 113.108 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.95 36.33 0.09 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.18 -1.373 . . . . 15.0 114.613 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.31 147.7 23.91 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.172 1.389 . . . . 15.0 110.519 -174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.435 ' HB3' HG12 ' A' ' 83' ' ' VAL . 17.1 t -70.86 143.38 51.07 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.21 -0.905 . . . . 15.0 112.142 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.49 167.9 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 113.988 -1.46 . . . . 15.0 111.264 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m 68.14 148.53 0.12 Allowed Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 125.918 1.687 . . . . 15.0 114.368 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -61.19 142.05 95.37 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.651 2.234 . . . . 15.0 113.102 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.87 136.72 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 112.838 -1.983 . . . . 15.0 107.216 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.55 129.66 54.78 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.408 -1.724 . . . . 15.0 110.13 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -122.65 131.54 53.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.102 -1.408 . . . . 15.0 112.061 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.38 99.04 0.92 Allowed Glycine 0 N--CA 1.475 1.278 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.786 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -115.5 145.52 18.7 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 124.79 0.936 . . . . 15.0 112.85 -174.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 127' ' ' ARG . 19.2 m -121.59 138.46 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.716 -0.742 . . . . 15.0 112.042 171.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.28 109.34 19.76 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.077 -1.874 . . . . 15.0 107.94 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -120.59 136.08 54.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.716 -1.584 . . . . 15.0 111.64 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.39 107.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.46 -1.7 . . . . 15.0 110.689 171.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.9 tp -113.22 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 122.837 1.303 . . . . 15.0 111.648 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.664 ' HD3' HG21 ' A' ' 121' ' ' THR . 47.9 mtt-85 -122.23 -30.79 3.95 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.791 2.515 . . . . 15.0 117.791 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.27 -28.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 118.456 2.762 . . . . 15.0 118.456 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 47.7 mtt-85 -101.09 149.71 23.68 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.393 1.077 . . . . 15.0 112.244 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.43 ' H ' HG13 ' A' ' 120' ' ' ILE . 16.9 mt -11.78 -81.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 128.311 2.644 . . . . 15.0 113.735 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.664 HG21 ' HD3' ' A' ' 117' ' ' ARG . 67.8 p 58.49 159.61 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 126.233 1.813 . . . . 15.0 115.489 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.64 161.87 33.79 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.655 2.236 . . . . 15.0 111.415 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -68.46 78.21 0.27 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.215 1.006 . . . . 15.0 112.191 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mm -120.94 105.35 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.595 1.158 . . . . 15.0 109.486 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.3 120.49 40.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.571 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -80.78 117.01 21.07 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.921 -1.036 . . . . 15.0 109.359 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.541 ' NE ' HH22 ' A' ' 78' ' ' ARG . 33.6 mtt180 -115.21 119.91 37.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.626 -1.17 . . . . 15.0 112.721 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.48 118.04 28.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.054 -1.43 . . . . 15.0 110.39 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 31.3 tt0 -120.65 132.98 55.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 112.727 -2.033 . . . . 15.0 111.285 -171.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 76.3 m-85 -97.4 128.22 44.02 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.302 -1.317 . . . . 15.0 110.336 171.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.717 ' HB3' ' HB2' ' A' ' 141' ' ' MET . 48.1 tt0 -109.85 108.76 19.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.432 -1.713 . . . . 15.0 109.108 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -117.93 146.58 43.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.599 -2.091 . . . . 15.0 112.066 -174.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 m -133.2 -78.16 0.48 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.138 -1.392 . . . . 15.0 111.791 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -173.25 -57.13 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.222 1.009 . . . . 15.0 110.973 -173.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -56.14 155.56 6.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.369 1.068 . . . . 15.0 110.287 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 139' ' ' ASN . . . 64.16 95.82 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.899 2.08 . . . . 15.0 112.611 -168.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.0 m -49.3 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.435 -1.711 . . . . 15.0 113.409 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 62.76 26.58 15.68 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 113.393 -1.73 . . . . 15.0 114.379 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.411 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 6.0 t-20 -129.61 169.13 15.43 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.272 1.029 . . . . 15.0 109.6 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -176.51 -152.8 10.01 Favored Glycine 0 N--CA 1.477 1.414 0 CA-C-O 122.033 0.796 . . . . 15.0 113.174 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.717 ' HB2' ' HB3' ' A' ' 131' ' ' GLN . 48.1 mtt -117.6 148.26 42.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.716 -1.242 . . . . 15.0 110.925 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.03 112.32 18.11 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.98 -1.009 . . . . 15.0 110.055 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.1 m -105.86 125.09 50.58 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.69 -1.595 . . . . 15.0 107.348 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 pp -132.65 141.1 48.47 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.84 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.13 -162.46 29.35 Favored Glycine 0 N--CA 1.473 1.121 0 O-C-N 124.191 0.932 . . . . 15.0 113.509 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.07 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.606 -1.297 . . . . 15.0 109.442 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 62.5 p -115.85 138.25 51.34 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.89 1.369 . . . . 15.0 110.731 170.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -111.51 135.22 52.38 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.009 -1.45 . . . . 15.0 110.768 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 45.8 ttm180 -78.86 123.93 27.72 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.544 -1.207 . . . . 15.0 108.562 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 7' ' ' TRP . 88.7 t80 -35.28 -74.97 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 O-C-N 125.347 1.654 . . . . 15.0 115.377 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 44.97 -121.28 4.33 Favored Glycine 0 N--CA 1.48 1.603 0 C-N-CA 125.137 1.351 . . . . 15.0 112.918 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -72.21 88.8 1.15 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.105 -1.048 . . . . 15.0 111.271 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.15 -146.42 0.14 Allowed Glycine 0 CA--C 1.539 1.586 0 CA-C-N 113.142 -1.844 . . . . 15.0 112.747 168.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.93 84.07 0.49 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.411 1.1 . . . . 15.0 113.424 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.81 84.51 4.12 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.15 -1.387 . . . . 15.0 111.3 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.261 0 CA-C-N 113.701 -1.591 . . . . 15.0 114.19 -179.771 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 114.823 1.416 . . . . 15.0 114.823 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.91 146.14 29.2 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.938 2.425 . . . . 15.0 112.138 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' HD3' ' HD3' ' A' ' 36' ' ' PRO . 2.3 ttmp? 64.31 164.11 0.13 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.169 1.788 . . . . 15.0 112.61 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 41.3 m-20 68.88 86.35 0.13 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.209 1.804 . . . . 15.0 112.505 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 66.06 41.99 3.41 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 111.759 -2.473 . . . . 15.0 113.501 -174.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 p -98.19 140.07 33.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.785 -1.098 . . . . 15.0 112.907 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -110.35 131.08 55.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.766 -2.015 . . . . 15.0 110.184 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.47 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 5.5 m-85 -124.1 131.28 53.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.617 -1.629 . . . . 15.0 108.978 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -126.96 133.43 50.6 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.496 0.718 . . . . 15.0 111.623 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -172.94 -146.23 5.34 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-N 115.191 -0.913 . . . . 15.0 113.191 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.42 150.1 51.79 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.423 0.898 . . . . 15.0 113.423 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.32 142.91 50.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.454 1.096 . . . . 15.0 112.727 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.6 tp -114.05 140.4 48.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.199 -1.819 . . . . 15.0 108.8 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.4 127.41 7.73 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.153 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 10.2 t-105 -118.33 141.15 48.82 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.463 -0.868 . . . . 15.0 110.948 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 t -108.73 105.2 14.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.528 -1.214 . . . . 15.0 109.818 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -52.79 -44.11 66.35 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.975 -1.466 . . . . 15.0 111.753 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -65.66 -49.15 69.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.111 0.964 . . . . 15.0 113.297 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -103.2 83.65 2.23 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.747 1.26 . . . . 15.0 112.045 -172.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HG2' ' HG3' ' A' ' 21' ' ' GLU . 53.8 ttt85 -5.98 -81.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.04 2.936 . . . . 15.0 117.614 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 40.6 mt-10 -125.4 92.01 3.53 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.89 0.852 . . . . 15.0 111.802 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -114.18 91.63 3.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.457 -1.247 . . . . 15.0 112.918 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.7 87.94 1.27 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.911 -1.495 . . . . 15.0 111.573 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -106.37 -41.41 5.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.993 -1.912 . . . . 15.0 112.848 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.62 -151.4 18.42 Favored Glycine 0 N--CA 1.476 1.308 0 O-C-N 123.905 0.753 . . . . 15.0 112.1 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.33 148.49 50.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.755 -1.223 . . . . 15.0 111.299 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.54 -166.64 16.29 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.776 1.297 . . . . 15.0 110.556 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.01 49.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.501 0.667 . . . . 15.0 111.44 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.01 113.37 19.48 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.722 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.72 112.0 3.95 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 112.732 -2.031 . . . . 15.0 110.198 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.84 142.88 15.95 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 110.702 -0.959 . . . . 15.0 110.702 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 11.4 t80 -141.11 132.67 27.04 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.104 -0.548 . . . . 15.0 111.124 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -121.41 94.1 4.22 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.966 0.888 . . . . 15.0 110.617 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 4' ' ' ASP . 7.1 p -68.31 -63.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.483 -2.144 . . . . 15.0 111.688 174.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -143.82 144.85 28.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.43 1.492 . . . . 15.0 109.618 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD3' ' HD3' ' A' ' 3' ' ' LYS . 73.4 Cg_endo -67.98 89.5 0.37 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.488 2.792 . . . . 15.0 111.768 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 t80 172.7 -48.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.51 -2.132 . . . . 15.0 109.058 -169.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 48.3 t -131.52 124.02 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.154 0.982 . . . . 15.0 108.83 175.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.37 148.23 16.72 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.924 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 78.5 m-85 -112.78 136.66 52.15 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.1 0.778 . . . . 15.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.54 114.21 14.0 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.843 -1.526 . . . . 15.0 112.034 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.4 ttp -104.08 128.66 51.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.686 -1.597 . . . . 15.0 109.062 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.25 114.16 3.9 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 113.88 -1.509 . . . . 15.0 109.751 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.66 109.44 18.6 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.407 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -121.2 124.08 43.81 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.559 -1.2 . . . . 15.0 111.361 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -125.11 145.18 50.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.753 -1.567 . . . . 15.0 109.783 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 42.1 tp -68.39 99.59 0.96 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.775 -0.648 . . . . 15.0 112.359 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.05 65.62 0.14 Allowed Glycine 0 CA--C 1.541 1.69 0 CA-C-N 114.044 -1.435 . . . . 15.0 113.437 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -169.43 -94.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 128.864 2.866 . . . . 15.0 107.165 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.3 mtt -126.19 93.13 44.15 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.594 0.758 . . . . 15.0 111.19 167.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 47' ' ' LEU . 83.2 Cg_endo -67.0 -17.94 51.57 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.544 2.829 . . . . 15.0 115.809 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -0.3 87.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.014 2.526 . . . . 15.0 117.656 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.12 20.15 4.24 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 117.809 2.522 . . . . 15.0 117.809 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.11 86.9 2.26 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.493 1.139 . . . . 15.0 113.316 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 pm0 -115.34 154.83 28.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.438 -1.256 . . . . 15.0 112.309 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.47 118.41 4.37 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 114.578 -1.192 . . . . 15.0 111.114 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.65 127.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 122.193 0.997 . . . . 15.0 111.687 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 82' ' ' MET . 0.3 OUTLIER -116.54 140.79 48.99 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.114 -1.403 . . . . 15.0 112.035 174.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.21 111.14 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.185 -1.825 . . . . 15.0 109.011 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -124.65 134.74 52.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.146 0.975 . . . . 15.0 112.621 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.16 46.09 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.836 -1.529 . . . . 15.0 110.79 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 1.8 ttpm? -84.18 129.15 34.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.301 -1.772 . . . . 15.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.675 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 41.7 tp -108.95 114.58 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.505 -2.134 . . . . 15.0 107.691 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 76' ' ' TYR . . . 127.94 -147.38 17.24 Favored Glycine 0 CA--C 1.541 1.692 0 O-C-N 126.346 2.279 . . . . 15.0 113.941 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 43.3 t80 160.81 -60.5 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 116.546 -1.692 . . . . 15.0 112.821 -160.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -79.15 -147.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.447 2.764 . . . . 15.0 112.788 -167.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 53.98 84.76 0.06 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.291 1.836 . . . . 15.0 110.053 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp 69.36 -26.13 0.15 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.245 1.418 . . . . 15.0 114.54 -165.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.83 64.22 0.19 Allowed Glycine 0 N--CA 1.483 1.786 0 C-N-CA 124.949 1.261 . . . . 15.0 114.312 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.89 37.77 3.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.038 1.335 . . . . 15.0 109.458 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -167.52 -63.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.386 1.074 . . . . 15.0 112.475 -172.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 114' ' ' TYR . 4.7 m-20 -56.62 -49.46 74.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.524 0.935 . . . . 15.0 113.524 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER 141.82 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 130.372 3.469 . . . . 15.0 107.385 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.528 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 7.7 m-20 -113.34 105.35 13.29 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.924 -0.485 . . . . 15.0 110.307 -174.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.616 ' HB ' HG12 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -119.85 111.0 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.656 -1.239 . . . . 15.0 107.656 176.014 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.675 ' HB3' ' O ' ' A' ' 63' ' ' LEU 0.437 0.2 OUTLIER -169.01 -171.74 1.4 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 111.384 -2.644 . . . . 15.0 114.773 -177.474 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.9 t -108.12 139.48 42.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.223 1.011 . . . . 15.0 110.585 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HG3' ' HB3' ' A' ' 109' ' ' ALA . 9.8 ptp180 -118.95 139.69 51.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.033 -1.894 . . . . 15.0 114.147 -170.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 108' ' ' PHE . 2.7 pp -125.19 143.48 50.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 112.07 -2.332 . . . . 15.0 111.015 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.42 -154.45 11.75 Favored Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.33 1.019 . . . . 15.0 114.671 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.12 151.52 21.83 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 113.567 -1.316 . . . . 15.0 114.059 -173.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 58' ' ' GLN . 90.1 mtp -116.54 115.41 25.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.588 1.555 . . . . 15.0 110.361 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.18 132.59 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 114.943 -1.026 . . . . 15.0 108.905 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -120.56 140.98 50.71 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.79 -1.095 . . . . 15.0 110.041 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.85 85.8 0.96 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 122.694 1.235 . . . . 15.0 112.75 173.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.43 83.72 3.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.557 -1.656 . . . . 15.0 112.167 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.4 -24.76 62.99 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.317 1.969 . . . . 15.0 116.317 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 t -89.93 142.19 27.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.623 0.972 . . . . 15.0 113.623 -171.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -172.55 155.79 3.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.813 1.645 . . . . 15.0 110.482 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -139.01 148.77 43.86 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.802 0.841 . . . . 15.0 111.756 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -114.01 128.01 56.2 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.92 0.762 . . . . 15.0 110.064 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -126.13 157.2 38.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.636 -1.62 . . . . 15.0 107.97 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.24 68.75 0.35 Allowed Glycine 0 N--CA 1.482 1.742 0 C-N-CA 125.032 1.301 . . . . 15.0 113.171 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -115.8 92.93 4.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.532 -1.334 . . . . 15.0 109.393 -171.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.8 44.75 0.29 Allowed Glycine 0 N--CA 1.485 1.913 0 C-N-CA 124.821 1.201 . . . . 15.0 114.763 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -170.66 35.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.835 2.054 . . . . 15.0 113.286 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.9 tp -117.56 129.8 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 116.007 -0.542 . . . . 15.0 111.131 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.8 t -171.61 167.85 6.46 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.288 1.435 . . . . 15.0 110.304 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 53.13 88.48 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.913 2.085 . . . . 15.0 116.089 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.78 129.59 51.29 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.693 -1.594 . . . . 15.0 110.106 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -166.56 146.94 6.02 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.444 1.098 . . . . 15.0 112.191 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.1 140.21 54.8 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.221 0.95 . . . . 15.0 111.894 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p -74.52 138.18 42.97 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.106 -0.952 . . . . 15.0 113.057 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -59.4 -32.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 15.0 113.263 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.81 84.62 0.19 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 127.265 2.226 . . . . 15.0 112.595 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -63.33 133.87 42.44 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.685 2.257 . . . . 15.0 112.747 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.33 138.02 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.422 -1.717 . . . . 15.0 109.695 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -122.88 129.86 52.15 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.636 -1.165 . . . . 15.0 111.817 175.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.565 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -133.7 147.32 51.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.281 -1.327 . . . . 15.0 111.149 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 138.64 10.75 Favored Glycine 0 N--CA 1.48 1.619 0 CA-C-O 119.011 -0.883 . . . . 15.0 111.221 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.14 -158.08 25.42 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 118.208 2.043 . . . . 15.0 118.208 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' HB ' ' A' ' 75' ' ' ILE . 33.0 m -120.67 130.66 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 111.911 -2.144 . . . . 15.0 111.556 -171.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.87 125.4 48.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.184 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 60.0 t80 -108.48 139.19 43.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 111.9 -2.409 . . . . 15.0 108.633 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 11.8 p -129.11 145.61 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 113.908 -1.496 . . . . 15.0 107.833 168.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 0.3 OUTLIER -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 124.483 1.114 . . . . 15.0 113.152 -177.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -80.64 -89.14 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.465 -2.152 . . . . 15.0 109.364 175.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 108.98 8.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.222 0.609 . . . . 15.0 109.81 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -167.71 164.55 14.4 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.568 -1.197 . . . . 15.0 111.37 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.1 mt -53.08 131.49 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.511 1.524 . . . . 15.0 109.95 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.6 m 55.83 79.84 0.32 Allowed Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 125.58 1.552 . . . . 15.0 109.68 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.46 80.36 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.633 2.888 . . . . 15.0 113.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 14.2 pt-20 -162.36 22.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.802 1.779 . . . . 15.0 115.802 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.524 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 20.4 mt -116.7 108.15 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.92 -0.487 . . . . 15.0 110.542 -169.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -110.68 143.13 41.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.024 -0.989 . . . . 15.0 111.031 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.8 m -139.63 116.93 11.24 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.254 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.24 137.61 52.08 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.832 -1.076 . . . . 15.0 112.78 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.34 120.02 16.17 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.774 -1.103 . . . . 15.0 112.089 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -137.29 142.33 41.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 112.547 -2.115 . . . . 15.0 112.879 -174.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 79.2 m-85 -97.43 112.57 24.35 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.218 -1.355 . . . . 15.0 110.053 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -108.04 130.86 55.05 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.887 1.367 . . . . 15.0 113.695 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.429 ' HZ3' ' HB3' ' A' ' 130' ' ' TYR . 1.3 m-90 -120.51 120.37 35.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.492 -1.685 . . . . 15.0 112.289 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 139' ' ' ASN . 60.3 p -81.99 -36.82 27.46 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 113.594 -1.639 . . . . 15.0 111.372 164.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 63.4 t30 58.18 96.64 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.529 1.932 . . . . 15.0 110.534 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 85.74 162.81 0.09 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.878 2.471 . . . . 15.0 111.673 -167.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 61.36 -169.17 0.17 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.37 1.868 . . . . 15.0 113.055 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.8 t -60.86 157.33 15.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.781 0.832 . . . . 15.0 112.233 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 69.54 -53.91 0.6 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.004 2.122 . . . . 15.0 114.04 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.442 ' HA ' ' OG1' ' A' ' 133' ' ' THR . 66.1 t30 52.09 -132.69 1.91 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.562 1.545 . . . . 15.0 111.902 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.23 95.77 1.08 Allowed Glycine 0 N--CA 1.478 1.436 0 C-N-CA 125.17 1.366 . . . . 15.0 112.042 171.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 9.6 ttt -126.15 148.18 49.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.919 0.888 . . . . 15.0 111.904 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 6.4 tt -88.38 126.75 35.36 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.192 -1.41 . . . . 15.0 107.192 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.2 t -120.4 125.35 47.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.774 0.797 . . . . 15.0 111.163 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.1 tp -121.19 126.87 50.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.705 -1.589 . . . . 15.0 109.332 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.38 138.17 10.33 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 114.482 -1.235 . . . . 15.0 112.813 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.1 m -125.55 127.61 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 113.91 -1.145 . . . . 15.0 110.651 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.409 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 14.5 p -134.6 155.81 49.81 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.742 1.386 . . . . 15.0 114.742 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.69 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 12.1 m-85 -114.1 139.32 49.4 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.228 -1.806 . . . . 15.0 111.24 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -70.25 157.41 37.73 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.198 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -51.8 144.64 10.91 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.003 . . . . 15.0 111.565 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.27 105.05 0.42 Allowed Glycine 0 N--CA 1.477 1.401 0 C-N-CA 125.762 1.649 . . . . 15.0 114.067 -173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -63.57 130.6 45.02 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.201 -1.0 . . . . 15.0 111.788 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -63.72 157.64 41.57 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-N 113.664 -1.607 . . . . 15.0 113.073 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -55.19 134.23 49.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.739 1.215 . . . . 15.0 111.422 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -107.95 145.44 33.83 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.313 -1.312 . . . . 15.0 110.866 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 CA-C-O 117.021 -1.466 . . . . 15.0 113.809 -179.2 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 122.696 1.236 . . . . 15.0 111.614 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.9 p -116.31 158.79 22.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.584 -1.644 . . . . 15.0 111.801 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.951 ' HB3' ' HA ' ' A' ' 150' ' ' PHE . 1.8 t90 -94.23 140.45 29.76 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.287 1.041 . . . . 15.0 111.76 -172.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -115.28 105.86 13.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.068 1.747 . . . . 15.0 109.234 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 m -124.33 118.2 26.21 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.6 161.81 28.58 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 115.151 0.82 . . . . 15.0 115.151 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.71 50.88 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.39 -0.905 . . . . 15.0 110.516 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -151.66 150.77 30.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.177 1.177 . . . . 15.0 114.177 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.69 133.46 55.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.287 -1.324 . . . . 15.0 112.66 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -124.6 151.09 17.2 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.307 -1.769 . . . . 15.0 114.984 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -126.06 140.76 52.33 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.515 -1.342 . . . . 15.0 111.557 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.7 p -113.2 144.33 42.86 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.18 1.467 . . . . 15.0 114.51 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -54.54 120.51 6.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.782 -2.008 . . . . 15.0 111.025 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.6 t80 58.86 41.63 21.07 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.228 -1.351 . . . . 15.0 113.727 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -67.18 80.56 0.13 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.34 1.067 . . . . 15.0 113.69 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -61.69 -37.29 83.57 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.194 -1.367 . . . . 15.0 114.112 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -82.72 141.96 32.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.133 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -70.28 87.09 0.6 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.303 1.002 . . . . 15.0 110.573 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -143.15 129.49 19.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.984 -1.916 . . . . 15.0 108.991 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.13 132.59 56.0 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.054 -1.43 . . . . 15.0 108.125 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.65 46.47 1.11 Allowed Glycine 0 N--CA 1.48 1.584 0 C-N-CA 125.099 1.333 . . . . 15.0 115.095 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.71 92.99 1.6 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.734 1.214 . . . . 15.0 109.192 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.33 139.57 14.29 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.189 -1.823 . . . . 15.0 112.903 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 121.2 41.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.725 -1.737 . . . . 15.0 106.928 171.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' MET . 21.4 m-85 -111.86 113.42 25.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.916 -1.493 . . . . 15.0 110.734 -173.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.99 146.51 16.15 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 112.453 -2.158 . . . . 15.0 110.243 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.27 -154.5 20.51 Favored Glycine 0 N--CA 1.473 1.165 0 CA-C-N 114.546 -0.827 . . . . 15.0 112.837 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 141.83 34.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 113.257 -1.471 . . . . 15.0 112.807 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -117.0 98.14 6.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.654 1.216 . . . . 15.0 110.772 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 m -79.74 -38.68 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 112.934 -1.939 . . . . 15.0 115.636 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -139.96 154.22 70.31 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 118.696 -0.669 . . . . 15.0 112.745 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.44 66.64 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 15.0 110.485 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.43 -79.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.792 2.037 . . . . 15.0 108.488 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.58 145.22 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.145 1.165 . . . . 15.0 114.145 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.36 -179.98 25.67 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 112.61 -2.086 . . . . 15.0 110.721 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.82 133.64 55.31 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.142 -0.529 . . . . 15.0 112.414 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 26.7 tt0 -129.49 128.83 43.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.339 -1.301 . . . . 15.0 110.673 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 67.1 mtm -123.21 139.33 54.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.381 -0.827 . . . . 15.0 110.586 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.04 114.17 2.44 Favored Glycine 0 N--CA 1.476 1.322 0 O-C-N 124.61 1.194 . . . . 15.0 111.778 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 46' ' ' TRP . 72.5 t80 -107.02 109.52 21.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.465 1.106 . . . . 15.0 111.235 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -113.7 118.45 34.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.49 -1.232 . . . . 15.0 108.768 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.477 ' HB2' ' CE2' ' A' ' 44' ' ' TYR . 24.0 t90 -114.84 119.16 35.65 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.984 -1.007 . . . . 15.0 110.84 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 18.7 tp . . . . . 0 N--CA 1.474 0.774 0 CA-C-N 114.556 -1.202 . . . . 15.0 110.983 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 122.486 1.136 . . . . 15.0 110.744 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -93.95 103.14 15.24 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.389 -2.187 . . . . 15.0 110.292 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.03 2.34 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 108.892 -1.683 . . . . 15.0 108.892 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 t -117.83 133.15 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 114.467 -0.867 . . . . 15.0 109.735 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.736 HE22 ' NH1' ' A' ' 78' ' ' ARG . 13.7 pt20 -109.7 139.52 44.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.486 -1.234 . . . . 15.0 111.487 170.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.32 111.05 17.28 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.489 -1.687 . . . . 15.0 108.893 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.416 HG21 ' CZ ' ' A' ' 78' ' ' ARG . 39.9 p -131.29 146.74 52.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.003 -1.453 . . . . 15.0 113.301 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -100.37 128.37 46.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.018 -1.446 . . . . 15.0 108.146 172.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.43 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.1 pttm -113.5 136.53 52.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.62 -1.173 . . . . 15.0 112.857 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 3.2 tt -105.98 108.41 19.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.532 -1.667 . . . . 15.0 108.226 172.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.88 98.12 2.11 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.011 -1.904 . . . . 15.0 109.363 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -117.21 138.22 24.7 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.975 -1.112 . . . . 15.0 111.761 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HA ' ' OD2' ' A' ' 74' ' ' ASP . 58.4 Cg_endo -64.22 -37.7 39.67 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.252 2.635 . . . . 15.0 115.814 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 tptt 49.92 32.06 5.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.838 1.655 . . . . 15.0 114.762 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.45 47.87 23.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.978 1.311 . . . . 15.0 114.138 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 73' ' ' LEU . . . -63.46 84.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.651 0 C-N-CA 124.257 0.932 . . . . 15.0 112.26 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -67.88 28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.938 2.94 . . . . 15.0 118.938 -165.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -169.82 -68.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.881 2.072 . . . . 15.0 107.775 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -170.05 87.48 0.14 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.009 1.324 . . . . 15.0 108.47 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.407 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 19.6 tp -159.35 141.09 13.27 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.334 171.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD2' ' HA ' ' A' ' 66' ' ' PRO . 10.7 m-20 -138.1 150.45 46.88 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.277 -1.328 . . . . 15.0 110.923 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 tt -108.68 140.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.394 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 51.5 p90 -125.71 128.73 48.24 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.548 -1.205 . . . . 15.0 109.33 169.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.4 m -113.66 122.54 47.47 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.46 -1.311 . . . . 15.0 107.46 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.736 ' NH1' HE22 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -120.67 123.29 42.39 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.057 -1.429 . . . . 15.0 113.108 -175.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 136.78 54.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.995 -1.457 . . . . 15.0 110.941 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.39 -143.21 7.47 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.448 1.092 . . . . 15.0 113.272 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 105' ' ' SER . . . -130.25 143.9 15.18 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 114.047 -1.077 . . . . 15.0 114.066 -174.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 25.5 ptt? -116.11 120.15 38.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.165 0.983 . . . . 15.0 112.93 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.67 140.82 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 113.359 -1.746 . . . . 15.0 108.493 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 18.7 p90 . . . . . 0 N--CA 1.474 0.762 0 CA-C-N 114.83 -1.077 . . . . 15.0 108.614 177.298 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.9 p . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 114.973 1.471 . . . . 15.0 114.973 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -71.46 137.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 113.398 -1.728 . . . . 15.0 111.461 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 78.8 p -120.09 117.94 31.79 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.372 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.6 101.78 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.096 2.531 . . . . 15.0 112.278 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.531 ' HB ' ' NE2' ' A' ' 131' ' ' GLN . 16.4 m -125.02 130.87 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.19 -1.823 . . . . 15.0 113.112 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -127.96 131.36 49.29 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 113.749 -1.569 . . . . 15.0 111.114 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 131' ' ' GLN . . . -128.77 143.73 50.99 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.722 1.008 . . . . 15.0 113.722 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.56 108.63 2.12 Favored Glycine 0 N--CA 1.474 1.217 0 CA-C-N 112.932 -1.94 . . . . 15.0 108.732 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -119.5 144.11 17.42 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.723 -0.739 . . . . 15.0 112.955 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.49 137.17 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 114.539 -0.831 . . . . 15.0 111.633 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -125.4 139.33 53.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.241 -1.799 . . . . 15.0 113.757 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -117.87 141.81 48.02 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 112.694 -2.048 . . . . 15.0 109.255 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.7 m -105.69 132.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.158 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 pt -62.2 95.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.104 1.89 . . . . 15.0 116.104 -171.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -78.6 82.9 4.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.503 1.144 . . . . 15.0 109.58 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.3 ttt-85 -175.38 -143.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.393 2.277 . . . . 15.0 107.366 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.34 99.85 0.15 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.829 1.252 . . . . 15.0 112.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.6 mt 64.63 85.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.715 2.006 . . . . 15.0 111.401 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 m -59.86 -45.78 98.28 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 117.188 -1.386 . . . . 15.0 114.076 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.89 70.75 6.89 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.938 1.759 . . . . 15.0 111.531 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 36.1 tt0 -138.74 -83.84 0.28 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.188 -1.823 . . . . 15.0 108.834 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.74 143.51 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.663 0.986 . . . . 15.0 113.663 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.42 123.53 48.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.611 -2.086 . . . . 15.0 109.406 172.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.455 ' HA ' HG12 ' A' ' 146' ' ' VAL . 11.9 m -80.83 116.87 21.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.423 -1.695 . . . . 15.0 106.423 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -125.49 135.44 52.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.104 -1.407 . . . . 15.0 113.749 -172.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.98 111.07 13.14 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.648 -2.069 . . . . 15.0 110.327 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.518 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 21.9 tt0 -114.67 135.24 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.984 -1.916 . . . . 15.0 110.156 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -115.31 107.17 14.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.69 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 0.0 OUTLIER -96.62 114.76 26.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 112.581 -2.099 . . . . 15.0 109.73 -170.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -118.77 146.57 44.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.326 1.232 . . . . 15.0 114.326 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.478 0.96 0 CA-C-N 113.268 -1.787 . . . . 15.0 112.363 172.152 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.212 0 CA-C-O 122.423 1.013 . . . . 15.0 114.639 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.69 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 56.9 ttm -117.79 137.14 52.94 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.287 -1.456 . . . . 15.0 109.141 170.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.93 101.94 11.17 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.165 -1.38 . . . . 15.0 109.98 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.436 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 57.0 m -109.98 125.14 52.56 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.892 -1.504 . . . . 15.0 110.616 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.85 140.89 44.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.441 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.04 -162.57 29.59 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 114.801 -1.091 . . . . 15.0 113.585 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 126' ' ' THR . 15.1 m -128.4 139.72 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 113.846 -1.177 . . . . 15.0 112.547 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 p -115.16 134.25 55.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.527 -1.215 . . . . 15.0 112.217 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 41.9 t80 -103.53 135.09 45.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.331 -1.304 . . . . 15.0 109.195 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -73.69 124.97 27.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.178 -1.828 . . . . 15.0 112.033 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 7' ' ' TRP . 55.1 m-85 . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 126.504 1.922 . . . . 15.0 111.806 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 121.025 0.44 . . . . 15.0 111.308 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 150' ' ' PHE . 4.7 p -148.39 139.38 23.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.579 -1.191 . . . . 15.0 111.195 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -127.86 136.21 51.1 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.91 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -125.72 127.57 46.41 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.131 -1.395 . . . . 15.0 110.728 168.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -126.6 137.93 53.38 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.524 -1.217 . . . . 15.0 111.19 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.51 -149.93 9.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 124.275 0.984 . . . . 15.0 113.847 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -160.77 139.25 9.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.906 1.282 . . . . 15.0 111.185 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.342 18.2 tptt -171.91 169.59 5.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.518 1.527 . . . . 15.0 113.205 166.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.458 HD23 ' HG3' ' A' ' 12' ' ' LYS . 1.5 pt? -114.73 161.73 17.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.178 0.991 . . . . 15.0 113.199 -164.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -122.8 140.73 13.43 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.484 -1.234 . . . . 15.0 111.719 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -118.41 145.39 45.23 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.582 0.813 . . . . 15.0 110.858 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 p -93.85 126.13 38.86 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -49.8 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.646 1.978 . . . . 15.0 114.703 -173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 49.58 25.91 1.58 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 116.273 1.953 . . . . 15.0 116.273 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 t -110.03 -39.41 5.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.294 -1.321 . . . . 15.0 113.003 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 72.36 -30.98 0.22 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.958 1.703 . . . . 15.0 113.165 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -59.54 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.08 1.352 . . . . 15.0 113.238 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -168.12 129.4 1.39 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.892 -1.958 . . . . 15.0 110.127 164.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.0 31.94 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.64 -1.618 . . . . 15.0 113.056 167.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -165.51 142.29 5.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.787 1.403 . . . . 15.0 114.787 -170.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.16 -92.38 0.6 Allowed Glycine 0 N--CA 1.475 1.289 0 CA-C-N 113.777 -1.556 . . . . 15.0 112.782 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 158.14 6.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.762 1.225 . . . . 15.0 113.745 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 -124.79 1.52 Allowed Glycine 0 N--CA 1.477 1.399 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.882 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.47 121.61 42.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.61 -0.795 . . . . 15.0 110.698 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 147' ' ' SER . 35.6 p90 -125.23 146.49 49.5 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.921 1.822 . . . . 15.0 115.921 -168.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.24 104.29 1.24 Allowed Glycine 0 CA--C 1.535 1.282 0 CA-C-N 111.769 -2.468 . . . . 15.0 108.527 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.53 100.77 1.09 Allowed Glycine 0 N--CA 1.476 1.332 0 N-CA-C 110.117 -1.193 . . . . 15.0 110.117 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -114.57 145.09 42.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.321 0.581 . . . . 15.0 110.807 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.643 HE21 ' HE3' ' A' ' 62' ' ' LYS . 5.3 tt0 -120.84 136.17 54.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.957 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -104.56 -34.55 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 113.607 -1.633 . . . . 15.0 113.755 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -121.0 134.77 24.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 106.574 -1.639 . . . . 15.0 106.574 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.63 84.09 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.137 2.558 . . . . 15.0 111.288 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 158.82 -41.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 128.182 2.593 . . . . 15.0 111.195 -165.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.83 138.83 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.811 1.411 . . . . 15.0 114.811 -171.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 33' ' ' GLN . . . -162.11 -154.6 7.6 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 112.412 -2.176 . . . . 15.0 110.824 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -143.28 145.45 32.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.804 0.811 . . . . 15.0 111.862 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.408 ' OE1' ' HG2' ' A' ' 78' ' ' ARG . 9.9 pt-20 -128.23 129.78 46.94 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.353 -1.294 . . . . 15.0 113.053 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -120.61 114.35 21.59 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.983 -1.462 . . . . 15.0 110.655 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.65 114.06 3.97 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 124.607 1.192 . . . . 15.0 110.71 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -102.84 141.17 36.09 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.178 0.99 . . . . 15.0 111.278 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -137.22 130.25 30.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.872 -1.967 . . . . 15.0 112.367 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 12.4 t90 -122.63 137.2 54.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.202 -1.817 . . . . 15.0 108.512 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 122.697 1.237 . . . . 15.0 108.982 -173.055 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HA ' ' CE2' ' A' ' 84' ' ' TRP . . . . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 113.361 0.874 . . . . 15.0 113.361 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 49.96 42.64 24.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.922 1.689 . . . . 15.0 113.964 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.561 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -116.29 165.28 12.25 Favored Glycine 0 N--CA 1.474 1.193 0 CA-C-N 113.699 -1.592 . . . . 15.0 114.329 -161.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.26 144.39 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 113.485 -1.357 . . . . 15.0 111.749 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -109.77 116.8 32.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.648 1.213 . . . . 15.0 109.421 162.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.9 pt? -121.47 120.3 34.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 113.074 -1.875 . . . . 15.0 111.383 -170.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.4 p -133.14 150.63 52.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.984 -1.462 . . . . 15.0 112.432 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.625 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -92.35 132.33 36.82 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.304 -1.316 . . . . 15.0 108.452 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HE3' HE21 ' A' ' 33' ' ' GLN . 35.4 ttpt -110.06 104.26 13.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.613 -1.63 . . . . 15.0 110.404 -166.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.7 tt -120.7 134.43 55.28 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.125 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.57 -151.23 11.64 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 115.604 -0.725 . . . . 15.0 113.635 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 75' ' ' ILE . 48.1 p90 -173.91 154.66 2.3 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.853 1.261 . . . . 15.0 113.044 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.6 Cg_endo -64.71 115.43 3.23 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.756 2.304 . . . . 15.0 110.989 169.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -66.2 127.54 32.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.818 -1.083 . . . . 15.0 109.584 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.3 tp 57.44 22.62 8.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.605 1.562 . . . . 15.0 113.397 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.69 20.19 61.46 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.039 1.304 . . . . 15.0 114.484 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -87.55 89.24 7.92 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.426 -1.324 . . . . 15.0 107.426 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.66 79.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 112.885 -1.962 . . . . 15.0 113.134 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -174.14 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 109.587 -3.46 . . . . 15.0 110.668 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.58 98.19 7.26 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.833 1.301 . . . . 15.0 111.711 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 22.6 p-10 -115.43 111.06 20.22 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.931 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.629 HG22 HG22 ' A' ' 112' ' ' VAL . 2.9 pp -79.05 148.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.896 -1.502 . . . . 15.0 110.925 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -146.36 143.23 28.95 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.783 1.302 . . . . 15.0 113.925 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -112.22 122.55 48.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.905 -1.952 . . . . 15.0 107.776 166.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 0.8 OUTLIER -115.05 123.23 48.49 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 112.923 -1.944 . . . . 15.0 109.62 -176.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.79 129.35 48.14 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.676 -1.602 . . . . 15.0 113.256 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.44 -103.98 0.2 Allowed Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.146 -1.182 . . . . 15.0 110.146 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.539 ' HA2' ' HB ' ' A' ' 107' ' ' VAL . . . 154.01 -152.15 23.78 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 124.641 0.848 . . . . 15.0 115.017 173.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 33.9 ttm -119.92 139.3 52.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.491 -0.854 . . . . 15.0 111.742 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' SER . 57.8 t -125.62 113.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 113.98 -1.463 . . . . 15.0 108.109 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 CA-C-N 114.419 -1.264 . . . . 15.0 110.766 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 28.5 t . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 120.85 0.357 . . . . 15.0 110.78 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 82' ' ' MET . 10.0 p -113.37 115.29 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 113.997 -1.456 . . . . 15.0 111.408 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.493 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 80.5 p -117.87 131.83 23.95 Favored Pre-proline 0 N--CA 1.479 1.001 0 CA-C-N 113.745 -1.571 . . . . 15.0 112.398 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 122.21 6.0 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.921 2.414 . . . . 15.0 111.397 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.539 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 53.1 t -131.11 140.03 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.597 -1.183 . . . . 15.0 109.69 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.47 123.29 48.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.16 -1.382 . . . . 15.0 109.844 171.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB2' ' A' ' 129' ' ' GLU . . . -123.23 112.58 17.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.352 -1.295 . . . . 15.0 111.263 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.63 137.07 13.51 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.6 -0.727 . . . . 15.0 112.618 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 128' ' ' LEU . . . 176.99 -147.79 8.56 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 116.198 1.239 . . . . 15.0 116.198 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 75' ' ' ILE . 16.3 t -130.76 144.68 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 113.506 -1.347 . . . . 15.0 109.805 -170.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.486 ' HB2' ' HG3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -109.75 120.95 44.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.292 -1.373 . . . . 15.0 107.292 165.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -117.75 117.66 29.94 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.115 -1.402 . . . . 15.0 111.24 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 116' ' ' ILE . 13.2 p -129.65 143.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 113.279 -1.782 . . . . 15.0 110.163 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.535 HG13 HG22 ' A' ' 115' ' ' VAL . 44.0 mt 62.95 144.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 125.877 1.671 . . . . 15.0 113.577 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 63.33 155.38 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.886 1.674 . . . . 15.0 111.746 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 69.33 -50.28 0.61 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.882 2.073 . . . . 15.0 113.925 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -66.57 126.63 29.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.152 1.381 . . . . 15.0 110.491 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.4 tt -45.1 -35.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 115.671 1.73 . . . . 15.0 115.671 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.2 m -129.12 97.61 25.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 108.398 -0.964 . . . . 15.0 108.398 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.47 66.06 2.89 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.706 2.937 . . . . 15.0 114.304 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 124' ' ' ILE . 15.0 pt-20 -120.04 -17.75 8.31 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.798 -1.546 . . . . 15.0 114.958 178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -119.57 152.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.708 0.766 . . . . 15.0 112.586 -173.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.47 34.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.516 -2.129 . . . . 15.0 109.03 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 37.1 m -93.25 116.76 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.182 -1.784 . . . . 15.0 106.182 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 34.4 ttp180 -115.6 108.07 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.101 -1.409 . . . . 15.0 107.925 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.467 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 5.3 tt -111.83 130.67 55.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.58 -1.646 . . . . 15.0 108.991 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.63 ' HG3' ' HB3' ' A' ' 143' ' ' SER . 13.6 pt-20 -128.57 140.97 51.52 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.435 -2.166 . . . . 15.0 111.421 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 11.7 m-85 -97.25 114.56 26.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.516 -1.22 . . . . 15.0 109.061 164.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 14.7 mt-30 -96.57 108.77 21.42 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.95 -1.932 . . . . 15.0 108.309 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -131.49 146.4 52.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 111.918 -2.401 . . . . 15.0 111.755 -171.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 N--CA 1.481 1.082 0 CA-C-N 112.56 -2.109 . . . . 15.0 115.524 177.444 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 N-CA-C 110.542 -1.023 . . . . 15.0 110.542 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 131' ' ' GLN . 67.0 mtt -121.47 122.69 40.31 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.565 0.95 . . . . 15.0 113.565 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.588 HD23 ' H ' ' A' ' 142' ' ' LEU . 1.2 pt? -84.77 97.34 9.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.035 -1.439 . . . . 15.0 108.032 171.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.649 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 37.1 t -114.0 128.63 56.47 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.433 -1.712 . . . . 15.0 110.896 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.644 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 1.3 pt? -126.36 139.51 53.23 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.962 -1.017 . . . . 15.0 111.043 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 12' ' ' LYS . . . -123.59 131.19 7.98 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 125.822 1.951 . . . . 15.0 111.128 173.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.5 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 34.8 m -112.58 127.42 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.801 0.8 . . . . 15.0 111.111 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . 63.5 p -131.68 153.49 49.94 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.845 -1.525 . . . . 15.0 114.605 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -108.02 143.64 36.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.052 -1.431 . . . . 15.0 109.468 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.798 ' HD3' ' H ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -70.29 115.88 9.98 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.941 -1.027 . . . . 15.0 112.896 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 81.0 m-85 . . . . . 0 N--CA 1.48 1.061 0 CA-C-N 112.751 -2.022 . . . . 15.0 114.288 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.751 ' HA ' HG22 ' A' ' 34' ' ' VAL . 24.6 t-20 . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 122.591 1.186 . . . . 15.0 111.064 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 p -126.92 152.6 46.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.062 -1.426 . . . . 15.0 110.554 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -118.66 138.57 52.52 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.032 1.123 . . . . 15.0 114.032 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -120.26 136.35 54.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.869 -1.514 . . . . 15.0 110.818 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -163.6 133.35 4.16 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.807 -1.088 . . . . 15.0 111.691 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -177.73 -167.76 36.33 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 115.163 -0.926 . . . . 15.0 112.711 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.54 134.82 47.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.802 -0.699 . . . . 15.0 112.107 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HD3' ' HD3' ' A' ' 127' ' ' ARG . 45.1 mtmt -134.16 144.74 48.7 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.898 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.5 pp -114.17 145.29 41.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.886 -1.052 . . . . 15.0 111.092 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.29 110.35 2.48 Favored Glycine 0 N--CA 1.477 1.414 0 O-C-N 125.003 1.439 . . . . 15.0 111.483 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.731 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 49.4 t90 -118.72 140.46 49.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.859 1.059 . . . . 15.0 113.859 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.9 p -92.85 98.16 11.21 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.336 1.236 . . . . 15.0 114.336 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -14.76 -76.91 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.207 2.603 . . . . 15.0 117.871 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -131.45 77.03 1.75 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.9 t -165.04 140.69 5.43 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 112.987 -1.915 . . . . 15.0 110.544 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -90.15 76.7 6.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.147 -1.388 . . . . 15.0 107.352 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -142.74 -70.86 0.33 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.448 -1.705 . . . . 15.0 114.071 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.731 ' ND2' ' HA ' ' A' ' 15' ' ' TRP . 7.3 m120 62.45 -65.52 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.09 1.885 . . . . 15.0 116.09 -171.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 63.43 -62.81 0.14 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 127.055 2.142 . . . . 15.0 110.612 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.06 139.8 50.51 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.889 -1.05 . . . . 15.0 108.658 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.55 -98.24 2.23 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 108.898 -1.681 . . . . 15.0 108.898 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.87 131.15 57.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.521 -1.34 . . . . 15.0 110.041 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.58 141.8 13.88 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-N 113.541 -1.663 . . . . 15.0 110.89 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.4 121.19 41.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.965 -1.118 . . . . 15.0 108.061 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 42' ' ' MET . 94.0 m-85 -116.24 113.39 22.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.075 -1.42 . . . . 15.0 110.351 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.17 145.96 17.15 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.468 -1.696 . . . . 15.0 112.189 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 41' ' ' GLU . . . 172.32 -161.6 33.33 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 114.461 -0.869 . . . . 15.0 112.765 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -126.46 142.17 51.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.943 -1.128 . . . . 15.0 111.986 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 59.3 tt0 -111.54 82.3 1.59 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 124.092 1.901 . . . . 15.0 106.397 169.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.751 HG22 ' HA ' ' A' ' 5' ' ' ASN . 29.4 t -140.75 72.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 111.842 -2.435 . . . . 15.0 105.941 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.437 HD22 HG23 ' A' ' 38' ' ' VAL . 50.0 t30 -175.89 144.88 0.74 Allowed Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 111.913 -2.403 . . . . 15.0 105.248 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.432 ' HD2' ' OD1' ' A' ' 35' ' ' ASN . 28.6 Cg_endo -50.33 104.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.57 2.847 . . . . 15.0 114.332 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 71.25 -24.47 0.17 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.477 2.311 . . . . 15.0 116.747 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.699 HG12 ' HG ' ' A' ' 63' ' ' LEU . 25.6 m -111.04 147.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.582 1.182 . . . . 15.0 113.5 -172.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -118.63 155.26 16.15 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.515 -2.13 . . . . 15.0 112.289 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -118.12 114.14 22.63 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.437 -0.882 . . . . 15.0 109.515 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.435 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -130.78 146.48 52.25 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.253 -1.794 . . . . 15.0 111.532 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 24.0 ptt? -112.59 145.0 41.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.412 -1.267 . . . . 15.0 111.268 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -106.03 127.62 9.02 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 113.22 -1.809 . . . . 15.0 109.726 172.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.82 104.57 11.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.578 -1.311 . . . . 15.0 111.191 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.6 121.59 43.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.098 -1.41 . . . . 15.0 110.127 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 t-105 -102.43 142.95 32.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.523 -1.671 . . . . 15.0 110.235 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 116.511 2.041 . . . . 15.0 116.511 -177.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 112.255 0.465 . . . . 15.0 112.255 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 28.3 pt20 34.13 86.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.603 1.961 . . . . 15.0 115.106 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.45 97.06 1.49 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.817 -1.992 . . . . 15.0 109.971 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 43' ' ' GLY . 11.8 p -109.88 118.53 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.956 1.033 . . . . 15.0 111.112 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.79 116.79 32.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.841 -1.527 . . . . 15.0 112.401 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.8 114.39 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.707 -1.588 . . . . 15.0 108.643 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.606 HG21 ' HD3' ' A' ' 78' ' ' ARG . 51.9 p -127.27 148.4 50.22 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.135 -1.848 . . . . 15.0 114.035 -170.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.53 128.52 54.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 113.136 -1.847 . . . . 15.0 107.823 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -119.75 138.35 53.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.119 -1.855 . . . . 15.0 111.83 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HG ' HG12 ' A' ' 38' ' ' VAL . 5.2 mp -117.07 131.36 56.94 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.157 -1.838 . . . . 15.0 108.669 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.71 131.66 10.1 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 124.616 1.198 . . . . 15.0 111.006 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.751 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 72.3 m-85 -121.75 97.98 45.95 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 124.512 0.772 . . . . 15.0 112.313 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.35 84.9 0.72 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.984 2.456 . . . . 15.0 110.991 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -120.18 153.02 36.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.726 -2.034 . . . . 15.0 110.008 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.8 84.61 0.31 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.374 -0.83 . . . . 15.0 112.809 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.25 141.9 15.35 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 113.812 -1.54 . . . . 15.0 112.398 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.515 ' O ' HD13 ' A' ' 73' ' ' LEU . 3.2 m -49.36 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.76 2.824 . . . . 15.0 112.639 -171.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 52.65 71.09 0.5 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.722 -1.581 . . . . 15.0 112.919 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 78.91 41.51 0.09 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.861 -1.518 . . . . 15.0 114.277 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 70' ' ' THR . 9.0 mp -105.32 115.37 30.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.168 -1.378 . . . . 15.0 111.157 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -105.26 135.97 45.65 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.231 -1.35 . . . . 15.0 108.255 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.751 ' HB ' ' HB2' ' A' ' 65' ' ' TYR . 37.1 mm -83.34 137.42 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.252 -1.018 . . . . 15.0 108.252 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -133.18 135.47 45.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.528 1.307 . . . . 15.0 114.528 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 58.5 m -118.35 124.93 48.94 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 112.537 -2.119 . . . . 15.0 107.424 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.606 ' HD3' HG21 ' A' ' 60' ' ' THR . 1.2 tmm_? -124.64 135.73 53.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.611 0.765 . . . . 15.0 109.864 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 pp -150.76 139.55 20.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.371 -0.832 . . . . 15.0 113.225 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.49 -151.68 10.73 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.626 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.33 151.6 20.87 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 114.154 -1.023 . . . . 15.0 113.088 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.0 ptm -114.49 135.28 54.29 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.712 1.004 . . . . 15.0 113.712 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 104' ' ' VAL . 44.7 t -125.34 119.92 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 113.756 -1.566 . . . . 15.0 108.024 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.411 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 35.9 p90 . . . . . 0 N--CA 1.478 0.927 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.689 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.642 0.734 . . . . 15.0 111.643 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 83' ' ' VAL . 42.9 t -83.52 80.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.49 -1.232 . . . . 15.0 109.216 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.7 m -65.27 132.07 95.18 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 113.762 -1.563 . . . . 15.0 111.909 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.68 113.7 2.84 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.115 2.543 . . . . 15.0 110.555 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.8 t -116.9 120.27 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.298 -1.319 . . . . 15.0 109.023 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -118.37 144.72 45.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 113.288 -1.778 . . . . 15.0 109.66 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -141.5 131.11 23.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.7 -1.136 . . . . 15.0 110.788 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.99 130.47 7.83 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 129' ' ' GLU . . . -173.1 -160.42 21.61 Favored Glycine 0 N--CA 1.476 1.338 0 CA-C-O 122.199 0.888 . . . . 15.0 115.228 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.32 144.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 113.244 -1.478 . . . . 15.0 109.682 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -121.2 129.06 53.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.96 -1.473 . . . . 15.0 109.058 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 116' ' ' ILE . 19.9 t80 -100.21 130.82 46.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.316 1.046 . . . . 15.0 109.88 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.4 113.07 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 113.336 -1.757 . . . . 15.0 110.597 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -54.44 100.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.089 -1.869 . . . . 15.0 113.32 -174.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -108.21 -32.56 7.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.405 -1.725 . . . . 15.0 112.976 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -54.54 -20.54 8.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.886 2.18 . . . . 15.0 116.886 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HD3' ' N ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -127.56 144.17 51.1 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.443 -0.947 . . . . 15.0 108.443 178.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.63 ' H ' HD12 ' A' ' 120' ' ' ILE . 4.7 mp -57.78 136.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.319 1.448 . . . . 15.0 109.653 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.434 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 28.7 m 65.14 92.22 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.045 1.738 . . . . 15.0 111.637 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 121' ' ' THR . 57.4 Cg_endo -64.58 134.21 40.2 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.924 2.416 . . . . 15.0 111.331 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.49 ' HG2' HG13 ' A' ' 124' ' ' ILE . 30.5 tt0 -119.34 -81.63 0.63 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.403 -1.271 . . . . 15.0 112.177 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.49 HG13 ' HG2' ' A' ' 123' ' ' GLU . 32.7 mt -116.36 146.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.64 24.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.794 1.238 . . . . 15.0 110.984 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.0 m -100.32 122.59 43.34 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.196 -0.911 . . . . 15.0 109.387 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.435 ' HD3' ' HD3' ' A' ' 12' ' ' LYS . 37.1 ttt85 -120.88 127.94 52.34 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.461 -0.79 . . . . 15.0 112.479 -175.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.0 119.53 24.45 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.93 -1.487 . . . . 15.0 110.775 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 6.1 pt-20 -134.2 145.42 49.19 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.88 -1.054 . . . . 15.0 113.49 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.38 122.09 43.1 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.307 -1.315 . . . . 15.0 109.307 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.59 122.48 47.93 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 113.656 -1.611 . . . . 15.0 110.942 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -124.45 145.28 49.6 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 111.985 -2.37 . . . . 15.0 110.532 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.477 0.888 0 CA-C-N 114.764 -1.107 . . . . 15.0 109.188 171.35 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 116.899 1.52 . . . . 15.0 116.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -117.42 139.0 51.45 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.046 0.927 . . . . 15.0 110.599 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.19 108.98 18.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 113.89 -1.505 . . . . 15.0 109.535 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.499 ' HB2' ' HG3' ' A' ' 129' ' ' GLU . 61.4 m -109.02 125.22 51.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.472 -1.24 . . . . 15.0 108.783 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 pp -148.22 145.25 28.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.201 -1.363 . . . . 15.0 112.311 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.96 -162.51 29.53 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 114.15 -1.386 . . . . 15.0 113.119 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.32 130.48 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.159 -1.52 . . . . 15.0 111.494 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.521 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 63.9 p -130.39 146.35 51.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.755 -1.566 . . . . 15.0 113.053 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -115.96 118.95 34.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.259 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.86 119.27 34.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.031 -1.44 . . . . 15.0 108.55 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 t80 . . . . . 0 N--CA 1.475 0.815 0 CA-C-N 113.873 -1.512 . . . . 15.0 110.112 -174.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 6.1 t30 . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 123.608 1.67 . . . . 15.0 112.461 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.411 ' HA ' ' CE1' ' A' ' 150' ' ' PHE . 11.6 t -120.94 150.91 40.36 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 112.207 -2.27 . . . . 15.0 111.448 173.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -106.92 131.79 53.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.568 -1.196 . . . . 15.0 111.959 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.35 101.6 8.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.619 -1.628 . . . . 15.0 108.681 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -108.07 118.32 36.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.246 -1.797 . . . . 15.0 107.114 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -130.9 153.0 20.1 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 114.316 -1.311 . . . . 15.0 113.971 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.29 124.11 42.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.736 -1.232 . . . . 15.0 108.261 170.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -144.19 155.97 44.12 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.756 -1.111 . . . . 15.0 112.869 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' SER . 3.1 pp -114.09 140.37 48.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.604 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -108.5 97.76 1.13 Allowed Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.691 -1.595 . . . . 15.0 111.097 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.466 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t90 -111.05 150.16 29.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.493 1.139 . . . . 15.0 112.418 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.3 p -122.34 159.38 27.58 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 112.439 -2.164 . . . . 15.0 111.081 -173.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -48.48 153.21 0.79 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.221 -0.899 . . . . 15.0 109.593 165.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.49 89.62 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.861 0.838 . . . . 15.0 111.641 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 t -167.81 141.0 3.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.651 -2.068 . . . . 15.0 107.963 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' H ' ' A' ' 21' ' ' GLU . 32.0 ttt-85 53.21 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.897 1.679 . . . . 15.0 113.649 -175.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 15.3 pt-20 -69.69 75.18 0.43 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.927 1.084 . . . . 15.0 113.927 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -130.1 147.59 51.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.877 -1.056 . . . . 15.0 112.242 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -173.15 -75.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.675 -1.602 . . . . 15.0 110.47 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -104.56 89.45 3.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.473 0.654 . . . . 15.0 111.394 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.98 111.97 1.02 Allowed Glycine 0 N--CA 1.478 1.485 0 CA-C-N 113.599 -1.637 . . . . 15.0 112.018 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -119.75 142.47 48.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.193 0.597 . . . . 15.0 112.081 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.41 20.38 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 124.952 1.408 . . . . 15.0 112.511 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . . . -102.96 135.94 43.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.733 -1.234 . . . . 15.0 111.2 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -111.72 118.0 34.42 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.007 -1.451 . . . . 15.0 110.817 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.12 90.12 0.45 Allowed Glycine 0 N--CA 1.476 1.325 0 CA-C-N 114.647 -1.161 . . . . 15.0 110.545 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.04 117.26 4.21 Favored Glycine 0 N--CA 1.477 1.419 0 O-C-N 124.44 0.729 . . . . 15.0 112.101 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -115.25 123.01 47.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.474 1.13 . . . . 15.0 111.856 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -109.03 82.21 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.499 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.464 HG13 ' H ' ' A' ' 35' ' ' ASN 0.276 7.3 p -71.2 -73.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.236 -2.257 . . . . 15.0 112.243 174.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.464 ' H ' HG13 ' A' ' 34' ' ' VAL . 22.7 t30 -70.55 127.86 91.61 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.229 1.411 . . . . 15.0 112.146 -176.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 35' ' ' ASN . 71.8 Cg_endo -72.5 69.5 3.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.323 2.682 . . . . 15.0 111.728 170.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -175.94 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.196 2.199 . . . . 15.0 107.941 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.28 141.01 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.465 -0.788 . . . . 15.0 111.962 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.67 158.95 14.08 Favored Glycine 0 N--CA 1.477 1.39 0 CA-C-N 113.638 -1.619 . . . . 15.0 109.577 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 136.2 52.73 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.257 0.551 . . . . 15.0 110.524 -176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB3' ' OG1' ' A' ' 60' ' ' THR . 0.9 OUTLIER -127.89 133.91 49.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.584 -1.189 . . . . 15.0 110.621 -173.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.4 mtm -124.23 128.27 48.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.133 -1.394 . . . . 15.0 111.547 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.99 134.08 11.93 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 113.385 -1.734 . . . . 15.0 109.676 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.524 ' HB2' ' HB3' ' A' ' 28' ' ' ALA . 82.8 m-85 -120.12 115.06 22.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.311 -0.945 . . . . 15.0 111.695 -173.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -128.93 143.67 50.95 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.066 -1.425 . . . . 15.0 109.719 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.85 142.53 50.15 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.744 0.646 . . . . 15.0 112.744 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 122.813 1.292 . . . . 15.0 110.075 -177.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 121.814 0.816 . . . . 15.0 112.419 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -127.69 156.27 42.63 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.973 -1.921 . . . . 15.0 111.219 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.43 100.57 0.88 Allowed Glycine 0 N--CA 1.475 1.295 0 O-C-N 124.482 1.114 . . . . 15.0 110.427 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -110.74 131.86 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.599 1.19 . . . . 15.0 112.306 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -109.86 124.1 50.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.52 -1.673 . . . . 15.0 109.003 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.19 111.18 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.673 -1.149 . . . . 15.0 109.305 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 78' ' ' ARG . 32.2 p -136.2 156.36 48.79 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.148 -1.842 . . . . 15.0 112.634 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -116.56 141.66 47.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.745 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -110.77 126.07 54.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.375 -1.284 . . . . 15.0 111.402 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.24 146.84 49.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.616 -1.629 . . . . 15.0 110.866 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.96 -155.29 21.56 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 115.694 -0.685 . . . . 15.0 112.04 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 67' ' ' LYS . 18.9 p90 -166.4 158.94 11.97 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -167.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.711 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.5 Cg_endo -68.57 134.0 29.39 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.825 2.35 . . . . 15.0 111.982 167.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 4.8 tmtp? -129.44 122.75 30.0 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.234 -1.348 . . . . 15.0 110.725 -177.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 68' ' ' LEU . 1.8 pt? -69.93 125.68 27.47 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.384 -1.28 . . . . 15.0 110.769 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.34 -86.18 0.41 Allowed Glycine 0 N--CA 1.477 1.378 0 CA-C-N 114.562 -1.199 . . . . 15.0 112.94 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.432 HG23 ' OH ' ' A' ' 114' ' ' TYR . 2.4 t -126.43 -39.8 2.0 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.634 -1.283 . . . . 15.0 110.517 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -116.87 -146.37 0.4 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.502 -1.296 . . . . 15.0 107.502 148.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -107.76 103.31 12.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 114' ' ' TYR . 1.2 pt? -111.1 143.54 41.66 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.056 -1.429 . . . . 15.0 113.733 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.711 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 1.1 m-20 -111.85 123.44 50.24 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.513 -1.221 . . . . 15.0 108.914 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.7 mt -111.59 113.19 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 124.38 1.05 . . . . 15.0 108.681 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -122.27 141.83 51.1 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.478 -1.692 . . . . 15.0 111.885 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 m -108.53 122.64 47.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.257 -2.127 . . . . 15.0 105.257 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.705 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 18.2 ttm180 -115.73 123.22 47.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 112.831 -1.986 . . . . 15.0 108.134 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.2 tp -131.57 138.39 48.84 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.244 -0.889 . . . . 15.0 111.065 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.22 -145.39 8.06 Favored Glycine 0 N--CA 1.477 1.423 0 O-C-N 124.749 1.281 . . . . 15.0 113.178 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.43 152.35 22.86 Favored Glycine 0 N--CA 1.476 1.349 0 O-C-N 125.235 1.197 . . . . 15.0 112.599 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.75 118.71 35.06 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.548 0.69 . . . . 15.0 111.136 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.75 125.71 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 113.768 -1.56 . . . . 15.0 108.089 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.8 p-90 . . . . . 0 N--CA 1.472 0.643 0 CA-C-N 114.286 -1.325 . . . . 15.0 110.729 176.233 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.363 -0.606 . . . . 15.0 109.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.45 99.74 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.438 -1.255 . . . . 15.0 108.843 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -118.65 136.45 24.15 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 114.31 -1.313 . . . . 15.0 111.904 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.21 96.58 0.72 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.06 2.507 . . . . 15.0 111.074 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.729 ' HB ' ' HA ' ' A' ' 133' ' ' THR . 21.5 m -116.98 143.48 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.836 -1.529 . . . . 15.0 111.566 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.65 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 5.6 p90 -129.7 138.18 51.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.8 -169.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -124.79 134.28 52.83 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.631 1.832 . . . . 15.0 111.962 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 131' ' ' GLN . . . -104.29 99.24 1.65 Allowed Glycine 0 N--CA 1.476 1.31 0 N-CA-C 108.251 -1.939 . . . . 15.0 108.251 175.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.67 114.45 4.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 125.081 1.107 . . . . 15.0 112.127 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.3 t -117.29 131.96 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 122.576 1.179 . . . . 15.0 108.997 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 10.5 mm-40 -110.74 109.58 19.87 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 112.623 -2.081 . . . . 15.0 108.711 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 73' ' ' LEU . 13.6 t80 -107.26 126.08 51.97 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.611 0.719 . . . . 15.0 112.21 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.5 t -114.22 133.01 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.389 -1.278 . . . . 15.0 109.023 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.1 mt -118.78 142.94 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 114.517 -1.219 . . . . 15.0 108.727 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -70.83 97.11 1.34 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.903 1.075 . . . . 15.0 113.903 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -127.12 149.91 49.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.331 -1.304 . . . . 15.0 112.095 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -57.03 -42.9 81.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.146 1.165 . . . . 15.0 114.146 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.9 mt -120.8 89.05 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.0 m -118.0 90.25 36.61 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.238 -1.346 . . . . 15.0 109.191 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.31 82.64 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.735 2.29 . . . . 15.0 112.281 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 148' ' ' TYR . 1.5 mp0 46.57 32.12 1.56 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.759 2.133 . . . . 15.0 116.759 176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.578 HD11 ' HB ' ' A' ' 146' ' ' VAL . 7.3 tp -116.71 129.57 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.103 0.954 . . . . 15.0 112.414 -169.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.61 153.2 38.41 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.077 -1.874 . . . . 15.0 110.563 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.3 m -80.76 122.61 27.38 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 108.11 20.72 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.348 -1.296 . . . . 15.0 107.995 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.57 111.02 16.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.548 -1.66 . . . . 15.0 108.017 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 110' ' ' GLY . 1.4 tm-20 -129.28 120.51 25.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.553 -1.203 . . . . 15.0 111.054 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 141' ' ' MET . 86.5 t80 -134.95 105.55 6.43 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 117.699 -1.143 . . . . 15.0 110.199 170.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.65 ' HB3' ' O ' ' A' ' 108' ' ' PHE 0.756 1.1 mp0 -149.88 159.28 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 110.884 -2.871 . . . . 15.0 116.751 164.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -78.23 111.6 14.36 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 122.422 1.106 . . . . 15.0 108.207 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.729 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 36.4 p . . . . . 0 N--CA 1.483 1.224 0 CA-C-N 113.457 -1.701 . . . . 15.0 115.583 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 CA-C-O 121.323 0.402 . . . . 15.0 113.262 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 130' ' ' TYR . 0.0 OUTLIER -130.79 133.9 46.38 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.921 1.082 . . . . 15.0 113.921 176.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -112.55 105.18 13.33 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.487 -1.688 . . . . 15.0 112.079 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 14.9 m -102.26 125.18 48.88 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.775 -2.012 . . . . 15.0 107.847 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.08 136.88 48.81 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.258 -1.337 . . . . 15.0 111.426 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.08 -162.46 29.39 Favored Glycine 0 N--CA 1.476 1.327 0 O-C-N 124.837 1.335 . . . . 15.0 112.612 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.578 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.7 m -121.0 140.1 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 113.824 -1.188 . . . . 15.0 112.022 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.495 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 25.0 t -123.63 136.17 54.35 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.437 -1.256 . . . . 15.0 110.661 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 123' ' ' GLU . 34.7 t80 -111.72 135.21 52.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.607 -1.179 . . . . 15.0 109.482 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -91.01 128.7 36.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.42 -1.263 . . . . 15.0 109.842 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 6' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.919 0 C-N-CA 126.888 2.075 . . . . 15.0 114.098 -173.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 123.348 1.547 . . . . 15.0 113.053 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 33' ' ' GLN . 12.2 p -98.27 115.12 27.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.013 -2.358 . . . . 15.0 109.337 -172.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -94.18 130.43 40.4 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.683 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 148' ' ' TYR . 1.2 t80 -143.4 111.26 6.03 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.487 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.569 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 40.4 p -117.96 174.57 6.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.869 -1.969 . . . . 15.0 110.503 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.0 -159.21 28.36 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.224 0.902 . . . . 15.0 114.4 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.82 132.75 24.22 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.725 -1.237 . . . . 15.0 111.019 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HA ' ' HA3' ' A' ' 145' ' ' GLY . 22.7 pttp -137.3 150.47 47.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.481 -1.236 . . . . 15.0 112.341 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.6 pp -114.21 143.59 44.58 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.875 -1.057 . . . . 15.0 111.723 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.31 119.09 6.26 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-N 113.2 -1.818 . . . . 15.0 110.316 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -114.82 141.1 48.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 113.502 -1.349 . . . . 15.0 111.72 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 m -122.21 98.04 5.75 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.063 -1.426 . . . . 15.0 113.708 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -85.32 48.64 1.61 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.45 1.278 . . . . 15.0 114.45 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -166.57 26.4 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.073 1.509 . . . . 15.0 115.073 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -155.38 144.23 20.65 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.593 0.59 . . . . 15.0 112.593 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -80.88 90.38 5.9 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 15.0 110.193 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 57.6 28.72 16.09 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.371 1.989 . . . . 15.0 116.371 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -114.82 133.96 55.51 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 10.5 mm-40 53.07 93.76 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.137 1.903 . . . . 15.0 116.137 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pp -154.23 137.22 15.47 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 111.681 -2.509 . . . . 15.0 110.151 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.07 -169.88 37.56 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.138 0.899 . . . . 15.0 113.486 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -124.39 142.62 51.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.573 0.749 . . . . 15.0 112.695 -175.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.16 145.92 16.75 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 114.188 -1.369 . . . . 15.0 111.16 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.67 121.27 43.21 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.32 -0.94 . . . . 15.0 109.351 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -127.23 152.88 46.81 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.699 -1.137 . . . . 15.0 112.165 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -174.36 149.23 10.46 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 115.413 -0.812 . . . . 15.0 114.813 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.22 -146.74 7.62 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 113.634 -1.283 . . . . 15.0 113.298 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -158.35 149.55 20.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.722 -1.239 . . . . 15.0 113.621 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 42.2 tt0 -114.66 95.17 5.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.303 1.441 . . . . 15.0 108.657 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.6 -48.17 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.222 -0.899 . . . . 15.0 111.693 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.99 154.93 61.37 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-O 118.055 -0.974 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.47 53.36 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.877 3.051 . . . . 15.0 113.42 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.91 -82.3 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.515 1.526 . . . . 15.0 108.667 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.38 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.939 0.896 . . . . 15.0 108.854 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.62 166.88 17.09 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.188 1.375 . . . . 15.0 110.671 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.96 139.39 52.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.41 137.15 43.83 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.363 -1.29 . . . . 15.0 111.805 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.18 143.33 31.41 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.756 -1.565 . . . . 15.0 109.85 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.32 7.75 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.05 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -118.99 133.96 55.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.364 1.078 . . . . 15.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -125.11 133.82 52.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.921 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.829 ' HA ' ' HG3' ' A' ' 55' ' ' GLN . 37.7 p-90 -102.8 133.54 47.69 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.814 -1.085 . . . . 15.0 110.192 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 N--CA 1.476 0.864 0 CA-C-N 113.595 -1.639 . . . . 15.0 113.764 -173.82 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 111.632 0.234 . . . . 15.0 111.632 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.829 ' HG3' ' HA ' ' A' ' 46' ' ' TRP . 2.9 mp0 -51.6 147.1 6.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.906 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 135.87 16.04 Favored Glycine 0 N--CA 1.478 1.467 0 CA-C-N 114.37 -1.286 . . . . 15.0 112.576 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.13 137.32 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.73 1.252 . . . . 15.0 112.988 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -126.84 139.77 52.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.089 -1.869 . . . . 15.0 111.733 175.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.44 111.19 17.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.585 -1.643 . . . . 15.0 109.114 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.532 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 34.2 m -124.55 140.86 52.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.986 -1.461 . . . . 15.0 109.884 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.833 ' O ' ' HB3' ' A' ' 78' ' ' ARG . . . -101.06 138.5 38.02 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.998 -1.853 . . . . 15.0 105.998 168.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.739 ' HA ' ' CB ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -124.95 139.24 54.0 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.93 2.019 . . . . 15.0 114.365 -178.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 77' ' ' THR 0.27 4.6 pp -127.15 120.7 29.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 166.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . -121.91 135.05 10.19 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.678 -2.51 . . . . 15.0 112.58 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.08 145.43 50.29 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 125.348 1.263 . . . . 15.0 114.118 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.4 91.22 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.069 2.513 . . . . 15.0 110.728 167.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' A' ' 68' ' ' LEU . 6.3 tmtt? -144.6 152.16 40.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.405 -1.725 . . . . 15.0 108.895 -178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.628 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 1.2 tm? 62.95 85.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.79 2.036 . . . . 15.0 109.624 -170.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -140.74 15.82 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 112.926 -1.943 . . . . 15.0 109.584 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 71' ' ' ASP . 3.2 t -136.34 -86.96 0.33 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.188 -1.006 . . . . 15.0 112.153 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.556 ' H ' HG23 ' A' ' 70' ' ' THR . 8.5 m-20 -124.97 106.6 10.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.108 1.363 . . . . 15.0 108.093 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t0 176.32 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 113.175 -1.83 . . . . 15.0 110.138 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 114' ' ' TYR . 1.3 pt? -135.32 151.79 50.86 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.799 1.312 . . . . 15.0 112.218 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 7.0 m-20 -132.56 138.78 47.58 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.398 -1.274 . . . . 15.0 111.022 172.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.474 ' HA ' HG12 ' A' ' 112' ' ' VAL . 7.8 tp -87.71 135.84 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.275 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -123.94 128.86 50.04 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.992 1.433 . . . . 15.0 111.646 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.495 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 24.0 p -137.2 122.35 19.18 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.942 -1.132 . . . . 15.0 107.942 158.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.833 ' HB3' ' O ' ' A' ' 61' ' ' ALA 0.609 8.0 mmt180 -158.9 164.6 35.53 Favored 'General case' 0 N--CA 1.478 0.972 1 N-CA-C 122.946 4.424 . . . . 15.0 122.946 172.822 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.707 HD13 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -127.93 156.0 43.33 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.096 0.776 . . . . 15.0 113.096 -176.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -165.12 -176.55 36.86 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 114.96 -1.018 . . . . 15.0 113.365 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.93 144.16 14.97 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 123.889 0.757 . . . . 15.0 113.286 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.552 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -123.79 140.68 52.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.617 1.34 . . . . 15.0 114.617 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.87 144.27 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 125.157 1.536 . . . . 15.0 112.309 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 . . . . . 0 N--CA 1.478 0.949 0 C-N-CA 124.38 1.072 . . . . 15.0 111.798 175.72 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.651 0.738 . . . . 15.0 111.903 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 t -117.0 120.67 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.0 m -122.12 142.01 35.67 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.305 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.16 148.7 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.666 2.244 . . . . 15.0 113.274 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.41 135.05 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.643 -1.617 . . . . 15.0 109.64 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -107.11 123.36 48.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -127.55 112.51 15.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.907 -173.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 138.56 11.76 Favored Glycine 0 N--CA 1.479 1.539 0 CA-C-N 113.581 -1.645 . . . . 15.0 110.713 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.79 -152.95 14.73 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.298 0.475 . . . . 15.0 113.244 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 75' ' ' ILE . 5.4 m -141.77 156.97 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.992 1.108 . . . . 15.0 113.992 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -110.13 136.89 48.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.426 -1.716 . . . . 15.0 108.669 159.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 73' ' ' LEU . 11.5 t80 -132.37 143.61 49.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.865 -1.516 . . . . 15.0 108.957 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.44 135.32 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 120.949 0.404 . . . . 15.0 109.991 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.7 mt -43.61 -39.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.805 1.78 . . . . 15.0 115.805 -164.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -164.1 -60.13 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.589 0.755 . . . . 15.0 110.495 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.16 135.52 34.34 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.767 -0.651 . . . . 15.0 109.701 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.79 -33.8 50.5 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.975 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.0 tt -99.84 82.92 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 122.236 1.017 . . . . 15.0 109.893 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 89.2 m -136.76 88.96 18.25 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 112.325 -2.216 . . . . 15.0 108.163 167.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.37 -177.11 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.949 2.433 . . . . 15.0 111.733 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 54.4 mt-10 66.83 -55.6 0.43 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.631 1.973 . . . . 15.0 115.309 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.531 HG12 ' CE2' ' A' ' 148' ' ' TYR . 6.6 mt -116.72 115.16 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.254 1.022 . . . . 15.0 108.649 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.07 147.98 44.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.369 -1.287 . . . . 15.0 111.343 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 m -80.75 116.8 20.94 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.49 HH11 ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -116.83 112.04 20.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.115 0.96 . . . . 15.0 109.889 -177.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.53 112.75 18.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 15.0 110.841 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -134.98 136.45 42.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.928 -1.487 . . . . 15.0 111.491 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 30.7 m-85 -97.4 131.96 43.56 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.425 -1.262 . . . . 15.0 109.341 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.38 117.0 30.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.356 -1.747 . . . . 15.0 111.592 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -120.72 111.83 18.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.493 -1.685 . . . . 15.0 113.186 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 N--CA 1.483 1.22 0 CA-C-N 112.64 -2.073 . . . . 15.0 111.557 167.11 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 109.057 -1.617 . . . . 15.0 109.057 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.0 ttt -117.65 135.11 54.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.586 0.708 . . . . 15.0 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.2 tt -105.17 108.8 20.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.694 -1.139 . . . . 15.0 109.708 -174.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m -93.25 125.11 37.68 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.208 1.004 . . . . 15.0 110.081 170.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.4 pp -133.9 135.22 43.49 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 112.903 -1.953 . . . . 15.0 110.109 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -178.94 -162.52 28.48 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 114.82 -1.082 . . . . 15.0 112.848 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.3 m -117.04 131.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 113.518 -1.341 . . . . 15.0 112.633 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.7 p -113.17 145.73 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 112.342 -2.208 . . . . 15.0 111.535 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 70.7 m-85 -124.07 143.45 50.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.009 -1.905 . . . . 15.0 112.482 -172.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -95.84 141.54 29.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 113.583 -1.644 . . . . 15.0 111.41 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 . . . . . 0 N--CA 1.484 1.267 0 C-N-CA 125.825 1.65 . . . . 15.0 114.347 -177.819 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.584 ' HA ' HG22 ' A' ' 34' ' ' VAL . 60.0 t30 . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.563 1.32 . . . . 15.0 114.563 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.598 ' HA ' ' HB3' ' A' ' 149' ' ' ARG . 10.2 t -110.98 114.72 28.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.162 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -136.79 133.57 36.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.905 -2.407 . . . . 15.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 144.17 -98.11 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 129.293 3.037 . . . . 15.0 108.09 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.647 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 11.2 t -163.51 153.18 15.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -131.06 -170.07 12.59 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.166 -1.379 . . . . 15.0 112.793 170.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.73 131.57 5.44 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.752 1.621 . . . . 15.0 109.522 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.682 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.425 5.2 tptp -171.94 169.61 5.65 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.185 -1.825 . . . . 15.0 115.142 168.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HB3' ' H ' ' A' ' 26' ' ' ALA . 1.9 pt? -130.47 161.64 30.98 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.427 -1.261 . . . . 15.0 111.681 -173.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -120.0 155.57 16.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.513 -1.222 . . . . 15.0 112.548 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -121.65 137.02 54.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.924 -1.138 . . . . 15.0 112.49 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -116.8 151.78 35.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.09 -1.414 . . . . 15.0 109.919 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -71.43 78.73 0.76 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.164 1.172 . . . . 15.0 114.164 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -158.92 139.49 12.51 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.135 -1.393 . . . . 15.0 111.717 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.9 m -66.46 -40.41 89.39 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 116.664 2.098 . . . . 15.0 116.664 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 mtt-85 -76.78 92.08 3.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.54 0.686 . . . . 15.0 111.841 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -124.58 131.5 53.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.096 -1.865 . . . . 15.0 113.03 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -131.65 -163.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.239 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -74.68 74.64 2.04 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.535 1.159 . . . . 15.0 111.024 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.63 101.43 3.67 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.663 -1.608 . . . . 15.0 108.502 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.66 -153.82 23.06 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 114.146 -1.388 . . . . 15.0 111.377 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.492 ' H ' ' HB3' ' A' ' 13' ' ' LEU . . . 50.13 91.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.191 1.796 . . . . 15.0 114.19 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.11 148.77 16.48 Favored Glycine 0 N--CA 1.475 1.269 0 CA-C-N 113.807 -1.542 . . . . 15.0 109.99 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.45 121.14 41.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.692 -0.855 . . . . 15.0 108.692 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 97.3 m-85 -125.75 113.43 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.562 -1.199 . . . . 15.0 110.114 -170.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.67 -174.59 14.44 Favored Glycine 0 N--CA 1.477 1.405 0 CA-C-N 115.353 -0.84 . . . . 15.0 114.309 -173.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.92 -140.04 13.86 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.441 -0.88 . . . . 15.0 113.705 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -127.19 104.93 8.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.406 -1.397 . . . . 15.0 112.969 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.505 HE22 ' HB2' ' A' ' 62' ' ' LYS . 15.5 mm100 -114.93 82.27 1.71 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 123.066 1.412 . . . . 15.0 108.249 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 5' ' ' ASN . 47.9 t -124.78 -63.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 112.749 -2.023 . . . . 15.0 113.315 -170.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.5 t-20 -62.17 139.09 96.13 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 114.354 1.242 . . . . 15.0 114.354 -170.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.59 41.13 0.59 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.652 3.568 . . . . 15.0 116.444 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 1.2 t80 -167.51 -58.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 15.0 111.236 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 57.2 t -124.65 136.32 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.794 0.806 . . . . 15.0 110.279 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.37 154.57 21.3 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 113.785 -1.552 . . . . 15.0 110.055 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.95 114.31 20.81 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.737 0.303 . . . . 15.0 110.503 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -131.94 119.91 21.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.159 -0.928 . . . . 15.0 111.047 -172.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.3 mtp -112.21 135.6 52.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.796 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 29' ' ' PHE . . . -115.87 147.67 18.91 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 113.382 -1.735 . . . . 15.0 111.948 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -132.29 143.03 49.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.846 1.425 . . . . 15.0 114.846 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.09 118.44 24.39 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 111.722 -2.49 . . . . 15.0 107.238 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -112.51 145.18 40.71 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.518 -1.219 . . . . 15.0 110.073 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.212 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 117.184 2.29 . . . . 15.0 117.184 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 58.41 109.54 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.125 1.77 . . . . 15.0 114.516 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.26 134.76 10.58 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 114.021 -1.445 . . . . 15.0 111.282 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.2 p -119.05 141.33 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 122.111 0.958 . . . . 15.0 111.259 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.503 ' HG2' ' HB3' ' A' ' 82' ' ' MET . 47.4 mt-30 -120.66 140.29 51.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.284 -1.326 . . . . 15.0 109.976 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.64 114.82 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.397 -1.274 . . . . 15.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.2 p -130.41 131.73 45.4 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.746 0.784 . . . . 15.0 110.881 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -114.77 123.3 48.87 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.982 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.647 ' HG2' ' CD2' ' A' ' 76' ' ' TYR . 11.9 tmtt? -79.31 106.41 11.32 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.2 -1.818 . . . . 15.0 108.575 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.79 108.82 15.32 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.472 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 37' ' ' TYR . . . 177.65 -153.69 13.85 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 114.021 -1.445 . . . . 15.0 113.517 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.98 152.22 76.87 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 113.934 -1.133 . . . . 15.0 111.23 -170.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 35.2 Cg_endo -61.29 -73.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.497 2.131 . . . . 15.0 111.24 170.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 60.95 143.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.599 1.96 . . . . 15.0 111.621 -176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.72 -61.63 2.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.878 -1.056 . . . . 15.0 112.055 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.11 -85.15 0.06 OUTLIER Glycine 0 N--CA 1.478 1.462 0 C-N-CA 124.76 1.171 . . . . 15.0 111.492 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 p -134.83 -73.01 0.47 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.653 1.181 . . . . 15.0 109.383 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -165.81 135.33 3.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.869 2.068 . . . . 15.0 108.684 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.565 ' HB2' ' CE1' ' A' ' 114' ' ' TYR . 7.3 m-20 62.03 43.64 8.78 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.903 1.281 . . . . 15.0 112.775 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tt -117.57 137.36 52.64 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.776 -1.102 . . . . 15.0 112.942 -167.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 14.9 t70 -126.61 139.41 53.21 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 112.079 -2.328 . . . . 15.0 109.002 165.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.9 tt -118.16 119.12 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.119 0.968 . . . . 15.0 109.831 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.647 ' CD2' ' HG2' ' A' ' 62' ' ' LYS . 8.8 p90 -153.86 168.9 24.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.012 1.115 . . . . 15.0 114.012 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.585 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 8.9 t -118.66 133.53 55.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.569 166.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.548 ' HB3' ' HE2' ' A' ' 76' ' ' TYR . 7.8 ppt_? -100.53 123.17 44.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.55 1.167 . . . . 15.0 109.149 172.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 pp -124.41 144.57 49.98 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.221 -2.263 . . . . 15.0 113.483 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.64 -97.36 0.17 Allowed Glycine 0 N--CA 1.476 1.304 0 CA-C-N 113.46 -1.7 . . . . 15.0 109.309 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.59 -153.66 23.75 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 115.057 0.783 . . . . 15.0 115.057 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.503 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 21.9 ptp -129.14 138.5 51.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.217 1.562 . . . . 15.0 115.217 -172.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.2 t -128.05 115.58 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 112.902 -1.953 . . . . 15.0 109.185 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 29.3 t90 . . . . . 0 N--CA 1.473 0.689 0 CA-C-N 113.85 -1.523 . . . . 15.0 109.721 170.858 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.964 0.888 . . . . 15.0 112.78 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.97 90.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 114.778 -1.101 . . . . 15.0 108.375 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.8 m -130.04 90.17 43.25 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.112 1.153 . . . . 15.0 114.112 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.11 141.42 29.47 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.288 2.659 . . . . 15.0 112.66 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.42 HG22 HG21 ' A' ' 133' ' ' THR . 97.8 t -134.37 139.31 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.363 -1.29 . . . . 15.0 109.855 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -124.32 123.34 39.99 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.656 1.223 . . . . 15.0 109.139 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -136.33 112.66 9.88 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.952 1.093 . . . . 15.0 113.952 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 77' ' ' THR . . . -113.29 142.07 17.24 Favored Glycine 0 N--CA 1.479 1.527 0 CA-C-N 114.096 -1.411 . . . . 15.0 112.662 -173.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.16 -148.93 10.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-O 121.928 0.738 . . . . 15.0 114.606 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.35 143.86 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 113.483 -1.358 . . . . 15.0 113.859 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -122.83 121.92 37.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.069 -1.878 . . . . 15.0 109.898 178.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 72' ' ' ASP . 78.1 t80 -117.71 137.36 52.74 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.888 1.367 . . . . 15.0 110.196 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.83 130.62 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.288 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.94 106.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.905 1.817 . . . . 15.0 115.905 -169.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -118.89 87.37 2.72 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.092 -1.413 . . . . 15.0 110.36 171.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.489 HH21 ' HD2' ' A' ' 119' ' ' ARG . 21.7 ttp180 -174.08 -79.94 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.512 -1.676 . . . . 15.0 112.438 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.489 ' HD2' HH21 ' A' ' 118' ' ' ARG . 65.1 ttt180 -101.53 146.86 27.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.425 0.631 . . . . 15.0 112.658 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.26 100.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.078 1.751 . . . . 15.0 112.523 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.1 p -140.18 151.41 64.61 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 112.066 -2.334 . . . . 15.0 110.281 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.68 82.21 1.22 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.377 2.051 . . . . 15.0 110.141 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -0.7 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.939 2.496 . . . . 15.0 116.596 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.426 HG22 ' HB3' ' A' ' 148' ' ' TYR . 2.7 pp -116.53 140.79 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 112.687 -2.051 . . . . 15.0 112.4 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.47 127.78 53.97 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.489 -2.141 . . . . 15.0 109.333 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 8.9 t -109.33 129.28 55.53 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.426 -1.261 . . . . 15.0 112.182 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 144' ' ' LEU . 52.0 ttp180 -113.3 108.12 16.82 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.431 -1.713 . . . . 15.0 110.19 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.5 tp -106.73 111.02 23.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.855 -1.521 . . . . 15.0 108.061 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -138.18 150.41 46.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.136 -2.302 . . . . 15.0 113.161 -168.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 38.3 p90 -96.99 129.52 44.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 172.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 44.5 tt0 -108.04 110.01 21.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.806 -1.997 . . . . 15.0 108.5 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -123.43 136.54 54.67 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.117 -1.856 . . . . 15.0 112.802 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.42 HG21 HG22 ' A' ' 107' ' ' VAL . 8.8 t . . . . . 0 N--CA 1.482 1.145 0 CA-C-N 110.927 -2.852 . . . . 15.0 108.761 173.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.435 0 CA-C-O 121.481 0.489 . . . . 15.0 112.616 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.467 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 25.5 ttt -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.129 -1.035 . . . . 15.0 110.874 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.1 tp -114.32 112.22 22.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.398 -1.334 . . . . 15.0 107.398 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.53 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 9.8 t -120.56 138.34 53.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.952 -1.476 . . . . 15.0 112.693 -166.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 37.7 tp -120.1 134.58 55.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.589 -1.641 . . . . 15.0 109.861 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.27 128.33 5.75 Favored Glycine 0 N--CA 1.481 1.655 0 O-C-N 125.774 1.921 . . . . 15.0 110.247 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.427 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 48.2 t -121.43 127.55 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 118.718 1.259 . . . . 15.0 109.249 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.565 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 65.9 p -118.71 138.68 52.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.551 ' CE2' ' HA2' ' A' ' 10' ' ' GLY . 13.5 p90 -125.26 148.31 48.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.481 1.134 . . . . 15.0 113.65 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.598 ' HB3' ' HA ' ' A' ' 6' ' ' THR . 36.6 ptt180 -101.32 153.37 19.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.354 -1.748 . . . . 15.0 114.516 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 N--CA 1.481 1.118 0 C-N-CA 127.251 2.22 . . . . 15.0 115.161 -178.059 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.652 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 58.8 t30 . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 123.016 1.388 . . . . 15.0 112.811 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.494 ' HB ' ' CE2' ' A' ' 8' ' ' TYR . 81.5 p -98.38 119.49 37.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.078 -1.873 . . . . 15.0 108.306 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 6.6 m0 -113.91 130.28 56.52 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.237 -1.023 . . . . 15.0 108.237 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.494 ' CE2' ' HB ' ' A' ' 6' ' ' THR . 89.6 m-85 -132.22 106.0 7.68 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.229 0.956 . . . . 15.0 112.348 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.0 p -104.07 137.9 41.36 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.547 -0.751 . . . . 15.0 111.341 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.11 -145.46 7.28 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 113.92 -1.491 . . . . 15.0 112.038 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.55 144.15 50.21 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.891 -0.655 . . . . 15.0 112.675 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -118.29 140.16 50.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.434 -1.257 . . . . 15.0 111.312 174.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 143' ' ' SER . 0.9 OUTLIER -127.53 133.43 49.81 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.247 -1.342 . . . . 15.0 111.391 176.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -111.45 116.99 4.36 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 125.223 1.577 . . . . 15.0 110.626 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -109.26 145.46 35.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.848 0.832 . . . . 15.0 111.723 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -98.98 98.17 9.25 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.5 -1.227 . . . . 15.0 114.289 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.92 90.0 7.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.82 -1.082 . . . . 15.0 109.438 170.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.22 -86.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.743 -2.026 . . . . 15.0 110.081 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -119.24 -165.45 1.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.537 1.135 . . . . 15.0 109.07 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.33 83.6 0.25 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.805 1.242 . . . . 15.0 113.904 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.94 136.97 50.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.669 -1.605 . . . . 15.0 111.763 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -121.18 97.1 5.36 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.117 -1.401 . . . . 15.0 109.549 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.01 133.72 55.27 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.329 1.233 . . . . 15.0 114.329 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.96 156.17 33.98 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.971 -1.922 . . . . 15.0 110.57 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.87 -86.91 0.07 OUTLIER Glycine 0 N--CA 1.478 1.495 0 O-C-N 124.245 0.965 . . . . 15.0 112.085 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 69.72 149.71 0.08 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.339 2.256 . . . . 15.0 114.801 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.25 149.8 16.96 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 113.636 -1.62 . . . . 15.0 110.812 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.54 121.34 42.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.226 0.536 . . . . 15.0 110.249 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 2.4 m-85 -129.83 150.3 51.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 116.103 1.89 . . . . 15.0 116.103 -166.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.29 121.07 4.43 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 112.985 -1.916 . . . . 15.0 110.352 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' HH12 ' A' ' 127' ' ' ARG . . . -104.99 98.91 1.54 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 113.732 -1.234 . . . . 15.0 110.215 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -105.97 101.1 10.62 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.586 1.184 . . . . 15.0 108.822 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.521 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 18.8 tm0? -106.37 82.46 1.74 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.8 -1.556 . . . . 15.0 106.8 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 44.0 t -80.37 -84.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.199 -1.819 . . . . 15.0 109.163 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.536 ' H ' ' CD ' ' A' ' 36' ' ' PRO . 19.3 t-20 163.5 51.42 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 128.916 2.886 . . . . 15.0 114.445 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.536 ' CD ' ' H ' ' A' ' 35' ' ' ASN . 96.0 Cg_endo -85.98 55.61 3.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 N-CA-C 108.669 -1.32 . . . . 15.0 108.669 157.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 66.72 -33.87 0.21 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.195 2.198 . . . . 15.0 114.858 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.08 160.5 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.894 1.677 . . . . 15.0 111.966 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -82.72 153.28 31.2 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 109.846 -1.302 . . . . 15.0 109.846 170.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -117.6 118.3 31.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.593 0.711 . . . . 15.0 110.774 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.7 tp10 -111.1 110.1 20.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.9 -1.518 . . . . 15.0 106.9 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.3 ttp -135.28 136.34 41.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.087 -1.415 . . . . 15.0 109.934 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 29' ' ' PHE . . . -172.73 177.23 45.38 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 114.7 -1.136 . . . . 15.0 112.921 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -116.16 145.69 42.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.74 1.257 . . . . 15.0 113.749 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -117.32 118.49 32.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.031 -2.349 . . . . 15.0 109.478 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.469 ' HE1' ' HB1' ' A' ' 54' ' ' ALA . 42.0 t90 -129.45 152.41 49.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.41 -1.268 . . . . 15.0 110.47 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 N--CA 1.482 1.152 0 O-C-N 125.188 1.555 . . . . 15.0 110.622 -176.816 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB1' ' HE1' ' A' ' 46' ' ' TRP . . . . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 116.087 1.884 . . . . 15.0 116.087 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.79 158.75 21.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.87 1.268 . . . . 15.0 113.566 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -121.41 148.33 17.35 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.498 169.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.25 131.97 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.446 0.641 . . . . 15.0 110.74 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.72 127.77 54.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.649 -1.16 . . . . 15.0 110.091 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.49 117.07 20.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.996 -1.911 . . . . 15.0 111.415 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.536 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 36.3 p -120.44 145.94 46.72 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.111 -1.404 . . . . 15.0 111.91 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.09 115.82 27.92 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.86 -1.518 . . . . 15.0 107.583 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.4 pttm -108.32 136.02 48.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 113.86 -1.518 . . . . 15.0 113.298 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.714 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 20.0 tp -128.99 135.9 49.59 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 113.599 -1.637 . . . . 15.0 108.812 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.04 137.56 11.58 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 125.366 1.666 . . . . 15.0 110.03 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.61 110.01 47.49 Favored Pre-proline 0 N--CA 1.477 0.882 0 N-CA-C 113.64 0.978 . . . . 15.0 113.64 177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.99 92.51 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.483 2.122 . . . . 15.0 109.893 172.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -46.59 -44.88 18.5 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.208 -1.36 . . . . 15.0 114.28 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -172.01 157.36 4.36 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.175 1.39 . . . . 15.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.73 -91.31 0.5 Allowed Glycine 0 N--CA 1.476 1.327 0 CA-C-N 114.794 -1.093 . . . . 15.0 111.028 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -158.9 -94.6 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.42 0.688 . . . . 15.0 109.661 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.97 94.53 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.052 0.941 . . . . 15.0 109.369 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -159.65 -58.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.81 -1.541 . . . . 15.0 110.824 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.74 122.64 47.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.619 0.768 . . . . 15.0 111.1 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.427 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -125.37 106.64 9.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.964 -1.471 . . . . 15.0 111.088 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 tt -104.74 107.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.089 -0.96 . . . . 15.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.714 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -168.78 -171.9 1.49 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 112.466 -2.152 . . . . 15.0 111.553 -178.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.0 p -119.21 154.05 33.99 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.092 0.949 . . . . 15.0 112.894 -163.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -128.4 140.41 51.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.868 -1.514 . . . . 15.0 112.704 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tt -134.92 141.53 46.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.611 -1.177 . . . . 15.0 109.563 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -173.7 -143.0 4.12 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 114.92 -1.037 . . . . 15.0 111.838 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.37 156.07 27.3 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 114.429 -0.885 . . . . 15.0 113.617 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -113.27 138.15 50.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.284 -1.458 . . . . 15.0 112.089 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.597 HG22 HG12 ' A' ' 104' ' ' VAL . 31.4 t -118.63 134.17 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.212 -1.774 . . . . 15.0 106.212 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.4 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.854 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.235 -174.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 121.585 0.707 . . . . 15.0 112.905 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.597 HG12 HG22 ' A' ' 83' ' ' VAL . 16.7 m -129.85 141.75 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.005 -1.907 . . . . 15.0 110.433 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.6 m -135.0 107.78 10.51 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-N 115.477 -0.783 . . . . 15.0 113.037 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -65.39 139.19 58.41 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.129 2.553 . . . . 15.0 112.561 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.91 139.62 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.968 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -126.57 137.29 53.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.516 -1.22 . . . . 15.0 110.98 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -137.6 137.44 38.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.228 -0.897 . . . . 15.0 111.864 176.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.86 138.0 10.0 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 115.43 -0.805 . . . . 15.0 112.329 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.41 -148.76 11.85 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 121.749 0.638 . . . . 15.0 114.582 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -124.49 131.47 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.513 1.149 . . . . 15.0 111.94 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 9.8 pt-20 -112.49 121.01 43.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.975 -1.921 . . . . 15.0 110.229 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -113.57 137.12 52.02 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.305 -1.316 . . . . 15.0 110.734 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.29 136.2 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 113.213 -1.812 . . . . 15.0 109.102 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.5 tp -63.24 142.97 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 114.441 -1.254 . . . . 15.0 112.424 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -90.42 -91.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.255 -1.339 . . . . 15.0 109.758 168.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -118.84 114.47 22.68 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.033 0.533 . . . . 15.0 111.872 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -169.34 172.91 6.9 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.085 1.754 . . . . 15.0 110.276 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.9 tt -53.79 124.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.874 0.87 . . . . 15.0 110.918 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 m 56.35 74.83 0.64 Allowed Pre-proline 0 N--CA 1.483 1.185 0 CA-C-N 113.738 -1.573 . . . . 15.0 110.091 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.07 72.82 5.71 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 15.0 112.744 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 149' ' ' ARG . 6.1 pt-20 -163.55 30.57 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.177 -1.829 . . . . 15.0 113.145 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 17.5 pt -116.64 136.17 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.251 -0.905 . . . . 15.0 113.438 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.93 140.61 52.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.021 -1.9 . . . . 15.0 111.654 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 t -125.14 116.76 22.55 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.056 -1.884 . . . . 15.0 109.763 175.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.49 HH12 ' HA3' ' A' ' 31' ' ' GLY . 97.9 mtt180 -115.69 108.18 16.04 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.453 -1.703 . . . . 15.0 110.475 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.64 110.88 19.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.666 1.222 . . . . 15.0 111.585 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.76 150.18 39.7 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.54 -2.118 . . . . 15.0 112.07 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 25.2 p90 -97.21 128.06 43.74 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.18 123.83 48.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.264 -1.334 . . . . 15.0 111.598 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -126.38 146.59 50.0 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.501 -2.136 . . . . 15.0 110.868 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.483 1.181 0 CA-C-N 113.582 -1.644 . . . . 15.0 110.762 -171.785 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.339 0 N-CA-C 110.619 -0.992 . . . . 15.0 110.619 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 98.8 mtp -117.58 135.14 54.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.508 -0.846 . . . . 15.0 109.956 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 100.87 11.18 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.845 0.831 . . . . 15.0 111.757 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 61.2 m -93.11 125.2 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.682 -2.054 . . . . 15.0 109.949 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.67 126.87 53.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.514 -2.13 . . . . 15.0 109.096 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -115.17 110.89 2.37 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 112.486 -2.143 . . . . 15.0 110.423 -176.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.92 127.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 113.95 -1.125 . . . . 15.0 108.731 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 77.6 p -148.05 154.1 39.81 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.38 -1.736 . . . . 15.0 113.032 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -116.4 142.86 46.31 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.093 -1.412 . . . . 15.0 110.892 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 33.6 ttp-105 -70.13 126.14 28.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.452 -1.704 . . . . 15.0 109.618 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 113.63 -1.623 . . . . 15.0 110.013 -178.649 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.965 0.888 . . . . 15.0 111.568 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 33' ' ' GLN . 29.5 m -153.58 142.95 21.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.09 1.756 . . . . 15.0 108.499 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -101.23 130.49 47.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.064 -0.971 . . . . 15.0 108.672 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -125.2 105.86 9.45 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.474 -166.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.566 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.0 m -123.24 128.97 50.74 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.421 0.451 . . . . 15.0 110.046 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -137.48 151.17 21.06 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 114.995 -1.002 . . . . 15.0 115.447 -173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.01 124.2 47.57 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.382 -1.409 . . . . 15.0 108.67 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.37 154.42 47.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.351 1.241 . . . . 15.0 114.351 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.2 161.76 20.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.339 -1.755 . . . . 15.0 111.949 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.62 96.72 0.59 Allowed Glycine 0 N--CA 1.476 1.362 0 N-CA-C 110.183 -1.167 . . . . 15.0 110.183 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.414 ' CZ3' ' HA ' ' A' ' 17' ' ' GLN . 50.2 t90 -102.63 123.1 45.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.767 0.794 . . . . 15.0 111.508 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 p -104.02 133.57 48.74 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.11 -0.95 . . . . 15.0 112.49 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.414 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 42.8 tt0 -64.12 -55.69 20.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.823 -1.535 . . . . 15.0 113.681 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.32 86.86 2.63 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.169 0.985 . . . . 15.0 111.689 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -137.41 134.1 35.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.968 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -54.54 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.048 1.499 . . . . 15.0 115.048 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -129.63 95.21 3.93 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.531 0.732 . . . . 15.0 110.293 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -122.76 149.16 44.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.58 -1.191 . . . . 15.0 113.761 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -74.31 154.07 39.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.849 -1.523 . . . . 15.0 110.314 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.63 -33.54 76.17 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.482 1.29 . . . . 15.0 114.482 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 140.38 8.61 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.519 1.057 . . . . 15.0 111.161 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 45' ' ' ASP . . . -141.6 86.47 2.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.613 -0.794 . . . . 15.0 110.136 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.15 92.93 0.59 Allowed Glycine 0 N--CA 1.474 1.19 0 CA-C-N 113.664 -1.607 . . . . 15.0 111.311 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -117.99 121.03 39.59 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.071 0.512 . . . . 15.0 109.866 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 42' ' ' MET 0.293 5.2 t80 -161.63 179.81 7.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.332 -1.758 . . . . 15.0 111.625 175.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.83 -178.55 15.55 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 115.044 -0.98 . . . . 15.0 112.091 -170.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.5 -155.04 12.97 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 113.071 -1.565 . . . . 15.0 112.722 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -126.28 138.81 53.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 112.597 -1.802 . . . . 15.0 112.976 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 1.1 tm0? -115.73 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.098 -1.41 . . . . 15.0 107.982 167.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.412 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 43.8 t -107.47 -29.74 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 111.095 -2.775 . . . . 15.0 110.412 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 48.6 54.48 16.07 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 116.954 2.205 . . . . 15.0 116.954 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.65 -22.42 37.76 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.097 1.865 . . . . 15.0 112.077 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -166.67 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 128.95 2.9 . . . . 15.0 109.292 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.1 m -135.33 160.49 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.255 1.422 . . . . 15.0 112.246 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 148.12 26.92 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 108.785 -1.726 . . . . 15.0 108.785 161.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.21 126.29 52.53 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.439 0.296 . . . . 15.0 111.399 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.578 ' HG3' HH22 ' A' ' 127' ' ' ARG . 4.1 pm0 -142.33 133.56 26.19 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.058 0.849 . . . . 15.0 113.123 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.641 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.5 137.11 54.84 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.271 -1.331 . . . . 15.0 108.233 174.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.52 129.81 8.5 Favored Glycine 0 N--CA 1.48 1.582 0 O-C-N 126.072 2.108 . . . . 15.0 110.745 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.423 ' N ' ' HB2' ' A' ' 29' ' ' PHE . 6.8 t80 -104.75 112.68 25.88 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.493 0.663 . . . . 15.0 109.602 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 15.0 t70 -106.74 118.4 36.58 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.122 -1.399 . . . . 15.0 110.005 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -120.54 110.05 15.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.613 -1.63 . . . . 15.0 111.06 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tt . . . . . 0 N--CA 1.48 1.027 0 CA-C-N 113.108 -1.86 . . . . 15.0 112.84 177.723 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 114.129 1.159 . . . . 15.0 114.129 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -115.46 101.97 9.38 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 15.0 112.467 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -119.26 142.19 16.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 112.226 -2.261 . . . . 15.0 111.141 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.71 135.16 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.185 -1.008 . . . . 15.0 111.164 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -109.8 116.63 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.912 -1.144 . . . . 15.0 107.912 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.6 111.19 21.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.82 -1.991 . . . . 15.0 109.095 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.7 p -130.21 147.41 51.93 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.453 -1.703 . . . . 15.0 113.797 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.28 134.21 47.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.422 -2.172 . . . . 15.0 109.232 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.59 ' HD3' HH21 ' A' ' 127' ' ' ARG . 22.0 ttpp -107.2 114.15 28.02 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.201 -1.363 . . . . 15.0 111.421 -172.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.91 142.81 46.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.084 -1.871 . . . . 15.0 109.755 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.88 -156.34 23.7 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.829 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.63 159.11 9.92 Favored Pre-proline 0 N--CA 1.481 1.116 0 N-CA-C 114.397 1.258 . . . . 15.0 114.397 -168.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.62 104.71 0.32 Allowed 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 123.264 2.643 . . . . 15.0 111.487 164.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -146.16 148.79 32.92 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.765 -2.016 . . . . 15.0 106.594 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp 70.29 -47.2 0.62 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.455 1.902 . . . . 15.0 111.548 -164.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.64 125.06 5.99 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.353 -1.099 . . . . 15.0 110.353 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -64.51 -57.28 9.63 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.58 0.752 . . . . 15.0 109.558 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -133.93 82.12 1.96 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.223 -0.899 . . . . 15.0 108.586 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -169.35 -75.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.979 -1.919 . . . . 15.0 108.944 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.525 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . 1.4 pt? -123.46 132.0 53.8 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.305 1.003 . . . . 15.0 110.847 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.92 135.56 54.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.436 -1.711 . . . . 15.0 108.757 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 tt -91.41 116.74 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.105 -0.952 . . . . 15.0 110.015 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CD1' ' HG2' ' A' ' 62' ' ' LYS . 26.9 m-85 -135.96 138.82 42.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.25 -1.796 . . . . 15.0 115.06 -175.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 55.4 p -113.08 143.3 44.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 112.083 -2.326 . . . . 15.0 109.598 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.501 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 29.0 mtm105 -115.09 123.22 48.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.832 -1.531 . . . . 15.0 109.735 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tt -119.65 122.92 42.61 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.51 -1.223 . . . . 15.0 109.315 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -130.83 2.22 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 110.102 -1.199 . . . . 15.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 105' ' ' SER . . . 170.98 -166.44 39.63 Favored Glycine 0 N--CA 1.477 1.431 0 O-C-N 125.171 1.16 . . . . 15.0 114.999 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.7 ttm -119.4 129.68 54.92 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.175 -1.012 . . . . 15.0 112.146 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -122.59 135.8 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 113.521 -1.672 . . . . 15.0 108.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.424 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 9.2 p90 . . . . . 0 N--CA 1.476 0.867 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.778 172.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 121.031 0.444 . . . . 15.0 111.912 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.26 -27.32 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.008 -0.996 . . . . 15.0 112.814 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.497 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 4.7 t 32.84 70.93 0.72 Allowed Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 127.328 2.251 . . . . 15.0 114.533 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.07 95.04 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.678 2.919 . . . . 15.0 114.26 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.566 HG11 HE21 ' A' ' 131' ' ' GLN . 70.2 t -123.96 134.37 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.508 -1.223 . . . . 15.0 109.981 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.91 123.35 40.76 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.245 -1.798 . . . . 15.0 109.626 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -120.99 136.75 54.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.232 0.613 . . . . 15.0 110.878 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.67 135.3 7.86 Favored Glycine 0 N--CA 1.478 1.453 0 CA-C-N 115.452 -0.794 . . . . 15.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.47 -146.84 8.19 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 124.362 0.683 . . . . 15.0 113.605 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.76 154.28 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.159 -1.021 . . . . 15.0 113.43 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -119.57 143.64 47.52 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.902 -1.499 . . . . 15.0 110.403 167.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.525 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 46.0 m-85 -117.0 139.1 51.08 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.527 1.142 . . . . 15.0 111.892 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.95 104.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.266 -1.334 . . . . 15.0 111.275 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . 0.265 18.1 tt -79.95 84.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 123.076 1.417 . . . . 15.0 112.97 -175.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -115.68 102.54 9.84 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.677 -2.056 . . . . 15.0 109.5 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.401 ' HB3' ' H ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -170.77 -83.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.617 -1.629 . . . . 15.0 106.804 176.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.401 ' H ' ' HB3' ' A' ' 118' ' ' ARG . 35.6 mtt180 -69.17 155.81 39.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.392 0.677 . . . . 15.0 111.572 166.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.62 97.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 114.359 -1.291 . . . . 15.0 113.534 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.2 p -110.0 135.94 20.46 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 113.83 -1.532 . . . . 15.0 111.642 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.92 73.31 4.31 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.788 2.325 . . . . 15.0 114.053 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 50.11 39.39 19.23 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.899 1.679 . . . . 15.0 114.636 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.463 HD11 ' HB ' ' A' ' 146' ' ' VAL . 3.9 tt -123.4 142.23 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.663 -1.153 . . . . 15.0 113.748 -164.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.89 157.82 29.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.017 -1.902 . . . . 15.0 110.338 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 32.7 p -106.41 132.23 52.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.296 -0.865 . . . . 15.0 111.046 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.59 HH21 ' HD3' ' A' ' 62' ' ' LYS . 19.4 ttm180 -112.85 130.53 56.06 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.824 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.62 111.03 8.5 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.9 1.375 . . . . 15.0 111.757 173.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.37 150.21 52.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.368 -1.287 . . . . 15.0 112.624 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 57.1 t80 -97.27 116.32 29.26 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.282 1.039 . . . . 15.0 108.376 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.566 HE21 HG11 ' A' ' 107' ' ' VAL . 62.5 tt0 -96.59 108.75 21.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 111.971 -2.377 . . . . 15.0 110.251 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -112.03 146.51 37.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.92 -1.945 . . . . 15.0 112.296 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.48 1.056 0 CA-C-N 112.762 -2.017 . . . . 15.0 109.896 176.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.098 0 CA-C-O 121.987 0.771 . . . . 15.0 111.401 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -119.19 148.24 43.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.048 -1.576 . . . . 15.0 109.983 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.8 97.42 10.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.681 -1.229 . . . . 15.0 107.681 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.6 t -94.96 125.13 39.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.211 -1.359 . . . . 15.0 107.947 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.54 150.08 24.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.944 -1.934 . . . . 15.0 111.818 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.02 -162.6 29.64 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 114.094 -1.412 . . . . 15.0 113.707 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.463 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.0 m -119.38 127.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.449 -1.876 . . . . 15.0 110.64 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.481 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 23.1 t -130.01 132.1 46.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.857 -1.519 . . . . 15.0 110.507 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.56 154.99 34.61 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.643 0.735 . . . . 15.0 111.793 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -115.48 135.18 54.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.383 -1.281 . . . . 15.0 112.119 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 90.9 m-85 . . . . . 0 N--CA 1.482 1.164 0 CA-C-N 113.355 -1.748 . . . . 15.0 115.373 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 122.357 1.075 . . . . 15.0 113.003 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m -98.02 124.63 42.61 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.422 -1.717 . . . . 15.0 108.263 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 21.4 m0 -97.86 130.42 44.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.389 -1.278 . . . . 15.0 111.027 -177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.405 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 97.6 m-85 -122.51 86.05 2.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.935 -1.939 . . . . 15.0 108.41 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -108.82 123.6 49.3 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.103 -1.408 . . . . 15.0 110.058 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.83 -144.52 4.14 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 125.019 1.449 . . . . 15.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.68 148.07 47.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -130.91 140.17 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 125.007 1.442 . . . . 15.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.1 tp -114.13 133.53 55.5 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.031 -1.441 . . . . 15.0 108.763 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.65 112.49 3.96 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 113.535 -1.666 . . . . 15.0 110.138 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -121.82 145.48 48.03 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.788 0.835 . . . . 15.0 110.833 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -130.32 145.48 51.78 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.308 -0.86 . . . . 15.0 111.259 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -79.94 79.34 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.055 0.931 . . . . 15.0 109.151 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -147.17 -82.36 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 112.846 -1.979 . . . . 15.0 111.281 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -116.18 136.84 52.65 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.402 0.681 . . . . 15.0 110.575 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.5 ptt-85 -65.77 -20.88 66.43 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.306 -1.315 . . . . 15.0 114.0 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -117.54 95.94 5.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.161 0.984 . . . . 15.0 109.683 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -173.69 -69.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.462 1.505 . . . . 15.0 111.048 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 54.8 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.652 1.581 . . . . 15.0 114.726 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.04 -37.54 80.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.477 -1.692 . . . . 15.0 114.556 -173.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.07 87.1 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 N-CA-C 118.0 1.96 . . . . 15.0 118.0 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.17 89.6 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.661 1.356 . . . . 15.0 114.661 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.43 -118.67 6.12 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.936 0.779 . . . . 15.0 111.9 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.42 137.99 39.94 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.306 -0.947 . . . . 15.0 110.112 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -117.6 113.66 22.26 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.643 -1.162 . . . . 15.0 111.143 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.3 101.42 1.04 Allowed Glycine 0 N--CA 1.476 1.342 0 CA-C-N 113.429 -1.714 . . . . 15.0 110.91 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.68 135.24 12.6 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 114.428 -0.886 . . . . 15.0 113.156 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -129.22 111.33 12.78 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.79 -1.205 . . . . 15.0 110.972 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.04 83.28 1.88 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.235 -0.893 . . . . 15.0 108.891 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.26 -83.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.552 -1.658 . . . . 15.0 110.456 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -81.22 135.44 50.76 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 117.535 -1.221 . . . . 15.0 109.407 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.26 78.93 0.81 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.436 2.758 . . . . 15.0 112.08 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -177.05 -76.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.005 2.122 . . . . 15.0 108.955 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.35 135.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.123 0.969 . . . . 15.0 108.466 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.34 -168.13 12.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 113.91 -1.496 . . . . 15.0 110.794 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.74 148.23 52.56 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.788 1.032 . . . . 15.0 113.788 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HG2' ' HD3' ' A' ' 62' ' ' LYS . 70.9 mm-40 -127.26 127.21 44.02 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.239 -1.346 . . . . 15.0 110.644 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 90.9 mtp -116.64 134.45 54.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.158 -1.383 . . . . 15.0 110.608 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -115.72 114.17 3.06 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.215 -1.554 . . . . 15.0 109.215 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -116.57 122.32 44.32 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.871 0.843 . . . . 15.0 111.561 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -137.78 142.61 40.89 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.485 -1.689 . . . . 15.0 111.397 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -165.03 129.46 2.47 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.74 0.645 . . . . 15.0 112.74 173.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 CA-C-N 112.344 -2.207 . . . . 15.0 113.862 165.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 123.648 1.69 . . . . 15.0 110.014 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -126.74 146.64 50.15 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.028 -1.896 . . . . 15.0 109.909 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.04 17.26 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 124.285 0.991 . . . . 15.0 113.978 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 82' ' ' MET . 12.7 p -147.29 148.26 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 112.978 -1.611 . . . . 15.0 111.239 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -121.27 126.22 49.01 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.536 1.934 . . . . 15.0 109.374 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.585 ' H ' ' HB2' ' A' ' 82' ' ' MET . 3.5 tm? -117.34 111.19 19.02 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.934 -0.395 . . . . 15.0 109.934 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 41' ' ' GLU . 13.7 t -131.9 146.32 52.04 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.42 -0.809 . . . . 15.0 112.829 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -103.13 136.39 43.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.039 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 59.6 pttt -115.83 143.56 45.23 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.914 1.45 . . . . 15.0 114.914 -171.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.4 mt -115.5 136.41 53.11 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.925 -1.943 . . . . 15.0 110.058 169.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.42 111.92 4.2 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 124.744 1.277 . . . . 15.0 111.529 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 4.1 m-30 -110.69 105.0 56.89 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.933 1.293 . . . . 15.0 111.713 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.58 -145.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.052 2.502 . . . . 15.0 111.584 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 69.03 -68.97 0.17 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 127.487 2.315 . . . . 15.0 115.181 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 75' ' ' ILE . 28.4 tp -60.91 99.7 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.439 1.096 . . . . 15.0 113.596 -168.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.92 -85.74 0.44 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.827 -1.988 . . . . 15.0 109.461 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 t -179.1 171.36 1.36 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.406 1.482 . . . . 15.0 110.083 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -51.54 -31.09 22.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.669 1.729 . . . . 15.0 115.669 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.05 -29.41 63.4 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.338 1.236 . . . . 15.0 114.338 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.46 112.99 18.17 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.098 0.959 . . . . 15.0 111.423 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.54 134.26 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.08 -1.418 . . . . 15.0 109.721 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.495 HD11 ' HB3' ' A' ' 68' ' ' LEU . 4.5 mp -91.34 141.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.509 -1.678 . . . . 15.0 107.388 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -126.6 128.79 47.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.793 -1.094 . . . . 15.0 109.763 173.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.2 p -108.4 122.57 47.28 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.378 -1.283 . . . . 15.0 108.397 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.541 HH22 ' NE ' ' A' ' 127' ' ' ARG . 99.2 mtt180 -125.19 123.22 39.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.508 -2.133 . . . . 15.0 111.534 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.44 132.09 52.77 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.908 -1.042 . . . . 15.0 112.449 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.34 -140.18 5.77 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.967 -1.015 . . . . 15.0 113.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.01 140.87 3.0 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.187 1.375 . . . . 15.0 111.8 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.603 ' HB3' ' O ' ' A' ' 57' ' ' VAL 0.364 0.4 OUTLIER -156.91 164.33 38.16 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.515 -2.168 . . . . 15.0 112.659 159.424 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 103' ' ' SER . 18.8 m -97.99 125.97 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.234 0.959 . . . . 15.0 110.18 -172.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.9 p90 . . . . . 0 N--CA 1.476 0.826 0 CA-C-N 115.484 -0.78 . . . . 15.0 112.858 -176.717 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.435 ' HB3' HG12 ' A' ' 83' ' ' VAL . 17.1 t . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.596 0.712 . . . . 15.0 112.142 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.49 167.9 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 113.988 -1.46 . . . . 15.0 111.264 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m 68.14 148.53 0.12 Allowed Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 125.918 1.687 . . . . 15.0 114.368 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -61.19 142.05 95.37 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.651 2.234 . . . . 15.0 113.102 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.87 136.72 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 112.838 -1.983 . . . . 15.0 107.216 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.55 129.66 54.78 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.408 -1.724 . . . . 15.0 110.13 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -122.65 131.54 53.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.102 -1.408 . . . . 15.0 112.061 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.38 99.04 0.92 Allowed Glycine 0 N--CA 1.475 1.278 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.786 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -115.5 145.52 18.7 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 124.79 0.936 . . . . 15.0 112.85 -174.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 127' ' ' ARG . 19.2 m -121.59 138.46 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.716 -0.742 . . . . 15.0 112.042 171.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.28 109.34 19.76 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.077 -1.874 . . . . 15.0 107.94 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -120.59 136.08 54.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.716 -1.584 . . . . 15.0 111.64 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.39 107.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.46 -1.7 . . . . 15.0 110.689 171.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.9 tp -113.22 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 122.837 1.303 . . . . 15.0 111.648 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.664 ' HD3' HG21 ' A' ' 121' ' ' THR . 47.9 mtt-85 -122.23 -30.79 3.95 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.791 2.515 . . . . 15.0 117.791 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.27 -28.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 118.456 2.762 . . . . 15.0 118.456 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 47.7 mtt-85 -101.09 149.71 23.68 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.393 1.077 . . . . 15.0 112.244 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.43 ' H ' HG13 ' A' ' 120' ' ' ILE . 16.9 mt -11.78 -81.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 128.311 2.644 . . . . 15.0 113.735 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.664 HG21 ' HD3' ' A' ' 117' ' ' ARG . 67.8 p 58.49 159.61 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 126.233 1.813 . . . . 15.0 115.489 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.64 161.87 33.79 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.655 2.236 . . . . 15.0 111.415 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -68.46 78.21 0.27 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.215 1.006 . . . . 15.0 112.191 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mm -120.94 105.35 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.595 1.158 . . . . 15.0 109.486 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.3 120.49 40.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.571 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -80.78 117.01 21.07 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.921 -1.036 . . . . 15.0 109.359 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.541 ' NE ' HH22 ' A' ' 78' ' ' ARG . 33.6 mtt180 -115.21 119.91 37.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.626 -1.17 . . . . 15.0 112.721 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.48 118.04 28.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.054 -1.43 . . . . 15.0 110.39 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 31.3 tt0 -120.65 132.98 55.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 112.727 -2.033 . . . . 15.0 111.285 -171.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 76.3 m-85 -97.4 128.22 44.02 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.302 -1.317 . . . . 15.0 110.336 171.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.717 ' HB3' ' HB2' ' A' ' 141' ' ' MET . 48.1 tt0 -109.85 108.76 19.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.432 -1.713 . . . . 15.0 109.108 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -117.93 146.58 43.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.599 -2.091 . . . . 15.0 112.066 -174.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.48 1.034 0 CA-C-N 114.138 -1.392 . . . . 15.0 111.791 174.565 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 CA-C-O 122.033 0.796 . . . . 15.0 113.174 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.717 ' HB2' ' HB3' ' A' ' 131' ' ' GLN . 48.1 mtt -117.6 148.26 42.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.716 -1.242 . . . . 15.0 110.925 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.03 112.32 18.11 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.98 -1.009 . . . . 15.0 110.055 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.1 m -105.86 125.09 50.58 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.69 -1.595 . . . . 15.0 107.348 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 pp -132.65 141.1 48.47 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.84 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.13 -162.46 29.35 Favored Glycine 0 N--CA 1.473 1.121 0 O-C-N 124.191 0.932 . . . . 15.0 113.509 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.07 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.606 -1.297 . . . . 15.0 109.442 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 62.5 p -115.85 138.25 51.34 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.89 1.369 . . . . 15.0 110.731 170.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -111.51 135.22 52.38 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.009 -1.45 . . . . 15.0 110.768 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 45.8 ttm180 -78.86 123.93 27.72 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.544 -1.207 . . . . 15.0 108.562 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 7' ' ' TRP . 88.7 t80 . . . . . 0 N--CA 1.483 1.189 0 O-C-N 125.347 1.654 . . . . 15.0 115.377 -173.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 122.092 0.948 . . . . 15.0 113.501 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 p -98.19 140.07 33.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.785 -1.098 . . . . 15.0 112.907 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -110.35 131.08 55.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.766 -2.015 . . . . 15.0 110.184 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.47 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 5.5 m-85 -124.1 131.28 53.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.617 -1.629 . . . . 15.0 108.978 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -126.96 133.43 50.6 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.496 0.718 . . . . 15.0 111.623 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -172.94 -146.23 5.34 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-N 115.191 -0.913 . . . . 15.0 113.191 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.42 150.1 51.79 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.423 0.898 . . . . 15.0 113.423 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.32 142.91 50.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.454 1.096 . . . . 15.0 112.727 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.6 tp -114.05 140.4 48.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.199 -1.819 . . . . 15.0 108.8 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.4 127.41 7.73 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.153 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 10.2 t-105 -118.33 141.15 48.82 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.463 -0.868 . . . . 15.0 110.948 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 t -108.73 105.2 14.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.528 -1.214 . . . . 15.0 109.818 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -52.79 -44.11 66.35 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.975 -1.466 . . . . 15.0 111.753 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -65.66 -49.15 69.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.111 0.964 . . . . 15.0 113.297 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -103.2 83.65 2.23 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.747 1.26 . . . . 15.0 112.045 -172.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HG2' ' HG3' ' A' ' 21' ' ' GLU . 53.8 ttt85 -5.98 -81.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.04 2.936 . . . . 15.0 117.614 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 40.6 mt-10 -125.4 92.01 3.53 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.89 0.852 . . . . 15.0 111.802 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -114.18 91.63 3.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.457 -1.247 . . . . 15.0 112.918 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.7 87.94 1.27 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.911 -1.495 . . . . 15.0 111.573 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -106.37 -41.41 5.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.993 -1.912 . . . . 15.0 112.848 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.62 -151.4 18.42 Favored Glycine 0 N--CA 1.476 1.308 0 O-C-N 123.905 0.753 . . . . 15.0 112.1 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.33 148.49 50.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.755 -1.223 . . . . 15.0 111.299 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.54 -166.64 16.29 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.776 1.297 . . . . 15.0 110.556 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.01 49.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.501 0.667 . . . . 15.0 111.44 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.01 113.37 19.48 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.722 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.72 112.0 3.95 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 112.732 -2.031 . . . . 15.0 110.198 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.84 142.88 15.95 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 110.702 -0.959 . . . . 15.0 110.702 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 11.4 t80 -141.11 132.67 27.04 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.104 -0.548 . . . . 15.0 111.124 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -121.41 94.1 4.22 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.966 0.888 . . . . 15.0 110.617 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.31 -63.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.483 -2.144 . . . . 15.0 111.688 174.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -143.82 144.85 28.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.43 1.492 . . . . 15.0 109.618 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.98 89.5 0.37 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.488 2.792 . . . . 15.0 111.768 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 t80 172.7 -48.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.51 -2.132 . . . . 15.0 109.058 -169.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 48.3 t -131.52 124.02 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.154 0.982 . . . . 15.0 108.83 175.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.37 148.23 16.72 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.924 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 78.5 m-85 -112.78 136.66 52.15 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.1 0.778 . . . . 15.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.54 114.21 14.0 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.843 -1.526 . . . . 15.0 112.034 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.4 ttp -104.08 128.66 51.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.686 -1.597 . . . . 15.0 109.062 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.25 114.16 3.9 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 113.88 -1.509 . . . . 15.0 109.751 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.66 109.44 18.6 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.407 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -121.2 124.08 43.81 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.559 -1.2 . . . . 15.0 111.361 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -125.11 145.18 50.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.753 -1.567 . . . . 15.0 109.783 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 42.1 tp . . . . . 0 N--CA 1.476 0.849 0 CA-C-N 115.775 -0.648 . . . . 15.0 112.359 179.376 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 122.493 1.139 . . . . 15.0 113.316 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 pm0 -115.34 154.83 28.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.438 -1.256 . . . . 15.0 112.309 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.47 118.41 4.37 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 114.578 -1.192 . . . . 15.0 111.114 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.65 127.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 122.193 0.997 . . . . 15.0 111.687 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 82' ' ' MET . 0.3 OUTLIER -116.54 140.79 48.99 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.114 -1.403 . . . . 15.0 112.035 174.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.21 111.14 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.185 -1.825 . . . . 15.0 109.011 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -124.65 134.74 52.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.146 0.975 . . . . 15.0 112.621 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.16 46.09 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.836 -1.529 . . . . 15.0 110.79 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 1.8 ttpm? -84.18 129.15 34.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.301 -1.772 . . . . 15.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.675 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 41.7 tp -108.95 114.58 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.505 -2.134 . . . . 15.0 107.691 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 76' ' ' TYR . . . 127.94 -147.38 17.24 Favored Glycine 0 CA--C 1.541 1.692 0 O-C-N 126.346 2.279 . . . . 15.0 113.941 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 43.3 t80 160.81 -60.5 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 116.546 -1.692 . . . . 15.0 112.821 -160.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -79.15 -147.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.447 2.764 . . . . 15.0 112.788 -167.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 53.98 84.76 0.06 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.291 1.836 . . . . 15.0 110.053 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp 69.36 -26.13 0.15 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.245 1.418 . . . . 15.0 114.54 -165.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.83 64.22 0.19 Allowed Glycine 0 N--CA 1.483 1.786 0 C-N-CA 124.949 1.261 . . . . 15.0 114.312 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.89 37.77 3.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.038 1.335 . . . . 15.0 109.458 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -167.52 -63.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.386 1.074 . . . . 15.0 112.475 -172.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 114' ' ' TYR . 4.7 m-20 -56.62 -49.46 74.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.524 0.935 . . . . 15.0 113.524 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER 141.82 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 130.372 3.469 . . . . 15.0 107.385 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.528 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 7.7 m-20 -113.34 105.35 13.29 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.924 -0.485 . . . . 15.0 110.307 -174.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.616 ' HB ' HG12 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -119.85 111.0 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.656 -1.239 . . . . 15.0 107.656 176.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.675 ' HB3' ' O ' ' A' ' 63' ' ' LEU 0.437 0.2 OUTLIER -169.01 -171.74 1.4 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 111.384 -2.644 . . . . 15.0 114.773 -177.474 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.9 t -108.12 139.48 42.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.223 1.011 . . . . 15.0 110.585 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HG3' ' HB3' ' A' ' 109' ' ' ALA . 9.8 ptp180 -118.95 139.69 51.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.033 -1.894 . . . . 15.0 114.147 -170.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 108' ' ' PHE . 2.7 pp -125.19 143.48 50.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 112.07 -2.332 . . . . 15.0 111.015 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.42 -154.45 11.75 Favored Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.33 1.019 . . . . 15.0 114.671 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.12 151.52 21.83 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 113.567 -1.316 . . . . 15.0 114.059 -173.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 58' ' ' GLN . 90.1 mtp -116.54 115.41 25.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.588 1.555 . . . . 15.0 110.361 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.18 132.59 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 114.943 -1.026 . . . . 15.0 108.905 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 . . . . . 0 N--CA 1.475 0.786 0 CA-C-N 114.79 -1.095 . . . . 15.0 110.041 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 121.871 0.843 . . . . 15.0 113.057 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -59.4 -32.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 15.0 113.263 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.81 84.62 0.19 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 127.265 2.226 . . . . 15.0 112.595 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -63.33 133.87 42.44 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.685 2.257 . . . . 15.0 112.747 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.33 138.02 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.422 -1.717 . . . . 15.0 109.695 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -122.88 129.86 52.15 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.636 -1.165 . . . . 15.0 111.817 175.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.565 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -133.7 147.32 51.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.281 -1.327 . . . . 15.0 111.149 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 138.64 10.75 Favored Glycine 0 N--CA 1.48 1.619 0 CA-C-O 119.011 -0.883 . . . . 15.0 111.221 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.14 -158.08 25.42 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 118.208 2.043 . . . . 15.0 118.208 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' HB ' ' A' ' 75' ' ' ILE . 33.0 m -120.67 130.66 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 111.911 -2.144 . . . . 15.0 111.556 -171.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.87 125.4 48.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.184 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 60.0 t80 -108.48 139.19 43.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 111.9 -2.409 . . . . 15.0 108.633 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 11.8 p -129.11 145.61 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 113.908 -1.496 . . . . 15.0 107.833 168.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 0.3 OUTLIER -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 124.483 1.114 . . . . 15.0 113.152 -177.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -80.64 -89.14 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.465 -2.152 . . . . 15.0 109.364 175.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 108.98 8.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.222 0.609 . . . . 15.0 109.81 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -167.71 164.55 14.4 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.568 -1.197 . . . . 15.0 111.37 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.1 mt -53.08 131.49 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.511 1.524 . . . . 15.0 109.95 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.6 m 55.83 79.84 0.32 Allowed Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 125.58 1.552 . . . . 15.0 109.68 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.46 80.36 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.633 2.888 . . . . 15.0 113.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 14.2 pt-20 -162.36 22.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.802 1.779 . . . . 15.0 115.802 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.524 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 20.4 mt -116.7 108.15 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.92 -0.487 . . . . 15.0 110.542 -169.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -110.68 143.13 41.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.024 -0.989 . . . . 15.0 111.031 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.8 m -139.63 116.93 11.24 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.254 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.24 137.61 52.08 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.832 -1.076 . . . . 15.0 112.78 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.34 120.02 16.17 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.774 -1.103 . . . . 15.0 112.089 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -137.29 142.33 41.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 112.547 -2.115 . . . . 15.0 112.879 -174.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 79.2 m-85 -97.43 112.57 24.35 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.218 -1.355 . . . . 15.0 110.053 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -108.04 130.86 55.05 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.887 1.367 . . . . 15.0 113.695 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.429 ' HZ3' ' HB3' ' A' ' 130' ' ' TYR . 1.3 m-90 -120.51 120.37 35.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.492 -1.685 . . . . 15.0 112.289 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.483 1.183 0 CA-C-N 113.594 -1.639 . . . . 15.0 111.372 164.148 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 112.042 -0.423 . . . . 15.0 112.042 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 9.6 ttt -126.15 148.18 49.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.919 0.888 . . . . 15.0 111.904 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 6.4 tt -88.38 126.75 35.36 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.192 -1.41 . . . . 15.0 107.192 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.2 t -120.4 125.35 47.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.774 0.797 . . . . 15.0 111.163 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.1 tp -121.19 126.87 50.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.705 -1.589 . . . . 15.0 109.332 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.38 138.17 10.33 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 114.482 -1.235 . . . . 15.0 112.813 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.1 m -125.55 127.61 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 113.91 -1.145 . . . . 15.0 110.651 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.409 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 14.5 p -134.6 155.81 49.81 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.742 1.386 . . . . 15.0 114.742 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.69 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 12.1 m-85 -114.1 139.32 49.4 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.228 -1.806 . . . . 15.0 111.24 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -70.25 157.41 37.73 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.198 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.1 t80 . . . . . 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.003 . . . . 15.0 111.565 174.823 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 116.865 2.172 . . . . 15.0 116.865 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 149' ' ' ARG . 69.1 Cg_endo -78.51 31.78 0.45 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.028 1.818 . . . . 15.0 114.611 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -132.32 146.96 52.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.116 0.966 . . . . 15.0 109.735 -173.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 28.1 m-20 72.21 99.2 0.07 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.94 1.696 . . . . 15.0 113.78 175.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.607 ' H ' ' HA ' ' A' ' 34' ' ' VAL . 33.7 m-80 59.67 48.31 9.54 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 112.799 -2.0 . . . . 15.0 111.614 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.9 p -116.31 158.79 22.85 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.584 -1.644 . . . . 15.0 111.801 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.951 ' HB3' ' HA ' ' A' ' 150' ' ' PHE . 1.8 t90 -94.23 140.45 29.76 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.287 1.041 . . . . 15.0 111.76 -172.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -115.28 105.86 13.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.068 1.747 . . . . 15.0 109.234 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 m -124.33 118.2 26.21 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.6 161.81 28.58 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 115.151 0.82 . . . . 15.0 115.151 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -126.68 133.71 50.88 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.39 -0.905 . . . . 15.0 110.516 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -151.66 150.77 30.63 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.177 1.177 . . . . 15.0 114.177 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.69 133.46 55.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.287 -1.324 . . . . 15.0 112.66 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -124.6 151.09 17.2 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-N 113.307 -1.769 . . . . 15.0 114.984 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.0 m-90 -126.06 140.76 52.33 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 113.515 -1.342 . . . . 15.0 111.557 172.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.7 p -113.2 144.33 42.86 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 123.18 1.467 . . . . 15.0 114.51 -173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -54.54 120.51 6.77 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.782 -2.008 . . . . 15.0 111.025 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.6 t80 58.86 41.63 21.07 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.228 -1.351 . . . . 15.0 113.727 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.4 p -67.18 80.56 0.13 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.34 1.067 . . . . 15.0 113.69 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -61.69 -37.29 83.57 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.194 -1.367 . . . . 15.0 114.112 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -82.72 141.96 32.01 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.317 -0.856 . . . . 15.0 110.133 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -70.28 87.09 0.6 Allowed 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.303 1.002 . . . . 15.0 110.573 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -143.15 129.49 19.95 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 112.984 -1.916 . . . . 15.0 108.991 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.13 132.59 56.0 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.054 -1.43 . . . . 15.0 108.125 171.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.65 46.47 1.11 Allowed Glycine 0 N--CA 1.48 1.584 0 C-N-CA 125.099 1.333 . . . . 15.0 115.095 -175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.71 92.99 1.6 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.734 1.214 . . . . 15.0 109.192 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.33 139.57 14.29 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 113.189 -1.823 . . . . 15.0 112.903 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.46 121.2 41.88 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.725 -1.737 . . . . 15.0 106.928 171.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' MET . 21.4 m-85 -111.86 113.42 25.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.916 -1.493 . . . . 15.0 110.734 -173.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.99 146.51 16.15 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 112.453 -2.158 . . . . 15.0 110.243 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.27 -154.5 20.51 Favored Glycine 0 N--CA 1.473 1.165 0 CA-C-N 114.546 -0.827 . . . . 15.0 112.837 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.06 141.83 34.23 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 113.257 -1.471 . . . . 15.0 112.807 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -117.0 98.14 6.32 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.654 1.216 . . . . 15.0 110.772 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.607 ' HA ' ' H ' ' A' ' 5' ' ' ASN . 14.6 m -79.74 -38.68 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 112.934 -1.939 . . . . 15.0 115.636 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -139.96 154.22 70.31 Favored Pre-proline 0 N--CA 1.478 0.974 0 CA-C-O 118.696 -0.669 . . . . 15.0 112.745 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -73.44 66.64 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 122.937 2.425 . . . . 15.0 110.485 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.43 -79.0 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.792 2.037 . . . . 15.0 108.488 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 m -122.58 145.22 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.145 1.165 . . . . 15.0 114.145 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.36 -179.98 25.67 Favored Glycine 0 N--CA 1.477 1.42 0 CA-C-N 112.61 -2.086 . . . . 15.0 110.721 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.82 133.64 55.31 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.142 -0.529 . . . . 15.0 112.414 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.43 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 26.7 tt0 -129.49 128.83 43.66 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.339 -1.301 . . . . 15.0 110.673 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 67.1 mtm -123.21 139.33 54.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.381 -0.827 . . . . 15.0 110.586 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.04 114.17 2.44 Favored Glycine 0 N--CA 1.476 1.322 0 O-C-N 124.61 1.194 . . . . 15.0 111.778 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 46' ' ' TRP . 72.5 t80 -107.02 109.52 21.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.465 1.106 . . . . 15.0 111.235 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -113.7 118.45 34.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.49 -1.232 . . . . 15.0 108.768 174.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.477 ' HB2' ' CE2' ' A' ' 44' ' ' TYR . 24.0 t90 -114.84 119.16 35.65 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.984 -1.007 . . . . 15.0 110.84 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 18.7 tp -81.69 75.2 8.65 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.556 -1.202 . . . . 15.0 110.983 177.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.96 55.86 2.23 Favored Glycine 0 N--CA 1.481 1.688 0 CA-C-N 113.72 -1.582 . . . . 15.0 112.121 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.07 -70.61 0.68 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.201 1.4 . . . . 15.0 108.554 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.8 mmt -63.88 147.66 95.89 Favored Pre-proline 0 N--CA 1.477 0.914 0 CA-C-O 118.163 -0.922 . . . . 15.0 111.334 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -70.27 30.54 0.2 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.589 2.859 . . . . 15.0 115.95 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -132.64 139.25 47.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.296 1.439 . . . . 15.0 107.919 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.441 ' HA ' ' HE1' ' A' ' 46' ' ' TRP . 63.4 mttp -75.57 76.26 2.59 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.888 1.328 . . . . 15.0 112.734 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.646 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . . . -76.22 83.38 3.02 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.994 -1.457 . . . . 15.0 110.744 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -93.95 103.14 15.24 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 112.389 -2.187 . . . . 15.0 110.292 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.88 103.03 2.34 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 108.892 -1.683 . . . . 15.0 108.892 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 t -117.83 133.15 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 114.467 -0.867 . . . . 15.0 109.735 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.736 HE22 ' NH1' ' A' ' 78' ' ' ARG . 13.7 pt20 -109.7 139.52 44.63 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.486 -1.234 . . . . 15.0 111.487 170.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.32 111.05 17.28 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.489 -1.687 . . . . 15.0 108.893 174.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.416 HG21 ' CZ ' ' A' ' 78' ' ' ARG . 39.9 p -131.29 146.74 52.43 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.003 -1.453 . . . . 15.0 113.301 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -100.37 128.37 46.45 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.018 -1.446 . . . . 15.0 108.146 172.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.43 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.1 pttm -113.5 136.53 52.69 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.62 -1.173 . . . . 15.0 112.857 -173.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 76' ' ' TYR . 3.2 tt -105.98 108.41 19.91 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.532 -1.667 . . . . 15.0 108.226 172.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.88 98.12 2.11 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.011 -1.904 . . . . 15.0 109.363 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -117.21 138.22 24.7 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 113.975 -1.112 . . . . 15.0 111.761 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HA ' ' OD2' ' A' ' 74' ' ' ASP . 58.4 Cg_endo -64.22 -37.7 39.67 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.252 2.635 . . . . 15.0 115.814 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.2 tptt 49.92 32.06 5.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.838 1.655 . . . . 15.0 114.762 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.45 47.87 23.8 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.978 1.311 . . . . 15.0 114.138 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 73' ' ' LEU . . . -63.46 84.77 0.05 OUTLIER Glycine 0 N--CA 1.481 1.651 0 C-N-CA 124.257 0.932 . . . . 15.0 112.26 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.4 t -67.88 28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 118.938 2.94 . . . . 15.0 118.938 -165.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -169.82 -68.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.881 2.072 . . . . 15.0 107.775 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -170.05 87.48 0.14 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.009 1.324 . . . . 15.0 108.47 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.407 ' O ' ' HA3' ' A' ' 69' ' ' GLY . 19.6 tp -159.35 141.09 13.27 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.081 -0.963 . . . . 15.0 111.334 171.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' OD2' ' HA ' ' A' ' 66' ' ' PRO . 10.7 m-20 -138.1 150.45 46.88 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 114.277 -1.328 . . . . 15.0 110.923 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.4 tt -108.68 140.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.394 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 51.5 p90 -125.71 128.73 48.24 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.548 -1.205 . . . . 15.0 109.33 169.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.4 m -113.66 122.54 47.47 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.46 -1.311 . . . . 15.0 107.46 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.736 ' NH1' HE22 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -120.67 123.29 42.39 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.057 -1.429 . . . . 15.0 113.108 -175.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.94 136.78 54.99 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.995 -1.457 . . . . 15.0 110.941 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.39 -143.21 7.47 Favored Glycine 0 N--CA 1.477 1.422 0 O-C-N 124.448 1.092 . . . . 15.0 113.272 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 105' ' ' SER . . . -130.25 143.9 15.18 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 114.047 -1.077 . . . . 15.0 114.066 -174.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.47 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 25.5 ptt? -116.11 120.15 38.13 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.165 0.983 . . . . 15.0 112.93 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.67 140.82 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 113.359 -1.746 . . . . 15.0 108.493 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -113.84 140.37 48.39 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.83 -1.077 . . . . 15.0 108.614 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.72 ' HD3' ' HB ' ' A' ' 88' ' ' THR . 88.9 mtt180 68.24 -36.01 0.3 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 117.164 2.283 . . . . 15.0 117.164 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 70.7 -54.06 0.65 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 128.289 2.635 . . . . 15.0 113.388 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 7.7 t70 -149.81 105.68 3.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.917 0.887 . . . . 15.0 109.532 172.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.72 ' HB ' ' HD3' ' A' ' 85' ' ' ARG . 10.1 t -79.99 157.65 26.76 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.877 -1.056 . . . . 15.0 112.948 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 t -116.37 151.79 35.23 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 114.771 -1.104 . . . . 15.0 111.278 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -169.84 -39.58 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 113.65 -1.614 . . . . 15.0 112.803 -171.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.9 tttm 56.61 88.28 0.05 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.011 1.724 . . . . 15.0 112.95 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.72 76.64 4.25 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.928 -1.487 . . . . 15.0 111.598 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.7 -89.72 0.19 Allowed Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.346 -1.297 . . . . 15.0 112.443 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -178.57 157.94 1.02 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.127 2.171 . . . . 15.0 110.544 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.96 -141.45 14.89 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.991 -1.004 . . . . 15.0 111.443 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -109.12 91.22 3.55 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.283 1.039 . . . . 15.0 111.64 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.7 130.41 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 113.1 -1.864 . . . . 15.0 107.647 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 t -64.68 150.69 46.69 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.134 -0.939 . . . . 15.0 111.913 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.62 130.23 42.57 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.837 -1.074 . . . . 15.0 111.613 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 87' ' ' ASP . . . -77.81 64.23 3.02 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.241 1.496 . . . . 15.0 113.198 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -76.16 124.42 27.41 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 113.106 -1.861 . . . . 15.0 111.464 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.09 149.61 30.57 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 113.984 -1.462 . . . . 15.0 111.086 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.9 p -91.12 144.8 25.25 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.973 1.471 . . . . 15.0 114.973 -170.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 m -71.46 137.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-N 113.398 -1.728 . . . . 15.0 111.461 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.623 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 78.8 p -120.09 117.94 31.79 Favored Pre-proline 0 N--CA 1.477 0.901 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.372 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.6 101.78 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.096 2.531 . . . . 15.0 112.278 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.531 ' HB ' ' NE2' ' A' ' 131' ' ' GLN . 16.4 m -125.02 130.87 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 113.19 -1.823 . . . . 15.0 113.112 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -127.96 131.36 49.29 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 113.749 -1.569 . . . . 15.0 111.114 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 131' ' ' GLN . . . -128.77 143.73 50.99 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.722 1.008 . . . . 15.0 113.722 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.56 108.63 2.12 Favored Glycine 0 N--CA 1.474 1.217 0 CA-C-N 112.932 -1.94 . . . . 15.0 108.732 176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -119.5 144.11 17.42 Favored Glycine 0 N--CA 1.473 1.151 0 CA-C-N 114.723 -0.739 . . . . 15.0 112.955 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.4 m -117.49 137.17 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-N 114.539 -0.831 . . . . 15.0 111.633 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -125.4 139.33 53.76 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.241 -1.799 . . . . 15.0 113.757 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -117.87 141.81 48.02 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 112.694 -2.048 . . . . 15.0 109.255 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.7 m -105.69 132.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.158 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.3 pt -62.2 95.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 116.104 1.89 . . . . 15.0 116.104 -171.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -78.6 82.9 4.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.503 1.144 . . . . 15.0 109.58 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.3 ttt-85 -175.38 -143.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.393 2.277 . . . . 15.0 107.366 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -62.34 99.85 0.15 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.829 1.252 . . . . 15.0 112.26 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.6 mt 64.63 85.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.715 2.006 . . . . 15.0 111.401 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.7 m -59.86 -45.78 98.28 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 117.188 -1.386 . . . . 15.0 114.076 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.89 70.75 6.89 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.938 1.759 . . . . 15.0 111.531 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 36.1 tt0 -138.74 -83.84 0.28 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.188 -1.823 . . . . 15.0 108.834 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 2.4 pp -121.74 143.51 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.663 0.986 . . . . 15.0 113.663 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.42 123.53 48.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 112.611 -2.086 . . . . 15.0 109.406 172.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.455 ' HA ' HG12 ' A' ' 146' ' ' VAL . 11.9 m -80.83 116.87 21.03 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 106.423 -1.695 . . . . 15.0 106.423 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -125.49 135.44 52.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.104 -1.407 . . . . 15.0 113.749 -172.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.98 111.07 13.14 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.648 -2.069 . . . . 15.0 110.327 174.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.518 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 21.9 tt0 -114.67 135.24 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.984 -1.916 . . . . 15.0 110.156 -171.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -115.31 107.17 14.89 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.375 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.69 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 0.0 OUTLIER -96.62 114.76 26.44 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 112.581 -2.099 . . . . 15.0 109.73 -170.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -118.77 146.57 44.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.326 1.232 . . . . 15.0 114.326 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.7 t -124.46 150.76 45.35 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.268 -1.787 . . . . 15.0 112.363 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.657 ' ND2' ' H ' ' A' ' 135' ' ' ASN . 36.5 t30 54.41 -162.84 0.13 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.752 2.021 . . . . 15.0 112.99 -173.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.657 ' H ' ' ND2' ' A' ' 134' ' ' ASN . 5.7 t-20 -110.71 166.81 10.71 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.782 0.833 . . . . 15.0 110.746 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 54.64 -171.89 0.05 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.156 1.782 . . . . 15.0 112.127 -170.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.4 p -65.99 85.3 0.09 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.811 0.815 . . . . 15.0 110.624 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -102.31 -101.63 0.28 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.242 -1.799 . . . . 15.0 110.187 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -133.89 125.97 29.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.58 0.752 . . . . 15.0 110.419 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -118.33 143.21 17.5 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 125.592 1.807 . . . . 15.0 114.639 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.69 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 56.9 ttm -117.79 137.14 52.94 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.287 -1.456 . . . . 15.0 109.141 170.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.93 101.94 11.17 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.165 -1.38 . . . . 15.0 109.98 176.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.436 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 57.0 m -109.98 125.14 52.56 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 113.892 -1.504 . . . . 15.0 110.616 -175.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.85 140.89 44.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.83 -1.077 . . . . 15.0 112.441 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.04 -162.57 29.59 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 114.801 -1.091 . . . . 15.0 113.585 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 126' ' ' THR . 15.1 m -128.4 139.72 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 113.846 -1.177 . . . . 15.0 112.547 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 24.7 p -115.16 134.25 55.32 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.527 -1.215 . . . . 15.0 112.217 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 41.9 t80 -103.53 135.09 45.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.331 -1.304 . . . . 15.0 109.195 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' A' ' 2' ' ' PRO . 19.2 mmt180 -73.69 124.97 27.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.178 -1.828 . . . . 15.0 112.033 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.951 ' HA ' ' HB3' ' A' ' 7' ' ' TRP . 55.1 m-85 69.55 -77.61 0.05 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.504 1.922 . . . . 15.0 111.806 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.35 77.69 1.0 Allowed Glycine 0 N--CA 1.477 1.403 0 N-CA-C 110.64 -0.984 . . . . 15.0 110.64 -171.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -56.1 -41.92 75.99 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.077 1.351 . . . . 15.0 113.287 -177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.92 73.98 2.23 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 108.995 -1.642 . . . . 15.0 108.995 168.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.79 85.68 0.21 Allowed 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.667 1.223 . . . . 15.0 112.828 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.88 99.14 0.6 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.643 -1.617 . . . . 15.0 112.827 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.324 0 CA-C-N 114.001 -1.454 . . . . 15.0 114.182 177.379 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 114.236 1.198 . . . . 15.0 114.236 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -76.34 62.56 6.95 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.32 2.68 . . . . 15.0 113.737 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.14 50.42 1.05 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.908 1.283 . . . . 15.0 112.756 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -164.58 45.69 0.1 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.141 -1.39 . . . . 15.0 112.205 -170.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -56.11 -54.23 47.52 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.091 -0.959 . . . . 15.0 111.308 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 150' ' ' PHE . 4.7 p -148.39 139.38 23.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.579 -1.191 . . . . 15.0 111.195 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -127.86 136.21 51.1 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.91 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -125.72 127.57 46.41 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.131 -1.395 . . . . 15.0 110.728 168.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -126.6 137.93 53.38 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.524 -1.217 . . . . 15.0 111.19 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.51 -149.93 9.01 Favored Glycine 0 N--CA 1.477 1.417 0 O-C-N 124.275 0.984 . . . . 15.0 113.847 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' LYS . . . -160.77 139.25 9.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.906 1.282 . . . . 15.0 111.185 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.342 18.2 tptt -171.91 169.59 5.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.518 1.527 . . . . 15.0 113.205 166.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.458 HD23 ' HG3' ' A' ' 12' ' ' LYS . 1.5 pt? -114.73 161.73 17.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.178 0.991 . . . . 15.0 113.199 -164.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -122.8 140.73 13.43 Favored Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.484 -1.234 . . . . 15.0 111.719 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -118.41 145.39 45.23 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.582 0.813 . . . . 15.0 110.858 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.8 p -93.85 126.13 38.86 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.708 ' HG3' ' HB2' ' A' ' 139' ' ' ASN . 9.1 mm100 -49.8 99.2 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.646 1.978 . . . . 15.0 114.703 -173.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 49.58 25.91 1.58 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 116.273 1.953 . . . . 15.0 116.273 -173.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 t -110.03 -39.41 5.04 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.294 -1.321 . . . . 15.0 113.003 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 72.36 -30.98 0.22 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 125.958 1.703 . . . . 15.0 113.165 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -59.54 97.25 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.08 1.352 . . . . 15.0 113.238 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -168.12 129.4 1.39 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.892 -1.958 . . . . 15.0 110.127 164.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.0 31.94 3.53 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.64 -1.618 . . . . 15.0 113.056 167.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -165.51 142.29 5.54 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.787 1.403 . . . . 15.0 114.787 -170.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.16 -92.38 0.6 Allowed Glycine 0 N--CA 1.475 1.289 0 CA-C-N 113.777 -1.556 . . . . 15.0 112.782 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 158.14 6.02 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.762 1.225 . . . . 15.0 113.745 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.06 -124.79 1.52 Allowed Glycine 0 N--CA 1.477 1.399 0 CA-C-N 114.914 -1.039 . . . . 15.0 111.882 -169.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.47 121.61 42.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.61 -0.795 . . . . 15.0 110.698 -174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 147' ' ' SER . 35.6 p90 -125.23 146.49 49.5 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.921 1.822 . . . . 15.0 115.921 -168.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -116.24 104.29 1.24 Allowed Glycine 0 CA--C 1.535 1.282 0 CA-C-N 111.769 -2.468 . . . . 15.0 108.527 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.53 100.77 1.09 Allowed Glycine 0 N--CA 1.476 1.332 0 N-CA-C 110.117 -1.193 . . . . 15.0 110.117 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -114.57 145.09 42.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.321 0.581 . . . . 15.0 110.807 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.643 HE21 ' HE3' ' A' ' 62' ' ' LYS . 5.3 tt0 -120.84 136.17 54.98 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.659 -1.155 . . . . 15.0 109.957 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.1 m -104.56 -34.55 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 113.607 -1.633 . . . . 15.0 113.755 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -121.0 134.77 24.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 N-CA-C 106.574 -1.639 . . . . 15.0 106.574 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.63 84.09 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.137 2.558 . . . . 15.0 111.288 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 158.82 -41.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 128.182 2.593 . . . . 15.0 111.195 -165.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -151.83 138.83 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.811 1.411 . . . . 15.0 114.811 -171.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 33' ' ' GLN . . . -162.11 -154.6 7.6 Favored Glycine 0 N--CA 1.477 1.385 0 CA-C-N 112.412 -2.176 . . . . 15.0 110.824 175.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -143.28 145.45 32.73 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.804 0.811 . . . . 15.0 111.862 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.408 ' OE1' ' HG2' ' A' ' 78' ' ' ARG . 9.9 pt-20 -128.23 129.78 46.94 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.353 -1.294 . . . . 15.0 113.053 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -120.61 114.35 21.59 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 113.983 -1.462 . . . . 15.0 110.655 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.65 114.06 3.97 Favored Glycine 0 N--CA 1.476 1.318 0 O-C-N 124.607 1.192 . . . . 15.0 110.71 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -102.84 141.17 36.09 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.178 0.99 . . . . 15.0 111.278 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -137.22 130.25 30.69 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 112.872 -1.967 . . . . 15.0 112.367 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.618 ' CZ2' ' HA ' ' A' ' 49' ' ' ARG . 12.4 t90 -122.63 137.2 54.97 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.202 -1.817 . . . . 15.0 108.512 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp -118.87 75.92 1.06 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 122.697 1.237 . . . . 15.0 108.982 -173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.44 -165.95 35.17 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 113.107 -1.86 . . . . 15.0 111.015 -167.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.618 ' HA ' ' CZ2' ' A' ' 46' ' ' TRP . 100.0 mtt180 -57.72 -88.54 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.904 0.882 . . . . 15.0 113.275 -174.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 65.4 mtt -134.35 95.86 16.04 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 123.996 0.918 . . . . 15.0 108.757 166.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.22 -38.83 3.39 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.739 2.293 . . . . 15.0 114.269 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 174.21 -62.38 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 128.433 2.693 . . . . 15.0 108.346 -175.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 86' ' ' ALA . 97.7 mttt -111.48 -112.39 0.33 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.369 -1.287 . . . . 15.0 110.814 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HA ' ' CE2' ' A' ' 84' ' ' TRP . . . 61.25 -142.0 0.49 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.651 1.58 . . . . 15.0 113.361 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 49.96 42.64 24.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.922 1.689 . . . . 15.0 113.964 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.561 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -116.29 165.28 12.25 Favored Glycine 0 N--CA 1.474 1.193 0 CA-C-N 113.699 -1.592 . . . . 15.0 114.329 -161.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.26 144.39 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 113.485 -1.357 . . . . 15.0 111.749 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -109.77 116.8 32.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.648 1.213 . . . . 15.0 109.421 162.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.9 pt? -121.47 120.3 34.52 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 113.074 -1.875 . . . . 15.0 111.383 -170.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.4 p -133.14 150.63 52.02 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.984 -1.462 . . . . 15.0 112.432 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.625 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -92.35 132.33 36.82 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.304 -1.316 . . . . 15.0 108.452 174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HE3' HE21 ' A' ' 33' ' ' GLN . 35.4 ttpt -110.06 104.26 13.11 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.613 -1.63 . . . . 15.0 110.404 -166.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.7 tt -120.7 134.43 55.28 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.125 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.57 -151.23 11.64 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-N 115.604 -0.725 . . . . 15.0 113.635 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CE2' HD11 ' A' ' 75' ' ' ILE . 48.1 p90 -173.91 154.66 2.3 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.853 1.261 . . . . 15.0 113.044 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.6 Cg_endo -64.71 115.43 3.23 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.756 2.304 . . . . 15.0 110.989 169.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -66.2 127.54 32.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.818 -1.083 . . . . 15.0 109.584 -173.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 18.3 tp 57.44 22.62 8.15 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.605 1.562 . . . . 15.0 113.397 -172.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.69 20.19 61.46 Favored Glycine 0 CA--C 1.541 1.684 0 C-N-CA 125.039 1.304 . . . . 15.0 114.484 -173.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -87.55 89.24 7.92 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.426 -1.324 . . . . 15.0 107.426 -176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -62.66 79.73 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 112.885 -1.962 . . . . 15.0 113.134 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -174.14 -39.24 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 109.587 -3.46 . . . . 15.0 110.668 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.58 98.19 7.26 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.833 1.301 . . . . 15.0 111.711 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 22.6 p-10 -115.43 111.06 20.22 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.931 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.629 HG22 HG22 ' A' ' 112' ' ' VAL . 2.9 pp -79.05 148.27 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 113.896 -1.502 . . . . 15.0 110.925 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -146.36 143.23 28.95 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 124.783 1.302 . . . . 15.0 113.925 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -112.22 122.55 48.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.905 -1.952 . . . . 15.0 107.776 166.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 0.8 OUTLIER -115.05 123.23 48.49 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 112.923 -1.944 . . . . 15.0 109.62 -176.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.79 129.35 48.14 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.676 -1.602 . . . . 15.0 113.256 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.44 -103.98 0.2 Allowed Glycine 0 N--CA 1.478 1.449 0 N-CA-C 110.146 -1.182 . . . . 15.0 110.146 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.539 ' HA2' ' HB ' ' A' ' 107' ' ' VAL . . . 154.01 -152.15 23.78 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 124.641 0.848 . . . . 15.0 115.017 173.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 33.9 ttm -119.92 139.3 52.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.491 -0.854 . . . . 15.0 111.742 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' SER . 57.8 t -125.62 113.09 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 113.98 -1.463 . . . . 15.0 108.109 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.561 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -115.98 136.86 52.64 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.419 -1.264 . . . . 15.0 110.766 175.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 50.0 mtt-85 -79.47 141.86 36.37 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.672 0.619 . . . . 15.0 112.672 -173.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.407 ' HA ' ' HG2' ' A' ' 53' ' ' LYS . . . -119.06 -50.27 2.38 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.112 -1.404 . . . . 15.0 114.119 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.2 t70 54.61 90.62 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.21 1.804 . . . . 15.0 115.193 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.3 m -72.33 86.68 1.12 Allowed 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 114.915 -1.039 . . . . 15.0 110.791 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -125.32 85.93 2.48 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.516 -1.22 . . . . 15.0 109.688 170.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -168.93 150.62 4.64 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 113.752 -1.567 . . . . 15.0 111.945 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -67.15 146.49 54.19 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.782 -1.099 . . . . 15.0 111.551 172.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -59.09 -25.06 63.47 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 115.778 1.77 . . . . 15.0 115.778 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 47.86 80.96 0.05 OUTLIER Glycine 0 N--CA 1.484 1.884 0 C-N-CA 125.648 1.594 . . . . 15.0 112.121 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 65.95 -165.32 0.23 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.04 1.336 . . . . 15.0 111.375 -156.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -78.56 61.15 3.98 Favored Glycine 0 N--CA 1.48 1.623 0 C-N-CA 124.092 0.853 . . . . 15.0 114.451 -175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -118.65 101.0 7.78 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.308 1.052 . . . . 15.0 112.01 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 97' ' ' ILE . 4.7 mp -73.73 80.91 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 113.776 -1.556 . . . . 15.0 108.875 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.7 t -72.83 59.71 0.49 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.001 -1.454 . . . . 15.0 113.544 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.01 87.83 2.36 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.958 -1.019 . . . . 15.0 113.324 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.05 137.51 51.31 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.634 -1.166 . . . . 15.0 112.921 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -123.79 163.42 21.22 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 113.09 -1.868 . . . . 15.0 110.86 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 131.37 50.58 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.268 0.556 . . . . 15.0 110.711 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 28.5 t -75.07 105.92 6.32 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.29 -1.323 . . . . 15.0 110.78 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 82' ' ' MET . 10.0 p -113.37 115.29 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-N 113.997 -1.456 . . . . 15.0 111.408 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.493 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 80.5 p -117.87 131.83 23.95 Favored Pre-proline 0 N--CA 1.479 1.001 0 CA-C-N 113.745 -1.571 . . . . 15.0 112.398 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 122.21 6.0 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.921 2.414 . . . . 15.0 111.397 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.539 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 53.1 t -131.11 140.03 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 114.597 -1.183 . . . . 15.0 109.69 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.47 123.29 48.19 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.16 -1.382 . . . . 15.0 109.844 171.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.589 ' HB1' ' HB2' ' A' ' 129' ' ' GLU . . . -123.23 112.58 17.83 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.352 -1.295 . . . . 15.0 111.263 -176.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.63 137.07 13.51 Favored Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.6 -0.727 . . . . 15.0 112.618 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 128' ' ' LEU . . . 176.99 -147.79 8.56 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 116.198 1.239 . . . . 15.0 116.198 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.629 HG22 HG22 ' A' ' 75' ' ' ILE . 16.3 t -130.76 144.68 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 113.506 -1.347 . . . . 15.0 109.805 -170.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.486 ' HB2' ' HG3' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -109.75 120.95 44.07 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.292 -1.373 . . . . 15.0 107.292 165.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -117.75 117.66 29.94 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.115 -1.402 . . . . 15.0 111.24 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 116' ' ' ILE . 13.2 p -129.65 143.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 113.279 -1.782 . . . . 15.0 110.163 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.535 HG13 HG22 ' A' ' 115' ' ' VAL . 44.0 mt 62.95 144.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 125.877 1.671 . . . . 15.0 113.577 174.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 63.33 155.38 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.886 1.674 . . . . 15.0 111.746 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 69.33 -50.28 0.61 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.882 2.073 . . . . 15.0 113.925 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 79.6 mtt-85 -66.57 126.63 29.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.152 1.381 . . . . 15.0 110.491 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.4 tt -45.1 -35.6 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 115.671 1.73 . . . . 15.0 115.671 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.2 m -129.12 97.61 25.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 N-CA-C 108.398 -0.964 . . . . 15.0 108.398 171.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.47 66.06 2.89 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.706 2.937 . . . . 15.0 114.304 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' HG3' HG23 ' A' ' 124' ' ' ILE . 15.0 pt-20 -120.04 -17.75 8.31 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.798 -1.546 . . . . 15.0 114.958 178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -119.57 152.09 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 121.708 0.766 . . . . 15.0 112.586 -173.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.47 34.14 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.516 -2.129 . . . . 15.0 109.03 174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 37.1 m -93.25 116.76 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.182 -1.784 . . . . 15.0 106.182 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 113' ' ' GLU . 34.4 ttp180 -115.6 108.07 15.94 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.101 -1.409 . . . . 15.0 107.925 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.467 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 5.3 tt -111.83 130.67 55.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 113.58 -1.646 . . . . 15.0 108.991 -175.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.63 ' HG3' ' HB3' ' A' ' 143' ' ' SER . 13.6 pt-20 -128.57 140.97 51.52 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.435 -2.166 . . . . 15.0 111.421 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 11.7 m-85 -97.25 114.56 26.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.516 -1.22 . . . . 15.0 109.061 164.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 14.7 mt-30 -96.57 108.77 21.42 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.95 -1.932 . . . . 15.0 108.309 -173.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -131.49 146.4 52.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 111.918 -2.401 . . . . 15.0 111.755 -171.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 38.2 p -122.91 -25.08 4.65 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 112.56 -2.109 . . . . 15.0 115.524 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -122.44 96.54 5.08 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 116.336 1.976 . . . . 15.0 116.336 -163.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -13.85 -58.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 127.995 2.518 . . . . 15.0 117.772 172.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.02 81.83 1.56 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.059 0.933 . . . . 15.0 110.075 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.4 t -171.04 160.29 6.4 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.082 -1.872 . . . . 15.0 110.605 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -62.67 151.06 39.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.477 1.111 . . . . 15.0 111.017 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.708 ' HB2' ' HG3' ' A' ' 17' ' ' GLN . 8.2 m120 -7.15 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 119.564 3.172 . . . . 15.0 119.564 171.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.57 -97.76 1.76 Allowed Glycine 0 N--CA 1.475 1.243 0 N-CA-C 110.542 -1.023 . . . . 15.0 110.542 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 131' ' ' GLN . 67.0 mtt -121.47 122.69 40.31 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.565 0.95 . . . . 15.0 113.565 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.588 HD23 ' H ' ' A' ' 142' ' ' LEU . 1.2 pt? -84.77 97.34 9.64 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.035 -1.439 . . . . 15.0 108.032 171.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.649 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 37.1 t -114.0 128.63 56.47 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.433 -1.712 . . . . 15.0 110.896 -171.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.644 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 1.3 pt? -126.36 139.51 53.23 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.962 -1.017 . . . . 15.0 111.043 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 12' ' ' LYS . . . -123.59 131.19 7.98 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 125.822 1.951 . . . . 15.0 111.128 173.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.5 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 34.8 m -112.58 127.42 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.801 0.8 . . . . 15.0 111.111 173.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 29' ' ' PHE . 63.5 p -131.68 153.49 49.94 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.845 -1.525 . . . . 15.0 114.605 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -108.02 143.64 36.44 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.052 -1.431 . . . . 15.0 109.468 172.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.798 ' HD3' ' H ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -70.29 115.88 9.98 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.941 -1.027 . . . . 15.0 112.896 -179.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 81.0 m-85 54.72 139.02 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 112.751 -2.022 . . . . 15.0 114.288 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.76 83.52 0.29 Allowed Glycine 0 N--CA 1.479 1.56 0 CA-C-N 114.611 -1.177 . . . . 15.0 113.366 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -58.59 -43.51 89.52 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.473 1.109 . . . . 15.0 113.572 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 169.09 -152.57 20.33 Favored Glycine 0 N--CA 1.478 1.448 0 C-N-CA 124.143 0.878 . . . . 15.0 111.485 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -125.52 141.55 51.98 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.681 -0.76 . . . . 15.0 111.38 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.1 90.6 1.2 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 122.194 0.997 . . . . 15.0 112.481 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 N-CA-C 114.925 1.454 . . . . 15.0 114.925 177.424 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 19.3 mmt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 116.426 2.01 . . . . 15.0 116.426 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 90.6 Cg_endo -68.66 -23.49 36.3 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.31 2.673 . . . . 15.0 114.86 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 50.06 46.36 24.61 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 123.459 1.6 . . . . 15.0 113.977 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.519 ' OD1' ' HA ' ' A' ' 36' ' ' PRO . 69.5 m-20 -122.35 26.4 8.43 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.503 -1.681 . . . . 15.0 113.315 -175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.751 ' HA ' HG22 ' A' ' 34' ' ' VAL . 24.6 t-20 178.89 48.67 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.469 1.508 . . . . 15.0 111.064 -173.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.1 p -126.92 152.6 46.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.062 -1.426 . . . . 15.0 110.554 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -118.66 138.57 52.52 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.032 1.123 . . . . 15.0 114.032 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -120.26 136.35 54.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.869 -1.514 . . . . 15.0 110.818 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -163.6 133.35 4.16 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.807 -1.088 . . . . 15.0 111.691 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -177.73 -167.76 36.33 Favored Glycine 0 N--CA 1.477 1.421 0 CA-C-N 115.163 -0.926 . . . . 15.0 112.711 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.54 134.82 47.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.802 -0.699 . . . . 15.0 112.107 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HD3' ' HD3' ' A' ' 127' ' ' ARG . 45.1 mtmt -134.16 144.74 48.7 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.081 -1.418 . . . . 15.0 110.898 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.5 pp -114.17 145.29 41.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.886 -1.052 . . . . 15.0 111.092 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.29 110.35 2.48 Favored Glycine 0 N--CA 1.477 1.414 0 O-C-N 125.003 1.439 . . . . 15.0 111.483 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.731 ' HA ' ' ND2' ' A' ' 22' ' ' ASN . 49.4 t90 -118.72 140.46 49.9 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.859 1.059 . . . . 15.0 113.859 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.9 p -92.85 98.16 11.21 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.336 1.236 . . . . 15.0 114.336 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -14.76 -76.91 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.207 2.603 . . . . 15.0 117.871 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -131.45 77.03 1.75 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.684 -0.858 . . . . 15.0 108.684 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.9 t -165.04 140.69 5.43 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 112.987 -1.915 . . . . 15.0 110.544 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttm105 -90.15 76.7 6.87 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.147 -1.388 . . . . 15.0 107.352 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -142.74 -70.86 0.33 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 113.448 -1.705 . . . . 15.0 114.071 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.731 ' ND2' ' HA ' ' A' ' 15' ' ' TRP . 7.3 m120 62.45 -65.52 0.09 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 116.09 1.885 . . . . 15.0 116.09 -171.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 63.43 -62.81 0.14 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 127.055 2.142 . . . . 15.0 110.612 -170.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.06 139.8 50.51 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.889 -1.05 . . . . 15.0 108.658 168.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -114.55 -98.24 2.23 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 108.898 -1.681 . . . . 15.0 108.898 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.87 131.15 57.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.521 -1.34 . . . . 15.0 110.041 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.58 141.8 13.88 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-N 113.541 -1.663 . . . . 15.0 110.89 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.4 121.19 41.82 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.965 -1.118 . . . . 15.0 108.061 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 42' ' ' MET . 94.0 m-85 -116.24 113.39 22.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.075 -1.42 . . . . 15.0 110.351 -170.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.17 145.96 17.15 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 113.468 -1.696 . . . . 15.0 112.189 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 41' ' ' GLU . . . 172.32 -161.6 33.33 Favored Glycine 0 N--CA 1.476 1.344 0 CA-C-N 114.461 -0.869 . . . . 15.0 112.765 177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -126.46 142.17 51.63 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.943 -1.128 . . . . 15.0 111.986 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 59.3 tt0 -111.54 82.3 1.59 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 124.092 1.901 . . . . 15.0 106.397 169.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.751 HG22 ' HA ' ' A' ' 5' ' ' ASN . 29.4 t -140.75 72.12 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 111.842 -2.435 . . . . 15.0 105.941 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.437 HD22 HG23 ' A' ' 38' ' ' VAL . 50.0 t30 -175.89 144.88 0.74 Allowed Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 111.913 -2.403 . . . . 15.0 105.248 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.519 ' HA ' ' OD1' ' A' ' 4' ' ' ASP . 28.6 Cg_endo -50.33 104.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.57 2.847 . . . . 15.0 114.332 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 71.25 -24.47 0.17 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.477 2.311 . . . . 15.0 116.747 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.699 HG12 ' HG ' ' A' ' 63' ' ' LEU . 25.6 m -111.04 147.7 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.582 1.182 . . . . 15.0 113.5 -172.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -118.63 155.26 16.15 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 112.515 -2.13 . . . . 15.0 112.289 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -118.12 114.14 22.63 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.437 -0.882 . . . . 15.0 109.515 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.435 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -130.78 146.48 52.25 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.253 -1.794 . . . . 15.0 111.532 -179.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 29' ' ' PHE . 24.0 ptt? -112.59 145.0 41.12 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.412 -1.267 . . . . 15.0 111.268 175.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -106.03 127.62 9.02 Favored Glycine 0 N--CA 1.471 1.013 0 CA-C-N 113.22 -1.809 . . . . 15.0 109.726 172.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.82 104.57 11.77 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.578 -1.311 . . . . 15.0 111.191 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.6 121.59 43.84 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.098 -1.41 . . . . 15.0 110.127 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 44.9 t-105 -102.43 142.95 32.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 113.523 -1.671 . . . . 15.0 110.235 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 44.09 39.6 2.94 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.511 2.041 . . . . 15.0 116.511 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.22 84.17 0.1 OUTLIER Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.423 -1.071 . . . . 15.0 110.423 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 56.3 mtt-85 68.53 -51.16 0.56 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.561 2.344 . . . . 15.0 116.266 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.2 mtt -66.9 107.33 1.59 Allowed Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 125.38 1.472 . . . . 15.0 113.494 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.16 -55.93 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.777 2.318 . . . . 15.0 112.473 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -82.2 84.81 6.94 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.141 0.976 . . . . 15.0 108.461 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 66.51 110.89 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 112.628 -2.078 . . . . 15.0 115.63 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.83 -78.0 0.58 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 112.27 -2.241 . . . . 15.0 112.255 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 84' ' ' TRP . 28.3 pt20 34.13 86.03 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 126.603 1.961 . . . . 15.0 115.106 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.45 97.06 1.49 Allowed Glycine 0 N--CA 1.473 1.135 0 CA-C-N 112.817 -1.992 . . . . 15.0 109.971 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 43' ' ' GLY . 11.8 p -109.88 118.53 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 124.956 1.033 . . . . 15.0 111.112 -179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.79 116.79 32.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.841 -1.527 . . . . 15.0 112.401 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.8 114.39 26.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.707 -1.588 . . . . 15.0 108.643 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.606 HG21 ' HD3' ' A' ' 78' ' ' ARG . 51.9 p -127.27 148.4 50.22 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.135 -1.848 . . . . 15.0 114.035 -170.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.53 128.52 54.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 113.136 -1.847 . . . . 15.0 107.823 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -119.75 138.35 53.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.119 -1.855 . . . . 15.0 111.83 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HG ' HG12 ' A' ' 38' ' ' VAL . 5.2 mp -117.07 131.36 56.94 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.157 -1.838 . . . . 15.0 108.669 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.71 131.66 10.1 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 124.616 1.198 . . . . 15.0 111.006 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.751 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 72.3 m-85 -121.75 97.98 45.95 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 124.512 0.772 . . . . 15.0 112.313 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.35 84.9 0.72 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.984 2.456 . . . . 15.0 110.991 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -120.18 153.02 36.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.726 -2.034 . . . . 15.0 110.008 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.8 84.61 0.31 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.374 -0.83 . . . . 15.0 112.809 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -103.25 141.9 15.35 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 113.812 -1.54 . . . . 15.0 112.398 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.515 ' O ' HD13 ' A' ' 73' ' ' LEU . 3.2 m -49.36 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 128.76 2.824 . . . . 15.0 112.639 -171.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 52.65 71.09 0.5 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.722 -1.581 . . . . 15.0 112.919 -173.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 78.91 41.51 0.09 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.861 -1.518 . . . . 15.0 114.277 165.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 70' ' ' THR . 9.0 mp -105.32 115.37 30.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.168 -1.378 . . . . 15.0 111.157 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -105.26 135.97 45.65 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.231 -1.35 . . . . 15.0 108.255 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.751 ' HB ' ' HB2' ' A' ' 65' ' ' TYR . 37.1 mm -83.34 137.42 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.252 -1.018 . . . . 15.0 108.252 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -133.18 135.47 45.12 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.528 1.307 . . . . 15.0 114.528 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 58.5 m -118.35 124.93 48.94 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 112.537 -2.119 . . . . 15.0 107.424 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.606 ' HD3' HG21 ' A' ' 60' ' ' THR . 1.2 tmm_? -124.64 135.73 53.32 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.611 0.765 . . . . 15.0 109.864 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.7 pp -150.76 139.55 20.8 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.371 -0.832 . . . . 15.0 113.225 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.49 -151.68 10.73 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-N 115.545 -0.752 . . . . 15.0 113.626 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.33 151.6 20.87 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 114.154 -1.023 . . . . 15.0 113.088 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 28.0 ptm -114.49 135.28 54.29 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.712 1.004 . . . . 15.0 113.712 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 104' ' ' VAL . 44.7 t -125.34 119.92 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 113.756 -1.566 . . . . 15.0 108.024 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.411 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 35.9 p90 -129.95 151.83 50.07 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.689 175.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 25.4 ttt-85 -102.11 80.98 2.04 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 123.09 1.424 . . . . 15.0 111.839 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.86 96.37 4.29 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.747 -2.024 . . . . 15.0 110.641 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -65.58 144.07 57.21 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.682 -1.145 . . . . 15.0 111.852 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.6 m -57.18 102.73 0.09 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.759 1.623 . . . . 15.0 112.888 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 34.8 t -61.54 147.15 46.39 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 113.729 -1.578 . . . . 15.0 113.229 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -66.4 151.22 47.61 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.52 -1.673 . . . . 15.0 109.264 165.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.3 tttt 66.53 145.93 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.718 2.007 . . . . 15.0 113.092 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -172.35 -41.42 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.392 1.477 . . . . 15.0 111.721 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.63 -87.28 0.39 Allowed Glycine 0 N--CA 1.475 1.287 0 N-CA-C 109.37 -1.492 . . . . 15.0 109.37 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -100.2 149.1 23.9 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.408 -0.896 . . . . 15.0 111.137 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.95 80.66 0.07 OUTLIER Glycine 0 N--CA 1.482 1.729 0 C-N-CA 124.638 1.114 . . . . 15.0 115.256 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -115.29 94.09 4.58 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 122.326 1.06 . . . . 15.0 112.783 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.0 pt -122.68 142.53 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 112.811 -1.995 . . . . 15.0 111.232 177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.1 t -170.34 -103.51 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.079 1.351 . . . . 15.0 109.57 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 63.02 152.31 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.741 2.016 . . . . 15.0 114.276 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.23 -65.71 0.15 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.169 -1.378 . . . . 15.0 112.584 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.29 142.21 50.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.781 0.833 . . . . 15.0 109.253 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 147.13 53.02 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 124.072 0.857 . . . . 15.0 110.543 173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.9 m -71.26 105.74 3.57 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.548 -0.751 . . . . 15.0 111.643 -174.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 83' ' ' VAL . 42.9 t -83.52 80.68 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 114.49 -1.232 . . . . 15.0 109.216 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.7 m -65.27 132.07 95.18 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 113.762 -1.563 . . . . 15.0 111.909 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.68 113.7 2.84 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.115 2.543 . . . . 15.0 110.555 176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.8 t -116.9 120.27 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.298 -1.319 . . . . 15.0 109.023 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -118.37 144.72 45.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 113.288 -1.778 . . . . 15.0 109.66 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -141.5 131.11 23.99 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.7 -1.136 . . . . 15.0 110.788 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -122.99 130.47 7.83 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 129' ' ' GLU . . . -173.1 -160.42 21.61 Favored Glycine 0 N--CA 1.476 1.338 0 CA-C-O 122.199 0.888 . . . . 15.0 115.228 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.1 t -133.32 144.02 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 113.244 -1.478 . . . . 15.0 109.682 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -121.2 129.06 53.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.96 -1.473 . . . . 15.0 109.058 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.433 ' CZ ' ' HA ' ' A' ' 116' ' ' ILE . 19.9 t80 -100.21 130.82 46.38 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.316 1.046 . . . . 15.0 109.88 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.6 m -98.4 113.07 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 113.336 -1.757 . . . . 15.0 110.597 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -54.44 100.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.089 -1.869 . . . . 15.0 113.32 -174.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -108.21 -32.56 7.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 113.405 -1.725 . . . . 15.0 112.976 176.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -54.54 -20.54 8.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.886 2.18 . . . . 15.0 116.886 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HD3' ' N ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -127.56 144.17 51.1 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.443 -0.947 . . . . 15.0 108.443 178.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.63 ' H ' HD12 ' A' ' 120' ' ' ILE . 4.7 mp -57.78 136.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.319 1.448 . . . . 15.0 109.653 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.434 ' HA ' ' HD2' ' A' ' 122' ' ' PRO . 28.7 m 65.14 92.22 0.07 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.045 1.738 . . . . 15.0 111.637 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 121' ' ' THR . 57.4 Cg_endo -64.58 134.21 40.2 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.924 2.416 . . . . 15.0 111.331 176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.49 ' HG2' HG13 ' A' ' 124' ' ' ILE . 30.5 tt0 -119.34 -81.63 0.63 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.403 -1.271 . . . . 15.0 112.177 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.49 HG13 ' HG2' ' A' ' 123' ' ' GLU . 32.7 mt -116.36 146.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.365 -0.976 . . . . 15.0 108.365 -176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.06 151.64 24.41 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.794 1.238 . . . . 15.0 110.984 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.0 m -100.32 122.59 43.34 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.196 -0.911 . . . . 15.0 109.387 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.435 ' HD3' ' HD3' ' A' ' 12' ' ' LYS . 37.1 ttt85 -120.88 127.94 52.34 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.461 -0.79 . . . . 15.0 112.479 -175.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.0 119.53 24.45 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 113.93 -1.487 . . . . 15.0 110.775 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 143' ' ' SER . 6.1 pt-20 -134.2 145.42 49.19 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.88 -1.054 . . . . 15.0 113.49 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -101.38 122.09 43.1 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 114.307 -1.315 . . . . 15.0 109.307 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -111.59 122.48 47.93 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 113.656 -1.611 . . . . 15.0 110.942 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -124.45 145.28 49.6 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 111.985 -2.37 . . . . 15.0 110.532 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.3 t -126.02 138.45 53.73 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.764 -1.107 . . . . 15.0 109.188 171.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -76.02 73.32 2.89 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 122.595 1.188 . . . . 15.0 110.644 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.48 154.0 49.18 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.83 -1.986 . . . . 15.0 110.218 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.21 85.72 1.9 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 122.921 1.343 . . . . 15.0 110.719 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.8 t -173.7 163.06 4.19 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 112.691 -2.05 . . . . 15.0 109.434 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.34 -26.88 68.96 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.179 -0.919 . . . . 15.0 111.555 164.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 57.61 -94.07 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.78 2.032 . . . . 15.0 112.656 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.31 85.6 0.01 OUTLIER Glycine 0 N--CA 1.482 1.714 0 C-N-CA 125.846 1.689 . . . . 15.0 116.899 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -117.42 139.0 51.45 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.046 0.927 . . . . 15.0 110.599 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.19 108.98 18.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 113.89 -1.505 . . . . 15.0 109.535 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.499 ' HB2' ' HG3' ' A' ' 129' ' ' GLU . 61.4 m -109.02 125.22 51.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.472 -1.24 . . . . 15.0 108.783 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 pp -148.22 145.25 28.18 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.201 -1.363 . . . . 15.0 112.311 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.96 -162.51 29.53 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 114.15 -1.386 . . . . 15.0 113.119 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.32 130.48 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 113.159 -1.52 . . . . 15.0 111.494 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.521 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 63.9 p -130.39 146.35 51.95 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.755 -1.566 . . . . 15.0 113.053 -177.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -115.96 118.95 34.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.259 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.86 119.27 34.37 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.031 -1.44 . . . . 15.0 108.55 175.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -152.75 -123.55 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.873 -1.512 . . . . 15.0 110.112 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 140.45 157.0 7.06 Favored Glycine 0 N--CA 1.478 1.482 0 C-N-CA 124.83 1.205 . . . . 15.0 111.424 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 53.52 33.66 16.69 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 116.623 2.083 . . . . 15.0 116.623 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -110.32 136.36 13.53 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 115.456 -0.793 . . . . 15.0 111.703 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -96.2 -56.77 2.53 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.208 -0.996 . . . . 15.0 113.442 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . 60.64 163.96 0.07 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.588 1.555 . . . . 15.0 113.536 -172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 CA-C-O 116.825 -1.559 . . . . 15.0 113.792 179.167 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 115.088 1.514 . . . . 15.0 115.088 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.14 128.15 17.09 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.77 2.313 . . . . 15.0 111.596 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.441 ' HG3' HG21 ' A' ' 6' ' ' THR . 0.4 OUTLIER -109.08 -71.49 0.76 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.12 -1.4 . . . . 15.0 114.339 -177.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.2 t0 43.51 82.81 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.67 1.588 . . . . 15.0 115.257 169.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.432 ' H ' ' HA ' ' A' ' 34' ' ' VAL . 6.1 t30 58.68 73.5 0.47 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.395 1.878 . . . . 15.0 112.461 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.441 HG21 ' HG3' ' A' ' 3' ' ' LYS . 11.6 t -120.94 150.91 40.36 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 112.207 -2.27 . . . . 15.0 111.448 173.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -106.92 131.79 53.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.568 -1.196 . . . . 15.0 111.959 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -118.35 101.6 8.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.619 -1.628 . . . . 15.0 108.681 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -108.07 118.32 36.43 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 113.246 -1.797 . . . . 15.0 107.114 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -130.9 153.0 20.1 Favored Glycine 0 N--CA 1.474 1.231 0 CA-C-N 114.316 -1.311 . . . . 15.0 113.971 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.29 124.11 42.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.736 -1.232 . . . . 15.0 108.261 170.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -144.19 155.97 44.12 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.756 -1.111 . . . . 15.0 112.869 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' SER . 3.1 pp -114.09 140.37 48.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.717 -0.674 . . . . 15.0 110.604 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -108.5 97.76 1.13 Allowed Glycine 0 N--CA 1.475 1.292 0 CA-C-N 113.691 -1.595 . . . . 15.0 111.097 -170.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.466 ' O ' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t90 -111.05 150.16 29.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.493 1.139 . . . . 15.0 112.418 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.3 p -122.34 159.38 27.58 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 112.439 -2.164 . . . . 15.0 111.081 -173.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -48.48 153.21 0.79 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.221 -0.899 . . . . 15.0 109.593 165.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -60.49 89.62 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.861 0.838 . . . . 15.0 111.641 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 t -167.81 141.0 3.3 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.651 -2.068 . . . . 15.0 107.963 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' H ' ' A' ' 21' ' ' GLU . 32.0 ttt-85 53.21 170.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.897 1.679 . . . . 15.0 113.649 -175.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 20' ' ' ARG . 15.3 pt-20 -69.69 75.18 0.43 Allowed 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.927 1.084 . . . . 15.0 113.927 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -130.1 147.59 51.86 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.877 -1.056 . . . . 15.0 112.242 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -173.15 -75.11 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.675 -1.602 . . . . 15.0 110.47 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.1 tp -104.56 89.45 3.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.473 0.654 . . . . 15.0 111.394 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.98 111.97 1.02 Allowed Glycine 0 N--CA 1.478 1.485 0 CA-C-N 113.599 -1.637 . . . . 15.0 112.018 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -119.75 142.47 48.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.193 0.597 . . . . 15.0 112.081 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.31 153.41 20.38 Favored Glycine 0 CA--C 1.537 1.436 0 O-C-N 124.952 1.408 . . . . 15.0 112.511 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . . . -102.96 135.94 43.7 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.733 -1.234 . . . . 15.0 111.2 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -111.72 118.0 34.42 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.007 -1.451 . . . . 15.0 110.817 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.12 90.12 0.45 Allowed Glycine 0 N--CA 1.476 1.325 0 CA-C-N 114.647 -1.161 . . . . 15.0 110.545 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.04 117.26 4.21 Favored Glycine 0 N--CA 1.477 1.419 0 O-C-N 124.44 0.729 . . . . 15.0 112.101 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -115.25 123.01 47.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.474 1.13 . . . . 15.0 111.856 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -109.03 82.21 1.56 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.499 -175.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.464 HG13 ' H ' ' A' ' 35' ' ' ASN 0.276 7.3 p -71.2 -73.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 112.236 -2.257 . . . . 15.0 112.243 174.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.464 ' H ' HG13 ' A' ' 34' ' ' VAL . 22.7 t30 -70.55 127.86 91.61 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.229 1.411 . . . . 15.0 112.146 -176.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 35' ' ' ASN . 71.8 Cg_endo -72.5 69.5 3.44 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.323 2.682 . . . . 15.0 111.728 170.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -175.94 -65.44 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.196 2.199 . . . . 15.0 107.941 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.28 141.01 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.465 -0.788 . . . . 15.0 111.962 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -115.67 158.95 14.08 Favored Glycine 0 N--CA 1.477 1.39 0 CA-C-N 113.638 -1.619 . . . . 15.0 109.577 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 136.2 52.73 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.257 0.551 . . . . 15.0 110.524 -176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HB3' ' OG1' ' A' ' 60' ' ' THR . 0.9 OUTLIER -127.89 133.91 49.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.584 -1.189 . . . . 15.0 110.621 -173.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 74.4 mtm -124.23 128.27 48.93 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.133 -1.394 . . . . 15.0 111.547 171.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.99 134.08 11.93 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 113.385 -1.734 . . . . 15.0 109.676 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.524 ' HB2' ' HB3' ' A' ' 28' ' ' ALA . 82.8 m-85 -120.12 115.06 22.91 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.311 -0.945 . . . . 15.0 111.695 -173.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -128.93 143.67 50.95 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.066 -1.425 . . . . 15.0 109.719 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -121.85 142.53 50.15 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.744 0.646 . . . . 15.0 112.744 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.4 tp -88.87 77.37 7.77 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 122.813 1.292 . . . . 15.0 110.075 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.23 -143.98 36.84 Favored Glycine 0 N--CA 1.478 1.488 0 CA-C-N 113.178 -1.828 . . . . 15.0 110.92 -175.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -69.85 -90.86 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.646 0.778 . . . . 15.0 111.178 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 58.0 ttm -142.03 98.67 6.17 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.176 0.991 . . . . 15.0 108.428 170.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.434 ' HG2' ' HB3' ' A' ' 54' ' ' ALA . 68.5 Cg_endo -69.47 -45.36 1.78 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.755 2.303 . . . . 15.0 112.428 177.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -179.24 -99.45 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 127.847 2.459 . . . . 15.0 106.048 172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -124.44 80.15 1.82 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 122.333 1.063 . . . . 15.0 108.438 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HB3' ' HG2' ' A' ' 51' ' ' PRO . . . -148.61 99.5 3.01 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 112.725 -2.034 . . . . 15.0 112.419 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -127.69 156.27 42.63 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.973 -1.921 . . . . 15.0 111.219 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.43 100.57 0.88 Allowed Glycine 0 N--CA 1.475 1.295 0 O-C-N 124.482 1.114 . . . . 15.0 110.427 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.8 m -110.74 131.86 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.599 1.19 . . . . 15.0 112.306 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -109.86 124.1 50.74 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.52 -1.673 . . . . 15.0 109.003 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.19 111.18 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.673 -1.149 . . . . 15.0 109.305 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.473 ' HB ' ' HG2' ' A' ' 78' ' ' ARG . 32.2 p -136.2 156.36 48.79 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.148 -1.842 . . . . 15.0 112.634 -173.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -116.56 141.66 47.89 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.284 -1.325 . . . . 15.0 110.745 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -110.77 126.07 54.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.375 -1.284 . . . . 15.0 111.402 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 pp -126.24 146.84 49.83 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.616 -1.629 . . . . 15.0 110.866 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.96 -155.29 21.56 Favored Glycine 0 N--CA 1.479 1.521 0 CA-C-N 115.694 -0.685 . . . . 15.0 112.04 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 67' ' ' LYS . 18.9 p90 -166.4 158.94 11.97 Favored Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -167.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.711 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 39.5 Cg_endo -68.57 134.0 29.39 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.825 2.35 . . . . 15.0 111.982 167.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 65' ' ' TYR . 4.8 tmtp? -129.44 122.75 30.0 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.234 -1.348 . . . . 15.0 110.725 -177.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.648 HD23 ' H ' ' A' ' 68' ' ' LEU . 1.8 pt? -69.93 125.68 27.47 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.384 -1.28 . . . . 15.0 110.769 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.34 -86.18 0.41 Allowed Glycine 0 N--CA 1.477 1.378 0 CA-C-N 114.562 -1.199 . . . . 15.0 112.94 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.432 HG23 ' OH ' ' A' ' 114' ' ' TYR . 2.4 t -126.43 -39.8 2.0 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 113.634 -1.283 . . . . 15.0 110.517 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -116.87 -146.37 0.4 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.502 -1.296 . . . . 15.0 107.502 148.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -107.76 103.31 12.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 114' ' ' TYR . 1.2 pt? -111.1 143.54 41.66 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.056 -1.429 . . . . 15.0 113.733 176.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.711 ' HA ' ' HA ' ' A' ' 66' ' ' PRO . 1.1 m-20 -111.85 123.44 50.24 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.513 -1.221 . . . . 15.0 108.914 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.7 mt -111.59 113.19 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 O-C-N 124.38 1.05 . . . . 15.0 108.681 -174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -122.27 141.83 51.1 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 113.478 -1.692 . . . . 15.0 111.885 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 m -108.53 122.64 47.49 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.257 -2.127 . . . . 15.0 105.257 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 18.2 ttm180 -115.73 123.22 47.75 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 112.831 -1.986 . . . . 15.0 108.134 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.2 tp -131.57 138.39 48.84 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.244 -0.889 . . . . 15.0 111.065 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.22 -145.39 8.06 Favored Glycine 0 N--CA 1.477 1.423 0 O-C-N 124.749 1.281 . . . . 15.0 113.178 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.43 152.35 22.86 Favored Glycine 0 N--CA 1.476 1.349 0 O-C-N 125.235 1.197 . . . . 15.0 112.599 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.75 118.71 35.06 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.548 0.69 . . . . 15.0 111.136 174.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.75 125.71 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 113.768 -1.56 . . . . 15.0 108.089 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.481 ' CZ3' ' HB2' ' A' ' 86' ' ' ALA . 15.8 p-90 -117.08 148.22 41.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.286 -1.325 . . . . 15.0 110.729 176.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -100.79 133.46 45.23 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.174 -1.376 . . . . 15.0 110.418 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HB2' ' CZ3' ' A' ' 84' ' ' TRP . . . -127.07 135.37 50.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.257 -1.338 . . . . 15.0 111.58 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -73.96 95.42 2.48 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.942 -1.026 . . . . 15.0 111.805 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 m 54.16 46.71 24.78 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.511 1.524 . . . . 15.0 110.727 -174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.4 p 61.8 -109.4 0.35 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.973 2.109 . . . . 15.0 112.22 -172.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -132.05 104.99 7.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.22 1.008 . . . . 15.0 109.814 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.4 tmmt? -64.27 98.47 0.23 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 114.902 -1.044 . . . . 15.0 111.955 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -108.28 85.85 2.19 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.063 -1.426 . . . . 15.0 110.233 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.62 -149.84 51.67 Favored Glycine 0 N--CA 1.478 1.451 0 CA-C-N 113.51 -1.677 . . . . 15.0 113.179 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -71.74 75.9 0.85 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.287 1.035 . . . . 15.0 113.705 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 176.31 137.83 2.72 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-N 114.404 -1.271 . . . . 15.0 113.14 173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -124.25 50.54 1.66 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 122.55 1.167 . . . . 15.0 112.237 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.419 ' H ' HD13 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -124.84 134.09 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 114.522 -1.217 . . . . 15.0 111.571 -177.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.6 t -172.27 147.7 2.02 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.856 1.347 . . . . 15.0 109.642 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.63 84.75 2.24 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 122.223 1.011 . . . . 15.0 110.869 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.72 140.13 24.5 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 113.549 -1.659 . . . . 15.0 111.179 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -116.53 89.33 3.09 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.196 -0.911 . . . . 15.0 110.104 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 53.84 -142.52 0.79 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.852 -1.522 . . . . 15.0 112.273 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 68.5 m -151.24 106.05 3.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.962 0.905 . . . . 15.0 109.363 174.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.45 99.74 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.438 -1.255 . . . . 15.0 108.843 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 41.7 p -118.65 136.45 24.15 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 114.31 -1.313 . . . . 15.0 111.904 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.21 96.58 0.72 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.06 2.507 . . . . 15.0 111.074 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.729 ' HB ' ' HA ' ' A' ' 133' ' ' THR . 21.5 m -116.98 143.48 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 113.836 -1.529 . . . . 15.0 111.566 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.65 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 5.6 p90 -129.7 138.18 51.01 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.961 -1.472 . . . . 15.0 111.8 -169.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . . . -124.79 134.28 52.83 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 125.631 1.832 . . . . 15.0 111.962 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.629 ' N ' ' HB2' ' A' ' 131' ' ' GLN . . . -104.29 99.24 1.65 Allowed Glycine 0 N--CA 1.476 1.31 0 N-CA-C 108.251 -1.939 . . . . 15.0 108.251 175.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -107.67 114.45 4.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 125.081 1.107 . . . . 15.0 112.127 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 52.3 t -117.29 131.96 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 122.576 1.179 . . . . 15.0 108.997 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.679 ' HB2' ' HB2' ' A' ' 74' ' ' ASP . 10.5 mm-40 -110.74 109.58 19.87 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 112.623 -2.081 . . . . 15.0 108.711 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 73' ' ' LEU . 13.6 t80 -107.26 126.08 51.97 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.611 0.719 . . . . 15.0 112.21 -174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.5 t -114.22 133.01 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 114.389 -1.278 . . . . 15.0 109.023 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.1 mt -118.78 142.94 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 114.517 -1.219 . . . . 15.0 108.727 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -70.83 97.11 1.34 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.903 1.075 . . . . 15.0 113.903 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -127.12 149.91 49.73 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.331 -1.304 . . . . 15.0 112.095 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -57.03 -42.9 81.3 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.146 1.165 . . . . 15.0 114.146 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.9 mt -120.8 89.05 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 108.36 -0.978 . . . . 15.0 108.36 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.0 m -118.0 90.25 36.61 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 114.238 -1.346 . . . . 15.0 109.191 173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.31 82.64 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.735 2.29 . . . . 15.0 112.281 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 148' ' ' TYR . 1.5 mp0 46.57 32.12 1.56 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.759 2.133 . . . . 15.0 116.759 176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.578 HD11 ' HB ' ' A' ' 146' ' ' VAL . 7.3 tp -116.71 129.57 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.103 0.954 . . . . 15.0 112.414 -169.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.61 153.2 38.41 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.077 -1.874 . . . . 15.0 110.563 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.3 m -80.76 122.61 27.38 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.132 -1.062 . . . . 15.0 108.132 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.48 108.11 20.72 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.348 -1.296 . . . . 15.0 107.995 -178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.9 tt -121.57 111.02 16.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.548 -1.66 . . . . 15.0 108.017 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 110' ' ' GLY . 1.4 tm-20 -129.28 120.51 25.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.553 -1.203 . . . . 15.0 111.054 -176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 141' ' ' MET . 86.5 t80 -134.95 105.55 6.43 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 117.699 -1.143 . . . . 15.0 110.199 170.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.65 ' HB3' ' O ' ' A' ' 108' ' ' PHE 0.756 1.1 mp0 -149.88 159.28 44.5 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 110.884 -2.871 . . . . 15.0 116.751 164.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -78.23 111.6 14.36 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 122.422 1.106 . . . . 15.0 108.207 -175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.729 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 36.4 p -119.34 -18.47 8.56 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 113.457 -1.701 . . . . 15.0 115.583 -176.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.557 ' ND2' ' HG3' ' A' ' 141' ' ' MET . 11.2 p30 -164.27 -166.49 1.13 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.547 1.939 . . . . 15.0 107.915 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 62.78 149.58 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.982 1.475 . . . . 15.0 114.982 -174.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.68 -67.5 0.9 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.433 -1.712 . . . . 15.0 111.935 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.2 t -99.82 82.29 2.57 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.036 -0.727 . . . . 15.0 109.036 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -171.21 141.47 1.62 Allowed 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.31 -1.768 . . . . 15.0 108.956 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -80.53 83.36 6.35 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.624 0.726 . . . . 15.0 112.301 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 62.26 -165.3 22.39 Favored Glycine 0 N--CA 1.482 1.71 0 CA-C-N 114.419 -1.264 . . . . 15.0 113.262 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.557 ' HG3' ' ND2' ' A' ' 134' ' ' ASN . 0.0 OUTLIER -130.79 133.9 46.38 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.921 1.082 . . . . 15.0 113.921 176.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -112.55 105.18 13.33 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.487 -1.688 . . . . 15.0 112.079 179.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 14.9 m -102.26 125.18 48.88 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 112.775 -2.012 . . . . 15.0 107.847 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp -131.08 136.88 48.81 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.258 -1.337 . . . . 15.0 111.426 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.08 -162.46 29.39 Favored Glycine 0 N--CA 1.476 1.327 0 O-C-N 124.837 1.335 . . . . 15.0 112.612 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.578 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.7 m -121.0 140.1 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 113.824 -1.188 . . . . 15.0 112.022 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.495 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 25.0 t -123.63 136.17 54.35 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.437 -1.256 . . . . 15.0 110.661 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 123' ' ' GLU . 34.7 t80 -111.72 135.21 52.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.607 -1.179 . . . . 15.0 109.482 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 56.8 ttt-85 -91.01 128.7 36.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.42 -1.263 . . . . 15.0 109.842 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 6' ' ' THR . 0.9 OUTLIER 60.05 82.89 0.15 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.888 2.075 . . . . 15.0 114.098 -173.134 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.42 -138.35 0.36 Allowed Glycine 0 CA--C 1.537 1.41 0 CA-C-N 112.667 -2.061 . . . . 15.0 112.179 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -66.95 79.66 0.12 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.284 1.587 . . . . 15.0 115.284 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.91 87.53 0.08 OUTLIER Glycine 0 N--CA 1.478 1.467 0 CA-C-N 113.895 -1.502 . . . . 15.0 112.852 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -123.68 135.74 54.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.808 0.843 . . . . 15.0 109.997 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.81 94.35 1.4 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.06 -0.973 . . . . 15.0 111.589 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-N 113.744 -1.571 . . . . 15.0 114.066 177.656 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mtt . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 115.513 1.671 . . . . 15.0 115.513 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HG2' ' OD1' ' A' ' 4' ' ' ASP . 89.0 Cg_endo -77.26 55.77 5.21 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.965 2.443 . . . . 15.0 114.004 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.27 0.6 OUTLIER 40.9 26.32 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 118.94 2.941 . . . . 15.0 118.94 178.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.431 ' OD1' ' HG2' ' A' ' 2' ' ' PRO . 18.5 p-10 -135.11 138.69 44.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.096 1.358 . . . . 15.0 110.294 177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 45.98 46.79 12.6 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.625 1.57 . . . . 15.0 113.053 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 33' ' ' GLN . 12.2 p -98.27 115.12 27.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.013 -2.358 . . . . 15.0 109.337 -172.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.626 ' HB3' ' H ' ' A' ' 151' ' ' GLY . 55.5 m95 -94.18 130.43 40.4 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.683 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 148' ' ' TYR . 1.2 t80 -143.4 111.26 6.03 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.487 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.569 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 40.4 p -117.96 174.57 6.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 112.869 -1.969 . . . . 15.0 110.503 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.0 -159.21 28.36 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-O 122.224 0.902 . . . . 15.0 114.4 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.82 132.75 24.22 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.725 -1.237 . . . . 15.0 111.019 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HA ' ' HA3' ' A' ' 145' ' ' GLY . 22.7 pttp -137.3 150.47 47.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.481 -1.236 . . . . 15.0 112.341 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 143' ' ' SER . 2.6 pp -114.21 143.59 44.58 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.875 -1.057 . . . . 15.0 111.723 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -103.31 119.09 6.26 Favored Glycine 0 N--CA 1.474 1.174 0 CA-C-N 113.2 -1.818 . . . . 15.0 110.316 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -114.82 141.1 48.34 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 113.502 -1.349 . . . . 15.0 111.72 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.4 m -122.21 98.04 5.75 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.063 -1.426 . . . . 15.0 113.708 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -85.32 48.64 1.61 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 114.45 1.278 . . . . 15.0 114.45 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -166.57 26.4 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 115.073 1.509 . . . . 15.0 115.073 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -155.38 144.23 20.65 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.593 0.59 . . . . 15.0 112.593 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -80.88 90.38 5.9 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.819 -1.082 . . . . 15.0 110.193 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 57.6 28.72 16.09 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 116.371 1.989 . . . . 15.0 116.371 173.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -114.82 133.96 55.51 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.713 0.634 . . . . 15.0 112.713 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 23' ' ' GLN . 10.5 mm-40 53.07 93.76 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.137 1.903 . . . . 15.0 116.137 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 pp -154.23 137.22 15.47 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 111.681 -2.509 . . . . 15.0 110.151 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.07 -169.88 37.56 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.138 0.899 . . . . 15.0 113.486 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . . . -124.39 142.62 51.15 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.573 0.749 . . . . 15.0 112.695 -175.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.16 145.92 16.75 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 114.188 -1.369 . . . . 15.0 111.16 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.67 121.27 43.21 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.32 -0.94 . . . . 15.0 109.351 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -127.23 152.88 46.81 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.699 -1.137 . . . . 15.0 112.165 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -174.36 149.23 10.46 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 115.413 -0.812 . . . . 15.0 114.813 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.22 -146.74 7.62 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 113.634 -1.283 . . . . 15.0 113.298 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -158.35 149.55 20.88 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.722 -1.239 . . . . 15.0 113.621 -170.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 42.2 tt0 -114.66 95.17 5.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.303 1.441 . . . . 15.0 108.657 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.6 -48.17 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.222 -0.899 . . . . 15.0 111.693 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -121.99 154.93 61.37 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-O 118.055 -0.974 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.47 53.36 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.877 3.051 . . . . 15.0 113.42 170.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.91 -82.3 0.23 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.515 1.526 . . . . 15.0 108.667 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.38 142.89 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.939 0.896 . . . . 15.0 108.854 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.62 166.88 17.09 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.188 1.375 . . . . 15.0 110.671 170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -119.96 139.39 52.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.41 137.15 43.83 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.363 -1.29 . . . . 15.0 111.805 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.18 143.33 31.41 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.756 -1.565 . . . . 15.0 109.85 173.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.06 129.32 7.75 Favored Glycine 0 N--CA 1.473 1.156 0 CA-C-N 114.571 -1.195 . . . . 15.0 111.05 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -118.99 133.96 55.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.364 1.078 . . . . 15.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -125.11 133.82 52.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.921 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.829 ' HA ' ' HG3' ' A' ' 55' ' ' GLN . 37.7 p-90 -102.8 133.54 47.69 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.814 -1.085 . . . . 15.0 110.192 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 87' ' ' ASP . 37.9 tp -106.23 -35.83 7.06 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.595 -1.639 . . . . 15.0 113.764 -173.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.81 29.62 4.89 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 124.459 1.028 . . . . 15.0 112.637 -175.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.57 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.7 OUTLIER -112.94 165.46 12.31 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.42 1.088 . . . . 15.0 110.992 -178.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.1 mtm -46.82 146.99 2.38 Favored Pre-proline 0 N--CA 1.48 1.029 0 N-CA-C 115.144 1.535 . . . . 15.0 115.144 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.01 157.03 55.19 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.662 2.242 . . . . 15.0 111.149 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 65.98 93.63 0.07 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.416 1.887 . . . . 15.0 112.394 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 57.17 94.56 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 116.211 1.93 . . . . 15.0 116.211 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.57 ' HB1' ' HB3' ' A' ' 49' ' ' ARG . . . -170.1 -66.53 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.584 -1.643 . . . . 15.0 111.632 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.829 ' HG3' ' HA ' ' A' ' 46' ' ' TRP . 2.9 mp0 -51.6 147.1 6.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.92 . . . . 15.0 112.906 172.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 135.87 16.04 Favored Glycine 0 N--CA 1.478 1.467 0 CA-C-N 114.37 -1.286 . . . . 15.0 112.576 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.13 137.32 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 122.73 1.252 . . . . 15.0 112.988 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 82' ' ' MET . 0.0 OUTLIER -126.84 139.77 52.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 113.089 -1.869 . . . . 15.0 111.733 175.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.44 111.19 17.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.585 -1.643 . . . . 15.0 109.114 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.532 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 34.2 m -124.55 140.86 52.55 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.986 -1.461 . . . . 15.0 109.884 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.833 ' O ' ' HB3' ' A' ' 78' ' ' ARG . . . -101.06 138.5 38.02 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 105.998 -1.853 . . . . 15.0 105.998 168.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.739 ' HA ' ' CB ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -124.95 139.24 54.0 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 125.93 2.019 . . . . 15.0 114.365 -178.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 77' ' ' THR 0.27 4.6 pp -127.15 120.7 29.45 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 166.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . -121.91 135.05 10.19 Favored Glycine 0 N--CA 1.474 1.195 0 CA-C-N 111.678 -2.51 . . . . 15.0 112.58 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -137.08 145.43 50.29 Favored Pre-proline 0 N--CA 1.477 0.877 0 O-C-N 125.348 1.263 . . . . 15.0 114.118 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.4 91.22 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.069 2.513 . . . . 15.0 110.728 167.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' A' ' 68' ' ' LEU . 6.3 tmtt? -144.6 152.16 40.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 113.405 -1.725 . . . . 15.0 108.895 -178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.628 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 1.2 tm? 62.95 85.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.79 2.036 . . . . 15.0 109.624 -170.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -140.74 15.82 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 112.926 -1.943 . . . . 15.0 109.584 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 71' ' ' ASP . 3.2 t -136.34 -86.96 0.33 Allowed 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.188 -1.006 . . . . 15.0 112.153 177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.556 ' H ' HG23 ' A' ' 70' ' ' THR . 8.5 m-20 -124.97 106.6 10.08 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.108 1.363 . . . . 15.0 108.093 175.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.6 t0 176.32 -44.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 113.175 -1.83 . . . . 15.0 110.138 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 114' ' ' TYR . 1.3 pt? -135.32 151.79 50.86 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 124.799 1.312 . . . . 15.0 112.218 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 7.0 m-20 -132.56 138.78 47.58 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.398 -1.274 . . . . 15.0 111.022 172.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.474 ' HA ' HG12 ' A' ' 112' ' ' VAL . 7.8 tp -87.71 135.84 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.275 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -123.94 128.86 50.04 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.992 1.433 . . . . 15.0 111.646 172.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.495 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 24.0 p -137.2 122.35 19.18 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.942 -1.132 . . . . 15.0 107.942 158.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.833 ' HB3' ' O ' ' A' ' 61' ' ' ALA 0.609 8.0 mmt180 -158.9 164.6 35.53 Favored 'General case' 0 N--CA 1.478 0.972 1 N-CA-C 122.946 4.424 . . . . 15.0 122.946 172.822 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.707 HD13 ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -127.93 156.0 43.33 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.096 0.776 . . . . 15.0 113.096 -176.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -165.12 -176.55 36.86 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 114.96 -1.018 . . . . 15.0 113.365 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.93 144.16 14.97 Favored Glycine 0 N--CA 1.479 1.559 0 C-N-CA 123.889 0.757 . . . . 15.0 113.286 -176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.552 ' HB3' ' HB3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -123.79 140.68 52.74 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.617 1.34 . . . . 15.0 114.617 179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 p -138.87 144.27 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 O-C-N 125.157 1.536 . . . . 15.0 112.309 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -122.75 151.26 41.76 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.38 1.072 . . . . 15.0 111.798 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.548 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -123.63 160.32 27.37 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.429 -0.805 . . . . 15.0 112.158 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 61.83 -145.01 0.42 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.757 1.623 . . . . 15.0 111.323 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.602 ' HB2' HD21 ' A' ' 47' ' ' LEU . 26.7 t0 46.76 59.53 3.89 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.987 1.477 . . . . 15.0 114.987 177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.6 p -102.63 -74.46 0.63 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.303 1.223 . . . . 15.0 114.303 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 t 68.92 117.64 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.16 2.184 . . . . 15.0 113.309 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -168.41 140.67 2.87 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.639 -1.619 . . . . 15.0 109.101 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -69.95 155.89 39.91 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.299 1.0 . . . . 15.0 111.21 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -115.56 150.31 36.82 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.173 -0.921 . . . . 15.0 112.675 -173.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.48 -108.01 0.24 Allowed Glycine 0 N--CA 1.478 1.453 0 O-C-N 125.359 1.662 . . . . 15.0 109.134 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -56.64 -31.22 64.14 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.877 1.436 . . . . 15.0 114.877 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.43 -103.41 0.79 Allowed Glycine 0 N--CA 1.478 1.451 0 C-N-CA 124.03 0.824 . . . . 15.0 113.209 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -69.94 92.69 0.73 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.261 1.024 . . . . 15.0 112.179 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.555 HG23 ' H ' ' A' ' 98' ' ' SER 0.326 0.0 OUTLIER -117.02 -88.61 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 114.436 -1.256 . . . . 15.0 112.384 174.141 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.555 ' H ' HG23 ' A' ' 97' ' ' ILE . 23.0 m -63.39 -20.37 65.47 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 118.219 2.674 . . . . 15.0 118.219 -172.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -10.84 84.91 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 118.227 2.677 . . . . 15.0 118.227 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.86 -32.92 66.32 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 117.199 2.296 . . . . 15.0 117.199 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 62.63 146.74 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.244 1.818 . . . . 15.0 114.684 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.32 90.35 5.57 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.484 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.2 t -73.44 143.98 46.48 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 113.759 -1.564 . . . . 15.0 111.903 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 t -117.0 120.67 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 106.635 -1.617 . . . . 15.0 106.635 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.0 m -122.12 142.01 35.67 Favored Pre-proline 0 N--CA 1.478 0.944 0 CA-C-N 115.045 -0.98 . . . . 15.0 113.305 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.16 148.7 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.666 2.244 . . . . 15.0 113.274 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.41 135.05 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.643 -1.617 . . . . 15.0 109.64 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -107.11 123.36 48.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -127.55 112.51 15.0 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.806 -1.088 . . . . 15.0 112.907 -173.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -123.03 138.56 11.76 Favored Glycine 0 N--CA 1.479 1.539 0 CA-C-N 113.581 -1.645 . . . . 15.0 110.713 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.79 -152.95 14.73 Favored Glycine 0 N--CA 1.478 1.446 0 C-N-CA 123.298 0.475 . . . . 15.0 113.244 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 75' ' ' ILE . 5.4 m -141.77 156.97 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.992 1.108 . . . . 15.0 113.992 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -110.13 136.89 48.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.426 -1.716 . . . . 15.0 108.669 159.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 73' ' ' LEU . 11.5 t80 -132.37 143.61 49.96 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.865 -1.516 . . . . 15.0 108.957 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.44 135.32 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-O 120.949 0.404 . . . . 15.0 109.991 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.7 mt -43.61 -39.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.805 1.78 . . . . 15.0 115.805 -164.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -164.1 -60.13 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.589 0.755 . . . . 15.0 110.495 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.16 135.52 34.34 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.767 -0.651 . . . . 15.0 109.701 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -52.79 -33.8 50.5 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.978 -1.01 . . . . 15.0 112.975 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.0 tt -99.84 82.92 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 122.236 1.017 . . . . 15.0 109.893 170.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 89.2 m -136.76 88.96 18.25 Favored Pre-proline 0 N--CA 1.479 0.99 0 CA-C-N 112.325 -2.216 . . . . 15.0 108.163 167.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.37 -177.11 3.6 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.949 2.433 . . . . 15.0 111.733 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 54.4 mt-10 66.83 -55.6 0.43 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.631 1.973 . . . . 15.0 115.309 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.531 HG12 ' CE2' ' A' ' 148' ' ' TYR . 6.6 mt -116.72 115.16 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.254 1.022 . . . . 15.0 108.649 -173.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.07 147.98 44.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.369 -1.287 . . . . 15.0 111.343 174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 m -80.75 116.8 20.94 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 107.959 -1.126 . . . . 15.0 107.959 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.49 HH11 ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -116.83 112.04 20.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.115 0.96 . . . . 15.0 109.889 -177.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.53 112.75 18.4 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 15.0 110.841 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -134.98 136.45 42.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.928 -1.487 . . . . 15.0 111.491 -173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 30.7 m-85 -97.4 131.96 43.56 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.425 -1.262 . . . . 15.0 109.341 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.38 117.0 30.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 113.356 -1.747 . . . . 15.0 111.592 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -120.72 111.83 18.1 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.493 -1.685 . . . . 15.0 113.186 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 92.1 m -111.02 -34.31 6.24 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 112.64 -2.073 . . . . 15.0 111.557 167.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -77.76 117.24 18.95 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.111 0.482 . . . . 15.0 111.417 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -54.6 -33.48 60.45 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 114.339 -1.301 . . . . 15.0 112.708 172.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.3 94.02 3.52 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.041 0.924 . . . . 15.0 111.048 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.2 m -56.56 85.15 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 113.185 -1.825 . . . . 15.0 112.712 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -110.42 -31.1 7.39 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 113.462 -1.699 . . . . 15.0 115.06 176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -176.8 -79.29 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.034 1.334 . . . . 15.0 109.444 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 117.25 -176.69 16.31 Favored Glycine 0 N--CA 1.478 1.436 0 N-CA-C 109.057 -1.617 . . . . 15.0 109.057 -177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.0 ttt -117.65 135.11 54.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.586 0.708 . . . . 15.0 109.231 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.2 tt -105.17 108.8 20.51 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.694 -1.139 . . . . 15.0 109.708 -174.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 2.1 m -93.25 125.11 37.68 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.208 1.004 . . . . 15.0 110.081 170.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.4 pp -133.9 135.22 43.49 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 112.903 -1.953 . . . . 15.0 110.109 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 12' ' ' LYS . . . -178.94 -162.52 28.48 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 114.82 -1.082 . . . . 15.0 112.848 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.3 m -117.04 131.32 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 113.518 -1.341 . . . . 15.0 112.633 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 36.7 p -113.17 145.73 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 112.342 -2.208 . . . . 15.0 111.535 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.613 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 70.7 m-85 -124.07 143.45 50.44 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 113.009 -1.905 . . . . 15.0 112.482 -172.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -95.84 141.54 29.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 113.583 -1.644 . . . . 15.0 111.41 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 69.1 92.11 0.09 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.825 1.65 . . . . 15.0 114.347 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.626 ' H ' ' HB3' ' A' ' 7' ' ' TRP . . . -78.69 101.87 1.83 Allowed Glycine 0 N--CA 1.476 1.354 0 CA-C-N 113.269 -1.787 . . . . 15.0 111.168 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -60.49 94.19 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.121 0.962 . . . . 15.0 112.526 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -62.25 94.75 0.1 Allowed Glycine 0 N--CA 1.476 1.332 0 CA-C-N 113.406 -1.724 . . . . 15.0 111.84 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 70.36 101.28 0.06 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.494 1.917 . . . . 15.0 112.632 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.78 93.19 0.1 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 113.698 -1.592 . . . . 15.0 112.268 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.261 0 CA-C-N 113.631 -1.622 . . . . 15.0 113.97 177.606 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 97.9 mtp . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 115.949 1.833 . . . . 15.0 115.949 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 72.7 Cg_endo -73.17 86.13 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.691 2.261 . . . . 15.0 110.797 172.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.819 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 14.7 ttpt -68.49 -87.87 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 113.598 -1.637 . . . . 15.0 112.506 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.487 ' H ' ' HE2' ' A' ' 3' ' ' LYS . 25.6 t0 -72.5 -41.25 66.14 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.414 0.686 . . . . 15.0 110.919 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.603 ' H ' ' HA ' ' A' ' 34' ' ' VAL . 60.0 t30 59.64 30.93 20.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.857 1.663 . . . . 15.0 114.563 165.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.598 ' HA ' ' HB3' ' A' ' 149' ' ' ARG . 10.2 t -110.98 114.72 28.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.162 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -136.79 133.57 36.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.905 -2.407 . . . . 15.0 111.18 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 144.17 -98.11 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 129.293 3.037 . . . . 15.0 108.09 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.647 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 11.2 t -163.51 153.18 15.01 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.616 0.599 . . . . 15.0 112.616 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -131.06 -170.07 12.59 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 114.166 -1.379 . . . . 15.0 112.793 170.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.73 131.57 5.44 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.752 1.621 . . . . 15.0 109.522 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.682 ' HB3' ' O ' ' A' ' 144' ' ' LEU 0.425 5.2 tptp -171.94 169.61 5.65 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.185 -1.825 . . . . 15.0 115.142 168.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HB3' ' H ' ' A' ' 26' ' ' ALA . 1.9 pt? -130.47 161.64 30.98 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.427 -1.261 . . . . 15.0 111.681 -173.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -120.0 155.57 16.13 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.513 -1.222 . . . . 15.0 112.548 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -121.65 137.02 54.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 113.924 -1.138 . . . . 15.0 112.49 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -116.8 151.78 35.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.09 -1.414 . . . . 15.0 109.919 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -71.43 78.73 0.76 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.164 1.172 . . . . 15.0 114.164 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -158.92 139.49 12.51 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.135 -1.393 . . . . 15.0 111.717 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.9 m -66.46 -40.41 89.39 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 116.664 2.098 . . . . 15.0 116.664 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.5 mtt-85 -76.78 92.08 3.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.54 0.686 . . . . 15.0 111.841 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -124.58 131.5 53.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.096 -1.865 . . . . 15.0 113.03 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -131.65 -163.09 1.29 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.067 -1.424 . . . . 15.0 110.239 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -74.68 74.64 2.04 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.535 1.159 . . . . 15.0 111.024 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 tt -144.63 101.43 3.67 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.663 -1.608 . . . . 15.0 108.502 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.66 -153.82 23.06 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 114.146 -1.388 . . . . 15.0 111.377 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.492 ' H ' ' HB3' ' A' ' 13' ' ' LEU . . . 50.13 91.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.191 1.796 . . . . 15.0 114.19 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.11 148.77 16.48 Favored Glycine 0 N--CA 1.475 1.269 0 CA-C-N 113.807 -1.542 . . . . 15.0 109.99 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.45 121.14 41.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.692 -0.855 . . . . 15.0 108.692 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HA ' ' HA2' ' A' ' 43' ' ' GLY . 97.3 m-85 -125.75 113.43 17.29 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.562 -1.199 . . . . 15.0 110.114 -170.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.67 -174.59 14.44 Favored Glycine 0 N--CA 1.477 1.405 0 CA-C-N 115.353 -0.84 . . . . 15.0 114.309 -173.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.92 -140.04 13.86 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.441 -0.88 . . . . 15.0 113.705 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -127.19 104.93 8.22 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.406 -1.397 . . . . 15.0 112.969 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.505 HE22 ' HB2' ' A' ' 62' ' ' LYS . 15.5 mm100 -114.93 82.27 1.71 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 123.066 1.412 . . . . 15.0 108.249 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.603 ' HA ' ' H ' ' A' ' 5' ' ' ASN . 47.9 t -124.78 -63.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 112.749 -2.023 . . . . 15.0 113.315 -170.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 12.5 t-20 -62.17 139.09 96.13 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 114.354 1.242 . . . . 15.0 114.354 -170.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.819 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 75.6 Cg_endo -73.59 41.13 0.59 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 124.652 3.568 . . . . 15.0 116.444 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 1.2 t80 -167.51 -58.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 15.0 111.236 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 57.2 t -124.65 136.32 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.794 0.806 . . . . 15.0 110.279 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.37 154.57 21.3 Favored Glycine 0 N--CA 1.478 1.471 0 CA-C-N 113.785 -1.552 . . . . 15.0 110.055 174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -121.95 114.31 20.81 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.737 0.303 . . . . 15.0 110.503 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -131.94 119.91 21.77 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.159 -0.928 . . . . 15.0 111.047 -172.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 87.3 mtp -112.21 135.6 52.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.816 -1.084 . . . . 15.0 110.796 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 29' ' ' PHE . . . -115.87 147.67 18.91 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 113.382 -1.735 . . . . 15.0 111.948 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -132.29 143.03 49.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.846 1.425 . . . . 15.0 114.846 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -127.09 118.44 24.39 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 111.722 -2.49 . . . . 15.0 107.238 169.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 7.4 m0 -112.51 145.18 40.71 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.518 -1.219 . . . . 15.0 110.073 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.619 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -91.2 71.37 6.23 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.914 -1.039 . . . . 15.0 110.212 -172.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 113.32 -152.37 18.02 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 112.248 -2.251 . . . . 15.0 110.704 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -122.91 -81.72 0.64 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.937 -1.132 . . . . 15.0 109.968 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.3 ttt -58.78 -35.76 35.97 Favored Pre-proline 0 N--CA 1.48 1.035 0 CA-C-O 118.391 -0.814 . . . . 15.0 112.353 169.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -94.33 141.4 1.45 Allowed 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 121.062 1.175 . . . . 15.0 111.038 160.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -140.56 94.24 2.71 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.591 -1.186 . . . . 15.0 108.592 169.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.619 ' H ' ' HB3' ' A' ' 47' ' ' LEU . 9.5 tmtt? -91.14 -89.28 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 114.458 -1.246 . . . . 15.0 112.886 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.28 -49.38 61.34 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 117.184 2.29 . . . . 15.0 117.184 -169.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 58.41 109.54 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.125 1.77 . . . . 15.0 114.516 176.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.26 134.76 10.58 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 114.021 -1.445 . . . . 15.0 111.282 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.2 p -119.05 141.33 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 122.111 0.958 . . . . 15.0 111.259 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.503 ' HG2' ' HB3' ' A' ' 82' ' ' MET . 47.4 mt-30 -120.66 140.29 51.79 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.284 -1.326 . . . . 15.0 109.976 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.64 114.82 20.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.397 -1.274 . . . . 15.0 110.195 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.2 p -130.41 131.73 45.4 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.746 0.784 . . . . 15.0 110.881 -176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -114.77 123.3 48.87 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.002 -1.454 . . . . 15.0 110.982 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.647 ' HG2' ' CD2' ' A' ' 76' ' ' TYR . 11.9 tmtt? -79.31 106.41 11.32 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.2 -1.818 . . . . 15.0 108.575 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.79 108.82 15.32 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.472 171.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 37' ' ' TYR . . . 177.65 -153.69 13.85 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-N 114.021 -1.445 . . . . 15.0 113.517 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.98 152.22 76.87 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 113.934 -1.133 . . . . 15.0 111.23 -170.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 35.2 Cg_endo -61.29 -73.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.497 2.131 . . . . 15.0 111.24 170.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.4 tptm 60.95 143.96 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.599 1.96 . . . . 15.0 111.621 -176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.72 -61.63 2.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.878 -1.056 . . . . 15.0 112.055 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.11 -85.15 0.06 OUTLIER Glycine 0 N--CA 1.478 1.462 0 C-N-CA 124.76 1.171 . . . . 15.0 111.492 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 p -134.83 -73.01 0.47 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.653 1.181 . . . . 15.0 109.383 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -165.81 135.33 3.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.869 2.068 . . . . 15.0 108.684 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.565 ' HB2' ' CE1' ' A' ' 114' ' ' TYR . 7.3 m-20 62.03 43.64 8.78 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.903 1.281 . . . . 15.0 112.775 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tt -117.57 137.36 52.64 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.776 -1.102 . . . . 15.0 112.942 -167.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 66' ' ' PRO . 14.9 t70 -126.61 139.41 53.21 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 112.079 -2.328 . . . . 15.0 109.002 165.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 15.9 tt -118.16 119.12 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.119 0.968 . . . . 15.0 109.831 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.647 ' CD2' ' HG2' ' A' ' 62' ' ' LYS . 8.8 p90 -153.86 168.9 24.79 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.012 1.115 . . . . 15.0 114.012 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.585 ' HA ' ' HA2' ' A' ' 110' ' ' GLY . 8.9 t -118.66 133.53 55.79 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.643 -1.162 . . . . 15.0 110.569 166.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.548 ' HB3' ' HE2' ' A' ' 76' ' ' TYR . 7.8 ppt_? -100.53 123.17 44.39 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.55 1.167 . . . . 15.0 109.149 172.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.3 pp -124.41 144.57 49.98 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 112.221 -2.263 . . . . 15.0 113.483 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.64 -97.36 0.17 Allowed Glycine 0 N--CA 1.476 1.304 0 CA-C-N 113.46 -1.7 . . . . 15.0 109.309 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.59 -153.66 23.75 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 115.057 0.783 . . . . 15.0 115.057 175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.503 ' HB3' ' HG2' ' A' ' 58' ' ' GLN . 21.9 ptp -129.14 138.5 51.82 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.217 1.562 . . . . 15.0 115.217 -172.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.2 t -128.05 115.58 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 112.902 -1.953 . . . . 15.0 109.185 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -100.92 151.44 21.74 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.85 -1.523 . . . . 15.0 109.721 170.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.71 67.72 0.1 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 123.527 1.632 . . . . 15.0 112.535 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 101' ' ' GLU . . . -72.15 89.3 1.15 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 113.983 -1.462 . . . . 15.0 111.15 174.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.9 t70 116.78 128.08 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 129.716 3.207 . . . . 15.0 111.376 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.6 t -131.32 157.46 43.27 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 113.09 -1.868 . . . . 15.0 109.313 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -24.59 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 117.055 2.243 . . . . 15.0 117.055 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -72.32 84.4 1.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.586 -1.188 . . . . 15.0 111.589 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -2.71 -75.69 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.231 2.613 . . . . 15.0 116.551 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -130.4 146.98 52.05 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.965 -1.124 . . . . 15.0 107.965 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.485 ' HA2' HD11 ' A' ' 97' ' ' ILE . . . -118.08 -153.48 9.59 Favored Glycine 0 N--CA 1.474 1.232 0 O-C-N 124.372 1.045 . . . . 15.0 113.744 -174.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -168.58 -160.99 0.32 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.981 1.712 . . . . 15.0 108.03 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.38 83.97 0.14 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.755 1.169 . . . . 15.0 112.971 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 51.15 82.55 0.06 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.736 2.014 . . . . 15.0 114.149 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 93' ' ' GLY . 10.9 pt -123.59 164.3 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 113.129 -1.85 . . . . 15.0 111.92 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.0 m 58.08 75.59 0.37 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.857 1.663 . . . . 15.0 113.977 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -104.23 85.72 2.42 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.071 -1.422 . . . . 15.0 111.097 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -161.25 140.44 10.2 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 113.17 -1.832 . . . . 15.0 110.72 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 86' ' ' ALA . 41.7 tt0 -160.3 134.94 7.58 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.156 -0.929 . . . . 15.0 110.373 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 60.1 152.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.565 1.946 . . . . 15.0 115.84 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 82.8 p -98.94 105.94 18.14 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.964 0.888 . . . . 15.0 112.78 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.97 90.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 114.778 -1.101 . . . . 15.0 108.375 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.8 m -130.04 90.17 43.25 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 114.112 1.153 . . . . 15.0 114.112 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.11 141.42 29.47 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.288 2.659 . . . . 15.0 112.66 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.42 HG22 HG21 ' A' ' 133' ' ' THR . 97.8 t -134.37 139.31 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-N 114.363 -1.29 . . . . 15.0 109.855 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -124.32 123.34 39.99 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.656 1.223 . . . . 15.0 109.139 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -136.33 112.66 9.88 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.952 1.093 . . . . 15.0 113.952 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 77' ' ' THR . . . -113.29 142.07 17.24 Favored Glycine 0 N--CA 1.479 1.527 0 CA-C-N 114.096 -1.411 . . . . 15.0 112.662 -173.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 173.16 -148.93 10.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-O 121.928 0.738 . . . . 15.0 114.606 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 m -119.35 143.86 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 113.483 -1.358 . . . . 15.0 113.859 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 126' ' ' THR . 0.0 OUTLIER -122.83 121.92 37.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 113.069 -1.878 . . . . 15.0 109.898 178.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 72' ' ' ASP . 78.1 t80 -117.71 137.36 52.74 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.888 1.367 . . . . 15.0 110.196 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.83 130.62 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.288 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.94 106.94 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.905 1.817 . . . . 15.0 115.905 -169.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -118.89 87.37 2.72 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 114.092 -1.413 . . . . 15.0 110.36 171.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.489 HH21 ' HD2' ' A' ' 119' ' ' ARG . 21.7 ttp180 -174.08 -79.94 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 113.512 -1.676 . . . . 15.0 112.438 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.489 ' HD2' HH21 ' A' ' 118' ' ' ARG . 65.1 ttt180 -101.53 146.86 27.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.425 0.631 . . . . 15.0 112.658 -169.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.26 100.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 126.078 1.751 . . . . 15.0 112.523 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.1 p -140.18 151.41 64.61 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 112.066 -2.334 . . . . 15.0 110.281 -174.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.68 82.21 1.22 Allowed 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.377 2.051 . . . . 15.0 110.141 171.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -0.7 96.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.939 2.496 . . . . 15.0 116.596 -175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.426 HG22 ' HB3' ' A' ' 148' ' ' TYR . 2.7 pp -116.53 140.79 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 112.687 -2.051 . . . . 15.0 112.4 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -118.47 127.78 53.97 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 112.489 -2.141 . . . . 15.0 109.333 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 113' ' ' GLU . 8.9 t -109.33 129.28 55.53 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.426 -1.261 . . . . 15.0 112.182 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.443 ' O ' HD12 ' A' ' 144' ' ' LEU . 52.0 ttp180 -113.3 108.12 16.82 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.431 -1.713 . . . . 15.0 110.19 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.5 tp -106.73 111.02 23.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 113.855 -1.521 . . . . 15.0 108.061 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -138.18 150.41 46.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.136 -2.302 . . . . 15.0 113.161 -168.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 38.3 p90 -96.99 129.52 44.44 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.144 -1.428 . . . . 15.0 107.144 172.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 44.5 tt0 -108.04 110.01 21.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 112.806 -1.997 . . . . 15.0 108.5 -172.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -123.43 136.54 54.67 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.117 -1.856 . . . . 15.0 112.802 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.42 HG21 HG22 ' A' ' 107' ' ' VAL . 8.8 t -179.08 74.99 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 110.927 -2.852 . . . . 15.0 108.761 173.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -171.74 149.88 2.6 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.439 -1.71 . . . . 15.0 111.964 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -61.4 -30.94 70.87 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.428 1.27 . . . . 15.0 114.428 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.7 91.12 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.966 1.365 . . . . 15.0 114.519 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 47.3 p -64.69 147.57 52.79 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.61 -1.632 . . . . 15.0 111.262 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 67.84 -3.43 1.18 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 115.331 1.604 . . . . 15.0 115.331 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -119.25 -163.16 0.95 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.626 1.17 . . . . 15.0 109.335 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 127.58 -153.2 19.13 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 124.506 1.051 . . . . 15.0 112.616 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.467 ' HB3' ' HB3' ' A' ' 131' ' ' GLN . 25.5 ttt -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.129 -1.035 . . . . 15.0 110.874 -174.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.1 tp -114.32 112.22 22.74 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.398 -1.334 . . . . 15.0 107.398 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.53 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 9.8 t -120.56 138.34 53.92 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.952 -1.476 . . . . 15.0 112.693 -166.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.682 ' O ' ' HB3' ' A' ' 12' ' ' LYS . 37.7 tp -120.1 134.58 55.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 113.589 -1.641 . . . . 15.0 109.861 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -129.27 128.33 5.75 Favored Glycine 0 N--CA 1.481 1.655 0 O-C-N 125.774 1.921 . . . . 15.0 110.247 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.427 ' H ' ' HB2' ' A' ' 12' ' ' LYS . 48.2 t -121.43 127.55 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 118.718 1.259 . . . . 15.0 109.249 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.565 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 65.9 p -118.71 138.68 52.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.551 ' CE2' ' HA2' ' A' ' 10' ' ' GLY . 13.5 p90 -125.26 148.31 48.73 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 122.481 1.134 . . . . 15.0 113.65 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.598 ' HB3' ' HA ' ' A' ' 6' ' ' THR . 36.6 ptt180 -101.32 153.37 19.71 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.354 -1.748 . . . . 15.0 114.516 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 64.13 132.47 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.251 2.22 . . . . 15.0 115.161 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.32 103.36 2.45 Favored Glycine 0 N--CA 1.475 1.291 0 CA-C-N 112.575 -2.102 . . . . 15.0 109.219 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 10.61 102.23 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 127.629 2.372 . . . . 15.0 115.559 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -67.84 72.81 0.27 Allowed Glycine 0 N--CA 1.48 1.626 0 CA-C-N 114.426 -1.261 . . . . 15.0 114.835 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 51.31 79.36 0.1 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.841 2.056 . . . . 15.0 114.357 170.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.87 88.98 2.33 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.456 1.122 . . . . 15.0 111.96 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 CA-C-N 113.76 -1.563 . . . . 15.0 114.866 178.429 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 119.06 2.985 . . . . 15.0 119.06 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.15 140.35 49.09 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 121.963 1.775 . . . . 15.0 112.764 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.9 107.67 1.04 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 113.909 -1.496 . . . . 15.0 112.593 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -143.97 134.99 25.45 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.168 -1.378 . . . . 15.0 109.985 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.652 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 58.8 t30 57.1 39.6 28.96 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.801 1.64 . . . . 15.0 112.811 178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.494 ' HB ' ' CE2' ' A' ' 8' ' ' TYR . 81.5 p -98.38 119.49 37.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.078 -1.873 . . . . 15.0 108.306 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 6.6 m0 -113.91 130.28 56.52 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.237 -1.023 . . . . 15.0 108.237 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.494 ' CE2' ' HB ' ' A' ' 6' ' ' THR . 89.6 m-85 -132.22 106.0 7.68 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 124.229 0.956 . . . . 15.0 112.348 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.0 p -104.07 137.9 41.36 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.547 -0.751 . . . . 15.0 111.341 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.11 -145.46 7.28 Favored Glycine 0 N--CA 1.477 1.401 0 CA-C-N 113.92 -1.491 . . . . 15.0 112.038 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.55 144.15 50.21 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.891 -0.655 . . . . 15.0 112.675 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 145' ' ' GLY . 0.0 OUTLIER -118.29 140.16 50.24 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.434 -1.257 . . . . 15.0 111.312 174.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 143' ' ' SER . 0.9 OUTLIER -127.53 133.43 49.81 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.247 -1.342 . . . . 15.0 111.391 176.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 143' ' ' SER . . . -111.45 116.99 4.36 Favored Glycine 0 N--CA 1.475 1.292 0 O-C-N 125.223 1.577 . . . . 15.0 110.626 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -109.26 145.46 35.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.848 0.832 . . . . 15.0 111.723 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -98.98 98.17 9.25 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.5 -1.227 . . . . 15.0 114.289 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.92 90.0 7.7 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.82 -1.082 . . . . 15.0 109.438 170.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -134.22 -86.75 0.41 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 112.743 -2.026 . . . . 15.0 110.081 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -119.24 -165.45 1.15 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.537 1.135 . . . . 15.0 109.07 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.33 83.6 0.25 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.805 1.242 . . . . 15.0 113.904 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.94 136.97 50.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 113.669 -1.605 . . . . 15.0 111.763 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -121.18 97.1 5.36 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.117 -1.401 . . . . 15.0 109.549 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.01 133.72 55.27 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.329 1.233 . . . . 15.0 114.329 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.96 156.17 33.98 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.971 -1.922 . . . . 15.0 110.57 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 176.87 -86.91 0.07 OUTLIER Glycine 0 N--CA 1.478 1.495 0 O-C-N 124.245 0.965 . . . . 15.0 112.085 -176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 69.72 149.71 0.08 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 127.339 2.256 . . . . 15.0 114.801 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.25 149.8 16.96 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 113.636 -1.62 . . . . 15.0 110.812 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.54 121.34 42.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.226 0.536 . . . . 15.0 110.249 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HA ' ' HA3' ' A' ' 43' ' ' GLY . 2.4 m-85 -129.83 150.3 51.19 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 116.103 1.89 . . . . 15.0 116.103 -166.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -123.29 121.07 4.43 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 112.985 -1.916 . . . . 15.0 110.352 170.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' HH12 ' A' ' 127' ' ' ARG . . . -104.99 98.91 1.54 Allowed Glycine 0 N--CA 1.474 1.228 0 CA-C-N 113.732 -1.234 . . . . 15.0 110.215 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -105.97 101.1 10.62 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.586 1.184 . . . . 15.0 108.822 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.521 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 18.8 tm0? -106.37 82.46 1.74 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.8 -1.556 . . . . 15.0 106.8 -177.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 44.0 t -80.37 -84.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.199 -1.819 . . . . 15.0 109.163 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.536 ' H ' ' CD ' ' A' ' 36' ' ' PRO . 19.3 t-20 163.5 51.42 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 128.916 2.886 . . . . 15.0 114.445 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.536 ' CD ' ' H ' ' A' ' 35' ' ' ASN . 96.0 Cg_endo -85.98 55.61 3.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 N-CA-C 108.669 -1.32 . . . . 15.0 108.669 157.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 66.72 -33.87 0.21 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.195 2.198 . . . . 15.0 114.858 -168.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.0 m -127.08 160.5 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.894 1.677 . . . . 15.0 111.966 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 33' ' ' GLN . . . -82.72 153.28 31.2 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 109.846 -1.302 . . . . 15.0 109.846 170.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -117.6 118.3 31.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.593 0.711 . . . . 15.0 110.774 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 62' ' ' LYS . 8.7 tp10 -111.1 110.1 20.48 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.9 -1.518 . . . . 15.0 106.9 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.3 ttp -135.28 136.34 41.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.087 -1.415 . . . . 15.0 109.934 -174.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 29' ' ' PHE . . . -172.73 177.23 45.38 Favored Glycine 0 N--CA 1.472 1.1 0 CA-C-N 114.7 -1.136 . . . . 15.0 112.921 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -116.16 145.69 42.88 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.74 1.257 . . . . 15.0 113.749 -171.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -117.32 118.49 32.4 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 112.031 -2.349 . . . . 15.0 109.478 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.469 ' HE1' ' HB1' ' A' ' 54' ' ' ALA . 42.0 t90 -129.45 152.41 49.02 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.41 -1.268 . . . . 15.0 110.47 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.9 tp -177.26 -46.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 125.188 1.555 . . . . 15.0 110.622 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.42 95.87 0.27 Allowed Glycine 0 N--CA 1.477 1.389 0 C-N-CA 124.948 1.261 . . . . 15.0 113.051 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.5 ptt-85 -69.03 79.76 0.32 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.62 1.2 . . . . 15.0 113.165 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -118.2 138.33 25.48 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 113.7 -1.591 . . . . 15.0 113.094 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.98 134.93 22.32 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.68 2.254 . . . . 15.0 110.787 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 0.3 OUTLIER 56.05 94.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.275 1.43 . . . . 15.0 112.234 -174.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 85' ' ' ARG . 99.1 mttt 65.96 150.49 0.05 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.869 1.667 . . . . 15.0 112.684 -172.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB1' ' HE1' ' A' ' 46' ' ' TRP . . . -174.96 -20.1 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 116.087 1.884 . . . . 15.0 116.087 -157.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.79 158.75 21.46 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.87 1.268 . . . . 15.0 113.566 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 84' ' ' TRP . . . -121.41 148.33 17.35 Favored Glycine 0 N--CA 1.475 1.298 0 CA-C-N 113.997 -1.456 . . . . 15.0 110.498 169.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.25 131.97 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.446 0.641 . . . . 15.0 110.74 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -117.72 127.77 54.24 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.649 -1.16 . . . . 15.0 110.091 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.49 117.07 20.69 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.996 -1.911 . . . . 15.0 111.415 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.536 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 36.3 p -120.44 145.94 46.72 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.111 -1.404 . . . . 15.0 111.91 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.09 115.82 27.92 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 113.86 -1.518 . . . . 15.0 107.583 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 26.4 pttm -108.32 136.02 48.65 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 113.86 -1.518 . . . . 15.0 113.298 -172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.714 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 20.0 tp -128.99 135.9 49.59 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 113.599 -1.637 . . . . 15.0 108.812 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.04 137.56 11.58 Favored Glycine 0 N--CA 1.478 1.443 0 O-C-N 125.366 1.666 . . . . 15.0 110.03 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.61 110.01 47.49 Favored Pre-proline 0 N--CA 1.477 0.882 0 N-CA-C 113.64 0.978 . . . . 15.0 113.64 177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.99 92.51 0.8 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.483 2.122 . . . . 15.0 109.893 172.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -46.59 -44.88 18.5 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.208 -1.36 . . . . 15.0 114.28 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.8 tp -172.01 157.36 4.36 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.175 1.39 . . . . 15.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.73 -91.31 0.5 Allowed Glycine 0 N--CA 1.476 1.327 0 CA-C-N 114.794 -1.093 . . . . 15.0 111.028 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -158.9 -94.6 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.42 0.688 . . . . 15.0 109.661 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -155.97 94.53 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.052 0.941 . . . . 15.0 109.369 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -159.65 -58.09 0.06 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.81 -1.541 . . . . 15.0 110.824 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.74 122.64 47.04 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.619 0.768 . . . . 15.0 111.1 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.427 ' HB2' ' HG3' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -125.37 106.64 9.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.964 -1.471 . . . . 15.0 111.088 -179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.8 tt -104.74 107.17 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.089 -0.96 . . . . 15.0 110.127 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.714 ' HB3' ' O ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -168.78 -171.9 1.49 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 112.466 -2.152 . . . . 15.0 111.553 -178.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.0 p -119.21 154.05 33.99 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.092 0.949 . . . . 15.0 112.894 -163.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -128.4 140.41 51.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.868 -1.514 . . . . 15.0 112.704 171.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tt -134.92 141.53 46.32 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.611 -1.177 . . . . 15.0 109.563 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 60' ' ' THR . . . -173.7 -143.0 4.12 Favored Glycine 0 N--CA 1.475 1.292 0 CA-C-N 114.92 -1.037 . . . . 15.0 111.838 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.37 156.07 27.3 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 114.429 -0.885 . . . . 15.0 113.617 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -113.27 138.15 50.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.284 -1.458 . . . . 15.0 112.089 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.597 HG22 HG12 ' A' ' 104' ' ' VAL . 31.4 t -118.63 134.17 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.212 -1.774 . . . . 15.0 106.212 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.4 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -113.97 141.66 47.12 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.919 -0.582 . . . . 15.0 112.235 -174.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 53' ' ' LYS . 47.5 mtt-85 -111.12 102.99 11.39 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.164 1.172 . . . . 15.0 114.164 -175.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -124.3 144.62 49.89 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 113.082 -1.872 . . . . 15.0 110.606 171.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 52' ' ' ARG . 22.2 t70 -58.18 147.34 30.57 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.636 1.347 . . . . 15.0 114.636 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.8 p -107.12 137.41 45.24 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 113.85 -1.523 . . . . 15.0 110.837 171.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m 61.91 144.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.318 1.847 . . . . 15.0 115.275 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -175.59 -46.02 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.346 -1.297 . . . . 15.0 112.345 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -60.94 142.82 56.11 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.489 0.716 . . . . 15.0 111.921 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -113.6 157.56 21.95 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.08 -1.418 . . . . 15.0 112.194 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.81 -97.13 0.45 Allowed Glycine 0 N--CA 1.477 1.424 0 O-C-N 124.655 1.222 . . . . 15.0 111.436 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -128.45 154.67 45.83 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 124.355 0.68 . . . . 15.0 110.415 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -121.06 146.44 17.41 Favored Glycine 0 N--CA 1.477 1.367 0 O-C-N 124.173 0.92 . . . . 15.0 112.475 -169.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -120.29 -84.5 0.66 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.962 -1.119 . . . . 15.0 112.479 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.2 tp -122.82 141.53 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.288 0.635 . . . . 15.0 111.952 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 m -65.4 88.88 0.09 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.617 -1.174 . . . . 15.0 111.132 172.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.46 -39.54 61.23 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.67 2.1 . . . . 15.0 116.67 -176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 56.25 163.81 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 115.202 1.556 . . . . 15.0 115.202 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -124.78 90.61 3.28 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.784 -1.098 . . . . 15.0 111.577 173.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.91 92.69 3.52 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.064 -1.425 . . . . 15.0 110.69 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -130.44 134.17 46.89 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.466 -1.243 . . . . 15.0 112.905 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.597 HG12 HG22 ' A' ' 83' ' ' VAL . 16.7 m -129.85 141.75 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 113.005 -1.907 . . . . 15.0 110.433 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.6 m -135.0 107.78 10.51 Favored Pre-proline 0 N--CA 1.477 0.925 0 CA-C-N 115.477 -0.783 . . . . 15.0 113.037 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -65.39 139.19 58.41 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 123.129 2.553 . . . . 15.0 112.561 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.91 139.62 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 113.784 -1.553 . . . . 15.0 111.968 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -126.57 137.29 53.32 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.516 -1.22 . . . . 15.0 110.98 175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 130' ' ' TYR . . . -137.6 137.44 38.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.228 -0.897 . . . . 15.0 111.864 176.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.86 138.0 10.0 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 115.43 -0.805 . . . . 15.0 112.329 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 170.41 -148.76 11.85 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-O 121.749 0.638 . . . . 15.0 114.582 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.7 p -124.49 131.47 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.513 1.149 . . . . 15.0 111.94 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 9.8 pt-20 -112.49 121.01 43.59 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.975 -1.921 . . . . 15.0 110.229 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -113.57 137.12 52.02 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.305 -1.316 . . . . 15.0 110.734 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.29 136.2 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 113.213 -1.812 . . . . 15.0 109.102 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.5 tp -63.24 142.97 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 114.441 -1.254 . . . . 15.0 112.424 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -90.42 -91.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.255 -1.339 . . . . 15.0 109.758 168.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -118.84 114.47 22.68 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.033 0.533 . . . . 15.0 111.872 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -169.34 172.91 6.9 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.085 1.754 . . . . 15.0 110.276 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 16.9 tt -53.79 124.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.874 0.87 . . . . 15.0 110.918 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.4 m 56.35 74.83 0.64 Allowed Pre-proline 0 N--CA 1.483 1.185 0 CA-C-N 113.738 -1.573 . . . . 15.0 110.091 -170.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.07 72.82 5.71 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.088 2.525 . . . . 15.0 112.744 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 149' ' ' ARG . 6.1 pt-20 -163.55 30.57 0.09 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.177 -1.829 . . . . 15.0 113.145 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 17.5 pt -116.64 136.17 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.251 -0.905 . . . . 15.0 113.438 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -122.93 140.61 52.81 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.021 -1.9 . . . . 15.0 111.654 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.6 t -125.14 116.76 22.55 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.056 -1.884 . . . . 15.0 109.763 175.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.49 HH12 ' HA3' ' A' ' 31' ' ' GLY . 97.9 mtt180 -115.69 108.18 16.04 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.453 -1.703 . . . . 15.0 110.475 -174.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.64 110.88 19.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.666 1.222 . . . . 15.0 111.585 -177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.76 150.18 39.7 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.54 -2.118 . . . . 15.0 112.07 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 25.2 p90 -97.21 128.06 43.74 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.3 -1.0 . . . . 15.0 108.3 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.18 123.83 48.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.264 -1.334 . . . . 15.0 111.598 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.537 ' HE1' ' HB3' ' A' ' 136' ' ' ALA . 16.7 t90 -126.38 146.59 50.0 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 112.501 -2.136 . . . . 15.0 110.868 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.594 HG23 ' H ' ' A' ' 134' ' ' ASN . 3.6 t -164.49 -86.1 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.582 -1.644 . . . . 15.0 110.762 -171.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.594 ' H ' HG23 ' A' ' 133' ' ' THR . 11.8 m-20 -42.3 138.1 1.81 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.461 1.504 . . . . 15.0 112.674 172.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -46.24 102.28 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.328 1.451 . . . . 15.0 114.858 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.537 ' HB3' ' HE1' ' A' ' 132' ' ' TRP . . . -148.18 -47.47 0.16 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 113.293 -1.776 . . . . 15.0 113.298 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 27.7 t 51.57 40.93 28.17 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 114.787 1.403 . . . . 15.0 114.787 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -151.9 -77.74 0.12 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.667 -1.151 . . . . 15.0 109.697 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -123.21 158.21 31.34 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.412 0.685 . . . . 15.0 110.267 173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -117.5 -148.81 8.8 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 114.112 -1.404 . . . . 15.0 110.619 176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 98.8 mtp -117.58 135.14 54.17 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.508 -0.846 . . . . 15.0 109.956 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.76 100.87 11.18 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.845 0.831 . . . . 15.0 111.757 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 61.2 m -93.11 125.2 37.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 112.682 -2.054 . . . . 15.0 109.949 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.67 126.87 53.84 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 112.514 -2.13 . . . . 15.0 109.096 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 12' ' ' LYS . . . -115.17 110.89 2.37 Favored Glycine 0 N--CA 1.469 0.865 0 CA-C-N 112.486 -2.143 . . . . 15.0 110.423 -176.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.2 m -100.92 127.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 113.95 -1.125 . . . . 15.0 108.731 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 77.6 p -148.05 154.1 39.81 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.38 -1.736 . . . . 15.0 113.032 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -116.4 142.86 46.31 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.093 -1.412 . . . . 15.0 110.892 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 33.6 ttp-105 -70.13 126.14 28.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 113.452 -1.704 . . . . 15.0 109.618 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -78.98 77.23 5.45 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 113.63 -1.623 . . . . 15.0 110.013 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -47.7 -35.66 11.98 Favored Glycine 0 N--CA 1.482 1.763 0 CA-C-N 112.963 -1.926 . . . . 15.0 114.995 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 61.46 136.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.809 2.044 . . . . 15.0 114.273 174.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -38.07 -62.97 0.97 Allowed Glycine 0 N--CA 1.485 1.913 0 C-N-CA 125.819 1.676 . . . . 15.0 113.005 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -126.78 91.96 3.45 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.584 -0.808 . . . . 15.0 109.653 161.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.66 88.37 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.876 1.322 . . . . 15.0 112.598 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.273 0 CA-C-N 113.606 -1.634 . . . . 15.0 114.216 179.199 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 114.801 1.408 . . . . 15.0 114.801 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.87 -46.12 5.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.046 2.498 . . . . 15.0 113.19 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.2 tttm 61.63 -58.59 0.11 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 128.18 2.592 . . . . 15.0 116.56 170.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.42 ' HA ' HG22 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -168.82 74.62 0.1 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.894 2.078 . . . . 15.0 109.277 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -55.27 -35.8 65.41 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 112.429 -2.169 . . . . 15.0 111.568 -176.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 33' ' ' GLN . 29.5 m -153.58 142.95 21.59 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.09 1.756 . . . . 15.0 108.499 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -101.23 130.49 47.36 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.064 -0.971 . . . . 15.0 108.672 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -125.2 105.86 9.45 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.558 -1.201 . . . . 15.0 111.474 -166.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.566 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.0 m -123.24 128.97 50.74 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.421 0.451 . . . . 15.0 110.046 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 147' ' ' SER . . . -137.48 151.17 21.06 Favored Glycine 0 N--CA 1.476 1.309 0 CA-C-N 114.995 -1.002 . . . . 15.0 115.447 -173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.01 124.2 47.57 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.382 -1.409 . . . . 15.0 108.67 170.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -139.37 154.42 47.85 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.351 1.241 . . . . 15.0 114.351 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.2 161.76 20.52 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.339 -1.755 . . . . 15.0 111.949 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.62 96.72 0.59 Allowed Glycine 0 N--CA 1.476 1.362 0 N-CA-C 110.183 -1.167 . . . . 15.0 110.183 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.414 ' CZ3' ' HA ' ' A' ' 17' ' ' GLN . 50.2 t90 -102.63 123.1 45.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.767 0.794 . . . . 15.0 111.508 -173.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 p -104.02 133.57 48.74 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.11 -0.95 . . . . 15.0 112.49 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.414 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 42.8 tt0 -64.12 -55.69 20.12 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 113.823 -1.535 . . . . 15.0 113.681 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.32 86.86 2.63 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.169 0.985 . . . . 15.0 111.689 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.9 p -137.41 134.1 35.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.712 -2.04 . . . . 15.0 111.968 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -54.54 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.048 1.499 . . . . 15.0 115.048 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -129.63 95.21 3.93 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.531 0.732 . . . . 15.0 110.293 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -122.76 149.16 44.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.58 -1.191 . . . . 15.0 113.761 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -74.31 154.07 39.07 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.849 -1.523 . . . . 15.0 110.314 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.63 -33.54 76.17 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.482 1.29 . . . . 15.0 114.482 173.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.74 140.38 8.61 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.519 1.057 . . . . 15.0 111.161 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' O ' ' HA ' ' A' ' 45' ' ' ASP . . . -141.6 86.47 2.01 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.613 -0.794 . . . . 15.0 110.136 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.15 92.93 0.59 Allowed Glycine 0 N--CA 1.474 1.19 0 CA-C-N 113.664 -1.607 . . . . 15.0 111.311 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -117.99 121.03 39.59 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.071 0.512 . . . . 15.0 109.866 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 42' ' ' MET 0.293 5.2 t80 -161.63 179.81 7.87 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.332 -1.758 . . . . 15.0 111.625 175.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 9' ' ' THR . . . -122.83 -178.55 15.55 Favored Glycine 0 N--CA 1.476 1.323 0 CA-C-N 115.044 -0.98 . . . . 15.0 112.091 -170.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.5 -155.04 12.97 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-N 113.071 -1.565 . . . . 15.0 112.722 174.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -126.28 138.81 53.64 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 112.597 -1.802 . . . . 15.0 112.976 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.555 ' HB3' ' HB ' ' A' ' 6' ' ' THR . 1.1 tm0? -115.73 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.098 -1.41 . . . . 15.0 107.982 167.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 4' ' ' ASP . 43.8 t -107.47 -29.74 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 111.095 -2.775 . . . . 15.0 110.412 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t30 48.6 54.48 16.07 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 116.954 2.205 . . . . 15.0 116.954 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -68.65 -22.42 37.76 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.097 1.865 . . . . 15.0 112.077 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -166.67 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 128.95 2.9 . . . . 15.0 109.292 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.1 m -135.33 160.49 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.255 1.422 . . . . 15.0 112.246 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 148.12 26.92 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 108.785 -1.726 . . . . 15.0 108.785 161.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -117.21 126.29 52.53 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.439 0.296 . . . . 15.0 111.399 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.578 ' HG3' HH22 ' A' ' 127' ' ' ARG . 4.1 pm0 -142.33 133.56 26.19 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.058 0.849 . . . . 15.0 113.123 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.641 ' O ' ' HB3' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -123.5 137.11 54.84 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 114.271 -1.331 . . . . 15.0 108.233 174.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -117.52 129.81 8.5 Favored Glycine 0 N--CA 1.48 1.582 0 O-C-N 126.072 2.108 . . . . 15.0 110.745 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.423 ' N ' ' HB2' ' A' ' 29' ' ' PHE . 6.8 t80 -104.75 112.68 25.88 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.493 0.663 . . . . 15.0 109.602 -176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 15.0 t70 -106.74 118.4 36.58 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.122 -1.399 . . . . 15.0 110.005 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -120.54 110.05 15.99 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 113.613 -1.63 . . . . 15.0 111.06 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.4 -31.08 71.71 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 113.108 -1.86 . . . . 15.0 112.84 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.28 -147.54 16.57 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 124.516 1.055 . . . . 15.0 111.717 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.8 ptt-85 -76.75 67.2 2.8 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 122.808 1.29 . . . . 15.0 113.672 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 14.0 tpt -118.2 102.12 50.87 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-N 114.386 -1.279 . . . . 15.0 112.277 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.63 69.95 5.11 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.915 2.41 . . . . 15.0 111.615 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.9 ttt85 -175.48 -97.36 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.762 2.025 . . . . 15.0 107.376 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -114.97 93.25 4.23 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.531 0.733 . . . . 15.0 111.231 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -111.13 -54.36 2.61 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.062 -2.335 . . . . 15.0 114.129 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -115.46 101.97 9.38 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.851 0.834 . . . . 15.0 112.467 -171.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 84' ' ' TRP . . . -119.26 142.19 16.38 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 112.226 -2.261 . . . . 15.0 111.141 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.71 135.16 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 114.185 -1.008 . . . . 15.0 111.164 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -109.8 116.63 32.02 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.912 -1.144 . . . . 15.0 107.912 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.6 111.19 21.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 112.82 -1.991 . . . . 15.0 109.095 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.7 p -130.21 147.41 51.93 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.453 -1.703 . . . . 15.0 113.797 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.28 134.21 47.88 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.422 -2.172 . . . . 15.0 109.232 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.59 ' HD3' HH21 ' A' ' 127' ' ' ARG . 22.0 ttpp -107.2 114.15 28.02 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.201 -1.363 . . . . 15.0 111.421 -172.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.91 142.81 46.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.084 -1.871 . . . . 15.0 109.755 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.88 -156.34 23.7 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 115.05 -0.977 . . . . 15.0 111.829 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.63 159.11 9.92 Favored Pre-proline 0 N--CA 1.481 1.116 0 N-CA-C 114.397 1.258 . . . . 15.0 114.397 -168.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -61.62 104.71 0.32 Allowed 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 123.264 2.643 . . . . 15.0 111.487 164.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -146.16 148.79 32.92 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.765 -2.016 . . . . 15.0 106.594 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 mp 70.29 -47.2 0.62 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 126.455 1.902 . . . . 15.0 111.548 -164.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.64 125.06 5.99 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.353 -1.099 . . . . 15.0 110.353 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.4 m -64.51 -57.28 9.63 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.58 0.752 . . . . 15.0 109.558 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -133.93 82.12 1.96 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.223 -0.899 . . . . 15.0 108.586 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -169.35 -75.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 112.979 -1.919 . . . . 15.0 108.944 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.525 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . 1.4 pt? -123.46 132.0 53.8 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.305 1.003 . . . . 15.0 110.847 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.92 135.56 54.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.436 -1.711 . . . . 15.0 108.757 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.7 tt -91.41 116.74 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 115.105 -0.952 . . . . 15.0 110.015 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.511 ' CD1' ' HG2' ' A' ' 62' ' ' LYS . 26.9 m-85 -135.96 138.82 42.71 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.25 -1.796 . . . . 15.0 115.06 -175.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 55.4 p -113.08 143.3 44.57 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 112.083 -2.326 . . . . 15.0 109.598 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.501 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 29.0 mtm105 -115.09 123.22 48.43 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.832 -1.531 . . . . 15.0 109.735 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 tt -119.65 122.92 42.61 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.51 -1.223 . . . . 15.0 109.315 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.3 -130.83 2.22 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 110.102 -1.199 . . . . 15.0 110.102 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 105' ' ' SER . . . 170.98 -166.44 39.63 Favored Glycine 0 N--CA 1.477 1.431 0 O-C-N 125.171 1.16 . . . . 15.0 114.999 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 57.7 ttm -119.4 129.68 54.92 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.175 -1.012 . . . . 15.0 112.146 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -122.59 135.8 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 113.521 -1.672 . . . . 15.0 108.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.424 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 9.2 p90 -108.0 119.18 38.73 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.119 -0.946 . . . . 15.0 109.778 172.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -121.18 -48.38 2.22 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 113.599 -1.637 . . . . 15.0 114.988 -170.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 60.5 -78.62 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.104 1.761 . . . . 15.0 114.911 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -173.9 108.77 0.14 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.937 1.295 . . . . 15.0 112.192 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.4 m -112.97 95.88 5.64 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 114.819 -1.082 . . . . 15.0 109.729 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -142.8 158.31 43.76 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.739 -1.119 . . . . 15.0 112.29 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.51 95.05 6.46 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.184 -0.917 . . . . 15.0 111.658 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -66.06 85.94 0.09 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 114.621 -1.172 . . . . 15.0 113.004 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -177.33 -55.99 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 112.472 -2.149 . . . . 15.0 110.296 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.34 -49.08 0.91 Allowed Glycine 0 CA--C 1.537 1.454 0 O-C-N 124.33 1.019 . . . . 15.0 110.889 -172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -66.85 156.27 36.1 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.81 0.67 . . . . 15.0 112.81 172.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.59 -97.47 0.62 Allowed Glycine 0 N--CA 1.474 1.215 0 CA-C-N 114.089 -1.414 . . . . 15.0 110.552 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.6 t80 47.95 86.7 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.375 1.47 . . . . 15.0 112.667 -176.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 tp -161.85 143.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 113.77 -1.559 . . . . 15.0 110.182 -175.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.0 t 63.44 172.98 0.16 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.798 1.639 . . . . 15.0 112.982 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.63 152.09 36.71 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.58 1.152 . . . . 15.0 111.12 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.21 87.44 0.11 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 122.7 1.238 . . . . 15.0 111.799 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.1 90.15 0.09 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.198 -1.819 . . . . 15.0 113.248 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.02 144.35 56.22 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 113.336 -1.756 . . . . 15.0 112.129 171.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -71.49 140.2 49.88 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.283 -0.871 . . . . 15.0 111.912 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.26 -27.32 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.008 -0.996 . . . . 15.0 112.814 169.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.497 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 4.7 t 32.84 70.93 0.72 Allowed Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 127.328 2.251 . . . . 15.0 114.533 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.07 95.04 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.678 2.919 . . . . 15.0 114.26 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.566 HG11 HE21 ' A' ' 131' ' ' GLN . 70.2 t -123.96 134.37 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 114.508 -1.223 . . . . 15.0 109.981 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -122.91 123.35 40.76 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.245 -1.798 . . . . 15.0 109.626 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -120.99 136.75 54.91 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.232 0.613 . . . . 15.0 110.878 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -134.67 135.3 7.86 Favored Glycine 0 N--CA 1.478 1.453 0 CA-C-N 115.452 -0.794 . . . . 15.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.47 -146.84 8.19 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 124.362 0.683 . . . . 15.0 113.605 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.76 154.28 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.159 -1.021 . . . . 15.0 113.43 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -119.57 143.64 47.52 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.902 -1.499 . . . . 15.0 110.403 167.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.525 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 46.0 m-85 -117.0 139.1 51.08 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.527 1.142 . . . . 15.0 111.892 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.95 104.0 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 114.266 -1.334 . . . . 15.0 111.275 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . 0.265 18.1 tt -79.95 84.84 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-O 123.076 1.417 . . . . 15.0 112.97 -175.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -115.68 102.54 9.84 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 112.677 -2.056 . . . . 15.0 109.5 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.401 ' HB3' ' H ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -170.77 -83.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.617 -1.629 . . . . 15.0 106.804 176.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.401 ' H ' ' HB3' ' A' ' 118' ' ' ARG . 35.6 mtt180 -69.17 155.81 39.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.392 0.677 . . . . 15.0 111.572 166.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.527 HD13 ' H ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.62 97.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 114.359 -1.291 . . . . 15.0 113.534 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.2 p -110.0 135.94 20.46 Favored Pre-proline 0 N--CA 1.479 1.018 0 CA-C-N 113.83 -1.532 . . . . 15.0 111.642 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.92 73.31 4.31 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.788 2.325 . . . . 15.0 114.053 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 50.11 39.39 19.23 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.899 1.679 . . . . 15.0 114.636 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.463 HD11 ' HB ' ' A' ' 146' ' ' VAL . 3.9 tt -123.4 142.23 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.663 -1.153 . . . . 15.0 113.748 -164.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -120.89 157.82 29.01 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.017 -1.902 . . . . 15.0 110.338 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 32.7 p -106.41 132.23 52.68 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.296 -0.865 . . . . 15.0 111.046 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.59 HH21 ' HD3' ' A' ' 62' ' ' LYS . 19.4 ttm180 -112.85 130.53 56.06 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.003 -0.999 . . . . 15.0 109.824 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.62 111.03 8.5 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.9 1.375 . . . . 15.0 111.757 173.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.37 150.21 52.2 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 114.368 -1.287 . . . . 15.0 112.624 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 57.1 t80 -97.27 116.32 29.26 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 122.282 1.039 . . . . 15.0 108.376 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.566 HE21 HG11 ' A' ' 107' ' ' VAL . 62.5 tt0 -96.59 108.75 21.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 111.971 -2.377 . . . . 15.0 110.251 -173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 46.4 t-105 -112.03 146.51 37.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.92 -1.945 . . . . 15.0 112.296 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 15.3 t -171.59 156.54 4.43 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 112.762 -2.017 . . . . 15.0 109.896 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -69.22 81.14 0.35 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.51 1.3 . . . . 15.0 114.51 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -114.22 169.71 8.82 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 113.851 -1.522 . . . . 15.0 112.474 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.61 44.46 2.47 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.322 1.049 . . . . 15.0 112.675 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.9 m -170.84 110.28 0.35 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.833 1.253 . . . . 15.0 113.263 -176.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.4 t0 63.98 -36.96 0.18 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 128.153 2.581 . . . . 15.0 115.637 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 54.34 82.13 0.09 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.647 2.379 . . . . 15.0 115.227 170.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 117.33 130.76 4.43 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 111.426 -2.625 . . . . 15.0 111.401 -177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -119.19 148.24 43.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.048 -1.576 . . . . 15.0 109.983 178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.8 97.42 10.4 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.681 -1.229 . . . . 15.0 107.681 174.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.6 t -94.96 125.13 39.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.211 -1.359 . . . . 15.0 107.947 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.2 pp -156.54 150.08 24.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.944 -1.934 . . . . 15.0 111.818 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.02 -162.6 29.64 Favored Glycine 0 N--CA 1.474 1.169 0 CA-C-N 114.094 -1.412 . . . . 15.0 113.707 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.463 ' HB ' HD11 ' A' ' 124' ' ' ILE . 11.0 m -119.38 127.68 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 112.449 -1.876 . . . . 15.0 110.64 -176.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.481 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 23.1 t -130.01 132.1 46.12 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.857 -1.519 . . . . 15.0 110.507 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -120.56 154.99 34.61 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.643 0.735 . . . . 15.0 111.793 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -115.48 135.18 54.36 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.383 -1.281 . . . . 15.0 112.119 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 6' ' ' THR . 90.9 m-85 61.62 156.86 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 113.355 -1.748 . . . . 15.0 115.373 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.08 89.69 1.52 Allowed Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.175 -1.375 . . . . 15.0 111.661 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -69.07 82.12 0.32 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.7 0.762 . . . . 15.0 112.861 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.55 133.88 1.82 Allowed Glycine 0 N--CA 1.477 1.412 0 CA-C-N 114.265 -1.334 . . . . 15.0 112.841 173.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -66.63 -23.11 66.12 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.487 1.662 . . . . 15.0 115.487 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -7.68 88.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 118.278 2.696 . . . . 15.0 118.278 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.242 0 CA-C-N 113.776 -1.556 . . . . 15.0 113.86 -179.41 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 115.564 1.69 . . . . 15.0 115.564 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.71 -46.37 1.81 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.062 2.508 . . . . 15.0 114.265 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 36' ' ' PRO . 10.0 mmpt? -132.98 140.14 47.63 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.437 1.095 . . . . 15.0 109.263 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 10.7 t70 -173.18 100.03 0.12 Allowed 'General case' 0 N--CA 1.481 1.085 0 O-C-N 124.485 1.116 . . . . 15.0 110.178 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 57.5 49.8 12.21 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.838 1.255 . . . . 15.0 113.003 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m -98.02 124.63 42.61 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.422 -1.717 . . . . 15.0 108.263 -172.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.611 ' O ' ' HA ' ' A' ' 149' ' ' ARG . 21.4 m0 -97.86 130.42 44.76 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.389 -1.278 . . . . 15.0 111.027 -177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.405 ' HB3' ' HB2' ' A' ' 147' ' ' SER . 97.6 m-85 -122.51 86.05 2.52 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.935 -1.939 . . . . 15.0 108.41 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -108.82 123.6 49.3 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.103 -1.408 . . . . 15.0 110.058 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.83 -144.52 4.14 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 125.019 1.449 . . . . 15.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.68 148.07 47.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -130.91 140.17 50.17 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 125.007 1.442 . . . . 15.0 112.19 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.1 tp -114.13 133.53 55.5 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.031 -1.441 . . . . 15.0 108.763 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.65 112.49 3.96 Favored Glycine 0 N--CA 1.475 1.241 0 CA-C-N 113.535 -1.666 . . . . 15.0 110.138 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -121.82 145.48 48.03 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.788 0.835 . . . . 15.0 110.833 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.7 p -130.32 145.48 51.78 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.308 -0.86 . . . . 15.0 111.259 173.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -79.94 79.34 6.48 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.055 0.931 . . . . 15.0 109.151 176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -147.17 -82.36 0.13 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 112.846 -1.979 . . . . 15.0 111.281 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -116.18 136.84 52.65 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.402 0.681 . . . . 15.0 110.575 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.5 ptt-85 -65.77 -20.88 66.43 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.306 -1.315 . . . . 15.0 114.0 169.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -117.54 95.94 5.17 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.161 0.984 . . . . 15.0 109.683 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -173.69 -69.31 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.462 1.505 . . . . 15.0 111.048 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 54.8 98.83 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.652 1.581 . . . . 15.0 114.726 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.04 -37.54 80.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 113.477 -1.692 . . . . 15.0 114.556 -173.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.07 87.1 0.01 OUTLIER Glycine 0 CA--C 1.542 1.757 0 N-CA-C 118.0 1.96 . . . . 15.0 118.0 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.17 89.6 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.661 1.356 . . . . 15.0 114.661 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.43 -118.67 6.12 Favored Glycine 0 N--CA 1.477 1.409 0 C-N-CA 123.936 0.779 . . . . 15.0 111.9 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.42 137.99 39.94 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.306 -0.947 . . . . 15.0 110.112 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -117.6 113.66 22.26 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.643 -1.162 . . . . 15.0 111.143 -171.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.3 101.42 1.04 Allowed Glycine 0 N--CA 1.476 1.342 0 CA-C-N 113.429 -1.714 . . . . 15.0 110.91 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -106.68 135.24 12.6 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 114.428 -0.886 . . . . 15.0 113.156 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -129.22 111.33 12.78 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.79 -1.205 . . . . 15.0 110.972 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.04 83.28 1.88 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.235 -0.893 . . . . 15.0 108.891 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 4' ' ' ASP . 59.8 t -69.26 -83.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.552 -1.658 . . . . 15.0 110.456 -176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -81.22 135.44 50.76 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 117.535 -1.221 . . . . 15.0 109.407 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 3' ' ' LYS . 72.7 Cg_endo -69.26 78.93 0.81 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.436 2.758 . . . . 15.0 112.08 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -177.05 -76.66 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.005 2.122 . . . . 15.0 108.955 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.35 135.11 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.123 0.969 . . . . 15.0 108.466 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.34 -168.13 12.45 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 113.91 -1.496 . . . . 15.0 110.794 170.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -131.74 148.23 52.56 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.788 1.032 . . . . 15.0 113.788 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HG2' ' HD3' ' A' ' 62' ' ' LYS . 70.9 mm-40 -127.26 127.21 44.02 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.239 -1.346 . . . . 15.0 110.644 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 90.9 mtp -116.64 134.45 54.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 114.158 -1.383 . . . . 15.0 110.608 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' VAL . . . -115.72 114.17 3.06 Favored Glycine 0 N--CA 1.476 1.354 0 N-CA-C 109.215 -1.554 . . . . 15.0 109.215 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -116.57 122.32 44.32 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.871 0.843 . . . . 15.0 111.561 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -137.78 142.61 40.89 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.485 -1.689 . . . . 15.0 111.397 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -165.03 129.46 2.47 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.74 0.645 . . . . 15.0 112.74 173.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.75 6.81 18.31 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 112.344 -2.207 . . . . 15.0 113.862 165.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.95 72.83 1.55 Allowed Glycine 0 N--CA 1.476 1.346 0 C-N-CA 124.599 1.095 . . . . 15.0 112.253 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -88.26 77.43 8.23 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 122.457 1.122 . . . . 15.0 112.022 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.562 ' HG2' ' HB2' ' A' ' 52' ' ' ARG . 1.7 pmm? -170.73 156.92 5.19 Favored Pre-proline 0 N--CA 1.481 1.09 0 CA-C-N 113.206 -1.816 . . . . 15.0 109.838 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.35 83.15 0.37 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.631 2.221 . . . . 15.0 111.678 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.664 HH21 ' HB2' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -169.32 145.32 3.28 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 112.68 -2.055 . . . . 15.0 107.809 -177.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.664 ' HB2' HH21 ' A' ' 52' ' ' ARG . 68.5 mttm -80.12 89.99 5.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.725 -0.671 . . . . 15.0 110.007 172.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.456 ' H ' ' NE2' ' A' ' 55' ' ' GLN . . . -133.01 56.69 1.84 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 112.542 -2.117 . . . . 15.0 110.014 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.456 ' NE2' ' H ' ' A' ' 54' ' ' ALA . 24.7 mp0 -126.74 146.64 50.15 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.028 -1.896 . . . . 15.0 109.909 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.67 148.04 17.26 Favored Glycine 0 N--CA 1.476 1.332 0 O-C-N 124.285 0.991 . . . . 15.0 113.978 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 82' ' ' MET . 12.7 p -147.29 148.26 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 112.978 -1.611 . . . . 15.0 111.239 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -121.27 126.22 49.01 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.536 1.934 . . . . 15.0 109.374 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.585 ' H ' ' HB2' ' A' ' 82' ' ' MET . 3.5 tm? -117.34 111.19 19.02 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.934 -0.395 . . . . 15.0 109.934 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 41' ' ' GLU . 13.7 t -131.9 146.32 52.04 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.42 -0.809 . . . . 15.0 112.829 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 78' ' ' ARG . . . -103.13 136.39 43.02 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.189 -0.914 . . . . 15.0 110.039 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 78' ' ' ARG . 59.6 pttt -115.83 143.56 45.23 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.914 1.45 . . . . 15.0 114.914 -171.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.4 mt -115.5 136.41 53.11 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 112.925 -1.943 . . . . 15.0 110.058 169.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.42 111.92 4.2 Favored Glycine 0 N--CA 1.48 1.571 0 O-C-N 124.744 1.277 . . . . 15.0 111.529 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 4.1 m-30 -110.69 105.0 56.89 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.933 1.293 . . . . 15.0 111.713 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.58 -145.23 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.052 2.502 . . . . 15.0 111.584 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 77.0 tttt 69.03 -68.97 0.17 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 127.487 2.315 . . . . 15.0 115.181 176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 75' ' ' ILE . 28.4 tp -60.91 99.7 0.09 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.439 1.096 . . . . 15.0 113.596 -168.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.92 -85.74 0.44 Allowed Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.827 -1.988 . . . . 15.0 109.461 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.2 t -179.1 171.36 1.36 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.406 1.482 . . . . 15.0 110.083 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -51.54 -31.09 22.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.669 1.729 . . . . 15.0 115.669 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -57.05 -29.41 63.4 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.338 1.236 . . . . 15.0 114.338 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.46 112.99 18.17 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.098 0.959 . . . . 15.0 111.423 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.54 134.26 55.05 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.08 -1.418 . . . . 15.0 109.721 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.495 HD11 ' HB3' ' A' ' 68' ' ' LEU . 4.5 mp -91.34 141.61 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 113.509 -1.678 . . . . 15.0 107.388 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -126.6 128.79 47.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.793 -1.094 . . . . 15.0 109.763 173.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.2 p -108.4 122.57 47.28 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.378 -1.283 . . . . 15.0 108.397 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.541 HH22 ' NE ' ' A' ' 127' ' ' ARG . 99.2 mtt180 -125.19 123.22 39.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.508 -2.133 . . . . 15.0 111.534 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 pp -125.44 132.09 52.77 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.908 -1.042 . . . . 15.0 112.449 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.34 -140.18 5.77 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 114.967 -1.015 . . . . 15.0 113.157 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.01 140.87 3.0 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.187 1.375 . . . . 15.0 111.8 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.603 ' HB3' ' O ' ' A' ' 57' ' ' VAL 0.364 0.4 OUTLIER -156.91 164.33 38.16 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.515 -2.168 . . . . 15.0 112.659 159.424 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 103' ' ' SER . 18.8 m -97.99 125.97 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 124.234 0.959 . . . . 15.0 110.18 -172.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 41.9 p90 -109.68 152.7 25.27 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.484 -0.78 . . . . 15.0 112.858 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -95.96 96.61 9.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.779 -1.101 . . . . 15.0 110.455 -172.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -120.58 -87.59 0.64 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.595 -1.638 . . . . 15.0 114.063 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -157.69 147.08 19.91 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.143 0.977 . . . . 15.0 110.733 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.3 t -167.1 158.71 12.41 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.069 1.348 . . . . 15.0 110.733 173.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -123.51 158.92 30.22 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.379 1.05 . . . . 15.0 111.113 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.13 150.01 52.34 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.17 -178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? 64.84 132.32 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.347 1.859 . . . . 15.0 113.248 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -119.09 -79.19 0.59 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 113.728 -1.578 . . . . 15.0 110.723 174.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -174.82 96.51 0.11 Allowed Glycine 0 N--CA 1.475 1.251 0 N-CA-C 108.954 -1.658 . . . . 15.0 108.954 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.3 t30 72.07 162.61 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.385 1.474 . . . . 15.0 111.015 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.22 87.06 0.33 Allowed Glycine 0 N--CA 1.477 1.43 0 C-N-CA 124.96 1.267 . . . . 15.0 111.397 -175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -124.74 141.76 51.88 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.307 -0.946 . . . . 15.0 111.194 -176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 98' ' ' SER . 15.8 tt -171.97 -69.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 O-C-N 125.11 1.506 . . . . 15.0 112.38 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.404 ' H ' HG23 ' A' ' 97' ' ' ILE . 57.3 p -167.59 -71.0 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.592 1.157 . . . . 15.0 112.691 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 67.0 142.75 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.575 2.35 . . . . 15.0 113.75 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.34 84.82 1.44 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.46 -1.245 . . . . 15.0 113.108 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -73.95 36.33 0.09 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.18 -1.373 . . . . 15.0 114.613 175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -155.31 147.7 23.91 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.172 1.389 . . . . 15.0 110.519 -174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.435 ' HB3' HG12 ' A' ' 83' ' ' VAL . 17.1 t -70.86 143.38 51.07 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.21 -0.905 . . . . 15.0 112.142 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.49 167.9 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 113.988 -1.46 . . . . 15.0 111.264 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m 68.14 148.53 0.12 Allowed Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 125.918 1.687 . . . . 15.0 114.368 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -61.19 142.05 95.37 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.651 2.234 . . . . 15.0 113.102 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.87 136.72 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 112.838 -1.983 . . . . 15.0 107.216 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.55 129.66 54.78 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 113.408 -1.724 . . . . 15.0 110.13 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . . . -122.65 131.54 53.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.102 -1.408 . . . . 15.0 112.061 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -114.38 99.04 0.92 Allowed Glycine 0 N--CA 1.475 1.278 0 CA-C-N 113.348 -1.751 . . . . 15.0 108.786 177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 129' ' ' GLU . . . -115.5 145.52 18.7 Favored Glycine 0 N--CA 1.476 1.314 0 O-C-N 124.79 0.936 . . . . 15.0 112.85 -174.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 127' ' ' ARG . 19.2 m -121.59 138.46 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 114.716 -0.742 . . . . 15.0 112.042 171.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -110.28 109.34 19.76 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.077 -1.874 . . . . 15.0 107.94 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -120.59 136.08 54.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 113.716 -1.584 . . . . 15.0 111.64 -176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.39 107.74 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 113.46 -1.7 . . . . 15.0 110.689 171.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 9.9 tp -113.22 65.57 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 122.837 1.303 . . . . 15.0 111.648 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.664 ' HD3' HG21 ' A' ' 121' ' ' THR . 47.9 mtt-85 -122.23 -30.79 3.95 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 117.791 2.515 . . . . 15.0 117.791 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.27 -28.89 0.11 Allowed 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 118.456 2.762 . . . . 15.0 118.456 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 47.7 mtt-85 -101.09 149.71 23.68 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.393 1.077 . . . . 15.0 112.244 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.43 ' H ' HG13 ' A' ' 120' ' ' ILE . 16.9 mt -11.78 -81.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 128.311 2.644 . . . . 15.0 113.735 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.664 HG21 ' HD3' ' A' ' 117' ' ' ARG . 67.8 p 58.49 159.61 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.407 0 C-N-CA 126.233 1.813 . . . . 15.0 115.489 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.64 161.87 33.79 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.655 2.236 . . . . 15.0 111.415 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -68.46 78.21 0.27 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.215 1.006 . . . . 15.0 112.191 -177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mm -120.94 105.35 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.595 1.158 . . . . 15.0 109.486 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.3 120.49 40.56 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.722 -1.126 . . . . 15.0 111.571 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -80.78 117.01 21.07 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.921 -1.036 . . . . 15.0 109.359 -178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.541 ' NE ' HH22 ' A' ' 78' ' ' ARG . 33.6 mtt180 -115.21 119.91 37.95 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.626 -1.17 . . . . 15.0 112.721 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.48 118.04 28.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.054 -1.43 . . . . 15.0 110.39 171.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 31.3 tt0 -120.65 132.98 55.38 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 112.727 -2.033 . . . . 15.0 111.285 -171.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 76.3 m-85 -97.4 128.22 44.02 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.302 -1.317 . . . . 15.0 110.336 171.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.717 ' HB3' ' HB2' ' A' ' 141' ' ' MET . 48.1 tt0 -109.85 108.76 19.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.432 -1.713 . . . . 15.0 109.108 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -117.93 146.58 43.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.599 -2.091 . . . . 15.0 112.066 -174.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 m -133.2 -78.16 0.48 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 114.138 -1.392 . . . . 15.0 111.791 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -173.25 -57.13 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.222 1.009 . . . . 15.0 110.973 -173.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -56.14 155.56 6.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.369 1.068 . . . . 15.0 110.287 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 139' ' ' ASN . . . 64.16 95.82 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.899 2.08 . . . . 15.0 112.611 -168.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.0 m -49.3 100.02 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.435 -1.711 . . . . 15.0 113.409 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 62.76 26.58 15.68 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 113.393 -1.73 . . . . 15.0 114.379 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.411 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 6.0 t-20 -129.61 169.13 15.43 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.272 1.029 . . . . 15.0 109.6 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -176.51 -152.8 10.01 Favored Glycine 0 N--CA 1.477 1.414 0 CA-C-O 122.033 0.796 . . . . 15.0 113.174 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.717 ' HB2' ' HB3' ' A' ' 131' ' ' GLN . 48.1 mtt -117.6 148.26 42.09 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 113.716 -1.242 . . . . 15.0 110.925 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.8 tp -122.03 112.32 18.11 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.98 -1.009 . . . . 15.0 110.055 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.1 m -105.86 125.09 50.58 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.69 -1.595 . . . . 15.0 107.348 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 pp -132.65 141.1 48.47 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.84 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 179.13 -162.46 29.35 Favored Glycine 0 N--CA 1.473 1.121 0 O-C-N 124.191 0.932 . . . . 15.0 113.509 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.07 140.11 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 113.606 -1.297 . . . . 15.0 109.442 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 62.5 p -115.85 138.25 51.34 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.89 1.369 . . . . 15.0 110.731 170.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -111.51 135.22 52.38 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.009 -1.45 . . . . 15.0 110.768 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 7' ' ' TRP . 45.8 ttm180 -78.86 123.93 27.72 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.544 -1.207 . . . . 15.0 108.562 171.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 7' ' ' TRP . 88.7 t80 -35.28 -74.97 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 O-C-N 125.347 1.654 . . . . 15.0 115.377 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 44.97 -121.28 4.33 Favored Glycine 0 N--CA 1.48 1.603 0 C-N-CA 125.137 1.351 . . . . 15.0 112.918 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -72.21 88.8 1.15 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.105 -1.048 . . . . 15.0 111.271 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.15 -146.42 0.14 Allowed Glycine 0 CA--C 1.539 1.586 0 CA-C-N 113.142 -1.844 . . . . 15.0 112.747 168.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -69.93 84.07 0.49 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.411 1.1 . . . . 15.0 113.424 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.81 84.51 4.12 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.15 -1.387 . . . . 15.0 111.3 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.261 0 CA-C-N 113.701 -1.591 . . . . 15.0 114.19 -179.771 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.9 mtt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 114.823 1.416 . . . . 15.0 114.823 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.91 146.14 29.2 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.938 2.425 . . . . 15.0 112.138 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' HD3' ' HD3' ' A' ' 36' ' ' PRO . 2.3 ttmp? 64.31 164.11 0.13 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.169 1.788 . . . . 15.0 112.61 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.63 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 41.3 m-20 68.88 86.35 0.13 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 126.209 1.804 . . . . 15.0 112.505 176.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 66.06 41.99 3.41 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 111.759 -2.473 . . . . 15.0 113.501 -174.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 p -98.19 140.07 33.04 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.785 -1.098 . . . . 15.0 112.907 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -110.35 131.08 55.37 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 112.766 -2.015 . . . . 15.0 110.184 -171.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.47 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 5.5 m-85 -124.1 131.28 53.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.617 -1.629 . . . . 15.0 108.978 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -126.96 133.43 50.6 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.496 0.718 . . . . 15.0 111.623 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 147' ' ' SER . . . -172.94 -146.23 5.34 Favored Glycine 0 N--CA 1.476 1.306 0 CA-C-N 115.191 -0.913 . . . . 15.0 113.191 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.42 150.1 51.79 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.423 0.898 . . . . 15.0 113.423 -173.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.32 142.91 50.46 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.454 1.096 . . . . 15.0 112.727 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.6 tp -114.05 140.4 48.49 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.199 -1.819 . . . . 15.0 108.8 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -114.4 127.41 7.73 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-N 114.361 -1.291 . . . . 15.0 111.153 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 142' ' ' LEU . 10.2 t-105 -118.33 141.15 48.82 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.463 -0.868 . . . . 15.0 110.948 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.5 t -108.73 105.2 14.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.528 -1.214 . . . . 15.0 109.818 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -52.79 -44.11 66.35 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.975 -1.466 . . . . 15.0 111.753 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -65.66 -49.15 69.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.111 0.964 . . . . 15.0 113.297 173.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -103.2 83.65 2.23 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.747 1.26 . . . . 15.0 112.045 -172.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.469 ' HG2' ' HG3' ' A' ' 21' ' ' GLU . 53.8 ttt85 -5.98 -81.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.04 2.936 . . . . 15.0 117.614 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 40.6 mt-10 -125.4 92.01 3.53 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.89 0.852 . . . . 15.0 111.802 -173.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -114.18 91.63 3.69 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 114.457 -1.247 . . . . 15.0 112.918 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -72.7 87.94 1.27 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.911 -1.495 . . . . 15.0 111.573 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -106.37 -41.41 5.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 112.993 -1.912 . . . . 15.0 112.848 170.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.62 -151.4 18.42 Favored Glycine 0 N--CA 1.476 1.308 0 O-C-N 123.905 0.753 . . . . 15.0 112.1 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -128.33 148.49 50.67 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.755 -1.223 . . . . 15.0 111.299 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.54 -166.64 16.29 Favored Glycine 0 N--CA 1.479 1.532 0 O-C-N 124.776 1.297 . . . . 15.0 110.556 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.5 130.01 49.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.501 0.667 . . . . 15.0 111.44 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.01 113.37 19.48 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.192 -1.367 . . . . 15.0 111.722 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.72 112.0 3.95 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 112.732 -2.031 . . . . 15.0 110.198 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -107.84 142.88 15.95 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 110.702 -0.959 . . . . 15.0 110.702 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 40' ' ' PHE . 11.4 t80 -141.11 132.67 27.04 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.104 -0.548 . . . . 15.0 111.124 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -121.41 94.1 4.22 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.966 0.888 . . . . 15.0 110.617 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 4' ' ' ASP . 7.1 p -68.31 -63.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.483 -2.144 . . . . 15.0 111.688 174.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -143.82 144.85 28.46 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.43 1.492 . . . . 15.0 109.618 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD3' ' HD3' ' A' ' 3' ' ' LYS . 73.4 Cg_endo -67.98 89.5 0.37 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.488 2.792 . . . . 15.0 111.768 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 t80 172.7 -48.21 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 112.51 -2.132 . . . . 15.0 109.058 -169.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LYS . 48.3 t -131.52 124.02 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.154 0.982 . . . . 15.0 108.83 175.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.37 148.23 16.72 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 113.909 -1.496 . . . . 15.0 110.924 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 78.5 m-85 -112.78 136.66 52.15 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.1 0.778 . . . . 15.0 113.1 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -132.54 114.21 14.0 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.843 -1.526 . . . . 15.0 112.034 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.4 ttp -104.08 128.66 51.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.686 -1.597 . . . . 15.0 109.062 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.25 114.16 3.9 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 113.88 -1.509 . . . . 15.0 109.751 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.66 109.44 18.6 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.407 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -121.2 124.08 43.81 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.559 -1.2 . . . . 15.0 111.361 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -125.11 145.18 50.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.753 -1.567 . . . . 15.0 109.783 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 42.1 tp -68.39 99.59 0.96 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.775 -0.648 . . . . 15.0 112.359 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.05 65.62 0.14 Allowed Glycine 0 CA--C 1.541 1.69 0 CA-C-N 114.044 -1.435 . . . . 15.0 113.437 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -169.43 -94.68 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 128.864 2.866 . . . . 15.0 107.165 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 50.3 mtt -126.19 93.13 44.15 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.594 0.758 . . . . 15.0 111.19 167.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' A' ' 47' ' ' LEU . 83.2 Cg_endo -67.0 -17.94 51.57 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.544 2.829 . . . . 15.0 115.809 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -0.3 87.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.014 2.526 . . . . 15.0 117.656 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 56.12 20.15 4.24 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 117.809 2.522 . . . . 15.0 117.809 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.11 86.9 2.26 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.493 1.139 . . . . 15.0 113.316 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 pm0 -115.34 154.83 28.44 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.438 -1.256 . . . . 15.0 112.309 171.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.47 118.41 4.37 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 114.578 -1.192 . . . . 15.0 111.114 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.4 p -122.65 127.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 122.193 0.997 . . . . 15.0 111.687 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.453 ' HB3' ' HG2' ' A' ' 82' ' ' MET . 0.3 OUTLIER -116.54 140.79 48.99 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.114 -1.403 . . . . 15.0 112.035 174.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.21 111.14 16.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.185 -1.825 . . . . 15.0 109.011 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -124.65 134.74 52.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.146 0.975 . . . . 15.0 112.621 175.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.12 123.16 46.09 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.836 -1.529 . . . . 15.0 110.79 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HE3' ' HB3' ' A' ' 74' ' ' ASP . 1.8 ttpm? -84.18 129.15 34.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 113.301 -1.772 . . . . 15.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.675 ' O ' ' HB3' ' A' ' 76' ' ' TYR . 41.7 tp -108.95 114.58 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.505 -2.134 . . . . 15.0 107.691 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 76' ' ' TYR . . . 127.94 -147.38 17.24 Favored Glycine 0 CA--C 1.541 1.692 0 O-C-N 126.346 2.279 . . . . 15.0 113.941 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 43.3 t80 160.81 -60.5 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 CA-C-O 116.546 -1.692 . . . . 15.0 112.821 -160.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -79.15 -147.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.447 2.764 . . . . 15.0 112.788 -167.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 53.98 84.76 0.06 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.291 1.836 . . . . 15.0 110.053 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp 69.36 -26.13 0.15 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.245 1.418 . . . . 15.0 114.54 -165.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.83 64.22 0.19 Allowed Glycine 0 N--CA 1.483 1.786 0 C-N-CA 124.949 1.261 . . . . 15.0 114.312 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.89 37.77 3.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.038 1.335 . . . . 15.0 109.458 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -167.52 -63.95 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.386 1.074 . . . . 15.0 112.475 -172.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 114' ' ' TYR . 4.7 m-20 -56.62 -49.46 74.9 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.524 0.935 . . . . 15.0 113.524 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER 141.82 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 130.372 3.469 . . . . 15.0 107.385 177.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.528 ' HB3' ' HE3' ' A' ' 62' ' ' LYS . 7.7 m-20 -113.34 105.35 13.29 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.924 -0.485 . . . . 15.0 110.307 -174.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.616 ' HB ' HG12 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -119.85 111.0 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.656 -1.239 . . . . 15.0 107.656 176.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.675 ' HB3' ' O ' ' A' ' 63' ' ' LEU 0.437 0.2 OUTLIER -169.01 -171.74 1.4 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 111.384 -2.644 . . . . 15.0 114.773 -177.474 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.9 t -108.12 139.48 42.71 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.223 1.011 . . . . 15.0 110.585 -172.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HG3' ' HB3' ' A' ' 109' ' ' ALA . 9.8 ptp180 -118.95 139.69 51.25 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.033 -1.894 . . . . 15.0 114.147 -170.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 108' ' ' PHE . 2.7 pp -125.19 143.48 50.92 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 112.07 -2.332 . . . . 15.0 111.015 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.42 -154.45 11.75 Favored Glycine 0 N--CA 1.475 1.276 0 O-C-N 124.33 1.019 . . . . 15.0 114.671 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -139.12 151.52 21.83 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 113.567 -1.316 . . . . 15.0 114.059 -173.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.453 ' HG2' ' HB3' ' A' ' 58' ' ' GLN . 90.1 mtp -116.54 115.41 25.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.588 1.555 . . . . 15.0 110.361 176.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.7 t -119.18 132.59 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 114.943 -1.026 . . . . 15.0 108.905 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -120.56 140.98 50.71 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.79 -1.095 . . . . 15.0 110.041 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.85 85.8 0.96 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 122.694 1.235 . . . . 15.0 112.75 173.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.43 83.72 3.85 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.557 -1.656 . . . . 15.0 112.167 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.4 -24.76 62.99 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 116.317 1.969 . . . . 15.0 116.317 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.4 t -89.93 142.19 27.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.623 0.972 . . . . 15.0 113.623 -171.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -172.55 155.79 3.47 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.813 1.645 . . . . 15.0 110.482 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -139.01 148.77 43.86 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.802 0.841 . . . . 15.0 111.756 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -114.01 128.01 56.2 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.92 0.762 . . . . 15.0 110.064 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -126.13 157.2 38.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.636 -1.62 . . . . 15.0 107.97 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.24 68.75 0.35 Allowed Glycine 0 N--CA 1.482 1.742 0 C-N-CA 125.032 1.301 . . . . 15.0 113.171 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -115.8 92.93 4.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.532 -1.334 . . . . 15.0 109.393 -171.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.8 44.75 0.29 Allowed Glycine 0 N--CA 1.485 1.913 0 C-N-CA 124.821 1.201 . . . . 15.0 114.763 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -170.66 35.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.835 2.054 . . . . 15.0 113.286 -173.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.9 tp -117.56 129.8 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 116.007 -0.542 . . . . 15.0 111.131 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.8 t -171.61 167.85 6.46 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.288 1.435 . . . . 15.0 110.304 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 53.13 88.48 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.913 2.085 . . . . 15.0 116.089 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.78 129.59 51.29 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 113.693 -1.594 . . . . 15.0 110.106 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -166.56 146.94 6.02 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.444 1.098 . . . . 15.0 112.191 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.1 140.21 54.8 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.221 0.95 . . . . 15.0 111.894 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.4 p -74.52 138.18 42.97 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.106 -0.952 . . . . 15.0 113.057 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -59.4 -32.07 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 15.0 113.263 167.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 46.81 84.62 0.19 Allowed Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 127.265 2.226 . . . . 15.0 112.595 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -63.33 133.87 42.44 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.685 2.257 . . . . 15.0 112.747 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.33 138.02 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.422 -1.717 . . . . 15.0 109.695 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -122.88 129.86 52.15 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 114.636 -1.165 . . . . 15.0 111.817 175.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.565 ' HB3' ' HG3' ' A' ' 78' ' ' ARG . . . -133.7 147.32 51.36 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.281 -1.327 . . . . 15.0 111.149 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.72 138.64 10.75 Favored Glycine 0 N--CA 1.48 1.619 0 CA-C-O 119.011 -0.883 . . . . 15.0 111.221 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.14 -158.08 25.42 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 118.208 2.043 . . . . 15.0 118.208 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' HB ' ' A' ' 75' ' ' ILE . 33.0 m -120.67 130.66 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 111.911 -2.144 . . . . 15.0 111.556 -171.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.87 125.4 48.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.789 -1.096 . . . . 15.0 111.184 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 72' ' ' ASP . 60.0 t80 -108.48 139.19 43.57 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 111.9 -2.409 . . . . 15.0 108.633 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 8' ' ' TYR . 11.8 p -129.11 145.61 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 113.908 -1.496 . . . . 15.0 107.833 168.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 124' ' ' ILE . 0.3 OUTLIER -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 124.483 1.114 . . . . 15.0 113.152 -177.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -80.64 -89.14 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 112.465 -2.152 . . . . 15.0 109.364 175.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 108.98 8.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.222 0.609 . . . . 15.0 109.81 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -167.71 164.55 14.4 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.568 -1.197 . . . . 15.0 111.37 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 26.1 mt -53.08 131.49 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 125.511 1.524 . . . . 15.0 109.95 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 17.6 m 55.83 79.84 0.32 Allowed Pre-proline 0 N--CA 1.483 1.195 0 C-N-CA 125.58 1.552 . . . . 15.0 109.68 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.46 80.36 1.09 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.633 2.888 . . . . 15.0 113.891 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.69 ' O ' ' HA ' ' A' ' 148' ' ' TYR . 14.2 pt-20 -162.36 22.33 0.1 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.802 1.779 . . . . 15.0 115.802 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.524 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 20.4 mt -116.7 108.15 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.92 -0.487 . . . . 15.0 110.542 -169.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -110.68 143.13 41.62 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.024 -0.989 . . . . 15.0 111.031 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.8 m -139.63 116.93 11.24 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.762 -1.108 . . . . 15.0 110.254 -173.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.24 137.61 52.08 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.832 -1.076 . . . . 15.0 112.78 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.34 120.02 16.17 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.774 -1.103 . . . . 15.0 112.089 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -137.29 142.33 41.93 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 112.547 -2.115 . . . . 15.0 112.879 -174.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 79.2 m-85 -97.43 112.57 24.35 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.218 -1.355 . . . . 15.0 110.053 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -108.04 130.86 55.05 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.887 1.367 . . . . 15.0 113.695 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.429 ' HZ3' ' HB3' ' A' ' 130' ' ' TYR . 1.3 m-90 -120.51 120.37 35.65 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.492 -1.685 . . . . 15.0 112.289 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 139' ' ' ASN . 60.3 p -81.99 -36.82 27.46 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 113.594 -1.639 . . . . 15.0 111.372 164.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 63.4 t30 58.18 96.64 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.529 1.932 . . . . 15.0 110.534 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 85.74 162.81 0.09 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.878 2.471 . . . . 15.0 111.673 -167.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 61.36 -169.17 0.17 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.37 1.868 . . . . 15.0 113.055 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.8 t -60.86 157.33 15.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.781 0.832 . . . . 15.0 112.233 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 69.54 -53.91 0.6 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.004 2.122 . . . . 15.0 114.04 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.442 ' HA ' ' OG1' ' A' ' 133' ' ' THR . 66.1 t30 52.09 -132.69 1.91 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.562 1.545 . . . . 15.0 111.902 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -76.23 95.77 1.08 Allowed Glycine 0 N--CA 1.478 1.436 0 C-N-CA 125.17 1.366 . . . . 15.0 112.042 171.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 9.6 ttt -126.15 148.18 49.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.919 0.888 . . . . 15.0 111.904 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 6.4 tt -88.38 126.75 35.36 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.192 -1.41 . . . . 15.0 107.192 174.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.2 t -120.4 125.35 47.74 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.774 0.797 . . . . 15.0 111.163 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 38.1 tp -121.19 126.87 50.74 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.705 -1.589 . . . . 15.0 109.332 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.38 138.17 10.33 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-N 114.482 -1.235 . . . . 15.0 112.813 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.1 m -125.55 127.61 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 113.91 -1.145 . . . . 15.0 110.651 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.409 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 14.5 p -134.6 155.81 49.81 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.742 1.386 . . . . 15.0 114.742 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.69 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 12.1 m-85 -114.1 139.32 49.4 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 113.228 -1.806 . . . . 15.0 111.24 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -70.25 157.41 37.73 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.53 -0.759 . . . . 15.0 112.198 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -51.8 144.64 10.91 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.003 . . . . 15.0 111.565 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.27 105.05 0.42 Allowed Glycine 0 N--CA 1.477 1.401 0 C-N-CA 125.762 1.649 . . . . 15.0 114.067 -173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -63.57 130.6 45.02 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 114.201 -1.0 . . . . 15.0 111.788 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -63.72 157.64 41.57 Favored Glycine 0 N--CA 1.478 1.472 0 CA-C-N 113.664 -1.607 . . . . 15.0 113.073 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -55.19 134.23 49.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.739 1.215 . . . . 15.0 111.422 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -107.95 145.44 33.83 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.313 -1.312 . . . . 15.0 110.866 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 CA-C-O 117.021 -1.466 . . . . 15.0 113.809 -179.2 . . . . . . . . 0 0 . 1 stop_ save_